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Preface 
The Healthy People 2010 Final Review presents a quantitative end-of-decade assessment of 
progress in achieving the Healthy People 2010 objectives and goals over the course of the 
decade. This report was compiled by the National Center for Health Statistics, Centers for 
Disease Control and Prevention (CDC), with considerable input from the Department of 
Health and Human Service’s lead agencies for the Healthy People initiative.  The Healthy 
People Federal Interagency Workgroup and the Office of Disease Prevention and Health 
Promotion served in a review capacity. 
The Healthy People 2010 Final Review continues the series of profiles of the Nation’s health 
objectives as an integral part of the Department’s disease prevention and health promotion 
initiative for the decade that began in 2000.  This initiative was unveiled in January 2000 by 
the Secretary of the Department of Health and Human Services with the release of Healthy 
People 2010:  Understanding and Improving Health and Objectives for Improving Health. 
This report presents a summary of progress toward achieving the Healthy People 2010 
goals of: 
1) Increasing quality and years of healthy life, and  
2) Eliminating health disparities. 
This publication provides the final tracking data used to present a quantitative assessment 
of progress for the 969 objectives in the 28 Healthy People 2010 Focus Areas. A summary of 
progress for the Healthy People 2010 Leading Health Indicators also is presented. This 
publication incorporates the modifications to objectives from the 2005 Healthy People 2010 
Midcourse Review, includes information about the status of each 2010 objective over the 
course of the decade, and a crosswalk that illustrates how Healthy People 2010 objectives 
were transitioned to Healthy People 2020. 
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Healthy People 2010 Final Review: 
Executive Summary 
Introduction 
History of the Healthy People Initiative 
In setting forth a vision for realizing improved health for all Americans, Healthy People 
2010, released in November 2000, identified a set of 10-year health goals and objectives to 
be achieved during the first decade of the 21st century. Its two overarching goals—to 
increase quality and years of healthy life and to eliminate health disparities—were 
supported by specific objectives in 28 Focus Areas. In this way, Healthy People 2010 built 
on initiatives that had been pursued over the previous few decades, beginning with the 
publication in 1979 of Healthy People: The Surgeon General's Report on Health Promotion 
and Disease Prevention [1]. That report led to the initiation of this decade-long, 
management-by-objective process with the publication in 1980 of Promoting 
Health/Preventing Disease: Objectives for the Nation [2]. This 1980 initiative was followed in 
turn by the publication in 1990 of Healthy People 2000: National Health Promotion and 
Disease Prevention Objectives [3]. Now, Healthy People 2020 will continue these efforts 
through the second decade of the 21st century. Appendix E provides a summary of the 
evolution of Healthy People over the past four decades. 
 
Healthy People 2010 
Through Healthy People 2010, the U.S. Department of Health and Human Services (HHS) set 
out objectives that called for improvements in health status, risk reduction, public and 
professional awareness of prevention, delivery of health services, protective measures, 
surveillance, and evaluation, all expressed in specific metrics that allowed the measurement 
of progress over time toward targets that were to be achieved by the year 2010. Like its 
predecessors, Healthy People 2010 was developed through a broad collaborative process 
that drew on the best scientific knowledge available. 
Full achievement of the goals and objectives of Healthy People 2010 was predicated on a 
health system accessible to all Americans that would integrate personal health care and 
population-based public health activities. The concept of “healthy people in healthy 
communities,” which is the foundation of the initiative, necessitates monitoring and 
tracking of data on broad-based prevention efforts beyond services provided within 
physicians' offices, clinics, and hospitals. The concept expands the traditional disease-
centered medical care system to recognize the impact of health promotion and disease 
prevention efforts based in schools, neighborhoods, workplaces, and families in which 
people live their daily lives. These are the environments in which a large proportion of 
preventive action takes place. 
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The 28 Focus Areas of Healthy People 2010 were developed by Federal agencies that had 
the most relevant scientific expertise in each subject area. The development process drew 
on the collective expertise of the Healthy People Consortium—an alliance which, at the 
time, encompassed more than 350 national membership organizations and 250 State 
health, mental health, substance abuse, and environmental agencies. In addition, through a 
series of regional and national meetings, more than 11,000 public comments on the draft 
objectives were collected and considered. The Secretary's Council on National Health 
Promotion and Disease Prevention Objectives for 2010 also provided leadership and advice 
in the development and implementation of these national health objectives. More 
information is available from www.healthypeople.gov/2010/data/midcourse/. 
 
Healthy People 2010 Midcourse Review 
Midway through the decade, staff of HHS and other Federal agencies together with experts 
from across the Nation assessed the status of the national objectives as they had developed 
over the first half of the decade. This Midcourse Review process involved an examination of 
trends in data that had become available by January 1, 2005, and it took into account any 
pertinent new science. The review resulted in changes to some objectives that were made to 
ensure that Healthy People 2010 remained current and accurate and kept abreast of 
emerging public health priorities. HHS solicited and considered public comments on these 
midcourse changes to the Healthy People 2010 objectives. The results of this midcourse 
assessment were published in the Healthy People 2010 Midcourse Review [4]. 
 
Changes to Healthy People 2010 Objectives at the Midcourse Review 
Midcourse changes to Healthy People 2010 objectives encompassed the following: 
rewordings of objectives; deletion of 66 objectives; additions of new objectives; revisions to 
baselines and targets; and establishment of baselines and targets for objectives that moved 
from “developmental” to “measurable,” as explained in the next paragraph. Changes were 
made to reflect the most current science, to reflect the data more accurately, or to provide a 
more logical or understandable presentation. 
To be included in Healthy People 2010, an objective must have a national data source that 
provides a baseline and at least one additional data point for tracking progress. Some 
objectives lacked baseline data at the time of their development but had a potential data 
source and were considered of sufficient national importance to be included in Healthy 
People. These are called developmental objectives; they provide a vision for a desired 
outcome or health status. Developmental objectives with no prospect of having a national 
(baseline) data source were deleted as part of the Midcourse Review. (At the Final Review, 
53 developmental objectives that were retained at the Midcourse Review still did not have 
baseline data.) 
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Measuring Healthy People 2010 Progress throughout the Decade 
Progress Reviews 
In addition to the Midcourse Review, progress reviews on the individual Focus Areas were 
conducted, one each month, until the full cycle of 28 had been completed. Two cycles of 
these reviews were held during the decade. The progress reviews were formal meetings, 
chaired by the Assistant Secretary for Health, at which the National Center for Health 
Statistics (NCHS) within the Centers for Disease Control and Prevention, HHS provided data 
updates for the Focus Area under review; Federal lead agencies for the Focus Area reported 
on progress toward achieving Focus Area objectives and initiatives to help in accomplishing 
that purpose. More information is available from 
www.healthypeople.gov/2010/data/PROGRVW/. 
 
DATA2010 
A critical part of Healthy People 2010 is measuring progress toward the targets for the year 
2010. The compilation and management of current health data sources are central to 
assessing and implementing Healthy People 2010 goals and objectives. The data that 
provide the basis for the Midcourse Review and the Healthy People 2010 final review are 
available on DATA2010, developed by the Health Promotion Statistics Branch at NCHS. This 
is an interactive database system that compiles the monitoring data for tracking all the 
measurable objectives. These are primarily national data; selected state-based data are 
provided when available. Additional information is available from 
wonder.cdc.gov/data2010. 
 
Healthy People 2010 Final Review 
The Healthy People 2010 Final Review presents a quantitative summary assessment of 
progress in achieving the Healthy People 2010 objectives over the course of the decade. 
This publication, which incorporates the 2005 Midcourse Review modifications to the 
objectives, provides the most recent data available for the objectives in each of the 28 Focus 
Areas. A Progress Chart included in each chapter provides a summary display of the 
progress of each objective for which there were at least two data points available during the 
decade. Also in each chapter, a Health Disparities Table provides a summary of disparities 
by race and ethnicity, sex, education level, income, geographic location, and disability status 
whenever data were available for each objective. Finally, the report includes a summary of 
progress for the Healthy People 2010 Leading Health Indicators as well as a summary of 
progress toward achieving the Healthy People 2010 goals of: 1) increasing quality and years 
of healthy life, and 2) eliminating health disparities. 
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Initiatives Related to Healthy People 
Other Departmental Priorities and Healthy People 
As the latest iteration of a long-running initiative, Healthy People 2020 follows the lead of 
Healthy People 2010 in supporting a wide range of HHS initiatives. Healthy People 2020 
aligns with and plays a foundational and/or mutually supportive role with several other 
major HHS undertakings, including the following: 
 The National Prevention and Health Promotion Strategy (NPS) was mandated by 
the March 23, 2010, Patient Protection and Affordable Care Act. The NPS aims to 
identify and prioritize national actions to reduce the incidence and burden of the 
leading causes of death and disability. The NPS aims to move the nation toward a 
system of health care that features prevention as the cornerstone of care, by 
concentrating on the underlying drivers of chronic disease. The NPS will promote 
actions aimed at prevention and healthy development and behavior throughout the 
stages of life, all of which will be directed toward its primary goal of achieving 
significant gains in Americans’ life expectancy at birth and age 65. The NPS targets 
reflect those of Healthy People 2020. 
 First Lady Michelle Obama’s Let’s Move! Campaign, begun in 2010, focuses on 
one ambitious goal: to halt and reverse the epidemic of childhood obesity within one 
generation, so that children today reach adulthood at a healthy weight. Over the past 
three decades, childhood obesity rates in America have tripled, and today, nearly 
one in three children in America are overweight or obese. The Let’s Move! initiative 
focuses on the reform of behavioral factors and environmental factors by promoting 
active lifestyles and healthy eating through community involvement by way of 
schools, parents, healthcare providers, and other agents of change. Implementation 
strategies are now in development for Healthy People 2020 objectives that relate to 
this initiative and support the Let’s Move! goal. 
 In July 2010, the White House released the National HIV/AIDS Strategy, the 
Nation’s first-ever comprehensive, coordinated HIV/AIDS roadmap with clear and 
measurable targets to be achieved by 2015. Since 1980, more than 575,000 
Americans have lost their lives to AIDS and, currently, more than 1.1 million 
Americans are living with HIV. Among the 2015 goals of the National Strategy are to: 
lower the annual number of new infections by 25 percent and to increase from 79 to 
90 percent the proportion of people living with HIV who know their serostatus. The 
objectives encompassed by the Healthy People 2020 HIV Topic Area are consonant 
with and supportive of these and other goals of the National HIV/AIDS Strategy. 
 Inaugurated in 2010 and updated yearly, the National Drug Control Strategy has 
set policy priorities of reducing prescription drug abuse and drugged driving and of 
promoting activities to prevent such abuse from occurring. Implementation of the 
National Strategy is centered in the White House Office of National Drug Control 
Policy and engages the energies of several other Federal agencies, as well, including 
the HHS Substance Abuse and Mental Health Services Administration (SAMHSA). 
SAMHSA is lead agency for the Healthy People 2020 Topic Area on Substance Abuse, 
which embraces a number of objectives that are directly supportive of the National 
Strategy. While the Strategy is primarily a blueprint for the Federal Government, it 
is also proving useful in guiding State and local decisions. 
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 The President’s Food Safety Working Group was created in 2009 to advise the 
President on how to upgrade the U.S. food safety system. Chaired jointly by the HHS 
Secretary and Secretary of Agriculture, the Working Group recommended a public 
health-focused approach to food safety based on three core principles: prioritizing 
prevention, strengthening surveillance and enforcement, and improving response 
and recovery. Taken together, the objectives of the Food Safety Topic Area of 
Healthy People 2020 all serve to advance these principles. 
 The HHS Action Plan to Reduce Racial and Ethnic Health Disparities outlines 
goals and actions HHS will take to reduce health disparities among racial and ethnic 
minorities. With the HHS Disparities Action Plan, the Department commits to 
continuously assessing the impact of all policies and programs on racial and ethnic 
health disparities. It will promote integrated approaches, evidence-based programs 
and best practices to reduce these disparities. The HHS Action Plan builds on the 
strong foundation of the Affordable Care Act and is aligned with programs and 
initiatives such as the First Lady's Let's Move initiative, the President's National 
HIV/AIDS Strategy, and Healthy People 2020. 
 In November 2010, HHS presented its new Tobacco Control Strategic Action Plan, 
which seeks to help smokers quit and stop others from starting to use tobacco. One 
high profile piece of the plan will result in bolder health warnings that must cover 
the upper half of the front and back of cigarette packages and at least 20 percent of 
tobacco product advertisements beginning in 2012. In June 2009, the Family 
Smoking Prevention and Tobacco Control Act had granted the Food and Drug 
Administration (FDA) the authority to regulate tobacco products. Under the law, the 
FDA now has sweeping new authorities related to the manufacture, marketing, and 
sale of tobacco products—authorities covered by a more expansive public health 
standard than had traditionally been granted to the agency. The objectives of the 
Healthy People 2020 Topic Area on Tobacco Use provide the data that underpin the 
Plan and give it direction toward the outcomes we hope to achieve by the end of the 
decade. 
 In February 2010, the U.S. announced a new Global Health Initiative (GHI), which 
invests $63 billion over 6 years to help partner countries improve health outcomes 
through strengthened health systems and integrated services, with a particular 
focus on improving the health of women, newborns, and children. Other topics of 
particular concern in developing countries include HIV/AIDS, malaria, tuberculosis, 
family planning and reproductive health, nutrition, safety of water supplies, and 
neglected tropical diseases. The GHI has set a number of targets for accomplishment 
in assisted countries, for example: reduction of maternal mortality by 30 percent, 
reduction of under-five mortality rates by 35 percent, reduction of child under-
nutrition by 30 percent, and prevention of 54 million unintended pregnancies. 
Healthy People 2020 has a Topic Area on Global Health, new in this decade. 
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Guide to Clinical Preventive Services 
The Guide to Clinical Preventive Services includes U.S. Preventive Services Task Force 
(USPSTF) recommendations on screening, counseling, and preventive medication topics, as 
well as clinical considerations for each topic. Sponsored since 1998 by the Agency for 
Healthcare Research and Quality (AHRQ), the USPSTF is an independent panel of experts in 
primary care and prevention that systematically reviews the evidence of effectiveness and 
develops recommendations for clinical preventive services. The task force rigorously 
evaluates clinical research to assess the merits of preventive measures. In the 2010–11 
edition of the Guide, the recommended preventive services for adults are in the clinical 
categories of: cancer; heart, vascular, and respiratory diseases; infectious diseases; injury 
and violence; mental health conditions and substance abuse; metabolic, nutritional, and 
endocrine conditions; musculoskeletal conditions; obstetrics and gynecologic conditions; 
and vision disorders. Recommendations for children and adolescents are given in a separate 
section. More information is available from www.ahrq.gov/clinic/cps3dix.htm. 
 
Guide to Community Preventive Services 
The Guide to Community Preventive Services serves as a filter for scientific literature on 
specific health problems that can have a large-scale impact on groups of people who share a 
common community setting. This guide summarizes what is known about the effectiveness, 
economic efficiency, and feasibility of interventions to promote community health and 
prevent disease. The Task Force on Community Preventive Services, an independent 
decision-making body convened by HHS, makes recommendations for the use of various 
interventions based on the evidence gathered in rigorous and systematic scientific reviews 
of published studies conducted by review teams for the guide. The findings from the 
reviews are published in peer-reviewed journals and also are made available online. Over 
the last decade or so, the task force has published hundreds of findings across the following 
topic areas: adolescent health; alcohol; asthma; birth defects; cancer; diabetes; health 
communication; HIV/AIDS, other STIs and pregnancy; mental health; motor vehicle 
occupant injury; nutrition; obesity; oral health; physical activity; social environment; 
tobacco use; vaccines; violence; and worksites. Additional information is available from 
www.thecommunityguide.org. 
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Healthy People 2010 Final Review: 
Executive Summary 
Summary of Progress 
Healthy People Objectives 
For the end-of-decade assessment of the Healthy People 2010 objectives, the status of 969 
specific objectives in 28 subject Focus Areas was assessed. Progress was assessed for 
objectives using the most recent tracking data available—that is, baseline data and at least 
one additional data point. For some objectives, although more recent data may have been 
available, the final Healthy People 2010 data year was selected to be consistent with the 
baseline year used for the new Healthy People 2020 objectives [5]. 
The status of the 969 objectives is shown on the left-hand side of Figure ES-1. Based on an 
evaluation of each objective and comments received from the public as part of the 
Midcourse Review process, 66 objectives were dropped because data were unavailable or 
because of a change in the science [6]. Tracking data were unavailable to assess progress for 
170 objectives (17.5% of the total), 53 of which lacked baseline data. 
Progress can be assessed for 733 objectives with tracking data available, as can be seen in 
the right-hand side panel of Figure ES-1. 
 170 objectives (23%) met the Healthy People 2010 targets. 
 349 objectives (48%) moved toward the Healthy People 2010 targets. 
 39 objectives (5%) demonstrated no change from the baseline. 
 175 objectives (24%) moved away from the Healthy People 2010 targets. 
In Figure ES-2 and Table ES-1, similar assessments are shown for each of the 28 Focus 
Areas. In all Focus Areas there were some objectives that moved toward, met, or exceeded 
their 2010 targets. For eight Focus Areas, Educational and Community-Based Programs 
(Focus Area 7), Environmental Health (Focus Area 8), Health Communication (Focus Area 
11), Heart Disease and Stroke (Focus Area 12), Immunization and Infectious Diseases 
(Focus Area 14), Mental Health and Mental Disorders (Focus Area 18), Occupational Safety 
and Health (Focus Area 20), and Tobacco Use (Focus Area 27) more than 75% of the 
objectives moved toward or achieved their targets. The proportion of objectives that could 
not be assessed was more than 30% for Access to Quality Health Services (Focus Area 1), 
Disability and Secondary Conditions (Focus Area 6), Educational and Community-based 
Programs (Focus Area 7), Environmental Health (Focus Area 8), and Mental Health and 
Mental Disorders (Focus Area 18). Two Focus Areas, Arthritis, Osteoporosis, and Chronic 
Back Conditions (Focus Area 2) and Nutrition and Overweight (Focus Area 19), moved 
toward or achieved less than 25% of their targets. 
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Figure ES-1. Healthy People 2010 Objectives: Status at the Final Review and 
Summary of Progress toward Target Attainment 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ES-2. Healthy People 2010 Objectives: Status at the Final Review by Focus 
Area 
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Table ES-1. Healthy People 2010 Objectives: Summary of Progress by Focus Area 
  Focus area 
Met or 
exceeded 
target 
Moved 
toward 
target 
Demonstrated 
no change 
Moved 
away 
from 
target Developmental 
No 
tracking 
data 
beyond 
baseline 
Dropped at 
Midcourse Total 
1. Access to quality health services 11 24 6 7 1 20 2 71 
2. Arthritis, osteoporosis, and chronic back conditions 1 2 3 7 0 0 0 13 
3. Cancer 2 11 1 4 0 7 0 25 
4. Chronic kidney disease 3 3 0 3 0 0 0 9 
5. Diabetes 5 5 2 2 0 1 2 17 
6. Disability and secondary conditions 2 7 1 3 4 7 0 24 
7. Educational and community-based programs 1 12 2 2 2 22 15 56 
8. Environmental health 21 30 2 8 9 18 5 93 
9. Family planning 8 9 2 13 6 1 0 39 
10. Food safety 5 11 0 6 1 0 15 38 
11. Health communication 5 9 0 2 0 2 0 18 
12. Heart disease and stroke 4 8 0 3 2 2 0 19 
13. HIV 4 7 0 4 6 0 4 25 
14. Immunization and infectious diseases 33 32 1 14 2 4 1 87 
15. Injury and violence prevention 8 24 2 9 0 3 0 46 
16. Maternal, child, and infant health 3 25 5 9 3 4 4 53 
17. Medical product safety 3 2 1 2 0 1 2 11 
18. Mental health and mental disorders 6 4 0 1 0 6 0 17 
19. Nutrition and overweight 0 2 3 15 0 1 1 22 
20. Occupational safety and health 14 5 0 3 0 0 0 22 
21. Oral health 4 13 0 7 0 2 0 26 
22. Physical activity and fitness 0 12 1 4 0 1 0 18 
23. Public health infrastructure 5 16 1 8 6 4 3 43 
24. Respiratory diseases 3 14 2 5 1 1 0 26 
25. Sexually transmitted diseases 2 8 0 6 1 1 7 25 
26. Substance abuse 4 20 3 11 5 2 3 48 
27. Tobacco use 6 28 0 6 4 3 2 49 
28. Vision and hearing 9 6 1 9 0 4 0 29 
  Total 172 349 39 173 53 117 66 969 
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Population Groups 
In Figure ES-3, progress is assessed for specific population groups. This assessment is 
limited to population-based objectives with tracking data for population groups. It does not 
include non-population-based objectives such as those based on States, worksites, or those 
monitored by the number of events. The number of objectives with tracking data varied 
according to the characteristic and, therefore, the bar’s length in the figure below varies for 
each population group. For Healthy People 2010, most population-based objectives were 
monitored by race and ethnicity, but the availability of data for specific race and ethnic 
populations varied. Comparisons by sex were not applicable to all population-based 
objectives because some applied only to females or males. Geographic location and 
disability status were optional characteristics included for monitoring selected objectives. 
When possible, population-based objectives were also monitored either by education level 
or by income, as a measure of socio-economic status. Most data systems used in Healthy 
People 2010 define income as a family’s income before taxes. In order to facilitate 
comparisons among groups and over time, while adjusting for family size and for inflation, 
Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. 
Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. 
These categories may be overridden by considerations specific to the data system, in which 
case they are modified as appropriate. 
In general, data on educational attainment are presented for persons aged 25 years and 
over, consistent with guidance given by the U.S. Census Bureau. However, because of the 
requirements of the different data systems, the age groups used to calculate educational 
attainment for any specific objective may differ from the age groups used to report the data 
for other Healthy People 2010 objectives, as well as from select populations within the 
same objective. The three categories of education level that are primarily used are: 
 Less than high school 
 High school graduate 
 At least some college education. 
Further information regarding population groups can be found in Healthy People 2010: 
General Data Issues, available from: http://www.cdc.gov/nchs/healthy_people.htm. 
For each select population group, the number of objectives is shown for each of the 
following: moved away from the target, demonstrated no change, moved toward the target, 
and met or exceeded the target. Because a single target was set for all population groups, 
there were some instances where certain population groups had met the Healthy People 
2010 target at baseline while other groups had not met the target. 
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In general, for each select population group, the number of objectives that moved toward or 
met the target exceeded the number that moved away from the target. For the American 
Indian or Alaska Native population, for example, 81 objectives moved toward or exceeded 
their respective targets while 59 moved away and 11 showed no change between the 
baseline and the final time points (Table ES-2). For the Native Hawaiian and Other Pacific 
Islander population, more objectives moved away from the target (26 objectives) than 
moved toward or met the target (21 objectives). 
Figure ES-3. Summary of Progress for Objectives with Tracking Data for Each 
Population Group 
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Table ES-2. Healthy People 2010 Objectives: Summary of Progress for Population 
Groups 
Characteristics and Groups 
Moved 
away from 
target 
Demonstrated 
no change 
Moved 
toward 
target 
Met or 
exceeded 
target 
Total 
Race and Ethnicity           
   American Indian or Alaska Native 59 11 63 18 151 
   Asian or Pacific Islander 21 3 11 18 53 
   Asian  37 16 46 28 127 
   Native Hawaiian or Other Pacific Islander 26 5 16 5 52 
   Two or more races 29 12 37 14 92 
   Hispanic 91 19 143 38 291 
   Black non-Hispanic
1
 88 31 183 62 364 
   White non-Hispanic
1
 112 33 155 90 390 
Sex           
   Female 96 15 151 67 329 
   Male 86 14 169 55 324 
Education           
   Less than high school 37 6 55 8 106 
   High school graduate 40 7 50 14 111 
   At least some college 25 5 45 38 113 
Income           
   Poor 34 4 47 14 99 
   Near poor  37 9 33 16 95 
   Middle/high income 28 11 31 31 101 
Geographic location           
   Urban/metropolitan 13 1 25 5 44 
   Rural/nonmetropolitan 16 4 18 8 46 
Disability status           
   Persons with disabilities 28 8 38 11 85 
   Persons without disabilities 27 12 39 12 90 
1
 For some objectives, data include persons of Hispanic origin. 
 
 
The progress for each objective with data beyond the baseline is shown in the Progress 
Chart in Focus Area chapters of this report. Health disparities between population groups 
and changes in disparities between the baseline and the most recent time point are 
examined in the section discussing Goal 2, the elimination of disparities among populations; 
they also are summarized in the Health Disparities Table in Focus Area chapters. 
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Healthy People 2010 Final Review: 
Executive Summary 
Goal 1: Increase Quality and Years of Healthy Life 
Healthy People 2010: Understanding and Improving Health highlighted the importance of 
maximizing and increasing both years of life and quality of life in the first overarching goal 
[6]. Progress toward achieving this goal is currently assessed by measuring life expectancy 
and three measures of healthy life expectancies: 1) Expected years in good or better health; 
2) Expected years free of activity limitations; and 3) Expected years free of selected chronic 
diseases. These assessments result in the following conclusions: 
 Life expectancy improved for the populations that could be assessed throughout the 
decade. 
 Women had longer life expectancy than men, and the white population had a longer 
life expectancy than the black population. 
 Expected years in good or better health and expected years free of activity limitation 
increased, and expected years free of selected chronic conditions decreased. 
 Differences by race and sex were observed in all three healthy life expectancy 
measures—expected years in good or better health, expected years free of activity 
limitations, and expected years free of selected chronic diseases. 
 
Life Expectancy 
Life expectancy is the average number of years a hypothetical cohort of people born in a 
given year could be expected to live based on the age-specific death rates in that year. Since 
the launch of Healthy People 2010, life expectancy at birth and at age 65 has increased for 
all populations (Table ES-3 and Figure ES-4). In 2006–07, life expectancy for the total 
population was 77.8 years, an increase from 76.8 years in 2000–01. Improvements in 
overall life expectancy reflect improvements in disease-specific death rate objectives within 
the Healthy People 2010 Focus Areas. Death rates declined for many Healthy People 2010 
cause-specific mortality objectives including: female breast cancer (objective 3-3), 
colorectal cancer (objective 3-5), prostate cancer (objective 3-7), coronary heart disease 
(objective 12-1), stroke (objective 12-7), cardiovascular disease and diabetes-related 
deaths among persons with diabetes (objectives 5-6 and 5-7) and HIV (objective 13-14). 
Even with these improvements, in 2007 U.S. male life expectancy ranked 26th and female life 
expectancy ranked 25th out of 33 selected countries [7]. 
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Between 2000–01 and 2006–07, the percent increase in life expectancy was greater at age 
65 years (5.1%) than at birth (1.3%). Men (75.3 years) had a lower life expectancy at birth 
than women (80.3 years), and the black population (73.4 years) had a lower life expectancy 
at birth than the white population (78.3 years) in 2006–07. However, between 2000–01 and 
2006–07, the black population (2.1%) had a greater relative increase in life expectancy at 
birth than the white population (1.2%). Men (1.5%) also had a greater relative increase in 
life expectancy at birth than women (1.1%). 
Table ES-3. Life Expectancy, at Birth and at Age 65, in Years 
 
 Total  Black White  Women Men 
Life expectancy, 
at birth 
2000–01 76.8  71.9 77.4  79.4 74.2 
2002–03 77.0  72.2 77.5  79.5 74.4 
2004–05 77.4  72.8 77.9  79.9 74.9 
 
2006–07 77.8  73.4 78.3  80.3 75.3 
Life expectancy, 
at age 65 
2000–01 17.7  16.1 17.8  19.0 16.1 
2002–03 17.9  16.4 18.0  19.1 16.4 
2004–05 18.3  16.8 18.3  19.5 16.8 
 
2006–07 18.6  17.1 18.6  19.8 17.1 
 
Source: National Vital Statistics System (NVSS), NCHS, CDC 
 
Figure ES-4. Expected Years of Life, by Sex and Race, 2006-07 
 
 
 
 
 
 
 
 
 
Source: National Vital Statistics System (NVSS), NCHS, CDC. 
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Life expectancy for the periods 2000–01 to 2006–07 is not presented for racial and ethnic 
groups other than the white population and the black population due to data quality 
problems which prevented the production of reliable U.S. life tables for minority 
populations, including the Hispanic population, until 2006. Two issues affected the quality 
of data available for the Hispanic population: misclassification in reporting of race and 
ethnic origins on U.S. death certificates in comparison with the Census, surveys, and birth 
certificates; and misstatement of age at the oldest ages in both Census and vital statistics 
data. Recent research has shown that the classification of race and Hispanic origin on death 
certificates has improved and that a relatively minor adjustment is required to correct for 
the effects of the misclassification. In addition, the issue of age misstatement at the oldest 
ages can be addressed by recent research on Hispanic mortality patterns. Due to the 
improvement in data quality for the Hispanic population, complete period life tables for the 
total Hispanic population in 2006 became available in October 2010. However, additional 
data years for the Hispanic population are not yet available and therefore the Hispanic 
population is not addressed in this report [8]. 
Much of the recent gain in life expectancy is concentrated in the older population, the age 
group with the highest prevalence of functional limitations. As a result, measuring longevity 
is no longer sufficient to describe the health of a population. Preventing disabling 
conditions, improving function, relieving physical pain and emotional distress, and 
maximizing health across the life span have become important public health goals along 
with increasing life expectancy [9]. 
 
Measuring Quality and Years of Healthy Life 
Given the multidimensional nature of health, assessing quality and healthy life is a much 
more complex process than measuring life expectancy, and the field is evolving. Various 
measures are used nationally and internationally to measure healthy life. These measures 
fall into three general categories: 
 Self-assessments of overall health status by individuals or their proxies. 
 Composite measures that include multiple dimensions of health. Scores on the 
various dimensions are combined into a single measure using a predetermined 
algorithm (for example, SF-36, Healthy Days) [11,12]. 
 Measures that combine death rates and health (where the health indicator can be 
either of the types described above or an indicator of a single dimension of health). 
These measures use years as the metric to quantify healthy life (for example, 
healthy life expectancies, Years of Healthy Life). 
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Healthy People 2010: Understanding and Improving Health mentioned several possible 
measures of population health: “self-perceived” health status; healthy days; and the 
measure used in Healthy People 2000, Years of Healthy Life (YHL) [6,13]. In response to the 
need to measure Goal 1 of Healthy People 2010, at the beginning of the decade, NCHS 
convened a workshop to select measures that best capture the complexity of assessing 
years of healthy life within the context of Healthy People 2010 [14]. As a result of the 
workshop, three measures of healthy life expectancies that combine death rates with 
different measures of health were selected to track progress toward Goal 1 of Healthy 
People 2010. These healthy life expectancies represent the breadth of recommendations 
from the workshop. The three new measures are: 1) Expected years in good or better 
health; 2) Expected years free of activity limitation; and 3) Expected years free of selected 
chronic diseases. The current set of healthy life expectancies has evolved from the YHL 
measure, used to track the years and quality of life in Healthy People 2000. YHL combined 
information about death rates, self-rated health, and activity limitation into a single 
measure. The current set of healthy life expectancies separate the self-rated health 
component from the limitation of activities component to better track and understand 
change over time. For more detail on these measures, see the Technical Appendix. 
Data for these three healthy life expectancies were analyzed for the period 2000–01 
through 2006–07 for expected years in good or better health and expected years free of 
activity limitation and for the period 2002–03 through 2006–07 for expected years free of 
selected chronic diseases. Prevalence data on physician or health professional diagnosed 
arthritis were unavailable for the years 2000 and 2001; therefore, the expected years free of 
selected chronic diseases was not analyzed for those years as arthritis is one of the chronic 
conditions included in the measure. Results of the analysis are mixed with years in good or 
better health and years free of activity limitation showing an increase while years free of 
chronic conditions decreased during the decade. 
 
Description of Healthy Life Expectancies for Healthy People 2010 
The healthy life expectancies are calculated using a life-table technique. This technique 
combines information about average health states and death rates to produce age-specific 
estimates of expected years of healthy life (see Technical Appendix for details on the 
methodology). 
Expected years in good or better health is defined as the average number of years a 
person can expect to live in good or better health. This measure assesses healthy life using a 
single global assessment question which asks a person to rate his or her health as 
“excellent,” “very good,” “good,” “fair,” or “poor”. 
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Expected years free of activity limitation is defined as the average number of years a 
person can expect to live free from limitation in activities, the need for assistance in 
personal or routine care needs, or the need to use special equipment because of health 
problems. 
Expected years free of selected chronic diseases is defined as the average number of years 
a person can expect to live without being diagnosed by a physician or health professional as 
having one or more of the following selected conditions for which nationally representative 
data are available annually: arthritis, asthma, cancer, diabetes, heart disease, high blood 
pressure, kidney disease, or stroke. 
 
Healthy Life Expectancy at Birth 
Table ES-4 and Figure ES-5 present healthy life expectancies at birth for each of the three 
measures. Life expectancy is included in the figures for comparison purposes. Based on data 
from the years 2006–07, individuals in the U.S. could expect to live 69.0 years in good or 
better health, 66.2 years without activity limitation, and 43.1 years without selected chronic 
diseases. Expected years in good or better health increased by 0.5 years and expected years 
free of activity limitations increased 0.7 years between 2000–01 and 2006–07. Expected 
years free of selected chronic conditions declined by 0.6 years between 2002–03 and 2006–
07. 
Women can expect to spend a slightly greater proportion of their lives in fair or poor health, 
with activity limitations, and with chronic conditions than their male counterparts do. 
Based on data from years 2006–07, women could expect to live 80.3 years, of which 70.7 
years would be in good or better health and 67.8 would be free of activity limitations. 
Women could, therefore, expect to spend 12% of their lives in fair or poor health, 16% with 
activity limitation, and 46% with one or more selected chronic diseases. In the years 2006–
07, men could expect to spend 11% of their lives in fair or poor health, 14% with activity 
limitation, and 43% with one or more selected chronic diseases. 
Compared to the white population, the black population could expect to spend a greater 
proportion of life in an unhealthy status. Based on data from years 2006–07, the black 
population at birth could expect to spend 16% of life in fair or poor health, 18% of life with 
activity limitation, and 47% of life with one or more selected chronic diseases. 
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Table ES-4. Healthy Life Expectancies at Birth, in Years 
 
 
 Total  Black White  Women Men 
Expected Years in 
Good or Better Health 
2000–01 68.5  59.8 69.7  70.2 66.6 
 
2006–07 69.0  61.3 70.0  70.7 67.3 
         
Expected Years free of 
activity limitations 
2000–01 65.5  59.3 66.1  67.2 63.8 
 
2006–07 66.2  60.2 66.8  67.8 64.7 
         
Expected years free of 
selected chronic 
diseases 
2002–03 43.7  38.9 43.9  43.6 43.8 
 
2006–07 43.1  38.6 43.4  43.5 42.7 
 
Source: National Vital Statistics System (NVSS), NCHS, CDC 
 
 
 
Figure ES-5. Life Expectancy and Healthy Life Expectancies at Birth, 2006–07 
 
 
 
 
 
 
 
 
 
 
 
Source: National Health Interview Survey (NHIS), NCHS, CDC; National Vital Statistics System 
(NVSS), NCHS, CDC. 
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Healthy Life Expectancy at Age 65 Years 
Table ES-5 and Figure ES-6 present healthy life expectancies at age 65 years. Based on 
2006–07 data, individuals at age 65 years could expect to live an additional 13.7 years in 
good or better health, 11.8 years without activity limitation, and 2.7 years without one or 
more selected chronic diseases. Between the years 2000–01 and 2006–07, for those at age 
65 years, expected years in good or better health and expected years free of activity 
limitation increased. Between 2002–03 and 2006–07 expected years free of selected 
chronic diseases declined. 
Similar to the patterns at birth, women at age 65 years could expect to live a greater 
number of years in a healthy life state, but they would spend a greater proportion of their 
lives with activity limitation or in fair or poor health. Based on data from years 2006–07, 
older women could expect to spend 39% of their remaining lives with activity limitation. 
Men could expect to spend 33% of their remaining lives with activity limitation. 
It was expected that both older men and older women would spend a large proportion of 
their remaining lives with selected chronic diseases (86% for men; 86% for women). Older 
men and older women were expected to spend similar proportions of their remaining lives 
in fair or poor health (26% for men; 27% for women). 
Similar to the patterns found at birth, the older black population could expect to spend a 
greater proportion of remaining life in unhealthy states than the older white population. 
Based on data from the years 2006–07, the black population aged 65 years could expect to 
live 39% of remaining life in fair or poor health, 46% with activity limitation, and 91% with 
selected chronic diseases. Between 2000–01 and 2006–07, the older black population 
experienced a greater increase in expected years in good or better health than the older 
white population. There was no statistically significant difference in the expected years free 
of activity limitation or expected years free of selected chronic conditions between the older 
black and white populations. 
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Table ES-5. Healthy Life Expectancies at Age 65, in years 
 
  Total  Black White  Women Men 
Expected Years in Good 
or Better Health 
2000–01 12.9  9.2 13.3  13.9 11.7 
 
2006–07 13.7  10.5 13.9  14.5 12.6 
         
Expected Years free of 
activity limitations 
2000–01 11.1  8.6 11.3  11.5 10.6 
 
2006–07 11.8  9.3 12.0  12.1 11.5 
         
Expected Years free of 
selected chronic diseases 
2002–03 2.8  2.0 2.9  2.9 2.7 
 
2006–07 2.7  1.6 2.6  2.8 2.4 
 
 
Figure ES-6. Life Expectancy and Healthy Life Expectancies at Age 65, 2006–07 
 
 
 
 
 
 
 
 
 
 
 
 
Source: National Health Interview Survey (NHIS), NCHS, CDC; National Vital Statistics System 
(NVSS), NCHS, CDC. 
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Goal 2: Eliminate Health Disparities 
The second goal of Healthy People 2010 was to eliminate health disparities that occured by 
race and ethnicity, gender, education, income, geographic location, disability status, or 
sexual orientation. Findings for specific objectives and populations are presented in 27 of 
the 28 Focus Area chapters. None of the objectives in Public Health Infrastructure (Focus 
Area 23) called for population-based data. The findings concerning health disparities among 
population groups are summarized below. 
Substantial health disparities between populations were observed for many Healthy People 
2010 objectives. Both increases and decreases in health disparities also were observed for 
individual populations for specific objectives; however, most of the population-based 
objectives with data to measure disparities had no change in health disparities.  
 
For specific population characteristics: 
 Among 169 objectives with data for racial and ethnic groups, health disparities 
decreased for 27 objectives and increased for 25. 
 Among 216 objectives with data for males and females, health disparities decreased 
for 26 objectives and increased for 23. Females more often had better group rates. 
 Among 132 objectives with data for education groups, health disparities decreased 
for seven objectives and increased for 20. 
 Health disparities among income groups, as well as by geographic location and 
disability status did not change, with the exception of a few objectives. 
 
There were 469 population-based objectives for which health disparities among 
populations could be measured. Presented as the second figure in each Focus Area chapter, 
the Health Disparities Table provides detailed information about health disparities among 
populations for the objectives in that Focus Area. The Health Disparities Table provides 
information about the availability of data for each population, the size of health disparities 
relative to the population group with the best rate for each characteristic, and the 
magnitude of changes in these disparities between the Healthy People 2010 baseline and 
the most recent time point for each objective. Data were not available for all populations for 
each objective, and tracking data were not always available to assess changes in disparity 
from baseline. 
Data were unavailable by sexual orientation for any of the Healthy People 2010 objectives. 
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In this Final Review, health disparities are measured using the “best” or most favorable 
group rate as the reference point. “Best” is used to identify the population group with the 
most favorable rate among the groups associated with a particular characteristic. “Best” 
does not imply that no further improvement is called for. Health disparities by race and 
ethnicity, for example, are measured using the rate for the racial and ethnic population with 
the best rate as the reference point. Health disparities are measured in relative terms as the 
percent difference between the rate for each population group and the best group rate for 
each characteristic. In the measurement of health disparities, objectives are generally 
expressed in terms of adverse events or conditions, such as death rates, to facilitate 
comparisons among them. Changes in disparities are measured by subtracting the percent 
difference from the best group rate at the baseline from the percent difference from the best 
group rate at the most recent time point. As a result, changes in disparities are measured in 
percentage points. In addition, when more than two groups are associated with a 
characteristic (race and ethnicity, education, or income), a summary index is used to 
describe the average percent difference from the best group in the population overall. The 
summary index provides a basis for conclusions about changes in the size of the disparities 
associated with these characteristics. A detailed description of the methods used to 
measure and evaluate disparities is provided in the Technical Appendix. 
 
Findings Concerning Disparities 
Race and Ethnicity 
Information about health disparities among racial and ethnic populations at the most recent 
time point based on the Health Disparities Table for each Focus Area is summarized in 
Figure ES-7. The measurement of health disparities depends on the availability of data for 
each population. The number of objectives with the data needed to measure health 
disparities varied from 38 for the Native Hawaiian or Other Pacific Islander population to 
354 for the white non-Hispanic population.  
American Indian or Alaska Native Population 
The data needed to assess health disparities for the American Indian or Alaska Native 
population were available for 157 objectives (Figure ES-7). This population had the best 
group rate for 6% of these objectives. The American Indian or Alaska Native population had 
a larger proportion of health disparities in the 100% or more category than any of the other 
racial and ethnic populations. The American Indian or Alaska Native population had rates at 
least twice as high as the best group rate (100% or more category) for 26% of these 
objectives. 
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Figure ES-7. Health Disparities at the Most Recent Time Point by Race and 
Ethnicity 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE: “Less than 10%” includes percent differences that were not statistically significant (when 
estimates of variability were available). 
 
Asian and Native Hawaiian or Other Pacific Islander Populations 
The data needed to assess health disparities for the Asian population (excluding the Native 
Hawaiian or Other Pacific Islander population) were available for 98 objectives; see Figure 
ES-7. The Asian population had the best group rate for 28% of these objectives. This 
population had rates at least twice as high as the best group rate (100% or more category) 
for 9% of the objectives with available data. 
Data for the Native Hawaiian or Other Pacific Islander population were available for 38 
objectives (Figure ES-7). This population had a smaller percentage of best group rates 
(11%) and a larger percentage of health disparities of 100% or more (24%) than the Asian 
population. 
Data were available for the combined Asian or Pacific Islander population for 66 objectives 
(Figure ES-7). This combined population had the best group rate for 64% of these 
objectives. The Asian or Pacific Islander population had rates at least twice as high as the 
best group rate (100% or more category) for two objectives: cases of hepatitis B in adults 
19–24 years (objective 14-3a) and cases of hepatitis A (objective 14-6). 
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Two or More Races 
Data for individuals who identified with more than one race were available for 96 objectives 
(Figure ES-7). The population of persons of two or more races had the best group rate for 
18% of these objectives. This population had rates at least twice as high as the best group 
rate (100% or more category) for 10% of these objectives. 
Hispanic Population 
The data needed to assess health disparities for the Hispanic population were available for 
311 objectives (Figure ES-7). The Hispanic population had the best group rate for 17% of 
these objectives. This population had rates at least twice as high as the best group rate 
(100% or more category) for 11% of these objectives. 
Black Non-Hispanic Population 
Data needed to assess health disparities for the black non-Hispanic population (or, in some 
cases, for the black population, including persons of Hispanic origin) were available for 345 
objectives (Figure ES-7). This population had the best group rate for 20% of these 
objectives. This population had rates at least twice as high as the best group rate (100% or 
more category) for 20% of these objectives, including most causes of death in many Focus 
Areas. 
White Non-Hispanic Population 
Data needed to assess health disparities for the white non-Hispanic population (or, in some 
cases, for the white population, including persons of Hispanic origin) were available for 354 
objectives (Figure ES-7). This population had the best group rate for 51% of these 
objectives. This population had rates at least twice as high as the best group rate (100% or 
more category) for 7% of these objectives. 
Changes in Health Disparities among Racial and Ethnic Groups 
In addition to the findings for specific racial and ethnic population groups, a summary index 
allows the evaluation of changes in overall health disparities by race and ethnicity over 
time. There was no change in health disparities among racial and ethnic populations for 111 
(69%) of the 169 objectives with the data to calculate the summary index and assess its 
change over time. (“No change” includes changes of less than 10 percentage points, 
regardless of statistical significance, and all changes that were not statistically significant, 
when estimates of variability were available; see Technical Appendix.) The average percent 
difference from the best group rate decreased for 27 objectives and increased for 25 
objectives (Figure ES-8). 
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Figure ES-8. Changes in Health Disparities from the Baseline to the Most Recent 
Time Points by Population Characteristic 
 
 
 
 
 
NOTES: Changes in disparity from the baseline to the most recent time points are only shown 
when they could be assessed. Changes could not be assessed for 54, 82, 4, 3, 10, and 17 
objectives by race/ethnicity, sex, education, income, geographic location, and disability status, 
respectively. “No change” includes: changes of less than 10 percentage points, regardless of 
statistical significance; and all changes that were not statistically significant, when estimates of 
variability were available. See Technical Appendix. 
 
* Number of objectives with changes in the summary index as a measure of disparity. Health 
disparities by income were not included for Focus Area 19 due to data limitations. 
  
Number of objectives
Disparity decrease Disparity increase                  No change         Total
Race and ethnicity* 117 169
Sex 167 216
Education* 107 132
Income* 64 75
Geographic location 23 33
Disability status 47 51
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Sex 
Data by sex were available for 318 objectives (Figure ES-9). As noted below, trends in 
disparity could only be measured for 216 objectives. Health disparities by sex were not 
relevant to objectives that applied only to females or only to males, including those in 
Family Planning (Focus Area 9), and a number of objectives in other Focus Areas. Findings 
concerning health disparities by sex are summarized in Figure ES-9. 
Females had the better group rate for 68% of these objectives, compared with 42% for 
males. (Those two percentages, 68% and 42%, add to over 100% because there were a 
number of cases in which the two groups had the same rate; therefore, both were counted 
as having achieved the best group rate.) Females had a smaller percentage of objectives 
with rates that were at least twice as high as those for males (100% or more category). 
 
Figure ES-9. Health Disparities at the Most Recent Time Point by Sex
 
NOTE: “Less than 10%” includes percent differences that were not statistically significant (when 
estimates of variability were available). 
 
Changes in Disparities by Sex 
The data needed to evaluate changes over time in health disparities by sex were available 
for 216 objectives. There was no change in disparity for 167 objectives, or 77% of the total 
with data. (“No change” includes changes of less than 10 percentage points, regardless of 
statistical significance, and all changes that were not statistically significant, when estimates 
of variability were available; see Technical Appendix.) Disparities decreased for 26 
objectives and increased for 23 (Figure ES-8). In addition, there were 33 objectives for 
which changes in disparities could not be assessed, but were changes in the group with the 
best rate was observed (e.g., from males to females). 
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Education Level 
The data needed to assess health disparities among populations by education level were 
available for 160 to 161 objectives (Figure ES-10). Education level was not included as a 
characteristic in all Focus Areas. The population with at least some college education had 
the best rate for 88% of the objectives with data by education. The population with less 
than a high school education and high school graduates had the best group rate for 8% and 
10% of the objectives with data by education, respectively. There were no objectives for 
which the disparity between the population with at least some college education and the 
group with the best rate was 100% or more. The population that completed high school had 
rates at least twice as high as the best group rate (100% or more category) for 18% of these 
objectives, and the population with less than a high school education had rates at least twice 
as high as the best group rate (100% or more category) for 24% of these objectives. 
 
Figure ES-10. Health Disparities at the Most Recent Time Point by Education Level 
 
NOTE: “Less than 10%” includes percent differences that were not statistically significant (when 
estimates of variability were available). 
 
Changes in Health Disparities by Education Level 
In addition to the findings for individual populations by education level, the summary index 
permits the evaluation of changes in overall health disparities over time by level of 
education. There was no change in health disparity among populations by education level 
for 107 objectives or 81% of the 132 objectives with the data to calculate the index and 
assess change over time. (“No change” includes changes of less than 10 percentage points, 
regardless of statistical significance, and all changes that were not statistically significant, 
when estimates of variability were available; see Technical Appendix.) The average percent 
difference from the best group rate decreased for five objectives and increased for 20 
(Figure ES-8). There was one increase and no decreases of 100 percentage points or more. 
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Income 
Income was not included as a characteristic in all Focus Areas. All of the objectives in 
Nutrition and Overweight (Focus Area 19) and six objectives in Immunization and 
Infectious Diseases (Focus Area 14) were excluded from this summary because data by 
income were available for only two population subgroups (persons with income at or below 
130% of the Federal poverty level, and persons with income above 130% of the Federal 
poverty level). This summary is based on 95 to 103 objectives with data for populations by 
income (Figure ES-11). The population with middle/high income (at or above 200% or the 
Federal poverty level) had the best rate for 74% of the objectives with data by income. The 
poor (below the Federal poverty level) and near-poor (100–199% of the Federal poverty 
level) populations each had the best rate for 21% and 19 % of their objectives, respectively. 
There were no objectives for which the disparities between persons with middle/high 
incomes and the group with the best rate were 100% or more. The near-poor population 
had rates at least twice as high as the best group rate (100% or more category) for 8% of 
the objectives with data. The poor or lowest income population had rates at least twice as 
high as the best group rate (100% or more category) for 10% of the objectives with data. 
 
Figure ES-11. Health Disparities at the Most Recent Time Point by Income 
 
NOTE: “Less than 10%” includes percent differences that were not statistically significant (when 
estimates of variability were available). 
 
Changes in Health Disparities by Income 
The summary index enables the evaluation of changes in disparity over time among 
populations by income. The data needed to evaluate changes in disparity among the 
populations by income were available for 75 objectives (Figure ES-8). There was little 
evidence of any change in disparity among populations by income. The average disparity 
relative to the rate with the best group decreased for three objectives and increased for 
eight (Figure ES-8). 
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Geographic Location 
Geographic location was defined in different ways in Healthy People 2010. For some 
objectives, the distinction was between urban and rural areas, while for others, the 
distinction was between metropolitan and nonmetropolitan areas. Findings for health 
disparities by geographic location for 52 objectives are summarized in Figure ES-12. 
Urban or metropolitan areas had the better rate for 71% of the objectives with data. Urban 
or metropolitan areas also had more objectives (four objectives) with health disparities of 
100% or more than rural or nonmetropolitan areas (one objective). Rural or 
nonmetropolitan areas had the better rate for 40% of these objectives. (Those two 
percentages, 71% and 40%, add to over 100% because there were a number of cases in 
which the two groups had the same rate; therefore, both were counted as having achieved 
the best group rate.) 
 
Figure ES-12. Health Disparities at the Most Recent Time Point by Geographic 
Location 
 
NOTE: “Less than 10%” includes percent differences that were not statistically significant (when 
estimates of variability were available). 
 
Changes in Health Disparities by Geographic Location 
The data needed to evaluate changes in health disparities between geographic areas were 
available for 33 objectives. Health disparities from the better group rate declined for two 
objectives, and increased for eight (Figure ES-8). 
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Disability Status 
Data for persons with disabilities and persons without disabilities for 77 objectives are 
summarized in Figure ES-13. Persons with disabilities had the better group rate for 42% of 
these objectives, and persons without disabilities had the better group rate for 62%. (Those 
two percentages, 42% and 62%, add to over 100% because there were a number of cases in 
which the two groups had the same rate; therefore, both were counted as having achieved 
the best group rate.) Persons with disabilities had rates at least twice as high as for persons 
without disabilities (100% or more category) for 6% of these objectives. 
Changes in Health Disparities by Disability Status 
The data needed to evaluate changes in health disparities between disability groups were 
available for 51 objectives (Figure ES-8). There were few changes in disparities by disability 
status. Health disparities between these populations declined for one objective and 
increased for three objectives. 
 
Figure ES-13. Health Disparities at the Most Recent Time Point by Disability Status 
 
NOTE: “Less than 10%” includes percent differences that were not statistically significant (when 
estimates of variability were available). 
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Data Limitations 
Several factors limited the number of objectives for which changes in disparities could be 
assessed. First, the number of years on which this assessment is based varied greatly. 
Second, this assessment is limited by a lack of data for select populations, such as American 
Indian or Alaska Native, Asian, Hispanic, and Native Hawaiian or Other Pacific Islander 
populations. 
These findings are also subject to the limitations of the data on which they are based. This 
assessment is based only on data at the baseline and at the most recent time points; 
intervening data values were not considered. The findings presented here also are limited 
by the reliability and validity of information about the persons on which data were based. 
The reporting of race and income from some data systems was particularly problematic. 
Assessments of the probability that health disparities or changes in disparities were due to 
random fluctuations in the data were limited by the lack of estimates of variability for some 
of the data on which Healthy People 2010 objectives were based. See the Technical 
Appendix for more information. 
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Transitioning to Healthy People 2020: The Decade Ahead 
In December 2010, HHS launched Healthy People 2020, the successor health promotion 
initiative for the second decade of the 21st century which builds on the strengths of Healthy 
People 2010 while breaking new ground in the scope, outreach, and scientific underpinning 
of the initiative. In contrast with the two goals of Healthy People 2010, Healthy People 2020 
is grounded in four overarching goals to: 
1) Attain high quality, longer lives free of preventable disease, disability, injury, and 
premature death. 
2) Achieve health equity and eliminate disparities. 
3) Create social and physical environments that promote good health for all. 
4) Promote quality of life, healthy development, and healthy behaviors across all life 
stages. 
The framework of Healthy People 2020 is organized into 42 Topic Areas (formerly Focus 
Areas), with 13 new areas added: 
 Adolescent Health 
 Blood Disorders and Blood Safety 
 Dementias, Including Alzheimer’s Disease 
 Early and Middle Childhood 
 Genomics 
 Global Health 
 Healthcare-Associated Infections 
 Health-Related Quality of Life and Well-Being 
 Lesbian, Gay, Bisexual, and Transgender Health 
 Older Adults 
 Preparedness 
 Sleep Health 
 Social Determinants of Health. 
 
In addition, the 2010 Vision and Hearing Focus Area was split into two separate Topic Areas 
for 2020: Vision, and Hearing and Other Sensory or Communication Disorders. 
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The Healthy People 2020 Topic Areas encompass approximately 1,200 objectives as 
compared with 969 objectives in Healthy People 2010; 366 objectives have been carried 
over without change into Healthy People 2020; 358 appear in modified form; 242 have been 
archived, that is, preserved on inactive but retrievable status on the strength of having at 
least one data point; and 84 have been discontinued because they had no prospect of 
acquiring a data source, an improved data source had been identified, or the science had 
changed. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to 
Healthy People 2020,” summarizes the changes between the two decades of objectives. 
 
Innovations of Healthy People 2020 
Healthy People 2020 places a renewed focus on identifying, measuring, tracking, and 
reducing health disparities using a determinants of health approach. Health status and 
health behaviors are determined by influences at multiple levels, including personal (i.e., 
biological, psychological), organizational/institutional, environmental (i.e., both social and 
physical), and policy levels. Because significant and dynamic inter-relationships exist 
among these different levels of health determinants, interventions are most likely to be 
effective when they address determinants at all levels. Historically, many initiatives have 
focused on individual-level health determinants and interventions. Healthy People 2020 
therefore expanded its focus from previous iterations to emphasize tracking and monitoring 
of health-enhancing social and physical environments. Integrating prevention into the 
continuum of education—from the earliest ages on—is an integral part of this ecological 
and determinants approach. Another important innovation in Healthy People 2020 is the 
expanded population template which will allow a more in-depth analysis of health 
disparities in comparison with Healthy People 2010. 
As with Healthy People 2010, each Healthy People 2020 objective has a: 
 Reliable data source 
 Baseline measure 
 Target for specific improvements to be achieved by the year 2020. 
 
Draft objectives have been prepared by experts from multiple lead Federal Agencies. The 
proposed objectives have then been reviewed through a public comment process and by the 
Healthy People Federal Interagency Workgroup, which used specific selection criteria to 
choose the final objectives. 
Many objectives focus on interventions that are designed to reduce or eliminate illness, 
disability, and premature death among individuals and communities. Others focus on 
broader issues such as: 
 Eliminating health disparities 
 Addressing social determinants of health 
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 Improving access to quality health care 
 Strengthening public health services 
 Improving the availability and dissemination of health-related information. 
 
Over the course of the decade, four foundation health areas will be used to monitor 
progress toward promoting health, preventing disease and disability, eliminating 
disparities, and improving quality of life. These broad, cross-cutting areas include: 
 General health status, as measured by such factors as life expectancy, healthy life 
expectancy, years of potential life lost, limitation of activity, chronic disease 
prevalence, self-assessed health status, and the CDC “Healthy Days Measures.” 
 Health-related quality of life and well-being, as measured in terms such as physical, 
mental, and social health-related quality of life; well-being/satisfaction; and 
participation in common activities. 
 Determinants of health, that is, a range of personal, economic, and environmental 
factors that influence health status, including factors such as biology, genetics, 
individual behavior, access to health services, and the particular environment(s) in 
which people may find themselves in the course of life or their daily round. 
 Disparities and inequities in health status observed across race/ethnicity, sex, 
physical and mental ability, and geographical location. 
 
Concurrent with the release of Healthy People 2020, a redesigned website 
(www.healthypeople.gov) was launched. Replacing the traditional print publication with an 
interactive website as the main vehicle for dissemination will expand the reach and 
accessibility of Healthy People and allow users to tailor information to their particular 
needs and explore evidence-based resources for implementation. Among the new features 
of the site’s contents are the following: 
 An index to the Topic Areas and their objectives, with information about each 
objective’s baseline, target, and data source. 
 A Determinants of Health section with an animated graphic to illustrate the range of 
personal, social, economic, and environmental factors that influence health status 
and often account for health-related disparities among population groups. 
 A Stay Connected section with information about signing up for the listserv and links 
to social networking sites.  
 
Plans for the future include adding capabilities for the website to disseminate research-
based implementation strategies for Topic Areas and objectives and to receive public 
comments on the objectives during periods set aside for this purpose on an annual basis. 
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Introduction 
The objectives used to monitor the Leading Health Indicators are a subset of the Healthy People 
2010 objectives that reflect the major public health concerns in the U.S. They were chosen on the 
basis of their ability to motivate action, the availability of data to measure their progress, and their 
relevance as broad public health issues. These indicators illuminate individual behaviors, physical 
and social environmental factors, and important health system issues that greatly affect the health 
of individuals and communities. 
Each of the 10 Leading Health Indicators is monitored through one or more specific Healthy People 
2010 objectives. At the launch of Healthy People 2010, the set of Leading Health Indicators included 
22 objectives. Six supplemental objectives have been added since, for a total of 28 objectives. 
The Leading Health Indicators for Healthy People 2010 are: 
 Physical Activity. Two objectives track moderate or vigorous physical activity among 
adults and vigorous physical activity among adolescents (objectives 22-2 and 22-7, 
respectively). 
 Nutrition and Obesity. Two objectives track obesity in adults and in children and 
adolescents (objectives 19-2 and 19-3c, respectively). 
 Tobacco use. Two objectives monitor cigarette smoking among adults and among 
adolescents (objectives 27-1a and 27-2b, respectively). 
 Substance Abuse. Three objectives track adolescents not using illicit drugs (objective 26-
10a), adults using illicit drugs (objective 26-10c), and adult binge drinking (objective 26-
11c). 
 Responsible Sexual Behavior. Five objectives monitor condom use by sexually-active 
unmarried persons (objectives 13-6a and b) and adolescent sexual behavior (objectives 25-
11a through c). Three supplemental objectives also were included: Condom use among 
sexually active unmarried males (objective 13-6b); adolescents who had sexual intercourse 
but not in the past three months (objective 25-11b); and adolescents who used condoms at 
last intercourse (objective 25-11c). 
 Mental Health. Two objectives track suicides (objective 18-1) and treatment of adults with 
depression (objective 18-9b). (Objective 18-1 is a supplemental objective.) 
 Injury and Violence. Two objectives monitor deaths from motor vehicle crashes (objective 
15-15a) and homicides (objective 15-32). 
 Environmental Quality. Three objectives track exposure to ozone (objective 8-1a), 
children’s exposure to tobacco smoke at home (objective 27-9), and nonsmoker exposure to 
tobacco smoke (objective 27-10). (Objective 27-9 is a supplemental objective.) 
 Immunization. Three objectives monitor fully-immunized young children (objective 14-
24a) and influenza and pneumonia vaccination of older adults (objectives 14-29a and b, 
respectively). 
 Access to Health Care. Four objectives track persons with health insurance (objective 1-1), 
persons with a source of ongoing care (objective 1-4a), hospitalizations for pediatric asthma 
(objective 1-9a), and the receipt of prenatal care beginning in the first trimester (objective 
16-6a). (Objective 1-9a is a supplemental objective.) 
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All Healthy People tracking data quoted in this chapter, along with technical information and 
operational definitions for each objective, can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
More information about the Leading Health Indicators can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from 
http://www.healthypeople.gov/2010/Document/html/uih/uih_bw/uih_4.htm. 
 Healthy People 2010 Midcourse Review, available from 
http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas. 
 Sondik EJ, Huang DT, Klein RJ, Satcher D. Progress Toward the Healthy People 2010 Goals 
and Objectives. Annu Rev of Public Health 31(1):271–81. 2010. 
 
Highlights 
 Substantial progress [1] was achieved for the Leading Health Indicators during the past 
decade. Almost two thirds (63%) of the Leading Health Indicator objectives with data to 
measure progress moved toward or achieved their Healthy People 2010 targets (Figure 
LHI-1). However, some health disparities [2] among select populations were observed 
(Figure LHI-2), as discussed below. 
Physical Activity 
 There was little or no progress toward targets for the objectives tracking this Leading 
Health Indicator. Between 1997 and 2008, the proportion of adults engaging in regular 
moderate or vigorous physical activity (objective 22-2) remained stable at 32%. The 
proportion of adolescents engaging in regular vigorous physical activity (objective 22-7) 
increased by 4.6% between 1999 and 2009, from 65% to 68%, moving toward the Healthy 
People 2010 target of 85%; however, that increase was not statistically significant. 
Obesity and Overweight 
 Obesity in the U.S. population has increased, moving away from Healthy People 2010 
targets. Based on directly measured weight and height, between 1988–94 and 2005–08 the 
proportion of adults aged 20 years and over who were obese (objective 19-2) rose by 
47.8%, from 23% to 34% (age adjusted), moving away from the 2010 target of 15%. During 
the same period, obesity in children and adolescents aged 6–19 years (objective 19-3c) 
increased by 63.6%, from 11% to 18%, moving away from the 2010 target of 5%.  
Tobacco Use 
Progress was seen for the objectives monitoring this Leading Health Indicator: 
 The percentage of adults aged 18 years and over who were current cigarette smokers 
(objective 27-1a) decreased by 12.5% between 1998 and 2008, from 24% to 21% (age 
adjusted), moving toward the 2010 target of 12%. However, from 2004 to 2008, the 
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proportion of U.S. adults who were current cigarette smokers did not noticeably change. 
Moreover, health disparities were observed for a number of populations, for example: 
 Among educational groups, adults aged 25 years and over with at least some college 
education had the lowest (best) current cigarette smoking rate, 15% (age adjusted) 
in 2008. Adults aged 25 years and over with less than a high school education had a 
rate of 30% (age adjusted) in 2008, twice the best group rate [2].  
 Adolescent use of cigarettes in the past month (objective 27-2b), decreased by 45.7%, from 
35% in 1999 to 19% in 2009, moving toward the 2010 target of 16%. 
 Among racial and ethnic groups, the black non-Hispanic population had the lowest 
(best) adolescent cigarette smoking rate, 10% in 2009. The rate for the white non-
Hispanic population was 22% in 2009, more than twice the best rate [2].  
Substance Abuse 
Progress for this Leading Health Indicator was mixed: 
 The proportion of adolescents not using alcohol or illicit drugs in the past month (objective 
26-10a) increased by 5.1% between 2002 and 2008, from 78% to 82%, moving toward the 
2010 target of 91%. 
 The proportion of adults using illicit drugs in the past month (objective 26-10c) did not 
change over the decade. As in 2002, the baseline year for this objective, 7.9% of adults aged 
18 years and over used illicit drugs in the past month in 2008. Similarly, the proportion of 
adults who engaged in binge drinking in the past month (26-11c) changed very little, 
increasing by 2.5% over the same tracking period, from 24.3% to 24.9%, and moving away 
from the 2010 target of 13.4%. 
Responsible Sexual Behavior 
Four of the five objectives used to monitor this Leading Health Indicator moved toward their 
targets: 
 Condom use among sexually active unmarried persons aged 18–44 years increased, moving 
toward the 2010 targets of 50% for females (objective 13-6a) and 54% for males (objective 
13-6b). The proportion of females (or their partners) that used condoms increased by 
43.5% between 1995 and 2006–08, from 23% to 33%, while the proportion of males (or 
their partners) who used condoms increased by 4.8% between 2002 and 2006–08, from 
42% to 44%. 
 The proportion of adolescents who had never had sexual intercourse (objective 25-11a) 
increased by 8.0% between 1999 and 2009, from 50% to 54%, moving toward the 2010 
target of 56%.  
 The proportion of adolescents who had had sexual intercourse but not in the past three 
months (objective 25-11b) declined by 3.7% between 1999 and 2009, from 27% to 26%, 
moving away from the target of 30%.  
 The proportion of adolescents who used condoms at last intercourse (objective 25-11c) 
increased by 5.2% between 1999 and 2009, from 58% to 61%, moving toward the 2010 
target of 65%. 
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Mental Health 
Data to measure progress was available for one of the two objectives used to monitor this 
Leading Health Indicator, objective 18-1, suicide, which increased over the decade, moving 
away from the 2010 target. Only baseline data were available for objective 18-9b, treatment for 
adults with depression. 
 The suicide rate (objective 18-1) increased by 7.6% between 1999 and 2007, from 10.5 to 
11.3 per 100,000 population (age adjusted), moving away from the 2010 target of 4.8 per 
100,000. Health disparities were observed for a number of population groups, for example: 
 Among racial and ethnic groups, the black non-Hispanic population had the lowest 
(best) suicide rate, 5.1 per 100,000 population (age adjusted) in 2007. The rates for 
the American Indian or Alaska Native and the white non-Hispanic populations were 
11.5 and 13.5 per 100,000 (age adjusted), respectively. The rate for the American 
Indian or Alaska Native population was almost two and a half times the best rate 
(that for the black non-Hispanic population), while the rate for the white non-
Hispanic population was more than two and a half times the best rate [2]. 
 The white non-Hispanic population had suicide rates of 12.0 per 100,000 
population (age adjusted) in 1999 and 13.5 in 2007, whereas the black non-
Hispanic population had rates of 5.7 in 1999 and 5.1 in 2007. The disparity 
between the white non-Hispanic and black non-Hispanic populations 
increased by 54 percentage points between 1999 and 2007 [3]. 
 Females had a lower (better) suicide rate than males, 4.7 per 100,000 population 
(age adjusted) in 2007. The rate for males was 18.4 per 100,000 (age adjusted) in 
2007, almost four times the rate for females [2]. 
 Males had suicide rates of 17.8 per 100,000 population (age adjusted) in 
1999 and 18.4 in 2007, whereas females had rates of 4.0 in 1999 and 4.7 in 
2007. The disparity between males and females declined by 53 percentage 
points between 1999 and 2007 [3]. 
 Among education groups, persons with at least some college education had the 
lowest (best) suicide rate, 9.9 per 100,000 population (age adjusted) in 2002, 
whereas high school graduates had a rate of 18.4 per 100,000 (age adjusted) in 
2002, almost twice the best group rate [2]. 
Injury and Violence 
Progress for this Leading Health Indicator was mixed: 
 Motor vehicle crash deaths per 100,000 population (objective 15-15a) declined by 6.1% 
between 1999 and 2007, from 14.7 to 13.8 (age adjusted), moving toward the 2010 target 
of 8.0.  
 Among racial and ethnic groups, the Asian or Pacific Islander population had the 
lowest (best) rate of motor vehicle crash deaths, 7.0 per 100,000 population (age 
adjusted) in 2007. The American Indian or Alaska Native, black non-Hispanic, and 
white non-Hispanic populations had rates of 22.5, 14.1, and 14.2 per 100,000 (age 
adjusted) in 2007, respectively. The rate for the American Indian or Alaska Native 
population was more than three times the best rate (that for the Asian or Pacific 
Islander population). The rates for the black non-Hispanic and white non-Hispanic 
populations were about twice the best rate [2].  
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 The homicide rate (objective 15-32) did not change significantly over the decade. In 1999, 
the baseline year for this objective, the homicide rate was 6.0 per 100,000 population (age 
adjusted), compared to a rate of 6.1 in 2007 [1]. 
 Among racial and ethnic groups, the Asian or Pacific Islander population had the 
lowest (best) rate of deaths from homicide, 2.3 per 100,000 population (age 
adjusted) in 2007. The rates for the American Indian or Alaska Native, Hispanic or 
Latino, and black non-Hispanic populations were 6.5, 6.9, and 21.8 per 100,000 (age 
adjusted) in 2007, respectively. The rate for the American Indian or Alaska Native 
population was almost three times the best rate (that for the Asian or Pacific 
Islander population). The rate for the Hispanic or Latino population was three times 
the best rate, and the rate for the black non-Hispanic population was about nine and 
a half times the best rate [2]. 
 The white non-Hispanic population had the lowest (best) rate of deaths from 
homicide at baseline, 2.9 deaths per 100.000 (age adjusted) in 1999, while the Asian 
or Pacific Islander population had the best rate at the most recent data point, 2.3 per 
100,000 (age adjusted) in 2007. The black non-Hispanic population had rates of 
20.7 and 21.8 per 100,000 (age adjusted) in 1999 and 2007, respectively. Between 
1999 and 2007, the disparity between the black non-Hispanic population and the 
group with the best rate increased by 234 percentage points [3]. 
 Females had a lower (better) homicide rate than males, 2.5 per 100,000 population 
(age adjusted) in 2007. The rate for males was 9.6 per 100,000 (age adjusted) in 
2007, nearly four times the rate for females [2]. 
 Among education groups, persons aged 25–64 years with at least some college 
education had the lowest (best) rate of deaths from homicide, 2.6 per 100,000 
population (age adjusted) in 2002. The rates for high school graduates and persons 
with less than a high school education were 10.5 and 16.0 per 100,000 (age 
adjusted) in 2002, respectively. High school graduates had a rate that was 
approximately four times the best group rate (that for persons aged 25–64 years 
with at least some college education); the rate for persons with less than a high 
school education was more than six times the best group rate [2]. 
Environmental Quality 
There was substantial progress for this Leading Health Indicator. Two of the three 
environmental quality objectives exceeded their 2010 targets: 
 The proportion of people living in counties that exceeded NAAQS for ozone (objective 8-1a) 
declined by 25% between 1997 and 2010, from 43% to 36%, moving toward the 2010 
target of 0%. However, the final data year by race and ethnicity was 2004 and, at that time, 
disparities were observed for a number of population groups: 
 Among racial and ethnic groups, the American Indian or Alaska Native population 
had the lowest (best) rate of living in counties that exceeded NAAQS for ozone 
(objective 8-1a), 23% in 2004, whereas the white non-Hispanic, Native Hawaiian or 
Other Pacific Islander, black non-Hispanic, Hispanic or Latino, and Asian 
populations had rates of 33%, 35%, 43%, 59%, and 67%, respectively.  
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 The rate for the white non-Hispanic population was almost one and a half 
times the best rate (that for the American Indian or Alaska Native 
population); the rate for the Native Hawaiian or Other Pacific Islander 
population was about one and a half times the best rate; that for the black 
non-Hispanic population was almost twice the best rate; that for the 
Hispanic or Latino population was more than two and a half times the best 
rate; that for the Asian population was nearly three times the best rate [2]. 
 The rural or nonmetropolitan population had better rates of exposure to ozone (4% 
in 1997 and 3% in 2004) than the urban or metropolitan population (52% in 1997 
and 48% in 2004). In 2004, the rate for the urban or metropolitan population was 
16 times as high as that for the rural or nonmetropolitan population. Between 1997 
and 2004, the disparity in ozone exposure between the rural/nonmetropolitan and 
the urban/metropolitan populations increased by 300 percentage points [3]. 
 The percentage of children aged six years and under exposed to tobacco smoke at home 
(objective 27-9) decreased by 70.4% between 1994 and 2005, from 27% to 8%, exceeding 
the 2010 target of 10%. However, disparities were observed among a number of population 
groups, for example: 
 Among income groups, children aged six years and under living in middle/high 
income households had the lowest (best) rates of exposure to tobacco smoke at 
home, 5% in 2005, whereas children living in poor or near-poor households had 
rates of 15% and 12% in 2005, respectively. The rate for children living in poor 
households was three times the best group rate, while the rate for children living in 
near-poor households was almost two and a half times the best group rate [2]. 
 Children living in poor households had rates of exposure to tobacco smoke of 38% 
in 1994 and 15% in 2005; those living in near-poor households had rates of 33% in 
1994 and 12% in 2005; whereas those living in middle/high income households had 
rates of 19% in 1994 and 5% in 2005. The disparity between children living in poor 
households and those living in middle/high income households increased by 100 
percentage points between 1994 and 2005. During the same period, the disparity 
between children living in near-poor households and those living in middle/high 
income households increased by 66 percentage points [3]. 
 The percentage of nonsmokers aged four years and over exposed to environmental tobacco 
smoke (objective 27-10) declined by 51.2% between 1988–94 and 2005–08, from 84% to 
41% (age adjusted), exceeding the 2010 target of 56%. 
Immunization 
Progress was seen for the three objectives monitoring this Leading Health Indicator: 
 The proportion of young children aged 19–35 months who were fully immunized (objective 
14-24a) increased by 6.8% between 1998 and 2008, from 73% to 78% moving toward the 
2010 target of 80%. 
 Vaccination of noninstitutionalized high risk persons aged 65 years and over for influenza 
and pneumonia both increased between 1998 and 2008, moving toward the 2010 targets of 
90%. The proportion who had received an influenza vaccination in the past 12 months 
(objective 14-29a) increased by 4.7%, from 64% to 67%, and the proportion who had ever 
received a pneumococcal vaccination (objective 14-29b) increased by 30.4%, from 46% to 
60% over the tracking period. 
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Access to Health Care 
Progress for this Leading Health Indicator was mixed: 
 Rates of persons with health insurance (objective 1-1) did not change over the decade. As in 
1997, the baseline year for this objective, 83% of the U.S. population under age 65 years had 
health insurance coverage in 2008. Disparities were observed for a number of population 
groups, for example: 
 Among racial and ethnic groups, the white non-Hispanic population had the highest 
(best) rate of health insurance coverage, 88% in 2008, whereas the American Indian 
or Alaska Native population and the Hispanic or Latino population had rates of 72% 
and 67% in 2008, respectively. When expressed as persons without health 
insurance, the rate for the American Indian or Alaska Native population was more 
than twice the best rate (that for the white non-Hispanic population). The rate for 
the Hispanic or Latino population was nearly three times the best rate [2]. 
 The American Indian or Alaska Native population had health insurance coverage 
rates of 62% in 1999 and 72% in 2008, whereas the white non-Hispanic population 
had rates of 88% in both 1999 in 2008. When rates are expressed in terms of 
persons without health insurance, the disparity between the American Indian or 
Alaska Native population and the white non-Hispanic population decreased by 83 
percentage points between 1999 and 2008 [2,3]. 
 Among income groups, the middle/high income population had the highest (best) 
rate of health insurance coverage, 89% in 2008, whereas the poor and near-poor 
populations had rates of 71% and 69% in 2008, respectively. When expressed as 
persons without health insurance, the rate for the poor population was more than 
two and a half times the best rate (that for the middle/high income population). The 
rate for the near-poor population was almost three times the best rate [2].  
 The poor population had health insurance coverage rates of 66% in 1997 and 71% 
in 2008, whereas the middle/high income population had rates of 90% in 1997 and 
89% in 2008. When rates are expressed in terms of persons without health 
insurance, the disparity between the poor population and the middle/high income 
population decreased by 76 percentage points between 1997 and 2008 [2,3]. 
 The proportion of persons with a source of ongoing care (objective 1-4a) declined by 1.1% 
between 1998 and 2008, from 87% to 86%, moving away from the 2010 target of 96%. 
 Among racial and ethnic groups, the white non-Hispanic population had the highest 
(best) rate, 89% in 2008, whereas the Hispanic or Latino population had a rate of 
77% in 2008. When expressed as persons without a specific source of ongoing care, 
the rate for the Hispanic or Latino population was more than twice the best rate [2]. 
 Among income groups, the middle/high income population had the highest rate, 
90% in 2008, whereas the poor and near-poor populations had rates of 78% and 
80% in 2008, respectively. When expressed as persons without a specific source of 
ongoing care, the rates for the poor and near-poor populations were about twice the 
best rate [2]. 
 Hospitalizations for pediatric asthma (objective 1-9a) declined by 35.2% between 1996 and 
2008, from 23.0 to 14.9 admissions per 100,000 population aged under 18 years, exceeding 
the 2010 target of 17.3 admissions per 100,000 population. 
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 The proportion of pregnant women who began prenatal care in the first trimester (objective 
16-6a) increased 1.2% between 1998 and 2002, from 83% to 84%, moving toward the 2010 
target of 90%. 
 White non-Hispanic women had the highest (best) rate of prenatal care among 
racial and ethnic populations, 89% in 2002, whereas the American Indian or Alaska 
Native, Hispanic or Latino, and black non-Hispanic women had rates of 70%, 77%, 
and 75%, in 2002, respectively. When expressed as women not receiving prenatal 
care, the rates for American Indian or Alaska Native, Hispanic or Latino, and black 
non-Hispanic women were more than twice the best rate (that for white non-
Hispanic women) [2]. 
 Women aged 20 years and over with at least some college education had the best 
rate of prenatal care among education groups, 92% in 2002, whereas high school 
graduates and women with less than a high school education had rates of 83% and 
72% in 2002, respectively, among women aged 20 years and over. When expressed 
as women aged 20 years and over not receiving prenatal care, the rate for high 
school graduates was more than twice the best rate; and the rate for women with 
less than a high school education was three and a half times the best rate [2]. 
 
Summary of Progress 
 Figure LHI-1 presents a quantitative assessment of progress [1] in achieving the Healthy 
People 2010 objectives for Leading Health Indicators. Data to measure progress toward 
target attainment were available for 27 objectives. Of these: 
 Three objectives exceeded their Healthy People 2010 targets (objectives 1-9a, 27-9, 
and 27-10). 
 Fourteen objectives moved toward their targets. A statistically significant difference 
between the baseline and the final data points was observed for eight of these 
objectives (14-24a, 14-29a and b, 15-15a, 16-6a, 26-10a, 27-1a, and 27-2b). No 
significant difference was observed for one objective (22-7); and data to test the 
significance of the difference were unavailable for five objectives (8-1a, 13-6a and b, 
and 25-11a and c). 
 Three objectives showed no change (objectives 1-1, 22-2, and 26-10c). 
 Seven objectives moved away from their targets. A statistically significant difference 
between the baseline and final data points was observed for four of these objectives 
(1-4a, 18-1, 19-2, and 19-3c). No significant differences were observed for two 
objectives (15-32 and 26-11c); and data to test the significance of the difference 
were unavailable for one objective (25-11b). 
 One objective had no data available to measure progress (objective 18-9b). 
 Figure LHI-2 displays health disparities [2] for the Leading Health Indicators from the best 
group rate for each characteristic at the most recent data point. It also displays changes in 
disparities from baseline to the most recent data point [3]. 
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 Twenty-four objectives had statistically significant racial and ethnic health 
disparities of 10% or more. In addition, one objective had racial and ethnic health 
disparities of 10% or more but lacked data to assess statistical significance. Of these 
25 objectives, the white non-Hispanic population had the best rate for 12 objectives 
(1-1, 1-4a, 14-29a and b, 16-6a, 18-9b, 19-2, 22-2, 22-7, 25-11a and c, and 27-9). The 
black non-Hispanic population had the best rate for six objectives (13-6a and b, 18-
1, 26-10a, 26-11c, and 27-2b); the Hispanic or Latino population had the best rate 
for three objectives (26-10c, 27-1a, and 27-10); the Asian or Pacific Islander 
population had the best rate for two objectives (15-15a and 15-32); the American 
Indian or Alaska Native population had the best rate for one objective (8-1a); and 
persons of two or more races had the best rate for one objective (14-24a). 
 Females had better rates for 12 of the 14 objectives with statistically significant 
health disparities of 10% or more by sex (objectives 1-1, 1-4a, 1-9a, 14-29b, 15-15a, 
15-32, 18-1, 18-9b, 26-10c, 26-11c, 27-1a, and 27-10). Males had better rates for the 
remaining two objectives (22-7 and 25-11c). 
 Persons with at least some college education had the best rate for all 12 objectives 
with statistically significant health disparities of 10% or more by education 
(objectives 13-6a and b, 14-29a and b, 15-15a, 15-32, 16-16a, 18-1, 22-2, 26-10c, 
27-1a, and 27-10). 
 Persons with middle/high incomes had the best rate for seven of the nine objectives 
with statistically significant health disparities of 10% or more by income (objectives 
1-1, 1-4a, 13-6a, 19-2, 19-3c, 27-1a, and 27-9). Near-poor and poor persons had the 
best rate for one objective each (14-24a and 26-10a, respectively)  
 One objective had a statistically significant health disparity of 10% or more by 
geographic location and one had a health disparity of 10% or more by geographic 
location but lacked data to assess statistical significance. Persons living in urban or 
metropolitan areas had a better rate for one (objective 1-1), while persons living in 
rural or nonmetropolitan areas had a better rate for the other (objective 8-1a). 
 Eight objectives had statistically significant health disparities of 10% or more by 
disability status. Persons with disabilities (objectives 1-1, 1-4a, and 14-29a and b) 
and those without disabilities (objectives 13-6a, 19-2, 22-2, 27-1a) each had the best 
rate for the four of these objectives. 
 Health disparities of 100% or more were observed for some objectives among racial 
and ethnic populations, as well as by sex, education level, income, and geographic 
location. Changes in disparities of 50 percentage points or more between the 
baseline and most recent data points also were observed. Many of these disparities 
are discussed in the Highlights, above. 
 
Transition to Healthy People 2020 
At the time of this publication, the Leading Health Indicators for Healthy People 2020 had not yet 
been finalized. Readers are encouraged to reference Appendix D “A Crosswalk Between Objectives 
From Healthy People 2010 to Healthy People 2020,” which summarizes the changes between the 
two decades of objectives, as well as HealthyPeople.gov for a complete list of Healthy People 2020 
topics and objectives. 
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Data Considerations 
Beginning in 2003, education data for the mortality objectives 15-15a (motor vehicle crash deaths), 
15-32 (homicides), and 18-1 (suicide), and the natality objective 16-6a (prenatal care), from the 
National Vital Statistics System, were suppressed. The educational attainment item was changed in 
the new U.S. Standard Certificates of Birth and Death in 2003 to be consistent with the U.S. Census 
Bureau data and to improve the ability to identify specific types of educational degrees. Many 
states, however, are still using the 1989 version of the U.S. Standard Certificate of Death, which 
focuses on highest school grade completed. As a result, educational attainment data collected using 
the 2003 version are not comparable with data collected using the 1989 version [4]. 
Data for objective 16-6a (early prenatal care) were based upon the information recorded on birth 
certificates and also collected by states and local vital records offices. Due to the desire to produce 
more robust information, the 2003 revision of the standard birth certificate introduced improved 
standards which produce non-comparable rates [6,7]. For Healthy People 2010, data obtained from 
the 1997 version of the standard birth certificate was used from baseline through 2002 to track this 
objective. 
The data label used for objective 19-3c “overweight or obesity” in children and adolescents was 
revised since the Healthy People 2010 Midcourse Review and progress reviews to “obesity” even 
though the definition (BMI at or above the sex- and age-specific 95th percentile from the 2000 CDC 
Growth Charts) and interpretation are still the same. This change is consistent with revisions made 
by the American Academy of Pediatrics, the Institute of Medicine, and other organizations. Strictly 
speaking, overweight refers to weight in excess of a weight standard which could be due to a 
greater lean body mass, and obesity refers to excess body fatness. Because the indexes used are 
based on body mass rather than fatness, the original terminology of “overweight” for children at or 
above the 95th percentile was intended to clarify that this cut-off point should not be used as 
diagnostic criteria. Rather, these children may or may not have excess body fat and should, 
therefore, be screened for obesity. However, because body fat is difficult to measure and the 
majority of children with BMI at or above the 95th percentile have high adiposity, on a population-
wide basis, high weight-for-height can be considered as an adequate indicator of obesity [5]. 
Education and income are the primary measures of socioeconomic status (SES) in Healthy People 
2010. Most data systems used in Healthy People 2010 define income as a family’s income before 
taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size 
and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed 
by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. 
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These categories may be overridden by considerations specific to the data system, in which case 
they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. 
In general, data on educational attainment are presented for persons aged 25 years and over, 
consistent with guidance given by the U.S. Bureau of the Census. However, because of the 
requirements of the different data systems, the age groups used to calculate educational attainment 
for any specific objective may differ from the age groups used to report the data for other Healthy 
People 2010 objectives, as well as from select populations within the same objective. Therefore, the 
reader is urged to exercise caution in interpreting the data by educational attainment shown in the 
Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. 
Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can 
be found in the Operational Definitions on the DATA2010 website, available from 
http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement 
can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, 
which is available in the Data Issues section of the NCHS Healthy People website under 
Healthy People 2010. 
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References and Notes 
1. Displayed in the Progress Chart (Figure LHI-1), the percent of targeted change achieved expresses 
the difference between the baseline and the final value relative to the initial difference between the 
baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward 
attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When 
standard errors were available, the difference between the baseline and the final value was tested at 
the 0.05 level of significance. See the Figure LHI-1 footnotes, as well as the Technical Appendix, for 
more detail. 
2. Information about disparities among select populations is shown in the Health Disparities Table 
(Figure LHI-2). Disparity from the best group rate is defined as the percent difference between the 
best group rate and each of the other group rates for a characteristic. For example, racial and ethnic 
health disparities are measured as the percent difference between the best racial and ethnic group 
rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as 
the percent difference between the better group rate (e.g., female) and the rate for the other group 
(e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be 
increased, while others are expressed in terms of adverse events or conditions that are to be reduced. 
In order to facilitate comparison of health disparities across different objectives, disparity is 
measured only in terms of adverse events or conditions. For comparability across objectives, 
objectives that are expressed in terms of favorable events or conditions are re-expressed using the 
adverse event or condition for the purpose of computing disparity, but they are not otherwise 
restated or changed. For example, objective 1-1, to increase the proportion of persons with health 
insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had 
some form of health insurance in 2008), is expressed in terms of the percentage of persons without 
health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged 
under 65 years did not have any form of health insurance in 2008) when the disparity from the best 
group rate is calculated. See the Reader’s Guide for more information. When standard errors were 
available, the difference between the best group rate and each of the other group rates was tested at 
the 0.05 level of significance. See the Figure LHI-2 footnotes, as well as the Technical Appendix, for 
more detail. 
3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the 
most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s 
Guide for more information. When standard errors were available, the change in disparity was tested 
at the 0.05 level of significance. See the Figure LHI-2 footnotes, as well as the Technical Appendix, for 
more detail. 
4. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics 
reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available from: 
http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf. 
5. Ogden CL, Flegal KM. Changes in terminology for childhood overweight and obesity. National health 
statistics reports; no 25. Hyattsville, MD: National Center for Health Statistics. 2010. Available from: 
http://www.cdc.gov/nchs/data/nhsr/nhsr025.pdf. 
6. National Center for Health Statistics. 2003 revision of the U.S. Standard Certificate of Live Birth. 2003. 
Available from: http://www.cdc.gov/nchs/nvss/vital_certificate_revisions.htm.  
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Reports. National Center for Health Statistics. 2000. Available from: 
http://www.cdc.gov/nchs/data/dvs/panelreport_acc.pdf. 
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Comprehensive Summary of Objectives: Leading Health Indicators 
Objective Description Data Source 
1-1 Persons with health insurance (<65 years) National Health Interview Survey (NHIS), CDC, NCHS. 
1-4a Source of ongoing care  National Health Interview Survey (NHIS), CDC, NCHS. 
1-9a Hospitalization for pediatric asthma (admissions per 10,000 
population, <18 years) 
Healthcare Cost and Utilization Project (HCUP), AHRQ. 
8-1a Percent of persons exposed to harmful air pollutants—Ozone Air Quality System (AQS), Environmental Protection Agency (EPA). 
13-6a Condom use among sexually active unmarried persons (18-44 years)—
Females 
National Survey of Family Growth (NSFG), CDC, NCHS. 
13-6b Condom use among sexually active unmarried persons (18-44 years)—
Males 
National Survey of Family Growth (NSFG), CDC, NCHS. 
14-24a Fully immunized young children 19–35 months National Immunization Survey (NIS), CDC, NCIRD; NCHS. 
14-29a Vaccination of noninstitutionalized high-risk older adults—Influenza 
vaccine in past 12 months (age adjusted, 65+ years) 
National Health Interview Survey (NHIS), CDC, NCHS. 
14-29b Vaccination of noninstitutionalized high-risk older adults—
Pneumococcal vaccine ever received (age adjusted, 65+ years) 
National Health Interview Survey (NHIS), CDC, NCHS. 
15-15a Deaths from motor vehicle crashes—Age adjusted per 100,000 
standard population 
National Vital Statistics System—Mortality (NVSS–M), CDC, NCHS. 
15-32 Homicides (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS–M), CDC, NCHS. 
16-6a Prenatal care—Beginning in first trimester National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
18-1 Suicide (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS–M), CDC, NCHS. 
18-9b Treatment for adults with depression (18+ years) National Comorbidity Survey—Replication (NCS–R), NIH, NIMH. 
19-2 Obesity in adults (age adjusted, 20+ years) National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
19-3c Obesity in children and adolescents 6–19 years National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
22-2 Regular physical activity—Moderate or vigorous (age adjusted, 18+ 
years) 
National Health Interview Survey (NHIS), CDC, NCHS. 
22-7 Vigorous physical activity in students (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.  
25-11a Students who never had sexual intercourse (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
25-11b Students who had sexual intercourse, but not in the past 3 months Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
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Objective Description Data Source 
(grades 9–12) 
25-11c Students who used condoms at last intercourse (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
26-10a Adolescents not using alcohol or illicit drugs in past 30 days (12–17 
years) 
National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-10c Adults using illicit drugs in past 30 days (18+ years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-11c Binge drinking in the past month—Adults (18+ years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 
27-1a Cigarette use by adults (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 
27-2b Cigarette use in past month by students (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.  
27-9 Exposure to tobacco smoke at home among children (≤6 years) National Health Interview Survey (NHIS), CDC, NCHS. 
27-10 Exposure to environmental tobacco smoke among nonsmokers (age 
adjusted, 4+ years) 
National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
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Figure LHI-1. Progress Toward Target Attainment for Leading Health Indicators 
Percent of targeted change achieved5 
(continued) 
Physical Activity 
22-2. Regular physical activity—Moderate or 
vigorous (age adjusted, 18+ years) 
22-7. Vigorous physical activity in students (grades 
9–12)   
Overweight and Obesity 
19-2. Obesity in adults (age adjusted, 20+ 
 years)   
19-3c. Obesity in children and adolescents 
 (6–19 years) 
Tobacco Use 
27-1a. Cigarette use by adults (age adjusted, 18+ 
years) 
27-2b. Cigarette use in past month by students 
(grades 9–12)  
 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
50% 
32% 
(1997) 
32% 
(2008) 
0 No 0.0% 
85% 
65% 
(1999) 
68% 
(2009) 
3 No 4.6% 
15% 
23% 
(1988–94) 
34% 
(2005–08) 
11 Yes 47.8% 
5% 
11% 
(1988–94) 
18% 
(2005–08) 
7 Yes 63.6% 
12% 
24% 
(1998) 
21% 
(2008) 
-3 Yes -12.5% 
16% 
35% 
(1999) 
19% 
(2009) 
-16 Yes -45.7% 
0.0% 
15.0% 
25.0% 
84.2% 
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Figure LHI-1. Progress Toward Target Attainment for Leading Health Indicators (continued) 
Percent of targeted change achieved5 
Substance Abuse 
26-10a. Adolescents not using alcohol or illicit drugs 
in past 30 days (12–17 years)    
26-10c. Adults using illicit drugs in past 30 days (18+ 
years)  
26-11c. Adults binge drinking in the past month  
 (18+ years)  
Responsible Sexual Behavior 
13-6. Condom use among sexually active 
unmarried persons (18–44 years)  
  a. Females  
  b. Males*  
25-11a. Students who never had sexual intercourse 
(grades 9–12)  
25-11b. Students who had sexual intercourse, but 
 not in the past 3 months (grades 9–12)* 
25-11c. Students who used condoms at last 
intercourse (grades 9–12)*  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
91% 
78% 
(2002) 
82% 
(2008) 
4 Yes 5.1% 
3.2% 
7.9% 
(2002) 
7.9% 
(2008) 
0 No 0.0% 
13.4% 
24.3% 
(2002) 
24.9% 
(2008) 
0.6 No 2.5% 
50% 
23% 
(1995) 
33% 
(2006–08) 
10 
Not 
tested 
43.5% 
54% 
42% 
(2002) 
44% 
(2006–08) 
2 
Not 
tested 
4.8% 
56% 
50% 
(1999) 
54% 
(2009) 
4 
Not 
tested 
8.0% 
30% 
27% 
(1999) 
26% 
(2009) 
-1 
Not 
tested 
-3.7% 
65% 
58% 
(1999) 
61% 
(2009) 
3 
Not 
tested 
5.2% 
30.8% 
0.0% 
37.0% 
16.7% 
42.9% 
66.7% 
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Percent of targeted change achieved5 
 
Mental Health 
18-1. Suicide (age adjusted, per 100,000 
  population)*  
Injury and Violence 
15-15a. Deaths from motor vehicle crashes (age 
adjusted, per 100,000 population)   
15-32. Homicides (age adjusted, per 100,000 
population)  
Environmental Quality 
8-1a. Percent of persons exposed to ozone 
 
27-9. Exposure to tobacco smoke at home among 
children (≤6 years)*  
 
27-10. Exposure to environmental tobacco smoke 
among nonsmokers (age adjusted, 4+ years)  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
4.8 
10.5 
(1999) 
11.3 
(2007) 
0.8 Yes 7.6% 
8.0 
14.7 
(1999) 
13.8 
(2007) 
-0.9 Yes -6.1% 
2.8 
6.0 
(1999) 
6.1 
(2007) 
0.1 No 1.7% 
0% 
43% 
(1997) 
36% 
(2010) 
-7 Not tested -16.3% 
10% 
27% 
(1994) 
8% 
(2005) 
-19 Yes -70.4% 
56% 
84% 
(1988–94) 
41% 
(2005–08) 
-43 Yes -51.2% 
 
Figure LHI-1. Progress Toward Target Attainment for Leading Health Indicators (continued) 
            153.6% 
13.4% 
16.3% 
            111.8% 
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Percent of targeted change achieved5 
 
Immunization 
14-24a. Fully immunized young children 19–35 
months 
14-29. Vaccination of noninstitutionalized high-risk 
older adults (age adjusted, 65+ years)  
  a. Influenza vaccine in past 12 months 
  b. Pneumococcal vaccine ever received 
Access to Health Care 
1-1. Persons with health insurance (<65 years)  
1-4a. Source of ongoing care 
1-9a. Hospitalization for pediatric asthma 
(admissions per 10,000 population, <18 
years)*  
16-6a. Prenatal care beginning in first trimester 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
80% 
73% 
(1998) 
78% 
(2008) 
5 Yes 6.8% 
90% 
64% 
(1998) 
67% 
(2008) 
3 Yes 4.7% 
90% 
46% 
(1998) 
60% 
(2008) 
14 Yes 30.4% 
100% 
83% 
(1997) 
83% 
(2008) 
0 No 0.0% 
96% 
87% 
(1998) 
86% 
(2008) 
-1 Yes -1.1% 
17.3 
23.0 
(1996) 
14.9 
(2008) 
-8.1 Yes -35.2% 
90% 
83% 
(1998) 
84% 
(2002) 
1 Yes 1.2% 
 
Figure LHI-1. Progress Toward Target Attainment for Leading Health Indicators (continued) 
0.0% 
            142.1% 
71.4% 
11.5% 
31.8% 
14.3% 
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(continued) 
DATA SOURCES  
 
1-1. National Health Interview Survey (NHIS), CDC, NCHS. 
1-4a. National Health Interview Survey (NHIS), CDC, NCHS. 
1-9a. Healthcare Cost and Utilization Project (HCUP), AHRQ. 
8-1a. Air Quality System (AQS), Environmental Protection Agency (EPA). 
13-6a–b. National Survey of Family Growth (NSFG), CDC, NCHS. 
14-24a. National Immunization Survey (NIS), CDC, NCIRD; NCHS. 
14-29a–b. National Health Interview Survey (NHIS), CDC, NCHS. 
15-15a. National Vital Statistics System—Mortality (NVSS–M), CDC, NCHS. 
15-32. National Vital Statistics System—Mortality (NVSS–M), CDC, NCHS. 
16-6a. National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
18-1. National Vital Statistics System—Mortality (NVSS–M), CDC, NCHS. 
19-2. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
19-3c. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
22-2. National Health Interview Survey (NHIS), CDC, NCHS. 
22-7. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.  
25-11a–c. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
26-10a. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-10c. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-11c. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
27-1a. National Health Interview Survey (NHIS), CDC, NCHS. 
27-2b. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.  
27-9. National Health Interview Survey (NHIS), CDC, NCHS. 
27-10. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
 
 
 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objective 18-9b. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
 
* Supplemental measure.  See LHI chapter text for more information. 
 
 
 
Figure LHI-1. Progress Toward Target Attainment for Leading Health Indicators (continued) 
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Figure LHI-2. Health Disparities Table for Leading Health Indicators
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22-2. Regular physical activity—Moderate 
or vigorous (age adjusted, 18+ 
years) (1997, 2008)1*
2 1 NA 2 2 2 Bi 2 1 B 2 2 B 2 NA NA NA NA B 1 2 B
22-7. Vigorous physical activity in 
students (grades 9–12) (1999, 
2009)*
NA NA NA NA 2 2 B 2 3 B NA NA NA NA NA NA NA NA NS NS NS NS
19-2. Obesity in adults (age adjusted, 20+ 
years) (1988–94, 2005–08)2,3* NA NA NA NA
2d1ii
2 B 2
1d1
B NA NA NA NA
2d1
NA B NA NA NA 2 B
19-3c. Obesity in children and adolescents 
6–19 years (1988–94, 2005–08)3* NA NA NA NA 1ii Bi b NA B 1 NA NA NA NA 2 NA B NA NA NA NA NA
27-1a. Cigarette use by adults (age 
adjusted, 18+ years) (1998, 2008)1* 3 b NA 2 B 2 3 NA B 2 4
3u1
B 3
3u1
3 B
3u1
NA NA
3u1
B
27-2b. Cigarette use in past month by 
students (grades 9–12) (1999, 
2009)*
NA NA NA NA 3 Bi
4u3
4iii B 1 NA NA NA NA NA NA NA NA NA NA NA NA
26-10a. Adolescents not using alcohol or 
illicit drugs in past 30 days (12–17 
years) (2002, 2008)4*
3 b NA 1 2 B 2 NA 1 B NA NA NA NA Bi 1 2 2 NA NA NA NA
26-10c. Adults using illicit drugs in past 30 
days (18+ years) (2002, 2008)* 2 b 1 4 B 3 2 NA B 3 2 2 B 2 NS NS NS NS NA NA NA NA
26-11c. Adults binge drinking in the past 
month (18+ years) (2002, 2008)4* 2 b NA 1 2 B 2 NA B 4 NS NS NS NS 1 B 1 1 NA NA NA NA
13-6a. Condom use among sexually active 
unmarried persons—females 
(18–44 years) (1995, 2006–08)5‡
NA NA NA NA
2u1
Bi 1
2u1
NS NS 2
2u1
B 2 2 2 B 2 B Bi 2iv B
13-6b. Condom use among sexually active 
unmarried persons—males (18–44 
years) (2002, 2006–08)5‡§
NA NA NA NA
1d1
B
2d1 1d1
NS NS
2d1
2 B
2d1 1d1
1 B 1 1 Bi 1 B
25-11a. Students who never had sexual 
intercourse (grades 9–12) (1999, 
2009)‡
NA NA NA NA 2 3 B 2 B Bi NS NS NS NS NS NS NS NS NA NA NA NA
25-11b. Students who had sexual intercourse, 
but not in the past 3 months (grades 
9–12) (1999, 2009)‡§
NA NA NA NA B 1 1 1 1 B NS NS NS NS NS NS NS NS NA NA NA NA
25-11c. Students who used condoms at last 
intercourse (grades 9–12) (1999, 
2009)‡§
NA NA NA NA
2d1
1 Bi
2d1
2 B NS NS NS NS NS NS NS NS NA NA NA NA
18-1. Suicide (age adjusted, per 100,000 
population) (1999, 2007)6*§
4u1
NA
2u1
B
4u2 3u1
B
4d2
3
4u1
B 3 NA NA NA NA NA NA NA NA
18-9b. Treatment for adults with depression 
(18+ years) (2002)* NA NA NA NA 3 3 B 3 B 2 1 1 B 1 NA NA NA NA NA NA NA NA
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Location Disability
2u1v
Overweight and Obesity
Physical Activity
Tobacco Use
Substance Abuse
Responsible Sexual Behavior
Mental Health
Population-based objectives
(continued)
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Figure LHI-2. Health Disparities Table for Leading Health Indicators (continued)
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15-15a. Deaths from motor vehicle crashes 
(age adjusted, per 100,000 population) 
(1999, 2007)6*
4 NA 3 4
4u1
4 B
4u1 4u1 4u1
B
4u1
NA NA NA NA NS NS NA NA
15-32. Homicides (age adjusted, per 100,000 
population) (1999, 2007)6* 4 NA
4u1 4u3
2
4u2
B
4u2
4 4 B 4 NA NA NA NA NS NS NS NS
8-1a. Percent of persons exposed to ozone 
(1997, 2010)7† B 4 3 4
4u1
3 2 4 B B NA NA NA NA NA NA NA NA
4u3
B NA NA
27-9. Exposure to tobacco smoke at home 
among children [≤6 years (yrs)] (1994, 
2005)8*§
NA NA NA 1 b 2 B NA 1 B NA NA NA NA
4u3 4u2
B
4u2
NA NA NS NS
27-10. Exposure to environmental tobacco smoke 
among nonsmokers (age adjusted, 4+ yrs) 
(1988–94, 2005–08)*
NA NA NA NA Bii
3u2
2
3u1
B 2
3u1 2u1
B
2u1
NS NS NS NS NA NA NS NS
14-24a. Fully immunized young children 19–35 
months (1998, 2008)9,10* b b NA Bi 1 2 1 NA Bi B NA NA NA NA 2 B NA NA NS NS NA NA
14-29a. Vaccination of noninstitutionalized high-risk 
older adults—Influenza vaccine in past 12 
months (age adjusted, 65+ yrs) (1998, 2008)1*
NA 1 NA NA 2 3 B 2iii Bi 1 2 1 B 2 NS NS NS NS NS NS B 2
14-29b. Vaccination of noninstitutionalized high-risk 
older adults—Pneumococcal vaccine ever 
received (age adjusted, 65+ yrs) (1998, 2008)1*
NA 3 NA NA
3u1
3 B
3u1
Bi
2u1
2 2 B 2 NS NS NS NS NS NS B 2
1-1. Persons with health insurance (<65 
years) (1997, 2008)1*
4d2
2 3 2 4 3 B 3iii B 2 NS NS NS NS
4d2 4d1
B
4d2
B 2 B 2
1-4a. Source of ongoing care (1998, 2008)1*
3 2 NA 1 4 2 B 3iii B 3 NS NS NS NS 4
4u1
B
4u1
1 B B 3
1-9a. Hospitalization for pediatric asthma 
(admissions per 10,000 population, <18 
years) (1996, 2008)*§
NA NA NA NA NA NA NA NA B 3 NS NS NS NS NA NA NA NA NS NS NS NS
16-6a. Prenatal care beginning in first 
trimester (1998, 2002)*
4u1
NA 4 4 B 4 NA NA
4u1 4u1
B
4u1
NA NA NA NA NA NA NA NA
Bv
Bi, v
2v
Population-based objectives
Injury and Violence
Environmental Quality
Immunization
Access to Health Care
Characteristics and Groups
Race and Ethnicity Sex Education Income Location Disability
(continued)
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
‡
§
1
2
3
4 Baseline data by income are for 2005.
5
6
7
8
9
10
i
ii
iii
iv
v
1-1. 
1-4a. 
1-9a. 
8-1a.
13-6a–b. 
14-24a. 
14-29a–b. 
15-15a. 
15-32. 
16-6a.
18-1. 
18-9b. 
National Vital Statistics System—Mortality (NVSS–M), CDC, NCHS.
National Comorbidity Survey—Replication (NCS–R), NIH, NIMH.
National Immunization Survey (NIS), CDC, NCIRD and NCHS.
National Health Interview Survey (NHIS), CDC, NCHS.
National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
National Vital Statistics System—Natality (NVSS-N), CDC, NCHS.
National Health Interview Survey (NHIS), CDC, NCHS.
National Health Interview Survey (NHIS), CDC, NCHS.
Healthcare Cost and Utilization Project (HCUP), AHRQ.
Air Quality System (AQS), Environmental Protection Agency (EPA).
National Survey of Family Growth (NSFG), CDC, NCHS.
NOTES
Years in parentheses represent the baseline and most recent data years (if available).
10%–49% 50%–99%
Figure LHI-2. Health Disparities Table for Leading Health Indicators (continued)
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race 
and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at 
baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary 
index at the most recent data point. See Technical Appendix for more information.
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
100% or more
Change in the summary index cannot be assessed. See Technical Appendix.
Data are for Asian or Pacific Islander.
Baseline data by race and ethnicity are for 1999.
Baseline data by disability status are for 1991–94.
Most recent data by race and ethnicity, by sex, and by location, are for 2004.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical Appendix.
Data are for Mexican American.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Baseline data by race and ethnicity are for 2005.
Baseline data by race and ethnicity are for 2000.
Baseline data by income exclude "middle/high income" for comparability with most recent data year.
Data by income are categorized using only two groups: lower income (≤130% of Federal poverty level, displayed under "poor") and higher income (>130% of Federal 
poverty level, displayed under "middle/high income").
Most recent data by education level are for 2002.
Decrease in disparity (percentage points)
10–49 points 50–99 points
Data not available. Characteristic not selected for this objective.
100 points or more
27-9. 
27-10. 
Reliability criterion for best group 
rate not met, or data available for 
only one group.
Data by education level are for persons aged 25–44 years.
Increase in disparity (percentage points)
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more are 
displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows when the 
changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. Nonetheless, 
disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
Measures of variability were available only for the most recent data. Thus, the variability of best group rates was assessed only for the most recent data, and 
statistical significance was tested only for the most recent data. Disparities of 10% or more are displayed when the differences from the best group rate are 
statistically significant at the 0.05 level. Changes in disparities over time are displayed according to their magnitude, since measures of variability were not available 
at baseline and therefore statistical significance of changes in disparity could not be tested. See Technical Appendix.
Supplemental measure. See LHI chapter text for more information.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
10–49 points 50–99 points 100 points or more
DATA SOURCES
FOOTNOTES
26-10a.
26-10c.
26-11c.
27-1a. 
27-2b. 
19-2. 
19-3c. 
22-2. 
22-7. 
25-11a–c.
National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
National Health Interview Survey (NHIS), CDC, NCHS.
Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
National Health Interview Survey (NHIS), CDC, NCHS.
National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
National Survey on Drug Use and Health (NSDUH), SAMHSA.
National Survey on Drug Use and Health (NSDUH), SAMHSA.
National Survey on Drug Use and Health (NSDUH), SAMHSA.
National Health Interview Survey (NHIS), CDC, NCHS.
Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
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Reader’s Guide 
Focus Area Chapters 
Each of the 28 Healthy People 2010 Focus Areas is reviewed in a standalone chapter in the Healthy 
People 2010 Final Review. 
The Focus Area chapter begins with a brief introduction to the Focus Area. 
The Highlights section describes the salient findings in relation to progress toward target 
attainment and to health disparities for selected objectives. 
The Summary of Progress section of each chapter provides a more in-depth assessment of progress 
toward target attainment, and provides the reader with an inventory of objectives that have 
achieved their Healthy People 2010 targets, moved toward their targets, demonstrated no change, 
moved away from their targets, or lacked data to assess progress. The Progress Chart, presented as 
Figure 1 in each Focus Area chapter, displays further quantitative information regarding progress 
toward target attainment for each objective for which data were available, including the percent of 
targeted change achieved. See Measuring Progress toward the Healthy People 2010 Targets below. 
The Summary of Progress section also discusses progress toward the elimination of health 
disparities. The Health Disparities Table, presented as Figure 2 in each Focus Area chapter, displays 
detailed findings in relation to health disparities among select populations for the objectives for 
which data were available. Objectives based on schools, worksites, states, or those that were 
measured using the numbers of events are not included in the discussion of health disparities. See 
Measuring Health Disparities below. 
When data are available at the sub-national level, selected objectives are mapped to display spatial 
variation in percents, rates, or counts. Sub-national data are presented either at the state or Health 
Service Area (HSA) level. When maps are included they are presented as Figure 3 or higher in each 
Focus Area chapter. See Displaying Data with Maps below. 
Previous Healthy People 2010 publications stated that there were 467 objectives to track progress 
over the decade. However, many of these objectives consisted of multiple “sub-objectives,” each 
with its own baseline data, data source, and target requiring separate analysis. The total number of 
objectives and subobjectives upon which the analyses in this report are based is 969. For the 
purposes of discussion, both objectives and subobjectives are referred to in this report as objectives 
given that each receives equal analysis and treatment.  
The Transition to Healthy People 2020 section of each chapter describes the framework of the 
Healthy People 2020 Topic Area(s), and changes and modifications made to the corresponding 
Healthy People 2010 Focus Area(s) and objectives. Some Healthy People 2010 Focus Areas were 
split and new Healthy People 2020 Topic Areas were added. As a result, Healthy People 2020 has 
42 Topic Areas. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to 
Healthy People 2020,” summarizes the changes between the two decades of objectives. 
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Each Focus Area chapter in the Healthy People 2010 Final Review concludes with a Data 
Considerations section and a Comprehensive Summary of Objectives section that lists all objectives 
in that Focus Area with the corresponding data sources or objective status in those cases where an 
objective was not retained. 
A description of the Progress Chart and a guide to the Health Disparities Table are presented below. 
The techniques used to develop the charts and tables are discussed in greater detail in the 
Technical Appendix. Further discussion of the methodological issues involved in the measurement 
of progress and of health disparities in Healthy People 2010 has also been published [1]. 
All Healthy People 2010 tracking data are available from http://wonder.cdc.gov/data2010 and are, 
therefore, not included in this publication. 
 
Measuring Progress toward the Healthy People 2010 Targets 
Progress toward the Healthy People 2010 targets at Final Review is shown in a Progress Chart for 
each Focus Area (Figure 1). This chart displays the percent of targeted change that was achieved for 
each objective. Targeted change is the difference between the baseline and the Healthy People 2010 
target. The formula for the percent of targeted change achieved is as follows: 
Percent of tar eted chan e achieved  
 inal value    aseline value
Healthy People 20 0 tar et    aseline value
  00  
The percent of targeted change achieved expresses the difference between the baseline and the 
final value relative to the initial difference between the baseline and the Healthy People 2010 
target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target, 
and it can be used to compare how much of the targeted change has been achieved for an objective 
relative to other objectives, though care must be exercised in its interpretation. In particular, 
movement away from the Healthy People 2010 target is not quantified using the percent of targeted 
change achieved, as it is more meaningful to examine the difference between the final and the 
baseline values in such cases. See Technical Appendix for more information. 
Although the Progress Chart was displayed in previous Healthy People publications, in this report 
several new columns have been added to provide more in-depth information on the movement that 
occurred for each objective for which there were at least two data points. 
The Progress Chart is divided into three panels. Objective numbers and short descriptions are listed 
in the left-most panel. The description of an objective includes in parentheses any applicable 
information regarding the age of the targeted population. Most Healthy People 2010 objectives are 
measured using proportions, expressed in percents. If the unit of measure for an objective is 
anything other than a percent (e.g., rate per 100,000 population), then this is also indicated in 
parentheses as part of the objective description. The percent of targeted change achieved for each 
objective is displayed in a bar chart in the central panel of the Progress Chart. In the right-most 
panel of the Progress Chart, a table displays the Healthy People 2010 target, the baseline value and 
year, the final value and year, the difference between final and baseline values, its statistical 
significance at the 0.05 level, and the percent change between the final and baseline values. 
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The formula for the percent change is as follows: 
Percent chan e                                    
 inal value    aseline value
 aseline value
  00  
The percent of targeted change achieved is shown for each objective with data more recent than the 
baseline. The percent of targeted change achieved is color-coded. Objectives that moved away from 
the target are in red, moved toward the target are in light blue, and met or exceeded the target are 
in dark blue. As mentioned earlier, movement away from the Healthy People 2010 target is not 
quantified using the percent of targeted change achieved in the Progress Chart. Instead, for such 
objectives, the reader should examine the difference between the final value and the baseline value 
in order to assess progress. See Technical Appendix. 
Objectives for which progress could not be assessed are identified in the notes at the end of the 
Progress Chart. These notations occur in two general types of situations: (a) the objective was 
deleted at Midcourse Review, or (b) the objective did not have a baseline, or had a baseline value 
but no follow up data. 
The following observations may be helpful to the interpretation of the percent of targeted change 
achieved by a specific objective and/or comparisons of progress among multiple objectives: 
 The percent of targeted change achieved measures the percent of the difference between 
the baseline year and the Healthy People 2010 target that was eliminated. For example a 
value of 25 percent indicates that a quarter of the difference between the baseline and the 
Healthy People 2010 target was achieved. 
 The use and interpretation of the percent of targeted change achieved has limits. It is 
calculated using only the Healthy People 2010 target, the baseline data point, and the final 
data point. Furthermore, it does not take into account the number of years that are included 
nor any fluctuations that may occur during the intervening years. The number of years 
included, which varies by objective, may also vary within an objective based on population 
data. See Technical Appendix. 
 There are situations in which the percent of targeted change achieved cannot be calculated 
or does not accurately reflect change in an objective. These situations include instances 
when the target was met at the baseline, when the amount of targeted change was small 
relative to the amount of actual change, or when the target was exceeded at baseline. Such 
situations are footnoted on the applicable charts, and illustrated in the Technical Appendix. 
 
Measuring Health Disparities 
Information about health disparities among select populations is shown in the Health Disparities 
Table (Figure 2 in each Focus Area chapter). Short descriptions of the population-based objectives 
are listed along the left side of the chart. The baseline data year(s) are shown in parentheses and, 
when more recent data were available, the most recent data year(s) are also shown. The 
description of an objective generally also includes in parentheses any applicable information 
regarding the underlying measure (e.g., measurement unit) and/or the age of the targeted 
population. 
 
 
Reader’s Guide  Page RG-5 
Characteristics of the population (race and ethnicity, sex, education, income, geographic location, 
and disability status) are depicted across the top of the Health Disparities Table. In general, 
characteristics applicable to each objective were designated in the original Healthy People 2010 
document [2]. 
Characteristics that were not designated for a particular objective are shaded in dark gray. When a 
characteristic is not applicable for any of the objectives in a Focus Area, it is omitted from the 
Health Disparities Table for that Focus Area. When data are not available for a designated 
population or for a particular characteristic, the corresponding boxes are shaded in light gray (see 
the fourth section of the legend reproduced below). If there are no characteristic-specific data 
available for an objective, the objective is excluded from the table and referenced in the notes. 
Definition. Disparity from the best group rate is defined as the percent difference between the best 
group rate and each of the other group rates for a characteristic at the most recent data point. 
For example, disparities by race and ethnicity are measured as the percent difference between the 
best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, 
disparities by sex are measured as the percent difference between the better group rate (e.g., 
female) and the rate for the other group (e.g., male). 
Formula. The formula for disparity from the best group rate for a group G is as follows: 
 isparity for  roup    
 ate                est  roup rate                   
 est  roup rate                   
  00  
Some Healthy People 2010 objectives are expressed in terms of favorable events or conditions that 
are to be increased, while others are expressed in terms of adverse events or conditions that are to 
be reduced. In order to facilitate comparison of health disparities across different objectives, 
disparity is measured only in terms of adverse events or conditions in Healthy People 2010 [1]. 
Those objectives that are expressed in terms of favorable events or conditions are re-expressed 
using the adverse event or condition for the purpose of computing disparity, but they are not 
otherwise restated or changed. See Technical Appendix for more information. 
Example. Healthy People 2010 objective 1-1, to increase the proportion of persons with health 
insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had 
some form of health insurance in 2008), is expressed in terms of the percentage of persons without 
health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged 
under 65 years did not have any form of health insurance in 2008) when the disparity from the best 
group rate is calculated. 
As a result, the group identified as having the best rate for a given characteristic is always the group 
with the least adverse event or condition. Thus, disparities defined by the above formula remain 
nonnegative quantities, equal zero only when the group G for which disparity is being assessed has 
rate equal to the best group rate. See Technical Appendix for more information. 
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The group with the best or most favorable rate is identified for each characteristic in the Health 
Disparities Table by a "B." In the few instances when two groups had identical best rates, both 
groups are identified by a "B." In some cases, the most favorable rate is not sufficiently reliable to be 
used as the best rate. In these situations, a small letter "b" is included in the cell, and the next most 
favorable group rate with sufficient reliability is identified with a "B" as the best group. When there 
is only one group with sufficiently reliable data, a best group is not identified for purposes of 
measuring disparity, and the cells for all groups with data are left blank in the Health Disparities 
Table, indicating that disparities could not be assessed. These symbols are described in the first 
section of the legend that accompanies each of these figures (reproduced below). 
A color gradient is used to represent the size of the percent difference from the best group rate for 
each group at the most recent data point. In some cases, baseline data might be the only data 
available. The color gradient is shown in the second section of the legend, reproduced below. When 
measures of variability are available, the variability of best group rates is assessed, and statistical 
significance is tested. For a given group G within a characteristic, a disparity of 10% or more is 
displayed when the difference from the best group rate (i.e., Rate for group G   Best group rate) is 
statistically significant at the 0.05 level. See Technical Appendix. 
Change in disparity over time is estimated by subtracting the disparity at baseline from the 
disparity at the most recent data point. The change is expressed in percentage points: positive 
differences represent an increase in disparity, and negative differences represent a decrease in 
disparity. The magnitude of the change is indicated by the number of arrows. (See the third section 
of the legend reproduced below.) Whenever data are available at both the baseline and most recent 
time points, changes in disparity over time are shown if the change is greater than or equal to 10 
percentage points and statistically significant, or when the change is greater than or equal to 10 
percentage points and estimates of variability are not available. See Technical Appendix for a more 
in-depth discussion. 
Footnotes indicate whether statistical testing was performed for either the differences from the 
best group rate at the most recent data point or the changes in disparities over time. 
When there are more than two groups associated with a population characteristic (for example, 
race and ethnicity, education, and income), a summary index provides a way to determine whether 
the disparity from the best group rate has increased or decreased on average. The summary index 
is the average of percent differences between the best group rate and each of the other group rates 
for a characteristic. These comparisons are made only when disparities data are available for 
exactly the same groups at the baseline and most recent data points. 
The statistical significance of the summary index at the most recent data point and changes in the 
index over time are assessed when possible. The magnitude of the summary index at the most 
recent data point, and the magnitude and direction of changes in the summary index over time, are 
indicated by the color gradient and the arrow symbols, respectively. 
More detail on measuring, tracking, and summarizing, health disparities can be found in the 
Technical Appendix, as well as in a related publication [1]. 
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Figure RG-1: Legend for the Health Disparities Table (Figure 2) in each of the Focus Area chapters 
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
100% or more
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
100 points or 
more
Decrease in disparity (percentage points)
10–49 points 50–99 points
Data not available. Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage points 
and estimates of variability were not available. See Technical Appendix.
Increase in disparity (percentage points)
10–49 points 50–99 points
LEGEND
The "best" group rate at the most 
recent data point.
The group with the best rate for 
specified characteristic.
100 points or 
more
Percent difference from the best group rate
Disparity from the best group rate at 
the most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99%
 
 
Reader’s Guide  Page RG-8 
 
Displaying Data with Maps 
When data are available at the sub-national level, selected objectives are mapped to display spatial 
variation in percents, rates, or counts. Sub-national data are presented either at the state or HSA 
level. HSAs are defined as “…one or more counties that are relatively self-contained with respect to 
the provision of routine hospital care” [3]. HSAs are contiguous but may span state boundaries. 
They frequently contain more than one county with an average of four and maximum of 20 
counties. Maps are presented as simple chloropleths and use either a Jenks or modified Jenks 
classification [4]. A Jenks classification is a method for grouping ordered data in such a way that 
within-group variance is minimized and between-group variance is maximized. When geographic 
units (states or HSAs) have values that meet the Healthy People 2010 target, the classification is 
modified by manually setting the “best” cut-point to the Healthy People 2010 target. The best cut-
point is the highest cut-point for objectives that are expressed in terms of favorable events or 
conditions that are to be increased, and the lowest cut-point for objectives that are expressed in 
terms of adverse events or conditions that are to be reduced In some instances where the number 
of geographic units meeting the target is large a cut-point in the middle of the distribution is set to 
the target. See Technical Appendix for more information. 
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Goal: Improve access to comprehensive, high-quality 
health care services 
Access to quality health services includes access to primary care, preventive services, and other health care services on a continuum of care in the health care delivery system. The objectives in this chapter monitor progress in four general areas: 
 The first section monitors clinical preventive care and includes objectives that track health insurance coverage and counseling about health behaviors. 
 Objectives in the second section are concerned with primary care and examine source of ongoing care, having a usual primary care provider, difficulties and delays obtaining needed health care, cultural diversity and racial and ethnic representation in health professions, and hospitalization for ambulatory-care-sensitive conditions. 
 Emergency services, including delay or difficulty getting emergency care, rapid prehospital emergency care, trauma care systems, and special needs of children are monitored in the third section. 
 The final section tracks the long-term care and rehabilitative services including long term care services and pressure ulcers among nursing home residents. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade [1]. Seventy-three percent of the Access to Quality Health Services objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 1-1). However, statistically significant health disparities of 10% or more were observed among racial and ethnic populations and income groups (Figure 1-2) [2]. 
 Rates of persons with health insurance (objective 1-1) did not change over the decade. As in 1997, the baseline year for this objective, 83% of the U.S. population under age 65 years had health insurance coverage in 2008. Disparities were observed for a number of population groups, for example: 
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• Among racial and ethnic groups, the white non-Hispanic population had the highest (best) rate of health insurance coverage, 88% in 2008, whereas the American Indian or Alaska Native population and the Hispanic or Latino population had rates of 72% and 67% in 2008, respectively. When expressed as persons without health insurance, the rate for the American Indian or Alaska Native population was more than twice the best group rate (that for the white non-Hispanic population) [2]. The rate for the Hispanic or Latino population was nearly three times the best rate. 
• The American Indian or Alaska Native population had health insurance coverage rates of 62% in 1999 and 72% in 2008, whereas the white non-Hispanic population had rates of 88% in both 1999 in 2008. When rates are expressed in terms of persons without health insurance, the disparity between the American Indian or Alaska Native population and the white non-Hispanic population decreased by 83 percentage points between 1999 and 2008 [2,3]. 
• Among income groups, the middle/high income population had the highest (best) rate of health insurance coverage, 89% in 2008, whereas the poor and near-poor populations had rates of 71% and 69% in 2008, respectively. When expressed as persons without health insurance, the rate for the poor population was more than two and a half times the best group rate (that for the middle/high income population) [2]. The rate for the near-poor population was almost three times the best rate. 
• The poor population had health insurance coverage rates of 66% in 1997 and 71% in 2008, whereas the middle/high income population had rates of 90% in 1997 and 89% in 2008. When rates are expressed in terms of persons without health insurance, the disparity between the poor population and the middle/high income population decreased by 76 percentage points between 1997 and 2008 [2,3]. 
• Health insurance coverage varied by state. Although no state had achieved the Healthy People 2010 target of total coverage, five states (Connecticut, Hawaii, Iowa, Massachusetts, and Minnesota) had rates of coverage over 88% in 2008. Texas, at 71%, had the lowest coverage rate (Figure 1-3). 
 Statistically significant health disparities of 100% or more were observed for several other objectives, for example: 
• Persons who had a specific source of ongoing care among all ages (objective 1-4a): 
 Among racial and ethnic groups, the white non-Hispanic population had the highest (best) rate, 89% in 2008, whereas the Hispanic or Latino population had a rate of 77% in 2008. When expressed as persons without a specific source of ongoing care, the rate for the Hispanic or Latino population was more than twice the best group rate [2]. 
 Among income groups, the middle/high income population had the highest rate, 90% in 2008, whereas the poor and near-poor populations had rates of 78% and 80% in 2008, respectively. When expressed as persons without a specific source of ongoing care, the rates for the poor and near-poor populations were about twice the best group rate [2]. 
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• Persons who had a specific source of ongoing care among adults aged 18 years and over (objective 1-4c): 
 Among racial and ethnic groups, the white non-Hispanic population had the highest (best) rate, 87% in 2008, whereas the Hispanic or Latino population had a rate of 69% in 2008. When expressed as persons without a specific source of ongoing care, the rate for the Hispanic or Latino population was almost two a half times the best group rate [2]. 
 Among income groups, the middle/high income population had the best rate, 88% in 2008, whereas the near-poor and poor populations had rates of 76% and 71% in 2008, respectively. When expressed as persons without a specific source of ongoing care, the rate for the near-poor population was twice the best group rate, while the rate for the poor population was almost two and a half times the best rate [2]. 
• Persons who delayed or had difficulty in getting emergency medical care (objective 1-10): 
 Among racial and ethnic groups, the rate for persons of two or more races (6.7% in 2001) was about three times the best group rate, that for the white non-Hispanic population (2.2% in 2001). 
 Among income groups, the rate for the poor population (4.5% in 2001) was more than twice that of the best group rate, that for the middle/high income population (2.0% in 2001). 
 The rate for persons with disabilities (5.7% in 2001) was more than three times that for persons without disabilities (1.8% in 2001).  
Summary of Progress 
 Figure 1-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Access to Quality Health Services [1]. Data to measure progress toward target attainment were available for 48 objectives. Of these: 
• Eleven objectives (1-7a through d; 1-8b, f, j, n, and r; 1-9a; and 1-12) met or exceeded their Healthy People 2010 targets. 
• Twenty-four objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for three of these objectives (1-3c, 1-6, and 1-9c). Data to test the significance of the difference were unavailable for 21 objectives (1-3f; 1-7e and g; 1-8a, d, e, g through i, l, p, q, s, and t; 1-13a, b, e, f, and i; and 1-14a and b). 
• Six objectives (1-1; 1-4b; 1-7f and h; and 1-8m and o) showed no change. 
• Seven objectives moved away from their targets. A statistically significant difference between the baseline and final data points was observed for three objectives (1-4a and c, and 1-9b). No significant differences were observed for two objectives (1-5 and 1-16); and data to test the significance of the difference were unavailable for two objectives (1-8c and k). 
 One objective (1-3g) remained developmental and 20 objectives (1-3a, b, d, h; 1-10; 1-11a through g; 1-13c, d, g, and h; and 1-15a through d) had no data available to measure progress [4]. Two objectives (1-2 and 1-3e) were dropped during the decade [5]. 
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 Figure 1-2 displays health disparities in Access to Quality Health Services from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Of the 10 objectives with statistically significant health disparities of 10% or more by race and ethnicity, the white non-Hispanic population had the best rate for seven objectives (1-1, 1-3c, 1-4a and c, 1-5, 1-10, and 1-16). The black non-Hispanic population had the best rate for two objectives (1-3a and b) and the Hispanic or Latino population had the best rate for one objective (1-6). 
• Females had better rates than males for eight of the nine objectives with statistically significant health disparities of 10% or more by sex (objectives 1-1, 1-3c, 1-4a and c, 1-5, 1-9a and b, and 1-16). Males had a better rate than females for the remaining objective (1-6). 
• Persons with at least some college education had the best rate for the three objectives with statistically significant health disparities of 10% or more by education level (objectives 1-3h, 1-5, and 1-10). 
• Persons with middle/high incomes had the best rate for all six objectives with statistically significant health disparities of 10% or more by income (objectives 1-1, 1-3h, 1-4a and c, 1-6, and 1-10). 
• Persons living in rural or nonmetropolitan areas had better rates than persons living in urban or metropolitan areas for two of the three objectives with statistically significant health disparities of 10% or more by geographic location (objectives 1-4c and 1-5). Persons living in urban or metropolitan areas had a better rate for the third objective (1-1). 
• Persons with disabilities had better rates than persons without disabilities for seven of the 10 objectives with statistically significant health disparities of 10% or more by disability status (objectives 1-1, 1-3a through c, 1-4a and c, and 1-5). Persons without disabilities had better rates for the remaining three objectives (1-3h, 1-6, and 1-10). 
• Health disparities of 100% or more were observed for four objectives: health insurance coverage (objective 1-1), source of ongoing care among all ages and among adults (objective 1-4a and c, respectively), and delay or difficulty in getting emergency care (objective 1-10). These are discussed in the Highlights, above. 
• As indicated in the Highlights, above, increases in disparity over time between select population groups and income groups were observed for health insurance coverage.  
Transition to Healthy People 2020 For Healthy People 2020, the Access to Health Services (AHS) Topic Area uses a new organizational approach based on two major components of health services delivery: access to health services and quality of health services. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. 
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Objectives that appear in the Healthy People 2020 AHS Topic Area focus on the first component only, access to health services, whereas objectives that pertain to the second component, quality of health services, have been shifted into the appropriate disease- or condition-specific Topic Area, and are, therefore, spread throughout Healthy People 2020. The Healthy People 2010 Focus Area name was changed from “Access to Quality Health Services” to “Access to Health Services” for Healthy People 2020 to be consistent with the new organizational structure. In order to capture the objectives that are related to quality of health services, a crosswalk will be created, consisting of objectives found in the other Healthy People 2020 chapters (e.g., cancer screening rates and primary care counseling services) that are aligned with the annual National Health Quality Report (NHQR) [6]. The Healthy People 2020 AHS Topic Area can be grouped into several sections: 
 Coverage 
 Workforce 
 Utilization and Services 
 Timeliness. The differences between the Healthy People 2010 and Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Access to Health Services Topic Area has a total of 26 objectives, 16 of which are developmental, whereas the Healthy People 2010 Focus Area had 71 objectives [4]. In transitioning to Healthy People 2020, many objectives were dropped due to the shift in Topic Area focus, as well as for data-related issues such as lack of viable data sources and successful attainment of 2010 targets [5]. 
 Four Healthy People 2010 objectives were retained “as is”: health (medical) insurance (objective 1-1), specific source of ongoing care for all ages and for children and adolescents aged 17 years and under (objectives 1-4a and b, respectively), and usual primary care provider (objective 1-5) [7]. 
 Two Healthy People 2010 objectives were modified [8]. The objective on source of ongoing care for adults 18 years and over (objective 1-4c) was split into adults 18–64 years and adults 65 years and over; and the objective on difficulties or delays in receiving needed health care (objective 1-6) was modified to measure individuals instead of families and split by type of care or service (all, medical care, dental care, and prescription medicines). 
 Two Healthy People 2010 objectives, the population covered by basic and advanced life support (objectives 1-11a and b), were reverted to developmental status in 2020 due to a lack of baseline data. 
 Three Healthy People 2010 objectives were dropped [5]. Counseling about vehicle restraints and bicycle helmets (objective 1-3e) and prevention of sexually transmitted diseases (objective 1-3g) were dropped. Health insurance coverage for the clinical preventive services objective (1-2) was dropped at the Healthy People 2010 Midcourse Review but then retained as developmental for 2020. 
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 The remaining 60 Healthy People 2010 AHS objectives were archived or moved to other Healthy People 2020 Topic Areas, including new Topic Areas related to age groups: Early and Middle Childhood, Adolescent Health, and Older Adults [9]. These objectives cover the following topics: counseling about health behaviors (objectives 1-3a through d, f, and h); health professions training on health promotion, disease prevention, and cultural diversity (objectives 1-7a through h); racial and ethnic representation in health professions (objectives 1-8a through t); hospitalization for specific conditions (objectives 1-9a through c); emergency care (objectives 1-10 and 1-11c through g); poison control (objectives 1-12); trauma care systems (objectives 1-13a through i); special needs of children (objectives 1-14a and b); and access to long-term care services (objectives 1-15a through d and 1-16). 
• In many cases, objectives were dropped or moved to other Topic Areas due to the revised focus of the AHS Topic Area, while in other cases the target was met or objectives no longer had viable data sources. 
• For example, the objective that tracks physician counseling about physical activity (objective 1-3a) was moved into the Healthy People 2020 Physical Activity Topic Area and modified to include objectives on physician counseling and education related to exercise. 
 Thirteen new objectives were added to the Healthy People 2020 AHS Topic Area: 
• The health insurance coverage objective was expanded from one to three objectives covering medical insurance (retained from Healthy People 2010), dental insurance (developmental), and prescription drug insurance (developmental). 
• Four new objectives related to workforce were added. These developmental objectives will track the practicing primary care providers in the following professions: medical doctor, doctor of osteopathy, physician assistant, and nurse practitioner. 
• One new developmental objective will track persons who receive appropriate evidence-based clinical services.  
• Six new developmental objectives track hospital emergency department visits for which wait time to see an emergency department clinician exceeds the recommended timeframe. Appendix D, “A Crosswalk Between Objectives from Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
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Data Considerations Data on health professions training on health promotion, disease prevention, and cultural diversity (objectives 1-7a through h) and racial and ethnic representation in health professions (objectives 1-8a through t) had definitional issues that resulted in difficulties in interpreting trends for certain objectives during the Healthy People 2010 tracking decade . For example, objectives 1-7e and f used a different survey in 2008 than for the 1999 baseline, which may result in data for those objectives not being comparable over time. The baseline survey data for objectives 1-7g and h did not include the D.N.P. degree as a response option, whereas the 2008 survey data did include that degree. Finally, objectives 1-8a through d, racial and ethnic representation for health professions, do not include data for dental professionals for the final year of data (2009) since those data were not available at the time of publication. Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Figure 1-3 (Persons with Heath Insurance) presents state-level data from the Behavioral Risk Factor Surveillance System (BRFSS). National data for these objectives come from the National Health Interview Survey (NHIS) and are the basis for setting the targets. BRFSS data may not be comparable to the National data from the NHIS. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
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 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
References and Notes 1. Displayed in the Progress Chart (Figure 1-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 1-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 1-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 1-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 1-2 footnotes, as well as the Technical Appendix, for more detail. 4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 5. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 
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6. Agency for Healthcare Research and Quality. National Healthcare Quality Report 2010 [Internet]. Washington: Agency for Healthcare Research and Quality; 2010. (AHRQ publication no. 11-0004). Available from: http://www.ahrq.gov/qual/qrdr10.htm. 7. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 8. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 9. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 
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Comprehensive Summary of Objectives: Access to Quality Health Services 
Objective Description Data Source or Objective Status 1-1 Persons with health insurance (<65 years) National Health Interview Survey (NHIS), CDC, NCHS. 1-2 Health insurance coverage for clinical preventive services Dropped 1-3a Counseling about physical activity or exercise (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 1-3b Counseling about diet and nutrition (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 1-3c Counseling about smoking cessation (age adjusted, smokers 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 1-3d Counseling about risky drinking (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 1-3e Counseling about childhood injury prevention (≤17 years) Dropped 1-3f Counseling about unintended pregnancy (females 15–44 years) National Survey of Family Growth (NSFG), CDC, NCHS. 1-3g Counseling about prevention of sexually transmitted diseases (15–44 years) Developmental 1-3h Counseling about management of menopause (females 45–57 years) National Health Interview Survey (NHIS), CDC, NCHS. 1-4a Source of ongoing care—All ages National Health Interview Survey (NHIS), CDC, NCHS. 1-4b Source of ongoing care—Children and adolescents (<18 years) National Health Interview Survey (NHIS), CDC, NCHS. 1-4c Source of ongoing care—Adults (18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 1-5 Persons with a usual primary care provider Medical Expenditure Panel Survey (MEPS), AHRQ. 1-6 Difficulties or delays in obtaining needed health care (families) Medical Expenditure Panel Survey (MEPS), AHRQ. 1-7a Medical doctor (M.D. degree)—Counseling for health promotion and disease prevention Liaison Committee on Medical Education (LCME) Annual Medical School Questionnaire, Association of American Medical Colleges. 1-7b Medical doctor (M.D. degree)—Cultural diversity  Liaison Committee on Medical Education (LCME) Annual Medical School Questionnaire, Association of American Medical Colleges. 1-7c Osteopathic medical doctor (D.O. degree)—Counseling for health promotion and disease prevention Annual Report on Osteopathic Medical Education, American Association of Colleges of Osteopathic Medicine. 1-7d Osteopathic medical doctor (D.O. degree)—Cultural diversity  Annual Report on Osteopathic Medical Education, American Association of Colleges of Osteopathic Medicine. 1-7e Baccalaureate-level nurse (B.S.N., B.A., or B.S. degree)—Counseling for health promotion and disease prevention Special Healthy People Survey of Entry-Level Baccalaureate Nursing School Curriculum, formerly Survey on Women's Health in the Entry-Level Baccalaureate Nursing School Curriculum, American Association of Colleges of Nursing. 
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Objective Description Data Source or Objective Status 1-7f Baccalaureate-level nurse (B.S.N., B.A., or B.S. degree)— Cultural diversity Special Healthy People Survey of Entry-Level Baccalaureate Nursing School Curriculum, formerly Survey on Women's Health in the Entry-Level Baccalaureate Nursing School Curriculum, American Association of Colleges of Nursing. 1-7g Nurse Practitioner (M.S., M.S.N., or D.N.P. degree)—Counseling for health promotion and disease prevention Collaborative Curriculum Survey, American Association of Colleges of Nursing and National Organization of Nurse Practitioner Faculties. 1-7h Nurse Practitioner (M.S., M.S.N., or D.N.P. degree)—Cultural diversity Collaborative Curriculum Survey, American Association of Colleges of Nursing and National Organization of Nurse Practitioner Faculties. 1-8a Racial and ethnic representation in health professions—American Indian or Alaska Native Survey of Predoctoral Dental Educational Institutions, American Dental Association; Profile of Pharmacy Students, American Association of Colleges of Pharmacy; AAMC Data Book, Association of American Medical Colleges; Annual Data Report, Association of Schools of Public Health. 1-8b Racial and ethnic representation in health professions—Asian or Pacific Islander Survey of Predoctoral Dental Educational Institutions, American Dental Association; Profile of Pharmacy Students, American Association of Colleges of Pharmacy; AMC Data Book, Association of American Medical Colleges; Annual Data Report, Association of Schools of Public Health. 1-8c Racial and ethnic representation in health professions—Black or African American Survey of Predoctoral Dental Educational Institutions, American Dental Association; Profile of Pharmacy Students, American Association of Colleges of Pharmacy; AAMC Data Book, Association of American Medical Colleges; Annual Data Report, Association of Schools of Public Health. 1-8d Racial and ethnic representation in health professions—Hispanic or Latino Survey of Predoctoral Dental Educational Institutions, American Dental Association; Profile of Pharmacy Students, American Association of Colleges of Pharmacy; AAMC Data Book, Association of American Medical Colleges; Annual Data Report, Association of Schools of Public Health. 1-8e Racial and ethnic representation in Nursing—American Indian or Alaska Native Annual Survey of RN (Registered Nurse) Programs, National League for Nursing, Center for Research in Nursing Education and Community Health. 1-8f Racial and ethnic representation in Nursing—Asian or Pacific Islander Annual Survey of RN (Registered Nurse) Programs, National League for Nursing, Center for Research in Nursing Education and Community Health. 1-8g Racial and ethnic representation in Nursing—Black or African American Annual Survey of RN (Registered Nurse) Programs, National League for Nursing, Center for Research in Nursing Education and Community Health. 
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Objective Description Data Source or Objective Status 1-8h Racial and ethnic representation in Nursing—Hispanic or Latino Annual Survey of RN (Registered Nurse) Programs, National League for Nursing, Center for Research in Nursing Education and Community Health. 1-8i Racial and ethnic representation in Medicine—American Indian or Alaska Native AAMC Data Book: Statistical Information Related to Medical Schools and Teaching Hospitals, Association of American Medical Colleges. 1-8j Racial and ethnic representation in Medicine—Asian or Pacific Islander AAMC Data Book: Statistical Information Related to Medical Schools and Teaching Hospitals, Association of American Medical Colleges. 1-8k Racial and ethnic representation in Medicine—Black or African American AAMC Data Book: Statistical Information Related to Medical Schools and Teaching Hospitals, Association of American Medical Colleges. 1-8l Racial and ethnic representation in Medicine—Hispanic or Latino AAMC Data Book: Statistical Information Related to Medical Schools and Teaching Hospitals, Association of American Medical Colleges. 1-8m Racial and ethnic representation in Dentistry—American Indian or Alaska Native Survey of Predoctoral Dental Educational Institutions, American Dental Association. 1-8n Racial and ethnic representation in Dentistry—Asian or Pacific Islander Survey of Predoctoral Dental Educational Institutions, American Dental Association. 1-8o Racial and ethnic representation in Dentistry—Black or African American Survey of Predoctoral Dental Educational Institutions, American Dental Association. 1-8p Racial and ethnic representation in Dentistry—Hispanic or Latino Survey of Predoctoral Dental Educational Institutions, American Dental Association. 1-8q Racial and ethnic representation in Pharmacy—American Indian or Alaska Native Profile of Pharmacy Students, American Association of Colleges of Pharmacy. 1-8r Racial and ethnic representation in Pharmacy—Asian or Pacific Islander Profile of Pharmacy Students, American Association of Colleges of Pharmacy. 1-8s Racial and ethnic representation in Pharmacy—Black or African American Profile of Pharmacy Students, American Association of Colleges of Pharmacy. 1-8t Racial and ethnic representation in Pharmacy—Hispanic or Latino Profile of Pharmacy Students, American Association of Colleges of Pharmacy. 1-9a Hospitalization for pediatric asthma (admissions per 10,000 population, <18 years) Healthcare Cost and Utilization Project (HCUP), AHRQ. 1-9b Hospitalization for uncontrolled diabetes (admissions per 10,000 population, 18–64 years) Healthcare Cost and Utilization Project (HCUP), AHRQ. Healthcare Cost and Utilization Project (HCUP), AHRQ. 1-9c Hospitalization for immunization—preventable pneumonia or influenza (admissions per 10,000 population, 65+ years) Healthcare Cost and Utilization Project (HCUP), AHRQ. Healthcare Cost and Utilization Project (HCUP), AHRQ. 
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Objective Description Data Source or Objective Status 1-10 Delay or difficulty in getting emergency care (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 1-11a Rapid pre-hospital emergency care—Population covered by Basic Life Support National Assessment of State Trauma System Development, Emergency Medical Services Resources, Disaster Readiness for Mass Casualty Events, HRSA. 1-11b Rapid pre-hospital emergency care—Population covered by Advanced Life Support National Assessment of State Trauma System Development, Emergency Medical Services Resources, Disaster Readiness for Mass Casualty Events, HRSA. 1-11c Rapid pre-hospital emergency care—Population covered by helicopter National Assessment of State Trauma System Development, Emergency Medical Services Resources, Disaster Readiness for Mass Casualty Events, HRSA. 1-11d Rapid pre-hospital emergency care—Pre-hospital access to online medical control National Assessment of State Trauma System Development, Emergency Medical Services Resources, Disaster Readiness for Mass Casualty Events, HRSA. 1-11e Rapid pre-hospital emergency care—Population covered by basic 9-1-1 National Assessment of State Trauma System Development, Emergency Medical Services Resources, Disaster Readiness for Mass Casualty Events, HRSA. 1-11f Rapid pre-hospital emergency care—Population covered by enhanced 9-1-1 National Assessment of State Trauma System Development, Emergency Medical Services Resources, Disaster Readiness for Mass Casualty Events, HRSA. 1-11g Rapid pre-hospital emergency care—Population two-way communication between hospitals National Assessment of State Trauma System Development, Emergency Medical Services Resources, Disaster Readiness for Mass Casualty Events, HRSA. 1-12 Single toll-free number for poison control centers American Association of Poison Control Centers Survey, U.S. Poison Control Centers. 1-13a Trauma care systems (no. States and D.C.)—Presence of active multidisciplinary trauma advisory committee Federal Trauma-EMS Systems Program Survey, HRSA. 1-13b Trauma care systems (no. States and D.C.)—Defined process for designing trauma centers Federal Trauma-EMS Systems Program Survey, HRSA. 1-13c Trauma care systems (no. States and D.C.)—Use of ACS standards for trauma center verification Federal Trauma-EMS Systems Program Survey, HRSA. 1-13d Trauma care systems (no. States and D.C.)—Use of on-site survey teams for trauma center verification Federal Trauma-EMS Systems Program Survey, HRSA. 
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Objective Description Data Source or Objective Status 1-13e Trauma care systems (no. States and D.C.)—Pre-hospital triage criteria allowing for the bypass of non-designated hospitals Federal Trauma-EMS Systems Program Survey, HRSA. 1-13f Trauma care systems (no. States and D.C.)—Standardized inter-hospital transfer protocols Federal Trauma-EMS Systems Program Survey, HRSA. 1-13g Trauma care systems (no. States and D.C.)—Policies describing the types of patients who should be transferred Federal Trauma-EMS Systems Program Survey, HRSA. 1-13h Trauma care systems (no. States and D.C.)—Process to monitor and evaluate trauma system outcomes Federal Trauma-EMS Systems Program Survey, HRSA. 1-13i Trauma care systems (no. States and D.C.)—Trauma System Plan Federal Trauma-EMS Systems Program Survey, HRSA. 1-14a Special needs of children (no. States and D.C.)—Pediatric protocols for online medical direction Emergency Medical Services for Children Annual Grantees Survey, HRSA. 1-14b Special needs of children (no. States and D.C.)—Pediatric guidelines for emergency and critical care Emergency Medical Services for Children Annual Grantees Survey, HRSA. 1-15a Lack of access to home health care among persons with long-term care needs (age adjusted, 65+ years) National Health Interview Survey (NHIS), CDC, NCHS. 1-15b Lack of access to adult day care among persons with long-term care needs (age adjusted, 65+ years) National Health Interview Survey (NHIS), CDC, NCHS. 1-15c Lack of access to assisted living among persons with long-term care needs (age adjusted, 65+ years) National Health Interview Survey (NHIS), CDC, NCHS. 1-15d Lack of access to nursing home care services among persons with long-term care needs (aged adjusted, 65+ years) National Health Interview Survey (NHIS), CDC, NCHS. 1-16 Pressure ulcers among nursing home residents (current diagnoses per 1,000 residents) National Nursing Home Survey (NNHS), CDC, NCHS.  
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Figure 1-1. Progress Toward Target Attainment for Focus Area 1: Access to Quality Health Services 
Percent of targeted change achieved5 (continued) 
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(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
87% 
79% 
(2003–04) 
95% 
(2007–08) 
16 Not tested 20.3% 
96% 
87% 
(1999–2000) 
99% 
(2007–08) 
12 Not tested 13.8% 
100% 
95% 
(2003–04) 
100% 
(2009) 
5 Not tested 5.3% 
39% 
35% 
(2003–04) 
96% 
(2009) 
61 Not tested 174.3% 
100% 
91% 
(1999) 
99% 
(2008) 
8 Not tested 8.8% 
100% 
98% 
(1999) 
98% 
(2008) 
0 Not tested 0.0% 
100% 
94% 
(2000–01) 
96% 
(2008) 
2 Not tested 2.1% 
100% 
97% 
(2000–01) 
97% 
(2008) 
0 Not tested 0.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 1-1. Progress Toward Target Attainment for Focus Area 1: Access to Quality Health Services (continued) 
Percent of targeted change achieved5 (continued) 
 
1-7. Medical doctor (M.D. degree) 
  a. Counseling for health promotion and 
    disease prevention 
  b. Cultural diversity   
 Osteopathic medical doctor (D.O. degree) 
  c. Counseling for health promotion and 
    disease prevention 
  d. Cultural diversity 
 Baccalaureate-level nurse (B.S.N., B.A., or 
B.S. degree) 
  e. Counseling for health promotion and 
   disease prevention  
  f. Cultural diversity  
 Nurse Practitioner (M.S., M.S.N., or D.N.P. 
degree) 
  g. Counseling for health promotion and 
   disease prevention 
  h. Cultural diversity 
            200.0% 
            133.3% 
100.0% 
          1,525.0% 
88.9% 
0.0% 
33.3% 
0.0% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
1.0% 
0.6% 
(1996–97) 
0.7% 
(2008–09) 
0.1 Not tested 16.7% 
4.0% 
16.3% 
(1996–97) 
21.2% 
(2008–09) 
4.9 Not tested 30.1% 
13.0% 
6.5% 
(1996–97) 
6.4% 
(2008–09) 
-0.1 Not tested -1.5% 
12.0% 
5.2% 
(1996–97) 
5.8% 
(2008–09) 
0.6 Not tested 11.5% 
1.0% 
0.7% 
(1995–96) 
0.9% 
(2006–07) 
0.2 Not tested 28.6% 
4.0% 
3.2% 
(1995–96) 
5.3% 
(2006–07) 
2.1 Not tested 65.6% 
13.0% 
6.9% 
(1995–96) 
10.9% 
(2006–07) 
4.0 Not tested 58.0% 
12.0% 
3.4% 
(1995–96) 
6.5% 
(2006–07) 
3.1 Not tested 91.2% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 1-1. Progress Toward Target Attainment for Focus Area 1: Access to Quality Health Services (continued) 
Percent of targeted change achieved5 (continued) 
 
1-8. Racial and ethnic representation in health 
professions 
  a. American Indian or Alaska Native 
  b. Asian or Pacific Islander 
  c. Black or African American 
  d. Hispanic or Latino 
. Racial and ethnic representation in 
Nursing 
  e. American Indian or Alaska Native  
  f. Asian or Pacific Islander 
  g. Black or African American 
  h. Hispanic or Latino 
25.0% 
   Target exceeded at baseline 
                   and final 
8.8% 
66.7% 
            262.5% 
65.6% 
36.0% 
Access to Quality Health Services Page 1-18 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
1.0% 
0.7% 
(1996–97) 
0.8% 
(2008–09) 
0.1 Not tested 14.3% 
4.0% 
16.0% 
(1996–97) 
21.1% 
(2008–09) 
5.1 Not tested 31.9% 
13.0% 
7.0% 
(1996–97) 
6.5% 
(2008–09) 
-0.5 Not tested -7.1% 
12.0% 
5.9% 
(1996–97) 
6.9% 
(2008–09) 
1.0 Not tested 16.9% 
1.0% 
0.5% 
(1996–97) 
0.5% 
(2007–08) 
0.0 Not tested 0.0% 
4.0% 
19.5% 
(1996–97) 
23.4% 
(2007–08) 
3.9 Not tested 20.0% 
13.0% 
5.1% 
(1996–97) 
5.1% 
(2007–08) 
0.0 Not tested 0.0% 
12.0% 
5.3% 
(1996–97) 
6.1% 
(2007–08) 
0.8 Not tested 15.1% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 1-1. Progress Toward Target Attainment for Focus Area 1: Access to Quality Health Services (continued) 
Percent of targeted change achieved5 (continued) 
 
1-8. Racial and ethnic representation in 
Medicine 
  i. American Indian or Alaska Native 
  j. Asian or Pacific Islander 
  k. Black or African American 
  l. Hispanic or Latino 
 Racial and ethnic representation in 
Dentistry 
  m. American Indian or Alaska Native  
  n. Asian or Pacific Islander 
  o. Black or African American 
  p. Hispanic or Latino 
33.3% 
   Target exceeded at baseline 
                   and final 
   Target exceeded at baseline 
                   and final 
0.0% 
0.0% 
11.9% 
16.4% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
1.0% 
0.4% 
(1996–97) 
0.6% 
(2008–09) 
0.2 Not tested 50.0% 
4.0% 
17.5% 
(1996–97) 
21.2% 
(2008–09) 
3.7 Not tested 21.1% 
13.0% 
5.7% 
(1996–97) 
6.3% 
(2008–09) 
0.6 Not tested 10.5% 
12.0% 
3.6% 
(1996–97) 
4.1% 
(2008–09) 
0.5 Not tested 13.9% 
17.3 
23.0 
(1996) 
14.9 
(2008) 
-8.1 Yes -35.2% 
5.4 
7.2 
(1996) 
8.7 
(2008) 
1.5 Yes 20.8% 
7.9 
10.5 
(1996) 
8.9 
(2008) 
-1.6 Yes -15.2% 
100% 
15% 
(1999) 
100% 
(2005) 
85 Not tested 566.7% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 1-1. Progress Toward Target Attainment for Focus Area 1: Access to Quality Health Services (continued) 
Percent of targeted change achieved5 (continued) 
 
1-8. Racial and ethnic representation in 
Pharmacy 
  q. American Indian or Alaska Native 
   r. Asian or Pacific Islander 
  s. Black or African American 
  t. Hispanic or Latino 
1-9a. Hospitalization for pediatric asthma 
(admissions per 10,000 population, <18 
years)  
1-9b. Hospitalization for uncontrolled  
 diabetes (admissions per 10,000 
 population, 18–64 years) 
1-9c. Hospitalization for immunization-
preventable pneumonia or influenza 
(admissions per 10,000 population, 65+ 
years) 
1-12. Single toll-free number for poison control 
centers 
33.3% 
   Target exceeded at baseline 
                   and final 
8.2% 
6.0% 
            142.1% 
61.5% 
100.0% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
51 
29 
(2002) 
46 
(2005) 
17 Not tested 58.6% 
51 
34 
(2002) 
39 
(2005) 
5 Not tested 14.7% 
51 
27 
(2002) 
31 
(2005) 
4 Not tested 14.8% 
51 
23 
(2002) 
31 
(2005) 
8 Not tested 34.8% 
51 
32 
(2002) 
47 
(2005) 
15 Not tested 46.9% 
51 
18 
(1997) 
44 
(2002) 
26 Not tested 144.4% 
51 
11 
(1997) 
41 
(2003) 
30 Not tested 272.7% 
8 
16 
(1997) 
20 
(2004) 
4 No 25.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 1-1. Progress Toward Target Attainment for Focus Area 1: Access to Quality Health Services (continued)  
Percent of targeted change achieved5 (continued) 
 
 1-13. Trauma care systems (no. States and D.C.) 
  a. Presence of active multidisciplinary 
    trauma advisory committee  
  b. Defined process for designing trauma 
  centers    
  e. Pre-hospital triage criteria allowing for 
   the bypass of non-designated hospitals  
  f. Standardized inter-hospital transfer  
   protocols  
   i. Trauma System Plan   
1-14. Special needs of children (no. States and 
D.C.)  
  a. Pediatric protocols for online medical 
   direction    
  b. Pediatric guidelines for emergency and 
   critical care   
1-16. Pressure ulcers among nursing home 
residents (current diagnoses per 1,000 
residents)  
77.3% 
29.4% 
16.7% 
28.6% 
78.9% 
78.8% 
75.0% 
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Figure 1-1. Progress Toward Target Attainment for Focus Area 1: Access to Quality Health Services (continued) 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 1-3a, 1-3b, 1-3d, 1-3g, 1-3h, 1-10, 1-11a through g, 1-13c, 1-13d, 1-13g, 1-13h, and 1-15a through d. Objectives 1-2 and 1-3e were deleted at the Midcourse Review. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =                × 100. 
     Healthy People 2010 target – Baseline value 
 
 
DATA SOURCES 
 
1-1. National Health Interview Survey (NHIS), CDC, NCHS. 
1-3c. National Health Interview Survey (NHIS), CDC, NCHS.  
1-3f. National Survey of Family Growth (NSFG), CDC, NCHS. 
1-4a–c. National Health Interview Survey (NHIS), CDC, NCHS. 
1-5–1-6. Medical Expenditure Panel Survey (MEPS), AHRQ. 
1-7a–b. Liaison Committee on Medical Education (LCME) Annual Medical School Questionnaire, Association of American Medical Colleges. 
1-7c–d. Annual Report on Osteopathic Medical Education, American Association of Colleges of Osteopathic Medicine. 
1-7e–f. Special Healthy People Survey of Entry-Level Baccalaureate Nursing School Curriculum, formerly Survey on Women's Health in the Entry-Level Baccalaureate Nursing 
 School Curriculum, American Association of Colleges of Nursing. 
1-7g–h. Collaborative Curriculum Survey, American Association of Colleges of Nursing and National Organization of Nurse Practitioner Faculties. 
1-8a–d. Survey of Predoctoral Dental Educational Institutions, American Dental Association; Profile of Pharmacy Students, American Association of Colleges of Pharmacy; 
 AAMC Data Book, Association of American Medical Colleges; Annual Data Report, Association of Schools of Public Health. 
1-8e–h. Annual Survey of RN (Registered Nurse) Programs, National League for Nursing, Center for Research in Nursing Education and Community Health. 
1-8i–l. AAMC Data Book: Statistical Information Related to Medical Schools and Teaching Hospitals, Association of American Medical Colleges. 
1-8m–p. Survey of Predoctoral Dental Educational Institutions, American Dental Association. 
1-8q–t. Profile of Pharmacy Students, American Association of Colleges of Pharmacy. 
1-9a–c. Healthcare Cost and Utilization Project (HCUP), AHRQ. 
1-12. American Association of Poison Control Centers Survey, U.S. Poison Control Centers. 
1-13a–b. Federal Trauma-EMS Systems Program Survey, HRSA. 
1-13e–f. Federal Trauma-EMS Systems Program Survey, HRSA. 
1-13i. Federal Trauma-EMS Systems Program Survey, HRSA. 
1-14a–b. Emergency Medical Services for Children Annual Grantees Survey, HRSA. 
1-16. National Nursing Home Survey (NNHS), CDC, NCHS. 
 
Access to Quality Health Services Page 1-22 
Access to Quality Health Services Page 1-23
A
m
er
ic
an
 In
di
an
 o
r 
A
la
sk
a 
N
at
iv
e
A
si
an
N
at
iv
e 
H
aw
ai
ia
n 
or
 
ot
he
r P
ac
ifi
c 
Is
la
nd
er
Tw
o 
or
 m
or
e 
ra
ce
s
H
is
pa
ni
c 
or
 L
at
in
o
B
la
ck
, n
ot
 H
is
pa
ni
c
W
hi
te
, n
ot
 H
is
pa
ni
c
Su
m
m
ar
y 
in
de
x
Fe
m
al
e
M
al
e
Le
ss
 th
an
 h
ig
h 
sc
ho
ol
H
ig
h 
sc
ho
ol
 
gr
ad
ua
te
A
t l
ea
st
 s
om
e 
co
lle
ge
Su
m
m
ar
y 
in
de
x
P
oo
r
N
ea
r p
oo
r
M
id
dl
e/
hi
gh
 in
co
m
e
Su
m
m
ar
y 
in
de
x
U
rb
an
 o
r 
m
et
ro
po
lit
an
R
ur
al
 o
r 
no
nm
et
ro
po
lit
an
P
er
so
ns
 w
ith
 
di
sa
bi
lit
ie
s
P
er
so
ns
 w
ith
ou
t 
di
sa
bi
lit
ie
s
1-1. Persons with health insurance (<65 
years) (1997, 2008)1
4d2
2 3 2 4 3 B 3ii B 2 NS NS NS NS
4d2 4d1
B
4d2
B 2 B 2
1-3a. Counseling about physical activity 
or exercise (age adjusted, 18+ 
years) (2001)
2 2 NA 2 2 B 2 2 B B 1 1 B 1 1 1 B 1 B 1 B 2
1-3b. Counseling about diet and nutrition 
(age adjusted, 18+ years) (2001) 2 2 NA 2 2 B 2 2 B 1 B 1 1 1 B 1 1 1 B 1 B 2
1-3c. Counseling about smoking 
cessation (age adjusted, smokers 
18+ years) (2000, 2005)
2 2 NA b 2 2 B NA B 2 1 Bi B 1 1 B 1 1 B 1 B 2
1-3d. Counseling about risky drinking 
(age adjusted, 18+ years) (2001) NA NA NA NA B B 1 1 1 B B 1 1 1 B 1 1 1 1 B B 1
1-3f. Counseling about unintended 
pregnancy (females 15–44 years) 
(1995, 2006–08)2
NA NA NA NA Bi 1 1 1 NS NS Bi 1 1 1 NS NS NS NS NS NS 1 B
1-3h. Counseling about management of 
menopause (females 45–57 years) 
(2001)
NA 1 NA NA B 1 B 1 NS NS 2 1 B 2 2 2 B 2 B 1 2 B
1-4a. Source of ongoing care—
All ages (1998, 2008)1 3 2 NA 1 4 2 B 3ii B 3 NS NS NS NS 4
4u1
B
4u1
1 B B 3
1-4b. Source of ongoing care—
Children and adolescents (<18 
years) (1998, 2008)1
NA NA NA NA Bi 1 NS NS NS NS NA
1-4c. Source of ongoing care—
Adults (18+ years) (1998, 2008)1 3
2d1
NA 3
4u1
2 B 3 B 4 NS NS NS NS
4u1 4u1
B
4u1
2 B B 3
1-5. Persons with a usual primary care 
provider (1996, 2007)3 1 3 NA 1 3 2 B 2 B 2 2 2 B 2 NS NS NS NS 2 B Biii 3iii
1-6. Difficulties or delays in obtaining 
needed health care (families) 
(2002, 2007)
1 b NA 2 B 1 1 NA 2 B NS NS NS NS 3 3 B 3 Bi 1 3iii Biii
1-9a. Hospitalization for pediatric asthma 
[admissions per 10,000 population 
(pop.), <18 years] (1996, 2008)
NA NA NA NA NA NA NA NA B 3 NS NS NS NS NA NA NA NA NS NS NS NS
1-9b. Hospitalization for uncontrolled 
diabetes (admissions per 10,000 
pop., 18–64 years) (1996, 2008)
NA NA NA NA NA NA NA NA B 2 NS NS NS NS NA NA NA NA NS NS NS NS
1-9c. Hospitalization for immunization-preventable 
pneumonia or influenza (admissions per 
10,000 pop., 65+ years) (1996, 2008)
NA NA NA NA NA NA NA NA B
1d1
NS NS NS NS NA NA NA NA NS NS NS NS
1-10. Delay or difficulty in getting 
emergency care (age-adjusted, 18+ 
years) (2001)
NA NA NA 4 1 1 B 3 1 B 3 1 B 2 4 3 B 4 B 1 4 B
1-15a. Lack of access to home health care 
among persons with long-term care 
needs (age adjusted, 65+ years) (2001)
NA NA NA NA NA NS NS NS NS NA NS NS
1-15b. Lack of access to adult day care among 
persons with long-term care needs (age 
adjusted, 65+ years) (2001)
NA NA NA NA NA NA NA NS NS NS NS NA NA NA NA NS NS
1-15c. Lack of access to assisted living among 
persons with long-term care needs (age 
adjusted, 65+ years) (2001)
NA NA NA NA NA NA NS NS NS NS NA NA NA NS NS
1-15d. Lack of access to nursing home care 
among persons with long-term care 
needs (age adjusted, 65+ years) (2001)
NA NA NA NA NA NA NA NA NS NS NS NS NA NA NA NA NA NS NS
1-16. Pressure ulcers among nursing 
home residents (current diagnoses 
per 1,000 residents) (1997, 2004)4
NA NA NA NA NA 3iv B NA B 3iv NA NA NA NA NS NS NS NS v v
Population-based objectives
(continued)
Figure 1-2. Health Disparities Table for Focus Area 1: Access to Quality Health Services
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Location Disability
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
1 Baseline data by race and ethnicity are for 1999.
2 Baseline data by disability status are for 2006–08.
3 Baseline data by race and ethnicity are for 2002.
4 Baseline data by disability status are for 2004.
i
ii
iii
iv
v
1-1. National Health Interview Survey (NHIS), CDC, NCHS.
1-3a–d. National Health Interview Survey (NHIS), CDC, NCHS.
1-3f. National Survey of Family Growth (NSFG), CDC, NCHS.
1-3h. National Health Interview Survey (NHIS), CDC, NCHS.
1-4a–c. National Health Interview Survey (NHIS), CDC, NCHS.
1-5–1-6. Medical Expenditure Panel Survey (MEPS), AHRQ.
1-9a–c. Healthcare Cost and Utilization Project (HCUP), AHRQ.
1-10. National Health Interview Survey (NHIS), CDC, NCHS.
1-15a–d. National Health Interview Survey (NHIS), CDC, NCHS.
1-16. National Nursing Home Survey (NNHS), CDC, NCHS.
Increase in disparity (percentage points)
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
100% or more
10–49 points 50–99 points
Change in the summary index cannot be assessed. See Technical Appendix.
For this objective, only activity limitations are considered as disabilities.
For this objective, only severe disabilities are considered as disabilities.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
100 points or more
100 points or more
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical Appendix.
DATA SOURCES
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points
Data not available. Characteristic not selected for this objective.
NOTES
Years in parentheses represent the baseline and most recent data years (if available).
10%–49% 50%–99%
Figure 1-2. Health Disparities Table for Focus Area 1: Access to Quality Health Services 
(continued)
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 1-3g, 
1-7a through h, 1-8a through t, 1-11a through g, 1-12, 1-13a through i, 1-14a and b. Objectives 1-2 and 1-3e were deleted at Midcourse Review.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race and 
ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at baseline 
from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary index at 
the most recent data point. See Technical Appendix for more information.
Measures of variability were available for all objectives in this table. Thus, the variability of best group rates was assessed, and statistical significance was tested. 
Disparities of 10% or more are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time 
are indicated by arrows when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
70.7 
70.8 - 79.8 
79.9 - 83.8 
83.9 - 88.1 
88.2 - 95.0 
Figure 1-3. Persons with Health Insurance (<65 Years) 2008 
Healthy People 2010 objective 1-1 
Target = 100 
NOTES: Data are age-adjusted to the 2000 standard population. Rates are displayed by a Jenks classification for U.S. states.  National data for the  
objective come from the National Health Interview Survey (NHIS) and is the basis for setting the target.  State data from the BRFSS may not be  
comparable to the national data from the NHIS.  Both US rates are shown for comparison purposes.  
SOURCE: Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP.  
Percent 
No states met  the target 
US (2008 NHIS) – 83.3 
US (2008 BRFSS) – 82.0 
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Goal: Prevent illness and disability related to arthritis 
and other rheumatic conditions, osteoporosis, and 
chronic back conditions 
The objectives in this chapter measure the prevention of illness and disability related to arthritis, osteoporosis, and chronic back conditions. The arthritis objectives track a variety of pain, function, and intervention measures. The osteoporosis objectives track bone mineral density, a measure of the major risk factor for fractures. Hospitalizations for osteoporosis-related vertebral fractures are also monitored. Activity limitation due to chronic back conditions is used to measure the effects of chronic back pain. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this focus area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Some progress was made for objectives in this Focus Area during the past decade [1]. Twenty-three percent of the Arthritis, Osteoporosis, and Chronic Back Conditions objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 2-1). However, statistically significant health disparities of 100% or more were observed among education and income groups (Figure 2-2), as discussed below [2]. 
Arthritis 
 The proportion of overweight and obese adults aged 18 years and over with arthritis who received counseling for weight reduction (objective 2-4a) increased by 17.1% between 2002 and 2006, from 35% to 41% (age adjusted), moving toward the Healthy People 2010 target of 46%. 
 Statistically significant disparities of 100% or more were observed in the unemployment rate among adults with arthritis (objective 2-5a). 
• Among education groups, persons with at least some college education had the lowest (best) unemployment rate among persons with arthritis aged 25–64 years, 27% (age-adjusted) in 2008, whereas the rate for persons with less than a high school education was 61% (age adjusted) in 2008. The rate for the population with less than a high school education was nearly two and a half times the best group rate [2]. 
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• Among income groups, the middle/high income population had the lowest (best) unemployment rate among persons aged 18–64 years with arthritis, 23% (age adjusted) in 2008, whereas the poor and near-poor populations had rates of 69% and 51% (age adjusted) in 2008, respectively. The rate for the poor population was three times the best group rate (that for the middle/high income population), while the rate for the near-poor population was more than twice the best rate [2]. 
 Statistically significant disparities of 100% or more also were observed in the effect of arthritis on paid work among adults with arthritis (objective 2-5b). 
• Among education groups, persons with at least some college education had the lowest (best) rate of effect of arthritis on paid work among persons with arthritis aged 25–64 years, 25% (age-adjusted) in 2006. The rate for persons with less than a high school education was 53% (age adjusted) in 2006, more than twice the best group rate [2]. 
• Among income groups, the middle/high income population had the lowest (best) rate of effect of arthritis on paid work among persons with arthritis aged 18–64 years, 24% (age adjusted) in 2006. The poor population had a rate of 58% (age adjusted) in 2008, almost two and a half times the best group rate [2]. 
 Activity limitations due to arthritis (objective 2-2) varied by geographic area. In 2007, the states of Connecticut, Delaware, Hawaii, Illinois, Iowa, New Jersey, North Dakota, Pennsylvania, Rhode Island, Virginia, Utah, and Wyoming had rates that met or exceeded the Healthy People 2010 target. The states of Alabama, Alaska, Georgia, Kentucky, Tennessee, and West Virginia had the highest rates (Figure 2-3). 
Osteoporosis 
 The prevalence of osteoporosis among adults aged 50 years and over (objective 2-9) declined by 50.0% between 1988–94 and 2005–08, from 12% to 6% (age adjusted), exceeding the Healthy People 2010 target of 10%. 
Chronic Back Conditions 
 Statistically significant disparities of 100% or more were observed for activity limitations among adults aged 18 years and over with chronic back conditions (objective 2-11). 
• Among racial and ethnic populations, the Hispanic or Latino population had the lowest (best) rate of activity limitations among adults with chronic back conditions, 26% (age adjusted) in 2008. Persons of two or more races had a rate of 80% (age adjusted) in 2008, more than three times the best group rate [2]. 
• Among education groups, persons aged 25 years and over with at least some college had the lowest (best) rate of activity limitations among adults with chronic back conditions, 27% (age adjusted) in 2008. The rate for persons with less than a high school education was 56% (age adjusted) in 2008, more than twice the best group rate [2]. 
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• Among income groups, the middle/high income population had the lowest (best) rate of activity limitations among adults with chronic back conditions, 22% (age adjusted) in 2008, whereas the rates for the poor and near-poor populations were 72% and 49% (age adjusted) in 2008, respectively. The rate for the poor population was nearly three and a half times the best group rate (that for the middle/high income population), while the rate for the near-poor population was more than twice the best group rate [2].  
Summary of Progress 
 Figure 2-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Arthritis, Osteoporosis, and Chronic Back Conditions [1]. Data to measure progress toward target attainment were available for all 13 objectives, although most objectives were only monitored over four to six years. Of these: 
• One objective (2-9) exceeded the Healthy People 2010 target. 
• Two objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for one of these objectives (2-4a). No significant difference was observed for the second objective (2-11). 
• Three objectives (2-1, 2-4b, and 2-8) showed no change. 
• Seven objectives moved away from their targets. A statistically significant difference between the baseline and the final data points was observed for two of these objectives (2-6 and 2-10). No significant differences were observed for the remaining five objectives (2-2, 2-3, 2-5a and b, and 2-7). 
 Figure 2-2 displays health disparities in Arthritis, Osteoporosis, and Chronic Back Conditions from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Of the seven objectives with statistically significant racial and ethnic health disparities of 10% or more, the white non-Hispanic population had the best rate for three objectives (2-5b, 2-6, and 2-7). The Hispanic or Latino population had the best rate for two objectives (2-4b and 2-11); and the Asian (objective 2-1) and black non-Hispanic (objective 2-4a) populations had the best rate for one objective each. 
• Females had better rates than males for three of the four objectives with statistically significant health disparities of 10% or more by sex (objectives 2-4a, 2-4b, and 2-7). Males had a better rate than females for the fourth objective (2-5a). 
• Persons with at least some college education had the best rate for all five of the objectives with statistically significant health disparities of 10% or more by education level (objectives 2-1, 2-2, 2-5a and b, and 2-11). 
• Persons with middle/high incomes had the best rate for five of the six objectives with statistically significant health disparities of 10% or more by income (objectives 2-1, 2-2, 2-5a and b, and 2-11). The poor and near-poor populations both had the best rate for the sixth objective (2-4a). 
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• Health disparities of 100% or more were observed for three objectives: the unemployment rate among adults with arthritis (objective 2-5a), the effect of arthritis on paid work among adults with arthritis (objective 2-5b), and activity limitations due to chronic back conditions (objective 2-11). These disparities are discussed in the Highlights, above.  
Transition to Healthy People 2020 For Healthy People 2020, the focus of the Arthritis, Osteoporosis, and Chronic Back Conditions Topic Area has been expanded to include more arthritis-specific activity limitations and other health outcomes associated with arthritis and osteoporosis. Consistent with Healthy People 2010, the primary goal of the Healthy People 2020 objectives is to prevent illness and disability related to arthritis and other rheumatic conditions, osteoporosis, and chronic back conditions. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 Arthritis, Osteoporosis, and Chronic Back Conditions Topic Area can be grouped into four sections: 
 Arthritis-related pain and impact 
 Arthritis health system interventions 
 Osteoporosis 
 Chronic Back Conditions. The differences between the Healthy People 2010 objectives and those included in Healthy People 2020 are summarized below: 
 The Healthy People 2020 Arthritis, Osteoporosis, and Chronic Back Condition Topic Area has a total of 18 objectives, whereas the Healthy People 2010 Focus Area had 13 objectives. 
• Eleven Healthy People 2010 objectives were retained “as is” [4]. Among adults with arthritis, retained objectives tracked joint pain (objective 2-1), activity limitations due to arthritis (objective 2-2), personal care limitations (objective 2-3), counseling for weight reduction (objective 2-4a), counseling for physical activity or exercise (objective 2-4b), unemployment (objective 2-5a), effect of arthritis on paid work (objective 2-5b), and arthritis education (objective 2-8). Other retained objectives include seeing a health care provider for chronic joint symptoms (objective 2-7), prevalence of osteoporosis (objective 2-9), and activity limitations due to chronic back conditions (objective 2-11). 
• Two Healthy People 2010 objectives were archived: racial disparity in total knee replacements (objective 2-6) and hospitalization for osteoporosis-associated vertebral fractures (objective 2-10) [5]. 
• Two objectives (15-28a and b) that track hospitalizations for hip fractures among older adults (separately for females and males) were moved from the Healthy People 2010 Injury and Violence Prevention Focus Area to the Healthy People 2020 Arthritis, Osteoporosis, and Chronic Back Conditions Topic Area. 
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 Five new objectives were added to the Healthy People 2020 Arthritis, Osteoporosis, and Chronic Back Conditions Topic Area: 
• Four new objectives assess difficulty in performing specific joint-related activities among adults with arthritis: walking a quarter of a mile; walking up 10 steps without resting; stooping, bending or kneeling; and using fingers to grasp or handle small objects. 
• A new objective assesses serious psychosocial distress among adults with arthritis. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations Figure 2-3 (Activity Limitations due to Arthritis) presents state-level data from the Behavioral Risk Factor Surveillance System (BRFSS). National data for these objectives come from the National Health Interview Survey (NHIS) and are the basis for setting the targets. BRFSS data may not be comparable to the National data from the NHIS. Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below, for additional information. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
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 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
Notes 1. Displayed in the Progress Chart (Figure 2-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 2-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 2-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 2-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 2-2 footnotes, as well as the Technical Appendix, for more detail. 4. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 5. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 
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Comprehensive Summary of Objectives: Arthritis, Osteoporosis, and Chronic Back Conditions 
Objective Description Data Source 2-1 Mean level of joint pain among adults with arthritis (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 2-2 Activity limitations due to arthritis (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 2-3 Personal care limitations in adults with arthritis (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 2-4a Overweight and obese adults with arthritis who receive counseling for weight reduction (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 2-4b Adults with arthritis who receive counseling for physical activity or exercise (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 2-5a Unemployment rate among adults with arthritis (age adjusted, 18–64 years) National Health Interview Survey (NHIS), CDC, NCHS. 2-5b Effect of arthritis on paid work among adults with arthritis (age adjusted, 18–64 years) National Health Interview Survey (NHIS), CDC, NCHS. 2-6 Racial disparity in total knee replacement (blacks vs. whites, 65+ years) Medicare data, CMS. 2-7 Adults with chronic joint symptoms who saw a health care provider for their symptoms (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 2-8 Arthritis education among adults with arthritis (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 2-9 Prevalence of osteoporosis (age adjusted, 50+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 2-10 Hospitalization for osteoporosis-associated vertebral fractures (age adjusted per 10,000 standard population, 65+ years) National Hospital Discharge Survey (NHDS), CDC, NCHS. 2-11 Activity limitations due to chronic back conditions (age adjusted per 1,000 standard population, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS.  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
5.3 
5.6 
(2002) 
5.6 
(2006) 
0 No 0.0% 
33% 
36% 
(2002) 
39% 
(2008) 
3 No 8.3% 
1.5% 
2.1% 
(2002) 
2.7% 
(2008) 
0.6 No 28.6% 
46% 
35% 
(2002) 
41% 
(2006) 
6 Yes 17.1% 
67% 
52% 
(2002) 
52% 
(2006) 
0 No 0.0% 
27% 
33% 
(2002) 
35% 
(2008) 
2 No 6.1% 
23% 
30% 
(2002) 
33% 
(2006) 
3 No 10.0% 
0.0% 
-35.9% 
(2002) 
-38.4% 
(2006) 
-2.5 Yes 7.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
2-1.     Mean level of joint pain among adults with 
arthritis (age adjusted, 18+ years) 
2-2.   Activity limitations due to arthritis (age 
adjusted, 18+ years)   
2-3.     Personal care limitations in adults with 
arthritis (age adjusted, 18+ years)  
2-4a.    Overweight and obese adults with arthritis 
who receive counseling for weight reduction 
(age adjusted, 18+ years) 
2-4b.   Adults with arthritis who receive counseling 
for physical activity or exercise (age 
adjusted, 18+ years)  
2-5a.     Unemployment rate among adults with 
arthritis (age adjusted, 18–64 years)  
2-5b.    Effect of arthritis on paid work among  
 adults with arthritis (age adjusted, 18–64 
years) 
2-6.     Racial disparity in total knee  
 replacement (blacks vs. whites, 65+  
 years) 
 
 
Figure 2-1. Progress Toward Target Attainment for Focus Area 2: Arthritis, Osteoporosis and Chronic Back Conditions 
Percent of targeted change achieved5 (continued) 
0.0% 
54.5% 
0.0% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
77% 
73% 
(2002) 
72% 
(2008) 
-1 No -1.4% 
13% 
11% 
(2002) 
11% 
(2006) 
0 No 0.0% 
10% 
12% 
(1988-94) 
6% 
(2005–08) 
-6 Yes -50.0% 
14.0 
17.5 
(1998) 
23.4 
(2007) 
5.9 Yes 33.7% 
25 
32 
(1997) 
31 
(2008) 
-1 No -3.1% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
2-7.     Adults with chronic joint symptoms who  
 saw a health care provider for their 
symptoms (age adjusted, 18+ years) 
2-8.     Arthritis education among adults with arthritis  
(age adjusted, 18+ years)    
2-9.     Prevalence of osteoporosis (age adjusted, 
50+ years) 
2-10.   Hospitalization for osteoporosis-associated 
vertebral fractures (age adjusted, per 
 10,000 population, 65+ years)  
2-11.   Activity limitations due to chronic back 
conditions (age adjusted, per 1,000 
population, 18+ years)  
 
 
Figure 2-1. Progress Toward Target Attainment for Focus Area 2: Arthritis, Osteoporosis and Chronic Back Conditions 
(continued) 
Percent of targeted change achieved5 (continued) 
14.3% 
0.0% 
            300.0% 
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Figure 2-1. Progress Toward Target Attainment for Focus Area 2: Arthritis, Osteoporosis and Chronic Back Conditions 
(continued) 
DATA SOURCES 
 
2-1–2-3. National Health Interview Survey (NHIS), CDC, NCHS. 
2-4a–b. National Health Interview Survey (NHIS), CDC, NCHS. 
2-5a–b. National Health Interview Survey (NHIS), CDC, NCHS. 
2-6. Medicare data, CMS. 
2-7–2-8. National Health Interview Survey (NHIS), CDC, NCHS. 
2-9. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
2-10. National Hospital Discharge Survey (NHDS), CDC, NCHS. 
2-11. National Health Interview Survey (NHIS), CDC, NCHS. 
  
 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data.  
 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix for 
more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =                × 100. 
     Healthy People 2010 target – Baseline value 
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2-1. Mean level of joint pain among adults with arthritis (age 
adjusted, 18+ years) (2002, 2006) NA Bi NA 2 2 2 1 2ii 1 B
2u1
2 B 2
2u1
2 B 2
2-2. Activity limitations due to arthritis (age adjusted, 18+ 
years) (2002, 2008) NA b NA 1 Bi 1 B NA 1 B 2 2 B 1 3 3 B 3
2-3. Personal care limitations in adults with arthritis (age 
adjusted, 18+ years) (2002, 2008) NA NA NA NA NA NA NA
2-4a. Overweight and obese adults with arthritis who receive 
counseling for weight reduction (age adjusted, 18+ 
years) (2002, 2006)
NA 1 NA NA 1 B 2 2ii B
2u1
1 Bi 1 1 B Bi 2 1
2-4b. Adults with arthritis who receive counseling for physical 
activity or exercise (age adjusted, 18+ years) (2002, 
2006)
NA 1 NA 1 Bi 1 2 2ii B 2 1 Bi B 1 1 1 B 1
2-5a. Unemployment rate among adults with arthritis (age 
adjusted, 18–64 years) (2002, 2008) NA 1 NA 1 1
1d1
B 1ii 2 B 4 2 B 3 4 4 B 4
2-5b. Effect of arthritis on paid work among adults with arthritis 
(age adjusted, 18–64 years) (2002, 2006) NA b NA NA 2 2 B NA 1 B 4 3 B 3 4 3 B 4
2-6. Racial disparity in total knee replacement (blacks vs. 
whites, 65+ years) (2000, 2006) NA NA NA NA NA 2 B NA NA NA NA NA NA NA NA NA NA NA
2-7. Adults with chronic joint symptoms who saw a health 
care provider for their symptoms (age adjusted, 18+ 
years) (2002, 2008)
1 b NA b 2 1 Bi NA B
2d1
1 Bi 1 1 B Bi B 1
2-8. Arthritis education among adults with arthritis  (age 
adjusted, 18+ years) (2002, 2006) NA NA NA NA Bi 1 1 1 1 Bi 1 1 B 1 Bi 1 B 1
2-9. Prevalence of osteoporosis (age adjusted, 50+ years) 
(1988–94, 2005–08) NA NA NA NA 1iii, iv b B NA NA NS NS NS NS
2-10. Hospitalization for osteoporosis-associated vertebral 
fractures (age adjusted, per 10,000 population, 65+ 
years) (1998, 2007)
NA NA NA NA NA NAv v NA NA NA NA NA NA NA NA NA
2-11. Activity limitations due to chronic back conditions (age 
adjusted, per 1,000 population, 18+ years) (1997, 2008)1 3 b NA 4 B 2 2 NA 1 B 4 2 B 3 4 4 B 4
Population-based objectives
Figure 2-2. Health Disparities Table for Focus Area 2: Arthritis, Osteoporosis, and Chronic 
Back Condition
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income
(continued)
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
1
i
ii
iii
iv
v
2-1–2-3. National Health Interview Survey (NHIS), CDC, NCHS.
2-4a–b. National Health Interview Survey (NHIS), CDC, NCHS.
2-5a–b. National Health Interview Survey (NHIS), CDC, NCHS.
2-6. Medicare data, CMS.
2-7–2-8. National Health Interview Survey (NHIS), CDC, NCHS.
2-9. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
2-10. National Hospital Discharge Survey (NHDS), CDC, NCHS.
2-11. National Health Interview Survey (NHIS), CDC, NCHS.
Increase in disparity (percentage points)
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
DATA SOURCES
Data are for Mexican American.
Data include persons of Hispanic origin.
Baseline data by race and ethnicity are for 1999.
Change in the summary index cannot be assessed. See Technical Appendix.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical 
Appendix.
NOTES
10–49 points 50–99 points 100 points or more
LEGEND
Figure 2-2. Health Disparities Table for Focus Area 2: Arthritis, Osteoporosis, and Chronic 
Back Condition (continued)
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Measures of variability were available for all objectives in this table. Thus, the variability of best group rates was assessed, and statistical significance was tested. 
Disparities of 10% or more are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over 
time are indicated by arrows when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical 
Appendix.
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
Most favorable group rate for 
specified characteristic, but reliability 
criterion not met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Figure 2-3.  Activity Limitations Due to Arthritis - Adults 18+ (2007) 
Healthy People 2010 objective 2-2 
Target = 33 
lowest category (green) shows 
states that met target 
Notes: Data are age-adjusted to the 2000 standard population. Rates are displayed by a modified Jenks classification for U.S. states. National data for  
the objective come  from the National Health Interview Survey (NHIS) and is the basis for setting the target. State data from the BRFSS may not be  
comparable to the national data from the NHIS.  
SOURCE: Behavioral Risk Factor Surveillance System (BRFSS), CDC.  
Percent 
28.7 - 33.0 
33.1 - 34.7 
34.8 - 38.8 
38.9 - 42.1 
42.2 - 46.2 
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Goal: Reduce the number of new cancer cases, as well 
as the illness, disability, and death caused by cancer 
This chapter includes objectives that track cancer death rates, survival after diagnosis, provider counseling for preventive behaviors such as smoking cessation, limiting sun exposure, the use of effective cancer screening tests, and the availability of statewide cancer registries. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade [1]. Over 70% of the Cancer objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 3-1). However, for a number of objectives, statistically significant health disparities of 10% or more were observed among racial and ethnic populations, as well as by sex and education level (Figure 3-2) [2]. 
 Cancer deaths (objectives 3-1 through 3-8) declined for all cancer mortality objectives except melanoma deaths (objective 3-8). Prostate cancer deaths (objective 3-7) declined by 24.9% between 1999 and 2007 from 31.1 to 23.5 per 100,000 population (age adjusted), exceeding the 2010 target of 28.2 per 100,000. The overall cancer death rate (objective 3-1) declined by 11.2% from 200.8 to 178.4 per 100,000 population (age adjusted) over the same tracking period. The melanoma death rate rose by 3.8% from 2.6 to 2.7 per 100,000 population (age adjusted) over the same tracking period, moving away from the 2010 target of 2.3 per 100,000. Disparities were observed for a number of population groups: 
• Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) cancer death rates for five of the eight cancer mortality objectives (3-1, 3-3 through 3-5, and 3-7). The Hispanic or Latino population had the best group rate for lung cancer (objective 3-2) and oropharyngeal cancer deaths (objective 3-6). The black non-Hispanic population had the best group rate for melanoma deaths (objective 3-8). 
 With the exception of melanoma deaths (objective 3-8), the black non-Hispanic population had rates that were at least 100% higher than the best rate for all cancer mortality objectives (objectives 3-1 through 3-8) [2].  
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 The white non-Hispanic population had rates that were at least 100% higher than the best group rate for four mortality objectives: lung cancer (objective 3-2), female breast cancer (objective 3-3), prostate cancer (objective 3-7), and melanoma (objective 3-8) deaths [2].  
 The American Indian or Alaska Native population had a melanoma death rate (1.0 death per 100,000 population in 2007, age adjusted) that was twice the best group rate (that for the black non-Hispanic population, 0.5 deaths per 100,000 in 2007, age adjusted) [2]. 
• Females had lower death rates than males for all five non-sex-specific cancer mortality objectives (objectives 3-1, 3-2, 3-5, 3-6, and 3-8). Male rates for oropharyngeal cancer (objective 3-6) and melanoma (objective 3-8) deaths were at least 100% higher than the female rates. 
• Among education groups, persons with at least some college education had the lowest (best) cancer death rates for six of the eight cancer mortality objectives (3-1, 3-2, and 3-4 through 3-7). Persons with less than a high school education had the best rates for female breast cancer (objective 3-3) and melanoma (objective 3-8) deaths. Persons with less than a high school education and high school graduates had rates of lung cancer (objective 3-2), cervical cancer (objective 3-4), and oropharyngeal cancer (objective 3-6) deaths that were at least 100% higher than the rates for persons with at least some college education. 
• Overall cancer mortality (objective 3-1) varied by geographic region. Death rates for the period 2005–07 were lower in the West than they were in the Midwest and Eastern U.S. Many of the health service areas with high death rates were in the South and the Mississippi River Valley (Figure 3-3). 
 The proportion of persons aged 50 years and over who had ever received a proctoscopy, colonoscopy, or sigmoidoscopy (objective 3-12b) increased by 48.6% between 1998 and 2008, from 37% to 55%, exceeding the Healthy People 2010 target of 50%. 
 The proportion of women aged 18 years and over who had ever received a Pap test (objective 3-11a) increased by 1.1% between 1998 and 2008, from 92% to 93%, moving toward the Healthy People 2010 target of 97%. However, the proportion who had been tested within the past three years (objective 3-11b) declined by 3.8%, from 79% to 76%, over the same tracking period, moving away from the 2010 target of 90%. Disparities were observed for a number of population groups, for example: 
• Among racial and ethnic groups, the populations of white non-Hispanic women and of women of two or more races both had the highest (best) rate of ever receiving a Pap test, 95% each in 2008, whereas the populations of American Indian or Alaska Native, Hispanic or Latino, and Asian women had rates of 90%, 89%, and 79% in 2008, respectively. When expressed as women who had never received a Pap test, the rate for American Indian or Alaska Native women was twice the best group rate; the rate for Hispanic or Latino women was more than twice the best group rate; and the rate for Asian women was more than four times the best group rate [2]. 
• Among education groups, women with at least some college education had the best rate of ever receiving a Pap test, 97% in 2008, whereas women with less than a high school education had a rate of 91% in 2008. When expressed as women who had never received a Pap test, women with less than a high school education had a rate that was three times the best group rate [2]. 
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• The proportion of women who received a Pap test within the past three years varied by state. Delaware, Georgia, Massachusetts, and North Carolina had the highest proportions in 2008, whereas Arkansas, Illinois, Louisiana, Oklahoma, and a contiguous group of western states (Idaho, Montana, Nevada, Utah, Wyoming) had the lowest proportions (Figure 3-4). No state met the Healthy People 2010 target. 
 Mammogram screening (objective 3-13) did not change between 1998 (baseline) and 2008 (most recent data point); in both years, 67% of women aged 40 and over had received a mammogram within the past two years, below the Healthy People 2010 target of 70%. 
• Most states met the 2010 target for mammograms. Only seven states were below the target in 2008: Alaska, Idaho, Mississippi, Nevada, Oklahoma, Utah, and Wyoming (Figure 3-5).  
Summary of Progress 
 Figure 3-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Cancer [1]. Data to measure progress toward target attainment were available for 18 objectives. Of these: 
• Two objectives (3-7 and 3-12b) exceeded their Healthy People 2010 targets. 
• Eleven objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for nine of these objectives (3-1 through 3-6, 3-9b, 3-11, and 3-15). No significant difference was observed for one objective (3-9a) and data to test the significance of the difference were unavailable for one objective (3-14). 
• One objective (3-13) showed no change. 
• Four objectives moved away from their targets. A statistically significant difference between the baseline and final data points was observed for three of these objectives (3-8, 3-11b, and 3-12a). No significant difference was observed for the remaining objective (3-10h). 
 Data were unavailable to measure progress for seven objectives (3-10a through g). 
 Figure 3-2 displays health disparities in Cancer from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Of the 14 objectives with statistically significant racial and ethnic health disparities of 10% or more, the Asian or Pacific Islander population had the best rate for five objectives (3-1, 3-3 through 3-5, and 3-7), and the white non-Hispanic population for four objectives (3-11a, 3-12b, 3-13, and 3-15). The black non-Hispanic and the Hispanic or Latino populations each had the best rate for three objectives (3-8, 3-11b, and 3-13; and 3-2, 3-6, and 3-9b, respectively). 
• Females had better rates than males for six of the seven objectives with statistically significant health disparities of 10% or more by sex (objectives 3-1, 3-2, 3-5, 3-6, 3-8, and 3-9b). Males had a better rate than females for the objective on ever receiving a proctoscopy, colonoscopy, or sigmoidoscopy (objective 3-12b). 
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• Of the 13 objectives with statistically significant health disparities of 10% or more by education level, persons with at least some college education had the best rate for 11 objectives (3-1, 3-2, 3-4 through 3-7, 3-9b, 3-11a and b, 3-12b, and 3-13). Persons with less than a high school education had the lowest (best) rate for female breast cancer (objective 3-3) and melanoma (objective 3-8) deaths. 
• Persons with middle/high incomes had the best rates for all four objectives with statistically significant health disparities of 10% or more by income (objectives 3-11a and b, 3-12b, and 3-13). 
• Persons living in urban or metropolitan areas had better rates than those living in rural areas for the two objectives with statistically significant health disparities of 10% or more by geographic location (objectives 3-11b and 3-13). 
• Persons without disabilities had better rates than persons with disabilities for two of the three objectives with statistically significant health disparities of 10% or more by disability status (objectives 3-11b and 3-13). Persons with disabilities had a better rate than persons without disabilities for adults who used protective measures to protect against skin cancer (objective 3-9b). 
• Health disparities of 100% or more were observed for several objectives among racial and ethnic populations, as well as by sex and education level. These are described in the Highlights, above.  
Transition to Healthy People 2020 For Healthy People 2020, the Cancer objectives have been expanded to include a broader range of measures than those presented in Healthy People 2010, reflecting the latest trends in cancer prevention and diagnosis. In addition to objectives on mortality, screening, counseling, survival, and cancer registries, the Healthy People 2020 Cancer Topic Area includes new objectives on cancer incidence, quality of life for cancer survivors, prevalence of sunburn, and use of artificial sources of ultraviolet light for tanning. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 Cancer Topic Area can be grouped into several sections: 
 Mortality 
 Incidence 
 Registries 
 Survivorship 
 Screening and counseling. The differences between the Healthy People 2010 objectives and those included in Healthy People 2020 are summarized below: 
 The Healthy People 2020 Cancer Topic Area has a total of 27 objectives, five of which are developmental, whereas the Healthy People 2010 Cancer Focus Area had 25 objectives [4]. 
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 Seven Healthy People 2010 objectives, including six of the eight cancer mortality objectives (3-1, 3-3, 3-4, 3-6 through 3-8) and the objective on adult protection against skin cancer (objective 3-9b), were retained “as is” [5]. 
 Thirteen Healthy People 2010 objectives were modified to create eleven Healthy People 2020 objectives [6]. 
• The objectives on lung cancer (objective 3-2) and colorectal cancer (objective 3-5) mortality were revised to match Surveillance Epidemiology and End Results (SEER) cause of death recodes [7]. 
• The objectives on adolescent protection against skin cancer (objective 3-9a), provider counseling on cancer screening (objectives 3-10f and g), cervical cancer screening (objective 3-11b), mammogram screening (objective 3-13), population-based cancer registries (objective 3-14), and cancer survivorship (objective 3-15) were all modified to match the most recent available data or the latest screening guidelines. 
• The objectives on fecal occult blood test (FOBT) (objective 3-12a) and sigmoidoscopy, colonoscopy, and proctoscopy (objective 3-12b) were combined into one objective on colorectal cancer screening (FOBT, sigmoidoscopy, and colonoscopy) to match the latest screening guidelines. 
• Similarly, the objectives on provider counseling for FOBT (objective 3-10d) and sigmoidoscopy, colonoscopy, and proctoscopy (objective 3-10e) were combined into one objective on provider counseling for colorectal cancer screening. 
 Five Healthy People 2010 Cancer objectives were either moved to other Healthy People 2020 topic areas or archived [8]. Counseling on smoking cessation (objectives 3-10a through c) and counseling on physical activity (objective 3-10h) were moved to the Healthy People 2020 Tobacco Use and Physical Activity topic areas, respectively. The objective on Pap tests ever received (objective 3-11a) was archived to match the latest screening guidelines. 
 Nine new objectives were added to the Healthy People 2020 Cancer Topic Area: 
• One developmental objective addresses the physical health-related quality of life of cancer survivors. 
• Three new objectives track the incidence of certain cancers, namely invasive colorectal cancer, invasive uterine cervical cancer, and late-stage disease breast cancer. 
• One developmental objective addresses the proportion of men who have discussed with their health care provider whether or not to have a prostate-specific antigen (PSA) test to screen for prostate cancer. 
• Two new objectives monitor the prevalence of sunburn, one for adolescents and one for adults. 
• Two developmental objectives focus on use of artificial sources of ultraviolet light for tanning, one for adolescents and one for adults. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area. 
Cancer  Page 3-7 
 
Data Considerations Figures 3-4 and 3-5 (Pap tests and Mammograms, respectively) present state-level data from the Behavioral Risk Factor Surveillance System (BRFSS). National data for these objectives come from the National Health Interview Survey (NHIS) and are the basis for setting the targets. BRFSS data may not be comparable to the National data from the NHIS. Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Beginning in 2003, education data for mortality objectives 3-1 through 3-8 from the National Vital Statistics System have been suppressed. The educational attainment item was changed in the new U.S. Standard Certificate of Death in 2003 to be consistent with the U.S. Census Bureau data and to improve the ability to identify specific types of educational degrees. Many states, however, are still using the 1989 version of the U.S. Standard Certificate of Death, which focuses on highest school grade completed. As a result, educational attainment data collected using the 2003 version are not comparable with data collected using the 1989 version [9]. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
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 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
References and Notes 1. Displayed in the Progress Chart (Figure 3-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 3-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 3-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 3-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 3-2 footnotes, as well as the Technical Appendix, for more detail. 4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 5. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 
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6. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 7. Cancer mortality data in Healthy People 2020 have been recoded for consistency with cancer incidence and mortality data reported by U.S. Cancer Statistics (USCS), CDC and Surveillance Epidemiology and End Results (SEER), NIH, NCI, resulting in slight changes to definitions for lung and colorectal cancer between Healthy People 2010 and Healthy People 2020. Specifications for the cancer mortality recodes can be found on the SEER website, available from: http://seer.cancer.gov/codrecode. 8. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 9. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf. 
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Comprehensive Summary of Objectives: Cancer 
Objective Description Data Source 3-1 Overall cancer deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 3-2 Lung cancer deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 3-3 Female breast cancer deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 3-4 Cervical cancer deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 3-5 Colorectal cancer deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 3-6 Oropharyngeal cancer deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 3-7 Prostate cancer deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 3-8 Melanoma deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 3-9a Sun exposure and skin cancer—Students who use protective measures (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 3-9b Sun exposure and skin cancer—Adults who use protective measures (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 3-10a Internist counseling about smoking cessation Survey of Physicians’ Attitudes and Practices in Early Cancer Detection, American Cancer Society. 3-10b Family physician counseling about smoking cessation Survey of Physicians’ Attitudes and Practices in Early Cancer Detection, American Cancer Society. 3-10c Dentist counseling about smoking cessation Survey of Current Issues in Dentistry, American Dental Association. 3-10d Primary care provider counseling about blood stool tests National Survey of Primary Care Physicians’ Recommendations and Practice for Breast, Cervical, Colorectal, and Lung Cancer Screening, NIH, NCI. 3-10e Primary care provider counseling about proctoscopic examinations Survey of Physicians’ Attitudes and Practices in Early Cancer Detection, American Cancer Society. 3-10f Primary care provider counseling about mammograms National Survey of Primary Care Physicians’ Recommendations and Practice for Breast, Cervical, Colorectal, and Lung Cancer Screening, NIH, NCI. 
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Objective Description Data Source 3-10g Primary care provider counseling about Pap tests National Survey of Primary Care Physicians’ Recommendations and Practice for Breast, Cervical, Colorectal, and Lung Cancer Screening, NIH, NCI. 3-10h Primary care provider counseling about physical activity National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS 3-11a Pap tests—Ever received (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 3-11b Pap tests—Received within past 3 years (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 3-12a Colorectal cancer screening—Fecal occult blood test (FOBT) within past 2 years (age adjusted, 50+ years) National Health Interview Survey (NHIS), CDC, NCHS. 3-12b Colorectal cancer screening—Proctoscopy, colonoscopy, or sigmoidoscopy ever received (age adjusted, 50+ years) National Health Interview Survey (NHIS), CDC, NCHS. 3-13 Women receiving a mammogram within past 2 years (age adjusted, 40+ years) National Health Interview Survey (NHIS), CDC, NCHS. 3-14 Statewide cancer registries (no. States and D.C.) National Program of Cancer Registries (NPCR), CDC, NCCDPHP. 3-15 Persons living 5+ years after a diagnosis of cancer Surveillance, Epidemiology, and End Results (SEER) Program, NIH, NCI.  
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Figure 3-1. Progress Toward Target Attainment for Focus Area 3: Cancer 
Percent of targeted change achieved5 (continued) 
 
3-1. Overall cancer deaths (age adjusted, per 
100,000 population) 
3-2. Lung cancer deaths (age adjusted, per 
100,000 population)   
3-3. Female breast cancer deaths (age adjusted, 
per 100,000 population) 
3-4. Cervical cancer deaths (age adjusted, per 
100,000 population) 
3-5. Colorectal cancer deaths (age adjusted, per 
100,000 population)  
3-6. Oropharyngeal cancer deaths (age adjusted, 
per 100,000 population)  
3-7. Prostate cancer deaths (age adjusted, per 
100,000 population) 
3-8. Melanoma deaths (age adjusted, per  
 100,000 population) 
53.1% 
40.2% 
69.8% 
50.0% 
55.6% 
66.7% 
            251.6% 
Cancer Page 3-12 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
28% 
24% 
(2005) 
25% 
(2007) 
1 No 4.2% 
85% 
65% 
(2005) 
67% 
(2008) 
2 Yes 3.1% 
85% 
12% 
(1998) 
10% 
(2007) 
-2 No -16.7 
97% 
92% 
(1998) 
93% 
(2008) 
1 Yes 1.1% 
90% 
79% 
(1998) 
76% 
(2008) 
-3 Yes -3.8% 
33% 
24% 
(2000) 
15% 
(2008) 
-9 Yes -37.5% 
50% 
37% 
(1998) 
55% 
(2008) 
18 Yes 48.6% 
70% 
67% 
(1998) 
67% 
(2008) 
0 No 0.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 3-1. Progress Toward Target Attainment for Focus Area 3: Cancer (continued) 
Percent of targeted change achieved5 (continued) 
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Figure 3-1. Progress Toward Target Attainment for Focus Area 3: Cancer (continued) 
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See the Reader’s Guide for more information on how to read this figure. See DATA 2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 3-10a through g. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
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3-1–3-8. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
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3-9b. National Health Interview Survey (NHIS), CDC, NCHS. 
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3-11a–b. National Health Interview Survey (NHIS), CDC, NCHS. 
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3-14. National Program of Cancer Registries (NPCR), CDC, NCCDPHP. 
3-15. Surveillance, Epidemiology, and End Results (SEER) Program, NIH, NCI. 
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Figure 3-2. Health Disparities Table for Focus Area 3: Cancer
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3-1. Overall cancer deaths (age adjusted, 
per 100,000 population) (1999, 
2007)1
2 NA 1 4 3 2 B 2 3 3 B 3 NS NS NS NS NS NS NA NA
3-2. Lung cancer deaths (age adjusted, 
per 100,000 population) (1999, 
2007)1
3 NA B 4
4u1 4u1
B
3d1
4u1 4u1
B
4u1
NS NS NS NS NS NS NA NA
3-3. Female breast cancer deaths (age 
adjusted, per 100,000 population) 
(1999, 2007)1
1 NA 2 4 4 3 NA NA Bii 2 1 2 NS NS NS NS NS NS NA NA
3-4. Cervical cancer deaths (age 
adjusted, per 100,000 population) 
(1999, 2007)1
1 NA 3 4 1 2 NA NA 4 4 B 4 NS NS NS NS NS NS NA NA
3-5. Colorectal cancer deaths (age 
adjusted, per 100,000 population) 
(1999, 2007)1
1 NA 2
4d1 3d1
2 B 2 3 3 B 3 NS NS NS NS NS NS NA NA
3-6. Oropharyngeal cancer deaths (age 
adjusted, per 100,000 population) 
(1999, 2007)1
1 NA B 4
3u1
3 B
4u1
4
4u1
B 4 NS NS NS NS NS NS NA NA
3-7. Prostate cancer deaths (age 
adjusted, per 100,000 population) 
(1999, 2007)1
2 NA 3 4 4 4 NA NA 3 3 B 3 NS NS NS NS NS NS NA NA
3-8. Melanoma deaths (age adjusted, per 
100,000 population) (1999, 2007)1 4 NA 3 Bii 4 NA B 4 B
3u1
2 2 NS NS NS NS NS NS NA NA
3-9a. Sun exposure and skin cancer—
Students who use protective measures 
(grades 9–12) (2005, 2007)
NA NA NA NA B 1 1 1 B 1 NA NA NA NA NA NA NA NA NA NA NA NA
3-9b. Sun exposure and skin cancer—
Adults who use protective measures 
(age adjusted, 18+ years) (2005, 2008)
b 1 NA 1 Bii 2 2 NA B 2 1 2 B 2 B 1 1 1 B Bii B 2
3-11a. Pap tests—Ever received (age 
adjusted, 18+ years) (1998, 2008)2 4 4 NA B
4d2
1 B 4iii NA NA 4 2 B 4
3d2
2 B 2 1iv B
3-11b. Pap tests—Received within past 3 
years (age adjusted, 18+ years) 
(1998, 2008)2
3
3d2
NA 1
2d1
B 1 2iii NA NA
3d1
2 B 3 3 3 B 3 B 2
2u1
B
3-12a. Colorectal cancer screening—Fecal occult 
blood test (FOBT) within past 2 yrs (age 
adjusted, 50+ yrs) (2000, 2008)
NA Bii NA NA 1 1 Bii 1iii 1 Bii
1d1
1 B 1 1 1 B 1 B 1 B 1
3-12b. Colorectal cancer screening—Proctoscopy, 
colonoscopy, or sigmoidoscopy ever receiv-
ed (age adjusted, 50+ yrs) (1998, 2008)3
3u1
2 NA 1
2u1
2 B 2iii 2 B
3u1 2u1
B
2u1 3u1 2u1
B
2u1
B 1 B 1
3-13. Women receiving a mammogram 
within past 2 years (age adjusted, 
40+ years) (1998, 2008)2
1
1d1
NA 2 2 B B 2iii NA NA 3 2 B 3 3 3 B 3 B
2u1
2 B
3-15. Persons living 5+ years after a 
diagnosis of cancer (1989–95, 
2000–06)
NA NA NA NA NA 2v Bv NA B Bii NA NA NA NA NS NS NS NS NS NS NS NS
Population-based objectives
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Location Disability
Bi
2i
Bi
Bi, ii
Bi
2i
Bi
bi
(continued)
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Figure 3-2. Health Disparities Table for Focus Area 3: Cancer (continued)
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
1
2
3
i
ii
iii
iv
v
3-1–3-8. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
3-9a. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
3-9b. National Health Interview Survey (NHIS), CDC, NCHS.
3-11a–b. National Health Interview Survey (NHIS), CDC, NCHS.
3-12a–b. National Health Interview Survey (NHIS), CDC, NCHS.
3-13. National Health Interview Survey (NHIS), CDC, NCHS.
3-15. Surveillance, Epidemiology, and End Results (SEER) Program, NIH, NCI.
Increase in disparity (percentage points)
10–49 points 50–99 points
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
3-10a through h, and 3-14.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Measures of variability were available for all objectives in this table. Thus, the variability of best group rates was assessed, and statistical significance was tested. 
Disparities of 10% or more are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over 
time are indicated by arrows when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical 
Appendix.
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
100 points or more
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99%
100 points or more
Data are for Asian or Pacific Islander.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points
Data not available. Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
Change in the summary index cannot be assessed. See Technical Appendix.
Data include persons of Hispanic origin.
DATA SOURCES
Most recent data by education level are for 2002.
Baseline data by race and ethnicity are for 1999.
Baseline data by race and ethinicity are for 2000.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical 
Appendix.
100% or more
NOTES
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Figure 3-3. Overall Cancer Deaths (2005-07) 
Healthy People 2010 objective 3-1 
Target = 158.6 
NOTES: Data are for ICD-10 codes C00-C97reported as underlying cause.  Rates are per 100,000 U. S. Population age-adjusted to  
the 2000 standard population.  Rates are displayed by a modified Jenks classification for U.S. health service area. 
SOURCE: National Vital Statistics System – Mortality (NVSS-M), CDC, NCHS. 
lowest category (green) shows health service areas that met target 
115.1 - 158.6 
158.7 - 178.7 
178.8 - 196.3 
196.4 - 216.0 
216.1 - 268.3 
Rate per 100,000 
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Figure 3-4.  Pap Test Received in the Past 3 Years (18+ Years) 2008 
Healthy People 2010 objective 3-11b 
Target = 90 
NOTES: Data are age-adjusted to the 2000 standard population. Rates are displayed by a modified Jenks classification for U.S. states.  
National data for the objective come from the National Health Interview Survey (NHIS) and is the basis for setting the target.  State data from  
the BRFSS may not be comparable to the national data from the NHIS.  Both US rates are shown for comparison purposes. 
SOURCE: Behavioral Risk Factor Surveillance System (BRFSS), CDC NCCDPHP.  
no states met the target 
Percent 
68.7 - 75.1 
75.2 - 78.1 
78.2 - 79.9 
80.0 - 82.4 
82.5 - 85.5 
US (2008 NHIS) – 75.6 
US (2008 BRFSS) – 79.2 
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Figure 3-5.  Women Receiving Mammograms within Past 2 Years (40+ Years) 2008 
Healthy People 2010 objective 3-13 
Target = 70 
NOTES: Data are age-adjusted to the 2000 standard population. Rates are displayed by a modified Jenks classification for U.S. states. 
National data for the objective come from the National Health Interview Survey (NHIS) and is the basis for setting the target.  State data from  
the BRFSS may not be comparable to the national data from the NHIS.  Both US rates are shown for comparison purposes. 
SOURCE: Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP.  
highest categories (green) shows states that met target 
Percent 
66.3 - 70.0 
70.1 - 75.5 
75.6 - 79.8 
79.9 - 84.6 
US (2008 NHIS) – 67.1 
US (2008 BRFSS) – 76.3 
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Goal: Reduce new cases of chronic kidney disease and 
its complications, disability, death, and economic costs 
This chapter includes objectives that monitor new cases of Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD), death and disability associated with ESRD, and treatments (including kidney transplantation) for chronic kidney diseases and ESRD and associated conditions. All tracking data quoted in this chapter, along with technical information and operational definitions, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved for the objectives in this Focus Area over the course of the past decade [1]. Two thirds of the CKD objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 4-1). However, most objectives exhibited statistically significant health disparities of 10% or more by sex and among racial and ethnic population groups (Figure 4-2) [2]. 
 Cardiovascular disease deaths among persons with chronic kidney failure (objective 4-2) declined by 31.6% between 1997 and 2008, from 93.7 to 64.1 per 1,000 patient years at risk, exceeding the Healthy People 2010 target of 66.1 per 1,000 patient years at risk. 
 New cases of ESRD (objective 4-1) increased by 12.1% between 1997 and 2008, from 313 to 351 per million population (adjusted for age, gender, and race), moving away from the Healthy People 2010 target of 230 per million population. 
 New cases of ESRD due to diabetes (objective 4-7) also increased by 10.9% between 1997 and 2008, from 138 to 153 per million population (adjusted for age, gender, and race), moving away from the Healthy People 2010 target of 100 per million population. 
 The cumulative proportion of persons receiving a kidney transplant within three years of the date of renal failure (objective 4-6) declined by 13.5% between 1998 and 2005, from 20.0% to 17.3%, moving away from the Healthy People 2010 target of 29.5%. 
Chronic Kidney Disease  Page 4-3 
 In 2005, the states of Idaho and Utah, the Upper-Midwest (Minnesota, North and South Dakota, and Wisconsin), and Vermont had the highest cumulative proportions of persons receiving a kidney transplant within three years of the date of renal failure (objective 4-6). These states achieved the Healthy People 2010 target. On the other hand, California, the Southwest (New Mexico, Louisiana, and Texas), and the Southeast (Alabama, Georgia, and North and South Carolina) had the lowest cumulative proportions of persons receiving a kidney transplant within three years of the date of renal failure (Figure 4-3). 
 The registration of dialysis patients aged under 70 years for kidney transplantation (objective 4-5) varied by geographic area. In 2007, the states of Delaware, Massachusetts, Pennsylvania, South Dakota, Vermont, and Wisconsin had the highest proportions of patients placed on the transplant waiting list within one year of an ESRD diagnosis. These states achieved the Healthy People 2010 target of 24.8% (Figure 4-4).  
Summary of Progress 
 Figure 4-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for CKD [1]. Data to measure progress toward target attainment were available for all nine objectives. Of these: 
• Three objectives exceeded the Healthy People 2010 targets (objectives 4-2, and 4-8a and b). 
• Three objectives moved toward their targets (objectives 4-3, 4-4, and 4-5). A statistically significant difference between the baseline and the final data points was observed for all three of these objectives. 
• Three objectives moved away from their targets (objectives 4-1, 4-6, and 4-7). A statistically significant difference between the baseline and final data points was observed for all of these objectives. 
 Figure 4-2 provides a quantitative assessment of health disparities in CKD from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Of the seven objectives with statistically significant racial and ethnic health disparities of 10% or more, the Asian population (objectives 4-2 and 4-5), white non-Hispanic population (objectives 4-4 and 4-6), and the population of persons of two or more races (objectives 4-1 and 4-7), each had the best group rate for two objectives. The combined Asian or Pacific Islander population had the best group rate for one objective (4-8a). 
 Health disparities of 100% or more relative to the group with the best rate were observed for two objectives: new cases of ESRD (objective 4-1) and new ESRD cases due to diabetes (objective 4-7). 
 Increases in disparities of 100 percentage points or more were observed for the same two objectives. 
• Females had better rates than males for two of the three objectives with statistically significant health disparities of 10% or more by sex (objectives 4-1 and 4-7). Men had a better rate than females for new hemodialysis patients who use arteriovenous fistulas (objective 4-4). 
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Transition to Healthy People 2020 The Healthy People 2020 Chronic Kidney Disease Topic Area features a broader range of objectives than those included in Healthy People 2010. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 objectives can be grouped into several sections: 
 CKD process and treatment 
 CKD outcomes 
 ESRD process and treatment 
 ESRD outcomes. The differences between the Healthy People 2010 and Healthy People 2020 CKD objectives are summarized below: 
 The Healthy People 2020 CKD Topic Area has 24 objectives, whereas the Healthy People 2010 Focus Area had nine objectives. 
 One Healthy People 2010 objective, new cases of ESRD (objective 4-1), was retained “as is” [4]. 
 Eight Healthy People 2010 objectives (4-2 through 4-7, and 4-8a and b) were modified [5]. Some were extended to include new measures of CKD and ESRD treatment and outcomes. 
 Fifteen new objectives were added to the Healthy People 2020 Topic Area: 
• Five CKD and ESRD mortality objectives were added. (Objective 4-2, the Healthy People 2010 objective measuring cardiovascular death in patients with chronic kidney failure, was retained.) The new objectives address the total death and cardiovascular death rates for persons on dialysis; the death rate for dialysis patients within the first three months of initiating therapy; the total and cardiovascular death rates for persons who have had a kidney transplant; and the death rate for persons with CKD. 
• Two objectives were added to the Healthy People 2010 objective on arteriovenous fistulas monitoring the use of arteriovenous fistulas and the use of incident catheters. 
• Two new objectives focus on improving cardiovascular care in persons with CKD: blood pressure and hyperlipidemia control. 
• Objectives measuring the proportion of the U.S. population with CKD and the proportion of persons with CKD who know they have impaired function were added to increase awareness of CKD among health professionals and the general public. 
• Three new objectives address recommended medical evaluation and treatment of patients with diabetes and CKD. 
• An objective measuring follow-up renal evaluation after acute kidney injury was included to emphasize the importance of timely evaluation in CKD prevention. 
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Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations Many of the objectives in this chapter are tracked using the U.S. Renal Data System (USRDS) data, which uses data collected by the Centers for Medicare & Medicaid Services. Since 1996, health care providers have been required to provide patient information on all persons with ESRD, regardless of health insurance. Therefore, incidence rates reflect the universe of ESRD cases in the U.S. There is some lag in reporting new cases of ESRD. As a result, each year’s USRDS Annual Data Report includes re-estimates of rates from earlier years [6]. Data for some race/ethnicity groups have not been collected or reported for all years from the Healthy People 2010 baseline to the most recent data point. For example, data in the category “two or more races” for objectives 4-1 and 4-7 were not available until 2006. Therefore, due to the re-estimation method used by the Annual Data Report, data for these groups might not be directly comparable with other race/ethnicity groups. The USRDS data, data collection procedures, calculation methods, and other technical information are included in its Annual Data Report [6]. Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010. 
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References and Notes 1. Displayed in the Progress Chart (Figure 4-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 4-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 4-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 4-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 4-2 footnotes, as well as the Technical Appendix, for more detail. 4. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 5. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 6. United States Renal Data System, USRDS. 2010 Annual Data Report: Atlas of End-Stage Renal Disease 
in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010. Available from http://www.usrds.org/adr.htm. 
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Comprehensive Summary of Objectives: Chronic Kidney Disease 
Objective Description Data Source 4-1 New cases of end-stage renal disease (ESRD) (per million population, adjusted for age, sex, and race) United States Renal Data System (USRDS), NIH, NIDDK. 4-2 Cardiovascular disease deaths in persons with chronic kidney failure (per 1,000 patient years at risk) United States Renal Data System (USRDS), NIH, NIDDK. 4-3 Pre-ESRD care from a nephrologist United States Renal Data System (USRDS), NIH, NIDDK. 4-4 New hemodialysis patients who use arteriovenous fistulas (20+ years) Centers for Medicare and Medicaid Services Clinical Performance Measures (CPM) project, CMS. 4-5 Dialysis patients registered on kidney transplant waiting list (<70 years) United States Renal Data System (USRDS), NIH, NIDDK. 4-6 Cumulative percent of persons receiving a kidney transplant within 3 years of the date of renal failure (<70 years) United States Renal Data System (USRDS), NIH, NIDDK. 4-7 New cases of ESRD due to diabetes (per million population, adjusted for age, sex, and race) United States Renal Data System (USRDS), NIH, NIDDK. 4-8a Medical evaluation for persons with type 1 or type 2 diabetes and chronic kidney disease Centers for Medicare and Medicaid Services Standard Analytic Files (SAF), CMS; U.S. Renal Data System (USRDS), NIH, NIDDK. 4-8b Medical treatment for persons with type 1 or type 2 diabetes and chronic kidney disease Centers for Medicare and Medicaid Services Standard Analytic Files (SAF), CMS; U.S. Renal Data System (USRDS), NIH, NIDDK.  
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4-8a. Medical evaluation for persons with type 1 or 
type 2 diabetes and chronic kidney disease 
      
Figure 4-1. Progress Toward Target Attainment for Focus Area 4: Chronic Kidney Disease 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
230 
313 
(1997) 
351 
(2008) 
38 Yes 12.1% 
66.1 
93.7 
(1997) 
64.1 
(2008) 
-29.6 Yes -31.6% 
34% 
25% 
(2005) 
28% 
(2008) 
3 Yes 12.0% 
45% 
26% 
(1998) 
41% 
(2007) 
15 Yes 57.7% 
24.8% 
15.2% 
(1998) 
17.1% 
(2007) 
1.9 Yes 12.5% 
29.5% 
20.0% 
(1998) 
17.3% 
(2005) 
-2.7 Yes -13.5% 
100 
138 
(1997) 
153 
(2008) 
15 Yes 10.9% 
25% 
21% 
(2000) 
34% 
(2008) 
13 Yes 61.9% 
33.3% 
78.9% 
19.8% 
            107.2% 
            325.0% 
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4-8b. Medical treatment for persons with type 1 
or type 2 diabetes and chronic kidney 
disease                                                      
 
 
 
      
Figure 4-1. Progress Toward Target Attainment for Focus Area 4: Chronic Kidney Disease (continued) 
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DATA SOURCES 
 
4-1–4-3. United States Renal Data System (USRDS), NIH, NIDDK.  
4-4. Centers for Medicare and Medicaid Services Clinical Performance Measures (CPM) project, CMS. 
4-5–4-7. United States Renal Data System (USRDS), NIH, NIDDK. 
4-8a–b. Centers for Medicare and Medicaid Services Standard Analytic Files (SAF), CMS; U.S. Renal Data System (USRDS), NIH, NIDDK. 
Moved away           Moved toward                   Met or exceeded 
from target1          target                   target 2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
71% 
69% 
(2000) 
74% 
(2006) 
5 No 7.2%             250.0% 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. 
 
FOOTNOTES  
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
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Figure 4-2. Health Disparities Table for Focus Area 4: Chronic Kidney Disease
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4-1.
4
4u3 4u3
Bi
4u3 4u3
4 4ii B
3u1
NA NA NA NA
4-2.
1d1
B 2 3 1
2u1
3 2ii Bi 1 NA NA NA NA
4-3. 1 1 1 NA Bi 1 1 1 Bi 1 NA NA NA NA
4-4.
b NA 2 2 Bi NA 2 B NA NA NA NA
4-5.
2 B
2u1
2 2 2 2 2ii 1 B NA NA NA NA
4-6.
2 1 2 2 2 2 B 2ii 1 B NA NA NA NA
4-7.
4
4u3
4 Bi
4u3 4u3
4 4ii B
2u1
NA NA NA NA
4-8a. 2 NA 1 1iv 1iv NA Bi 1 NA NA NA NA
4-8b.
NA NA NA NA NA NA NA NA NA NA NA
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
§
i
ii
iii
iv
4-1–4-3. United States Renal Data System (USRDS), NIH, NIDDK.
4-4. Centers for Medicare and Medicaid Services Clinical Performance Measures (CPM) project, CMS.
4-5–4-7. United States Renal Data System (USRDS), NIH, NIDDK.
4-8a–b. Centers for Medicare and Medicaid Services Standard Analytic Files (SAF), CMS; U.S. Renal Data System (USRDS), NIH, NIDDK.
DATA SOURCES
FOOTNOTES
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See Technical Appendix.
Data include persons of Hispanic origin.
Change in the summary index cannot be assessed. See Technical Appendix.
Data are for Asian or Pacific Islander.
Data for “Two or more races” were not available until 2006; therefore, these data may not be directly comparable with other groups. See Data Issues section for more information.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
50–99 points
Disparity from the best group rate at the most 
recent data point.
NOTES
Biii
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data.
Race and Ethnicity
Characteristics and Groups
Cumulative percent of persons receiving a kidney 
transplant within 3 years of the date of renal failure 
(<70 years) (1998, 2005)
New cases of ESRD due to diabetes (per million 
population, adjusted for age, gender, and race) 
(1997, 2008)§
Medical evaluation for persons with type 1 or type 2 
diabetes and chronic kidney disease (2000, 2008)
Medical treatment for persons with type 1 or type 2 
diabetes and chronic kidney disease (2000, 2006)
New cases of end-stage renal disease (ESRD) (per 
million population, adjusted for age, gender, and 
race) (1997, 2008)§
Cardiovascular disease deaths in persons with 
chronic kidney failure (per 1,000 patient years at risk) 
(1997, 2008)
Dialysis patients registered on kidney transplant 
waiting list (<70 years) (1998, 2007)
Sex
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Population-based objectives
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99%
Increase in disparity (percentage points)
Income
1iii
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race 
and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at 
baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the 
summary index at the most recent data point. See Technical Appendix for more information.
Years in parentheses represent the baseline and most recent data years (if available).
Measures of variability were available for all objectives in this table. Thus, the variability of best group rates was assessed, and statistical significance was tested. 
Disparities of 10% or more are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over 
time are indicated by arrows when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical 
Appendix.
Most favorable group rate for specified 
characteristic, but reliability criterion not 
met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
LEGEND
The "best" group rate at the most recent data 
point.
100% or 
more
Pre-ESRD care from a nephrologist (2005, 2008)
New hemodialysis patients who use arteriovenous 
fistulas (20+ years) (1998, 2007)
Data not available.
10–49 points 50–99 points
Decrease in disparity (percentage points)
10–49 points 100 points or more
Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage points and 
estimates of variability were not available. See Technical Appendix.
100 points or 
more
Figure 4-3. Dialysis Patients Registered on Kidney Transplant  
Waiting List (<70 Years) 2007 
Healthy People 2010 objective 4-5 
Target = 24.8 
Percent 
NOTES:  Dialysis patients under age 70 years registered on the kidney transplant waiting list within one year of the date of end stage renal 
disease. Rates are displayed by a modified Jenks classification for U.S. states. The USRDS data, data collection procedures, calculation 
methods, and other technical information are included in USRDS Annual Data Report, available at http://www.usrds.org/adr.htm . SOURCE: 
U.S. Renal Data System (USRDS), NIH, NIDDK. 
8.7 - 12.0 
12.1 - 15.5 
15.6 - 18.6 
18.7 - 24.7 
24.8 - 31.5 
highest category (green)  
shows states that met target 
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NOTES: Among patients with treated chronic kidney failure who receive a transplant within 3 years of registration on the waiting list.  
Rates are displayed by a modified Jenks classification for U.S. states. The USRDS data, data collection procedures, calculation methods, and  
other technical information are included in USRDS Annual Data Report, available at http://www.usrds.org/adr.htm .   
SOURCE: U.S. Renal Data System (USRDS), NIH, NIDDK. 
Figure 4-4. Cumulative Percent of Persons Receiving a Kidney Transplant within 3 Years of the Date of Renal 
Failure (<70 Years) 2005 
Healthy People 2010 objective 4-6 
Target = 29.5 
highest category (green)  
shows states that met target 
7.3 - 13.4 
13.5 - 17.6 
17.7 - 22.4 
22.5 - 29.4 
29.5 - 37.6 
Percent 
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A reformatted, typeset version of this report will replace the current version 
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Goal: Through prevention programs, reduce the disease 
and economic burden of diabetes, and improve the quality 
of life for all persons who have or are at risk for diabetes 
This chapter includes objectives that track new cases of diabetes, diabetes-related deaths, the diagnosis and treatment of diabetes and related conditions, and diabetes education. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved for the objectives in this Focus Area during the past decade [1]. Seventy-one percent of the Diabetes objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 5-1). Most of the health disparities observed by race and ethnicity, sex, education level, and disability status, ranged from 10% to 99% in magnitude; larger disparities are discussed below (Figure 5-2) [2]. 
 The rate of new cases of diabetes (objective 5-2) increased by 45.5% between 1997–99 and 2006–08, from 5.5 to 8.0 per 1,000 population aged 18–84 years (age adjusted), moving away from the Healthy People 2010 target of 3.8 per 1,000. Disparities were observed for a number of population groups, for example: 
• Among education groups, persons with at least some college education had the lowest (best) rate of new cases of diabetes, 6.9 per 1,000 population aged 25–84 years (age adjusted) in 2006–08. Persons with less than a high school education had a rate of 14.0 per 1,000 population aged 25–84 years (age adjusted) in 2006–08. The rate for persons with less than a high school education was about twice the best group rate [2]. 
• Among disability status groups, persons without disabilities had the lowest (best) rate of new cases of diabetes, 6.3 per 1,000 population aged 18–84 years (age adjusted) in 2006–08. Persons with disabilities had a rate of 18.5 per 1,000 population aged 18–84 years (age adjusted) in 2006–08, nearly three times as high as the best group rate [2]. 
 The prevalence of diabetes (objective 5-3) increased by 47.5% between 1997 and 2008, from 40 to 59 per 1,000 population (age adjusted), moving away from the 2010 target of 25 per 1,000. Disparities were observed for a number of population groups, for example: 
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• Among racial and ethnic groups, the white non-Hispanic population had the lowest (best) diabetes prevalence rate, 52 per 1,000 population (age adjusted) in 2008, whereas the American Indian or Alaska Native population had a rate of 109 per 1,000 population (age adjusted) in 2008. The rate for the American Indian or Alaska Native population was more than twice the best group rate [2]. 
• Among disability status groups, persons without disabilities had the lowest (best) diabetes prevalence rate, 43 per 1,000 population (age adjusted) in 2008. Persons with disabilities had a rate of 120 per 1,000 population (age adjusted) in 2008, almost three times the best group rate [2]. 
• The prevalence of diabetes varied by geographic region. West Virginia and several southern states (Alabama, Georgia, Louisiana, Mississippi Tennessee, and Texas) had the highest rates of diabetes (Figure 5-3). 
 The proportion of persons aged 20 years and over with diabetes whose condition had been diagnosed (objective 5-4) increased by 20.3% between 1988–94 and 2005–08, from 64% to 77% (age adjusted), moving toward the 2010 target of 78%. 
 The diabetes-related death rate among the total population (objective 5-5) declined by 5.2% between 1999 and 2007, from 77 to 73 per 100,000 population (age adjusted), moving toward the 2010 target of 46 per 100,000. Disparities were observed for a number of population groups, for example: 
• Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) rate of diabetes-related deaths, 54 per 100,000 population (age adjusted) in 2007. The black non-Hispanic population had a rate of 127 per 100,000 population (age adjusted) in 2007, nearly two and a half times the best group rate [2]. 
 The rate of lower extremity amputation in persons with diabetes (objective 5-10) declined by 47.0% between 1997–99 and 2005–07, from 6.6 to 3.5 per 1,000 population (age adjusted), moving toward the 2010 target of 2.9 per 1,000.  
• Females had a lower (better) rate of lower extremity amputations than males. The rate for females was 2.2 per 1,000 population (age adjusted) in 2005–07. The rate for males was 4.8 per 1,000 population (age adjusted) in 2005–07, more than twice the rate for females [2]. 
 No change was observed in the percentage of persons who received annual foot examinations (objective 5-14) or annual dental examinations (objective 5-15). The percentage of persons aged 18 years and over who received an annual foot examination was 68% (age adjusted) in both 1998 and 2008. The percentage of persons aged two years and over who had annual dental examinations was 56% (age adjusted) in both 1997 and 2008.  
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Summary of Progress 
 Figure 5-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Diabetes [1]. Data to measure progress toward target attainment were available for 14 objectives. Of these: 
• Five objectives (5-6, 5-7, 5-11, 5-12, and 5-17) met or exceeded the Healthy People 2010 targets. 
• Five objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for four of these objectives (5-1, 5-4, 5-5, and 5-10). No significant difference was observed for the remaining objective (5-13). 
• Two objectives (5-14 and 5-15) showed no change. 
• Two objectives (5-2 and 5-3) moved away from their targets. A statistically significant difference between the baseline and final data point was observed for both of these objectives. 
 Data were unavailable to measure progress for one objective (5-16). Two objectives (5-8 and 5-9) were dropped during the decade [3]. 
 Figure 5-2 displays health disparities in Diabetes from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [4]. 
• Of the 11 objectives with statistically significant racial and ethnic health disparities of 10% or more, the white non-Hispanic population had the only best rate for six objectives (5-1 through 5-3, 5-12, 5-13, and 5-16). The Asian or Pacific Islander population had the best rate for two objectives (5-5 and 5-11) and the Hispanic or Latino population and black non-Hispanic population each had the only best rate for one objective (5-7 and 5-14, respectively). In addition, the black non-Hispanic and white non-Hispanic populations were tied for the best rate for one objective (5-17). 
• For all five objectives with statistically significant health disparities of 10% or more by sex, females had better rates than males (objectives 5-5 through 5-7, 5-10, and 5-17). 
• Persons with at least some college education had the best rate for nine of the 10 objectives with statistically significant health disparities of 10% or more by education level (objectives 5-1 through 5-3, 5-5, 5-7, 5-12, and 5-13 through 5-15). Persons with less than a high school education had the best rate for one objective (5-17). 
• Persons without disabilities had better rates than persons with disabilities for the two objectives with statistically significant health disparities of 10% or more by disability status (objectives 5-2 and 5-3; see Highlights). 
• Health disparities of 100% or more were observed for four objectives (5-2, 5-3, 5-5, and 5-10; see Highlights).  
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Transition to Healthy People 2020 For Healthy People 2020, the focus of the Diabetes Topic Area has been expanded to include more objectives on diabetes prevention and control. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The differences between the Healthy People 2010 objectives and those included in Healthy People 2020 are summarized below: 
 The Healthy People 2020 Diabetes Topic Area includes 20 objectives, three of which are developmental, whereas the Healthy People 2010 Diabetes Focus Area had 17 objectives, including two objectives (5-8 and 5-9) that were dropped at the Midcourse Review [3,5]. 
 Nine Healthy People 2010 objectives, including diabetes incidence (objective 5-2), diabetes related deaths (objective 5-5), lower extremity amputations (objective 5-10), annual urinary microalbumin measurement (objective 5-11), A1C test at least two times a year (objective 5-12), annual dilated eye examination (objective 5-13), annual foot examination (objective 5-14), annual dental examination (objective 5-15), and self-blood glucose monitoring (objective 5-17) were retained “as is” [6]. 
 Two Healthy People 2010 objectives were modified [7]. The objectives tracking diabetes education (objective 5-1) and persons with diagnosed diabetes (objective 5-4) will be measured differently in Healthy People 2020. 
 Four Healthy People 2010 objectives were archived: the prevalence of diabetes (objective 5-3), two objectives related to deaths among persons with diabetes (objectives 5-6 and 5-7), and aspirin therapy (objective 5-16) [8]. 
 Nine new objectives were added to the Healthy People 2020 Diabetes Topic Area: 
• Four new objectives on control of diabetes and its complications include the proportion of the diabetic population with hemoglobin A1C test values >9%, and A1C <7%, as well as blood pressure control and cholesterol control among the population with diabetes. 
• Three new objectives on diabetes prevention focus on persons at high risk for diabetes with pre-diabetes who report increasing physical activity, trying to lose weight, and reducing fat or calories in diet. 
• Two new objectives were added to replace the archived mortality objectives: total mortality among the population with diabetes, and cardiovascular disease deaths in persons with diabetes. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
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Data Considerations Figure 5-3 presents state-level data for diabetes prevalence (objective 5-3) from the Behavioral Risk Factor Surveillance System (BRFSS). National data for this objective comes from the National Health Interview Survey (NHIS) and are the basis for setting targets. BRFSS data may not be comparable to the National data from NHIS. The BRFSS state rates are for the population aged 18 years and over. The NHIS National rate includes all ages. Beginning in 2003, education data for mortality objectives 5-5, 5-6, and 5-7 from the National Vital Statistics System have been suppressed. The educational attainment item was changed in the new U.S. Standard Certificate of Death in 2003 to be consistent with the U.S. Census Bureau data and to improve the ability to identify specific types of educational degrees. Many states, however, are still using the 1989 version of the U.S. Standard Certificate of Death, which focuses on highest school grade completed. As a result, educational attainment data collected using the 2003 version are not comparable with data collected using the 1989 version [9]. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
References and Notes 1. Displayed in the Progress Chart (Figure 5-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 5-1 footnotes, as well as the Technical Appendix, for more detail. 
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2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 5-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 5-2 footnotes, as well as the Technical Appendix, for more detail. 3. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 4. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 5-2 footnotes, as well as the Technical Appendix, for more detail. 5. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 6. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 7. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 8. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 9. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf.   
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Comprehensive Summary of Objectives: Diabetes 
Objective Description Data Source or Objective Status 5-1 Diabetes education (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 5-2 New cases of diabetes (3-year average, age adjusted per 1,000 standard population, 18–84 years)  National Health Interview Survey (NHIS), CDC, NCHS. 5-3 Prevalence of diabetes (age adjusted per 1,000 standard population) National Health Interview Survey (NHIS), CDC, NCHS. 5-4 Proportion of persons with diagnosed diabetes (age adjusted, 20+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 5-5 Diabetes-related deaths (age adjusted per 100,000 standard population)  National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 5-6 Diabetes-related deaths among persons with diabetes (age adjusted per 1,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS; National Health Interview Survey (NHIS), CDC, NCHS. 5-7 Cardiovascular disease deaths among persons with diabetes (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS; National Health Interview Survey (NHIS), CDC, NCHS. 5-8 Gestational diabetes among pregnant women Dropped 5-9 Foot ulcers among persons with diabetes Dropped 5-10 Lower extremity amputations in persons with diabetes (3-year average, age adjusted per 1,000 standard population) National Hospital Discharge Survey (NHDS), CDC, NCHS; National Health Interview Survey (NHIS), CDC, NCHS. 5-11 Annual urinary microalbumin measurement among Medicare beneficiaries with diabetes United States Renal Data System (USRDS), NIH, NIDDK. 5-12 A1C Test, at least twice a year among persons with diabetes (age adjusted, 18+ years) Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP. 5-13 Annual dilated eye examinations among persons with diabetes (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 5-14 Annual foot examinations among persons with diabetes (age adjusted, 18+ years) Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP. 5-15 Annual dental examinations among persons with diabetes (age adjusted, 2+ years) National Health Interview Survey (NHIS), CDC, NCHS. 5-16 Aspirin intake 15+ times per month among persons with diabetes (age adjusted, 40+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 5-17 Self-blood-glucose-monitoring at least once daily among persons with diabetes (age adjusted, 18+ years) Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP.  
0           25          50          75         100
Moved away Moved toward Met or exceeded     
from target1 target target
Figure 5-1. Progress Toward Target Attainment for Focus Area 5: Diabetes
Percent of targeted change achieved5 (continued)
5-1. Diabetes education (age adjusted, 18+ 
years)
5-2. New cases of diabetes (3-year average,
age adjusted, per 1,000 population,
18–84 years)  
5-3. Prevalence of diabetes (age adjusted,
per 1,000 population)
5-4. Proportion of persons with diagnosed 
diabetes (age adjusted, 20+ years)
5-5. Diabetes-related deaths (age adjusted, per 
100,000 population) 
5-6. Diabetes-related deaths among persons with 
diabetes (age adjusted, per 1,000 
population) 
5-7. Cardiovascular disease deaths among 
persons with diabetes (age adjusted, per 
100,000 population)
5-10. Lower extremity amputations in persons with 
diabetes (3-year average, age adjusted, per 
1,000 population)
2010 
Target
Baseline
(Year)
Final
(Year)
Baseline vs. Final
Difference2
Statistically 
Significant3
Percent 
Change4
60%
45%
(1998)
55%
(1999)
10 Yes 22.2%
3.8
5.5
(1997–99)
8.0
(2006–08)
2.5 Yes 45.5%
25
40
(1997)
59
(2008)
19 Yes 47.5%
78%
64%
(1988–94)
77%
(2005–08)
13 Yes 20.3%
46
77
(1999)
73
(2007)
-4 Yes -5.2%
7.8
8.8
(1999)
6.3
(2007)
-2.5 Yes -28.4%
299
332
(1999)
205
(2007)
-127 Yes -38.3%
2.9
6.6
(1997–99)
3.5
(2005–07)
-3.1 Yes -47.0%
250.0%
384.8%
66.7%
92.9%
12.9%
83.8%
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2010 
Target
Baseline
(Year)
Final
(Year)
Baseline vs. Final
Difference2
Statistically 
Significant3
Percent 
Change4
14%
12%
(2000)
34%
(2007)
22 Yes 183.3%
65%
59%
(2000)
65%
(2008)
6 Yes 10.2%
76%
49%
(1998)
53%
(2008)
4 No 8.2%
91%
68%
(1998)
68%
(2008)
0 No 0.0%
71%
56%
(1997)
56%
(2008)
0 No 0.0%
61%
43%
(1998)
64%
(2008)
21 Yes 48.8%
0           25          50          75         100
Moved away Moved toward Met or exceeded     
from target1 target target
Figure 5-1. Progress Toward Target Attainment for Focus Area 5: Diabetes (continued)
100.0%
0.0%
Percent of targeted change achieved5 (continued)
5-11. Annual urinary microalbumin measurement 
among Medicare beneficiaries with diabetes
5-12. A1C Test, at least twice a year among 
persons with diabetes (age adjusted, 18+ 
years)  
5-13. Annual dilated eye examinations among 
persons with diabetes (age adjusted, 18+ 
years)
5-14. Annual foot examinations among persons 
with diabetes (age adjusted, 18+ years)
5-15. Annual dental examinations among persons 
with diabetes (age adjusted, 2+ years) 
5-17. Self-blood-glucose-monitoring at least once 
daily among persons with diabetes (age 
adjusted, 18+ years)
1,100.0%
14.8%
0.0%
116.7%
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DATA SOURCES
5-1–5-3. National Health Interview Survey (NHIS), CDC, NCHS.
5-4. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
5-5. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
5-6–5-7. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS; National Health Interview Survey (NHIS), CDC, NCHS. 
5-10. National Hospital Discharge Survey (NHDS), CDC, NCHS; National Health Interview Survey (NHIS), CDC, NCHS.  
5-11. United States Renal Data System (USRDS), NIH, NIDDK. 
5-12. Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP.  
5-13. National Health Interview Survey (NHIS), CDC, NCHS. 
5-14. Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP. 
5-15. National Health Interview Survey (NHIS), CDC, NCHS.  
5-17. Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP.
NOTES
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objective 5-16. Objectives 5-8 and 5-9 were deleted at the Midcourse Review.
FOOTNOTES
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information.
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points.
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix
for more information.
Final value – Baseline value
4 Percent change = × 100.
Baseline value
Final value – Baseline value
5 Percent of targeted change achieved = × 100.
Healthy People 2010 target – Baseline value
Figure 5-1. Progress Toward Target Attainment for Focus Area 5: Diabetes (continued)
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Figure 5-2. Health Disparities Table for Focus Area 5: Diabetes
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5-1. Diabetes education (age adjusted, 18+ years) (1998, 
1999)1 NA NA NA NA 3 2 B 2 B 1 2 1 B 2 B 1 Bi 1
5-2. New cases of diabetes (3-year average, age 
adjusted, per 1,000 population, 18–84 years) 
(1997–99, 2006–08)2
NA 1 NA NA 2 2 B 2 B 1 4 3 B 3 B 1 4 B
5-3. Prevalence of diabetes (age adjusted, per 1,000 
population) (1997, 2008)1 4 1 NA 3 3
3d1
B 3ii Bi 1 3 2 B 3 Bi 2 4 B
5-4. Proportion of persons with diagnosed diabetes (age 
adjusted, 20+ years) (1988–94, 2005–08)3 NA NA NA NA iii NA NA NA NA
5-5. Diabetes-related deaths (age adjusted per 100,000 
standard population) (1999, 2007)4
3d1
NA 3
4u1 2u1
3 B
2u1 4u1 4u1
B
4u1
NS NS NA NA
5-6. Diabetes-related deaths among persons with 
diabetes (age adjusted, per 1,000 population) (1999, 
2007)4
NA NA NA NA b 1 B NA B 2 NA NS NS NA NA
5-7. Cardiovascular disease deaths among persons with 
diabetes (age adjusted, per 100,000 population) 
(1999, 2007)4
NA NA NA NA B 3
3d1 3d1
B
2u1
2d1
3 B
3d1
NS NS NA NA
5-10. Lower extremity amputations in persons with 
diabetes (3-year average, age adjusted, per 1,000 
population) (1997–99, 2005–07)
NA NA NA NA NA v v NA B 4 NA NA NA NA NA NA NA NA
5-11. Annual urinary microalbumin measurement among 
Medicare beneficiaries with diabetes (2000, 2007)
2u1
NA 1 1 1 1 1 B NA NA NA NA NS NS NA NA
5-12. A1C Test, at least twice a year among persons with 
diabetes (age adjusted, 18+ years) (2000, 2008)5 b b b 1 3 1 B NA 1 B 3
2u1
B
2u1
NS NS NS NS
5-13. Annual dilated eye examinations among persons with 
diabetes (age adjusted, 18+ years) (1998, 2008)1 NA NA NA NA 1 2 B 1ii Bi 1 2 2 B 2 NS NS NS NS
5-14. Annual foot examinations among persons with 
diabetes (age adjusted, 18+ years) (1998, 2008)5 1 1 NA 3
3u2
Bi 2 2ii Bi B 2 1 B 2 NS NS NS NS
5-15. Annual dental examinations among persons with 
diabetes (age adjusted, 2+ years) (1997, 2008)1 NA NA NA NA 1 1 B 1 1 Bi 3 2 B 3 NS NS 1 B
5-16. Aspirin intake 15+ times per month among persons 
with diabetes (age adjusted, 40+ years) (1999–2002) NA NA NA NA 2iii 2 B 2 1 B 1 1 B 1 NA NA NS NS
5-17. Self-blood-glucose-monitoring at least once daily 
among persons with diabetes (age adjusted, 18+ 
years) (1998, 2008)5
b 2 NA 1 1 Bi B NA B 2 Bi
2u1 2u1 2u1
NS NS NS NS
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity 
from the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Location Disability
Population-based objectives
Biv
Biv
(continued)
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Figure 5-2. Health Disparities Table for Focus Area 5: Diabetes (continued)
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
1
2
3
4
5
i
ii
iii
iv
v
5-1–5-3. National Health Interview Survey (NHIS), CDC, NCHS.
5-4. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
5-5. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
5-6–5-7. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS; National Health Interview Survey (NHIS), CDC, NCHS. 
5-10. National Hospital Discharge Survey (NHDS), CDC, NCHS; National Health Interview Survey (NHIS), CDC, NCHS.
5-11. United States Renal Data System (USRDS), NIH, NIDDK.
5-12. Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP.
5-13. National Health Interview Survey (NHIS), CDC, NCHS.
5-14. Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP.
5-15. National Health Interview Survey (NHIS), CDC, NCHS.
5-16. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
5-17. Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Measures of variability were available for all objectives in this table. Thus, the variability of best group rates was assessed, and statistical significance was tested. 
Disparities of 10% or more are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over 
time are indicated by arrows when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical 
Appendix.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Objectives 5-8 and 5-9 were deleted at Midcourse Review. 
Baseline data by race and ethnicity are for 1999–2001.
50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
10–49 points 50–99 points 100 points or more
Baseline data by race and ethnicity are for 1999.
Baseline data by disability status are for 1991–94.
Most recent data by education level are for 2002.
Baseline data by race and ethnicity are for 2001.
NOTES
Years in parentheses represent the baseline and most recent data years (if available).
Increase in disparity (percentage points)
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
Reliability criterion for best 
group rate not met, or data 
available for only one group.
DATA SOURCES
Change in the summary index cannot be assessed. See Technical Appendix.
Data are for Mexican American.
Data are for Asian or Pacific Islander.
Data include persons of Hispanic origin.
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
Figure 5-3.  Diabetes Prevalence (Aged 18+) 2008 
Healthy People 2010 objective 5-3 
U.S. / National Target = 25 † 
NOTES: Data are age-adjusted to the 2000 standard population. Rates are displayed by a Jenks classification for U.S. states. National data for the objective come  
from the National Health Interview Survey (NHIS) and is the basis for setting the target †. State data from the BRFSS may not be comparable to the national data from  
the NHIS. Both US rates are shown for comparison purposes.  BRFSS state-based rates are for population 18+, NHIS national rate is for all ages.   
SOURCE: Behavioral Risk Factor Surveillance System (BRFSS), CDC.  
57.1 - 64.4 
64.5 - 73.4 
73.5 - 82.6 
82.7 - 94.7 
94.8 - 107.4 
Rate per 1,000 
US (2008 NHIS) – 59 per 1,000 
US (2008 BRFSS) – 83.5 per 1,000 
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Goal: Promote the health of people with disabilities, 
prevent secondary conditions, and eliminate disparities 
between people with and without disabilities in the U.S. 
population 
The objectives in this chapter include measures of life satisfaction among people with disabilities, barriers to their participation in everyday aspects of life, and the availability of public health programs to support these individuals and their caregivers. The objectives also track the use of congregate care as well as the availability of surveillance systems that identify persons with disabilities. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved for the objectives in this Focus Area during the past decade [1]. Over two thirds of the Disability and Secondary Conditions objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 6-1). However, health disparities of 50% to 99% were observed among racial and ethnic populations, education groups, and income groups (Figure 6-2), as highlighted below [2]. 
 The number of states and the District of Columbia (D.C.) with public health surveillance systems for persons with disabilities (objective 6-13a) increased from 14 states in 1999 to 51 in 2009, meeting the 2010 target of 51. During the same time period, the number of states and D.C. with surveillance systems for caregivers of persons with disabilities (objective 6-13e) increased from zero to 51, also meeting the target of 51. 
 A statistically significant downward trend was observed during the past decade in the number of adults in congregate care facilities (objective 6-7a) [3]. The number dropped by 36.2% between 1997 and 2009, from 93,362 to 59,604, moving toward the 2010 target of 46,681. However, the number of children and young adults in congregate care facilities (objective 6-7b) increased by 11.0% between 1997 and 2008, from 26,028 to 28,890, moving away from the target of 0. The proportion of children and youth aged 6–21 years with disabilities who are enrolled in regular education programs (objective 6-9) increased by 28.9% between 1995–96 and 2008–09, from 45% to 58%, moving toward the 2010 target of 60%. 
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 Sadness or depression among children and adolescents aged 4–17 years with disabilities (objective 6-2) decreased by 25.8% between 1997 and 2007, from 31% to 23%, moving toward the 2010 target of 17%. 
 The employment rate among adults aged 18–64 years with disabilities (objective 6-8) declined by 14.0% between 1997 and 2008, from 43% to 37%, moving away from the 2010 target of 80%. Disparities were observed for a number of population groups, for example: 
• Among racial and ethnic groups, white non-Hispanic adults with disabilities had the highest (best) employment rate, 41% in 2008, whereas Hispanic or Latino and black non-Hispanic adults with disabilities had rates of 29% and 27% in 2008, respectively. When expressed as unemployment rates among adults with disabilities, the rate for Hispanic or Latino adults was 20% higher than the best group rate (that for white non-Hispanic adults) and the rate for black non-Hispanic adults was 24% higher than the best group rate [2]. 
• Among educational groups, persons with disabilities and at least some college education had the highest (best) employment rate, 52% in 2008, whereas the rate for persons with disabilities who had less than a high school education was 22% in 2008. When expressed as unemployment rates among persons with disabilities, the rate for persons with less than a high school education was more than one and a half times the best group rate [2]. 
 Disparities among racial and ethnic groups were observed for several objectives, for example: 
• The white non-Hispanic population had the lowest (best) proportion of persons with disabilities reporting barriers to participation in community activities (objective 6-12d), 11% in 2002. Persons of two or more races had a rate of 24% in 2002, more than twice the best group rate [2]. 
• The white non-Hispanic population had the highest (best) proportion of persons with disabilities reporting access to health and wellness programs (objective 6-10), 54% in 2002, whereas the rate for the Hispanic or Latino population was 27% in 2002. When expressed as persons with disabilities reporting no access to health and wellness programs, the rate for the Hispanic or Latino population was more than one and a half times the best group rate [2]. 
• The white-non-Hispanic population had the highest (best) proportion of sufficient emotional support among adults with disabilities (objective 6-5), 73% in 2008, whereas the American Indian or Alaska Native, Asian, and black non-Hispanic populations had rates of 59%, 58%, and 58% in 2008, respectively. When expressed as persons with disabilities without sufficient emotional support, the rates for the American Indian or Alaska Native, Asian, and black non-Hispanic populations were all about one and a half times as high as the best group rate (that for the white non-Hispanic population) [2].  
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Summary of Progress 
 Figure 6-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Disability and Secondary Conditions [1]. Data to measure progress toward target attainment were available for 13 objectives. Of these: 
• Two objectives (6-13a and e) met their Healthy People 2010 targets. 
• Seven objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for two of these objectives (6-5 and 6-6). No significant difference was observed for one objective (6-2); and data to test the significance of the difference were unavailable for four objectives (6-1, 6-7a, 6-9, and 6-13c). 
• One objective showed no change (6-13g). 
• Three objectives moved away from their targets. A statistically significant difference between the baseline and final data points was observed for two objectives (6-3 and 6-8); data to test the significance of the difference were unavailable for one objective (6-7b). 
 There were four objectives that remained developmental (objectives 6-13b, d, f, and h), and seven that had no additional data available to measure progress (objectives 6-4, 6-10, 6-11, and 6-12a through d) [4]. 
 Figure 6-2 displays health disparities in Disability and Secondary Conditions from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [5]. 
• Of the seven objectives with statistically significant racial and ethnic health disparities of 10% or more, the white non-Hispanic population had the best rate for six objectives (6-4, 6-5, 6-8, 6-10, and 6-12a and d). The Hispanic or Latino population had the best rate for one objective (6-6). 
 One health disparity of 100% or more was observed: barriers to participation in community activities were lowest among the white non-Hispanic population; the rate for persons of two or more races was more than twice the best group rate (objective 6-12d; see Highlights). 
• Males had better rates for five of the six objectives with statistically significant health disparities of 10% or more by sex (objectives 6-3, 6-8, 6-11, and 6-12a and d). Females had better rates for the remaining objective (6-4). 
• Persons with at least some college education had the best rate for the seven objectives with statistically significant health disparities of 10% or more by education level (objective 6-3 through 6-6, 6-8, 6-10, and 6-11). 
 Health disparities of 50% to 99% between persons with less than high school education and persons with at least some college education were observed for five objectives (6-4 through 6-6, 6-8, and 6-10). 
• Persons with middle/high incomes had the best rates for the six objectives with statistically significant health disparities of 10% or more by income (objectives 6-3, 6-4, 6-10, 6-11, and 6-12a and d). 
 Health disparities of 50% to 99% between low-income (poor) persons and middle/high income persons were observed for four objectives (6-3, 6-4, 6-10, and 6-12d). 
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Transition to Healthy People 2020 For Healthy People 2020, the Healthy People 2010 Disability and Secondary Conditions Focus Area was expanded to include a broader range of objectives, with increased emphasis on health determinants. Consequently the Healthy People 2020 Topic Area name was changed from “Disability and Secondary Conditions” to “Disability and Health.” See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives The differences between the Healthy People 2010 objectives and those included in Healthy People 2020 objectives are summarized below: 
 The Healthy People 2010 Disability and Secondary Conditions Focus Area had 24 objectives whereas Healthy People 2020 Disability and Health Topic Area has a total of 28 objectives.  
 Three of the Healthy People 2010 objectives were retained “as is” [6]. These include the inclusion of children and youth in regular education programs, Tribal disability surveillance, and Tribal caregiver surveillance (objectives 6-9, and 6-13b and f). 
 Nineteen of the Healthy People 2010 objectives were modified [7]. 
• Identifying people with disabilities in “surveillance instruments” was reworded to clarify “population data systems” (objective 6-1). 
• Two objectives on depressive symptoms among children and adults with disabilities were combined so that the age groups could be better reflected in a demographic template (objectives 6-2 and 6-3). 
• Social participation among adults with disabilities was reworded to reflect all ages and a broader range of social activities (objective 6-4). 
• Emotional support among adults with disabilities was reworded to include “social” support as well (objective 6-5). 
• Two objectives on congregate care among children/youth and adults with disabilities were reworded to reflect residences that serve people instead of facilities with “beds” (objectives 6-7a and b). 
• Employment among adults with disabilities was reworded to include youth with disabilities in the new measurement (objective 6-8). 
• Two objectives on access to health and wellness programs and not having needed assistive devices and technology were both reworded to reflect barriers (objectives 6-10 and 6-11). 
• Four objectives on “reported environmental barriers” to participation in home, school, work, or community activities were reworded to reflect “encountering” barriers” (objectives 6-12a through d). 
• Five objectives on state or Tribal health surveillance and health promotion among people with disabilities and their caregivers were reworded to specify state “health departments” with at least “one” program (objectives 6-13c through e, and 6-13g through h). 
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 Two Healthy People 2010 objectives were archived [8]. Due to relatively high reported rates and lack of specific public health interventions, life satisfaction among adults with disabilities (objective 6-6) was archived. After meeting the target for several consecutive years, state disability surveillance (objective 6-13a) was archived. 
 Nine new objectives were added to the Healthy People 2020 Disability and Health Topic Area. These objectives address: 
• Delays in receiving preventive care among persons with disabilities 
• Transition planning from pediatric to adult health care for youth with disabilities 
• The receipt of appropriate medical care for persons with epilepsy 
• Use of inappropriate medications among older adults with disabilities 
• Unemployment among persons with disabilities 
• Unintentional injury among persons with disabilities 
• Early intervention services for children with disabilities 
• Master of Public Health (MPH) programs that offer courses in disability and health 
• Homes and residential buildings that have visitable features (e.g., no-step entrance to the home). Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. 
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Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
Notes 1. Displayed in the Progress Chart (Figure 6-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 6-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 6-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 6-2 footnotes, as well as the Technical Appendix, for more detail. 3. The presence of a monotonic increasing or decreasing trend in the underlying measure was tested with the nonparametric Mann-Kendall test, then the slope of a linear trend was estimated with the nonparametric Sen’s method. See Technical Appendix for more information. 4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 
Disability and Secondary Conditions  Page 6-8 
5. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 1-2 footnotes, as well as the Technical Appendix, for more detail. 6. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 7. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 8. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020.  
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Comprehensive Summary of Objectives: Disability and Secondary Conditions 
Objective  Description Data Source or Objective Status 6-1 Standard questions to identify people with disabilities in data sets CDC, NCBDDD. 6-2 Sadness or depression among children and adolescents with disabilities (4–17 years) National Health Interview Survey (NHIS), CDC, NCHS. 6-3 Negative feelings interfering with activities among adults with disabilities (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 6-4 Social participation among adults with disabilities (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 6-5 Sufficient emotional support among adults with disabilities (age adjusted, 18+ years) Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP. 6-6 Satisfaction with life among adults with disabilities (age adjusted, 18+ years) Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP. 6-7a Congregate care of adults with disabilities (number, 22+ years) Survey of State Developmental Disabilities Directors, University of Minnesota. 6-7b Congregate care of children and young adults with disabilities (number, 
≤22 years) Survey of State Developmental Disabilities Directors, University of Minnesota. 6-8 Employment rate among adults with disabilities (18–64 years) National Health Interview Survey (NHIS), CDC, NCHS. 6-9 Inclusion of children and youth with disabilities in regular education programs (6–21 years) Data Analysis System (DANS), Department of Education. 6-10 Access to health and wellness programs among adults with disabilities (age adjusted 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 6-11 Lack of assistive devices and technology among adults with disabilities (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 6-12a Environmental barriers affecting participation in activities at home among adults with disabilities (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 6-12b Environmental barriers affecting participation in activities at school among adults with disabilities (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 6-12c Environmental barriers affecting participation in activities at work among adults with disabilities (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 
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Objective  Description Data Source or Objective Status 6-12d Environmental barriers affecting participation in community activities among adults with disabilities (age adjusted, 18+ years National Health Interview Survey (NHIS), CDC, NCHS. 6-13a Surveillance for persons with disabilities (no. States and D.C.) CDC, NCDBBB, DH-Team. 6-13b Surveillance for persons with disabilities (Tribes) Developmental 6-13c Health promotion programs for persons with disabilities (no. States and D.C.) CDC, NCDBBB, DH-Team. 6-13d Health promotion programs for persons with disabilities (Tribes) Developmental 6-13e Surveillance for caregivers (no. States and D.C.) CDC, NCDBBB, DH-Team. 6-13f Surveillance for caregivers (Tribes) Developmental 6-13g Health promotion programs for caregivers (no. States and D.C.) CDC, NCDBBB, DH-Team. 6-13h Health promotion programs for caregivers (Tribes) Developmental  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
100% 
0% 
(1999) 
33% 
(2009) 
33 Not tested * 
17% 
31% 
(1997) 
23% 
(2007) 
-8 No -25.8% 
7% 
28% 
(1997) 
32% 
(2008) 
4 Yes 14.3% 
80% 
67% 
(2005) 
69% 
(2008) 
2 Yes 3.0% 
97% 
84% 
(2005) 
86% 
(2008) 
2 Yes 2.4% 
46,681 
93,362 
(1997) 
59,604 
(2009) 
-33,758 Not tested -36.2% 
0 
26,028 
(1997) 
28,890 
(2008) 
2,862 Not tested 11.0% 
80% 
43% 
(1997) 
37% 
(2008) 
-6 Yes -14.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 6-1. Progress Toward Target Attainment for Focus Area 6: Disability and Secondary Conditions 
Percent of targeted change achieved5 (continued) 
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disabilities in data sets 
6-2. Sadness or depression among children and 
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6-3. Negative feelings interfering with 
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 (age adjusted, 18+ years) 
6-5. Sufficient emotional support among adults 
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6-6. Satisfaction with life among adults with 
disabilities (age adjusted, 18+ years)  
6-7a. Congregate care of adults with disabilities 
(number, 22+ years)  
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6-8. Employment rate among adults with 
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60% 
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6-9. Inclusion of children and youth with 
disabilities in regular education programs (6–
21 years)  
6-13a. Surveillance for persons with disabilities (no. 
States and D.C.)     
6-13c. Health promotion programs for persons with 
disabilities (no. States and D.C.)  
6-13e. Surveillance for caregivers (no. States and 
D.C.)  
6-13g. Health promotion programs for caregivers 
(no. States and D.C.)   
 
 
Figure 6-1. Progress Toward Target Attainment for Focus Area 6: Disability and Secondary Conditions (continued) 
Percent of targeted change achieved5 
(continued) 
 86.7% 
5.4% 
0.0% 
100.0% 
100.0% 
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Figure 6-1. Progress Toward Target Attainment for Focus Area 6: Disability and Secondary Conditions (continued) 
DATA SOURCES 
 
6-1. CDC, NCBDDD. 
6-2–6-3. National Health Interview Survey (NHIS), CDC, NCHS. 
6-5–6-6.  Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP. 
6-7a–b. Survey of State Developmental Disabilities Directors, University of Minnesota. 
6-8. National Health Interview Survey (NHIS), CDC, NCHS. 
6-9. Data Analysis System (DANS), Department of Education. 
6-13a. CDC/NCDBBB/DH-Team. 
6-13c. CDC/NCDBBB/DH-Team. 
6-13e. CDC/NCDBBB/DH-Team. 
6-13g. CDC/NCDBBB/DH-Team. 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data  
are not available for objectives 6-4, 6-10, 6-11, 6-12a through d, 6-13b, 6-13d, 6-13f, and 6-13h. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
 
* Percent change cannot be calculated. See Technical Appendix for more information. 
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Figure 6-2. Health Disparities Table for Focus Area 6: Disability and Secondary Conditions
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6-2. Sadness or depression among children and 
adolescents with disabilities (4–17 years) (1997, 
2007)1
NA NA NA NA NA NA NA NA NA NA
6-3. Negative feelings interfering with activities 
among adults with disabilities (age adjusted, 18+ 
years) (1997, 2008)1
NA b NA b 1 1 B NA 2 B 2 2 B 2 3 2 B 2 1 B
6-4. Social participation among adults with 
disabilities (age adjusted, 18+ years) (2001) b 1 NA 1 2 1 B NA B 2 3 2 B 3 3 2 B 3 1 B
6-5. Sufficient emotional support among adults with 
disabilities (age adjusted, 18+ years) (2005, 
2008)
3 3 1 2
2d1
3 B 2 1 B 3 2 B 3 NS NS NS NS NS NS
6-6. Satisfaction with life among adults with 
disabilities (age adjusted, 18+ years) (2005, 
2008)
3 b NA 2 Bi 3
1d1
NA 1 B 3
2u1
B
3u1
NS NS NS NS NS NS
6-8. Employment rate among adults with disabilities 
(18–64 years) (1997, 2008)1 NA NA NA b 2
2d1
B NA 2 B 3 2 B 3 NS NS NS NS NS NS
6-10. Access to health and wellness programs among 
adults with disabilities (age adjusted, 18+ years) 
(2002)
NA 2 NA 1 3 2 B 2 1 B 3 2 B 3 3 2 B 3 B 1
6-11. Lack of assistive devices and technology among 
adults with disabilities (age adjusted, 18+ years) 
(2002)
NA NA NA 1 1 b B NA 2 B 1 2 B 2 2 3 B 2
6-12a. Environmental barriers affecting participation in 
activities at home among adults with disabilities 
(age adjusted, 18+ years) (2002)
NA NA NA 3 1 2 B 3 2 B 1 b B NA 2 1 B 2
6-12b. Environmental barriers affecting participation in 
activities at school among adults with disabilities 
(age adjusted, 18+ years) (2002)
NA NA NA NA NA NA NA NA NA NA NA
6-12c. Environmental barriers affecting participation in 
activities at work among adults with disabilities 
(age adjusted, 18+ years) (2002)
NA NA NA NA NA NA NA
6-12d. Environmental barriers affecting participation in 
community activities among adults with 
disabilities (age adjusted, 18+ years) (2002)
NA NA NA 4 b 1 B NA 2 B 1 b B NA 3 2 B 3
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Location
(continued)
Population-based objectives
Disability and Secondary Conditions Page 6-15
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
1
i
6-2–6-4. National Health Interview Survey (NHIS), CDC, NCHS.
6-5–6-6. Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP.
6-8. National Health Interview Survey (NHIS), CDC, NCHS.
6-10–6-11. National Health Interview Survey (NHIS), CDC, NCHS.
6-12a–d. National Health Interview Survey (NHIS), CDC, NCHS.
NOTES
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 6-
1, 6-7a and b, 6-9, and 6-13a through h.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race 
and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at 
baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the 
summary index at the most recent data point. See Technical Appendix for more information.
Figure 6-2. Health Disparities Table for Focus Area 6: Disability and Secondary Conditions 
(continued)
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage points 
and estimates of variability were not available. See Technical Appendix.
50–99 points 100 points or more
DATA SOURCES
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Baseline data by race and ethnicity are for 1999.
FOOTNOTES
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Reliability criterion for best group 
rate not met, or data available for 
only one group.
Measures of variability were available for all objectives in this table. Thus, the variability of best group rates was assessed, and statistical significance was tested. 
Disparities of 10% or more are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over 
time are indicated by arrows when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical 
Appendix.
Increase in disparity (percentage points)
10–49 points
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
 A reformatted, typeset version of this report will replace the current version   
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Goal: Increase the quality, availability, and effectiveness 
of educational and community-based programs designed 
to prevent disease and improve health and quality of life 
This chapter monitors a number of school-related objectives including high school completion, health-related educational programs in schools, and the availability of school nurses. In addition, objectives track health promotion programs in worksites, as well as community-based programs established by local health departments. The number of older adults participating in organized health promotion activities is also monitored. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved for the objectives in this Focus Area during the past decade [1]. Seventy-six percent of the Educational and Community-Based Programs objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 7-1). However, statistically significant health disparities were observed by race and ethnicity, sex, and education level, some of which are highlighted below (Figure 7-2) [2]. 
 The high school completion rate among persons aged 18–24 years (objective 7-1) increased by 4.7% between 1998 and 2007, from 85% to 89%, moving toward the Healthy People 2010 target of 90%. Disparities were observed for racial and ethnic population groups as follows: 
• Among racial and ethnic groups, the white non-Hispanic population had the highest (best) rate of high school completion, 93% in 2006, whereas the Hispanic or Latino population, the black non-Hispanic population, and persons of two or more races had rates of 71%, 85%, and 90% in 2006, respectively. When expressed as persons not completing high school, the rate for the Hispanic or Latino population was more than four times the best group rate (that for the white non-Hispanic population) [2]. The rate for the black non-Hispanic population was more than twice the best group rate and the rate for persons of two or more races was nearly one and a half times the best group rate. 
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 The proportion of schools with a nurse-to-student ratio of at least one nurse for every 750 students increased for all types of schools (objectives 7-4a through d). Nationally, middle and junior high schools (objective 7-4c) met the 2010 target of 50% exactly in 2006. There was a 46.2% increase in the proportion of senior high schools with a 1:750 nurse-to-student ratio (objective 7-4b) between 1994 and 2006, from 26% to 38%. Although the proportion of elementary schools with a 1:750 nurse-to-student ratio (objective 7-4d) increased by 7.1% between 2000 and 2006, from 42% to 45%, the increase was not statistically significant. 
 School health education programs increased in a number of areas. Two examples where such increases were statistically significant are education programs focusing on unintentional injuries (objective 7-2b), which increased by 21.2% between 1994 and 2006, from 66% to 80%, and programs addressing violence (objective 7-2c), which increased by 32.8% between 1994 and 2006, from 58% to 77%.  
Summary of Progress 
 Figure 7-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Educational and Community-Based Programs [1]. Data to measure progress toward target attainment were available for 17 objectives. Of these: 
• One objective (7-4c, middle and junior high schools with a nurse-to-student ratio of at least one nurse for every 750 students) met the Healthy People 2010 target. 
• Twelve objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for six of these objectives (7-1, 7-2a through c, and 7-4a and b). No significant differences were observed for five objectives (7-2d, e, g, and i; and 7-4d); and data to test the significance of the difference were unavailable for one objective (7-3). 
• Two objectives (7-2h and j) showed no change. 
• Two objectives (7-2f and 7-6) moved away from their targets. A statistically significant difference between the baseline and final data points was observed for one objective (7-6, participation in employer sponsored health promotion activities). No significant difference was observed for the other objective (7-2f, school health education on alcohol and other drug use in middle/junior and senior high schools). 
• No data were available to measure progress for the following 39 objectives.  
 Two objectives (7-5a and 7-10) remained developmental [3]. 
 Twenty-two objectives (7-5b through f; 7-11c, g through i, m through o, q through v, y, z, aa; and 7-12) had baseline data only.  
 Fifteen objectives (7-7 through 7-9; 7-11a, b, d through f, j through l, p, w, x, and bb) were dropped during the decade [4]. 
 Figure 7-2 displays health disparities in Educational and Community-Based Programs from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [5]. 
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• Three objectives (7-1, 7-3, and 7-12) had racial and ethnic health disparities of 10% or more. For each of these three objectives, a different group had the best rate, including the white non-Hispanic (objective 7-1), the black non-Hispanic (objective 7-3), and the Asian or Pacific Islander populations (objective 7-12). 
• Females had a better rate of high school completion than males (objective 7-1). When expressed as persons not completing high school, the rate for females (9%) was significantly lower than the rate for males (13%).  
Transition to Healthy People 2020 The Healthy People 2020 Educational and Community-Based Programs Topic Area has expanded from Healthy People 2010 to include objectives that track core clinical prevention and population health content in training of health care professionals. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 Educational and Community-Based Programs Topic Area can be grouped into several sections: 
 School Settings 
 Worksite Settings 
 Health Care Settings 
 Community Settings and Select Populations 
 Training of Health Care Professionals. The differences between the Healthy People 2010 objectives and those included in Healthy People 2020 are summarized below: 
 The Healthy People 2020 Educational and Community-Based Programs Topic Area has a total of 94 objectives, 18 of which are developmental, whereas the Healthy People 2010 Educational and Community-Based Programs Focus Area had 56 objectives, two of which remained developmental [3]. 
 Four Healthy People 2010 objectives, including high school completion (objective 7-1), student to nurse ratio in senior high schools and in elementary schools (objective 7-4b and d, respectively), and worksite health promotion program in worksites with fewer than 50 employees (objective 7-5a), were retained “as is” [6]. 
 Twenty Healthy People 2010 objectives were modified [7]: 
• School health education objectives (7-2a through j) were modified to include elementary schools. Currently, objective 7-2 addresses middle and senior high schools. Adding elementary schools expands this objective to all grades K–12 (elementary, middle, and senior high schools), thus providing comprehensive information on health education in the nation’s schools. 
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• Student to nurse ratio in all schools (objective 7-4a) was modified to include elementary schools because elementary schools were added to the 2006 School Health Policies and Programs Study (SHPPS). Student to nurse ratio in middle and junior high schools (objective 7-4c) was modified to be limited to middle schools only because the language, “junior high schools,” is no longer used in SHPPS. 
• Most worksite setting objectives were reverted to developmental status because the data sources used over the last decade are no longer available. New data sources have been identified but currently lack baseline data. The objectives that are now developmental include: 
 Culturally appropriate and linguistically competent community health promotion and disease prevention programs in educational and community-based programs (objective 7-11g) 
 Worksite health promotion programs in worksites with 50 or more employees, 50–99, 100–249, 250–749, and 750 or more employees (objectives 7-5b through f, respectively), and employer-sponsored health promotion activities (objective 7-6). 
• One Community Settings and Select Populations objective (7-10, community health promotion programs), which was developmental, was modified. The objective expanded to nine objectives addressing population-based primary prevention services in the following priority areas: injury, violence, mental illness, tobacco use, substance abuse, unintended pregnancy, chronic disease programs, nutrition, and physical activity.  
• The Healthy People 2010 objective on culturally appropriate and linguistically competent community health promotion programs in educational and community-based programs (objective 7-11g) was retained as developmental. The data source used in Healthy People 2010 no longer identifies or tracks culturally appropriate or linguistically competent programs, and a new data source is being sought in coordination with the Office of Minority Health within the U.S. Department of Health and Human Services. 
 The following 17 objectives were archived [8]: 
• School health education in environmental health (objective 7-2j) was archived because information about the topic is no longer collected by the data source (the School Health Policies and Program Study). 
• Sixteen community setting and select populations objectives were archived because the data sources used for the past decade no longer collect the data: 
 Fifteen objectives that address culturally appropriate and linguistically competent community health promotion and disease prevention programs (objectives 7-11c, h, i, m, n, o, q through v, y, z and aa) were archived because they are no longer tracked by the National Profile of Local Health Departments. 
 One objective that addresses older adults who have participated in organized health promotion activities (objective 7-12) was archived because the questions used to collect the data are no longer included on the National Health Interview Survey. 
 The following 15 objectives were dropped during the last decade due to either a lack of a national data source or a shift in program priority [4]. 
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• All three health care setting objectives: patient and family education (objective 7-7), satisfaction with patient education (objective 7-8), and health care organization sponsorship of community health promotion activities (objective 7-9) were dropped. 
• Twelve of the community setting and select populations objectives were dropped due to lack of national data source: culturally appropriate and linguistically competent community health promotion programs (objectives 7-11a, b, d through f, j through l, p, w, x, and bb). 
 Sixty-two new objectives were added to the Healthy People 2020 Educational and Community-Based Programs Topic Area: 
• Nine developmental objectives address preschools and Early Health Start programs in select priority areas. 
• Seven objectives address school health education based on the National Health Education Standards. 
• Seven objectives address school health education that promotes personal health and wellness. 
• Nine objectives address college and university students who receive information from their institution on select priority health risk behavior areas. 
• Thirty new objectives that address the training of health care professionals were added. These include six objectives that focus on training in core clinical prevention and population health content for each of the following professions: 
 Doctor of Medicine (M.D.) 
 Doctor of Osteopathy (D.O.) 
 Undergraduate nursing  
 Nurse Practitioner 
 Physician Assistant. The Healthy People 2020 objectives reflect the ongoing importance of Educational and Community-Based Programs. For objectives that were deleted due to lack of data, the U.S. Department of Health and Human Services and the agencies that serve as the leads for the Healthy People 2020 initiative will consider ways to ensure that these public health issues retain prominence despite the lack of data to monitor them. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
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Data Considerations Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
Notes 1. Displayed in the Progress Chart (Figure 7-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 7-1 footnotes, as well as the Technical Appendix, for more detail. 
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2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 7-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 7-2 footnotes, as well as the Technical Appendix, for more detail. 3. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 4. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 5. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 7-2 footnotes, as well as the Technical Appendix, for more detail. 6. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 7. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 8. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 
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Comprehensive Summary of Objectives: Educational and Community-Based Programs 
Objective Description Data Source or Objective Status 7-1 High school completion (18–24 years) Current Population Survey (CPS), Department of Commerce, Census Bureau. 7-2a School health education—All priority areas (middle/junior, senior  high schools) School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-2b School health education—Unintentional injury (middle/junior, senior high schools) School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-2c School health education—Violence (middle/junior, senior high schools) School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-2d School health education—Suicide (middle/junior, senior high schools) School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-2e School health education—Tobacco use and addiction (middle/junior, senior high schools) School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-2f School health education—Alcohol and other drug use (middle/junior, senior high schools) School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-2g School health education—Unintended pregnancy, HIV/AIDS, and STD infection (middle/junior, senior high schools) School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-2h School health education—Unhealthy dietary patterns (middle/junior, senior high schools) School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-2i School health education—Inadequate physical activity (middle/junior, senior high schools) School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-2j School health education—Environmental health (middle/junior, senior high schools) School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-3 Health-risk behavior information for college and university students National College Health Risk Behavior Survey, CDC, NCCDPHP. 7-4a School nurse-to-student ratio of at least 1:750—All middle/junior and senior high schools School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-4b School nurse-to-student ratio of at least 1:750—Senior high schools School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-4c School nurse-to-student ratio of at least 1:750—Middle and junior high schools School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-4d School nurse-to-student ratio of at least 1:750— Elementary schools School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 7-5a Worksite health promotion programs—Worksites with fewer than 50 employees Developmental 
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Objective Description Data Source or Objective Status 7-5b Worksite health promotion programs—Worksites with 50 or more employees National Worksite Health Promotion Survey (NWHPS), Association for Worksite Health Promotion (AWHP) and OPHS, ODPHP. 7-5c Worksite health promotion programs—Worksites with 50 to 99 employees National Worksite Health Promotion Survey (NWHPS), Association for Worksite Health Promotion (AWHP) and OPHS, ODPHP. 7-5d Worksite health promotion programs—Worksites with 100 to 249 employees National Worksite Health Promotion Survey (NWHPS), Association for Worksite Health Promotion (AWHP) and OPHS, ODPHP. 7-5e Worksite health promotion programs—Worksites with 250 to 749 employees National Worksite Health Promotion Survey (NWHPS), Association for Worksite Health Promotion (AWHP) and OPHS, ODPHP. 7-5f Worksite health promotion programs—Worksites with 750 or more employees National Worksite Health Promotion Survey (NWHPS), Association for Worksite Health Promotion (AWHP) and OPHS, ODPHP. 7-6 Participation in employer-sponsored health promotion activities (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 7-7 Health care organizations that provide patient and family education Dropped 7-8 Satisfaction with patient education Dropped 7-9 Hospital and managed care organization sponsorship of community health promotion activities Dropped 7-10 Community health promotion programs addressing Healthy People 2010 focus areas Developmental 7-11a Culturally appropriate and linguistically competent community health promotion programs—Access to quality health services Dropped 7-11b Culturally appropriate and linguistically competent community health promotion programs—Arthritis, osteoporosis and chronic back conditions Dropped 7-11c Culturally appropriate and linguistically competent community health promotion programs—Cancer National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11d Culturally appropriate and linguistically competent community health promotion programs—Chronic kidney disease Dropped 7-11e Culturally appropriate and linguistically competent community health promotion programs—Diabetes Dropped 7-11f Culturally appropriate and linguistically competent community health promotion programs—Disability and secondary conditions Dropped 
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Objective Description Data Source or Objective Status 7-11g Culturally appropriate and linguistically competent community health promotion programs—Educational and community-based programs National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11h Culturally appropriate and linguistically competent community health promotion programs—Environmental health  National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11i Culturally appropriate and linguistically competent community health promotion programs—Family planning National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11j Culturally appropriate and linguistically competent community health promotion programs—Food safety Dropped 7-11k Culturally appropriate and linguistically competent community health promotion programs—Medical product safety Dropped 7-11l Culturally appropriate and linguistically competent community health promotion programs—Health communication Dropped 7-11m Culturally appropriate and linguistically competent community health promotion programs—Heart disease and stroke National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11n Culturally appropriate and linguistically competent community health promotion programs—HIV National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11o Culturally appropriate and linguistically competent community health promotion programs—Immunization and infectious diseases National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11p Culturally appropriate and linguistically competent community health promotion programs—Injury and violence prevention Dropped 7-11q Culturally appropriate and linguistically competent community health promotion programs— Maternal, infant (and child) health National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11r Culturally appropriate and linguistically competent community health promotion programs—Mental health (and mental disorders)  National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11s Culturally appropriate and linguistically competent community health promotion programs—Nutrition and overweight National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11t Culturally appropriate and linguistically competent community health promotion programs—Occupational safety and health National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11u Culturally appropriate and linguistically competent community health promotion programs—Oral health National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11v Culturally appropriate and linguistically competent community health promotion programs—Physical activity and fitness National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 
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Objective Description Data Source or Objective Status 7-11w Culturally appropriate and linguistically competent community health promotion programs—Public health infrastructure  Dropped 7-11x Culturally appropriate and linguistically competent community health promotion programs—Respiratory diseases Dropped 7-11y Culturally appropriate and linguistically competent community health promotion programs—Sexually transmitted diseases National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11z Culturally appropriate and linguistically competent community health promotion programs—Substance abuse (alcohol and other drugs) National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11aa Culturally appropriate and linguistically competent community health promotion programs—Tobacco use National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 7-11bb Culturally appropriate and linguistically competent community health promotion programs—Vision and hearing Dropped 7-12 Participation in community health promotion activities (age adjusted, 65+ years) National Health Interview Survey (NHIS), CDC, NHCS.  
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Figure 7-1. Progress Toward Target Attainment for Focus Area 7: Educational and Community-Based Programs 
Percent of targeted change achieved5 (continued) 
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Figure 7-1. Progress Toward Target Attainment for Focus Area 7: Educational and Community-Based Programs 
(continued) 
Percent of targeted change achieved5 (continued) 
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Figure 7-1. Progress Toward Target Attainment for Focus Area 7: Educational and Community-Based Programs 
(continued) 
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NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 7-5a through f, 7-10, 7-11c, 7-11g through i, 7-11m through o, 7-11q through v, 7-11y, 7-11z, 7-11aa, and 7-12. Objectives 7-7, 7-8, 7-9, 7-11a, 7-11b, 7-11d through 
f, 7-11j through l, 7-11p, 7-11w, 7-11x, and 7-11bb were deleted at the Midcourse Review.  
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
 
 
DATA SOURCES 
 
7-1. Current Population Survey (CPS): Department of Commerce, Census Bureau; Department of Labor, Bureau of Labor Statistics. 
7-2a–j. School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 
7-3. National College Health Risk Behavior Survey, CDC, NCCDPHP. 
7-4a–d. School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 
7-6. National Health Interview Survey (NHIS), CDC, NCHS. 
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7-1. High school completion (18–24 
years) (1998, 2007)1,2* NA 3
4u2
3 B 4ii B 2 NS NS NS NS NA NA NA NA NS NS NA NA
7-3. Health-risk behavior information for 
college and university students 
(1995, 2008)†
NA NA NA NA 2 B 1 2 1 B NS NS NS NS NA NA NA NA NS NS NA NA
7-6. Participation in employer-sponsored 
health promotion activities (age adjusted, 
18+ years) (1994, 1998)3*
NA b NA NA B 1 1 NA 1 B 1 B Biii 1 b 1 B NA 1 B
7-12. Participation in community health 
promotion activities among older adults 
(age adjusted, 65+ years) (1998)*
NA NA 2 2 2 2 B 1 2 2 B 2 1 1 B 1 NS NS 1 B
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
1
2
3
i
ii
iii
7-1. Current Population Survey (CPS), Department of Commerce, Census Bureau.
7-3. National College Health Risk Behavior Survey, CDC, NCCDPHP.
7-6. National Health Interview Survey (NHIS), CDC, NCHS.
7-12. National Health Interview Survey (NHIS), CDC, NCHS.
Figure 7-2. Health Disparities Table for Focus Area 7: Educational and Community-Based 
Programs
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Reliability criterion for best group 
rate not met, or data available for 
only one group.
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Location Disability
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
Increase in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more are 
displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows when the 
changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. Nonetheless, 
disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
Most recent data by race and ethnicity are for 2006.
Baseline data by disability status are for 1995.
Change in the summary index cannot be assessed. See Technical Appendix.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Baseline data by race and ethnicity are for 1998.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
Population-based objectives
Bi
NOTES
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 7-2a 
through j, 7-4a through d, 7-5a through f, 7-10, and 7-11c, g, h, i, m, n, o, q through v, y, z, and aa. Objectives 7-7 through 7-9, and 7-11a, b, d, e, f, j, k, l, p, w, x, and 
bb were deleted at Midcourse Review.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race and 
ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at baseline 
from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary index at 
the most recent data point. See Technical Appendix for more information.
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
FOOTNOTES
DATA SOURCES
1i
Data are for Asian or Pacific Islander.
A reformatted, typeset version of this report will replace the current version 
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Goal: Promote health for all through a healthy 
environment 
This chapter includes objectives that monitor progress in six general Healthy People areas: 
 The Outdoor Air Quality area monitors the proportion of persons exposed to air containing harmful air pollutants. 
 The Surface and Ground Water Quality area tracks contaminants in drinking water, fish, and recreational water. 
 The Toxics and Waste area monitors exposures to toxic substances and hazardous waste. 
 Objectives in the Healthy Homes and Healthy Communities area focus on environmental factors in homes, schools, and worksites. 
 The fifth area, Infrastructure and Surveillance, addresses the availability of methods to detect environmental hazards (for example chemical, biological, and other factors that may adversely affect health), exposures to these hazards, and the diseases potentially caused by these hazards. 
 Objectives in the final area reflect Global Environmental Health concerns. These objectives address the global burden of disease due to poor water quality, sanitation, and personal and domestic hygiene and the proportion of the population in the U.S.-Mexico border region that has adequate drinking water and sanitation facilities. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from: http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade [1]. Eighty-four percent of the Environmental Health objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 8-1). However, health disparities were observed among racial and ethnic populations in their exposure to harmful air pollutants (Figure 8-2) [2]. Similar disparities were observed between populations residing in urban and rural locations. 
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 Between 1997 and 2010, exposure to harmful air pollutants (objective 8-1) declined for all pollutants tracked. The proportion of persons living in counties that exceed National Ambient Air Quality Standards (NAAQS) for carbon monoxide (objective 8-1c) declined from 20% to 0%; that for nitrogen dioxide (objective 8-1d) declined from 5% to 0%; that for sulfur dioxide (objective 8-1e) declined from 2% to 0%; and that for lead (objective 8-1f) declined from less than 1% to 0% in 2010, all meeting the Healthy People 2010 targets of 0% for those pollutants. While the 2010 targets were not met for ozone (objective 8-1a) and particulate matter (objective 8-1b), air quality for these pollutants improved, declining by 16.3% and 25%, respectively. The data presented here do not reflect tighter standards that were issued after the targets had been set. 
 The proportion of people living in counties that exceeded NAAQS for ozone (objective 8-1a) declined by 25% between 1997 and 2010, from 43% to 36%, moving toward the 2010 target of 0%. However, the final data year by race and ethnicity was 2004 and, at that time, disparities were observed for a number of population groups: 
• Among racial and ethnic groups, the American Indian or Alaska Native population had the lowest (best) rate of living in counties that exceeded NAAQS for ozone (objective 8-1a), 23% in 2004, whereas the white non-Hispanic, Native Hawaiian or Other Pacific Islander, black non-Hispanic, Hispanic or Latino, and Asian populations had rates of 33%, 35%, 43%, 59%, and 67%, respectively. The rate for the white non-Hispanic population was almost one and a half times the best group rate (that for the American Indian or Alaska Native population); the rate for the Native Hawaiian or Other Pacific Islander population was about one and a half times the best group rate; the rate for the black non-Hispanic population was almost twice the best group rate; the rate for the Hispanic or Latino population was more than two and a half times the best group rate; and the rate for the Asian population was nearly three times the best group rate [2]. 
• The rural or nonmetropolitan population had better rates of exposure to ozone (4% in 1997 and 3% in 2004) than the urban or metropolitan population (52% in 1997 and 48% in 2004). In 2004, the rate for the urban or metropolitan population was 16 times as high as that for the rural or nonmetropolitan population. Between 1997 and 2004, the disparity in ozone exposure between the rural/nonmetropolitan and the urban/metropolitan populations increased by 300 percentage points [3]. 
 The proportion of people living in counties that exceeded NAAQS for particulate matter (objective 8-1b) declined by 25% between 1997 and 2010, from 12% to 9%. However, the final data year by race and ethnicity also was 2004 and, at that time, disparities were observed for a number of population groups. 
• Among racial and ethnic groups, the black non-Hispanic population had the lowest (best) rate of particulate matter exposure (objective 8-1b), 6% in 2004. The American Indian or Alaska Native population had a rate of 13% in 2004, more than twice the best rate. The Asian and Native Hawaiian or Other Pacific Islander populations each had a rate of 22% in 2004, over three and one half times the best rate. The Hispanic or Latino population had a rate of 28% in 2004, more than four and one half times the best rate [2]. 
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• The rural or nonmetropolitan population had lower (better) rates of exposure to particulate matter (1% in 1997 and 2004) than the urban or metropolitan population (15% in 1997 and 13% in 2004). In 2004, the rate for the urban or metropolitan population was 13 times that of the rural or nonmetropolitan population. Between 1997 and 2004, the disparity in particulate matter between the rural/nonmetropolitan and the urban/metropolitan populations decreased by 200 percentage points [3]. 
 The use of alternate modes of transportation increased. Trips made by transit (objective 8-2c) increased by 116.7% between 1995 and 2009, from 1.8% to 3.9%, exceeding the 2010 target of 3.6%. Trips made by walking (objective 8-2b) increased by 92.6%, from 5.4% to 10.4%, almost achieving the 2010 target of 10.8%. Smaller gains were made for trips by bicycle (objective 8-2a) and telecommuting (objective 8-2d), which increased by 11.1% and 40% respectively. 
 The proportion of persons served by water systems that met safe drinking water standards (objective 8-5) increased by 9.5% between 1995 and 2008, from 84% to 92%, moving toward the 2010 target of 95%. The number of waterborne disease outbreaks (objective 8-6) declined by 83.3% between 1987–96 and 2008, from 6 outbreaks to 1, exceeding the target of 2 outbreaks. However, there was little progress in water conservation (objective 8-7). Between 1995 and 2005, the daily per capita gallons of domestic water usage declined by only 2%. 
 The risks posed by hazardous sites on the National Priority Sites List (objective 8-12a) declined by 11.8% between 1998 and 2008, from 1,290 to 1,138 sites, exceeding the 2010 target of 1,176 sites. 
 Progress was made in exposure to environmental pesticides and chemicals (objectives 8-24 and 8-25). Four of the 15 objectives with data to measure progress met or exceeded their 2010 targets: exposure to propoxur (objective 8-24d) declined from 1.1 µg/gm of creatinine for the 90th percentile of the population aged 6–59 years to below the level of detection (0.4 µg); o-Phenylphenol (objective 8-25g) declined 40%; diazinon (objective 8-25i) was below the level of detection (0.58 µg ) in 1999–2000 and (0.5 µg) in 2001–02; and mercury in females aged 16–49 years (objective 8-25q) declined by 35.3%. Eight objectives made progress toward their targets. However, three moved away from their targets, including exposure to chlorpyrifos (objective 8-24c) which increased by 10.8%, cadmium (objective 8-25b) which increased by 14.3%, and DDT (objective 8-25o) which increased by 1.6%.  
Summary of Progress 
 Figure 8-1 presents a quantitative assessment of progress in achieving the Healthy People objectives for Environmental Health. Data to measure progress toward target attainment were available for 61 objectives [1]. Of these: 
• Twenty-one objectives met or exceeded the Healthy People 2010 targets (objectives 8-1c through f; 8-2c; 8-6; 8-12a; 8-19; 8-24d; 8-25g, i, and q; 8-27d and e; and 8-30a, e through i, and l). 
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• Thirty objectives moved toward their targets. A statistically significant difference between the baseline and final data points was observed for one objective (8-22). Data to test the significance of the difference between the baseline and final data points were unavailable for all the remaining objectives (8-1a b, and g; 8-2a, b, and d; 8-3 through 5; 8-7; 8-9; 8-13; 8-15; 8-23; 8-24b; 8-25c, e, m, n, p, r, and s; 8-27a through c, i, and o; and 8-29). 
• Two objectives showed no change (objectives 8-27g and 8-30b). 
• Eight objectives moved away from their targets (objectives 8-10a and b, 8-24c, 8-25b and o, 8-27h, and 8-30j and l). Data to test the significance of the difference between the baseline and final data points were unavailable for any of these objectives. 
 There were five objectives (8-14a and b, and 8-25j through l) that remained developmental and 21 that had no data available to measure progress (objectives 8-8a and b; 8-12b through d; 8-16a through c; 8-18; 8-20; 8-21; 8-25a, d, f, and h; 8-27f, j and k; and 8-30c and d) [4]. Seven objectives (8-17, 8-24a, 8-25d, 8-27l through n, and 8-28) were dropped during the decade [5]. 
 Figure 8-2 displays health disparities in Environmental Health from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• One objective (8-22) had statistically significant racial and ethnic health disparities of 10% or more. Five other objectives (8-1a through c, e, and g) had racial and ethnic health disparities of 10% or more but lacked data to assess statistical significance. Of these six objectives, the American Indian or Alaska Native, Native Hawaiian or Other Pacific Islander, and black non-Hispanic populations each had the best group rate for one objective. The black non-Hispanic and white non-Hispanic populations were tied for the best group rate for objective 8-1c (exposure to carbon monoxide); persons of two or more races and the black non-Hispanic populations were tied for the best group rate for objective 8-22 (persons in pre-1950s homes tested for lead paint). All racial and ethnic populations except for the Native Hawaiian or Other Pacific Islander population were tied for the best group rate for objective 8-1e (exposure to sulfur dioxide). 
• Females had a better rate than males for the one objective with health disparities of 10% or more by sex (8-1b, exposure to particulate matter). 
• Persons living in rural or nonmetropolitan areas had better rates than persons living in urban or metropolitan areas for all four objectives (8-1a through c, and g) with health disparities of 10% or more by geographic location. 
• Several objectives with health disparities of 100% or more by race and ethnicity and by geographic location were observed. So were objectives with changes in health disparities of 100 percentage points or more over time. These objectives are discussed in the Highlights, above.  
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Transition to Healthy People 2020 The Healthy People 2020 Environmental Health Topic Area has fewer objectives than those included in Healthy People 2010. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 objectives can be grouped into several sections: 
 Outdoor air quality 
 Water quality 
 Toxics and waste 
 Healthy homes and healthy communities 
 Infrastructure and surveillance. The differences between the Healthy People 2010 and Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Environmental Health Topic Area has a total of 67 objectives, whereas the Healthy People 2010 Environmental Health Focus Area had 93 objectives. 
 Twenty-seven Healthy People 2010 objectives were retained “as is” [6]. 
• Increase the proportion of persons served by community water systems who receive a supply of drinking water that meets the regulations of the Safe Drinking Water Act (objective 8-5). 
• Reduce waterborne disease outbreaks arising from water intended for drinking among persons served by community water systems (objective 8-6). 
• Eliminate elevated blood lead levels in children (objective 8-11). 
• Minimize the risks to human health and the environment posed by hazardous sites: National Priority List sites (objective 8-12a). 
• Reduce pesticide exposures that result in visits to a health care facility (objective 8-13). 
• Increase recycling of municipal solid waste (objective 8-15). 
• Reduce the proportion of occupied housing units that have moderate or severe physical problems (objective 8-22). 
• Reduce exposure to pesticides as measured by urine concentrations of metabolites: 
 Paranitrophenol (methyl parathion and parathions) (objective 8-24b) 
 3,4,6-trichloro-2-pyridinol (chlorpyrifos) (objective 8-24c). 
• Reduce exposure to selected environmental chemicals in the population, as measured by blood and urine concentrations of the substances or their metabolites: 
 Arsenic (objective 8-25a) 
 Cadmium (objective 8-25b) 
 Lead (objective 8-25c) 
 Mercury, children aged 1–5 years (objective 8-25e) 
 Mercury, females aged 16–49 years ( objective 8-25q) 
 Chlordane (Oxychlordane) (objective 8-25m) 
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 DDT (DDE) (objective 8-25o) 
 beta-hexacyclochlorohexane or beta-HCH (objective 8-25p) 
 cis-and trans-Permethrin (objective 8-25h) 
 Dioxins (objective 8-25k). 
• Improve the utility, awareness, and use of existing information systems for environmental health (objective 8-26). 
• Increase the number of territories, tribes, and states (including the District of Columbia) that monitor diseases or conditions that can be caused by exposure to environmental hazards: 
 Lead poisoning (objective 8-27a) 
 Pesticide poisoning (objective 8-27b) 
 Mercury poisoning (objective 8-27c) 
 Arsenic poisoning (objective 8-27d) 
 Cadmium poisoning (objective 8-27e) 
 Acute chemical poisoning (objective 8-27g) 
 Carbon monoxide poisoning (objective 8-27h). 
 Twenty-one Healthy People 2010 objectives were modified, expanded, and retained, resulting in 35 objectives in Healthy People 2020 [7]. 
• In Healthy People 2010 there were seven objectives (8-1a through g) that tracked air quality separately for each of six criteria air pollutants (ozone, carbon monoxide, nitrogen dioxide, particulate matter, sulfur dioxide, and lead), and the total population exposed to any of these. In Healthy People 2020 air quality is tracked by a single objective (Air Quality Index), which is a composite measure of criteria air pollutants. 
• The objectives (8-2a through d) to increase use of alternative modes of transportation for work commutes to reduce motor vehicle emissions and improve the nation’s air quality, has a new, more timely data source. 
• The objective to reduce air toxic emissions to decrease the risk of adverse health effects caused by airborne toxics (objective 8-4) was split into three objectives by source type. 
• The objective for school policies to protect against environmental hazards (objective 8-20) was split into nine objectives to separately track specific policies. 
• Other objectives had changes in operational definition. 
 Thirty-six Healthy People 2010 objectives were archived [8]. These include objectives addressing: cleaner alternative fuels (objective 8-3); water bodies safe for fishing and recreation (objectives 8-8a and b); fish consumption advisories (objectives 8-10a and b); risks posed by hazardous sites (objectives 8-12b through d); indoor allergens (objectives 8-16a and b); proportion of persons living in homes tested for radon (objective 8-18); disaster preparedness plans, protocols, and exercises (objective 8-21); exposure to pesticides (objectives 8-24d, and 8-25f, g, i, n, r, and s); monitoring environmentally related diseases (objectives 8-27f, i through k, and o); and water quality in the U.S.-Mexico border region (objectives 8-30a through l).  
Environmental Health  Page 8-8 
• In general, these objectives were archived because the data source could not produce consistent, comparable data. In the case of cleaner alternative fuels, it was not clear what negative externalities would be associated with the increased use of these fuels. Objectives related to monitoring exposure to environmental chemicals were archived because the measures used to monitor them were below the limits of detection, or because the public health concern could be tracked by a related chemical or was not deemed a significant public health concern by CDC. 
 Nine objectives were dropped, either due to the lack of a data source, because data was never produced by the data source, the measure was consistently below the level of detection, or it was an inadequate environmental marker [5]. 
• Production-related waste released by the business sector (objective 8-14a) 
• Office building air quality—Number that are managed using good indoor air quality practices (objective 8-17) 
• Exposure to pesticides—Urine concentrations in µg/g creatinine—1-naphthol (carbaryl) (aged 6 years and over) (objective 8-24a) 
• Exposure to pesticides, heavy metals, and selected environmental chemicals—Manganese (objective 8-25d) 
• Exposure to pesticides, heavy metals, and selected environmental chemicals—Furans (objective 8-25l) 
• Monitoring environmentally related diseases—Skin cancer (objective 8-27l) 
• Monitoring environmentally related diseases—Malignant melanoma (objective 8-27m) 
• Monitoring environmentally related diseases—Other skin cancer (objective 8-27n) 
• Local agencies using surveillance data for vector control (objective 8-28). 
 Five new objectives were added for Healthy People 2020. 
• Exposure to potential endocrine disruptors—Bisphenol A 
• Exposure to potential endocrine disruptors—Perchlorate 
• Exposure to potential endocrine disruptors—Mono-n-butyl phthalate 
• Exposure to potential endocrine disruptors—BDE 47, (2,2',4,4'-tetrabromodiphenyl ether) 
• Reduce the number of new schools sited within 500 feet of an interstate or federal or state highway. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
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Data Considerations Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. Information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
Notes 1. Displayed in the Progress Chart (Figure 8-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 8-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 8-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise 
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restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 8-2 footnotes, as well as the Technical Appendix, for more detail 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 8-2 footnotes, as well as the Technical Appendix, for more detail. 4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 5. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 6. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 7. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 8. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 
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Comprehensive Summary of Objectives: Environmental Health 
Objective Description Data Source or Objective Status 8-1a Percent of persons exposed to harmful air pollutants—Ozone Air Quality System (AQS), Environmental Protection Agency (EPA). 8-1b Percent of persons exposed to harmful air pollutants—Particulate matter (≤10 µm in diameter) Air Quality System (AQS), Environmental Protection Agency (EPA). 8-1c Percent of persons exposed to harmful air pollutants—Carbon monoxide Air Quality System (AQS), Environmental Protection Agency (EPA). 8-1d Percent of persons exposed to harmful air pollutants—Nitrogen dioxide Air Quality System (AQS), Environmental Protection Agency (EPA). 8-1e Percent of persons exposed to harmful air pollutants—Sulfur dioxide Air Quality System (AQS), Environmental Protection Agency (EPA). 8-1f Percent of persons exposed to harmful air pollutants—Lead Air Quality System (AQS), Environmental Protection Agency (EPA). 8-1g Number of persons (thousands) exposed to any harmful air pollutants Air Quality System (AQS), Environmental Protection Agency (EPA). 8-2a Alternative modes of transportation—Trips made by bicycling National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT). 8-2b Alternative modes of transportation—Trips made by walking National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT). 8-2c Alternative modes of transportation—Trips made by transit National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT). 8-2d Alternative modes of transportation—Persons who telecommute National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT). 8-3 Cleaner alternative fuels Alternatives to Traditional Transportation Fuels, Department of Energy, (DOE). 8-4 Airborne toxins (million tons) National Emissions Inventory (NEI), Environmental Protection Agency (EPA). 8-5 Safe drinking water Potable Water Surveillance System (PWSS) and Safe Drinking Water Information System (SDWIS), Environmental Protection Agency (EPA). 8-6 Waterborne disease outbreaks (average no. per year) State Reporting Systems, CDC, NCID. 
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Objective Description Data Source or Objective Status 8-7 Water conservation (gallons of domestic water usage per capita per day) Estimated Use of Water in the United States, Department of Interior (DOI). 8-8a Water bodies safe for fishing and recreation—Rivers and streams  National Water Quality Inventory, U.S Environmental Protection Agency (EPA), Office of Water (OW), Office of Wetlands, Oceans, and Watersheds (OWOW). 8-8b Water bodies safe for fishing and recreation—Lakes, ponds, and reservoirs National Water Quality Inventory, U.S Environmental Protection Agency (EPA), Office of Water (OW), Office of Wetlands, Oceans, and Watersheds (OWOW). 8-9 Beach open and safe for swimming (percent of days during beach season) Beaches Environmental Assessment, Closure and Health Program (BEACH), Environmental Protection Agency (EPA). 8-10a Fish consumption advisories—Rivers National Listing of Fish Advisories, Environmental Protection Agency (EPA). 8-10b Fish consumption advisories—Lakes National Listing of Fish Advisories, Environmental Protection Agency (EPA). 8-11 Elevated blood lead levels in children 1–5 years (≥10 μg/dL)  National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-12a Risks posed by hazardous sites—National Priority List sites Comprehensive Environmental Response and Cleanup Liability Information System (CERCLIS), Environmental Protection Agency (EPA). 8-12b Risks posed by hazardous sites—Resource Conservation and Recovery Act facilities Resource Conservation Recovery Act Info (RCRAInfo), Environmental Protection (EPA), Office of Solid Waste and Emergency Response (OSWER), Office of Solid Waste (OSW). 8-12c Risks posed by hazardous sites—Leaking underground storage facilities Environmental Protection (EPA), Office of Solid Waste and Emergency Response (OSWER), Office of Underground Storage Tanks (OUST). 8-12d Risks posed by hazardous sites—Brownfield properties Environmental Protection (EPA), Office of Solid Waste and Emergency Response (OSWER), Office of Brownfields Cleanup and Redevelopment (OBCR). 8-13 Pesticide exposures resulting in visits to a health care facility (no. of visits per year) National Poison Data System (NPDS) (formerly the Toxic Exposure Surveillance System [TESS]), American Association of Poison Control Centers. 8-14a Production-related waste released by the business sector (per unit of production)  Developmental 
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Objective Description Data Source or Objective Status 8-14b Toxic chemicals released by the business sector (per unit of production) Dropped 8-15 Recycled municipal solid waste (percent of total municipal solid waste) Municipal Solid Waste in The United States, Environmental Protection Agency (EPA). 8-16a Indoor allergens—Group 1 dust mite allergens >2 μg/g of dust in bed National Survey of Lead and Allergens in Housing, NIH, NIEHS, and U. S. Department of Housing and Urban Development (HUD). 8-16b Indoor allergens—Group 1 dust mite allergens >10 μg/g of dust in bed  National Survey of Lead and Allergens in Housing, NIH, NIEHS, and U. S. Department of Housing and Urban Development (HUD). 8-16c Indoor allergens—German cockroach allergens >0.1 unit/g of dust in the bed National Survey of Lead and Allergens in Housing, NIH, NIEHS, and U. S. Department of Housing and Urban Development (HUD). 8-17 Office buildings that are managed using good indoor air quality practices (number) Dropped 8-18 Proportion of persons living in homes tested for radon (age adjusted) National Health Interview Survey (NHIS), CDC, NCHS. 8-19 Radon-resistant new home construction (number) National Association of Home Builders Research Center Survey, National Association of Home Builders. 8-20 School policies to protect against environmental hazards  School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 8-21 Disaster preparedness plans, protocols, and exercises (no. States and D.C.) Association of State and Territorial Health Officials (ASTHO); CDC, Division of State and Local Readiness, (DSLR). 8-22 Proportion of persons in pre-1950s homes tested for lead-based paint (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 8-23 Substandard housing (percent of homes with moderate or severe physical problems) American Housing Survey (AHS), Department of Commerce, Census Bureau. 8-24a Pesticide exposure—Urine concentrations (µg/g creatinine, 6–59 years)—1 naphthol (carbaryl) (µg/g creatinine)  Dropped 8-24b Pesticide exposure—Urine concentrations (µg/g creatinine, 6–59 years)—Paranitrophenol (methyl parathion and parathions) (µg/g creatinine) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-24c Pesticide exposure—Urine concentrations (µg/g creatinine, 6–59 years)—3, 5, 6-trichloro-2-pyridinol (chlorpyrifos) (µg/g creatinine) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-24d Pesticide exposure—Urine concentrations (µg/g creatinine, 6–59 years)—Isopropoxyphenol (propoxur) (µg/g creatinine) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
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Objective Description Data Source or Objective Status 8-25a Exposure to Arsenic National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25b Exposure to Cadmium—Blood concentration (µg/L blood) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25c Exposure to Lead—Blood concentration (µg/L blood) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25d Exposure to Manganese Dropped 8-25e Mercury in children 1–5 years—Blood concentration (µg/L blood) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25f Exposure to 2, 4-D (µg/g creatinine) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25g Exposure to o-Phenylphenol—Urine concentration (µg/g creatinine) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25h Exposure to cis-and-trans-Permethrin Developmental 8-25i Exposure to Diazinon—Urine concentration (µg/g creatinine) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25j Exposure to Polychlorinated biphenyls Developmental 8-25k Exposure to Dioxins Developmental 8-25l Exposure to Furans Dropped 8-25m Exposure to Chlordane/Oxychlordane—Serum concentration (ng/g lipid) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25n Exposure to Dieldrin—Serum concentration (ng/g lipid) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
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Objective Description Data Source or Objective Status 8-25o Exposure to DDT/DDE—Serum concentration (ng/g lipid) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25p Exposure to Lindane/beta-HCH—Serum concentration (ng/g lipid) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25q Exposure to Mercury in females 16–49 years—Blood concentration (µg/L) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25r Exposure to Chlordane/trans-Nonachlor—Serum concentration (ng/g lipid) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-25s Exposure to Chlordane/Heptachlor epoxide—Serum concentration (ng/g lipid) National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 8-26 Information systems used for public health (no. States) National Environmental Public Health Tracking Network (EPHT), CDC, NCEH. 8-27a Monitoring environmentally related diseases (no. States and D.C.)—Lead poisoning State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 8-27b Monitoring environmentally related diseases (no. States and D.C.)—Pesticide poisoning State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 8-27c Monitoring environmentally related diseases (no. States and D.C.)—Mercury poisoning State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 8-27d Monitoring environmentally related diseases (no. States and D.C.)—Arsenic poisoning State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 8-27e Monitoring environmentally related diseases (no. States and D.C.)—Cadmium poisoning State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 8-27f Monitoring environmentally related diseases (no. States and D.C.)—Methemoglobinemia Periodic surveys, Public Health Foundation (PHF) and Council of State and Territorial Epidemiologist (CSTE). 8-27g Monitoring environmentally related diseases (no. States and D.C.)—Acute chemical poisoning by nonmedicinal chemicals not identified above State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 
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Objective Description Data Source or Objective Status 8-27h Monitoring environmentally related diseases (no. States and D.C.)—Carbon monoxide poisoning State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 8-27i Monitoring environmentally related diseases (no. States and D.C.)—Asthma State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 8-27j Monitoring environmentally related diseases (no. States and D.C.)—Hyperthermia Periodic surveys, Public Health Foundation (PHF) and Council of State and Territorial Epidemiologist (CSTE). 8-27k Monitoring environmentally related diseases (no. States and D.C.)—Hypothermia Periodic surveys, Public Health Foundation (PHF) and Council of State and Territorial Epidemiologist (CSTE). 8-27l Monitoring environmentally related diseases (no. States and D.C.)—Skin cancer Dropped 8-27m Monitoring environmentally related diseases (no. States and D.C.)—Malignant melanoma Dropped 8-27n Monitoring environmentally related diseases (no. States and D.C.)—Other skin cancer Dropped 8-27o Monitoring environmentally related diseases (no. States and D.C.)—Birth defects State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 8-28 Local agencies using surveillance data for vector control Dropped 8-29 Global burden of disease (no. deaths in thousands) Global Burden of Disease Project, World Health Organization (WHO). 8-30a Proportion of population in U.S.-Mexico border region with wastewater sewer service—Ciudad Acuna Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association. 8-30b Proportion of population in U.S.-Mexico border region with wastewater sewer service—Matamoros Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association. 8-30c Proportion of population in U.S.-Mexico border region with wastewater sewer service—Mexicali Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association. 
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Objective Description Data Source or Objective Status 8-30d Proportion of population in U.S.-Mexico border region with wastewater sewer service—Nogales, Sonora Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association. 8-30e Proportion of population in U.S.-Mexico border region with wastewater sewer service—Piedras Negras Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association.  8-30f Proportion of population in U.S.-Mexico border region with wastewater sewer service—Reynosa Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association.  8-30g Proportion of population in U.S.-Mexico border region with wastewater treatment service—Ciudad Acuna Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association.  8-30h Proportion of population in U.S.-Mexico border region with wastewater treatment service—Matamoros Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association.  8-30i Proportion of population in U.S.-Mexico border region with wastewater treatment service—Mexicali Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association.  
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Objective Description Data Source or Objective Status 8-30j Proportion of population in U.S.-Mexico border region with wastewater treatment service—Nogales, Sonora Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association.  8-30k Proportion of population in U.S.-Mexico border region with wastewater treatment service—Piedras Negras Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association.  8-30l Proportion of population in U.S.-Mexico border region with wastewater treatment service—Reynosa Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association.   
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
0% 
43% 
(1997) 
36% 
(2010) 
-7 Not tested -16.3% 
0% 
12% 
(1997) 
9% 
(2010) 
-3 Not tested -25% 
0% 
20% 
(1997) 
0% 
(2010) 
-20 Not tested -100% 
0% 
5% 
(1997) 
0% 
(2010) 
-5 Not tested -100% 
0% 
2% 
(1997) 
0% 
(2010) 
-2 Not tested -100% 
0% 
<1% 
(1997) 
0% 
(2010) 
>-1 Not tested -100% 
0 
137,019 
(1997) 
107,991 
(2010) 
-29,028 Not tested -21.2% 
1.8% 
0.9% 
(1995) 
1.0% 
(2009) 
0.1 Not tested 11.1% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 8-1. Progress Toward Target Attainment for Focus Area 8: Environmental Health 
Percent of targeted change achieved5 (continued) 
 
8-1. Percent of persons exposed to harmful air 
pollutants 
   a. Ozone 
   b. Particulate matter (≤10 µm in diameter)  
  c. Carbon monoxide 
  d. Nitrogen dioxide 
   e. Sulfur dioxide  
  f. Lead  
8-1g. Number of persons (thousands) exposed to 
any harmful air pollutants 
8-2. Alternative modes of transportation 
  a. Trips made by bicycling 
16.3% 
25.0% 
21.2% 
11.1% 
100.0% 
100.0% 
100.0% 
100.0% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
10.8% 
5.4% 
(1995) 
10.4% 
(2009) 
5.0 Not tested 92.6% 
3.6% 
1.8% 
(1995) 
3.9% 
(2009) 
2.1 Not tested 116.7% 
4.0% 
2.0% 
(2001) 
2.8% 
(2009) 
0.8 Not tested 40.0% 
8.0% 
0.8% 
(1997) 
4.1% 
(2008) 
3.3 Not tested 412.5% 
2.0 
8.1 
(1993) 
4.6 
(2002) 
-3.5 Not tested -43.2% 
95% 
84% 
(1995) 
92% 
(2008) 
8 Not tested 9.5% 
2 
6 
(1987–96) 
1 
(2006) 
-5 Not tested -83.3% 
91 
101 
(1995) 
99 
(2005) 
-2.0 Not tested -2.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 8-1. Progress Toward Target Attainment for Focus Area 8: Environmental Health (continued) 
Percent of targeted change achieved5 (continued) 
 
 8-2. Alternative modes of transportation 
  b. Trips made by walking  
  c. Trips made by transit    
  d. Persons who telecommute  
8-3. Cleaner alternative fuels  
8-4. Airborne toxins (million tons)   
8-5. Safe drinking water  
8-6. Waterborne disease outbreaks (average no. 
per year)  
8-7. Water conservation (gallons of domestic 
water usage per capita per day)  
92.6% 
            116.7% 
40.0% 
45.8% 
57.4% 
72.7% 
            125.0% 
19.8% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
98% 
94% 
(2002) 
95% 
(2008) 
1 Not tested 1.1% 
13.8% 
15.3% 
(2002) 
24% 
(2004) 
8.7 Not tested 56.9% 
29.6% 
32.9% 
(2002) 
35% 
(2004) 
2.1 Not tested 6.4% 
1,176 
1,290 
(1998) 
1,138 
(2008) 
-152 Not tested -11.8% 
11,398 
22,933 
(1997) 
14,963 
(2008) 
-7970 Not tested -34.8% 
38% 
27% 
(1996) 
33% 
(2008) 
6 Not tested 22.2% 
978,750 
652,500 
(1997) 
1,027,500 
(2007) 
375,000 Not tested 57.5% 
50% 
16% 
(1998) 
21% 
(2002) 
5 Yes 31.3% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
Percent of targeted change achieved5 (continued) 
 
8-9. Beach open and safe for swimming (percent 
of days during beach season)  
8-10. Fish consumption advisories 
   a. Rivers    
  b. Lakes  
8-12a. Risks posed by hazardous sites—National 
Priority List sites   
8-13. Pesticide exposures resulting in visits to a 
health care facility (no. of visits per year)   
8-15. Recycled municipal solid waste (percent of 
total municipal solid waste)  
8-19. Radon-resistant new home construction 
(number)  
8-22. Proportion of persons in pre-1950s homes 
tested for lead-based paint (age adjusted, 
18+ years)  
 
 
Figure 8-1. Progress Toward Target Attainment for Focus Area 8: Environmental Health (continued) 
25.0% 
            133.3% 
69.1% 
54.5% 
14.7% 
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            114.9% 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
3.1% 
6.5% 
(1995) 
5.2% 
(2007) 
-1.3 Not tested -20.0% 
2.7 
3.8 
(1988–94) 
2.9 
(2001–02) 
-0.9 Not tested -23.7% 
5.8 
8.3 
(1988–94) 
9.2 
(2001–02) 
0.9 Not tested 10.8% 
1.1 
1.6 
(1988–94) 
BLOD6 
(2001-02) 
* Not tested * 
1.0 
1.4 
(1999–00) 
1.6 
(2003–04) 
0.2 Not tested 14.3% 
3.5 
5.0 
(1988–94) 
4.2 
(2003–04) 
-0.8 Not tested -16.0% 
1.6 
2.3 
(1999–00) 
1.8 
(2003–04) 
-0.5 Not tested -21.7% 
2.1 
3.0 
(1999–00) 
1.8 
(2001–02) 
-1.2 Not tested -40.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
Percent of targeted change achieved5 (continued) 
 
8-23. Substandard housing (percent of homes with 
moderate or severe physical problems)    
8-24. Pesticide exposure—Urine concentrations 
(µg/g creatinine, 6–59 years) 
  b. Paranitrophenol (methyl parathion and 
   parathions) (µg/g creatinine) 
  c. 3, 5, 6-trichloro-2-pyridinol  
   (chlorpyrifos) (µg/g creatinine)  
  d. Isopropoxyphenol (propoxur) (µg/g  
  creatinine)  
8-25. Exposure to  
  b. Cadmium—Blood concentration 
   (µg/L blood)   
  c. Lead—Blood concentration (µg/L blood)  
   e. Mercury in children 1–5 years—Blood 
   concentration (µg/L blood)  
  g. o-Phenylphenol—Urine concentration 
   (µg/g creatinine)  
 
 
Figure 8-1. Progress Toward Target Attainment for Focus Area 8: Environmental Health (continued) 
38.2% 
81.8% 
   Target exceeded at final† 
53.3% 
71.4% 
            133.3% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
BLOD6 
BLOD6 
(1999–00) 
BLOD6 
(2001–02) 
BLOD6 Not tested * 
31.4 
44.8 
(1999–00) 
37.7 
(2003–04) 
-7.1 Not tested -15.8% 
14.2 
20.3 
(2001–02) 
19.0 
(2003–04) 
-1.3 Not tested -6.4% 
1,281 
1,830 
(1999–00) 
1,860 
(2003–04) 
30 Not tested 1.6% 
48.2 
68.9 
(1999–00) 
56.5 
(2003–04) 
-12.4 Not tested -18.0% 
5.0 
7.1 
(1999–00) 
4.6 
(2001–02) 
-2.5 Not tested -35.2% 
55.6 
79.4 
(1999–00) 
68.3 
(2003–04) 
-11.1 Not tested -14.0% 
16.8 
24.0 
(1999–00) 
18.9 
(2003–04) 
-5.1 Not tested -21.3% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
Percent of targeted change achieved5 (continued) 
 
8-25. Exposure to 
   i. Diazinon—Urine concentration (µg/g 
   creatinine)    
  m. Chlordane/Oxychlordane—Serum 
   concentration (ng/g lipid)  
  n. Dieldrin—Serum concentration (ng/g 
   lipid)    
  o. DDT/DDE—Serum concentration  
   (ng/g lipid)  
  p. Lindane/beta-HCH—Serum 
   concentration (ng/g lipid)   
  q. Mercury in females 16–49 years— 
  Blood concentration (µg/L)   
  r. Chlordane/trans-Nonachlor—Serum 
   concentration (ng/g lipid)  
  s. Chlordane/Heptachlor epoxide—Serum 
   concentration (ng/g lipid)   
 
   
 
Figure 8-1. Progress Toward Target Attainment for Focus Area 8: Environmental Health (continued) 
Target met at baseline and final 
53.0% 
21.3% 
59.9% 
            119.0% 
46.6% 
70.8% 
Environmental Health Page 8-23 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
30 
1 
(2008) 
16 
(2010) 
15 Not tested 1,500.0% 
51 
22 
(2007) 
26 
(2010) 
4 Not tested 18.2% 
25 
11 
(2007) 
14 
(2009) 
3 Not tested 27.3% 
20 
14 
(2007) 
16 
(2010) 
2 Not tested 14.3% 
15 
12 
(2007) 
15 
(2010) 
3 Not tested 25.0% 
15 
11 
(2007) 
16 
(2010) 
5 Not tested 45.5% 
15 
9 
(2008) 
9 
(2009) 
0 Not tested 0.0% 
51 
10 
(2007) 
9 
(2009) 
-1 Not tested -10.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
Percent of targeted change achieved5 (continued) 
 
8-26. Information systems used for public health 
(no. States)  
8-27. Monitoring environmentally related diseases 
(no. States and D.C.) 
  a. Lead poisoning     
  b. Pesticide poisoning 
   c. Mercury poisoning  
  d. Arsenic poisoning   
   e. Cadmium poisoning   
   g. Acute chemical poisoning by 
   nonmedicinal chemicals not identified 
   above  
  h. Carbon monoxide poisoning   
   
 
Figure 8-1. Progress Toward Target Attainment for Focus Area 8: Environmental Health (continued) 
51.7% 
13.8% 
21.4% 
33.3% 
100.0% 
            125.0% 
0.0% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
25 
2 
(2007) 
3 
(2009) 
1 Not tested 50.0% 
51 
6 
(2007) 
8 
(2009) 
2 Not tested 33.3% 
2,135.0 
2,668.2 
(1990) 
2,200.0 
(2004) 
-468.2 Not tested -17.5% 
49% 
39% 
(1997) 
75% 
(2002) 
36 Not tested 92.3% 
57% 
47% 
(1997) 
47% 
(2002) 
0 Not tested 0.0% 
90% 
80% 
(1997) 
100% 
(2002) 
20 Not tested 25.0% 
67% 
57% 
(1997) 
75% 
(2002) 
18 Not tested 31.6% 
10% 
0% 
(1997) 
89% 
(2009) 
89 Not tested * 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
Percent of targeted change achieved5 (continued) 
 
8-27. Monitoring environmentally related diseases 
(no. States and D.C.) 
  i. Asthma    
  o. Birth defects 
8-29. Global burden of disease (no. deaths in 
thousands)  
8-30. Proportion of population in U.S.-Mexico 
border region with wastewater sewer service  
  a. Ciudad Acuna   
   b. Matamoros   
  e. Piedras Negras   
  f. Reynosa 
8-30. Proportion of population in U.S.-Mexico 
border region with wastewater treatment 
service  
  g. Ciudad Acuna  
   
 
Figure 8-1. Progress Toward Target Attainment for Focus Area 8: Environmental Health (continued) 
4.3% 
4.4% 
87.8% 
            360.0% 
0.0% 
            890.0% 
            180.0% 
            200.0% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
10% 
0% 
(1997) 
87% 
(2010) 
87 Not tested * 
82% 
72% 
(1997) 
95% 
(2010) 
23 Not tested 31.9% 
100% 
100% 
(1997) 
89% 
(2010) 
-11 Not tested -11.0% 
10% 
0% 
(1997) 
98% 
(2010) 
98 Not tested * 
100% 
100% 
(1997) 
89% 
(2010) 
-11 Not tested -11.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
8-30. Proportion of population in U.S.-Mexico 
border region with wastewater treatment 
service  
  h. Matamoros  
   i. Mexicali  
  j. Nogales, Sonora  
  k. Piedras Negras    
  l. Reynosa  
 
Percent of targeted change achieved5 
(continued) 
 
Figure 8-1. Progress Toward Target Attainment for Focus Area 8: Environmental Health (continued) 
            870.0% 
            230.0% 
            980.0% 
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Figure 8-1. Progress Toward Target Attainment for Focus Area 8: Environmental Health (continued) 
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DATA SOURCES 
 
8-1a–g. Air Quality System (AQS), Environmental Protection Agency (EPA). 
8-2a–d. National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT).  
8-3. Alternatives to Traditional Transportation Fuels, Department of Energy, (DOE). 
8-4. National Emissions Inventory (NEI), Environmental Protection Agency (EPA). 
8-5. Potable Water Surveillance System (PWSS) and Safe Drinking Water Information System (SDWIS), Environmental Protection Agency (EPA). 
8-6. State Reporting Systems, CDC, NCID. 
8-7. Estimated Use of Water in the United States, Department of Interior (DOI). 
8-9. Beaches Environmental Assessment, Closure and Health Program (BEACH), Environmental Protection Agency (EPA). 
8-10a–b. National Listing of Fish Advisories, Environmental Protection Agency (EPA). 
8-12a. Comprehensive Environmental Response and Cleanup Liability Information System (CERCLIS), Environmental Protection Agency (EPA). 
8-13. Toxic Exposure Surveillance System (TESS), American Association of Poison Control Centers. 
8-15. Municipal Solid Waste in The United States, Environmental Protection Agency (EPA). 
8-19. National Association of Home Builders Research Center Survey, National Association of Home Builders. 
8-22. National Health Interview Survey (NHIS), CDC, NCHS. 
8-23. American Housing Survey (AHS), Department of Commerce, Census Bureau. 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data  
are not available for objectives 8-8a, 8-8b, 8-12b through d, 8-14a, 8-14b, 8-16a through c, 8-17, 8-18, 8-20, 8-21, 8-25a, 8-25d, 8-25f, 8-25h, 8-25j through l, 8-27f, 8-27j, 8-27k, 8-30c, 
and 8-30d. Final tracking data for objective 8-11 are not statistically reliable. Objectives 8-24a, 8-27l through n, and 8-28 were deleted at the Midcourse Review.  
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                   × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
 
6 Below level of detection (BLOD) 
 
* Difference and/or percent change cannot be calculated. See Technical Appendix for more information. 
 
† Percent of targeted change cannot be calculated. See Technical Appendix for more information. 
 
 
(continued) 
DATA SOURCES (continued) 
 
8-24b–d. National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
8-25b–c. National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
8-25e. National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
8-25g. National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
8-25i. National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
8-25m–s. National Report on Human Exposure To Environmental Chemicals, CDC, NCEH; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
8-26. National Environmental Public Health Tracking Network (EPHT), CDC, NCEH. 
8-27a–e. State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 
8-27g–i. State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE).  
8-27o. State Reportable Conditions Assessment (SRCA), Council of State and Territorial Epidemiologists (CSTE). 
8-29. Global Burden of Disease Project, World Health Organization (WHO). 
8-30a–b. Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health 
 Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association. 
8-30e–l. Environmental Protection Agency (EPA), Office of Water (OW), Office of Wastewater Management (OWM); Mexico's Comision Nacional de Agua; State and Local Health 
 Departments; American Water Works Association; Rural Water Association; U.S.-Mexican Border Health Association. 
 
 
Figure 8-1. Progress Toward Target Attainment for Focus Area 8: Environmental Health (continued) 
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Figure 8-2. Health Disparities Table for Focus Area 8: Environmental Health
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8-1a. Percent of persons exposed to harmful air pollutants—
Ozone (1997, 2010)1† B 4 3 4
4u1
3 2 4 B B NA NA NA NA
4u3
B
8-1b. Percent of persons exposed to harmful air pollutants—
Particulate matter (≤10 µm in diameter) (1997, 2010)1†
4u1 4u2 4u2 4u2 4u2
B 2
4u2
B 2 NA NA NA NA
4d3
B
8-1c. Percent of persons exposed to harmful air pollutants—
Carbon monoxide (1997, 2010)1†
4u2 4u3 4u3 4u2 4u3
Bi B
4u3
B B NA NA NA NA
4u3
B
8-1d. Percent of persons exposed to harmful air pollutants—
Nitrogen dioxide (1997, 2010)1† Bi Bi Bi Bi Bi B B 1 B B NA NA NA NA Bi B
8-1e. Percent of persons exposed to harmful air pollutants—
Sulfur dioxide (1997, 2010)1† B B 4 B B Bi Bi
2d1
B B NA NA NA NA NA
8-1f. Percent of persons exposed to harmful air pollutants—
Lead (1997, 2010)1† B B B B B B B 1 B B NA NA NA NA Bi B
8-1g. Number of persons (thousands) exposed to any harmful air 
pollutants (1997, 2010)1†
4d1
4u3
B 4
4u3 4u3
4d3 4d2
1 B NA NA NA NA
4u3
B
8-11. Elevated blood lead levels in children 1–5 years (≥10 
µg/dL) (1991–94, 2005–08)* NA NA NA NA NA NAii NAii NA NA NA NA NA NA NA NA NA
8-18. Proportion of persons living in homes tested for radon (age 
adjusted) (1998)* 1 B NA NA 1 1 1 1 B 1 1 1 B 1 NS NS
8-22. Proportion of persons in pre-1950s homes tested for lead-
based paint (age adjusted, 18+ years) (1998, 2002)2* NA 1 NA B 2 B 2 1 B 1 B 1 Bi 1 NS NS
Disparities from the best group rate for each characteristic at the most recent data point and changes in 
disparity from the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Income Location
Population-based objectives
(continued)
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
1
2
i
ii
8-1a–g. Air Quality System (AQS), Environmental Protection Agency (EPA).
8-11. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
8-18. National Health Interview Survey (NHIS), CDC, NCHS.
8-22. National Health Interview Survey (NHIS), CDC, NCHS.
50%–99%
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
100% or more
100 points or more
100 points or more
Increase in disparity (percentage points)
10–49 points 50–99 points
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49%
Data not available.
NOTES
Years in parentheses represent the baseline and most recent data years (if available).
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
8-2a through d, 8-3 through 8-7, 8-8a and b, 8-9, 8-10a and b, 8-12a through d, 8-13, 8-14a and b, 8-15, 8-16a through c, 8-17, 8-19 through 8-21, 8-23, 8-24b 
through d, 8-25a through s, 8-26, 8-27a through k, 8-27o, 8-29, and 8-30a through l. Objectives 8-24a, 8-27l through n, and 8-28 were deleted at Midcourse 
Review.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Figure 8-2. Health Disparities Table for Focus Area 8: Environmental Health (continued)
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Most favorable group rate for specified 
characteristic, but reliability criterion not 
met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Characteristic not selected for this objective.
DATA SOURCES
Data are for Mexican American.
Baseline data by race and ethnicity are for 2002.
Most recent data by race and ethnicity, by sex, and by location, are for 2004.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows 
when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. 
Nonetheless, disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
 A reformatted, typeset version of this report will replace the current version  
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Goal: Improve family planning and spacing and prevent 
unintended pregnancy 
This chapter includes objectives that track intended pregnancies, birth spacing, infertility, and adolescent pregnancies. Contraceptive use and family planning clinic visits among adolescents and persons at risk of unintended pregnancy are also monitored, and so is instruction on reproductive health issues for adolescents. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, (DATA2010), available from http://wonder.cdc.gov/data2010/. More information about this focus area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Progress was achieved in objectives for this Focus Area during the past decade [1]. About half (53%) of the Family Planning objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 9-1). However, health disparities among racial and ethnic population groups, as well as by income and by disability status, were observed (Figure 9-2), some of which are highlighted below [2]. 
 While several Family Planning objectives did not meet the Healthy People 2010 targets overall, some objectives met or even exceeded their targets for certain population groups. For example, in order for intended pregnancy (objective 9-1), considered as the principal objective of the Family Planning Focus Area, to have met the 2010 target, this objective would have had to increase from 52% to 70%. This targeted increase was not achieved, and no progress was made during the decade overall. Nonetheless, married women did meet the 2010 target: 73% of their pregnancies were intended in 2002. Differential progress by marital status and income continues to be observed. 
 Contraceptive failure, the proportion of women aged 15–44 years who experienced pregnancy within 12 months of continuous contraceptive use (objective 9-4), declined by 20% between 1995 and 2002, from 15% to 12%, moving toward the 2010 target of 8%. Although the 2010 target was not met overall, middle/high income women almost met the target with an 8.4% failure rate in 2002. However, the failure rate for poor women was 20%, which is almost double the overall population rate of 12%. Moreover, health disparities by income increased, as seen next [3]. 
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• Middle/high income women had the lowest (best) rates of contraceptive failure among income groups, 12% in 1995 and 8.4% in 2002; whereas near-poor women had rates of 17% in 1995 and 18% in 2002, and poor women had rates of 26% in 1995 and 20% in 2002. In 2002, the rate for near-poor women was more than twice the best group rate (that for middle/high income women), while the rate for poor women was almost two and a half times the best group rate [2]. Between 1995 and 2002, the disparity between near-poor and middle/high income women increased by 83 percentage points [3]. 
• Among racial and ethnic groups, white non-Hispanic women had the lowest (best) rate of contraceptive failure, 10% in 2002. The rate for black non-Hispanic women was 21% in 2002, more than twice that of white non-Hispanic women [2]. 
 Adolescent pregnancy among females aged 15–17 years (objective 9-7) declined by 37% between 1996 and 2005, from 63 to 40 per 1,000 females, moving toward the 2010 target of 39 per 1,000. 
• Among racial and ethnic groups, white non-Hispanic females aged 15–17 had the lowest (best) adolescent pregnancy rate, 22 per 1,000 in 2005. Hispanic or Latino and black non-Hispanic females aged 15–17 had rates of 85 and 88 per 1,000 in 2005, respectively. The rate for Hispanic or Latino females aged 15–17 was almost four times the best group rate (that for white non-Hispanic females aged 15–17), while the rate for black non-Hispanic females aged 15–17 was four times the best group rate [2]. 
• White non-Hispanic females aged 15–17 had adolescent pregnancy rates of 40 per 1,000 in 1996 and 22 per 1,000 in 2005, whereas Hispanic or Latino females aged 15–17 had rates of 109 per 1,000 in 1996 and 80 per 1,000 in 2005. Between 1996 and 2005, the disparity between Hispanic or Latino and white non-Hispanic females aged 15–17 increased by 91 percentage points [3].  
Summary of Progress 
 Figure 9-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Family Planning [1]. Data to measure progress toward target attainment were available for 32 objectives. Of these: 
• Eight objectives (9-8a; 9-10c through h; and 9-11i) met or exceeded the Healthy People 2010 targets. 
• Nine objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for one of these objectives (9-9a). No significant differences were observed for two objectives (9-11a and o); and data to test the significance of the difference were unavailable for the remaining six objectives (9-4, 9-7, 9-8b, 9b, 9-10b, and 9-12). 
• Two objectives (9-6a and 9-11k) showed no change. 
• Thirteen objectives moved away from their targets. A statistically significant difference between the baseline and final data points was observed for two of these objectives (9-3 and 9-6b). No significant differences were observed for eight objectives (9-6c; 9-10a; and 9-11b through d, j, l, and p). Data to test the significance of the difference were unavailable for three objectives (9-1, 9-2 and 9-5). 
Family Planning  Page 9-4 
 Six objectives (9-11e through h, m, and n) remained developmental [4]. 
 Data were unavailable to measure progress for one objective (9-13). 
 Figure 9-2 displays health disparities in Family Planning from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Statistically significant racial and ethnic health disparities of 10% or more were observed for seven objectives (9-6b; 9-10c and d; and 9-11j through l, and p); three additional objectives (9-1, 9-4 and 9-7) had racial and ethnic health disparities of 10% or more but no data to assess statistical significance. Of these 10 objectives, the white non-Hispanic population had the best group rate for eight objectives (9-1; 9-4; 9-7; 9-10c and d; and 9-11j through l). The Hispanic or Latino population and the black non-Hispanic population each had the best group rate for the two remaining objectives (9-6b and 9-11p). 
• Statistically significant health disparities of 10% or more by income were observed for five objectives (9-2; 9-3; and 9-11c, d, and k); two additional objectives (9-1 and 9-4) had a health disparity of 10% or more by income but no data to assess statistical significance. Persons with middle/high incomes had the best group rate for all seven of these objectives. 
• Two objectives (9-4 and 9-7) had health disparities of 100% or more among racial and ethnic populations and/or income groups, as well as changes in disparities of 50 percentage points or more over time. These disparities are discussed in the Highlights, above.  
Transition to Healthy People 2020 The focus of the Healthy People 2020 Family Planning Topic Area—increasing the proportion of pregnancies that are intended, improving pregnancy planning and spacing, and preventing unintended pregnancy—is consistent with that of the Healthy People 2010 Focus Area. As publicly funded family planning services prevent 1.94 million unintended pregnancies, including 400,000 teen pregnancies each year, new objectives addressing services provided by publicly funded family planning clinics have been added to the Healthy People 2020 Topic Area [5]. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 Family Planning topic area can be grouped into four sections: 
 Proportion of pregnancies that are intended and the rate of adolescent pregnancy 
 Receipt of reproductive health services 
 Effective use of contraception for pregnancy prevention and protection against disease 
 Receipt of education on prevention of sexually transmitted diseases (STD) and unwanted pregnancy. The differences between the Healthy People 2010 and Healthy People 2020 objectives are summarized below: 
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 The Healthy People 2020 Family Planning Topic Area has 40 objectives, one of which is developmental, whereas the Healthy People 2010 Focus Area had 39 objectives, six of which were developmental [4]. 
 Twenty-one Healthy People 2010 objectives (9-1; 9-4; 9-9a and b; 9-11a through p; and 9-13) were retained “as is” [6]. These include objectives that focus on the proportion of pregnancies that are intended, contraceptive failure within 12 months of continuous use, abstinence among adolescents insurance coverage for contraceptive supplies and services, and reproductive health prevention education. Data are not shown in the DATA2010 database for six of these objectives (including formal and informal instruction on HIV/AIDS prevention and formal instruction on sexually transmitted diseases) but data are available in Healthy People 2020. 
 One Healthy People 2010 objective, the rate of adolescent pregnancy (objective 9-7), was retained “as is” for ages 15–17 in Healthy People 2020 [6]. An additional objective on adolescent pregnancy also was added to Healthy People 2020 and focuses on ages 18–19. 
 Thirteen Healthy People 2010 objectives (9-2; 9-3; 9-5; 9-8a and b; and 9-10a through h) were modified, including the objectives on birth spacing, contraceptive use among females at risk of unintended pregnancy, emergency contraception, abstinence before age 15, pregnancy prevention and STD protection [7,8]. 
 One objective (9-12) addressing problems in becoming pregnant and maintaining a pregnancy was modified and moved to the Maternal, Infant, and Child Health Topic Area [7]. 
 Three Healthy People 2010 objectives (9-6a through c) that focused on male involvement in pregnancy prevention were archived [9]. Other objectives on male involvement in family planning are spread throughout the Healthy People 2020 Topic Area. 
 Five new objectives were added to the Healthy People 2020 Topic Area: 
• One new objective tracks the proportion of publicly funded family planning clinics that offer a full range of FDA-approved contraceptive methods on-site. 
• Two new objectives track the proportion of sexually active persons who receive reproductive health services. 
• One new objective monitors the number of states that set the income eligibility level for Medicaid-covered family planning services to at least the same level used to determine eligibility for Medicaid-covered pregnancy-related care. 
• One new objective tracks the proportion of females in need of publicly-supported contraceptive services and supplies who receive those services and supplies. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
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Data Considerations Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. Information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
References and Notes 1. Displayed in the Progress Chart (Figure 9-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 9-1 footnotes, as well as the Technical Appendix, for more detail.  2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 9-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise 
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restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 9-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 9-2 footnotes, as well as the Technical Appendix, for more detail. 4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 5. Guttmacher Institute. In brief: Facts on publicly funded contraceptive services in the United States. Washington; Guttmacher Institute. April 2010. Available from: http://www.guttmacher.org/pubs/fb_contraceptive_serv.pdf 6. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 7. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 8. Objectives 9-8a and b (abstinence before age 15) are defined as abstinence by age 15 in Healthy People 2020.  9. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020.  
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Comprehensive Summary of Objectives: Family Planning 
Objective Description Data Source or Objective Status 9-1 Intended pregnancy (females 15–44 years) National Survey of Family Growth (NSFG), CDC, NCHS; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS; Abortion Provider Survey, Guttmacher Institute; Abortion Surveillance Data, CDC, NCCDPHP. 9-2 Births occurring within 24 months of a previous birth (females 15–44 years) National Survey of Family Growth (NSFG), CDC, NCHS. 9-3 Contraceptive use—Females at risk of unintended pregnancy (15–44 years) National Survey of Family Growth (NSFG), CDC, NCHS. 9-4 Contraceptive failure within 12 months of continuous use—Females experiencing pregnancy (15–44 years) National Survey of Family Growth (NSFG), CDC, NCHS; Abortion Patient Survey, Guttmacher Institute. 9-5 Emergency contraception provided by family planning agencies Guttmacher Institute. 9-6a Involvement in pregnancy prevention among unmarried males 15–24 years—Family planning clinic visit with female partner in last 12 months National Survey of Family Growth (NSFG), CDC, NCHS. 9-6b Involvement in pregnancy prevention among unmarried males 15–24 years—Family planning clinic visit for himself in last 12 months National Survey of Family Growth (NSFG), CDC, NCHS. 9-6c Involvement in pregnancy prevention among unmarried males 15–24 years—Advice/counseling from a doctor on birth control in last 12 months National Survey of Family Growth (NSFG), CDC, NCHS. 9-7 Adolescent pregnancy (per 1,000 population, 15–17 years) National Survey of Family Growth (NSFG), CDC, NCHS; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS; Abortion Provider Survey, Guttmacher Institute; Abortion Surveillance Data, CDC, NCCDPHP. 9-8a Abstinence before age 15 years—Females (15–19 years) National Survey of Family Growth (NSFG), CDC, NCHS. 9-8b Abstinence before age 15 years—Males (15–19 years) National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 9-9a Abstinence among adolescents 15–17 years—Females National Survey of Family Growth (NSFG), CDC, NCHS. 9-9b Abstinence among adolescents 15–17 years—Males National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 
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Objective Description Data Source or Objective Status 9-10a Pregnancy prevention and STD protection in unmarried adolescents 15–17 years—Condom use (partner) at first intercourse, females National Survey of Family Growth (NSFG), CDC, NCHS. 9-10b Pregnancy prevention and STD protection in unmarried adolescents 15–17 years—Condom use at first intercourse, males National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 9-10c Pregnancy prevention and STD protection in unmarried adolescents 15–17 years—Condom use (partner) and hormonal method use at first intercourse, females National Survey of Family Growth (NSFG), CDC, NCHS. 9-10d Pregnancy prevention and STD protection in unmarried adolescents 15–17 years—Condom use and hormonal method (partner) at first intercourse, males National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 9-10e Pregnancy prevention and STD protection in unmarried adolescents 15–17 years—Condom use (partner) at last intercourse, females National Survey of Family Growth (NSFG), CDC, NCHS. 9-10f Pregnancy prevention and STD protection in unmarried adolescents 15–17 years—Condom use at last intercourse, males National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 9-10g Pregnancy prevention and STD protection in unmarried adolescents 15–17 years—Condom use (partner) and hormonal method at last intercourse, females National Survey of Family Growth (NSFG), CDC, NCHS. 9-10h Pregnancy prevention and STD protection in unmarried adolescents 15–17 years—Condom use and hormonal method (partner) at last intercourse, males National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 9-11a Reproductive health prevention education among young adults 15–19 years—Formal education on abstinence, females National Survey of Family Growth (NSFG), CDC, NCHS. 9-11b Reproductive health prevention education among young adults 15–19 years—Formal education on abstinence, males National Survey of Family Growth (NSFG), CDC, NCHS. 9-11c Reproductive health prevention education among young adults 15–19 years—Formal education on birth control methods, females National Survey of Family Growth (NSFG), CDC, NCHS. 9-11d Reproductive health prevention education among young adults 15–19 years—Formal education on birth control methods, males National Survey of Family Growth (NSFG), CDC, NCHS. 9-11e Reproductive health prevention education among young adults 15–19 years—Formal education on HIV/AIDS prevention, females Developmental 9-11f Reproductive health prevention education among young adults 15–19 years—Formal education on HIV/AIDS prevention, males Developmental 
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Objective Description Data Source or Objective Status 9-11g Reproductive health prevention education among young adults 15–19 years—Formal education on sexually transmitted diseases, females Developmental 9-11h Reproductive health prevention education among young adults 15–19 years—Formal education on sexually transmitted diseases, males Developmental 9-11i Reproductive health prevention education among young adults 15–19 years—Informal education on abstinence, females National Survey of Family Growth (NSFG), CDC, NCHS. 9-11j Reproductive health prevention education among young adults 15–19 years—Informal education on abstinence, males National Survey of Family Growth (NSFG), CDC, NCHS. 9-11k Reproductive health prevention education among young adults 15–19 years—Informal education on birth control methods, females National Survey of Family Growth (NSFG), CDC, NCHS. 9-11l Reproductive health prevention education among young adults 15–19 years—Informal education on birth control methods, males National Survey of Family Growth (NSFG), CDC, NCHS. 9-11m Reproductive health prevention education among young adults 15–19 years—Informal education on HIV/AIDS prevention, females Developmental 9-11n Reproductive health prevention education among young adults 15–19 years—Informal education on HIV/AIDS prevention, males Developmental 9-11o Reproductive health prevention education among young adults 15–19 years—Informal education on sexually transmitted diseases, females National Survey of Family Growth (NSFG), CDC, NCHS. 9-11p Reproductive health prevention education among young adults 15–19 years—Informal education on sexually transmitted diseases, males National Survey of Family Growth (NSFG), CDC, NCHS. 9-12 Problems in becoming pregnant and maintaining a pregnancy—Wives of married couples (15–44 years) National Survey of Family Growth (NSFG), CDC, NCHS. 9-13 Insurance coverage for contraceptive supplies and services The Alan Guttmacher Institute.  
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Figure 9-1. Progress Toward Target Attainment for Focus Area 9: Family Planning 
Percent of targeted change achieved5 (continued) 
 
9-1. Intended pregnancy (females 15–44 
 years) 
9-2. Births occurring within 24 months of a 
previous birth (females 15–44 years)   
9-3. Contraceptive use—Females at risk of 
unintended pregnancy (15–44 years) 
9-4. Contraceptive failure within 12 months of 
continuous use—Females experiencing 
pregnancy (15–44 years) 
9-5.     Emergency contraception provided by 
 family planning agencies  
9-6. Involvement in pregnancy prevention  
 among unmarried males 15–24 years 
  a. Family planning clinic visit with female 
   partner in last 12 months 
  b. Family planning clinic visit for  
   himself in last 12 months 
  c. Advice/counseling from a doctor  
  on birth control in last 12 months 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
70% 
52% 
(1995) 
51% 
2002 
-1 
Not 
tested 
-1.9% 
6% 
11% 
(1995) 
16% 
(2006–08) 
5 
Not 
tested 
45.5% 
100% 
93% 
(1995) 
89% 
(2006–08) 
-4 Yes -4.3% 
8% 
15% 
(1995) 
12% 
(2002) 
-3 
Not 
tested 
-20% 
90% 
80% 
(1999) 
79% 
(2003) 
-1 
Not 
tested 
-1.3% 
22% 
21% 
(2002) 
21% 
(2006–08) 
0 No 0.0% 
37% 
31% 
(2002) 
25% 
(2006–08) 
-6 Yes -19.4% 
37% 
21% 
(2002) 
20% 
(2006–08) 
-1 No -4.8% 
42.9% 
0.0% 
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Figure 9-1. Progress Toward Target Attainment for Focus Area 9: Family Planning (continued) 
Percent of targeted change achieved5 (continued) 
 
9-7. Adolescent pregnancy (per 1,000 population, 
15–17 years)  
9-8. Abstinence before age 15 years 
  a. Females (15–19 years)    
  b. Males (15–19 years)  
9-9. Abstinence among adolescents 15–17 years 
  a. Females  
  b. Males   
9-10. Pregnancy prevention and STD protection in 
unmarried adolescents 15–17 years  
  a. Condom use (partner) at first  
  intercourse, females 
   
  b. Condom use at first intercourse, males 
  c. Condom use (partner) and hormonal 
  method use at first intercourse, females  
 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
39 
63 
(1996) 
40 
(2005) 
-23 
Not 
tested 
-36.5% 
88% 
81% 
(1995) 
89% 
(2006–08) 
8 
Not 
tested 
9.9% 
88% 
79% 
(1995) 
85% 
(2006–08) 
6 
Not 
tested 
7.6% 
75% 
62% 
(1995) 
72% 
(2006–08) 
10 Yes 16.1% 
75% 
57% 
(1995) 
71% 
(2006–08) 
14 
Not 
tested 
24.6% 
75% 
69% 
(1995) 
62% 
(2006–08) 
-7 No -10.1% 
83% 
72% 
(1995) 
80% 
(2006–08) 
8 
Not 
tested 
11.1% 
9% 
7% 
(1995) 
11% 
(2006–08) 
4 No 57.1% 
 95.8% 
            114.3% 
66.7% 
76.9% 
77.8% 
72.7% 
            200.0% 
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Percent of targeted change achieved5 (continued) 
9-10. Pregnancy prevention and STD protection in 
unmarried adolescents 15–17 years  
  d. Condom use and hormonal method 
  (partner) at first intercourse, males 
  e. Condom use (partner) at last  
  intercourse, females  
  
  f. Condom use at last intercourse, males 
  g. Condom use (partner) and hormonal 
  method at last intercourse, females  
  h. Condom use and hormonal method 
  (partner) at last intercourse, males 
9-11. Reproductive health prevention education 
among young adults 15–19 years  
  a. Formal education on abstinence, 
   females 
  b. Formal education on abstinence, 
   males 
  c. Formal education on birth control  
   methods, females 
 
 
Figure 9-1. Progress Toward Target Attainment for Focus Area 9: Family Planning (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
11% 
8% 
(1995) 
19% 
(2006–08) 
11 
Not 
tested 
137.5% 
49% 
39% 
(1995) 
61% 
(2006–08) 
22 Yes 56.4% 
79% 
70% 
(1995) 
85% 
(2006–08) 
15 
Not 
tested 
21.4% 
11% 
7% 
(1995) 
16% 
(2006–08) 
9 Yes 128.6% 
20% 
16% 
(1995) 
37% 
(2006–08) 
21 
Not 
tested 
131.3% 
88% 
86% 
(2002) 
87% 
(2006–08) 
1 No 1.2% 
85% 
83% 
(2002) 
81% 
(2006–08) 
-2 No -2.4% 
73% 
70% 
(2002) 
69% 
(2006–08) 
-1 No -1.4% 
50.0% 
            366.7% 
            166.7% 
            225.0% 
            220.0% 
            525.0% 
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Percent of targeted change achieved5 (continued) 
 
9-11. Reproductive health prevention education 
among young adults 15–19 years 
  d. Formal education on birth control 
   methods, males 
  i. Informal education on abstinence, 
   females   
  j. Informal education on abstinence, 
   males 
  k. Informal education on birth control 
   methods, females  
   l. Informal education on birth control 
   methods, males  
  o. Informal education on sexually 
   transmitted diseases, females  
  p. Informal education on sexually 
   transmitted diseases, males 
9-12. Problems in becoming pregnant and 
maintaining a pregnancy—Wives of married 
couples (15–44 years) 
 
Figure 9-1. Progress Toward Target Attainment for Focus Area 9: Family Planning (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
70% 
66% 
(2002) 
62% 
(2006–08) 
-4 No -6.1% 
62% 
57% 
(2002) 
63% 
(2006–08) 
6 Yes 10.5% 
49% 
45% 
(2002) 
42% 
(2006–08) 
-3 No -6.7% 
57% 
51% 
(2002) 
51% 
(2006–08) 
0 No 0.0% 
38% 
33% 
(2002) 
31% 
(2006–08) 
-2 No -6.1% 
60% 
51% 
(2002) 
55% 
(2006–08) 
4 No 7.8% 
57% 
52% 
(2002) 
49% 
(2006–08) 
-3 No -5.8% 
10% 
13% 
(1995) 
11% 
(2006–08) 
-2 
Not 
tested 
-15.4% 
44.4% 
66.7% 
            120.0% 
0.0% 
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 DATA SOURCES 
 
9-1. National Survey of Family Growth (NSFG), CDC, NCHS; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS; Abortion Provider Survey, Guttmacher Institute;  
 Abortion Surveillance Data, CDC, NCCDPHP. 
9-2–9-3. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-4. National Survey of Family Growth (NSFG), CDC, NCHS; Abortion Patient Survey, Guttmacher Institute. 
9-5. Guttmacher Institute. 
9-6a–c. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-7. National Survey of Family Growth (NSFG), CDC, NCHS; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS; Abortion Provider Survey, Guttmacher Institute; 
  Abortion Surveillance Data, CDC, NCCDPHP. 
9-8a. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-8b. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 
9-9a. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-9b. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 
9-10a. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-10b. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 
9-10c. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-10d. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 
9-10e. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-10f. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 
9-10g. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-10h. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS. 
9-11a–d. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-11i–l. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-11o–p. National Survey of Family Growth (NSFG), CDC, NCHS. 
9-12. National Survey of Family Growth (NSFG), CDC, NCHS. 
 
Figure 9-1. Progress Toward Target Attainment for Focus Area 9: Family Planning (continued) 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 9-11e through h, 9-11m, 9-11n, and 9-13. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =              × 100. 
     Healthy People 2010 target – Baseline value 
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Figure 9-2. Health Disparities Table for Focus Area 9: Family Planning
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9-1. Intended pregnancy (females 15–44 years) (1995, 2002)†
NA NA NA NA NA 3i Bi NA 3
3u1
B
3u1
NA NA
9-2. Births occurring within 24 months of a previous birth (females 
15–44 years) (1995, 2006–08)1‡ NA NA NA NA NA
3d3 2d1
B
3d2
1 B
9-3.  Contraceptive use—Females at risk of unintended pregnancy 
(15–44 years) (1995, 2006–08)1* NA NA NA NA NA 3 1 B 2
9-4. Contraceptive failure within 12 months of continuous use—Females 
experiencing pregnancy (15–44 years) (1995, 2002)† NA NA NA NA
3u1 4u1
B
3u1 4u1 4u2
B
4u2
NA NA
9-6a. Involvement in pregnancy prevention among unmarried males 
15–24 years—Family planning clinic visit with female partner in last 
12 months (2002, 2006–08)*
NA NA NA NA B 1 1 1 1 Bii 1 1 B 1
9-6b. Involvement in pregnancy prevention among unmarried males 
15–24 years—Family planning clinic visit for himself in last 12 
months (2002, 2006–08)*
NA NA NA NA Bii 2 2 2 Bii 1 1 1 B 1iii
9-6c. Involvement in pregnancy prevention among unmarried males 
15–24 years—Advice/counseling from a doctor on birth control in 
last 12 months (2002, 2006–08)*
NA NA NA NA 1 B 1 1 1 1 Bii 1 NA
9-7. Adolescent pregnancy (per 1,000 population, 15–17 years) (1996, 
2005)† NA NA NA NA
4u2 4u1
B
4u2
NA NA NA NA NA NA
9-8a. Abstinence before age 15 years—Females (15–19 years) (1995, 
2006–08)1‡ NA NA NA NA NA NA 1iii B
9-8b. Abstinence before age 15 years—Males (15–19 years) (1995, 
2006–08)1,2‡ NA NA NA NA NA NA NA
9-9a. Abstinence among adolescents 15–17 years—Females (1995, 
2006–08)1* NA NA NA NA NA NA NA
9-9b. Abstinence among adolescents 15–17 years—Males (1995, 
2006–08)1,2‡ NA NA NA NA NA NA NA
9-10a. Pregnancy prevention and STD protection in unmarried 
adolescents 15–17 years—Condom use (partner) at first    
intercourse, females (1995, 2006–08)1*
NA NA NA NA NA NA
9-10b. Pregnancy prevention and STD protection in unmarried 
adolescents 15–17 years—Condom use at first intercourse, males 
(1995, 2006–08)1,2‡
NA NA NA NA NA NA NA
9-10c. Pregnancy prevention and STD protection in unmarried 
adolescents 15–17 years—Condom use (partner) and hormonal 
method use at first intercourse, females (1995, 2006–08)1*
NA NA NA NA 2 NA Bii NA 1 1 Bii 1 NA
9-10d. Pregnancy prevention and STD protection in unmarried 
adolescents 15–17 years—Condom use and hormonal method 
(partner) at first intercourse, males (1995, 2006–08)1,2‡
NA NA NA NA
2u1iv
1 Bii
2u1iv
1 1 B 2v NA
9-10e. Pregnancy prevention and STD protection in unmarried 
adolescents 15–17 years—Condom use (partner) at last    
intercourse, females (1995, 2006–08)1*
NA NA NA NA NA NA NA NA NA NA
9-10f. Pregnancy prevention and STD protection in unmarried 
adolescents 15–17 years—Condom use at last intercourse, males 
(1995, 2006–08)1,2‡
NA NA NA NA NA NA NA NA NA NA NA NA NA
9-10g. Pregnancy prevention and STD protection in unmarried 
adolescents 15–17 years—Condom use (partner) and hormonal 
method at last intercourse, females (1995, 2006–08)1*
NA NA NA NA NA NA NA NA NA NA NA
9-10h. Pregnancy prevention and STD protection in unmarried 
adolescents 15–17 years—Condom use and hormonal method 
(partner) at last intercourse, males (1995, 2006–08)1,2‡
NA NA NA NA NA NA NA NA NA
Population-based objectives
Disparities from the best group rate for each characteristic at the most recent data point and changes in 
disparity from the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Income Disability
(continued)
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Population-based objectives
Characteristics and Groups
Race and Ethnicity Income Disability
Figure 9-2. Health Disparities Table for Focus Area 9: Family Planning (continued)
9-11a. Reproductive health prevention education among young adults 
15–19 years—Formal education on abstinence, females (2002, 
2006–08)*
NA NA NA NA NA NA NA
9-11b. Reproductive health prevention education among young adults 
15–19 years—Formal education on abstinence, males (2002, 
2006–08)*
NA NA NA NA NA NA NA
9-11c. Reproductive health prevention education among young adults 
15–19 years—Formal education on birth control methods, females 
(2002, 2006–08)*
NA NA NA NA NA 2 2 B 2 1 B
9-11d. Reproductive health prevention education among young adults 
15–19 years—Formal education on birth control methods, males 
(2002, 2006–08)*
NA NA NA NA 1 1 B 1 2 2 B 2 1 B
9-11i. Reproductive health prevention education among young adults 
15–19 years—Informal education on abstinence, females (2002, 
2006–08)*
NA NA NA NA 1 b B NA 1 1 Bii 1
9-11j. Reproductive health prevention education among young adults 
15–19 years—Informal education on abstinence, males (2002, 
2006–08)*
NA NA NA NA 2 1 B 2 1 Bii B 1 NA
9-11k. Reproductive health prevention education among young adults 
15–19 years—Informal education on birth control methods, females 
(2002, 2006–08)*
NA NA NA NA 2 1 B 2 2 1 B 2
9-11l. Reproductive health prevention education among young adults 
15–19 years—Informal education on birth control methods, males 
(2002, 2006–08)*
NA NA NA NA 2 2 B 2 1 1 B 1 NA
9-11o. Reproductive health prevention education among young adults 
15–19 years—Informal education on sexually transmitted diseases, 
females (2002, 2006–08)*
NA NA NA NA Bii b 1 NA 1 1 Bii 1
9-11p. Reproductive health prevention education among young adults 
15–19 years—Informal education on sexually transmitted diseases, 
males (2002, 2006–08)*
NA NA NA NA
2u1iv
B
3u1iv 3u1iv
1 1 Bii 1
9-12. Problems in becoming pregnant and maintaining a 
pregnancy—Wives of married couples (15–44 years) (1995, 
2006–08)1‡
NA NA NA NA NA NA
(continued)
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Figure 9-2. Health Disparities Table for Focus Area 9: Family Planning (continued)
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
‡
1
2
i
ii
iii
iv
v
9-1. 
9-2–9-3. National Survey of Family Growth (NSFG), CDC, NCHS.
9-4. National Survey of Family Growth (NSFG), CDC, NCHS; Abortion Patient Survey, Guttmacher Institute.
9-6a–c. National Survey of Family Growth (NSFG), CDC, NCHS.
9-7. 
9-8a. National Survey of Family Growth (NSFG), CDC, NCHS.
9-8b. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS.
9-9a. National Survey of Family Growth (NSFG), CDC, NCHS.
9-9b. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS.
9-10a. National Survey of Family Growth (NSFG), CDC, NCHS.
9-10b. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS.
9-10c. National Survey of Family Growth (NSFG), CDC, NCHS.
9-10d. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS.
9-10e. National Survey of Family Growth (NSFG), CDC, NCHS.
9-10f. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS.
9-10g. National Survey of Family Growth (NSFG), CDC, NCHS.
9-10h. National Survey of Adolescent Males (NSAM), Urban Institute; National Survey of Family Growth (NSFG), CDC, NCHS.
9-11a–d. National Survey of Family Growth (NSFG), CDC, NCHS.
9-11i–l. National Survey of Family Growth (NSFG), CDC, NCHS.
9-11o–p. National Survey of Family Growth (NSFG), CDC, NCHS.
9-12. National Survey of Family Growth (NSFG), CDC, NCHS.
Measures of variability were available only for the most recent data. Thus, the variability of best group rates was assessed only for the most recent data, and 
statistical significance was tested only for the most recent data. Disparities of 10% or more are displayed when the differences from the best group rate are 
statistically significant at the 0.05 level. Changes in disparities over time are displayed according to their magnitude, since measures of variability were not 
available at baseline and therefore statistical significance of changes in disparity could not be tested. See Technical Appendix.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
At baseline, persons reported only one race or reported more than one race and identified one primary race. Therefore, disparities at the most recent and the 
baseline data points may not be directly comparable.
National Survey of Family Growth (NSFG), CDC, NCHS; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS; Abortion Provider Survey, Guttmacher Institute; 
Abortion Surveillance Data, CDC, NCCDPHP.
DATA SOURCES
Data include persons of Hispanic origin.
Baseline data by disability status are for 2002. Measures of variability were available for disability, see footnote * above.
Baseline data by income are for 2002. Measures of variability were available for income, see footnote * above.
Change in the summary index cannot be assessed. See Technical Appendix.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical Appendix.
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
Most favorable group rate for specified 
characteristic, but reliability criterion not 
met.
NOTES
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
9-5, 9-11e through h, 9-11m and n, and 9-13.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Years in parentheses represent the baseline and most recent data years (if available).
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
National Survey of Family Growth (NSFG), CDC, NCHS; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS; Abortion Provider Survey, Guttmacher Institute; 
Abortion Surveillance Data, CDC, NCCDPHP.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
100 points or more
100 points or more
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows 
when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. 
Nonetheless, disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
Increase in disparity (percentage points)
10–49 points 50–99 points
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points
Data not available. Characteristic not selected for this objective.
A reformatted, typeset version of this report will replace the current version 
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Goal: Reduce foodborne illnesses 
This chapter addresses the rate of disease caused by microorganisms transmitted commonly by 
food, such as Salmonella and Campylobacter. Specific objectives monitor new cases of infections 
caused by important foodborne pathogens as well as the food-safety practices of consumers and of 
retail food establishments. 
All Healthy People tracking data quoted in this chapter, along with technical information and 
operational definitions for each objective, can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from 
http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from 
http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas. 
 
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade 
[1]. Almost three-quarters (73%) of the Food Safety Focus Area objectives moved toward or 
achieved their Healthy People 2010 targets (Figure 10-1). With the exception of one 
objective (10-5), data on health disparities by race and ethnicity were unavailable [2]. 
However, most objectives exhibited heath disparities of 10% or more by sex (Figure 10-2). 
 Statistically significant downward trends were observed in the rates of foodborne infections 
from Campylobacter species and Shiga toxin-producing Escherichia coli O157 (STEC O157) 
(objectives 10-1a and b) [3]. Between 1997 and 2009, rate of Campylobacter species 
infections decreased by 47.6%, from 24.6 to 12.9 per 100,000 population, moving toward 
the Healthy People 2010 target of 12.3 per 100,000; the rate of STEC O157 infections 
decreased by 52.4%, from 2.1 to 1.0 per 100,000 population, meeting the 2010 target of 1.0 
per 100,000. In addition, the rate of Listeria monocytogenes infections (objective 10-1c) 
declined by 36.2% between 1997 and 2009, from 0.47 to 0.30, moving toward the 2010 
target of 0.24 per 100,000 population. 
 The proportion of non-Typhi Salmonella from humans (percent of isolates) resistant to 
gentamicin (objective 10-3c) and ampicillin (objective 10-3d) declined. Gentamicin-
resistant isolates declined by 51.7% between 1997 and 2008, from 2.9% to 1.4%, exceeding 
the 2010 target of 2.9%. Ampicillin-resistant isolates declined by 49.2% between 1997 and 
2008, from 18.3% to 9.3%, exceeding the 2010 target of 18.3%. 
 Progress in outbreaks of foodborne infections was mixed. Outbreaks due to Salmonella 
serotype Enteritidis (objective 10-2b) decreased by 44.9% between 1997 and 2008, from 
49 to 27, achieving 88.0% of the 2010 target of 24 outbreaks. However, outbreaks due to 
Escherichia coli O157:H7 (objective 10-2a) increased between 1997 and 2008, from 10 to 
32 outbreaks, moving away from the 2010 target of five outbreaks. 
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 Consumer food safety practices (objective 10-5) improved by 4.2% between 1998 and 
2006, from 72% to 75%, moving toward the 2010 target of 79% of the population following 
safe food practices. 
 Food safety practices in retail establishments (objectives 10-6a through i) increased in all 
nine categories, moving toward or exceeding the 2010 targets. 
 Safe retail food preparation in meat and poultry departments (objective 10-6g) 
increased by 8.6% between 1998 and 2008, from 81% to 88%, exceeding the 2010 
target of 86%. 
 Safe retail food preparation in produce departments (objective 10-6h) increased by 
10.5% between 1998 and 2008, from 76% to 84%, exceeding the 2010 target of 
82%. 
 
Summary of Progress 
 Figure 10-1 presents a quantitative assessment of progress in achieving the Healthy People 
2010 objectives for Food Safety [1]. Data to measure progress toward target attainment 
were available for 22 objectives. Of these: 
 Five objectives met or exceeded their Healthy People 2010 targets (objectives 10-
1b, 10-3c and d, and 10-6f and g). 
 Eleven objectives moved toward their targets. A statistically significant difference 
between the baseline and the final data points was observed for one of these 
objectives (10-5, consumer food safety practices). No significant differences were 
observed for seven objectives (10-6a through f, and i); and data to test the 
significance of the difference were unavailable for three objectives (10-1a and c, and 
10-2b). 
 Six objectives moved away from their targets. No statistically significant differences 
between the baseline and final data points were observed for one objective (10-4b). 
Data to test the significance of the difference were unavailable for five objectives 
(10-1d and f, 10-2a, and 10-3a and b). 
 Sixteen objectives were dropped during the decade (objectives 10-1e and g, 10-3e through 
p, 10-4a, and 10-7) [4]. 
 Figure 10-2 displays health disparities in the Food Safety Focus Area objectives from the 
best group rate for each characteristic at the most recent data point [2]. It also displays 
changes in disparities from baseline to the most recent data point [5]. 
 The white non-Hispanic population had the best group rate for one objective with 
statistically significant racial and ethnic disparities of 10% or more (objective 10-5). 
 One objective had statistically significant health disparities by sex of 10% or more 
(objective 10-5). Four additional objectives had health disparities by sex of 10% or 
more but lacked data to measure variability (objectives 10-1a through c, and f). 
Males were the better group for three of these five objectives (10-1b, c, and f). 
Females were the better group for two objectives (10-1a and 10-5). 
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Transition to Healthy People 2020 
The Healthy People 2020 Food Safety Topic Area has fewer objectives than those included in 
Healthy People 2010. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and 
objectives. 
The Healthy People 2020 objectives can be grouped into several sections: 
 Food-related infections 
 Antimicrobial resistance 
 Consumer food safety practices 
 Retail food safety practices. 
The differences between the Healthy People 2010 and Healthy People 2020 objectives are 
summarized below: 
 The Healthy People 2020 Food Safety Topic Area has 28 objectives, whereas the Healthy 
People 2010 Focus Area had 38 objectives. 
 Eight Healthy People 2010 objectives were retained “as is” [6]. 
 Infections caused by microorganisms transmitted commonly by food: 
 Campylobacter species (objective 10-1a) 
 Shiga toxin-producing Escherichia coli O157 (objective 10-1b) 
 Listeria monocytogenes (objective 10-1c) 
 Salmonella species (objective 10-1d) 
 Cases of post-diarrheal hemolytic uremic syndrome (HUS) in persons under 
5 years of age (HUS) (objective 10-1f). 
 Non-Typhi Salmonella from humans (percent of isolates) resistant to: 
 Gentamicin (objective 10-3c) 
 Ampicillin (objective 10-3d). 
 Severe allergic reactions to food among adults aged 18 years and over with food 
allergy diagnosis (objective 10-4b). 
 Three Healthy People 2010 objectives were modified and expanded to six Healthy People 
2020 objectives [7]. Non-Typhi Salmonella from humans (percent of isolates) resistant to 
fluoroquinolones (objective 10-3a) and third-generation cephalosporins (objective 10-3b) 
will be tracked in Healthy People 2020 with nalidixic acid and ceftriaxone, respectively. The 
consumer food safety practices objective (10-5) was modified by subdividing the existing 
composite objective into four discrete objectives to track specific consumer practices. 
 Nine objectives for improving food safety practices in retail and foodservice establishments 
were measurable in Healthy People 2010 but are developmental in Healthy People 2020 
(objectives 10-6a through i) [8]. Actual measures and targets for improvement will be 
modified but will continue to be based on observed levels of compliance in select retail 
establishment types. 
 Two Healthy People 2010 objectives were archived: Outbreaks of food borne infections due 
to Escherichia coli O157:H7 (objective 10-2a) and Salmonella serotype Enteritidis (objective 
10-2b) [9]. 
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 Sixteen Healthy People 2010 objectives were dropped during the decade [4]. Two of these 
were determined not to be a significant public health concern (objectives 10-1e and 10-7). 
One did not have a national data source (objective 10-1g). Twelve objectives (10-3e through 
p) were dependent upon data from a regulatory program of the U.S. Department of 
Agriculture’s Food Safety and Inspection Service that was not designed to estimate 
prevalence and, therefore, could not be used to establish measurable objectives. One 
objective (10-4a, food allergy deaths) was dropped because the data source did not reliably 
track the actual number of cases of anaphylaxis mortality. 
 Nine new objectives were added for Healthy People 2020. These will track the number of 
infections caused by Vibrio species and Yersinia species; the number of outbreak-associated 
infections caused by food commodity group for beef, dairy, fruits and nuts, leafy vegetables, 
and poultry; prevention of Non-Typhi Salmonella occurring in humans (percent of isolates) 
resistant to three or more classes of antimicrobial agents; and prevention of Campylobacter 
jejuni from occurring in humans (percent of isolates) resistant to erythromycin. 
Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” 
summarizes the changes between the two decades of objectives, reflecting new knowledge and 
direction for this area. 
 
Data Considerations 
Education and income are the primary measures of socioeconomic status (SES) in Healthy People 
2010. Most data systems used in Healthy People 2010 define income as a family’s income before 
taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size 
and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed 
by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. 
These categories may be overridden by considerations specific to the data system, in which case 
they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. 
In general, data on educational attainment are presented for persons aged 25 years and over, 
consistent with guidance given by the U.S. Bureau of the Census. However, because of the 
requirements of the different data systems, the age groups used to calculate educational attainment 
for any specific objective may differ from the age groups used to report the data for other Healthy 
People 2010 objectives, as well as from select populations within the same objective. Therefore, the 
reader is urged to exercise caution in interpreting the data by educational attainment shown in the 
Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below, for 
additional information. 
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Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can 
be found in the Operational Definitions on the DATA2010 website, available from 
http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement 
can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, 
which is available in the Data Issues section of the NCHS Healthy People website under 
Healthy People 2010. 
 
Notes 
1. Displayed in the Progress Chart (Figure 10-1), the percent of targeted change achieved expresses the 
difference between the baseline and the final value relative to the initial difference between the 
baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward 
attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When 
standard errors were available, the difference between the baseline and the final value was tested at 
the 0.05 level of significance. See the Figure 10-1 footnotes, as well as the Technical Appendix, for 
more detail. 
2. Information about disparities among select populations is shown in the Health Disparities Table 
(Figure 10-2). Disparity from the best group rate is defined as the percent difference between the 
best group rate and each of the other group rates for a characteristic. For example, racial and ethnic 
health disparities are measured as the percent difference between the best racial and ethnic group 
rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as 
the percent difference between the better group rate (e.g., female) and the rate for the other group 
(e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be 
increased, while others are expressed in terms of adverse events or conditions that are to be reduced. 
In order to facilitate comparison of health disparities across different objectives, disparity is 
measured only in terms of adverse events or conditions. For comparability across objectives, 
objectives that are expressed in terms of favorable events or conditions are re-expressed using the 
adverse event or condition for the purpose of computing disparity, but they are not otherwise 
restated or changed. For example, objective 1-1, to increase the proportion of persons with health 
insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had 
some form of health insurance in 2008), is expressed in terms of the percentage of persons without 
health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged 
under 65 years did not have any form of health insurance in 2008) when the disparity from the best 
group rate is calculated. See the Reader’s Guide for more information. When standard errors were 
available, the difference between the best group rate and each of the other group rates was tested at 
the 0.05 level of significance. See the Figure 10-2 footnotes, as well as the Technical Appendix, for 
more detail. 
3. The presence of a monotonic increasing or decreasing trend in the underlying measure was tested 
with the nonparametric Mann-Kendall test, then the slope of a linear trend was estimated with the 
nonparametric Sen’s method. See Technical Appendix for more information. 
4. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either 
developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in 
Healthy People 2010. 
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5. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the 
most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s 
Guide for more information. When standard errors were available, the change in disparity was tested 
at the 0.05 level of significance. See the Figure 10-2 footnotes, as well as the Technical Appendix, for 
more detail. 
6. Retained “as is” objectives have no change in the numerator definition or in the denominator 
definition between the Healthy People 2010 and Healthy People 2020 objectives. These include 
objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 
2020 and for which no numerator or denominator information was available. 
7. Modified objectives have some change in the numerator definition or in the denominator definition 
between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that 
went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice 
versa. 
8. To be included in Healthy People 2010, an objective must have a national data source that provides a 
baseline and at least one additional data point for tracking progress. Some objectives lacked baseline 
data at the time of their development but had a potential data source and were considered of 
sufficient national importance to be included in Healthy People. These are called “developmental” 
objectives. When data become available, a developmental objective is moved to measurable status 
and a Healthy People target can be set. 
9. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward 
into Healthy People 2020. 
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Comprehensive Summary of Objectives: Food Safety 
Objective Description Data Source or Objective Status 
10-1a Foodborne infections—Campylobacter species (per 100,000 
population) 
Foodborne Disease Active Surveillance Network (FoodNet): CDC, 
NCEZID 
10-1b Foodborne infections—Escherichia coli O157:H7 (per 100,000 
population) 
Foodborne Disease Active Surveillance Network (FoodNet): CDC, 
NCEZID. 
10-1c Foodborne infections—Listeria monocytogenes (per 100,000 
population) 
Foodborne Disease Active Surveillance Network (FoodNet): CDC, 
NCEZID. 
10-1d Foodborne infections—Salmonella species (per 100,000 population) Foodborne Disease Active Surveillance Network (FoodNet): CDC, 
NCEZID. 
10-1e Foodborne infections: —Cyclospora cayetanensis (per 100.000 
population) 
Dropped 
10-1f Foodborne infections—Cases of postdiarrheal hemolytic uremic 
syndrome (HUS) (per 100,000 population <5 years) 
Foodborne Disease Active Surveillance Network (FoodNet): CDC, 
NCEZID.  
10-1g Foodborne infections—Congenital Toxoplasma gondii Dropped 
10-2a Outbreaks of foodborne infections—Escherichia coli O157:H7 Foodborne Disease Outbreak Surveillance System, CDC, NCEZID. 
10-2b Outbreaks of foodborne infections—Salmonella serotype Enteritidis Foodborne Disease Outbreak Surveillance System, CDC, NCEZID. 
10-3a Non-Typhi Salmonella from humans (percent of isolates) resistant to 
fluoroquinolones 
National Antimicrobial Resistance Monitoring System: Enteric 
Bacteria- (NARMS), CDC, NCEZID. 
10-3b Non-Typhi Salmonella from humans (percent of isolates) resistant to 
third-generation cephalosporins 
National Antimicrobial Resistance Monitoring System: Enteric 
Bacteria- (NARMS), CDC, NCEZID. 
10-3c Non-Typhi Salmonella from humans (percent of isolates) resistant to 
gentamicin 
National Antimicrobial Resistance Monitoring System: Enteric 
Bacteria- (NARMS), CDC, NCEZID 
10-3d Non-Typhi Salmonella from humans (percent of isolates) resistant to 
ampicillin 
National Antimicrobial Resistance Monitoring System: Enteric 
Bacteria- (NARMS), CDC, NCEZID 
10-3e Non-Typhi Salmonella from cattle at slaughter (percent of isolates) 
resistant to fluoroquinolones 
Dropped 
10-3f Non-Typhi Salmonella from cattle at slaughter (percent of isolates) 
resistant to third-generation cephalosporins 
Dropped 
10-3g Non-Typhi Salmonella from cattle at slaughter (percent of isolates) 
resistant to gentamicin 
Dropped 
10-3h Non-Typhi Salmonella from cattle at slaughter (percent of isolates) 
resistant to ampicillin 
Dropped 
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Objective Description Data Source or Objective Status 
10-3i Non-Typhi Salmonella from poultry at slaughter (percent of isolates) 
resistant to fluoroquinolones 
Dropped 
10-3j Non-Typhi Salmonella from poultry at slaughter (percent of isolates) 
resistant to third-generation cephalosporins 
Dropped 
10-3k Non-Typhi Salmonella from poultry at slaughter (percent of isolates) 
resistant to gentamicin 
Dropped 
10-3l Non-Typhi Salmonella from poultry at slaughter (percent of isolates) 
resistant to ampicillin 
Dropped 
10-3m Non-Typhi Salmonella from swine at slaughter (percent of isolates) 
resistant tofluoroquinolones 
Dropped 
10-3n Non-Typhi Salmonella from swine at slaughter (percent of isolates) 
resistant to third-generation cephalosporins 
Dropped 
10-3o Non-Typhi Salmonella from swine at slaughter (percent of isolates) 
resistant to gentamicin 
Dropped 
10-3p Non-Typhi Salmonella from swine at slaughter (percent of isolates) 
resistant to ampicillin 
Dropped 
10-4a Deaths from food-induced anaphylaxis Dropped, NCHS. 
10-4b Severe allergic reactions to food among adults with food allergy 
diagnosis (18+ years) 
Food Safety Survey (FSS), FDA, CFSAN; and Department of 
Agriculture (USDA). 
10-5 Consumer food safety practices (18+ years) Food Safety Survey (FSS), FDA, CFSAN; and Department of 
Agriculture (USDA). 
10-6a Safe retail food preparation—Hospitals Retail Food Database of Foodborne Illness Risk Factors, FDA, CFSAN. 
10-6b Safe retail food preparation—Nursing homes Retail Food Database of Foodborne Illness Risk Factors, FDA, CFSAN. 
10-6c Safe retail food preparation—Elementary schools Retail Food Database of Foodborne Illness Risk Factors, FDA, CFSAN. 
10-6d Safe retail food preparation—Fast food restaurants Retail Food Database of Foodborne Illness Risk Factors, FDA, CFSAN. 
10-6e Safe retail food preparation—Full-service restaurants Retail Food Database of Foodborne Illness Risk Factors, FDA, CFSAN. 
10-6f Safe retail food preparation—Deli departments Retail Food Database of Foodborne Illness Risk Factors, FDA, CFSAN. 
10-6g Safe retail food preparation—Meat/poultry departments Retail Food Database of Foodborne Illness Risk Factors, FDA, CFSAN. 
10-6h Safe retail food preparation—Produce departments Retail Food Database of Foodborne Illness Risk Factors, FDA, CFSAN. 
10-6i Safe retail food preparation—Seafood departments Retail Food Database of Foodborne Illness Risk Factors, FDA, CFSAN. 
10-7 Human exposure to organophosphate pesticide from food Dropped 
 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
12.3 
24.6 
(1997) 
12.9 
(2009) 
-11.7 Not tested -47.6% 
1.0 
2.1 
(1997) 
1.0 
(2009) 
-1.1 Not tested -52.4% 
0.24 
0.47 
(1997) 
0.30 
(2009) 
-0.17 Not tested -36.2% 
6.8 
13.6 
(1997) 
15.0 
(2009) 
1.4 Not tested 10.3 
0.90 
1.80 
(2000) 
2.03 
(2006) 
0.23 Not tested 12.8% 
5 
10 
(1997) 
32 
(2008) 
22 Not tested 220.0% 
24 
49 
(1997) 
27 
(2008) 
-22 Not tested -44.9% 
0.0% 
0.0% 
(1997) 
0.1% 
(2008) 
0.1 Not tested * 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 10-1. Progress Toward Target Attainment for Focus Area 10: Food Safety 
Percent of targeted change achieved5 (continued) 
 
10-1. Foodborne infections (per 100,000 
population) 
  a. Campylobacter species  
  b. Escherichia coli O157:H7     
  c. Listeria monocytogenes   
  d. Salmonella species  
  f. Cases of postdiarrheal hemolytic 
    uremic syndrome (HUS) 
   (<5 years)   
10-2. Outbreaks of foodborne infections 
  a. Escherichia coli O157:H7   
  b. Salmonella serotype Enteritidis    
10-3. Non-Typhi Salmonella from humans 
 (percent of isolates) resistant to: 
   a. fluoroquinolones   
95.1% 
100.0% 
73.9% 
88.0% 
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       Target met at baseline and  
              exceeded at final            
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
0.1% 
0.1% 
(1997) 
0.3% 
(2008) 
0.2 Not tested 200.0% 
2.9% 
2.9% 
(1997) 
1.4% 
(2008) 
-1.5 Not tested -51.7% 
18.3% 
18.3% 
(1997) 
9.3% 
(2008) 
-9 Not tested -49.2% 
21% 
26% 
(2001) 
29% 
(2006) 
3 No 11.5% 
79% 
72% 
(1998) 
75% 
(2006) 
3 Yes 4.2% 
85% 
80% 
(1998) 
81% 
(2008) 
1 No 1.3% 
87% 
82% 
(1998) 
83% 
(2008) 
1 No 1.2% 
85% 
80% 
(1998) 
84% 
(2008) 
4 No 5.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 10-1. Progress Toward Target Attainment for Focus Area 10: Food Safety (continued) 
Percent of targeted change achieved5 (continued) 
 
10-3. Non-Typhi Salmonella from humans 
 (percent of isolates) resistant to: 
   b. Third-generation cephalosporins   
  c. Gentamicin     
  d. Ampicillin  
10-4b. Severe allergic reactions to food among 
adults with food allergy diagnosis (18+ 
years)  
10-5. Consumer food safety practices (18+ years)   
10-6 Safe retail food preparation 
  a. Hospitals 
  b. Nursing homes 
  c. Elementary schools  
       Target met at baseline and  
              exceeded at final            
42.9% 
20.0% 
80.0% 
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20.0% 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
81% 
74% 
(1998) 
78% 
(2008) 
4 No 5.4% 
70% 
60% 
(1998) 
64% 
(2008) 
4 No 6.7% 
80% 
73% 
(1998) 
74% 
(2008) 
1 No 1.4% 
86% 
81% 
(1998) 
88% 
(2008) 
7 No 8.6% 
82% 
76% 
(1998) 
84% 
(2008) 
8 No 10.5% 
87% 
83% 
(1998) 
86% 
(2008) 
3 No 3.6% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 10-1. Progress Toward Target Attainment for Focus Area 10: Food Safety (continued) 
Percent of targeted change achieved5 
(continued) 
 
10-6. Safe retail food preparation 
  d. Fast food restaurants 
  e. Full-service restaurants 
  f. Deli departments 
  g. Meat/poultry departments 
   h. Produce departments  
  i. Seafood departments 
57.1% 
40.0% 
14.3% 
            140.0% 
75.0% 
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            133.3% 
 NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objective 10-4a. Objectives 10-1e, 10-1g, 10-3e through p, and 10-7 were deleted at the Midcourse Review.  
 
FOOTNOTES  
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
 
* Percent change cannot be calculated. See Technical Appendix for more information. 
 
 
 
 
 
 
Figure 10-1. Progress Toward Target Attainment for Focus Area 10: Food Safety (continued) 
DATA SOURCES  
 
10-1a–d. Foodborne Disease Active Surveillance Network (FoodNet): CDC, NCPDCID; FDA, CFSAN; Department of Agriculture (USDA); State agencies.  
10-1f. Foodborne Disease Active Surveillance Network (FoodNet): CDC, NCPDCID; FDA, CFSAN; Department of Agriculture (USDA); State agencies.  
10-2a–b. Foodborne Disease Outbreak Surveillance System, CDC, NCID. 
10-3a–d. National Antimicrobial Resistance Monitoring System: Enteric Bacteria-Salmonella (NARMS: Enteric Bacteria), CDC, NCID; FDA, CVM; Department of Agriculture (USDA). 
 Foodborne Disease Active Surveillance Network (FoodNet): CDC, NCPDCID; FDA, CFSAN; USDA; State agencies. 
10-4b. Food Safety Survey (FSS), FDA, CFSAN; and Department of Agriculture (USDA). 
10-5. Food Safety Survey (FSS), FDA, CFSAN; and Department of Agriculture (USDA). 
10-6a–i. Retail Food Database of Foodborne Illness Risk Factors, FDA, CFSAN. 
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Figure 10-2. Health Disparities Table for Focus Area 10: Food Safety
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10-1a. Foodborne infections—Campylobacter species 
(per 100,000 population) (1997, 2009)† NA NA NA NA NA NA NA NA B 2 NS NS NS NS NA NA NA NA NS NS
10-1b. Foodborne infections—Escherichia coli 
O157:H7 (per 100,000 population) (1997, 
2009)†
NA NA NA NA NA NA NA NA
2u1
B NS NS NS NS NA NA NA NA NS NS
10-1c. Foodborne infections—Listeria 
monocytogenes (per 100,000 population) 
(1997, 2009)†
NA NA NA NA NA NA NA NA 2 Bi NS NS NS NS NA NA NA NA NS NS
10-1d. Foodborne infections—Salmonella species 
(per 100,000 population) (1997, 2009)† NA NA NA NA NA NA NA NA 1 Bi NS NS NS NS NA NA NA NA NS NS
10-1f. Foodborne infections—Cases of postdiarrheal 
hemolytic uremic syndrome (HUS) (per 100,000 
population <5 years) (2000, 2006)†
NA NA NA NA NA NA NA NA
3u2
B NS NS NS NS NA NA NA NA NS NS
10-4b. Severe allergic reactions to food among adults 
with food allergy diagnosis (18+ years) (2001, 
2006)*
NA NA NA NA NA NA NA NA NA NA NA NA NA NS NS
10-5. Consumer food safety practices (18+ years) 
(1998, 2006)* NA NA NA NA 2 1 B 1ii B 2 Bi 1 Bi 1 NS NS NS NS NA NA
The "best" group rate at the most recent data point. B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
i
ii
10-1a–d. Foodborne Disease Active Surveillance Network (FoodNet): CDC, NCPDCID; FDA, CFSAN; Department of Agriculture (USDA); State agencies.
10-1f. Foodborne Disease Active Surveillance Network (FoodNet): CDC, NCPDCID; FDA, CFSAN; Department of Agriculture (USDA); State agencies.
10-4b. Food Safety Survey (FSS), FDA, CFSAN; and Department of Agriculture (USDA).
10-5. Food Safety Survey (FSS), FDA, CFSAN; and Department of Agriculture (USDA).
Reliability criterion for best 
group rate not met, or data 
available for only one group.
NOTES
LEGEND
Disparity from the best group rate at the most 
recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
The group with the best rate 
for specified characteristic.
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
10-2a and b, 10-3a through d, 10-4a, and 10-6a through i. Objectives 10-1e and g, 10-3e through p, and 10-7, were deleted at Midcourse Review.
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Percent difference from the best group rate
DATA SOURCES
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Disability
Population-based objectives
Data not available.
FOOTNOTES
Increase in disparity (percentage points)
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race 
and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at 
baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the 
summary index at the most recent data point. See Technical Appendix for more information.
Years in parentheses represent the baseline and most recent data years (if available).
Change in the summary index cannot be assessed. See Technical Appendix.
Characteristic not selected for this objective.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows 
when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. Nonetheless, 
disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
10–49 points 50–99 points
Decrease in disparity (percentage points)
10–49 points 50–99 points
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage points and 
estimates of variability were not available. See Technical Appendix.
100 points 
or more
100 points 
or more
A reformatted, typeset version of this report will replace the current version 
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Goal: Use communication strategically to improve health 
The objectives in this chapter monitor the availability of Internet access, health literacy, and the characteristics of health communication campaigns and health-related websites. The number of centers for excellence in health communication and patient perception of health provider communication skills are also tracked. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this focus area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade [1]. Fourteen of the 16 Health Communication objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 11-1). However, health disparities of 10% or more were observed for a number of population groups (Figure 11-2), some of which are highlighted below [2]. 
 The proportion of adults with Internet access at home (objective 11-1) increased by 165.4% between 1998 and 2009, from 26% to 69%, moving toward the Healthy People 2010 target of 80%. 
• Among racial and ethnic groups, the Asian population had the highest (best) rate of Internet access at home, 80% in 2009, whereas the American Indian or Alaska Native, Hispanic or Latino, and black non-Hispanic populations each had a rate of 53% in 2009. When expressed as persons without Internet access at home, the rates for these three populations were almost two and a half times the best group rate (that for the Asian population) [2]. 
• Among education groups, persons with at least some college education had the highest (best) rates of Internet access at home, 31% in 1998 and 82% in 2009, whereas high school graduates had rates of 16% in 1998 and 57% in 2009, and persons with less than a high school education had rates of 5% in 1998 and 32% in 2009.  
 In 2009, when expressed as persons without Internet access at home, the rate for high school graduates was almost two and a half times the best group rate (that for persons with at least some college education), while the rate for persons with less than a high school education was nearly four times the best group rate [2]. 
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 Between 1998 and 2009, the disparity between high school graduates and persons with at least some college education (the group with the best rate) increased by 117 percentage points, while the disparity between persons with less than a high school education and the group with the best rate increased by 240 percentage points [3]. 
• Internet access at home varied by geographic area. In 2009, the proportion of adults with Internet access at home was highest in the states of Alaska, Connecticut, Massachusetts, New Hampshire, New Jersey, Oregon, Utah, and Washington. The states with the lowest proportion of adults with Internet access at home were Alabama, Arkansas, Mississippi, and South Carolina (Figure 11-3). 
 The proportion of health websites disclosing information that could be used to assess the quality of the site (objectives 11-4a through g) increased for all categories. The Healthy People 2010 targets were exceeded for four objectives: 
• The proportion of websites that disclosed their purpose, uses, and limitations (objective 11-4b) increased by 20.0% between 2006 and 2009, from 35% to 42%, exceeding the target of 40%. 
• The proportion that disclosed their privacy policies (objective 11-4d) increased by 13.3% between 2006 and 2009, from 75% to 85%, exceeding the target of 80%. 
• The proportion that provided user feedback options (objective 11-4e) increased by 49.2% between 2006 and 2009, from 59% to 88%, exceeding the target of 64%.  
• The proportion of websites that met at least three of the six disclosure criteria (objective 11-4g) increased by 116.7% between 2006 and 2009, from 24% to 52%, exceeding the target of 29%. 
 Health disparities of 100% or more in the proportion of persons with below basic health literacy skills (objective 11-2b) were observed for a number of population groups: 
• Among racial and ethnic groups, the white non-Hispanic population had the lowest (best) rate of persons with below basic health literacy, 9% in 2003, whereas the black non-Hispanic, American Indian or Alaska Native, and Hispanic or Latino populations had rates of 24%, 25%, and 41% in 2003, respectively. The rate for the black non-Hispanic population was more than two and a half times the best rate (that for the white non-Hispanic population); the rate for the American Indian or Alaska Native population was almost three times the best rate; and the rate for the Hispanic or Latino population was more than four and a half times the best rate [2]. 
• Among education groups, persons with at least some college education had the lowest (best) rate of persons below basic health literacy, 5% in 2003. High school graduates and persons with less than a high school education had rates of 15% and 54% in 2003, respectively. The rate for high school graduates was three times the best group rate (that for persons with at least some college education), while the rate for persons with less than a high school education was nearly 11 times the best group rate [2]. 
• Persons without disabilities had a lower (better) rate of persons below basic health literacy than persons with disabilities, 10% in 2003. The rate for persons with disabilities was 23% in 2003, nearly two and a half times the rate for persons without disabilities [2].  
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Summary of Progress 
 Figure 11-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Health Communication. Data to measure progress toward target attainment were available for 16 objectives [1]. Of these: 
• Five objectives (11-4b, d, e, and g; and 11-5) exceeded the Healthy People 2010 targets. 
• Nine objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for six of these objectives (11-1; 11-4c and f; and 11-6a, c, and d). No significant differences were observed for two objectives (11-4a and 11-6b); and data to test the significance of the difference were unavailable for one objective (11-3c).  
• Two objectives moved away from their targets (objectives 11-3a and b). Data to test the significance of the difference between the baseline and the final data points were unavailable for either of these objectives. 
 Data were unavailable to measure progress for two objectives (11-2a and b). 
 Figure 11-2 displays health disparities in Health Communication from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Of the seven objectives with statistically significant racial and ethnic health disparities of 10% or more, the black non-Hispanic population had the best rate for four objectives (11-6a through d). The Asian population had the best rate for two objectives (11-1 and 11-2b) and the white non-Hispanic population had the best rate for one objective (11-2b). 
• Males had better rates than females for two of the three objectives with statistically significant health disparities of 10% or more by sex (objectives 11-1 and 11-6a). Females had a better rate for objective 11-2b. 
• Of the seven objectives with statistically significant health disparities of 10% or more by education level, high school graduates had the best rate for three objectives (11-6a, c, and d), persons with at least some college education also had the best rate for three objectives (11-1a, and 11-2a and b). The population of high school graduates and the population of persons with at least some college education both had the best group rate for one objective (persons reporting their health care providers explained things so they could understand; objective 11-6b). 
• Residents of urban or metropolitan areas had the better group rate for the one objective with statistically significant health disparities of 10% or more by geographic location (persons with Internet access at home; objective 11-1). 
• Persons without disabilities had the better group rate for all three objectives with statistically significant health disparities of 10% or more by disability status (objectives 11-2b, and 11-6b and c). 
• As discussed in the Highlights, above, health disparities of 100% or more were observed for two objectives (11-1 and 11-2b). Changes in health disparities of 100 percentage points or more were observed for one objective (11-1).  
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Transition to Healthy People 2020 For Healthy People 2020, the focus of the Health Communication and Health Information Technology (IT) objectives has been expanded from those presented in Healthy People 2010 to include more objectives that are shaped by the communication processes and the information technology that people interact with every day. The Healthy People 2010 Focus Area name was changed from Health Communication to Health Communication and Health IT to strategically combine health IT tools and effective health communication processes. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 Health Communication and Health IT objectives are geared toward: 
 Providing personalized self-management tools and resources 
 Building social support networks 
 Delivering accurate, accessible, and actionable health information that is targeted or tailored 
 Facilitating the meaningful use of health IT and exchange of health information among health care and public health professionals 
 Enabling quick and informed action to health risks and public health emergencies 
 Increasing health literacy skills 
 Providing new opportunities to connect with culturally diverse and hard-to-reach populations 
 Providing a trained workforce for the design of programs and interventions that result in healthier behaviors 
 Increasing Internet and mobile access. The differences between the Healthy People 2010 and Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Health Communication and Health IT Area has a total of 24 objectives, 10 of which are developmental, whereas the Healthy People 2010 Health Communication Focus Area had 18 objectives [4]. 
 Four Healthy People 2010 objectives were retained “as is” [5]. These objectives address patient reports of health care provider communication skills (objectives 11-6a through d). 
 Two Healthy People 2010 objectives were modified [6]. These objectives include Internet access at home (objective 11-1) and health websites that disclose at least three of select criteria (objective 11-4g) [6]. 
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 Twelve Healthy People 2010 objectives were archived [7]. These objectives include: persons with proficient health literacy (objective 11-2a); persons with below basic health literacy (objective 11-2b); health communication campaigns sponsored by the U.S. Department of Health and Human Services that include formative evaluations (objective 11-3a); health communication campaigns sponsored by the U.S. Department of Health and Human Services that include process evaluation (objective 11-3b); health websites that disclose the identity of the responsible persons or organizations (objective 11-4a); health websites that disclose the purpose, uses and limitations of the sites (objective 11-4b); health websites that disclose content development practices and policies on the sites (objective 11-4c); health websites that disclose privacy policy and protection on the sites (objective 11-4d); health websites that disclose user feedback and evaluation on the sites (objective 11-4e); health websites that disclose content creation on the sites (objective 11-4f); and the number of Centers for Excellence in Health Communication (objective 11-5). 
 Seventeen new objectives were added to the Healthy People 2020 Topic Area: 
• Three new health literacy objectives monitor the proportion of persons who report that their health care provider always give them easy-to-understand instructions about what to do to take care of their illness or health condition; that their health care provider always ask them to describe how they will follow the instructions; and that their health care providers’ office always offers help in filling out a form. 
• Three new social marketing objectives track the proportion of state health departments using social marketing in health promotion and disease prevention programs; schools of public health and accredited master of public health (MPH) programs that offer one or more courses in social marketing; and schools of public health and accredited MPH programs that offer workforce development activities in social marketing for public health practitioners. 
• Two new Internet access objectives track the proportion of persons with broadband access to the Internet and the proportion of persons who use mobile devices. 
• Two new electronic personal health management tools objectives target the proportion of persons who use the Internet to keep track of personal health information, such as care received, test results, or upcoming medical appointments; and persons who use the Internet to communicate with their provider. 
• The remaining seven new objectives track the proportion of: 
 Persons who report that their health care providers always involve them in decisions about their health care as much as they want 
 Patients whose doctor recommends personalized health information resources to help them manage their health 
 Adults who report having friends or family members whom they talk with about their health 
 Online health information seekers who report easily accessing health information 
 Medical practices that use electronic health records 
 Meaningful users of health IT 
 Crisis and emergency risk messages intended to protect the public’s health that demonstrate the use of best practices. 
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The Healthy People 2020 objectives continue to reflect the importance of the use of health communication strategies and health IT to improve population health outcomes and health care quality, and to achieve health equity. For objectives that were deleted due to lack of data, the U.S. Department of Health and Human Services and the agencies that serve as the leads for the Healthy People 2020 initiative will consider ways to ensure that these public health issues retain prominence despite their current lack of data. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
Notes 1. Displayed in the Progress Chart (Figure 11-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 11-1 footnotes, as well as the Technical Appendix, for more detail. 
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2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 11-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 11-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 11-2 footnotes, as well as the Technical Appendix, for more detail. 4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 5. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 6. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 7. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020.  
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Comprehensive Summary of Objectives: Health Communication 
Objective Description Data Source 11-1 Persons with Internet access at home (18+ years) Current Population Survey (CPS): Department of Commerce, Census Bureau; Department of Labor, Bureau of Labor Statistics. 11-2a Persons with proficient health literacy (16+ years) National Assessment of Health Literacy (NAAL), National Center for Education Statistics (NCES), U.S. Department of Education. 11-2b Persons with below basic health literacy (16+ years) National Assessment of Health Literacy (NAAL), National Center for Education Statistics (NCES), U.S. Department of Education. 11-3a DHHS-sponsored health communication campaigns that include formative evaluation DHHS, Office of Disease Prevention and Health Promotion. 11-3b DHHS-sponsored health communication campaigns that include process evaluation DHHS, Office of Disease Prevention and Health Promotion. 11-3c DHHS-sponsored health communication campaigns that include outcome evaluation DHHS, Office of Disease Prevention and Health Promotion. 11-4a Health websites that disclose identity persons/organization responsible DHHS, Office of Disease Prevention and Health Promotion. 11-4b Health websites that disclose purpose/uses/limitations DHHS, Office of Disease Prevention and Health Promotion. 11-4c Health websites that disclose content development practices/policies DHHS, Office of Disease Prevention and Health Promotion. 11-4d Health websites that disclose privacy policy/protection DHHS, Office of Disease Prevention and Health Promotion. 11-4e Health websites that disclose user feedback/evaluation DHHS, Office of Disease Prevention and Health Promotion. 11-4f Health websites that disclose content creation/updating DHHS, Office of Disease Prevention and Health Promotion. 11-4g Health websites that disclose three or more of the above criteria DHHS, Office of Disease Prevention and Health Promotion. 11-5 Centers for excellence in health communication NIH, NCI. 11-6a Patients reporting doctors or other health providers always listen carefully to them (18+ years) Medical Expenditure Panel Survey (MEPS), AHRQ. 11-6b Patients reporting doctors or other health providers always explain things so they can understand (18+ years) Medical Expenditure Panel Survey (MEPS), AHRQ. 11-6c Patients reporting doctors or other health providers always show respect for what they have to say (18+ years) Medical Expenditure Panel Survey (MEPS), AHRQ. 11-6d Patients reporting doctors or other health providers always spend enough time with them (18+ years) Medical Expenditure Panel Survey (MEPS), AHRQ.  
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Figure 11-1. Progress Toward Target Attainment for Focus Area 11: Health Communication 
Percent of targeted change achieved6 (continued) 
 
11-1. Persons with Internet access at home (18+ 
years) 
11-3. DHHS-sponsored health communication 
campaigns that include 
  a. Formative evaluation  
  b. Process evaluation 
  c. Outcome evaluation 
11-4. Health websites that disclose 
   a. Identity (persons/organization 
   responsible) 5 
  b. Purpose/uses/limitations  
  c. Content development practices/policies5 
  d. Privacy policy/protection 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
80% 
26% 
(1998) 
69% 
(2009) 
43 Yes 165.4% 
100% 
95% 
(2005) 
80% 
(2009) 
-15 
Not 
tested 
-15.8% 
89% 
81% 
(2005) 
68% 
(2009) 
-13 
Not 
tested 
-16.0% 
65% 
59% 
(2005) 
64% 
(2009) 
5 
Not 
tested 
8.5% 
19% 
10% 
(2006) 
12% 
(2009) 
2 No 20.0% 
40% 
35% 
(2006) 
42% 
(2009) 
7 No 20.0% 
10% 
1% 
(2006) 
4% 
(2009) 
3 Yes 300.0% 
80% 
75% 
(2006) 
85% 
(2009) 
10 No 13.3% 
 79.6% 
83.3% 
22.2% 
33.3% 
            140.0% 
            200.0% 
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Figure 11-1. Progress Toward Target Attainment for Focus Area 11: Health Communication (continued) 
Percent of targeted change achieved6 (continued) 
 
11-4   Health websites that disclose 
  e. User feedback/evaluation  
  f. Content creation/updating5    
  g. Three or more of the above criteria  
11-5. Centers for excellence in health 
communication  
11-6. Patients (18+ years) reporting doctors or 
other health providers always 
  a. Listen carefully to them   
  b. Explain things so they can understand   
  c. Show respect for what they have to say  
  d. Spend enough time with them  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
64% 
59% 
(2006) 
88% 
(2009) 
29 Yes 49.2% 
10% 
1% 
(2006) 
7% 
(2009) 
6 Yes 600.0% 
29% 
24% 
(2006) 
52% 
(2009) 
28 
Not 
tested 
116.7% 
6 
4 
(2003) 
8 
(2006) 
4 
Not 
tested 
100.0% 
65% 
57% 
(2000) 
59% 
(2007) 
2 Yes 3.5% 
66% 
59% 
(2000) 
60% 
(2007) 
1 No 1.7% 
66% 
59% 
(2000) 
62% 
(2007) 
3 Yes 5.1% 
53% 
46% 
(2000) 
49% 
(2007) 
3 Yes 6.5% 
66.7% 
25.0% 
14.3% 
42.9% 
42.9% 
            580.0% 
            560.0% 
            200.0% 
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Figure 11-1. Progress Toward Target Attainment for Focus Area 11: Health Communication (continued) 
DATA SOURCES 
 
11-1. Current Population Survey (CPS): Department of Commerce, Census Bureau; Department of Labor, Bureau of Labor Statistics. 
11-3a–c. DHHS, Office of Disease Prevention and Health Promotion. 
11-4a–g. DHHS, Office of Disease Prevention and Health Promotion. 
11-5. NIH, NCI.  
11-6a–d. Medical Expenditure Panel Survey (MEPS), AHRQ. 
 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 11-2a and 11-2b. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
5  Baseline data are statistically unreliable.  Values are shown to allow assessment of full criteria set. Refer to Operational Definition for more information. 
 
                  Final value – Baseline value 
6 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
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Figure 11-2. Health Disparities Table for Focus Area 11: Health Communication
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11-1. Persons with Internet access at home (18+ years) 
(1998, 2009)
4u3
Bi NA NA
4u3 4u3
2 4ii 2 B
4u3 4u3
B
4u3
B
2u1
NA NA
11-2a. Persons with proficient health literacy (16+ years) 
(2003) 2 B NA 2 2 2 1 2 B 1 2 2 B 2 B 1 1 B
11-2b. Persons with below basic health literacy (16+ 
years) (2003) 4 1 NA NA 4 4 B 4 B 2 4 4 B 4 B B 4 B
11-6a. Patients reporting doctors or other health 
providers always listen carefully to them (18+ 
years) (2000, 2007)1,2
b 3 NA 3
2u1
B 2 NA 2 B 2 Bi 2 2
1d1
B 1 B
11-6b. Patients reporting doctors or other health 
providers always explain things so they can 
understand (18+ years) (2000, 2007)1,2
b
3u1
NA 2
2u1
B 2 NA B Bi 2 Bi B 1 Bi B 2 B
11-6c. Patients reporting doctors or other health 
providers always show respect for what they have 
to say (18+ years) (2000, 2007)1,2
b 3 NA 3
2u1
B
2u1
NA B B 1 Bi 2 2 1 B 2 B
11-6d. Patients reporting doctors or other health 
providers always spend enough time with them 
(18+ years) (2000, 2007)1,2
b
2u1
NA 3
2u1
B 2 NA 1 B 1 Bi 2 2 1 B 1 B
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
1
2
i
ii
11-1. 
11-2a–b. National Assessment of Health Literacy (NAAL), Department of Education, National Center for Education Statistics (NCES).
11-6a–d. Medical Expenditure Panel Survey (MEPS), AHRQ.
50%–99%
Increase in disparity (percentage points)
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically significant, or 
when the change is greater than or equal to 10 percentage points and estimates of variability 
were not available. See Technical Appendix.
DATA SOURCES
Baseline data by race and ethnicity are for 2002.
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Characteristic not selected for this 
objective.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Current Population Survey (CPS), Department of Commerce, Census Bureau.
Characteristics and Groups
Race and Ethnicity Sex Education Location Disability
Population-based objectives
Data not available.
FOOTNOTES
Most recent data by disability status are for 2004.
10–49 points 50–99 points
LEGEND
The "best" group rate at the most recent data point.
Percent difference from the best group rate
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race 
and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at 
baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the 
summary index at the most recent data point. See Technical Appendix for more information.
Change in the summary index cannot be assessed. See Technical Appendix.
NOTES
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity 
from the baseline to the most recent data point.
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
11-3a through c, 11-4a through g, and 11-5.
Years in parentheses represent the baseline and most recent data years (if available).
Measures of variability were available for all the objectives in this table. Thus, the variability of best group rates was assessed, and statistical significance was 
tested. Disparities of 10% or more are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities 
over time are indicated by arrows when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See 
Technical Appendix.
Most favorable group rate for specified 
characteristic, but reliability criterion not 
met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
The group with the best rate for 
specified characteristic.
100% or 
more
100 points or 
more
Disparity from the best group rate at the most recent 
data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49%
Figure 11-3. Persons with Internet Access at Home (18+ years) 2009 
Healthy People 2010 objective 11-1 
Target = 80 
Notes: Rates are displayed by a Jenks classification for U.S. states.  
SOURCE: Current Population Survey (CPS), U.S. Department of Commerce, Bureau of the Census. 
Percent 
No states met the target 
51.8 - 58.3 
58.4 - 64.1 
64.2 - 68.3 
68.4 - 73.4 
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Goal: Improve cardiovascular health and quality of life 
through the prevention of risk factors; detection and 
treatment of risk factors; early identification and 
treatment of heart attacks and strokes; and prevention of 
recurrent cardiovascular events 
This chapter includes objectives for the Focus Area that monitors coronary heart disease (CHD) and stroke deaths, heart failure hospitalizations, risk factors for heart disease and stroke, knowledge of heart attack and stroke symptoms and response, and the availability of treatment options. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved for the majority of objectives in this Focus Area over the last decade [1]. Two-thirds of the Heart Disease and Stroke objectives with data to monitor progress moved toward or achieved their Healthy People 2010 targets. However, for three objectives, the change was opposite the direction of the target (Figure 12-1). Moreover, health disparities of 50% or more among racial and ethnic populations and education groups were observed (Figure 12-2), as highlighted below [2]. 
 The CHD death rate (objective 12-1) declined by 35.4% between 1999 and 2007, from 195 to 126 deaths per 100,000 population (age adjusted), exceeding the Healthy People 2010 target of 156 deaths per 100,000. Disparities were observed for a number of population groups, for example: 
• Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) CHD mortality rate, 71 deaths per 100,000 population (age adjusted) in 2007, whereas the black non-Hispanic population had a rate of 153 deaths per 100,000 (age adjusted) in 2007. The rate for the black non-Hispanic population was more than twice the best group rate [2]. 
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• Among education groups, persons aged 25–64 years with at least some college education had the lowest (best) CHD mortality rate, 30 deaths per 100,000 population (age adjusted) in 2002. Persons aged 25–64 years with less than a high school education had a rate of 83 deaths per 100,000 (age adjusted) in 2002, and high school graduates in the same age group had a rate of 71 deaths per 100,000 (age adjusted) in 2002. The rate for persons with less than a high school education was almost three times the best group rate, while the rate for high school graduates was almost two and a half times the best group rate [2]. 
• While the Healthy People 2010 target for CHD deaths was largely met throughout the U.S., there remained geographic pockets with higher rates along the Ohio-Mississippi River Basin, a geographic region commonly referred to as the “Coronary Valley” (Figure 12-3). 
 The stroke death rate (objective 12-7) declined by 32.3% between 1999 and 2007, from 62 to 42 deaths per 100,000 (age adjusted), exceeding the 2010 target of 50 deaths per 100,000. Disparities were observed for a number of population groups, for example: 
• Among racial and ethnic groups, the American Indian or Alaska Native population had the lowest (best) rate, 30 deaths per 100,000 population (age adjusted) in 2007. The black non-Hispanic population had a rate of 62 deaths per 100,000 (age adjusted) in 2007, more than twice the best group rate [2]. 
• Among education groups, persons aged 25–64 years with at least some college education had the lowest (best) stroke death rate, 7 deaths per 100,000 population (age adjusted) in 2002. Persons aged 25–64 years with less than a high school education had a rate of 21 deaths per 100,000 (age adjusted) in 2002, and high school graduates in the same age group had a rate of 16 deaths per 100,000 (age adjusted) in 2002. The rate for persons with less than a high school education was three times the best group rate, while the rate for high school graduates was almost two and a half times the best group rate [2]. 
• While the Healthy People 2010 target for stroke deaths was largely met throughout the U.S., there remained geographic pockets with higher rates in the Southeast, a geographic region commonly referred to as the “Stroke Belt” (Figure 12-4). 
 Hospitalization rates for congestive heart failure among persons aged 65–74 years (objective 12-6a) declined by 35.6% between 1997 and 2007, from 13.2 to 8.5 hospitalizations per 1,000, moving toward the 2010 target of 6.5 hospitalizations per 1,000. Congestive heart failure hospitalizations among persons aged 75–84 years (objective 12-6b), declined by 26.2% between 1997 and 2007, from 26.7 to 19.7 hospitalizations per 1,000, moving toward the 2010 target of 13.5 hospitalizations per 1,000; and among persons aged 85 years and over (objective 12-6c), hospitalizations declined by 37.6%, from 52.7 to 32.9 per 1,000, moving toward the 2010 target of 26.5 hospitalizations per 1,000.   
• In the 65–74 years age group (objective 12-6a), the white population had the lowest (best) rate among racial and ethnic groups, 5.9 hospitalizations per 1,000 population in 2007. The black population had a rate of 14.0 per 1,000 in 2007, nearly two and a half times the best group rate [2]. 
• In the 75–84 years age group (objective 12-6b), the white population also had the lowest (best) rate among racial and ethnic groups, 14.8 hospitlaizations per 1,000 population in 2007. The black population had a rate of 25.9 per 1,000 in 2007, almost twice the best group rate [2]. 
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 The proportion of persons aged 18 years and over who had their blood pressure measured in the past two years and who know their blood pressure level (objective 12-12) increased by 1.1% between 1998 and 2008, from 90% to 91% (age adjusted), moving toward the Healthy People 2010 target of 95%. Disparities were observed for a number of population groups, for example: 
• Among racial and ethnic groups, the white non-Hispanic and black non-Hispanic populations had the highest (best) rate of blood pressure monitoring, 92% (age adjusted) in 2008, whereas the Hispanic or Latino population had a rate of 82% (age adjusted) in 2008. When expressed as persons who do no monitoring, the rate for the Hispanic or Latino population was more than twice the best group rate [2]. 
• Among education groups, persons aged 25 years and over with at least some college education had the highest (best) rate of blood pressure monitoring, 94% in 2008, whereas persons aged 25 years and over with less than a high school education had a rate of 83% in 2008. When expressed as persons who do no monitoring, the rate for persons with less than a high school education was almost three times the best group rate [2]. 
 Persons with less than a high school education had blood pressure monitoring rates of 84% in 1998 and 83% in 2008, whereas persons with at least some college education had rates of 93% in 1998 and 94% in 2008. When rates are expressed in terms of persons who do no monitoring, the disparity between persons without a high school education and those with at least some college education decreased by 55 percentage points between 1998 and 2008 [2,3]. 
 Mean total blood cholesterol levels among persons aged 20 years and over (objective 12-13) declined by 3.9% between 1988–94 and 2005–08, from 206 to 198 mg/dL (age adjusted), exceeding the 2010 target of 199 mg/dL. During the same period, the proportion of persons aged 20 years and over with high blood cholesterol levels (objective 12-14) fell by 28.6%, from 21% to 15% (age adjusted), exceeding the 2010 target of 17%. 
 The proportion of persons aged 18 years and over who were aware of the symptoms of a heart attack and the importance of calling 911 (objective 12-2) declined by 11.9% between 2001 and 2008, from 42% to 37% (age adjusted), moving away from the 2010 target of 47%. 
 The proportion of persons aged 18 years and over who were aware of the symptoms of a stroke (objective 12-8) declined by 10.0% between 2001 and 2009, from 60% to 54% (age adjusted), moving away from the 2010 target of 65%. 
 The prevalence of hypertension among persons aged 18 years and over (objective 12-9) increased by 20.0% between 1988–94 and 2005–08, from 25% to 30% (age adjusted), moving away from the 2010 target of 14%. Disparities were observed for a number of population groups, for example: 
• Among racial and ethnic populations, the Mexican American population had the lowest (best) rate, 26% (age adjusted) in 2005–08. The rate for the black non-Hispanic population was 42% (age adjusted) in 2005–08, more than one and a half times the best group rate [2].  
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Summary of Progress 
 Figure 12-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Heart Disease and Stroke [1]. Data to measure progress toward target attainment were available for 15 objectives. Of these: 
• Four objectives (12-1, 12-7, 12-13, and 12-14) exceeded their Healthy People 2010 targets. 
• Eight objectives (12-4, 12-6a through c, 12-10 through 12-12, and 12-15) moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for each of these objectives. 
• Three objectives (12-2, 12-8, and 12-9) moved away from their targets. A statistically significant difference between the baseline and final data points was observed for each of these objectives. 
 Two objectives (12-5 and 12-16) remained developmental and two objectives (12-3a and b) had no data available to measure progress [4]. 
 Figure 12-2 displays health disparities in Heart Disease and Stroke from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Of the 11 objectives with statistically significant racial and ethnic health disparities of 10% or more, the white non-Hispanic population had the only best rate for three objectives (12-2, 12-8, and 12-10) and the white population (including persons of Hispanic origin) had the best rate for two objectives (12-6a and b). The American Indian or Alaska Native (objective 12-7), Asian or Pacific Islander (objective 12-1), Asian (objective 12-15), Mexican American (objective 12-9) and black non-Hispanic populations (objective 12-14) each had the only best rate for one objective. The black non-Hispanic and white non-Hispanic populations were tied for the best group rate for one objective (12-12). 
• Females had better rates than males for eight of the nine objectives with statistically significant health disparities of 10% or more by sex (objectives 12-1, 12-2, 12-6a and b, 12-8, 12-10, 12-12, and 12-15). Males had a better rate for one objective (12-14). 
• Persons with at least some college education had the best rates for all seven of the objectives with statistically significant health disparities of 10% or more by education level (objectives 12-1, 12-2, 12-4, 12-7, 12-8, 12-12, and 12-15). 
• Persons with middle/high incomes had the best rate for both of the objectives with statistically significant health disparities of 10% or more by income (objectives 12-9 and 12-10). 
• Persons without disabilities had a better rate than persons with disabilities for two of the three objectives with statistically significant health disparities of 10% or more by disability status (objectives 12-8 and 12-9). Persons with disabilities had a better rate for the other objective (12-10). 
• There were several objectives with health disparities of 100% or more. Most of these are discussed in the Highlights, above.  
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Transition to Healthy People 2020 The goal of the Healthy People 2020 Heart Disease and Stroke Topic Area is consistent with the Healthy People 2010 goal (stated on page 12-2, above). The Healthy People 2020 objectives expand upon the prevalence, treatment, and control of individual heart disease and stroke risk factors and also include an overall measure of cardiovascular health that takes into account the status and interaction of all major cardiovascular disease (CVD) risk factors to generate a composite CVD risk score. The objectives also plan to monitor rehabilitation following heart attack and stroke. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 Heart Disease and Stroke Topic Area can be grouped into five sections: 
 Prevention of risk factors 
 Detection and treatment of risk factors 
 Early identification and treatment of heart attack and strokes 
 Prevention of recurrent cardiovascular events 
 Cross-cutting. The differences between the Healthy People 2010 objectives and those included in Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Heart Disease and Stroke Topic Area has a total of 49 objectives, 31 of which are developmental [4]. The Healthy People 2010 Heart Disease and Stroke Focus Area had 19 objectives, two of which were developmental. 
 Ten Healthy People 2010 objectives were retained “as is” [5]. 
• Nine objectives were retained as measurable: coronary heart disease deaths (objective 12-1), stroke deaths (objective 12-7), knowledge of stroke symptoms (objective 12-8), hypertension prevalence (objective 12-9), blood pressure control (objective 12-10), blood pressure monitoring (objective 12-12), mean total cholesterol (objective 12-13), prevalence of high cholesterol (objective 12-14), and cholesterol screening (objective 12-15). 
• One objective, adults with CHD who have their LDL-cholesterol at or below the recommended level (objective 12-16), was retained as developmental. 
 Eight Healthy People 2010 objectives were modified to create 12 Healthy People 2020 objectives [6]. 
• Three objectives for congestive heart failure hospitalizations among older adults aged 65–74, 75–84, and 85 years and over (objectives 12-6a through c) were expanded to heart failure hospitalizations. 
• Fibrinolytic therapy within an hour of symptom onset and percutaneous intervention therapy within 90 minutes of symptom onset of heart attack (objectives 12-3a and b) were modified to within 30 and 90 minutes of hospital arrival, respectively. 
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• Training in cardiopulmonary resuscitation (CPR) in the past year (objective 12-4) and timely electrical shock therapy for out-of-hospital cardiac arrest (objective 12-5) were combined into one developmental objective. The resulting Healthy People 2020 objective addresses appropriate bystander response to, and emergency medical services for, out-of hospital cardiac arrest. 
• Taking action to help control blood pressure (objective 12-11) was divided into six objectives. There are five developmental objectives for hypertension regarding meeting recommended guidelines for body mass index (BMI), saturated fat consumption, sodium intake, physical activity, and moderate alcohol consumption as well as one objective for prescribed antihypertensive medication use among adults with hypertension. 
 One Healthy People 2010 objective (objective 12-2) that tracks knowledge of heart attack symptoms and importance of calling 911 was retained “as is” and also modified to create three Healthy People 2020 objectives. The other two objectives separately track the two knowledge components. 
 Twenty-four new objectives, all of which are developmental, were added to the Healthy People 2020 Heart Disease and Stroke Topic Area: 
• A new objective tracking overall cardiovascular health. 
• A new objective monitoring hypertension prevalence among children and adolescents. 
• Five new objectives for prehypertension regarding meeting recommended guidelines for body mass index (BMI), saturated fat consumption, sodium intake, physical activity, and moderate alcohol consumption. 
• Eight new objectives on cholesterol lowering management advice and adherence: diet, physical activity, weight control, and prescribed drug therapy. 
• Three new objectives on aspirin use for CVD risk reduction. 
• Two new rehabilitation objectives for heart attack and stroke survivors. 
• Four new stroke objectives including knowledge of stroke symptoms and the importance of calling 911, knowledge of the importance of calling 911 for stroke, acute reperfusion therapy within three hours of symptom onset for stroke patients, and adults who have had a stroke who have their LDL-cholesterol at or below recommended levels. Six new objectives that address incidence, case fatality, and recurrence rates for both heart attacks and strokes were proposed but not included in the Healthy People 2020 Heart Disease and Stroke Topic Area due to lack of national data sources. Appendix D, “A Crosswalk Between Objectives from Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
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Data Considerations Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. Beginning in 2003, education data for CHD and stroke deaths (objectives 12-1 and 12-7) from the National Vital Statistics System were suppressed. The educational attainment item was changed in the new U.S. Standard Certificate of Death in 2003 to be consistent with the U.S. Census Bureau data and to improve the ability to identify specific types of educational degrees. Many states, however, are still using the 1989 version of the U.S. Standard Certificate of Death, which focuses on highest school grade completed. As a result, educational attainment data collected using the 2003 version are not comparable with data collected using the 1989 version [7]. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
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References and Notes 1. Displayed in the Progress Chart (Figure 12-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 12-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 12-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 12-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 12-2 footnotes, as well as the Technical Appendix, for more detail. 4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 5. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 6. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 7. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf. 
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Comprehensive Summary of Objectives: Heart Disease and Stroke 
Objective Description Data Source or Objective Status 12-1 Coronary heart disease (CHD) deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 12-2 Knowledge of heart attack symptoms and importance of calling 911 (age adjusted, 20+ years) National Health Interview Survey (NHIS), CDC, NCHS. 12-3a Fibrinolytics within an hour of symptom onset National Registry of Myocardial Infarction (NRMI-4), National Acute Myocardial Infarction Project, CMS 12-3b Percutaneous intervention (PCI) within 90 minutes of symptom onset National Registry of Myocardial Infarction (NRMI-4), National Acute Myocardial Infarction Project, CMS 12-4 Training in cardiopulmonary resuscitation (CPR) in past year (age adjusted, 20+ years) National Health Interview Survey (NHIS), CDC, NCHS. 12-5 Timely electrical shock therapy for out-of-hospital cardiac arrest Developmental. 12-6a Congestive heart failure hospitalizations—65–74 years (per 1,000 population) National Hospital Discharge Survey (NHDS), CDC, NCHS. 12-6b Congestive heart failure hospitalizations—75–84 years (per 1,000 population) National Hospital Discharge Survey (NHDS), CDC, NCHS. 12-6c Congestive heart failure hospitalizations—85+ years (per 1,000 population) National Hospital Discharge Survey (NHDS), CDC, NCHS. 12-7 Stroke deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 12-8 Knowledge of stroke symptoms (age adjusted, 20+ years) National Health Interview Survey (NHIS), CDC, NCHS. 12-9 High blood pressure (age adjusted, 18+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 12-10 High blood pressure control (age adjusted, 18+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 12-11 Taking action to help control blood pressure (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 12-12 Adults who had their blood pressure measured in past 2 years and know their blood pressure level (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 12-13 Mean total blood cholesterol levels (mg/dL, age adjusted, 20+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 12-14 High blood cholesterol levels (age adjusted, 20+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 12-15 Blood cholesterol screening in past 5 years (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 12-16 Adults with CHD who have their LDL-cholesterol at or below the recommended level Developmental.  
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Figure 12-1. Progress Toward Target Attainment for Focus Area 12: Heart Disease and Stroke 
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Figure 12-1. Progress Toward Target Attainment for Focus Area 12: Heart Disease and Stroke (continued) 
Percent of targeted change achieved5 
(continued) 
 
12-9. High blood pressure (age adjusted, 18+  
 years)  
12-10. High blood pressure control (age adjusted, 
18+ years)  
12-11. Taking action to help control blood pressure 
(age adjusted, 18+ years)    
12-12. Adults who had their blood pressure 
measured in past 2 years and know their 
blood pressure level (age adjusted, 18+ years) 
12-13. Mean total blood cholesterol levels (mg/dL, 
age adjusted, 20+ years)  
12-14. High blood cholesterol levels (age adjusted, 
20+ years)   
12-15. Blood cholesterol screening in past 5 years 
(age adjusted, 18+ years)   
2010 
Target 
Baseline 
(Year) 
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-8 Yes -3.9% 
17% 
21% 
(1988–94) 
15% 
(2005–08) 
-6 Yes -28.6% 
80% 
67% 
(1998) 
75% 
(2008) 
8 Yes 11.9% 
44.2% 
50.0% 
20.0% 
61.5% 
            114.3% 
            150.0% 
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Figure 12-1. Progress Toward Target Attainment for Focus Area 12: Heart Disease and Stroke (continued) 
 
DATA SOURCES 
 
12-1. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
12-2. National Health Interview Survey (NHIS), CDC, NCHS. 
12-4. National Health Interview Survey (NHIS), CDC, NCHS. 
12-6a–c. National Hospital Discharge Survey (NHDS), CDC, NCHS. 
12-7. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
12-8. National Health Interview Survey (NHIS), CDC, NCHS. 
12-9–12-10. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
12-11–12-12. National Health Interview Survey (NHIS), CDC, NCHS. 
12-13–12-14. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
12-15. National Health Interview Survey (NHIS), CDC, NCHS. 
  
  
 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 12-3a, 12-3b, 12-5 and 12-16. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =                × 100. 
     Healthy People 2010 target – Baseline value 
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12-1. Coronary heart disease (CHD) 
deaths (age adjusted, per 100,000 
population) (1999, 2007)1* 
2 NA 2
4u1 3u1
3 B 3
4u1 4u1
B
4u1
NA NA NA NA NS NS NA NA
12-2. Knowledge of heart attack symptoms 
and importance of calling 911 (age 
adjusted, 20+ years) (2001, 2008)*
2 2 NA 1 2 2 B 2 B 2 2 2 B 2 NS NS NS NS NS NS Biii B
12-3a. Fibrinolytics within an hour of 
symptom onset (2000–04)† B NA 1 1ii 1ii 1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA
12-3b. Percutaneous intervention (PCI) 
within 90 minutes of symptom onset 
(2000–04)†
1 NA 1 1ii Bii 1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA
12-4. Training in cardiopulmonary 
resuscitation (CPR) in past year (age 
adjusted, 20+ years) (2001, 2008)*
1 1 NA B 1 1 1 1 B 1 2 1 B 1 NS NS NS NS NS NS 1 B
12-6a. Congestive heart failure 
hospitalizations—65–74 years (per 
1,000 population) (1997, 2007)*
NA NA NA NA NA 4ii Bii NA B 2 NA NA NA NA NA NA NA NA NA NA NA NA
12-6b. Congestive heart failure 
hospitalizations—75–84 years (per 
1,000 population) (1997, 2007)*
NA NA NA NA NA 3ii, iii Bii NA B 2 NA NA NA NA NA NA NA NA NA NA NA NA
12-6c. Congestive heart failure 
hospitalizations—85+ years (per 
1,000 population) (1997, 2007)*
NA NA NA NA NA 1ii Bii NA 1 Biv NA NA NA NA NA NA NA NA NA NA NA NA
12-7. Stroke deaths (age adjusted, per 
100,000 population) (1999, 2007)1* Biv NA 2
4u1
2 2 B 1 4 4 B 4 NA NA NA NA NS NS NA NA
12-8. Knowledge of stroke symptoms (age 
adjusted, 20+ years) (2001, 2009)* 2 2 3 2
2d1
2 B 2v B 2
3d1
2 B
2d1
NS NS NS NS NS NS 2 B
12-9. High blood pressure (BP) (age 
adjusted, 18+ years) (1988–94, 
2005–08)2*
NA NA NA NA Biii, vi 3 2 2 B 1 NS NS NS NS
2d1
2 B 2 NA NA 2 B
12-10. High BP control (age adjusted, 18+ 
years) (1988–94, 2005–08)2* NA NA NA NA 2vi 1 B 2 B 2 NS NS NS NS 1 2 Biv 2 NA NA B 2
12-11. Taking action to help control BP (age 
adjusted, 18+ years) (1998, 2008)3* NA NA NA NA NS NS NS NS NA
12-12. Adults who had their BP measured in past 
2 years and know their BP level (age 
adjusted, 18+ years) (1998, 2008)3*
1
1d2
NA 1 4 B B 2 B 3
4u2 3u1
B
4u1
NS NS NS NS NS NS
12-13. Mean total blood cholesterol levels 
(mg/dL, age adjusted, 20+ years) 
(1988–94, 2005–08)2*
NA NA NA NA 1vi B 1 1 1 B NS NS NS NS 1 1 Biv 1 NA NA Biv 1
12-14. High blood cholesterol levels (age 
adjusted, 20+ years) (1988–94, 
2005–08)2*
NA NA NA NA 2vi Biv 2 2 2 B Biv 1 B 1 NS NS NS NS NA NA Biv B
12-15. Blood cholesterol screening in past 5 
years (age adjusted, 18+ years) 
(1998, 2008)3*
3 B NA 1 2 2
2u1
2v B 2 4
3u1
B
3u1
NS NS NS NS B
2u1
B 1
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Location Disability
Population-based objectives
Bi
1i
1i
2i
(continued)
Figure 12-2. Health Disparities Table for Focus Area 12: Heart Disease and Stroke
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
1
2
3
i
ii
iii
iv
v
vi
12-1. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
12-2. National Health Interview Survey (NHIS), CDC, NCHS.
12-
3a–b. 
National Registry of Myocardial Infarction (NRMI-4), National Acute Myocardial Infarction Project, CMS.
12-4. National Health Interview Survey (NHIS), CDC, NCHS.
12-
6a–c. 
National Hospital Discharge Survey (NHDS), CDC, NCHS.
12-7. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
12-8. National Health Interview Survey (NHIS), CDC, NCHS.
12-9–
12-10. 
National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
12-11–
12-12. 
National Health Interview Survey (NHIS), CDC, NCHS.
12-13–
12-14. 
National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
12-15. National Health Interview Survey (NHIS), CDC, NCHS.
50–99 pointsChanges in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
Reliability criterion for best group 
rate not met, or data available for 
only one group.
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
100 points or more
Increase in disparity (percentage points)
10–49 points
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points
Data not available. Characteristic not selected for this objective.
100 points or more
NOTES
Years in parentheses represent the baseline and most recent data years (if available).
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 12-5 
and 12-16.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race and 
ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at baseline 
from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary index at 
the most recent data point. See Technical Appendix for more information.
Figure 12-2. Health Disparities Table for Focus Area 12: Heart Disease and Stroke (continued)
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Most favorable group rate for specified 
characteristic, but reliability criterion not 
met.
DATA SOURCES
Data are for Asian or Pacific Islander.
Data include persons of Hispanic origin.
Change in the summary index cannot be assessed. See Technical Appendix.
Data are for Mexican American.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical Appendix.
Baseline data by disability status are for 1991–94.
Baseline data by race and ethnicity are for 2003.
Most recent data by education level are for 2002.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more are 
displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows when the 
changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. Nonetheless, 
disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
44.3 - 99.5 
99.6 - 126.0 
126.1 - 156.0 
156.1 - 191.1 
191.2 - 298.1 
Figure 12-3.  Coronary Heart Disease Deaths (2005-07) 
Healthy People 2010 objective 12-1 
Target = 156 
NOTES: Data are for ICD-10 codes I20-I25reported as underlying cause.  Rates are per 100,000 U. S. Population age-adjusted to the 2000  
standard population.  Rates are displayed by a modified Jenks classification for U.S. health service area. 
SOURCE: National Vital Statistics System – Mortality, CDC, NCHS. 
lowest categories (green) show health service areas that met target 
Rates are unreliable 
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Rate per 100,000 
Figure 12-4.  Stroke Deaths (2005-07) 
Healthy People 2010 objective 12-7 
Target = 50 
20.1 - 40.0 
40.1 - 50.0 
50.1 - 56.7 
56.8 - 70.5 
70.6 - 100.4 
Rates are unreliable 
NOTES: Data are for ICD-10 codes I60-I69reported as underlying cause.  Rates are per 100,000 U. S. Population age-adjusted to the 2000 standard  
population.  Rates are displayed by a  modified Jenks classification for U.S. health service area. 
SOURCE: National Vital Statistics System – Mortality, CDC, NCHS. 
lowest categories (green) show health service areas that met target 
Heart Disease and Stroke Page 12-17
Rate per 100,000 
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Goal: Prevent human immunodeficiency virus (HIV) 
infection and its related illness and death 
The objectives in this chapter track cases of HIV infection and acquired immunodeficiency 
syndrome (AIDS), HIV/AIDS deaths, HIV/AIDS prevention and HIV/AIDS testing. 
All Healthy People 2010 tracking data quoted in this chapter, along with technical information and 
operational definitions for each objective, can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from 
http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from 
http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas. 
 
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade 
[1]. Over 70% of the HIV objectives with data to measure progress moved toward or 
achieved their Healthy People 2010 targets (Figure 13-1). However, health disparities were 
observed among racial and ethnic population groups, as well as by sex, education level, 
income, and disability status (Figure 13-2), as discussed below [2]. 
 A statistically significant downward trend was observed in the rate of new AIDS diagnoses 
among persons aged 13 years and over (objective 13-1) [3]. The rate decreased by 20.7% 
between 1998 and 2007, from 18.4 to 14.6 new cases per 100,000 population, moving 
toward the Healthy People 2010 target of 0.9 per 100,000 population. 
 Among racial and ethnic groups, the Asian or Pacific Islander population had the 
lowest (best) rate of AIDS diagnoses, 4.7 new cases per 100,000 population in 2007. 
The rate for the Hispanic or Latino population, 20.9 new cases per 100,000 in 2007, 
was almost four and a half times the best rate; the rate for the black non-Hispanic 
population, 58.6 per 100,000 in 2007, was over 12 times the best rate [2]. 
 Females had a lower (better) rate of annual AIDS diagnoses than males, 7.6 per 
100,000 population in 2007. Males had a rate of 21.9 per 100,000 in 2007, almost 
three times the rate for females [2]. 
 The rate of annual AIDS diagnoses varied by state. In 2007, Alaska, the Central and Midwest 
states, Maine, New Hampshire, Vermont, and West Virginia, had the lowest rates. The 
District of Columbia, with 154.6 new cases per 100,000 population, had the highest rate 
(Figure 13-3). 
 The annual number of new AIDS diagnoses attributed to male-to-male sexual contact among 
adults and adolescents aged 13 years and over (objective 13-2) increased by 0.7% between 
1998 and 2007, from 16,882 to 16,992, moving away from the 2010 target of 12,661. 
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 The number of new cases of AIDS among persons aged 13 years and over who injected 
drugs (objective 13-3) decreased by 47.1% between 1998 and 2007, from 11,514 to 6,093, 
exceeding the 2010 target of 8,636. 
 The number of new cases of AIDS among adult and adolescent males, aged 13 years and 
over, who had sex with men and who injected drugs (objective 13-4) declined by 36.1% 
between 1998 and 2007, from 2,751 to 1,759, exceeding the 2010 target of 2,064. 
 HIV-infection deaths (objective 13-14) declined by 30.2% between 1999 and 2007, from 5.3 
to 3.7 deaths per 100,000 population (age adjusted), moving toward the 2010 target of 0.7 
deaths per 100,000 population. 
 Among racial and ethnic groups, the white non-Hispanic population had the best 
rates of HIV-infection deaths, 2.3 per 100,000 population (age adjusted) in 1999 and 
1.5 in 2007. The Hispanic or Latino population had a rate of 4.1 in 2007, while the 
black non-Hispanic population had rates of 24.0 in 1999 and 17.8 in 2007.  
 In 2007, the HIV infection death rate for the Hispanic or Latino population 
was more than two and a half times the best rate (that for the white non-
Hispanic population), while the rate for the black non-Hispanic population 
was almost 12 times the best rate [2].  
 Between 1999 and 2007, the disparity between the black non-Hispanic and 
white non-Hispanic populations increased by 143 percentage points [4]. 
 Females had lower (better) HIV-infection death rates than males, 2.5 deaths per 
100,000 population (age adjusted) in 1999 and 2.1 in 2007. Males had rates of 8.2 in 
1999 and 5.4 in 2007. In 2007, the rate for males was more than two and a half 
times that for females. Between 1999 and 2007, the disparity between males and 
females declined by 71 percentage points [4]. 
 The HIV-infection death rates varied by state. Among those states with reliable data for the 
period 2005–07, the HIV-infection death rates for Delaware, Florida, Georgia, Louisiana, 
Maryland, Mississippi, New York, and South Carolina ranged from 4.6 to 9.3 deaths per 
100,000 population (age adjusted). The District of Columbia, with an HIV-infection death 
rate of 34.9 per 100,000 (age adjusted), had the highest rate (Figure 13-4). 
 A statistically significant upward trend was observed in the proportion of HIV-infected 
persons surviving three or more years after an AIDS diagnosis (objective 13-16) [3]. The 
proportion increased by 12.8% between 1998 and 2006, from 78% to 88%, exceeding the 
2010 target of 86%. 
 A statistically significant downward trend was observed in the number of perinatally-
acquired AIDS diagnoses (objective 13-17b) [3]. The number declined by 88.5% between 
1998 and 2007, from 243 to 28 new cases, exceeding the 2010 target of 75 new cases. 
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 HIV testing of tuberculosis patients aged 25–44 years (objective 13-11) increased by 19.7% 
between 1998 and 2008, from 61% to 73%, moving toward the 2010 target of 89%. 
 Among racial and ethnic groups, the black non-Hispanic population had the highest 
(best) rate of HIV testing among tuberculosis patients aged 25–44 years, 88% in 
2008, whereas the Asian, the Native Hawaiian or Other Pacific Islander, and the 
Hispanic or Latino populations had rates of 61%, 61%, and 69% in 2008, 
respectively. When expressed in terms of patients who were not tested for HIV, the 
rates for the Asian and the Native Hawaiian or Other Pacific Islander populations 
were almost three and a half times the best rate (that for the black non-Hispanic 
population), while the rate for the Hispanic or Latino population was more than two 
and a half times the best rate [2]. 
 
Summary of Progress 
 Figure 13-1 presents a quantitative assessment of progress in achieving the Healthy People 
2010 objectives for HIV [1]. Data to measure progress toward target attainment were 
available for 15 objectives. Of these: 
 Four objectives exceeded their Healthy People 2010 targets (objectives 13-3, 13-4, 
13-16, and 13-17b). 
 Seven objectives moved toward their targets. A statistically significant difference 
between the baseline and the final data points was observed for one of these 
objectives (13-14). Data were unavailable to test the significance of the difference 
for the remaining six objectives (13-1, 13-6a and b, 13-11, and 13-13d and f). 
 Four objectives moved away from their targets (objectives 13-2, 13-8, and 13-13c 
and e). Data were unavailable to test the significance of the difference between the 
baseline and the final data points for all of these objectives. 
 Six objectives (13-5, 13-13a and b, 13-15, 13-17a, and 13-18) remained developmental and 
four objectives (13-7, 13-9, 13-10 and 13-12) were dropped during the decade [5,6]. 
 Figure 13-2 displays health disparities from the best group rate for each characteristic at 
the most recent data point [2]. It also displays changes in disparities from baseline to the 
most recent data point [4]. 
 Statistically significant health disparities of 10% or more by race and ethnicity were 
observed for three objectives. Health disparities of 10% or more by race and 
ethnicity were observed for seven additional objectives, though their significance 
could not be tested. Of these 10 objectives, the black non-Hispanic population had 
the best rate for four objectives (13-6a and b, 13-11, and 13-13f). The Asian or 
Pacific Islander (objective 13-1), the Hispanic or Latino (objective 13-13d), the 
American Indian or Alaska Native (objective 13-13e), and the white non-Hispanic 
(objective 13-14) populations each had the only best rate for one objective. The 
Asian or Pacific Islander and Hispanic or Latino populations were tied for the best 
rate for one objective (13-13c), while the Asian or Pacific Islander and white non-
Hispanic populations were tied for the best rate for another (objective 13-16). 
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 One objective had statistically significant health disparities of 10% or more by sex 
and three objectives had health disparities of 10% or more by sex but no data to 
assess significance. Of these four objectives, females had better rates than males for 
two (objectives 13-1 and 13-14) and males had better rates than females for the 
other two (objectives 13-11 and 13-13c).  
 Persons with at least some college education had the best rates for all three of the 
objectives with statistically significant health disparities of 10% or more by 
education level (objectives 13-6a and b, and 13-14). 
 Persons with middle/high incomes had the best rate for the one objective (13-6a) 
with statistically significant health disparities of 10% or more by income. 
 Persons without disabilities had a better rate than persons with disabilities for the 
one objective (13-6a) with statistically significant health disparities of 10% or more 
by disability status. 
 Several objectives exhibited health disparities of 100% or more, and some had 
changes in disparities of 50 percentage points or more over time. Many of these are 
discussed in the Highlights, above. 
 
Transition to Healthy People 2020 
For Healthy People 2020, the focus of the HIV objectives has expanded to focus more on HIV testing 
among populations at increased risk of HIV infection. The general terminology has transitioned 
from the term HIV/AIDS to HIV. The term HIV focuses on persons diagnosed with HIV infection 
regardless of their stage of disease. Nevertheless, AIDS diagnoses are still tracked for selected 
objectives. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. 
The Healthy People 2020 HIV Topic Area can be grouped into several sections: 
 Diagnosis of HIV Infection and AIDS 
 Medical Healthcare, Survival, and Death after Diagnosis of HIV Infection and AIDS 
 HIV Testing 
 HIV Prevention. 
The differences between the Healthy People 2010 objectives and those included in Healthy People 
2020 objectives are summarized below: 
 The Healthy People 2020 HIV Topic Area has a total of 23 objectives, seven of which are 
developmental, whereas the Healthy People 2010 HIV Focus Area had 25 objectives of 
which six were developmental and four were dropped at the Midcourse Review [5,6]. 
 Ten Healthy People 2010 objectives were retained “as is” [7]. These include,  
 Eight measurable objectives: new AIDS cases (objective 13-1), AIDS among men 
who have sex with men (objective 13-2), AIDS among persons who inject drugs 
(objective 13-3), HIV counseling and education for persons in substance abuse 
treatment (objective 13-8), HIV testing in tuberculosis patients (objective 13-11), 
HIV-infection deaths (objective 13-14), HIV infected persons surviving three or 
more years after a diagnosis of AIDS (objective 13-16), and perinatally-acquired 
AIDS (objective 13-17b). 
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 Two developmental objectives: new HIV/AIDS cases (objective 13-5) and new HIV 
infections diagnosed before progression to AIDS (objective 13-15). 
 Ten Healthy People 2010 objectives were modified to create five Healthy People 2020 
objectives [8]: 
 Two developmental and four measurable objectives addressing treatment according 
to guidelines among HIV-infected persons (objectives 13-13a through f) were 
combined to create one developmental objective in Healthy People 2020. 
 Objective 13-7, measuring the number of HIV-positive persons who know their 
serostatus, was deleted during the Healthy People 2010 Midcourse Review. It was 
reinstated in Healthy People 2020, as a measurable objective. 
 Condom use among females and males (objectives 13-6a and b, respectively) was 
modified to expand the age group of the target population from 18–44 years to 15–
44 years. 
 Perinatally-acquired HIV/AIDS diagnosed (objective 13-17a) was modified to 
monitor HIV only. This objective is still developmental. 
 One Healthy People 2010 objective, AIDS among men who have sex with men and who 
inject drugs (objective 13-4), was archived [9]. 
 Four Healthy People 2010 objectives were dropped [6]. HIV/AIDS, STD, and TB education in 
state prisons (objective 13-9), HIV counseling and testing in state prisons (objective 13-10), 
and screening for STDs and immunization for hepatitis B (objective 13-12) were dropped at 
the Midcourse Review. One developmental objective, HIV/AIDS diagnosed in adolescent and 
young females aged 13–24 years (objective 13-18) was dropped due to lack of a data 
source. 
 Eight new objectives were added to the Healthy People 2020 HIV Topic Area: 
 Five new objectives, including HIV transmission among adolescents and adults, new 
AIDS cases among adolescent and adult heterosexuals, HIV testing among 
adolescents and adults, HIV testing among pregnant women, and HIV testing among 
adolescents and young adults, were added as measurable objectives.  
 Three new objectives, including new (incident) HIV infections among adolescents 
and adults, HIV testing among men who have sex with men, and the proportion of 
men who have sex with men who reported unprotected anal sex in the past 12 
months, were added as developmental objectives. 
Appendix D, “A Crosswalk Between Objectives from Healthy People 2010 to Healthy People 2020,” 
summarizes the changes between the two decades of objectives, reflecting new knowledge and 
direction for this area. 
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Data Considerations 
The HIV/AIDS Surveillance System—the data source for many Health People 2010 HIV objectives—
was renamed the HIV Surveillance System in 2008, highlighting the focus on diagnosis of HIV 
infection regardless of the person’s stage of disease. Data in the HIV/AIDS Surveillance System are 
continually updated, and new records are added as they are reported. For this reason, data for any 
given year may change over time. All data points for HIV objectives monitored through the HIV 
Surveillance System are updated annually, often resulting in revisions of baselines and targets. 
Education and income are the primary measures of socioeconomic status (SES) in Healthy People 
2010. Most data systems used in Healthy People 2010 define income as a family’s income before 
taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size 
and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed 
by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. 
These categories may be overridden by considerations specific to the data system, in which case 
they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. 
Beginning in 2003, education data for the mortality objective 13-14 (HIV-infection deaths) from the 
National Vital Statistics System have been suppressed. The educational attainment item was 
changed in the new U.S. Standard Certificate of Death in 2003 to be consistent with the U.S. Census 
Bureau data and to improve the ability to identify specific types of educational degrees. However, 
many states are still using the 1989 version of the U.S. Standard Certificate of Death, which focuses 
on highest school grade completed. As a result, educational attainment data collected using the 
2003 version are not comparable with data collected using the 1989 version [10]. 
In general, data on educational attainment are presented for persons aged 25 years and over, 
consistent with guidance given by the U.S. Bureau of the Census. However, because of the 
requirements of the different data systems, the age groups used to calculate educational attainment 
for any specific objective may differ from the age groups used to report the data for other Healthy 
People 2010 objectives, as well as from select populations within the same objective. Therefore, the 
reader is urged to exercise caution in interpreting the data by educational attainment shown in the 
Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. 
Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can 
be found in the Operational Definitions on the DATA2010 website, available from 
http://wonder.cdc.gov/data2010/focusod.htm. 
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 More information on statistical issues related to Healthy People tracking and measurement 
can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, 
which is available in the Data Issues section of the NCHS Healthy People website under 
Healthy People 2010. 
 
References and Notes 
1. Displayed in the Progress Chart (Figure 13-1), the percent of targeted change achieved expresses the 
difference between the baseline and the final value relative to the initial difference between the 
baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward 
attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When 
standard errors were available, the difference between the baseline and the final value was tested at 
the 0.05 level of significance. See the Figure 13-1 footnotes, as well as the Technical Appendix, for 
more detail. 
2. Information about disparities among select populations is shown in the Health Disparities Table 
(Figure 13-2). Disparity from the best group rate is defined as the percent difference between the 
best group rate and each of the other group rates for a characteristic. For example, racial and ethnic 
health disparities are measured as the percent difference between the best racial and ethnic group 
rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as 
the percent difference between the better group rate (e.g. female) and the rate for the other group 
(e.g. male). Some objectives are expressed in terms of favorable events or conditions that are to be 
increased, while others are expressed in terms of adverse events or conditions that are to be reduced. 
In order to facilitate comparison of health disparities across different objectives, disparity is 
measured only in terms of adverse events or conditions. For comparability across objectives, 
objectives that are expressed in terms of favorable events or conditions are re-expressed using the 
adverse event or condition for the purpose of computing disparity, but they are not otherwise 
restated or changed. For example, objective 1-1, to increase the proportion of persons with health 
insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had 
some form of health insurance in 2008), is expressed in terms of the percentage of persons without 
health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged 
under 65 years did not have any form of health insurance in 2008) when the disparity from the best 
group rate is calculated. See the Reader’s Guide for more information. When standard errors were 
available, the difference between the best group rate and each of the other group rates was tested at 
the 0.05 level of significance. See the Figure 13-2 footnotes, as well as the Technical Appendix, for 
more detail. 
3. The presence of a monotonic increasing or decreasing trend in the underlying measure was tested 
with the nonparametric Mann-Kendall test, then the slope of a linear trend was estimated with the 
nonparametric Sen’s method. See Technical Appendix for more information. 
4. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the 
most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s 
Guide for more information. When standard errors were available, the change in disparity was tested 
at the 0.05 level of significance. See the Figure 13-2 footnotes, as well as the Technical Appendix, for 
more detail. 
5. To be included in Healthy People 2010, an objective must have a national data source that provides a 
baseline and at least one additional data point for tracking progress. Some objectives lacked baseline 
data at the time of their development but had a potential data source and were considered of 
sufficient national importance to be included in Healthy People. These are called “developmental” 
objectives. When data become available, a developmental objective is moved to measurable status 
and a Healthy People target can be set. 
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6. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either 
developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy 
People 2010. 
7. Retained “as is” objectives have no change in the numerator definition or in the denominator 
definition between the Healthy People 2010 and Healthy People 2020 objectives. These include 
objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 
2020 and for which no numerator or denominator information was available. 
8. Modified objectives have some change in the numerator definition or in the denominator definition 
between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that 
went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice 
versa. 
9. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward 
into Healthy People 2020. 
10. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics 
reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010.. Available from: 
http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf 
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Comprehensive Summary of Objectives: HIV 
Objective Description Data Source or Objective Status 
13-1 New AIDS cases (per 100,000 population, 13+ years) HIV Surveillance System, CDC, NCHHSTP. 
13-2 AIDS among men who have sex with men (no. new cases, 13+ years) HIV Surveillance System, CDC, NCHHSTP. 
13-3 AIDS among persons who inject drugs (no. new cases, 13+ years) HIV Surveillance System, CDC, NCHHSTP. 
13-4 AIDS among men who have sex with men and who inject drugs (no. 
new cases, 13+ years) 
HIV Surveillance System, CDC, NCHHSTP. 
13-5 New HIV/AIDS cases diagnosed among adolescents and adults Developmental 
13-6a Condom use among sexually active unmarried persons (18–44 years)—
Females 
National Survey of Family Growth (NSFG), CDC, NCHS. 
13-6b Condom use among sexually active unmarried persons (18–44 years)—
Males 
National Survey of Family Growth (NSFG), CDC, NCHS. 
13-7 Knowledge of serostatus—Among HIV positive persons  Dropped 
13-8 HIV counseling and education for persons in substance abuse treatment Baseline: Uniform Facility Data Set (UFDS), SAMHSA; Final: National 
Survey of Substance Abuse Treatment Services (N-SSATS), SAMHSA. 
13-9 HIV/AIDS, STD, and TB education in State prisons Dropped 
13-10 HIV counseling and testing in State prisons Dropped 
13-11 HIV testing in TB patients (25–44 years)  National TB Surveillance System, CDC, NCHHSTP. 
13-12 Screening for STDs and immunization for hepatitis B—Among HIV 
counselees (18+ years) 
Dropped 
13-13a Treatment according to guidelines—Viral load testing among HIV-
infected persons (13+ years) 
Developmental 
13-13b Treatment according to guidelines—Tuberculin skin testing (TST) 
among HIV-infected persons (13+ years) 
Developmental 
13-13c Any antiretroviral therapy among HIV-infected persons (13+ years) Adult and Adolescent Spectrum of HIV Disease (ASD) Surveillance 
Project, CDC, NCHHSTP. 
13-13d Highly active antiretroviral therapy (HAART) among HIV-infected 
persons (13+ years) 
Adult and Adolescent Spectrum of HIV Disease (ASD) Surveillance 
Project, CDC, NCHHSTP. 
13-13e Pneumocystis carinii pneumonia (PCP) prophylaxis among HIV-infected 
persons (13+ years) 
Adult and Adolescent Spectrum of HIV Disease (ASD) Surveillance 
Project, CDC, NCHHSTP. 
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Objective Description Data Source or Objective Status 
13-13f Mycobacterium avium complex (MAC) prophylaxis among HIV-infected 
persons (13+ years) 
Adult and Adolescent Spectrum of HIV Disease (ASD) Surveillance 
Project, CDC, NCHHSTP. 
13-14 HIV-infection deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
13-15 New HIV infection diagnosed before progression to AIDS Developmental 
13-16 HIV infected persons surviving 3+ years after diagnosis of AIDS HIV Surveillance System, CDC, NCHHSTP. 
13-17a Perinatally acquired HIV/AIDS diagnosed (no. new cases) Developmental 
13-17b Perinatally acquired AIDS (no. new cases) HIV Surveillance System, CDC, NCHHSTP. 
13-18 HIV/AIDS diagnosed in adolescent and young females (13–24 years) Developmental 
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Figure 13-1. Progress Toward Target Attainment for Focus Area 13: HIV 
Percent of targeted change achieved5 (continued) 
 
13-1. New AIDS cases (per 100,000 population, 
13+ years) 
13-2. AIDS among men who have sex with 
 men (number of new cases, 13+ years)   
13-3. AIDS among persons who inject drugs 
(number of new cases, 13+ years) 
13-4. AIDS among men who have sex with men 
and who inject drugs (number of new cases, 
13+ years) 
13-6. Condom use among sexually active 
unmarried persons (18–44 years)  
  a. Females  
  b. Males  
13-8. HIV counseling and education for 
 persons  in substance abuse treatment 
13-11. HIV testing in TB patients (25–44 years)  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
0.9 
18.4 
(1998) 
14.6 
(2007) 
-3.8 
Not 
tested 
-20.7% 
12,661 
16,882 
(1998) 
16,992 
(2007) 
110 
Not 
tested 
0.7% 
8,636 
11,514 
(1998) 
6,093 
(2007) 
-5,421 
Not 
tested 
-47.1% 
2,064 
2,751 
(1998) 
1,759 
(2007) 
-992 
Not 
tested 
-36.1% 
50% 
23% 
(1995) 
33% 
(2006–08) 
10 
Not 
tested 
43.5% 
54% 
42% 
(2002) 
44% 
(2006–08) 
2 
Not 
tested 
4.8% 
70% 
58% 
(1997) 
54% 
(2008) 
-4 
Not 
tested 
-6.9% 
89% 
61% 
(1998) 
73% 
(2008) 
12 
Not 
tested 
19.7% 
 21.7% 
            188.4% 
            144.4% 
37.0% 
16.7% 
42.9% 
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Figure 13-1. Progress Toward Target Attainment for Focus Area 13: HIV (continued) 
Percent of targeted change achieved5 
(continued) 
 
13-13c. Any antiretroviral therapy among HIV-
infected persons (13+ years)   
13-13d. Highly active antiretroviral therapy (HAART) 
among HIV-infected persons (13+ years)   
13-13e. Pneumocystis carinii pneumonia (PCP) 
prophylaxis among HIV-infected persons 
(13+ years)     
13-13f. Mycobacterium avium complex (MAC) 
prophylaxis among HIV-infected persons 
(13+ years)   
13-14. HIV-infection deaths (age adjusted, per 
100,000 population)   
13-16. HIV infected persons surviving 3+ years after 
a diagnosis of AIDS    
13-17b. Perinatally acquired AIDS (number of new 
cases)    
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
95% 
85% 
(1997) 
84% 
(2003) 
-1 
Not 
tested 
-1.2% 
95% 
61% 
(1997) 
70% 
(2003) 
9 
Not 
tested 
14.8% 
95% 
81% 
(1997) 
68% 
(2003) 
-13 
Not 
tested 
-16.0% 
95% 
53% 
(1997) 
57% 
(2003) 
4 
Not 
tested 
7.5% 
0.7 
5.3 
(1999) 
3.7 
(2007) 
-1.6 Yes -30.2% 
86% 
78% 
(1998) 
88% 
(2006) 
10 
Not 
tested 
12.8% 
75 
243 
(1998) 
28 
(2007) 
-215 
Not 
tested 
-88.5% 
26.5% 
9.5% 
34.8% 
            125.0% 
            128.0% 
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Figure 13-1. Progress Toward Target Attainment for Focus Area 13: HIV (continued) 
 
DATA SOURCES 
 
13-1–13-4. HIV Surveillance System, CDC, NCHHSTP. 
13-6a–b. National Survey of Family Growth (NSFG), CDC, NCHS. 
13-8. Baseline: Uniform Facility Data Set (UFDS), SAMHSA; Final: National Survey of Substance Abuse Treatment Services (N-SSATS), SAMHSA.  
13-11. National TB Surveillance System, CDC, NCHHSTP. 
13-13c–f. Adult and Adolescent Spectrum of HIV Disease (ASD) Surveillance Project, CDC, NCHHSTP. 
13-14. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
13-16. HIV Surveillance System, CDC, NCHHSTP. 
13-17b. HIV Surveillance System, CDC, NCHHSTP. 
  
 
 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objective 13-5, 13-13a, 13-13b, 13-15, 13-17a, and 13-18. Objectives 13-7, 13-9, 13-10, and 13-12 were deleted at the Midcourse Review. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
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Figure 13-2. Health Disparities Table for Focus Area 13: HIV
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13-1. New AIDS cases (per 100,000 
population, 13+ years) (1998, 
2007)† 3d2
NA
4d3 4d3 2d2 4d3
B
4d1
NS NS NS NS NA NA NA NA NS NS NS NS
13-6a. Condom use among sexually active 
unmarried persons—females 
(18–44 years) (1995, 2006–08)1‡
NA NA NA NA
2u1
Bii 1
2u1
NS NS 2
2u1
B 2 2 2 B 2 B Bii 2iii B
13-6b. Condom use among sexually active 
unmarried persons—males (18–44 
years) (2002, 2006–08)1‡
NA NA NA NA
1d1
B
2d1 1d1
NS NS
2d1
2 B
2d1 1d1
1 B 1 1 Bii 1 B
13-11. HIV testing in TB patients (25–44 
years) (1998, 2008)†
3d2 4d1 4d1
NA
4u1
B
3u1
4d1
2 B NS NS NS NS NA NA NA NA NS NS NS NS
13-13c. Any antiretroviral therapy among 
HIV-infected persons (13+ years) 
(1997, 2003)† 3d2
NA Bii
3d3 2d2 2d2
2u1
B NS NS NS NS NA NA NA NA NS NS NS NS
13-13d. Highly active antiretroviral therapy 
(HAART) among HIV-infected 
persons (13+ years) (1997, 2003)† 2d2
NA Bii
2d3 2d1 2d2 1d1
B NS NS NS NS NA NA NA NA NS NS NS NS
13-13e. Pneumocystis carinii  pneumonia (PCP) 
prophylaxis among HIV-infected 
persons (13+ years) (1997, 2003)†
Bii NA
3d3 3d3 4d3 3d3
Bii 1 NS NS NS NS NA NA NA NA NS NS NS NS
13-13f. Mycobacterium avium  complex (MAC) 
prophylaxis among HIV-infected 
persons (13+ years) (1997, 2003)†
NA NA NA NA
2d1
B
2u1 2u1
Bii 1 NS NS NS NS NA NA NA NA NS NS NS NS
13-14. HIV-infection deaths (age adjusted, 
per 100,000 population) (1999, 
2007)2,3*
3u2
NA
4d1
4u3
B NA B
4d2
4u2 4u1
B
4u2
NS NS NS NS NS NS NS NS
13-16. HIV infected persons surviving 3+ 
years after a diagnosis of AIDS 
(1998, 2006)† 2d2
NA
2d1 2d1
Bii
2d1
Bii B NS NS NS NS NA NA NA NA NS NS NS NS
Population-based objectives
Bi
Bi
bi
1
i
Bi
3
i
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Location Disability
(continued)
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Figure 13-2. Health Disparities Table for Focus Area 13: HIV (continued)
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
‡
1
2
3
i
ii
iii
13-1. HIV Surveillance System, CDC, NCHHSTP.
13-6a–b. National Survey of Family Growth (NSFG), CDC, NCHS.
13-11. National TB Surveillance System, CDC, NCHHSTP.
13-13c–f. Adult and Adolescent Spectrum of HIV Disease (ASD) Surveillance Project, CDC, NCHHSTP.
13-14. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
13-16. HIV Surveillance System, CDC, NCHHSTP.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more are 
displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows when the 
changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. Nonetheless, 
disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
DATA SOURCES
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Data are for Asian or Pacific Islander.
Data by education level are for persons aged 25–44 years.
Measures of variability were available only for the most recent data. Thus, the variability of best group rates was assessed only for the most recent data, and statistical 
significance was tested only for the most recent data. Disparities of 10% or more are displayed when the differences from the best group rate are statistically 
significant at the 0.05 level. Changes in disparities over time are displayed according to their magnitude, since measures of variability were not available at baseline 
and therefore statistical significance of changes in disparity could not be tested. See Technical Appendix.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical Appendix.
Data by education level are for persons aged 25–64 years.
Most recent data by education level is for 2002.
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
Increase in disparity (percentage points)
10–49 points 50–99 points 100 points or more
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Most favorable group rate for specified characteristic, 
but reliability criterion not met.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
Reliability criterion for best group 
rate not met, or data available for 
only one group.
NOTES
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 13-2 
through 13-5, 13-8, 13-13a and b, 13-15, 13-17a and b, and 13-18. Objectives 13-7, 13-9, 13-10, and 13-12 were deleted at Midcourse Review.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race 
and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at 
baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary 
index at the most recent data point. See Technical Appendix for more information.
NOTES: Data are age-adjusted to the 2000 standard population.  Rates are displayed by a Jenks classification for U.S. states.   
SOURCE: HIV Surveillance System, CDC, NCHHSTP. 
Figure 13-3. New AIDS Cases (13+ Years) 2007 
Healthy People 2010 objective 13-1 
Target = 0.9 
No states met the target 
Rate per 100,000 
HIV Page 13-17 
1.4 - 3.4 
3.5 - 6.8 
6.9 - 11.1 
11.2 - 18.6 
18.7 - 31.5 
District of Columbia 
rate = 154.6 
NOTES: Data are for ICD-10 codes B20-B24 reported as underlying cause.  Rates age-adjusted to the 2000 standard population. 
Rates are displayed by a Jenks classification for U.S. states.   
SOURCE:National Vital Statistics System – Mortality (NVSS-M), CDC, NCHS. 
Figure 13-4. HIV Infection Deaths 2005-07 
Healthy People 2010 objective 13-14 
Target = 0.7 
No states met the target 
Rate per 100,000 
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0.5 - 1.2 
1.3 - 2.7 
2.8 - 4.5 
4.6 - 9.3 
Rates are unreliable 
District of Columbia 
rate = 34.9 
A reformatted, typeset version of this report will replace the current version 
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Goal: Prevent disease, disability, and death from 
infectious diseases, including vaccine-preventable 
diseases 
The 87 objectives in this chapter cover five general areas in immunization and infectious diseases: 
 Diseases preventable through universal vaccination. This area includes objectives monitoring progress in the reduction of vaccine-preventable diseases such as polio, pertussis, rubella, and hepatitis B. 
 Diseases preventable through targeted vaccination. The objectives in this area address diseases affecting high-risk populations or certain endemic areas that can be prevented through targeted vaccination.  
 Infectious diseases and emerging antimicrobial resistance. The objectives in this area focus on conditions such as tuberculosis and its treatment, hepatitis C, and hospital-acquired infections. 
 Vaccine coverage and strategy. These objectives address immunization rates for children, adolescents, and adults. 
 Vaccine safety. These objectives address the monitoring of adverse outcomes to vaccination. All Healthy People 2010 tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade [1]. Over eighty percent of the Immunization and Infectious Diseases objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 14-1). However, health disparities of 10% or more were observed among select population groups (Figure 14-2), some of which are highlighted below [2]. 
Diseases preventable through universal vaccination Most of the objectives in this area moved toward or achieved the Healthy People 2010 targets. 
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 New cases of hepatitis B among children aged 2–18 years (objective 14-1d) declined by 92.9% between 1997 and 2008, from 708 to 50 cases, moving toward the 2010 target of 7 cases. 
 Cases of rubella (objective 14-1i) declined by 97.3% between 1998 and 2008, from 364 to 10 cases, moving toward the 2010 target of 0 cases. Similarly, cases of varicella (chicken pox) among persons aged under 18 years (objective 14-1k) declined by 73.7% between 1999 and 2008, from 2,229,000 to 586,000 cases, moving toward the 2010 target of 223,000 cases. 
 The prevalence of hepatitis B in adults (objectives 14-3a through g) declined for all age groups and high-risk groups. The number of cases of hepatitis B among injection drug users (objective 14-3d) declined by 80.3% between 1997 and 2008, from 7,135 to 1,408 cases, exceeding the 2010 target of 1,784 cases. 
Hepatitis B—Persons aged 19–24 years (objective 14-3a) 
• Among racial and ethnic populations, the Hispanic or Latino population had the lowest (best) rate of hepatitis B for persons aged 19–24 years, 1.4 cases per 100,000 population in 2008. The Asian or Pacific Islander, American Indian or Alaska Native, and black non-Hispanic populations had hepatitis B rates of 3.1, 5.1 and 5.7 cases per 100,000 in 2008, respectively.  
 The rate for the Asian or Pacific Islander population was more than twice the best group rate (that for the Hispanic or Latino population); the rate for the American Indian or Alaska Native population was more than three and a half times the best group rate; and the rate for the black non-Hispanic population was more than four times the best group rate [2]. 
 The white non-Hispanic population had the best rate in 1997 (7.7 cases per 100,000 population), while the Hispanic or Latino population had the best rate in 2008 (1.4 cases per 100,000). The rates for the Asian or Pacific Islander population were 33.7 cases per 100,000 in 1997 and 3.1 in 2008. Between 1997 and 2008, the disparity between the Asian or Pacific Islander population and the group with the best rate declined by 216 percentage points [3]. 
Hepatitis B—Persons aged 25–39 years (objective 14-3b) 
• The Asian or Pacific Islander population had the lowest (best) rate of hepatitis B for persons aged 25–39 years, 2.7 cases per 100,000 population in 2008. The rate for the white non-Hispanic population, 2.7 cases per 100,000 in 2008, was twice the best group rate; the American Indian or Alaska Native population had a rate of 9.7 cases per 100,000 in 2008, more than three and a half times the best group rate; and the rate for the black non-Hispanic population, 10.7 cases per 100,000 in 2008, was about four times the best group rate [2]. 
Hepatitis B—Persons aged 40 years and over (objective 14-3c)  
• The Asian or Pacific Islander population also had the lowest (best) rate of hepatitis B for persons aged 40 years and over, 4.0 cases per 100,000 population in 2008. The American Indian or Alaska Native and black non-Hispanic populations had rates of 10.3 and 13.2 cases per 100,000 in 2008, respectively.  
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 The rate for the American Indian or Alaska Native population was more than two and a half times the best group rate (that for the Asian or Pacific Islander population), while the rate for the black non-Hispanic population was almost three and a half times the best group rate [2]. 
• Among persons aged 40 years and over, the hepatitis B rate for males was twice the rate for females, 9.5 and 4.6 cases per 100,000 population in 2008, respectively [2]. 
Hepatitis B—All age groups (objectives 14-3a through c)  
• Between 1997 and 2008, the disparity in hepatitis B rates between the American Indian or Alaska Native population and the population with the best rate increased by at least 100 percentage points for all age groups (objectives 14-3a through c) [3]. 
 The incidence of bacterial meningitis in young children aged 1–23 months (objective 14-4) declined by 34.6% between 1998 and 2008, from 13.0 to 8.5 cases per 100,000 population, exceeding the 2010 target of 8.6 per 100,000. 
 The incidence of invasive pneumococcal infections among young children and older adults (objective 14-5a and b) declined between 1997 and 2008. 
• Among children aged under 5 years (objective 14-5a), the incidence of invasive pneumococcal infections decreased by 74.0% between 1997 and 2008, from 77 to 20 new cases per 100,000 population, exceeding the 2010 target of 46 per 100,000. 
• Among adults aged 65 years and over (objective 14-5b), the incidence of invasive pneumococcal infections decreased by 33.9% between 1997 and 2008, from 62 to 41 new cases per 100,000 population, exceeding the 2010 target of 42 per 100,000. 
 The incidence of penicillin-resistant pneumococcal infections among young children under 5 years of age (objective 14-5c) declined by 56.3% between 1997 and 2008, from 16 to 7 new cases per 100,000, moving toward the 2010 target of 6 per 100,000.  
Diseases preventable through targeted vaccination Two objectives in this area exceeded their Healthy People 2010 targets. 
 The incidence of hepatitis A (objective 14-6) declined by 92.0% between 1997 and 2008, from 11.2 to 0.9 new cases per 100,000 population, exceeding the Healthy People 2010 target of 4.3 per 100,000. 
• Among racial and ethnic groups, the black non-Hispanic population had the lowest (best) rate of hepatitis A, 0.4 new cases per 100,000 population in 2008. The rate for the Asian or Pacific Islander population was 1.3 new cases per 100,000 in 2008, almost three and a half times the best group rate [2]. The rate for Hispanic or Latino population was 1.0 new cases per 100,000 in 2008, two and a half times the best group rate. 
• The Asian or Pacific Islander population had the best group rate in 1997 (4.4 new cases per 100,000), while the black non-Hispanic population had the best group rate in 2008 (0.4 per 100,000). The Hispanic or Latino population had rates of 23.4 per 100,000 in 1997 and 1.0 in 2008. Between 1997 and 2008, the disparity between the Hispanic or Latino population and the best group declined by 282 percentage points [3]. 
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 The incidence of meningococcal disease (objective 14-7) declined by 69.2% between 1997 and 2008, from 1.3 to 0.4 new cases per 100,000 population, exceeding the Healthy People 2010 target of 1.0 per 100,000. 
Infectious diseases and emerging antimicrobial resistance Many objectives in this area moved toward their 2010 targets over the past decade. 
 The following objectives exceeded the Healthy People 2010 targets: 
• The incidence of hepatitis C (objective 14-9) decreased by 88.0% between 1997 and 2007, from 2.5 to 0.3 new cases per 100,000 population, exceeding the target of 1.0. 
• Treatment for high-risk persons with latent tuberculosis infection (objective 14-13) increased by 51.1% between 2000 and 2007, from 45% to 68%, exceeding the target of 57%. 
• Invasive early onset group B streptococcal disease (objective 14-16) declined by 70.0% between 1996 and 2008, from 1.0 to 0.3 cases per 1,000 live births, exceeding the target of 0.5. 
• Peptic ulcer hospitalizations (objective 14-17) decreased by 39.4% between 1998 and 2007, from 71 to 43 hospitalizations per 100,000 population (age adjusted), exceeding the target of 46. 
• Antibiotics prescribed for ear infections in children aged under 5 years (objective 14-18) declined by 29.0% between 1996–97 and 2006–07, from 69 to 49 courses per 100 population, exceeding the target of 56. 
• Hospital-acquired infections among adult and infant intensive care patients (objectives 14-20a through e) declined for all categories, exceeding the targets. 
 The incidence of tuberculosis (TB; objective 14-11) decreased by 36.4% between 1998 and 2008, from 6.6 to 4.2 new cases per 100,000 population, moving toward the 2010 target of 1.0 per 100,000. 
• Among racial and ethnic groups, the white non-Hispanic population had the lowest (best) rates of new TB cases, 1.5 per 100,000 population in 1998 and 1.1 in 2008. All other racial and ethnic populations with data to measure disparity had rates that were at least 100% higher than the best rate [2]. The rates for the Hispanic or Latino population were 12.6 new cases per 100,000 population in 1998, and 8.1 in 2008. Between 1998 and 2008, the disparity between the Hispanic or Latino and the white non-Hispanic populations increased by 189 percentage points [3]. 
Vaccination coverage and strategy Many of the vaccination coverage objectives either achieved or made substantial progress toward their Healthy People 2010 targets. 
 Targets for the vaccination of children aged 19–35 months were exceeded for the 
Haemophilus influenza type b (Hib), hepatitis B (Hep B), measles-mumps-rubella (MMR), polio, and varicella vaccines (objectives 14-22b through f, respectively). Vaccination rates for pneumococcal conjugate vaccine (PCV) (objective 14-22g) increased by 300.0% between 2002 and 2008, from 20% to 80%, moving toward the 2010 target of 90%. 
Immunization and Infectious Diseases  Page 14-6 
 All but three states (Montana, Nevada, and Washington) had achieved the 90% target for Hep B vaccination (objective 14-22c) in 2008 (Figure 14-3).  
 Thirty-eight states had achieved the 90% target for MMR vaccination. MMR vaccination rates for the rest of the U.S. were all above 85% (Figure 14-4). 
 Vaccination rates for PCV, one of the newest vaccines, still varied among states. Only one state, Connecticut, had achieved the 90% target for PCV (objective 14-22g) in 2008. The rates were lowest, at or below 70%, in Nevada, Oklahoma, and Wyoming (Figure 14-5). 
 The vaccination targets for children in day care (objective 14-23) were met for diphtheria-tetanus-acellular pertussis (DTap), MMR, polio, and Hib vaccines (objectives 14-23a, b, c, and l, respectively). 
 The proportion of private providers who measured childhood vaccine coverage levels (objective 14-25b) tripled between 1999 and 2009, from 11% to 33%, moving toward the 2010 target of 55%. 
 The percentage of children aged under 6 years who participated in population-based immunization registries (objective 14-26) increased by 257.1% between 1999 and 2008, from 21% to 75%, exceeding the 2010 target of 62%. 
 Targets for the vaccination of adolescents aged 13–15 years were exceeded for Hep B and MMR vaccines (objective 14-27a and b, respectively). The proportion of adolescents in this age group who had received a varicella vaccination (objective 14-27d) increased by 91.1% between 1997 and 2008, from 45% to 86%, moving toward the 2010 target of 90%. However, the receipt of a tetanus-diphtheria (Td) booster (objective 14-27c) decreased 23.7% between 1997 and 2008, from 93% to 71%, moving away from the target. The Combined Tetanus, Diptheria and Pertussis vaccine (Tdap) was introduced in 2006, leading to the decline in Td administration. However, overall tetanus booster vaccination (either through Td or Tdap) had been increasing over time. 
Vaccine safety 
 One objective in this area, the proportion of Vaccine Adverse Event Reports (VAERS) that were submitted electronically (objective 14-31b) increased by 112.5% between 2003 and 2009, from 16% to 34%, exceeding the 2010 target of 30%.  
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Summary of Progress 
 Figure 14-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Immunization and Infectious Diseases [1]. Data to measure progress toward target attainment were available for 80 objectives. Of these: 
• Thirty-three objectives met or exceeded the Healthy People 2010 targets (objectives 14-1a, b, and h; 14-3d; 14-4; 14-5a and b; 14-6; 14-7; 14-9; 14-13; 14-16 through 14-18; 14-20a through e; 14-22b through f; 14-23a through c, and l; 14-26; 14-27a and b; 14-30a; and 14-31b). 
• Thirty-two objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for eight of these objectives (14-1k, 14-19, 14-24a, 14-27d, and 14-29a through d). No significant difference was observed for one objective (14-22a); and data to test the significance of the difference were unavailable for 23 objectives (14-1d, f, i, and j; 14-2; 14-3a, through c, and e through g; 14-5c; 14-10 through 14-12; 14-22g; 14-25b; 14-28a and b; 14-29f and g; 14-30b; and 14-31a). 
• One objective (14-25a) showed no change. 
• Fourteen objectives moved away from their targets. A statistically significant difference between the baseline and final data points was observed for one objective (14-27c). Data to test the significance of the difference were unavailable for 13 objectives (14-1c, e, and g; 14-5d; 14-8; 14-21; 14-23f through j; 14-28c; and 14-29e). 
• Two objectives (14-22h and 14-24b) remained developmental and four objectives (14-14; and 14-23d, e, and k) had no follow-up data available to measure progress [4]. One objective (14-15) was dropped during the decade [5]. 
 Figure 14-2 displays health disparities in Immunization and Infectious Diseases from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Ten objectives had statistically significant racial and ethnic health disparities of 10% or more. An additional 11 objectives had racial and ethnic health disparities of 10% or more but lacked data to test significance. Of these 21 objectives, the white non-Hispanic population had the only best rate for eight objectives (14-11; 14-22g; 14-27d; and 14-29a, b, and e through g), while the white population (including persons of Hispanic origin) had the best rate for five objectives (14-5a through c, 14-7, and 14-16). The Asian or Pacific Islander (objectives 14-3b and c), Hispanic or Latino (objectives 14-3a and 14-22f), and black non-Hispanic (objectives 14-6 and 14-12) populations each had the only best rate for two objectives. Persons of two or more races had the best group rate for one objective (14-24a). The Hispanic or Latino and white non-Hispanic populations both had the best rate for one objective (14-24a). 
• Five objectives had statistically significant health disparities of 10% or more by sex. Eleven additional objectives had health disparities of 10% or more by sex, but lacked data to test significance. Females had the better rates for 15 of these 16 objectives (14-3a through c; 14-4; 14-5a, c, and d; 14-6; 14-8; 14-11; 14-12; 14-18; 14-22d; and 14-29b and c). Males had the better rate for the remaining objective (14-27a). 
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• Persons with at least some college education had the best group rate for all four objectives (14-29a through c, and g) with statistically significant health disparities of 10% or more by education level. 
• Persons living in an urban or metropolitan area had better rates than persons living in rural or nonmetropolitan areas for all three objectives (14-27a, c, and d) with statistically significant health disparities of 10% or more by geographic location. 
• Persons with disabilities had better rates than persons without disabilities for four of the five objectives (14-29a through d) with statistically significant health disparities of 10% or more by disability status, while persons without disabilities had the better rate for the remaining objective (14-29e). 
• Racial and ethnic health disparities of 100% or more, as well as changes in disparities of 100 percentage points or more over time, were observed for several objectives. Most of these are discussed in the Highlights, above.  
Transition to Healthy People 2020 For Healthy People 2020, the focus of the Immunization and Infectious Diseases Topic Area was expanded to include vaccinations against seasonal influenza in more defined segments of the population. Also, the Healthy People 2010 objectives were modified to better address healthcare-acquired infections. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 Immunization and Infectious Diseases Topic Area can be grouped into several sections: 
 Diseases Preventable Through Universal Vaccination 
 Diseases Preventable Through Targeted Vaccination 
 Infectious Diseases and Emerging Antimicrobial Resistance 
 Vaccination Coverage and Strategies 
 Surveillance and Monitoring. The differences between the Healthy People 2010 and Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Immunization and Infectious Disease Topic Area has a total of 77 objectives, five of which are developmental, whereas the Healthy People 2010 Immunization and Infectious Disease Focus Area had 87 objectives, of which two were developmental. 
 Twenty-nine Healthy People 2010 objectives were retained “as is” [6]. 
• Diseases preventable through universal vaccination. Nine objectives were retained, including: Congenital Rubella Syndrome (CRS) (objective 14-1a), measles (objective 14-1e), mumps (objective 14-1f), polio wild-type virus (objective 14-1h), rubella (objective 14-1i), varicella (objective 14-1k), chronic hepatitis B perinatal infections (objective 14-2), new invasive pneumococcal infections in children under five years (objective 14-5a), and new invasive pneumococcal infections in persons aged 65 years and over (objective 14-5b). 
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• Diseases preventable through targeted vaccination. The two retained objectives in this category are new hepatitis A (objective 14-6) and new meningococcal disease (objective 14-7). 
• Infectious diseases and emerging antimicrobial resistance. The following six objectives were retained: TB (objective 14-11), curative therapy for TB (objective 14-12), treatment for latent TB (objective 14-13), group B streptococcal disease among newborns (objective 14-16), antibiotic misuse for ear infections (objective 14-18), and antibiotic misuse for common cold (objective 14-19). 
• Vaccination coverage and strategies. Twelve objectives were retained: 
 Six childhood vaccination objectives: four doses DTaP (objective 14-22a), three doses Hep B (objective 14-22c), one dose MMR (objective 14-22d), three doses polio (objective 14-22e), one dose varicella (objective 14-22f), and four doses PCV (objective 14-22g) 
 Public health and private providers who measure childhood vaccination coverage levels (objectives 14-25a and b) 
 Population-based immunization registries for children under six years (objective 14-26) 
 Hep B vaccination among occupationally exposed workers (objective 14-28c); pneumococcal vaccination among noninstitutionalized adults aged 65 years and over (objective 14-29b); and pneumococcal vaccination among noninstitutionalized high-risk adults aged 18–64 years (objective 14-29d). 
 Thirty Healthy People 2010 objectives were modified to created 28 Healthy People 2020 objectives [7]. 
• Diseases preventable through universal vaccination. Ten objectives were modified: 
 Hib among children aged under 5 years (objective 14-1c) and new hepatitis B cases among persons aged 2–18 years (objective 14-1d) were modified due to new measurement units.  
 The target population for pertussis (objective 14-1g) was changed from children aged under 7 years in Healthy People 2010 to children aged under 1 year in Healthy People 2020.  
 Three hepatitis B infection objectives among high-risk adults aged 19–24, 25–39, and 40 years and over (objectives 14-3a through c) were consolidated into one for adults aged 19 years and over.  
 Hepatitis B infection among injection drug users and men who have sex with men (objectives 14-3d and f) were modified because of changes in the case definition. 
 Invasive penicillin-resistant pneumococcal infections among children aged under 5 years and adults aged 65 years and over (objectives 14-5c and d) were modified because of changes in the case definition. 
• Infectious Diseases and Emerging Antimicrobial Resistance. Two objectives were modified: the data source for Hepatitis C (objective 14-9) was changed, and timely laboratory confirmation of tuberculosis cases (objective 14-14) was modified due to a change in the measurement unit and the data source. 
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• Vaccination Coverage and Strategies. Seventeen objectives were modified: 
 Vaccination with three doses Hib (objective 14-22b) was modified due to a change in the data collection method. 
 The dosage for influenza vaccination among children aged 6–23 months (objective 14-22h) was modified from one dose for the developmental Healthy People 2010 objective to 1–2 doses, depending on age appropriateness, for the measurable Healthy People 2020 objective. 
 All five vaccination objectives for kindergarten (DTaP, MMR, polio, Hep B, and varicella; objectives 14-23f through j, respectively) were modified to exclude children in licensed day care settings. 
 Complete vaccination coverage among children (objective 14-24a) was updated to be consistent with the current guidelines established by the Advisory Committee for Immunization Practices. The revised series reflects a recommendation of: at least four doses of DTaP, at least three doses of polio, at least one dose of MMR, at least three or four doses of Hib (depending on vaccine brand), at least three doses of Hep B, at least one dose of varicella, and at least four doses of PCV. 
 Among teens aged 13–15 years, the tetanus and diphtheria (Td) booster (objective 14-27c) was changed to the combined tetanus-diphtheria-acellular-pertussis (Tdap) booster, and the dosage was changed for the varicella vaccine from one or more (objective 14-27d) to two doses. 
 Two Hep B vaccination objectives among high-risk adults including long-term hemodialysis patients and men who have sex with men (objectives 14-28a and b) were reverted to developmental status [4].  
 The data source for influenza and pneumococcal vaccination among institutionalized adults (objective 14-29f) was changed in Healthy People 2020. All four influenza vaccination objectives (14-29a, c, e, and g) were modified to conform to a new definition of seasonal flu. 
• Vaccine Safety. Active surveillance for vaccine safety via large linked databases (objective 14-31a) was modified to address the scientific knowledge on vaccine safety and adverse events. This objective is developmental in Healthy People 2020.  
 Twenty-five Healthy People 2010 objectives were archived [8]. 
• Diseases preventable through universal vaccination. Five objectives were archived: diphtheria (objective 14-1b) and tetanus (objective 14-1j) among persons aged under 35 years, hepatitis B among heterosexually active persons (objective 14-3e), hepatitis B among occupationally exposed workers (objective 14-3g), and bacterial meningitis in young children (objective 14-4). 
• Diseases preventable through targeted vaccination. One objective (14-8), Lyme disease, was archived because it was dependent on the availability of the vaccine for Lyme disease which was pulled off the market by the manufacturer. 
• Infectious diseases and emerging antimicrobial resistance. Seven objectives were archived due to changes in program priorities: identification of persons with chronic hepatitis C (objective 14-10); hospitalizations for peptic ulcer (objective 14-17); four hospital intensive care unit-acquired infections objectives (objectives 14-20a, and c through e); and antimicrobial use in intensive care unit (objective 14-21). 
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• Vaccination Coverage and Strategies. Seven vaccination (DTaP, MMR, polio, Hep B, varicella, PCV, and Hib) objectives for day care (objectives 14-23a through e, and 14-23k and l) were archived due to the lack of a data source; and two vaccination objectives for teens (Hep B and MMR, objectives 14-27a and b) were archived. 
• Vaccine safety. Three objectives were archived: vaccine-associated paralytic polio (objective 14-30a), febrile seizures following pertussis vaccines (objective 14-30b), and the number of vaccine adverse event reports (VAERS) that are submitted electronically (objective 14-31b). 
 Prevention services for international travelers (objective 14-15) was dropped at the Midcourse Review and the developmental objective intended to track adolescents aged 13–15 years who received the recommended vaccines (objective 14-24b) was dropped at the end of the decade due to lack of data sources [5]. 
 Twenty new objectives were added to the Healthy People 2020 Immunization and Infectious Diseases Topic Area: 
• Diseases preventable through universal vaccination. One objective, pertussis among adolescents, was added. 
• Vaccination coverage and strategies. Fifteen new objectives were added to this section: two doses hepatitis A vaccine, a birth dose of Hep B vaccine, two or three doses of rotavirus vaccine, one dose meningococcal vaccine (MCV) among adolescents, three doses human papillomavirus vaccine (HPV) among female adolescents, five influenza (flu) vaccine objectives, zoster (shingles) vaccination, Hep B vaccination among injection drug users (developmental), the number of states collecting kindergarten vaccination records using minimum standards, and State participation in the Immunization Information System for adolescent vaccination. An objective that measures zero doses of vaccine among children aged 19–35 months was also added. 
• Infectious diseases and emerging antimicrobial resistance. Four new objectives were added: electronic surveillance of rabies, influenza-virus resistance to antiviral agents, awareness of hepatitis C infection status and hepatitis B testing within minority communities experiencing health disparities (developmental). 
 One objective, central line-associated bloodstream infection among intensive care unit patients (objective 14-20b), was moved to the Healthcare-Associated Infections Topic Area. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations The data source used to track the four vaccination coverage objectives among adolescents, (objectives 14-27a through d) was the National Health Interview Survey for data years between 1997 and 2003. Starting in 2006, the data source was the newly implemented National Immunization Survey-Teen (NIS-Teen). 
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Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, (DATA2010), available from http://wonder.cdc.gov/data2010/ 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
Notes 1. Displayed in the Progress Chart (Figure 14-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 14-1 footnotes, as well as the Technical Appendix, for more detail. 
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2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 14-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 14-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 14-2 footnotes, as well as the Technical Appendix, for more detail. 4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 5. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 6. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 7. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 8. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020.  
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Comprehensive Summary of Objectives: Immunization and Infectious Disease 
Objective Description Data Source or Objective Status 14-1a Vaccine-preventable diseases—Congenital rubella syndrome (no. cases, <1 year) National Congenital Rubella Syndrome Registry (NCRSR), CDC, NCIRD. 14-1b Vaccine-preventable diseases—Diphtheria (no. cases, <35 years) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-1c Vaccine-preventable diseases—Haemophilus influenza type b and unknown (no. cases, <5 years) National Notifiable Disease Surveillance System (NNDSS), CDC, NCPHI; Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 14-1d Vaccine-preventable diseases—Hepatitis B (no. cases, 2–18 years) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-1e Vaccine-preventable diseases—Measles (no. cases) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-1f Vaccine-preventable diseases—Mumps (no. cases) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-1g Vaccine-preventable diseases—Pertussis (no. cases, <7 years) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-1h Vaccine-preventable diseases—Polio (wild-type virus) (no. cases) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-1i Vaccine-preventable diseases—Rubella (no. cases) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-1j Vaccine-preventable diseases—Tetanus (no. cases, <35 years) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-1k Vaccine-preventable diseases—Varicella (chicken pox) (no. cases in thousands, <18 years) National Health Interview Survey (NHIS), CDC, NCHS. 14-2 Perinatal hepatitis B infections in infants and young children (no. cases, 1–24 months) Perinatal Hepatitis B Prevention Program, CDC, NCHHSTP; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 14-3a Hepatitis B in adults 19–24 years (cases per 100,000) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-3b Hepatitis B in adults 25–39 years (cases per 100,000) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-3c Hepatitis B in adults 40+ years (cases per 100,000) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-3d Hepatitis B in injection drug users (no. cases) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-3e Hepatitis B in heterosexually active persons (no. cases) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-3f Hepatitis B in men who have sex with men (no. cases) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-3g Hepatitis B in occupationally exposed workers (no. cases) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-4 Bacterial meningitis in young children (new cases per 100,000 population, 1–23 months) Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 14-5a Invasive pneumococcal infections—Children (new cases per 100,000 population, <5 years) Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 14-5b Invasive pneumococcal infections—Adults (new cases per 100,000 population, 65+ years) Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 
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Objective Description Data Source or Objective Status 14-5c Penicillin-resistant invasive pneumococcal infections—Children (new cases per 100,000 population, <5 years) Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 14-5d Penicillin-resistant invasive pneumococcal infections—Adults (new cases per 100,000 population, 65+ years) Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 14-6 Hepatitis A (new cases per 100,000 population) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-7 Meningococcal disease (new cases per 100,000 population) Active Bacterial Core Surveillance (ABCs), CDC, NCIRD; National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-8 Lyme disease in endemic States (new cases per 100,000 population) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-9 Hepatitis C (new cases per 100,000 population) Sentinel Counties Study of Viral Hepatitis, CDC, NCHHSTP. 14-10 States reporting chronic HCV infection (no. States) State health department databases of persons with HCV infection; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 14-11 Tuberculosis (new cases per 100,000 population) National TB Surveillance System, CDC, NCHHSTP. 14-12 Curative therapy for tuberculosis National TB Surveillance System, CDC, NCHHSTP. 14-13 Treatment for high-risk persons with latent tuberculosis infection Aggregate Reports for Tuberculosis Program Evaluation, CDC, NCHHSTP. 14-14 Timely laboratory confirmation of tuberculosis cases—Average number of days to report 75% of cases Survey of State Public Health Laboratories, CDC, NCHSTP. 14-15 Prevention services for international travelers Dropped 14-16 Invasive early onset group B streptococcal disease (per 1,000 live births) National Notifiable Disease Surveillance System (NNDSS), CDC, NCPHI; Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 14-17 Peptic ulcer hospitalizations (age adjusted, per 100,000 population) National Hospital Discharge Survey (NHDS), CDC, NCHS. 14-18 Antibiotics prescribed for ear infections in children (courses prescribed per 100 population, <5 years) National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 14-19 Antibiotics prescribed for common cold (courses prescribed per 100,000 population) National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 14-20a Hospital-acquired infections among adult intensive care patients—Catheter-associated urinary tract infection (per 1,000 days use) Baseline: National Noscomial Infections Surveillance System (NNIS), CDC, NCPDCID; Final: National Healthcare Safety Network (NHSN), CDC, NCPDCID. 
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Objective Description Data Source or Objective Status 14-20b Hospital-acquired infections among adult intensive care—Central line-associated bloodstream infection (per 1,000 days use) Baseline: National Noscomial Infections Surveillance System (NNIS), CDC, NCPDCID; Final: National Healthcare Safety Network (NHSN), CDC, NCPDCID. 14-20c Hospital-acquired infections among adult intensive care patients—Ventilator-associated pneumonia (per 1,000 days use) Baseline: National Noscomial Infections Surveillance System (NNIS), CDC, NCPDCID; Final: National Healthcare Safety Network (NHSN), CDC, NCPDCID. 14-20d Hospital-acquired infections among infants in intensive care weighing 
≤1,000 grams at birth—Central line-associated bloodstream infection (per 1,000 days use) Baseline: National Noscomial Infections Surveillance System (NNIS), CDC, NCPDCID; Final: National Healthcare Safety Network (NHSN), CDC, NCPDCID. 14-20e Hospital-acquired infections among infants in intensive care weighing 
≤1,000 grams at birth—Ventilator-associated pneumonia (per 1,000 days use) Baseline: National Noscomial Infections Surveillance System (NNIS), CDC, NCPDCID; Final: National Healthcare Safety Network (NHSN), CDC, NCPDCID. 14-21 Antimicrobial use in intensive care units (daily doses per 1,000 patient days) National Noscomial Infections Surveillance System (NNIS), CDC, NCPDCID. 14-22a Vaccination of children 19–35 months—4 doses diphtheria-tetanus-acellular pertussis (DTaP) vaccine National Immunization Survey (NIS): CDC, NCIRD; CDC, NCHS. 14-22b Vaccination of children 19–35 months—3 doses Haemophilus influenza type b (Hib) vaccine National Immunization Survey (NIS): CDC, NCIRD; CDC, NCHS. 14-22c Vaccination of children 19–35 months—3 doses hepatitis B (Hep B) vaccine National Immunization Survey (NIS): CDC, NCIRD; CDC, NCHS. 14-22d Vaccination of children 19–35 months—1 dose measles-mumps-rubella (MMR) vaccine National Immunization Survey (NIS): CDC, NCIRD; CDC, NCHS. 14-22e Vaccination of children 19–35 months—3 doses polio vaccine National Immunization Survey (NIS): CDC, NCIRD; CDC, NCHS. 14-22f Vaccination of children 19–35 months—1 dose varicella vaccine National Immunization Survey (NIS): CDC, NCIRD; CDC, NCHS. 14-22g Vaccination of children 19–35 months—4 doses pneumococcal conjugate vaccine (PCV) National Immunization Survey (NIS): CDC, NCIRD; CDC, NCHS. 14-22h Vaccination of children 6–23 months—1 dose influenza vaccine Developmental 14-23a Vaccine coverage of children in day care—Diphtheria-tetanus-acellular pertussis (DTaP) vaccine Annual Immunization Assessment Reports, CDC, NCIRD. 14-23b Vaccine coverage of children in day care—Measles-mumps-rubella (MMR) vaccine Annual Immunization Assessment Reports, CDC, NCIRD. 14-23c Vaccine coverage of children in day care—Polio vaccine Annual Immunization Assessment Reports, CDC, NCIRD. 
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Objective Description Data Source or Objective Status 14-23d Vaccine coverage of children in day care—Hepatitis B (Hep B) vaccine Day Care and Head Start Assessment Reports, CDC, NCIRD. 14-23e Vaccine coverage of children in day care—Varicella vaccine Day Care and Head Start Assessment Reports, CDC, NCIRD. 14-23f Vaccine coverage of children in kindergarten—Diphtheria-tetanus-acellular pertussis (DTaP) vaccine School Immunization Assessment Survey, CDC, NCIRD. 14-23g Vaccine coverage of children in kindergarten—Measles-mumps-rubella (MMR) vaccine School Immunization Assessment Survey, CDC, NCIRD. 14-23h Vaccine coverage of children in kindergarten—Polio vaccine School Immunization Assessment Survey, CDC, NCIRD. 14-23i Vaccine coverage of children in kindergarten—Hepatitis B (Hep B) vaccine School Immunization Assessment Survey, CDC, NCIRD. 14-23j Vaccine coverage of children in kindergarten—Varicella vaccine School Immunization Assessment Survey, CDC, NCIRD. 14-23k Vaccine coverage of children in daycare—Pneumococcal conjugate vaccine (PCV) Day Care and Head Start Assessment Reports, CDC, NCIRD. 14-23l Vaccine coverage of children in licensed daycare facilities— 
 Haemophilus influenzae type b (Hib) vaccine  Day Care and Head Start Assessment Program, CDC, NCIRD. 14-24a Fully immunized young children 19–35 months National Immunization Survey (NIS): CDC, NCIRD; CDC, NCHS. 14-24b Fully immunized young children and adolescents 13–15 years Developmental 14-25a Providers who measure childhood vaccination coverage levels—Public health providers Annual Immunization Assessment Reports, CDC, NCIRD. 14-25b Providers who measure childhood vaccination coverage levels—Private providers Annual Immunization Assessment Reports, CDC, NCIRD. 14-26 Children <6 years participating in population-based immunization registries Annual Immunization Assessment Reports, CDC, NCIRD. 14-27a Vaccination coverage among adolescents 13–15 years—3+ doses hepatitis B (Hep B) vaccine Baseline: National Health Interview Survey (NHIS), CDC, NCHS. Final: National Immunization Survey—Teen (NIS–Teen), CDC, NCIRD and CDC, NCHS. 14-27b Vaccination coverage among adolescents 13–15 years—2+ doses measles-mumps-rubella (MMR) vaccine Baseline: National Health Interview Survey (NHIS), CDC, NCHS. Final: National Immunization Survey—Teen (NIS–Teen), CDC, NCIRD and CDC, NCHS. 14-27c Vaccination coverage among adolescents 13–15 years—1+ doses tetanus-diptheria booster Baseline: National Health Interview Survey (NHIS), CDC, NCHS. Final: National Immunization Survey—Teen (NIS–Teen), CDC, NCIRD and CDC, NCHS. 
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Objective Description Data Source or Objective Status 14-27d Vaccination coverage among adolescents 13–15 years—1+ doses varicella (excluding adolescents who have had varicella) Baseline: National Health Interview Survey (NHIS), CDC, NCHS. Final: National Immunization Survey—Teen (NIS–Teen), CDC, NCIRD and CDC, NCHS. 14-28a Hepatitis B vaccination among high-risk groups—Long-term hemodialysis patients Annual Survey of Chronic Hemodialysis Centers: CDC, NCHHSTP; CMS. 14-28b Hepatitis B (Hep B) vaccination among high-risk groups—Men who have sex with men Young Men's Survey, CDC, NCHHSTP. 14-28c Hepatitis B (Hep B) vaccination among high-risk groups—Occupationally exposed workers Periodic vaccine coverage surveys, CDC, NCPDCID. 14-29a Vaccination of noninstitutionalized high-risk older adults—Influenza vaccine in past 12 months (age adjusted, 65+ years) National Health Interview Survey (NHIS), CDC, NCHS. 14-29b Vaccination of noninstitutionalized high-risk older adults—Pneumococcal vaccine ever received (age adjusted, 65+ years) National Health Interview Survey (NHIS), CDC, NCHS. 14-29c Vaccination of noninstitutionalized high-risk adults—Influenza vaccine in past 12 months (age adjusted, 18–64 years) National Health Interview Survey (NHIS), CDC, NCHS. 14-29d Vaccination of noninstitutionalized high-risk adults—Pneumococcal vaccine ever received (age adjusted, 18–64 years) National Health Interview Survey (NHIS), CDC, NCHS. 14-29e Vaccination of adults in long-term care or nursing homes—Influenza vaccine in past 12 months (age adjusted, 18+ years) National Nursing Home Survey (NNHS), CDC, NCHS. 14-29f Vaccination of adults in long-term care or nursing homes—Pneumococcal vaccine ever received (age adjusted, 18+ years) National Nursing Home Survey (NNHS), CDC, NCHS. 14-29g Vaccination of health care workers—Influenza vaccine in past 12 months (age adjusted, 18–64 years) National Health Interview Survey (NHIS), CDC, NCHS. 14-30a Adverse events from vaccinations—Associated paralytic polio (number) National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 14-30b Adverse events from vaccinations—Febrile seizures caused by pertussis vaccines (number) Vaccine Adverse Event Reporting System (VAERS) CDC, OD; FDA. Vaccine Safety Datalink (VSD), CDC, OD. 14-31a Active surveillance for vaccine safety via large linked databases (number in millions) Vaccine Safety Datalink (VSD), CDC, OD. 14-31b Vaccine Adverse Event Reports (VAERS) submitted electronically Vaccine Adverse Event Reporting System (VAERS): CDC, OD; FDA.  
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Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases 
Percent of targeted change achieved5 (continued) 
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Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
Percent of targeted change achieved5 (continued) 
 
14-1. Vaccine-preventable diseases (no. cases) 
   i. Rubella 
  j. Tetanus (<35 years) 
  k. Varicella (chicken pox)  (no. cases in 
  thousands, <18 years) 
14-2. Perinatal hepatitis B infections in infants and 
young children (no. cases, 1–24 months)  
14-3. Hepatitis B (cases per 100,000) 
  a. Adults 19–24 years 
  b. Adults 25–39 years 
  c. Adults 40+ years  
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Percent of targeted change achieved5 (continued) 
 
14-3. Hepatitis B (no. cases) 
  e. Heterosexually active persons   
  f. Men who have sex with men    
  g. Occupationally exposed workers 
14-4. Bacterial meningitis in young children (new 
cases per 100,000 population, 1–23 months)  
14-5. Invasive pneumococcal infections (new 
cases per 100,000 population) 
  a. Children (<5 years)   
  b. Adults (65+ years)   
  c. Penicillin-resistant—Children (<5 years)  
  d. Penicillin-resistant—Adults  
   (65+ years)  
 
Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
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Percent of targeted change achieved5 (continued) 
 
14-6. Hepatitis A (new cases per 100,000 
population)  
14-7. Meningococcal disease (new cases per 
100,000 population)    
14-8. Lyme disease in endemic States (new 
cases per 100,000 population)  
14-9. Hepatitis C (new cases per 100,000 
population) 
14-10. States reporting chronic HCV infection (no.  
States)   
14-11. Tuberculosis (new cases per 100,000 
population)   
14-12. Curative therapy for tuberculosis  
14-13. Treatment for high-risk persons with latent 
tuberculosis infection  
 
Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
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Percent of targeted change achieved5 (continued) 
 
14-16. Invasive early onset group B streptococcal 
disease (per 1,000 live births)  
14-17. Peptic ulcer hospitalizations (age adjusted, 
per 100,000 population) 
14-18. Antibiotics prescribed for ear infections in 
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  c. Ventilator-associated pneumonia 
 Hospital-acquired infections among infants in 
intensive care weighing ≤1,000 grams at birth 
  d. Central line-associated bloodstream  
   infection (per 1,000 days use) 
 
Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
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Percent of targeted change achieved5 (continued) 
 
14-20. Hospital-acquired infections among infants in 
intensive care weighing ≤1,000 grams at birth 
  e. Ventilator-associated pneumonia (per 
   1,000 days use)   
14-21. Antimicrobial use in intensive care units   
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  f. 1 dose varicella vaccine 
 
 
Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
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Percent of targeted change achieved5 (continued) 
 
14-22. Vaccination of children 19–35 months  
  g. 4 doses pneumococcal conjugate 
   vaccine (PCV) 
14-23. Vaccine coverage of children in day care 
  a. Diphtheria-tetanus-acellular pertussis 
   (DTaP) vaccine 
  b. Measles-mumps-rubella (MMR) vaccine  
  c. Polio vaccine  
 Vaccine coverage of children in kindergarten  
  f. Diphtheria-tetanus-acellular  
   pertussis (DTaP) vaccine  
  g. Measles-mumps-rubella (MMR) 
    vaccine 
  h. Polio vaccine  
 
  i. Hepatitis B (Hep B) vaccine 
 
 
Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
85.7% 
   Target exceeded at baseline 
                and met at final 
            116.7% 
   Target exceeded at baseline 
                and met at final 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
90% 
20% 
(2002) 
80% 
(2008) 
60 
Not 
tested 
300.0% 
95% 
96% 
(1997–98) 
95% 
(2000) 
-1 
Not 
tested 
-1.0% 
95% 
89% 
(1997–98) 
96% 
(2000) 
7 
Not 
tested 
7.9% 
95% 
96% 
(1997–98) 
95% 
(2000) 
-1 
Not 
tested 
-1.0% 
95% 
95% 
(2002–03) 
93% 
(2008) 
-2 
Not 
tested 
-2.1% 
95% 
96% 
(2002–03) 
92% 
(2008) 
-4 
Not 
tested 
-4.2% 
95% 
96% 
(2002–03) 
94% 
(2008) 
-2 
Not 
tested 
-2.1% 
95% 
96% 
(2002–03) 
94% 
(2008) 
-2 
Not 
tested 
-2.1% 
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14-23.  Vaccine coverage of children in kindergarten 
  j. Varicella vaccine 
 Vaccine coverage of children in licensed 
daycare facilities 
 l. Haemophilus influenzae type b (Hib) 
vaccine    
14-24a. Fully immunized young children 19–35 
months 
14-25. Providers who measure childhood 
vaccination coverage levels 
  a. Public health providers 
  b. Private providers  
14-26. Children <6 years participating in population-
based immunization registries  
14-27. Vaccination coverage among adolescents 
13–15 years 
  a. 3+ doses hepatitis B (Hep B) vaccine 
  b. 2+ doses measles-mumps-rubella 
   (MMR) vaccine 
 
Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
71.4% 
0.0% 
50.0% 
   Target exceeded at baseline 
            131.7% 
            104.8% 
            200.0% 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
95% 
93% 
(2002–03) 
91% 
(2008) 
-2 
Not 
tested 
-2.2% 
90% 
94% 
(2003–04) 
N/A6 N/A6 N/A6 N/A6 
80% 
73% 
(1998) 
78% 
(2008) 
5 Yes 6.8% 
55% 
40% 
(1999) 
40% 
(2009) 
0 
Not 
tested 
0.0% 
55% 
11% 
(1999) 
33% 
(2009) 
22 
Not 
tested 
200.0% 
62% 
21% 
(1999) 
75% 
(2008) 
54 
Not 
tested 
257.1% 
90% 
48% 
(1997) 
92% 
(2008) 
44 Yes 91.7% 
90% 
89% 
(1997) 
91% 
(2008) 
2 Yes 2.2% 
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14-27. Vaccination coverage among adolescents 
13–15 years  
  c. 1+ doses tetanus-diptheria booster 
  d. 1+ doses varicella (excluding 
   adolescents who have had varicella) 
14-28. Hepatitis B vaccination among high-risk 
groups 
  a. Long-term hemodialysis patients   
  b. Men who have sex with men 
  c. Occupationally exposed workers 
14-29. Vaccination of noninstitutionalized high- 
 risk older adults (age adjusted, 65+ years)  
  a. Influenza vaccine in past 12 months 
  b. Pneumococcal vaccine ever received 
 Vaccination of noninstitutionalized high-risk 
adults (age adjusted, 18–64 years)  
  c.  Influenza vaccine in past 12 months 
  
 
Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
91.1% 
45.5% 
7.8% 
11.5% 
31.8% 
17.6% 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
90% 
93% 
(1997) 
71% 
(2008) 
-22 Yes -23.7% 
90% 
45% 
(1997) 
86% 
(2008) 
41 Yes 91.1% 
90% 
35% 
(1995) 
60% 
(2001) 
25 
Not 
tested 
71.4% 
60% 
9% 
(1994–99) 
13% 
(1998–00) 
4 
Not 
tested 
44.4% 
93% 
67% 
(1995) 
64% 
(2008) 
-3 
Not 
tested 
-4.5% 
90% 
64% 
(1998) 
67% 
(2008) 
3 Yes 4.7% 
90% 
46% 
(1998) 
60% 
(2008) 
14 Yes 30.4% 
60% 
26% 
(1998) 
32% 
(2008) 
6 Yes 23.1% 
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14-29. Vaccination of noninstitutionalized high-risk 
adults (age adjusted, 18–64 years) 
  d. Pneumococcal vaccine ever received 
 Vaccination of adults in long-term care or 
nursing homes (age adjusted, 18+ years) 
  e. Influenza vaccine in past 12 
   months  
  f. Pneumococcal vaccine ever received   
 Vaccination of health care workers (age 
adjusted, 18–64 years) 
   g. Influenza vaccine in past 12 months    
14-30. Adverse events from vaccinations (number) 
  a. Associated paralytic polio   
  b. Febrile seizures caused by pertussis 
   vaccines 
14-31a. Active surveillance for vaccine safety via 
large linked databases (number in millions)   
14-31b. Vaccine Adverse Events Reports (VAERS)  
submitted electronically      
 
Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
14.9% 
20.0% 
30.4% 
100.0% 
72.4% 
42.9% 
            128.6% 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
60% 
13% 
(1998) 
20% 
(2008) 
7 Yes 53.8% 
90% 
59% 
(1997) 
57% 
(2004) 
-2 
Not 
tested 
-3.4% 
90% 
25% 
(1997) 
38% 
(2004) 
13 
Not 
tested 
52.0% 
60% 
37% 
(2000) 
44% 
(2008) 
7 
Not 
tested 
18.9% 
0 
5 
(1997) 
0 
(2006) 
-5 
Not 
tested 
-100.0% 
57 
115 
(1998) 
73 
(2006) 
-42 
Not 
tested 
-36.5% 
13 
6 
(1999) 
9 
(2009) 
3 
Not 
tested 
50.0% 
30% 
16% 
(2003) 
34% 
(2009) 
18 
Not 
tested 
112.5% 
(continued) 
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Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
 
DATA SOURCES 
 
14-1a. National Congenital Rubella Syndrome Registry (NCRSR), CDC, NCIRD. 
14-1b. National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 
14-1c. National Notifiable Disease Surveillance System (NNDSS), CDC, NCPHI; Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 
14-1d–j. National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 
14-1k. National Health Interview Survey (NHIS), CDC, NCHS. 
14-2. Perinatal Hepatitis B Prevention Program, CDC, NCHHSTP; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
14-3a–g. National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI.  
14-4. Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 
14-5a–d. Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 
14-6. National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 
14-7. Active Bacterial Core Surveillance (ABCs), CDC, NCIRD; National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 
14-8. National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 
14-9. Sentinel Counties Study of Viral Hepatitis, CDC, NCHHSTP. 
14-10. State health department databases of persons with HCV infection; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.  
14-11–12. National TB Surveillance System, CDC, NCHHSTP. 
14-13. Aggregate Reports for Tuberculosis Program Evaluation, CDC, NCHHSTP. 
14-16. National Notifiable Disease Surveillance System (NNDSS), CDC, NCPHI; Active Bacterial Core Surveillance (ABCs), CDC, NCIRD. 
 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 14-14, 14-22h, 14-23d, 14-23e, 14-23k, and 14-24b. Objective 14-15 was deleted at the Midcourse Review.  
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100.   
     Healthy People 2010 target – Baseline value 
 
6 Data beyond the baseline are not available; difference, statistical significance , and percent change cannot be calculated. See Technical Appendix for more information. 
 
* Percent change cannot be calculated. See Technical Appendix for more information. 
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DATA SOURCES (continued) 
 
14-17. National Hospital Discharge Survey (NHDS), CDC, NCHS. 
14-18–19. National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 
14-20a–e. Baseline: National Noscomial Infections Surveillance System (NNIS), CDC, NCPDCID; Final: National Healthcare Safety Network (NHSN), CDC, NCPDCID 
14-21. National Noscomial Infections Surveillance System (NNIS), CDC, NCPDCID. 
14-22a–g. National Immunization Survey (NIS): CDC, NCIRD; CDC, NCHS. 
14-23a–c. Annual Immunization Assessment Reports, CDC, NCIRD. 
14-23f–j. School Immunization Assessment Survey, CDC, NCIRD. 
14-23l. Day Care and Head Start Assessment Program, CDC, NCIRD. 
14-24a. National Immunization Survey (NIS): CDC, NCIRD; CDC, NCHS. 
14-25a–b. Annual Immunization Assessment Reports, CDC, NCIRD. 
14-26. Annual Immunization Assessment Reports, CDC, NCIRD. 
14-27a–d. Baseline: National Health Interview Survey (NHIS), CDC, NCHS. Final: National Immunization Survey—Teen (NIS–Teen), CDC, NCIRD and CDC, NCHS. 
14-28a. Annual Survey of Chronic Hemodialysis Centers: CDC, NCHHSTP; CMS. 
14-28b. Young Men's Survey, CDC, NCHHSTP. 
14-28c. Periodic vaccine coverage surveys, CDC, NCPDCID. 
14-29a–d. National Health Interview Survey (NHIS), CDC, NCHS. 
14-29e–g. National Nursing Home Survey (NNHS), CDC, NCHS. 
14-30a. National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI. 
14-30b. Vaccine Adverse Event Reporting System (VAERS) CDC, OD; FDA. Vaccine Safety Datalink (VSD), CDC, OD. 
14-31a. Vaccine Safety Datalink (VSD), CDC, OD. 
14-31b. Vaccine Adverse Event Reporting System (VAERS): CDC, OD; FDA. 
 
 
 
 
 
 
Figure 14-1. Progress Toward Target Attainment for Focus Area 14: Immunization and Infectious Diseases (continued) 
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14-3a. Hepatitis B in adults 19–24 years [cases per 
100,000 population (pop.)] (1997, 2008)†
4u3
NA Bi
4d2
2
4d1
Bi 2 NA NA NA NA NA NA NA NA NS NS NS NS
14-3b. Hepatitis B in adults 25–39 years (cases per 
100,000 pop.) (1997, 2008)†
4u3
NA 2
4u2
4
4u1
B 3 NS NS NS NS NA NA NA NA NS NS NS NS
14-3c. Hepatitis B in adults 40+ years (cases per 
100,000 pop.) (1997, 2008)†
4u3
NA
2d3 4d2
1
4d3
B
4d1
NS NS NS NS NA NA NA NA NS NS NS NS
14-4. Bacterial meningitis in young children (new 
cases per 100,000 pop., 1–23 months) 
(1998, 2008)†
NA NA NA NA NA
1d3iii
Biii NA B
2u1
NA NA NA NA NA NA NA NA NS NS NS NS
14-5a. Invasive pneumococcal infections in children 
(new cases per 100,000 pop., <5 years) 
(1997, 2008)†
NA NA NA
4d2iii
Bi,iii NA B 2 NA NA NA NA NA NA NA NA NS NS NS NS
14-5b. Invasive pneumococcal infections in adults 
(new cases per 100,000 pop., 65+ years) 
(1997, 2008)†
NA NA NA NA NA
2d1iii
Biii NA B 1 NS NS NS NS NA NA NA NA NS NS NS NS
14-5c. Penicillin-resistant invasive pneumococcal 
infections in children (new cases per 
100,000 pop., <5 years) (1997, 2008)1†
NA NA NA NA NA
4u2iii
Biii NA B 2 NA NA NA NA NA NA NA NA NS NS NS NS
14-5d. Penicillin-resistant invasive pneumococcal 
infections in adults (new cases per 100,000 
pop., 65+ years) (1997, 2008)1†
NA NA NA NA NA Biii Biii NA Bi 2 NS NS NS NS NA NA NA NA NS NS NS NS
14-6. Hepatitis A (new cases per 100,000 pop.) 
(1997, 2008)†
3d3
NA
4d3
Bi
3d1 4d3
B
2d1
NS NS NS NS NA NA NA NA NS NS NS NS
14-7. Meningococcal disease (new cases per 
100,000 pop.) (1997, 2008)† NA NA NA NA NA
2d1iii
Biii NA B B NS NS NS NS NA NA NA NA NS NS NS NS
14-8. Lyme disease in endemic States (5-year 
average, new cases per 100,000 pop.) 
(1992–96, 2008)†
NA NA NA NA NA NA NA NA B
2u1
NS NS NS NS NA NA NA NA NS NS NS NS
14-9. Hepatitis C (new cases per 100,000 pop.) 
(1997, 2007)2† NA NA NA NA NA NAiii iii NA 1 Bi NS NS NS NS NA NA NA NA NS NS NS NS
14-11. Tuberculosis (new cases per 100,000 pop.) 
(1998, 2008)† 4 4 4 NA
4u3 4u2
B 4iv B 3 NS NS NS NS NA NA NA NA NS NS NS NS
14-12. Curative therapy for tuberculosis (1996, 
2007)† 2 2 2 NA
2d1
Bi
1d1
2iv B 2 NS NS NS NS NA NA NA NA NS NS NS NS
14-16 Invasive early onset group B streptococcal 
disease (per 1,000 live births) (1996, 2008)† NA NA NA NA
3u1iii
Biii NA NS NS NS NS NS NS NA NA NA NA NS NS NS NS
14-17. Peptic ulcer hospitalizations (age adjusted, 
per 100,000 pop.) (1998, 2007)* NA NA NA NA NA 1iii Biii NA B 1 NA NA NA NA NA NA NA NA NA NA NA NA
14-18. Antibiotics prescribed for ear infections in 
children (courses prescribed per 100 pop., 
<5 years) (1996–97, 2006–07)*
NA NA NA NA NA iii iii NA B 2 NA NA NA NA NA NA NA NA NA NA NA NA
14-19. Antibiotics prescribed for common cold 
(courses prescribed per 100,000 pop.) 
(1996–97, 2006–07)3‡
NA NA NA NA NA
1d1iii
Biii NA NA NA NA NA NA NA NA NA NA NA NA NA
Population-based objectives
Bi, ii
Bi, ii
4ii
4d3ii
(continued)
NAii
Figure 14-2. Health Disparities Table for Focus Area 14: Immunization and Infectious 
Diseases
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from the 
baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Location Disability
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Population-based objectives
Characteristics and Groups
Race and Ethnicity Sex Education Income Location Disability
Figure 14-2. Health Disparities Table for Focus Area 14: Immunization and Infectious 
Diseases (continued)
14-22a. Vaccination of children 19–35 months— 
4 doses diphtheria-tetanus-acellular pertussis 
(DTaP) vaccine (1998, 2008)4,5‡
b b NA b Bi
2d1
B NA 1 B NA NA NA NA 2 B NA NA NS NS NA NA
14-22b. Vaccination of children 19–35 months— 
3 doses Haemophilus influenza type b (Hib) 
vaccine (1998, 2008)4,5‡
b b NA 1 b
1d1
B NA B Bi NA NA NA NA 2 B NA NA NS NS NA NA
14-22c. Vaccination of children 19–35 months— 
3 doses hepatitis B (Hep B) vaccine (1998, 
2008)4,5‡
b b NA b b
1d1
Bi NA B B NA NA NA NA NA NA NS NS NA NA
14-22d. Vaccination of children 19–35 months— 
1 dose measles-mumps-rubella (MMR) 
vaccine (1998, 2008)4,5‡
NA NA NA B 2 NA NA NA NA B 1 NA NA NS NS NA NA
14-22e. Vaccination of children 19–35 months— 
3 doses polio vaccine (1998, 2008)4,5‡ NA b NA b b
1d1
Bi NA B Bi NA NA NA NA NA NA NS NS NA NA
14-22f. Vaccination of children 19–35 months— 
1 dose varicella vaccine (1998, 2008)4,5‡ b b NA 1 Bi 1
2d1
NA B B NA NA NA NA B Bi NA NA NS NS NA NA
14-22g. Vaccination of children 19–35 months— 
4 doses pneumococcal conjugate vaccine 
(PCV) (2002, 2008)6*
1 b NA b 1
2u1
Bi NA 1v B NA NA NA NA 2 B NA NA NS NS NA NA
14-24a. Fully immunized young children 19–35 
months (1998, 2008)4,5* b b NA Bi 1 2 1 NA Bi B NA NA NA NA 2 B NA NA NS NS NA NA
14-27a. Vaccination coverage among adolescents 
13–15 years—3+ doses of hepatitis B (Hep B) 
vaccine (1997, 2008)7,8*
NA NA NA NA 2 Bi NA NA NA NA NA B 2 1 B
14-27b. Vaccination coverage among adolescents 
13–15 years—2+ doses of measles, mumps, 
rubella (MMR) vaccine (1997, 2008)7,8*
NA NA NA b 1v 1v B NA 1v B NA NA NA NA 1 Bi b NA B 1 NA
14-27c. Vaccination coverage among adolescents 
13–15 years—1+ doses of tetanus-diptheria 
booster (1997, 2008)7,8*
b b NA b b 1v B NA B 1v NA NA NA NA 2v 2v B 2iv B 3v
14-27d. Vaccination coverage among adolescents 
13–15 years—1+ doses of varicella vaccine 
(exclud. those with varicella) (1997, 2008)7,8*
NA NA NA NA b
3u2
B NA 1 B NA NA NA NA 3 Bi b NA B
4u2
NA
14-29a. Vaccination of noninstitutionalized high-risk 
older adults—Influenza vaccine in past 12 
months (age adjusted, 65+ yrs) (1998, 2008)7*
NA 1 NA NA 2 3 B 2iv Bi 1 2 1 B 2 NS NS NS NS NS NS B 2
14-29b. Vaccination of noninstitutionalized high-risk 
older adults—Pneumococcal vaccine ever 
received (age adjusted, 65+ yrs) (1998, 2008)7*
NA 3 NA NA
3u1
3 B
3u1
Bi 2u1 2 2 B 2 NS NS NS NS NS NS B 2
14-29c. Vaccination of noninstitutionalized high-risk 
adults—Influenza vaccine in past 12 months 
(age adjusted, 18–64 yrs) (1998, 2008)7*
b Bi NA B 1 1 1 NA B 2 2 2 B 2 NS NS NS NS NS NS B 2
14-29d. Vaccination of noninstitutionalized high-risk 
older adults—Pneumococcal vaccine ever re-
ceived (age adjusted, 18–64 yrs) (1998, 2008)7*
NA 1 NA b 1 1 Bi NA B B 1 B B 1 NS NS NS NS NS NS B 2
14-29e. Vaccination of adults in long-term care or 
nursing homes—Influenza vaccine in past 12 
months (age adjusted, 18+ yrs) (1997, 2004)9‡
b 2 1 NA 1 1 B NA NA NA NA NA NS NS NS NS NS NS 3vi Bvi
14-29f. Vaccination of adults in long-term care or 
nursing homes—Pneumococcal vaccine ever 
received (age adjusted, 18+ yrs) (1997, 2004)9‡
b 2 1 NA
2u1 2u1
B NA B 1v NA NA NA NA NS NS NS NS NS NS 1vi Bvi
14-29g. Vaccination of health care workers— 
Influenza vaccine in past 12 months (age 
adjusted, 18–64 years) (2000, 2008)*
NA b NA NA 1 2 B NA Bi 1
3u1 2u1
B
2u1
NS NS NS NS NS NS B 1v
(continued)
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
‡
1
2
3
4
5
6
7
8
9
i
ii
iii
iv
v
vi
14-3a–c. 
14-4. 
14-5a–d. 
14-6. 
14-7. 
14-8. 
14-9. 
14-11–14-12. 
14-16. National Notifiable Disease Surveillance System (NNDSS), CDC, NCPHI; Active Bacterial Core Surveillance (ABCs), CDC, NCIRD.
14-17. 
14-18–14-19. 
14-22a–g. 
14-24a. 
14-27a–d. 
14-29a–d. 
14-29e–f. 
14-29g. 
National Immunization Survey (NIS), CDC, NCIRD and NCHS.
National Immunization Survey (NIS), CDC, NCIRD and NCHS.
National Health Interview Survey (NHIS), CDC, NCHS.
National Nursing Home Survey (NNHS), CDC, NCHS.
National Health Interview Survey (NHIS), CDC, NCHS.
Baseline: National Health Interview Survey (NHIS), CDC, NCHS. Final: National Immunization Survey—Teen (NIS–Teen), CDC, NCIRD and NCHS.
National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI.
Sentinel Counties Study of Viral Hepatitis, CDC, NCHHSTP.
National TB Surveillance System, CDC, NCHHSTP.
National Hospital Discharge Survey (NHDS), CDC, NCHS.
National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS.
National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI.
Active Bacterial Core Surveillance (ABCs), CDC, NCIRD.
Active Bacterial Core Surveillance (ABCs), CDC, NCIRD.
National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI.
Active Bacterial Core Surveillance (ABCs), CDC, NCIRD; National Notifiable Diseases Surveillance System (NNDSS), CDC, NCPHI.
DATA SOURCES
Data are for Asian or Pacific Islander.
Data include persons of Hispanic origin.
Change in the summary index cannot be assessed. See Technical Appendix.
For this objective, only severe disabilities are considered as disabilities.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical Appendix.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
FOOTNOTES
Baseline data by income are for 2004.
Most recent data by race and ethnicity are for 2002.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows 
when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. 
Nonetheless, disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
Measures of variability were available only for the most recent data. Thus, the variability of best group rates was assessed only for the most recent data, and 
statistical significance was tested only for the most recent data. Disparities of 10% or more are displayed when the differences from the best group rate are 
statistically significant at the 0.05 level. Changes in disparities over time are displayed according to their magnitude, since measures of variability were not 
available at baseline and therefore statistical significance of changes in disparity could not be tested. See Technical Appendix.
Baseline data by race and ethnicity are for 1999.
Most recent data by disability status are for 2003.
Baseline data by disability status are for 2004.
Most recent data by sex and race and ethnicity are for 2003.
Baseline data by income exclude "middle/high income" for comparability with most recent data year.
Baseline data by race and ethnicity are for 1998–99. Measures of variability by sex were available at both data points, see footnote * above.
Baseline data by race and ethnicity are for 2000. Measures of variability by sex and income were available at both data points, see footnote * above.
Data not available. Characteristic not selected for this objective.
10–49 points 50–99 points 100 points or more
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
Increase in disparity (percentage points)
100% or more
NOTES
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Figure 14-2. Health Disparities Table for Focus Area 14: Immunization and Infectious 
Diseases (continued)
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
14-1a through k, 14-2, 14-3d through g, 14-10, 14-13, 14-14, 14-20a through e, 14-21, 14-22h, 14-23a through l, 14-24b, 14-25a and b, 14-26, 14-28a through c, 
14-30a and b, and 14-31a and b. Objective 14-15 was deleted at Midcourse Review.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Most favorable group rate for specified 
characteristic, but reliability criterion not 
met.
Reliability criterion for best group 
rate not met, or data available for 
only one group.
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99%
Percent difference from the best group rate
Percent 
Figure 14-3. Vaccination of Children (19 to 35 months) –  
3 Doses Hepatitis B (HepB) Vaccine 2008 
Healthy People 2010 objective 14-22c 
Target = 90 
NOTES: Rates are displayed by a modified Jenks classification for U.S. states. 
SOURCE: National Immunization Survey (NIS), CDC, NCIRD  
highest categories (green) shows states that met target 
84.9 - 89.9 
90.0 - 93.1 
93.2 - 95.0 
95.1 - 98.1 
Immunization and Infectious Disease Page 14-34 
Percent 
Figure 14-4. Vaccination of Children (19 to 35 months) –  
1 Dose Measles-Mumps-Rubella (MMR) Vaccine  2008 
Healthy People 2010 objective 14-22d 
Target = 90 
NOTES: Rates are displayed by a modified Jenks classification for U.S. states. 
SOURCE: National Immunization Survey (NIS), CDC, NCIRD  
highest categories (green) shows states that met target 
85.9 - 89.9 
90.0 - 91.2 
91.3 - 93.1 
93.2 - 95.6 
Immunization and Infectious Disease Page 14-35 
NOTES: Rates are displayed by a modified Jenks classification for U.S. states.   
SOURCE: National Immunization Survey (NIS), CDC, NCIRD and NCHS. 
Figure 14-5. Universally Recommended Vaccination of Children (19 to 35 months) – 
4 Doses Pneumococcal Conjugate Vaccine  2008 
Healthy People 2010 objective 14-22g 
Target = 90 
Immunization and Infectious Diseases Page 14-36 
highest category (green) shows states that met target 
Percent 
63.6 - 69.2 
69.3 - 76.3 
76.4 - 80.9 
81.0 - 89.9 
90.0 - 91.5 
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Goal: Reduce injuries, disabilities, and deaths due to 
unintentional injuries and violence 
The objectives in this chapter monitor progress in three major areas: 
 Injuries. This area includes objectives that track deaths and nonfatal injuries caused by both accidents (unintentional) and violence such as traumatic brain injuries, poisoning, and suffocation. The availability of surveillance systems to track injury-related incidents and deaths are also monitored. 
 Unintentional injuries. This area includes objectives that track deaths and nonfatal injuries caused by accidents such as motor vehicle-related injuries, falls, drownings, and residential fire deaths. Individual behaviors and state laws for unintentional injury prevention are also monitored. 
 Violence. The objectives in this area track deaths and injuries from violent acts such as homicide, child maltreatment, and sexual assault. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade [1]. Seventy-four percent of the Injury and Violence Prevention objectives with data to monitor progress moved toward or exceeded their Healthy People 2010 targets (Figure 15-1). Statistically significant health disparities were observed among racial and ethnic populations, as well as by sex, education level, and geographic location (Figure 15-2), as highlighted below [2]. 
Injuries 
 The poisoning death rate (objective 15-8) increased by 84.5% between 1999 and 2007, from 7.1 to 13.1 per 100,000 population (age adjusted), moving away from the Healthy People 2010 target of 1.5 per 100,000 population. 
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• Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) rates of poisoning deaths: 1.6 deaths per 100,000 population (age adjusted) in 1999 and 2.5 in 2007. The Hispanic or Latino population had rates of 5.9 per 100,000 (age adjusted) in 1999 and 6.9 in 2007; the black non-Hispanic population had rates of 8.2 in 1999 and 10.6 in 2007; and the white non-Hispanic population had rates of 7.3 in 1999 and 15.8 in 2007. 
 In 2007, the rate for the Hispanic or Latino population was almost three times the best group rate (that for the Asian or Pacific Islander population); the rate for the black non-Hispanic population was more than four times the best group rate; and the rate for the white non-Hispanic population was almost six and a half times the best group rate [2]. 
 Between 1999 and 2007, the disparity in the poisoning death rate between the Hispanic or Latino population and the Asian or Pacific Islander population (group with the best rate) decreased by 93 percentage points [3]; similarly, the disparity between the black non-Hispanic and the Asian or Pacific Islander population decreased by 89 percentage points; and the disparity between the white non-Hispanic and the Asian or Pacific Islander population increased by 176 percentage points. 
• Among education groups, persons aged 25–64 years with at least some college education had the lowest (best) poisoning death rate, 7.9 deaths per 100,000 population (age adjusted) in 2002. Persons with less than a high school education had a rate of 25.8 deaths per 100,000 population (age adjusted) in 2002, almost three and a half times the best group rate (that for persons with at least some college education) [2]. High school graduates had a rate of 22.4 per 100,000 (age adjusted) in 2002, almost three times the best group rate. 
Unintentional Injuries 
 The unintentional injury death rate (objective 15-13) increased by 13.3% between 1999 and 2007, from 35.3 to 40.0 per 100,000 population (age adjusted), moving away from the Healthy People 2010 target of 17.1 per 100,000 population. 
• Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) rate of unintentional injury deaths, 17.0 per 100,000 population (age adjusted) in 2007. The American Indian or Alaska Native, black non-Hispanic, and white non-Hispanic populations had rates of 55.7, 37.6, and 43.0 deaths per 100,000 population (aged adjusted) in 2007, respectively. The rate for the American Indian or Alaska Native population was almost three and a half times the best group rate (that for the Asian or Pacific Islander population); the rate for the black non-Hispanic population was more than twice the best group rate; and the rate for the white non-Hispanic population was about two and a half times the best rate [2]. 
• Females had a lower (better) unintentional injury death rate than males, 25.8 deaths per 100,000 population (age adjusted) in 2007. The rate for males, 55.8 per 100,000 (age adjusted) in 2007, was more than twice the rate for females [2]. 
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• Among education groups, persons aged 25–64 years with at least some college education had the lowest (best) unintentional injury death rate, 18.3 deaths per 100,000 population (age adjusted) in 2002. Persons with less than a high school education had a rate of 61.0 per 100,000 (age adjusted) in 2002, almost three and a half times the best group rate; while high school graduates had a rate of 50.0 per 100,000 (age adjusted) in 2002, more than two and a half times the best rate [2]. 
• Unintentional injury death rates varied by geographic area. In 2005–07, there were clusters of elevated rates in Appalachian West Virginia, Kentucky, and Tennessee, the Lower Mississippi Delta, and the Mountain West (Figure 15-3). 
 The motor vehicle crash death rates decreased, moving toward the 2010 targets. Motor vehicle crash deaths per 100,000 population (objective 15-15a) declined by 6.1% between 1999 and 2007, from 14.7 to 13.8 (age adjusted), moving toward the target of 8.0. Motor vehicle crash deaths per 100 million vehicle miles travelled (objective 15-15b) declined by 18.8% between 1998 and 2008, from 1.6 to 1.3, moving toward the target of 0.8. 
• The disparity patterns for motor vehicle crash death rates (objective 15-15a) were very similar to those for unintentional injury death rates, described above. Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) rate, 7.0 per 100,000 population (age adjusted) in 2007. The American Indian or Alaska Native, black non-Hispanic, and white non-Hispanic populations had rates of 22.5, 14.1, and 14.2 per 100,000 (age adjusted) in 2007, respectively. The rate for the American Indian or Alaska Native population was more than three times the best group rate; the rates for the black non-Hispanic and white non-Hispanic populations were about twice the best group rate [2].  
• Females had a lower (better) motor vehicle crash death rate than males, 7.9 per 100,000 population (age adjusted) in 2007. The rate for males, 19.9 per 100,000 (age adjusted) in 2007, was approximately two and a half times that for females [2]. 
• Among education groups, persons aged 25–64 years with at least some college education had the lowest (best) rate of motor vehicle crash deaths, 8.4 per 100,000 population (age adjusted) in 2002. High school graduates and persons with less than a high school education had rates of 22.3 and 26.0 per 100,000 (age adjusted) in 2002, respectively. The rate for high school graduates was more than two and a half times the best group rate, while the rate for persons with less than a high school education was more than three times the best group rate [2]. 
• Motor vehicle death rates varied by geographic area. In 2005–07, there were clusters of higher rates in Kentucky, South Florida, and the Mountain West. Several areas met the Healthy People 2010 target (Figure 15-4). 
 The nonfatal motor vehicle crash-related injury rate (objective 15-17) declined by 34.7% between 1998 and 2008, from 1,181 to 771 per 100,000 population, exceeding the 2010 target of 933 per 100,000 population. 
 The use of safety belts (objective 15-19) increased by 25.4% between 1999 and 2009, from 67% to 84%, moving toward the 2010 target of 89%. However, there was no improvement in the use of child restraints (objective 15-20). As in 2002, the baseline year for this objective, in 2009, 88% of children aged seven years and under were properly restrained in child safety seats. The number of states that had adopted graduated driver licensing laws (objective 15-22) increased from 23 states in 1999 to 50 states (including the District of Columbia) in 2009, moving toward the target of 51 (50 states and the District of Columbia). 
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 The residential fire death rate (objective 15-25) declined by 10.0% between 1999 and 2007, from 1.0 to 0.9 per 100,000 population (age adjusted), moving toward the 2010 target of 0.2 per 100,000. 
 The use of smoke alarms in residences also increased. The proportion of persons living in residences with functioning alarms on every floor (objective 15-26a) and the proportion of residences with functioning alarms on every floor (objective 15-26b) both increased by 3.4% between 1998 and 2003, from 88% to 91% (age adjusted for objective 15-26a), moving toward the Healthy People 2010 targets of 100%. 
 The death rate from unintentional falls (objective 15-27) increased by 45.8% between 1999 and 2007, from 4.8 to 7.0 per 100,000 population (age adjusted), moving away from the 2010 target of 3.3 per 100,000. 
• Among racial and ethnic groups, the black non-Hispanic population had the lowest (best) rates of deaths from unintentional falls, 3.5 per 100,000 population (age adjusted) in both 1999 and 2007. The rates for the white non-Hispanic population were 5.0 per 100,000 (age adjusted) in 1999 and 7.6 in 2007. In 2007, the rate for the white non-Hispanic population was more than twice that of the black non-Hispanic population [2]. Between 1999 and 2007, the disparity between the white non-Hispanic and black non-Hispanic populations increased by 74 percentage points [3]. 
• Among education groups, persons aged 25–64 years with at least some college education had the lowest (best) death rate from unintentional falls, 1.3 per 100,000 population (age adjusted) in 2002. The rates for high school graduates and persons with less than a high school education were 2.6 and 3.1 per 100,000 (age adjusted) in 2002, respectively. The rate for high school graduates was twice the best group rate, while the rate for persons with less than a high school education was almost two and a half times the best group rate [2]. 
 Hospitalization rates for hip fractures among women and men aged 65 years and over (objectives 15-28a and b) each decreased by 22% between 1998 and 2007, from 1,055.8 to 823.5 per 100,000 population (age adjusted) for women and from 592.7 to 464.9 per 100,000 (age adjusted) for men. The hospitalization rate for females moved toward the 2010 target of 416.0 per 100,000, whereas the rate for males exceeded the target 474.0 per 100,000. 
Violence 
 The homicide rate did not change significantly over the decade. In 1999, the baseline year for this objective (15-32), the homicide rate was 6.0 per 100,000 population (age adjusted), compared to a rate of 6.1 in 2007 [1]. 
• Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) rate of deaths from homicide, 2.3 per 100,000 population (age adjusted) in 2007. The rates for the American Indian or Alaska Native, Hispanic or Latino, and black non-Hispanic populations were 6.5, 6.9, and 21.8 per 100,000 (age adjusted) in 2007, respectively. The rate for the American Indian or Alaska Native population was almost three times the best group rate; the rate for the Hispanic or Latino population was three times the best group rate; and the rate for the black non-Hispanic population was about nine and a half times the best group rate [2]. 
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• The white non-Hispanic population had the lowest (best) rate of deaths from homicide at baseline, 2.9 deaths per 100.000 (age adjusted) in 1999, while the Asian or Pacific Islander population had the best rate at the most recent data point, 2.3 per 100,000 (age adjusted) in 2007. The black non-Hispanic population had rates of 20.7 and 21.8 per 100,000 (age adjusted) in 1999 and 2007, respectively. Between 1999 and 2007, the disparity between the black non-Hispanic population and the group with the best rate increased by 234 percentage points [3]. 
• Females had a lower (better) homicide rate than males, 2.5 per 100,000 population (age adjusted) in 2007. The rate for males was 9.6 per 100,000 (age adjusted) in 2007, nearly four times the rate for females [2]. 
• Among education groups, persons aged 25–64 years with at least some college education had the lowest (best) rate of deaths from homicide, 2.6 per 100,000 population (age adjusted) in 2002. The rates for high school graduates and persons with less than a high school education were 10.5 and 16.0 per 100,000 (age adjusted) in 2002, respectively. High school graduates had a rate that was approximately four times the best group rate; the rate for persons with less than a high school education was more than six times the best group rate [2]. 
 Physical assault by intimate partners (objective 15-34) decreased by 36.1% between 1998 and 2009, from 3.6 to 2.3 per 1,000 population aged 12 years and over, exceeding the 2010 target of 2.7 per 1,000 population. 
 Rape or attempted rape (objective 15-35) declined by 66.7% between 1998 and 2009, from 0.9 to 0.3 per 1,000 population aged 12 years and over, exceeding the 2010 target of 0.8 per 1,000 population. 
 Sexual assault other than rape (objective 15-36) declined by 66.7% between 1998 and 2009, from 0.6 to 0.2 per 1,000 population aged 12 years and over, exceeding the 2010 target of 0.4 per 1,000 population. 
 Physical assaults (objective 15-37) declined by 47.6% between 1998 and 2008, from 31.1 to 16.3 per 1,000 population aged 12 years and over, moving toward the 2010 target of 13.6 per 1,000 population. 
 Physical fighting among students in grades 9–12 (objective 15-38) declined by 13.9% between 1999 and 2009, from 36% to 31%, exceeding the 2010 target of 32%.  
Summary of Progress 
 Figure 15-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Injury and Violence Prevention [1]. Data to measure progress toward target attainment were available for 43 objectives. Of these: 
• Eight objectives (15-12, 15-17, 15-28b, 15-33a, 15-34 through 15-36, and 15-38) met or exceeded their Healthy People 2010 targets. 
• Twenty-four objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for eight of these objectives (15-15a, 15-19, 15-25, 15-26a and b, 15-28a, 15-29, and 15-37). No significant differences were observed for nine objectives (15-2, 15-3, 15-5, 15-7, 15-14, 15-18, 15-21, 15-30, and 15-39); and data to test significance were unavailable for seven objectives (15-6, 15-10, 15-11, 15-15b, 15-16, 15-22, and 15-24). 
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• Two objectives (15-20 and 15-31a) showed no change. 
• Nine objectives moved away from their targets. A statistically significant difference between the baseline and final data points was observed for six of these objectives (15-1, 15-8, 15-9, 15-13, 15-27, and 15-31b). No significant differences were observed for two objectives (15-31c and 15-32); and data to test the significance of the difference were unavailable for one objective (15-33b). 
 Three objectives (15-4 and 15-23a and b) had no data available to measure progress. 
 Figure 15-2 displays health disparities in Injury and Violence Prevention from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Of the 14 objectives with statistically significant racial and ethnic health disparities of 10% or more, the Asian or Pacific Islander population had the only best rate for five objectives (15-3, 15-8, 15-13, 15-15a, and 15-32). The white non-Hispanic population had the best rate for four objectives (15-4, 15-26a, 15-37, and 15-38) and the white population had the best rate for one objective (15-12). The Hispanic or Latino population had the only best rate for two objectives (15-25 and 15-29). The black non-Hispanic population had the best rate for one objective (15-27). The Asian or Pacific Islander and Hispanic or Latino populations both had the best rate for one objective (15-9). The Asian population had the best rate for one objective (15-16) with racial and ethnic health disparities of 10% or more, but without available data to assess statistical significance. 
• Females had the better group rate for all 16 of the objectives with statistically significant health disparities of 10% or more by sex (objectives 15-1, 15-3, 15-4, 15-8, 15-9, 15-12 through 15-14, 15-15a, 15-25, 15-27, 15-29, 15-32, and 15-37 through 15-39) and one objective with health disparities of 10% or more by sex that lacked data to assess statistical significance (objective 15-16). Males had the better rate for one objective with health disparities of 10% or more by sex that lacked data to assess statistical significance (objective 15-33a). 
• Persons with at least some college education had the best rate for 10 of the 11 objectives with statistically significant health disparities of 10% or more by education level (objectives 15-3, 15-8, 15-9, 15-13, 15-15a, 15-25, 15-26a, 15-27, 15-29, and 15-32). High school graduates had the best rate for one objective (objective 15-4). 
• Persons living in urban or metropolitan areas had the better rate for the one objective with statistically significant health disparities of 10% or more by geographic location (objective 15-29). 
• Health disparities of 100% or more among racial and ethnic populations, by sex, and by education level were observed for a number of objectives in this Focus Area. Changes in disparities over time also were observed. Many of these disparities are discussed in the Highlights, above.  
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Transition to Healthy People 2020 For Healthy People 2020, the focus of the Injury and Violence Prevention objectives has been expanded to include a broader range of types of injuries and violence and improved strategies for prevention, surveillance, and reducing the consequences of injuries. The Injury and Violence Prevention objectives primarily assess the rates of unintentional and violence-related injuries of varying severity, prevention including individual behaviors and state laws, and surveillance systems. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 Injury and Violence Prevention Topic Area can be grouped into three sections: 
 Injury Prevention 
 Unintentional Injury Prevention 
 Violence Prevention. The differences between the Healthy People 2010 objectives and those included in Healthy People 2020 are summarized below: 
 The Healthy People 2020 Injury and Violence Prevention Topic Area has a total of 65 objectives, nine of which are developmental, whereas the Healthy People 2010 Injury and Violence Prevention Focus Area had 46 objectives [4]. 
 Twenty-two Healthy People 2010 objectives were retained “as is” [5]. These include: nonfatal traumatic brain injury hospitalizations (objective 15-1); nonfatal spinal cord injury hospitalizations (objective 15-2); firearm-related deaths (objective 15-3); nonfatal firearm-related injuries (objective 15-5); unintentional injury deaths (objective 15-13); nonfatal unintentional injuries (objective 15-14); motor vehicle crash-related deaths per population (objective 15-15a); motor vehicle crash-related deaths per vehicle miles traveled (objective 15-15b); pedestrian deaths (objective 15-16); nonfatal motor vehicle crash-related injuries (objective 15-17); nonfatal pedestrian injuries (objective 15-18); safety belt use (objective 15-19); motorcycle helmet use (objective 15-21); states with bicycle helmet laws (objective 15-24); residential fire deaths (objective 15-25); unintentional drowning deaths (objective 15-29); schools requiring students to wear appropriate protective gear in physical education (objective 15-31a) and intramural activities or physical activity clubs (objective 15-31c); homicides (objective 15-32); physical assaults (objective 15-37); physical fighting among adolescents (objective 15-38); and weapon carrying by adolescents on school property (objective 15-39). 
 Thirteen Healthy People 2010 objectives were modified to create 19 Healthy People 2020 objectives, five of which are developmental [4,6]. 
• The threshold for the developmental objective on state-level child fatality review for deaths due to external causes (objective 15-6) was decreased from 100% to 90% of such deaths. 
• A more reliable data source was selected for nonfatal poisonings (objective 15-7). 
• Deaths from suffocation (objective 15-9) was modified to create three Healthy People 2020 objectives to track only those that are unintentional among all persons, infants, and older adults (the age groups at highest risk). 
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• Emergency department and hospital discharge surveillance of ICD-9-CM external cause of injury codes (objectives 15-10 and 15-11) were modified to better assess how well states are performing. 
• Emergency department visits for injuries (objective 15-12) was modified to eliminate the double counting of the more severe injuries that will be tracked by the new objectives for nonfatal injury hospitalizations and injury deaths. 
• Child restraints use (objective 15-20) was modified to separately accommodate the four age specific guidelines for types of child restraints. 
• States with graduated driver licensing laws (objective 15-22) was modified to track those states with laws rated as “good” based on the criteria set by the Insurance Institute for Highway Safety. 
• Maltreatment of children (objective 15-33a) was modified to track only nonfatal maltreatment and avoid overlap with the child maltreatment fatalities objective (15-33b). The methodology for counting cases also was revised for both objectives. 
• The data source for physical assault by intimate partners, rape or attempted rape, and sexual assault other than rape (objectives 15-34 through 15-36), was changed to enable the prevalence of such violence to be monitored within a health context rather than a crime context, allowing for greater disclosure. Sexual assault other than rape (objective 15-36) was divided into two Healthy People 2020 objectives to separately track abusive sexual contact other than rape or attempted rape and noncontact sexual abuse. The Healthy People 2020 data source is new and, therefore, these four objectives are developmental. 
 Two Healthy People 2010 objectives were retained “as is” and also modified to create six Healthy People 2020 objectives [5,6]: 
• Poisoning deaths among all ages (objective 15-8) was retained. This objective also was modified to create three other Healthy People 2020 objectives: 1) poisoning deaths among adults aged 35–54 years (the age group at highest risk); and unintentional or undetermined poisoning deaths among 2) all persons and 3) adults aged 35–54 years. 
• Deaths from unintentional falls (objective 15-27) was retained. This objective also was modified to track unintentional fall-related deaths among older adults 65 years and over, the age group at highest risk. 
 Seven Healthy People 2010 objectives were archived [7]. Objectives tracking improper firearm storage in homes (objective 15-4), regular bicycle helmet use among children and adults (objectives 15-23a and b), persons living in residences with functional smoke alarms on every floor (objective 15-26a), and residences with functional smoke alarms on every floor (objective 15-26b) were deleted due to the lack of an ongoing national data source. The objective regarding emergency department visits for dog bites (objective 15-30) was deleted due to the low rate and lack of effective prevention programs. The objective on schools requiring students to wear appropriate protective gear in interscholastic sports (objective 15-31b) was deleted because it was near the maximum achievement level. 
 Two objectives that track hospitalizations for hip fractures among older adults (separately for females and males, objectives 15-28a and b) were moved from the Healthy People 2010 Injury and Violence Prevention Focus Area to the Healthy People 2020 Arthritis, Osteoporosis, and Chronic Back Topic Area. 
Injury and Violence Prevention  Page 15-10 
 Eighteen new objectives, four of which are developmental, were added to the Healthy People 2020 Injury and Violence Prevention Topic Area: 
• Eight new injury objectives include fatal injuries, hospitalizations visits for nonfatal injuries, fatal traumatic brain injuries, emergency department visits for nonfatal traumatic brain injuries, fatal spinal cord injuries, a developmental objective on state-level child fatality review for sudden and unexpected infant deaths, population with trauma care access, and land mass with trauma care access. 
• Two new unintentional injury objectives include pedalcyclist deaths and sports and recreation injuries. 
• Eight new violence objectives include nonfatal physical assault injuries, bullying among adolescents, nonfatal intentional self harm injuries, children’s exposure to violence, three developmental objectives on types of intimate partner violence (sexual violence, psychological abuse, and stalking), and states with national violent death reporting systems. Appendix D, “A Crosswalk Between Objectives from Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations Beginning in 2003, education data for mortality objectives 15-3, 15-8, 15-9, 15-13, 15-15a, 15-25, 15-27, 15-29, and 15-32 from the National Vital Statistics System were suppressed. The educational attainment item was changed in the new U.S. Standard Certificate of Death in 2003 to be consistent with the U.S. Census Bureau data and to improve the ability to identify specific types of educational degrees. Many states, however, are still using the 1989 version of the U.S. Standard Certificate of Death, which focuses on highest school grade completed. As a result, educational attainment data collected using the 2003 version are not comparable with data collected using the 1989 version [8]. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. 
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The age-adjusted rate of initial emergency department visits for injuries (objective 15-12) was significantly lower in 2007 (91 visits per 1,000 population) than in 2006 (108 visits per 1,000 population); see DATA2010. In contrast, a flat trend in the rate of initial emergency department visits for injuries was observed between 2001 and 2006 [9]. Some of the observed decrease in the rate from 2006 to 2007 may be related to a modification in the data collection instrument. In 2007, the checkbox for “initial visit for problem” under the “episode of care” item in the National Hospital Ambulatory Medical Care Survey patient record form was reinstated. This item was used in 1992 and 2001–04, but removed from the patient record in 2005. A proxy for initial visits was imputed in 2005–06. The item was restored in 2007. The percentage of unknown or blank responses was higher in 2007 than in 2001–04. The rate of child maltreatment (objective 15-33a) was significantly lower in 2007–09 than in 2000–06, even though the rates were relatively stable during these two separate time periods. Between 2006 and 2007, the rate of victimization dropped from 12.1 to 10.6 per 1,000 children, which was a change of 12%. This decrease can be attributed to several factors including the increase in children who received an “other” disposition which is mostly used for low- or medium-risk cases, the decrease in the percentage of children who received a substantiated or indicated disposition, and the decrease in the number of children who received an investigation or assessment. It is not possible to tell whether this decrease indicates a trend until more data are collected [10]. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
References and Notes 1. Displayed in the Progress Chart (Figure 15-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 15-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 15-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as 
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the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 15-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 15-2 footnotes, as well as the Technical Appendix, for more detail. 4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 5. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 6. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 7. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 8. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf. 9. The presence of a monotonic increasing or decreasing trend in the underlying measure was tested with the nonparametric Mann-Kendall test, then the slope of a linear trend was estimated with the nonparametric Sen’s method. See Technical Appendix for more information. 10. U.S. Department of Health and Human Services, Administration for Children and Families, Administration on Children, Youth and Families, Children’s Bureau. Child Maltreatment 2009. Washington, DC; 2010. Available from: http://www.acf.hhs.gov/programs/cb/stats_research/index.htm#can 
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Comprehensive Summary of Objectives: Injury and Violence Prevention 
Objective Description Data Source 15-1 Nonfatal traumatic brain injury hospitalizations (age adjusted per 100,000 standard population) National Hospital Discharge Survey (NHDS), CDC, NCHS. 15-2 Nonfatal spinal cord injury hospitalizations (age adjusted per 100,000 standard population) National Hospital Discharge Survey (NHDS), CDC, NCHS. 15-3 Firearm-related deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 15-4 Persons in homes with improperly stored firearms (loaded and unlocked) (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 15-5 Nonfatal firearm-related injuries (per 100,000 population) National Electronic Injury Surveillance System (NEISS), Consumer Product Safety Commission (CPSC). 15-6 State-level child fatality review for deaths due to external causes (≤17 years, no. states and D.C.) Michigan Public Health Institute; National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 15-7 Emergency department visits for nonfatal poisonings (age adjusted per 100,000 standard population) National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 15-8 Deaths from poisoning (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 15-9 Deaths from suffocation (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 15-10 Emergency department routine collection of ICD-9-CM external causes of injury codes (no. states and D.C.) External Cause of Injury Survey, American Public Health Association (APHA). 15-11 Hospital discharge mandated use of ICD-9-CM external causes of injury codes (no. states and D.C.) External Cause of Injury Survey, American Public Health Association (APHA). 15-12 Initial emergency department visits for injuries (age adjusted per 1,000 standard population) National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 15-13 Deaths from unintentional injuries (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 15-14 Nonfatal unintentional injuries (age adjusted per 100,000 standard population) National Electronic Injury Surveillance System - All Injury Program (NEISS-AIP), CDC, NCIPC; Consumer Product Safety Commission (CPSC). 
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Objective Description Data Source 15-15a Deaths from motor vehicle crashes—Age adjusted per 100,000 standard population National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 15-15b Deaths from motor vehicle crashes—Per 100 million vehicle miles traveled Fatality Analysis Reporting System (FARS), Department of Transportation (DOT). 15-16 Pedestrian deaths on public roads (per 100,000 population) Fatality Analysis Reporting System (FARS), Department of Transportation (DOT). 15-17 Nonfatal motor vehicle crash-related injuries on public roads (per 100,000 population) General Estimates System (GES), Department of Transportation (DOT). 15-18 Nonfatal pedestrian injuries on public roads (per 100,000 population) General Estimates System (GES), Department of Transportation (DOT). 15-19 Safety belt use National Occupant Protection Use Survey (NOPUS), Department of Transportation (DOT). 15-20 Child restraint use (≤7 years) National Occupant Protection Use Survey (NOPUS), Department of Transportation (DOT). 15-21 Motorcycle helmet use National Occupant Protection Use Survey (NOPUS), Department of Transportation (DOT). 15-22 Graduated driver licensing laws (no. states and D.C.) U.S. Licensing Systems for Young Drivers, Insurance Institute for Highway Safety. 15-23a Regular bicycle helmet use—Children (1–15 years) National Bike Helmet Survey, Consumer Product Safety Commission (CPSC). 15-23b Regular bicycle helmet use—Adults (16+ years) National Bike Helmet Survey, Consumer Product Safety Commission (CPSC). 15-24 Bicycle helmet laws for riders <15 years (no. states and D.C.) Bicycle Helmet Safety Institute. 15-25 Residential fire deaths (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 15-26a Functional smoke alarms in residences—Persons living in residences with alarms on every floor (age adjusted) National Health Interview Survey (NHIS), CDC, NCHS. 15-26b Functional smoke alarms in residences—Proportion of residences with alarms on every floor National Health Interview Survey (NHIS), CDC, NCHS. 15-27 Deaths from unintentional falls (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
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Objective Description Data Source 15-28a Hospitalizations for hip fractures (age adjusted per 100,000 standard population, 65+ years)—Females National Hospital Discharge Survey (NHDS), CDC, NCHS. 15-28b Hospitalizations for hip fractures (age adjusted per 100,000 standard population, 65+ years)—Males National Hospital Discharge Survey (NHDS), CDC, NCHS. 15-29 Unintentional drownings (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 15-30 Emergency department visits for dog bite injuries (age adjusted per 100,000 standard population) National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 15-31a Schools requiring students to wear appropriate protective gear—Physical education School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 15-31b Schools requiring students to wear appropriate protective gear—Interscholastic sports School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 15-31c Schools requiring students to wear appropriate protective gear—Intramural activities or physical activity clubs School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 15-32 Homicides (age adjusted per 100,000 standard population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 15-33a Maltreatment of children (per 1,000 population, <18 years) National Child Abuse and Neglect Data System (NCANDS), ACF. 15-33b Child maltreatment fatalities (per 100,000 population, <18 years) National Child Abuse and Neglect Data System (NCANDS), ACF. 15-34 Physical assault by intimate partners (per 1,000 population, 12+ years) National Crime Victimization Survey (NCVS), Department of Justice (DOJ), Bureau of Justice Statistics (BJS). 15-35 Rape or attempted rape (per 1,000 population, 12+ years) National Crime Victimization Survey (NCVS), Department of Justice (DOJ), Bureau of Justice Statistics (BJS). 15-36 Sexual assault other than rape (per 1,000 population, 12+ years) National Crime Victimization Survey (NCVS), Department of Justice (DOJ), Bureau of Justice Statistics (BJS). 15-37 Physical assaults (per 1,000 population, 12+ years)  National Crime Victimization Survey (NCVS), Department of Justice (DOJ), Bureau of Justice Statistics (BJS). 15-38 Physical fighting among students (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 15-39 Weapon carrying by students on school property (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.  
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Figure 15-1. Progress Toward Target Attainment for Focus Area 15: Injury and Violence Prevention 
Percent of targeted change achieved5 (continued) 
 
15-1. Nonfatal traumatic brain injury 
hospitalizations (age adjusted. per 
100,000 population) 
15-2. Nonfatal spinal cord injury 
hospitalizations (age adjusted, per 
100,000 population)   
15-3. Firearm-related deaths (age adjusted, 
per 100,000 population) 
15-5. Nonfatal firearm-related injuries (per 
100,000 population) 
15-6. State-level child fatality review for deaths 
due to external causes (≤17 years, no. 
States and D.C.)  
15-7. Emergency department visits for nonfatal 
poisonings (age adjusted, per 100,000 
population)  
15-8. Deaths from poisoning (age adjusted,  
 per 100,000 population) 
15-9. Deaths from suffocation (age adjusted,  
 per 100,000 population) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
53.6 
71.7 
(1998) 
85.6 
(2007) 
13.9 Yes 19.4% 
2.6 
4.9 
(1998) 
3.6 
(2007) 
-1.3 No -26.5% 
3.6 
10.3 
(1999) 
10.2 
(2007) 
-0.1 No -1.0% 
9.1 
23.6 
(1997) 
20.7 
(2007) 
-2.9 No -12.3% 
51 
10 
(2000) 
14 
(2007) 
4 
Not 
tested 
40.0% 
288.6 
343.6 
(1997) 
322.4 
(2007) 
-21.2 No -6.2% 
1.5 
7.1 
(1999) 
13.1 
(2007) 
6 Yes 84.5% 
3.3 
4.2 
(1999) 
4.9 
(2007) 
0.7 Yes 16.7% 
56.5% 
1.5% 
20.0% 
9.8% 
38.5% 
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Figure 15-1. Progress Toward Target Attainment for Focus Area 15: Injury and Violence Prevention (continued) 
Percent of targeted change achieved5 (continued) 
 
15-10. Emergency department routine collection of 
ICD-9-CM external causes of injury codes 
(no. States and D.C.)  
15-11. Hospital discharge mandated use of ICD-9-
CM external causes of injury codes (no. 
States and D.C.)    
15-12. Initial emergency department visits for 
injuries (age adjusted, per 1,000 
 population)  
15-13. Deaths from unintentional injuries (age 
adjusted, per 100,000 population)  
15-14. Nonfatal unintentional injuries (age adjusted, 
per 100,000 population)   
15-15. Deaths from motor vehicle crashes 
   a. Age adjusted, per 100,000 population 
  b. Per 100 million vehicle miles traveled  
15-16. Pedestrian deaths on public roads (per 
100,000 population)  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
51 
12 
(1998) 
26 
(2007) 
14 
Not 
tested 
116.7% 
51 
24 
(1998) 
27 
(2007) 
3 
Not 
tested 
12.5% 
107 
107 
(2001) 
91 
(2007) 
-16 Yes -15.0% 
17.1 
35.3 
(1999) 
40.0 
(2007) 
4.7 Yes 13.3% 
9,000.0 
9,767.4 
(2000) 
9,219.3 
(2008) 
-548.1 No -5.6% 
8.0 
14.7 
(1999) 
13.8 
(2007) 
-0.9 Yes -6.1% 
0.8 
1.6 
(1998) 
1.3 
(2008) 
-0.3 
Not 
tested 
-18.8% 
1.4 
1.9 
(1998) 
1.5 
(2008) 
-0.4 
Not 
tested 
-21.1% 
35.9% 
11.1% 
71.4% 
13.4% 
37.5% 
80.0% 
   Target met at baseline and  
exceed at final 
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Percent of targeted change achieved5 (continued) 
 
15-17. Nonfatal motor vehicle crash-related injuries 
on public roads (per 100,000 population)  
15-18. Nonfatal pedestrian injuries on public roads 
(per 100,000 population)   
15-19. Safety belt use  
15-20. Child restraint use (≤7 years)  
15-21. Motorcycle helmet use   
15-22. Graduated driver licensing laws (no. States 
and D.C.)   
15-24. Bicycle helmet laws for riders <15 years (no.  
States and D.C.)  
15-25. Residential fire deaths (age adjusted, per 
100,000 population) 
 
Figure 15-1. Progress Toward Target Attainment for Focus Area 15: Injury and Violence Prevention (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
933 
1,181 
(1998) 
771 
(2008) 
-410 Yes -34.7% 
19 
26 
(1998) 
23 
(2008) 
-3 No -11.5% 
89% 
67% 
(1999) 
84% 
(2009) 
17 Yes 25.4% 
100% 
88% 
(2002) 
88% 
(2009) 
0 No 0.0% 
68% 
58% 
(2002) 
67% 
(2009) 
9 No 15.5% 
51 
23 
(1999) 
50 
(2009) 
27 
Not 
tested 
117.4% 
51 
11 
(1999) 
19 
(2009) 
8 
Not 
tested 
72.7% 
0.2 
1.0 
(1999) 
0.9 
(2007) 
-0.1 Yes -10.0% 
42.9% 
77.3% 
0.0% 
90.0% 
96.4% 
20.0% 
12.5% 
165.3% 
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Percent of targeted change achieved5 (continued) 
 
15-26. Functional smoke alarms in residences 
   a. Persons living in residences with alarms 
   on every floor (age adjusted)  
  b. Proportion of residences with alarms on 
   every floor    
15-27. Deaths from unintentional falls (age  
 adjusted, per 100,000 population)  
15-28. Hospitalizations for hip fractures (age 
adjusted, per 100,000 population, 65+ years)  
  a. Females 
  b. Males 
15-29. Unintentional drownings (age adjusted per 
100,000 standard population)   
15-30. Emergency department visits for dog bite 
injuries (age adjusted, per 100,000 
population)  
15-31. Schools requiring students to wear 
appropriate protective gear 
  a. Physical education  
 
Figure 15-1. Progress Toward Target Attainment for Focus Area 15: Injury and Violence Prevention (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
100% 
88% 
(1998) 
91% 
(2003) 
3 Yes 3.4% 
100% 
88% 
(1998) 
91% 
(2003) 
3 Yes 3.4% 
3.3 
4.8 
(1999) 
7.0 
(2007) 
2.2 Yes 45.8% 
416.0 
1,055.8 
(1998) 
823.5 
(2007) 
-232.3 Yes -22.0% 
474.0 
592.7 
(1998) 
464.9 
(2007) 
-127.8 No -21.6% 
0.7 
1.5 
(1999) 
1.2 
(2007) 
-0.3 Yes -20.0% 
113.0 
150.2 
(1997) 
121.7 
(2007) 
-28.5 No -19.0% 
85% 
77% 
(2000) 
77% 
(2006) 
0 No 0.0% 
25.0% 
25.0% 
36.3% 
37.5% 
76.6% 
0.0% 
            107.7% 
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Percent of targeted change achieved5 (continued) 
 
15-31. Schools requiring students to wear 
appropriate protective gear 
  b. Interscholastic sports  
  c. Intramural activities or physical 
   activity clubs    
15-32. Homicides (age adjusted, per 100,000 
population)  
15-33a. Maltreatment of children (per 1,000 
population, <18 years)  
15-33b. Child maltreatment fatalities (per 
 100,000 population, <18 years)   
15-34. Physical assault by intimate partners (per 
1,000 population, 12+ years)   
15-35. Rape or attempted rape (per 1,000 
population, 12+ years)  
15-36. Sexual assault other than rape (per 1,000 
population, 12+ years)  
 
Figure 15-1. Progress Toward Target Attainment for Focus Area 15: Injury and Violence Prevention (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
100% 
98% 
(2000) 
94% 
(2006) 
-4 Yes -4.1% 
97% 
88% 
(2000) 
86% 
(2006) 
-2 No -2.3% 
2.8 
6.0 
(1999) 
6.1 
(2007) 
0.1 No 1.7% 
10.2 
12.7 
(1998) 
10.1 
(2009) 
-2.6 
Not 
tested 
-20.5% 
1.5 
1.7 
(1998) 
2.4 
(2009) 
0.7 
Not 
tested 
41.2% 
2.7 
3.6 
(1998) 
2.3 
(2009) 
-1.3 Yes -36.1% 
0.8 
0.9 
(1998) 
0.3 
(2009) 
-0.6 Yes -66.7% 
0.4 
0.6 
(1998) 
0.2 
(2009) 
-0.4 Yes -66.7% 
            144.4% 
            200.0% 
            600.0% 
            104.0% 
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Percent of targeted change achieved5 
 
15-37. Physical assaults (per 1,000 population, 12+ 
years)   
15-38.  Physical fighting among students (grades  
 9–12)     
15-39. Weapon carrying by students on school 
property (grades 9–12)   
 
Figure 15-1. Progress Toward Target Attainment for Focus Area 15: Injury and Violence Prevention (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
13.6 
31.1 
(1998) 
16.3 
(2008) 
-14.8 Yes -47.6% 
32% 
36% 
(1999) 
31% 
(2009) 
-5 Yes -13.9% 
4.9% 
6.9% 
(1999) 
5.6% 
(2009) 
-1.3 No -18.8% 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 15-4, 15-23a, and 15-23b. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
 
 
84.6% 
65.0% 
125.0% 
(continued) 
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DATA SOURCES 
 
15-1–15-2. National Hospital Discharge Survey (NHDS), CDC, NCHS. 
15-3. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
15-5. National Electronic Injury Surveillance System (NEISS), Consumer Product Safety Commission (CPSC). 
15-6. Michigan Public Health Institute; National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
15-7. National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 
15-8–9. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
15-10–15-11. External Cause of Injury Survey, American Public Health Association (APHA). 
15-12. National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 
15-13. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
15-14. National Electronic Injury Surveillance System—All Injury Program (NEISS-AIP): CDC, NCIPC; Consumer Product Safety Commission (CPSC). 
15-15a. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
15-15b. Fatality Analysis Reporting System (FARS), Department of Transportation (DOT). 
15-16. Fatality Analysis Reporting System (FARS), Department of Transportation (DOT). 
15-17–15-18. General Estimates System (GES), Department of Transportation (DOT). 
15-19–15-21. National Occupant Protection Use Survey (NOPUS), Department of Transportation (DOT). 
15-22. U.S. Licensing Systems for Young Drivers, Insurance Institute for Highway Safety. 
15-24. Bicycle Helmet Safety Institute. 
15-25. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
15-26a–b. National Health Interview Survey (NHIS), CDC, NCHS. 
15-27. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
15-28a–b. National Hospital Discharge Survey (NHDS), CDC, NCHS. 
15-29. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
15-30. National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 
15-31a–c. School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 
15-32. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
15-33a–b. National Child Abuse and Neglect Data System (NCANDS), ACF. 
15-34–15-37. National Crime Victimization Survey (NCVS), Department of Justice (DOJ), Bureau of Justice Statistics (BJS). 
15-38–15-39. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
 
 
 
Figure 15-1. Progress Toward Target Attainment for Focus Area 15: Injury and Violence Prevention (continued) 
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15-1. Nonfatal traumatic brain injury hospitalizations (age 
adjusted, per 100,000 population) (1998, 2007)* NA NA NA NA NA 1i Bi NA B 3 NA NA NA NA NA NA
15-2. Nonfatal spinal cord injury hospitalizations (age adjusted, 
per 100,000 population) (1998, 2007)* NA NA NA NA NA NAi i NA NA NA NA NA NA NA
15-3. Firearm-related deaths (age adjusted, per 100,000 
population) (1999, 2007)1* 4 NA
4u1 4u3 4u2 4u2
B
4u1
4
4u1
B 4 NS NS
15-4. Persons in homes with impoperly stored firearms (loaded 
and unlocked) (age adjusted, 18+ years) (1998)* 1 NA b 3 B NA B 2 2 B 2 2 NS NS
15-5. Nonfatal firearm-related injuries (per 100,000 population) 
(1997, 2007)* NA NA NA NA NA NA NA NA NA NA NA NA NA NA
15-7. Emergency department visits for nonfatal poisonings (age 
adjusted, per 100,000 population) (1997, 2007)* NA NA NA NA NA i i NA NA NA NA NA NA NA
15-8. Deaths from poisoning (age adjusted, per 100,000 
population) (1999, 2007)1* 4 NA
4d2 4d2
4u3
4 B
3d1
4
4u1
B 4 NS NS
15-9. Deaths from suffocation (age adjusted, per 100,000 
population) (1999, 2007)1*
4u2
NA B
2d1
2u1 3u1
B 4 4 4 B 4 NS NS
15-12. Initial emergency department visits for injuries (age 
adjusted, per 1,000 population) (2001, 2007)* NA NA NA NA NA
3u1i
Bi NA B 2 NA NA NA NA NA NA
15-13. Deaths from unintentional injuries (age adjusted, per 
100,000 population) (1999, 2007)1* 4 NA 3
4d1
4u1
4 B 4
4u1 4u1
B
4u1
NS NS
15-14. Nonfatal unintentional injuries (age adjusted, per 100,000 
population) (2000, 2008)* NA NA NA NA NA NA NA NA B 2 NS NS NS NS NA NA
15-15a. Deaths from motor vehicle crashes (age adjusted, per 
100,000 population) (1999, 2007)1* 4 NA 3 4
4u1
4 B
4u1 4u1 4u1
B
4u1
NS NS
15-16. Pedestrian deaths on public roads (per 100,000 
population) (1998, 2008)2†
4u3
B 4 NA
3u1 4u2
2
4u2
B 4 NA NA NA NA NA NA
15-17. Nonfatal motor vehicle crash-related injuries on public 
roads (per 100,000 population) (1998, 2008)* NA NA NA NA NA NA NA NA 1 B NA NA NA NA NA NA
15-18. Nonfatal pedestrian injuries on public roads (per 100,000 
population) (1998, 2008)* NA NA NA NA NA NA NA NA B 1iv NA NA NA NA NA NA
15-25. Residential fire deaths (age adjusted, per 100,000 
population) (1999, 2007)1* 4 NA B 4 3 NA B
2d1
4
4u2
B 4 NS NS
15-26a. Persons living in residences with functional smoke alarms 
on every floor (age adjusted) (1998, 2003)3* 3 b NA 1 4 1 B NA B Biii
4u1
2 B
3u1
NS NS
15-27. Deaths from unintentional falls (age adjusted, per 100,000 
population) (1999, 2007)1* 3 NA
2u1
B
4u2 3u1
B
3d1
4 4 B 4 NS NS
15-28a. Hospitalizations for hip fractures—Females (age adjusted, 
per 100,000 population, 65+ years) (1998, 2007)* NA NA NA NA NA NAi i NA NA NA NA NA NA NA NA NA
15-28b. Hospitalizations for hip fractures—Males (age adjusted, 
per 100,000 population, 65+ years) (1998, 2007)* NA NA NA NA NA NAi i NA NA NA NA NA NA NA NA NA
15-29. Unintentional drownings (age adjusted, per 100,000 
population) (1999, 2007)1* 4 NA Biii
2d1
2 2 B
4d2
4 4 B 4 B 3
Figure 15-2. Health Disparities Table for Focus Area 15: Injury and Violence 
(continued)
Disparities from the best group rate for each characteristic at the most recent data point and changes in 
disparity from the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Location
Population-based objectives
Bii
Bii
Bii,iii
Bii
Bii
bii
2d1ii
1ii
1ii
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Characteristics and Groups
Race and Ethnicity Sex Education Location
Figure 15-2. Health Disparities Table for Focus Area 15: Injury and Violence Prevention 
(continued)
Population-based objectives
15-30. Emergency department visits for dog bite injuries (age 
adjusted, per 100,000 population) (1997, 2007)* NA NA NA NA NA NAi i NA NA NA NA NA NA NA
15-32. Homicides (age adjusted, per 100,000 population) (1999, 
2007)1* 4 NA
4u1 4u3
2
4u2
B
4u2
4 4 B 4 NS NS
15-33a. Maltreatment of children (per 1,000 population, <18 years) 
(1998, 2009)† NA NA NA NA NA NA NA NA 2 B NA NA NA NA NA NA
15-33b. Child maltreatment fatalities (per 100,000 population, <18 
years) (1998, 2009)† NA NA NA NA NA NA NA NA B 1 NA NA NA NA NA NA
15-34. Physical assault by intimate partners (per 1,000 
population, 12+ years) (1998, 2009)4* NA NA NA NA NA NA NA NA NA NA NA
15-35. Rape or attempted rape (per 1,000 population, 12+ years) 
(1998, 2009)4* NA NA NA NA NA NAi i NA NA NA NA NA NA NA NA
15-36. Sexual assault other than rape (per 1,000 population, 12+ 
years) (1998, 2009)4,5* NA NA NA NA NA i i NA NA NA NA NA NA NA NA NA
15-37. Physical assaults (per 1,000 population, 12+ years) (1998, 
2008)4* 1 NA NA 4 b 1 B NA B
2d1
NA NA NA NA NA NA
15-38. Physical fighting among students (grades 9–12) (1999, 
2009)* NA NA NA NA 2 2 B 2 B 3 NA NA NA NA NA NA
15-39. Weapon carrying by students on school property (grades 
9–12) (1999, 2009)* NA NA NA NA
1d2
b Biii NA Biii 4iv NA NA NA NA NA NA
Bii, iii
(continued)
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
1
2
3
4
5
i
ii
iii
iv
15-1–15-2. National Hospital Discharge Survey (NHDS), CDC, NCHS.
15-3. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
15-4. National Health Interview Survey (NHIS), CDC, NCHS.
15-5. National Electronic Injury Surveillance System (NEISS), Consumer Product Safety Commission (CPSC).
15-7. National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS.
15-8–15-9. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
15-12. National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS.
15-13. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
15-14. National Electronic Injury Surveillance System—All Injury Program (NEISS-AIP): CDC, NCIPC; Consumer Product Safety Commission (CPSC).
15-15a. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
15-16. Fatality Analysis Reporting System (FARS), Department of Transportation (DOT).
15-17–15-18. General Estimates System (GES), Department of Transportation (DOT).
15-25. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
15-26a. National Health Interview Survey (NHIS), CDC, NCHS.
15-27. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
15-28a–b. National Hospital Discharge Survey (NHDS), CDC, NCHS.
15-29. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
15-30. National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS.
15-32. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
15-33a–b. 
15-34–15-37. National Crime Victimization Survey (NCVS), Department of Justice (DOJ), Bureau of Justice Statistics (BJS).
15-38–15-39. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
National Child Abuse and Neglect Data System (NCANDS), Administration on Children, Youth and Families, Administration for Children and Families (ACF), Children's Bureau.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
100 points or more
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more are 
displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows when 
the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. Nonetheless, 
disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
DATA SOURCES
Data include persons of Hispanic origin.
Data are for Asian or Pacific Islander.
NOTES
Years in parentheses represent the baseline and most recent data years (if available).
Figure 15-2. Health Disparities Table for Focus Area 15: Injury and Violence Prevention 
(continued)
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 15-
6, 15-10, 15-11, 15-15b, 15-19 through 15-22, 15-23a and b, 15-24, 15-26b, and 15-31a through c.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race 
and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at 
baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the 
summary index at the most recent data point. See Technical Appendix for more information.
Increase in disparity (percentage points)
10–49 points 50–99 points
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage points 
and estimates of variability were not available. See Technical Appendix.
Baseline data by race and ethnicity are for 2003.
Baseline data by race and ethnicity are for 2003.
Most recent data by education level are for 2002.
Baseline data by race and ethnicity are for 2000.
Most recent data by race and ethnicity are for 2008.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical Appendix.
NOTES: Data are for ICD-10 codes V01-X59, Y85-Y86 reported as underlying cause.  Rates are per 100,000 U. S. Population age-adjusted to  
the 2000 standard population.  Rates are displayed by a Jenks classification for U.S. health service area. 
SOURCE: National Vital Statistics System – Mortality, CDC, NCHS. 
Figure 15-3. Deaths from Unintentional Injuries  2005-07 
Healthy People 2010 objective 15-13 
Target = 17.1 
no health service areas met target 
rates are unreliable 
21.4 - 38.5 
38.6 - 50.2 
50.3 - 64.8 
64.9 - 88.3 
88.4 - 132.1 
Rate per 100,000 
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NOTES: Data are for ICD-10 codes V02-V04 (.1- .9), V09.2, V12-V14 (.3-.9), V19 (.4-.6), V20-V28 (.3-.9), V29 (.4-.9), V30-V39 (.4-.9), V40-V49 (.4-.9),  
V50-V59 (.4-.9), V60-V69 (.4-.9), V70-V79 (.4-.9), V80 (.3-.5), V81.1, V82.1, V83-V86 (.0-.3), V87 (.0-.8), V89.2 reported as underlying cause.   
Rates are per 100,000 U. S. Population age-adjusted to the 2000 standard population.  Rates are displayed by modified Jenks classification for U. S.  
health service area. 
SOURCE: National Vital Statistics System – Mortality, CDC, NCHS. 
Figure 15-4.  Motor Vehicle Deaths  2005-07 
Healthy People 2010 objective 15-15a 
Target = 8.0 
lowest category (green) shows health service areas meeting target 
4.6 - 8.0 
8.1 - 21.3 
21.4 - 29.9 
30.0 - 44.3 
44.4 - 73.6 
rates are unreliable 
Rate per 100,000 
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Goal: Improve the health and well-being of women, 
infants, children, and families 
The objectives in this chapter address a wide range of conditions related to the health and quality of 
life for mothers, infants, and children. These include infant and child deaths, congenital anomalies, 
pregnancy-related illness, low birth weight and preterm deliveries, prenatal care, breastfeeding, 
newborn screenings, and availability of medical homes for children with special health care needs. 
All Healthy People tracking data quoted in this chapter, along with technical information and 
operational definitions for each objective, can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
More information about this focus area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from 
http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from 
http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas. 
 
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade 
[1]. Two-thirds (66.7%) of the Maternal, Infant, and Child Health objectives with data to 
measure progress moved toward or achieved their Healthy People 2010 targets (Figure 16-
1). However, health disparities of 100% or more among racial and ethnic population 
groups, as well as by sex and education level also were observed (Figure 16-2) [2]. 
 The fetal, perinatal, infant, neonatal, and postneonatal mortality rates (objectives 16-1a 
through 16-1e) declined over the decade, moving toward their 2010 targets. Between 1997 
and 2005, the fetal mortality rate (deaths to fetuses of 20 weeks or more gestation per 
1,000 live births and fetal deaths, objective 16-1a) decreased by 8.8%, from 6.8 to 6.2, 
moving toward the 2010 target of 4.1. The infant mortality rate (deaths to infants aged less 
than one year per 1,000 live births, objective 16-1c) declined by 6.9% between 1998 and 
2006, from 7.2 to 6.7, moving toward the 2010 target of 4.5. 
 Among racial and ethnic groups, the Asian or Pacific Islander population had the 
lowest (best) death rates for all of these objectives (16-1a through e). Disparities of 
100% or more in all these objectives were observed for the black non-Hispanic 
population compared to the group with the best rate. For example: 
 In 2005, the fetal mortality rate for the Asian or Pacific Islander population 
(objective 16-1a) was 4.8 fetal deaths per 1,000 live births plus fetal deaths, 
whereas the rate for the black non-Hispanic population was 11.1, almost two 
and a half times that for the Asian or Pacific Islander population [2]. 
 Similarly, the infant mortality rate for the Asian or Pacific Islander 
population (objective 16-1c) was 4.5 per 1,000 live births in 2006, whereas 
the rate for the black non-Hispanic population was 13.4, about three times 
that for the Asian or Pacific Islander population [2]. 
Maternal, Infant, and Child Health  Page 16-3 
 The American Indian or Alaska Native population also experienced large 
disparities in infant (objective 16-1c) and postneonatal mortality rates 
(objective 16-1e; deaths to infants aged 28 days to less than one year per 
1,000 live births). In 2006, the American Indian or Alaska Native population 
had an infant mortality rate of 8.3, almost twice the Asian or Pacific Islander 
population rate of 4.5. The American Indian or Alaska Native population also 
had a postneonatal mortality rate of 4.0 per 1,000 live births, almost three 
times the Asian or Pacific Islander population rate of 1.4. The postneonatal 
mortality rate for the black non-Hispanic population (4.4 per 1,000 live 
births) was more than three times that for the Asian or Pacific Islander 
population [2]. 
 Among education groups, infants of mothers aged 20 years and over with at least 
some college education had the lowest (best) postneonatal mortality rate (objective 
16-1e), 1.4 postneonatal deaths per 1,000 live births in 2002. Infants whose 
mothers had less than a high school education had a rate of 3.3 postneonatal deaths 
per 1,000 live births in 2002, almost two and a half times the best group rate [2]. 
 Deaths from sudden infant death syndrome (SIDS; objective 16-1h) among infants less than 
one year of age declined by 17.9% between 1999 and 2006, from 0.67 to 0.55 deaths per 
1,000 live births, moving toward the 2010 target of 0.23. The proportion of infants aged less 
than eight months who were placed to sleep on their backs (objective 16-13) increased by 
105.6% between 1996 and 2009, from 36% to 74%, exceeding the target of 70%. Placing 
infants to sleep on their backs is considered one of the best ways to reduce risk of SIDS [3]. 
 Among racial and ethnic groups, the Hispanic or Latino population had the lowest 
(best) SIDS death rate, 0.27 deaths per 1,000 live births in 2006. In 2006, the white 
non-Hispanic population had a SIDS death rate of 0.56 per 1,000 live births, more 
than twice the best group rate (that for the Hispanic or Latino population); the black 
non-Hispanic population had a rate of 1.05 per 1,000 live births, almost four times 
the best rate; and the rate for the American Indian or Alaska Native population was 
1.19 per 1,000 live births, almost four and a half times the best group rate [2]. 
 Among education groups, infants of mothers with at least some college education 
had the lowest (best) rate of SIDS death in 2002, 0.27 per 1,000 live births. In 2002, 
the rate for infants whose mothers were high school graduates was 0.69, about two 
and a half times the best group rate. The rate for infants whose mothers had less 
than a high school education was 0.86, more than three times the best rate [2]. 
 Death rates among children and adolescents (objectives 16-2a and b, and 16-3a and b) 
declined by 11% to 21% between 1998 and 2007, moving toward the 2010 targets. Yet the 
death rate for young adults aged 20–24 years (objective 16-3c) increased by 6.0%, from 
92.7 to 98.3 deaths per 100,000 population, moving away from the 2010 target of 41.5. 
 In 2007, among racial and ethnic groups, the Asian or Pacific Islander population 
had the lowest (best) mortality rates for all age groups, although the rate for 
children aged 5–9 years (objective 16-2b) did not meet the reliability criterion for 
the best group rate. Therefore, the white non-Hispanic population was considered 
to have the best rate for the purpose of racial and ethnic disparity comparisons for 
this objective; see Figure 16-2 footnotes. 
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Mortality—Children aged 1–4 years (objective 16-2a) 
 The Asian or Pacific Islander population had the lowest (best) mortality rate among 
children aged 1–4 years, 21.7 deaths per 1,000 population in 2007, whereas the 
American Indian or Alaska Native and black non-Hispanic populations had rates of 
54.9 and 43.7 per 1,000 in 2007, respectively. The rate for the American Indian or 
Alaska Native population was about two and a half times the best rate, while that for 
the black non-Hispanic population was about twice the best rate [2]. 
Mortality—Adolescents aged 10–14 years (objective 16-3a) 
 The Asian or Pacific Islander population had the lowest (best) mortality rate among 
adolescents aged 10–14 years, 12.3 deaths per 100,000 population in 2007. The 
black non-Hispanic population had a rate of 24.6 per 100,000 in 2007, twice the best 
rate [2]. 
Mortality—Adolescents aged 15–19 years (objective 16-3b) 
 In 2007, the Asian or Pacific Islander population had the lowest (best) mortality rate 
among adolescents aged 15–19 years, 32.7 deaths per 100,000 population, whereas 
the American Indian or Alaska Native and black non-Hispanic populations had rates 
of 86.5 and 85.7 deaths per 100,000, respectively, more than two and a half times 
the best rate [2]. 
Mortality—Young adults aged 20–24 years (objective 16-3c) 
 The Asian or Pacific Islander population had the lowest (best) mortality rates 
among young adults aged 20–24 years, 41.6 deaths per 100,00 population in 1998 
and 53.2 in 2007. The American Indian or Alaska Native population had rates of 
127.6 in 1998 and 120.7 in 2007, while the black non-Hispanic population had rates 
of 163.4 in 1998 and 142.2 in 2007.  
 In 2007, the rate for the American Indian or Alaska Native population was 
almost two and a half times the best rate (that for the Asian or Pacific 
Islander population); and the rate for the black non-Hispanic population was 
more than two and a half times the best rate [2]. 
 Between 1998 and 2007, the disparity between the American Indian or 
Alaska Native population and the Asian or Pacific Islander population (group 
with the best rate) decreased by 80 percentage points, while the disparity 
between the black non-Hispanic population and the Asian or Pacific Islander 
population decreased by 125 percentage points [4]. 
Mortality—Females aged 15–19 and 20–24 years (objectives 16-3b and c) 
 Females aged 15–19 and 20–24 years had lower (better) death rates than males, 
35.7 and 48.4 deaths per 100,000 population, respectively in 2007. The rate for 
males aged 15–19 years was 86.8 per 100,000, almost two and a half times the rate 
for females. The rate for males aged 20–24 years was 145.2 per 100,000, three times 
the rate for females [2]. 
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 Cesarean births to low risk women increased between 1998 and 2007. During this period 
the proportion of cesarean births to low risk women who had not had a previous cesarean 
(objective 16-9a) rose by 44.4%, from 18% to 26%, moving away from the 2010 target of 
15%. The proportion of repeat cesarean births (objective 16-9b) increased by 26.4%, from 
72% to 91%, moving away from the 2010 target of 63%. 
 Between 1998 and 2007, the proportion of live births that were low birth weight (under 
2,500 grams, objective 16-10a) and very low birth weight (under 1,500 grams, objective 16-
10b) increased by 7.9% (from 7.6% to 8.2%) and 7.1% (from 1.4% to 1.5%), respectively, 
moving away from the 2010 targets of 5.0% and 0.9%. 
 Among racial and ethnic groups, the Hispanic or Latino population had the lowest 
(best) rate of low birth weight births, 6.9% in 2007. The black non-Hispanic 
population had a rate of 13.9% in 2007, about twice the best rate. The Asian or 
Pacific Islander population had the lowest (best) rate of very low birth weight 
births, 1.1% in 2007. The rate of very low birth weight births for the black non-
Hispanic population was 3.2% in 2007, almost three times the best rate [2]. 
 Low birth weight birth rates varied by geographic region. In 2006–08, the proportions of 
low birth weight infants born in the Southeast and Mountain West were higher than the 
proportions of low birth weight infants born in the Northwest, Midwest, and Northeast 
regions of the U.S. A few geographic areas met the 2010 target of 5.0 low birth weight births 
per 1,000 live births (Figure 16-3). 
 Between 1998 and 2007, the proportion of live births that were preterm (less than 37 
completed weeks of gestation, objective 16-11a) increased by 9.5%, from 11.6% to 12.7%, 
moving away from the 2010 target of 7.6%. 
 Preterm births varied by geographic region. In 2006–08, the proportion of preterm infants 
born in the Southeast was higher than the proportion of preterm infants born in the 
Northwest, Midwest, or Northeast regions of the U.S. (Figure 16-4). 
 The proportion of non-pregnant women aged 15–44 years who consumed at least 400 µg of 
folic acid (objective 16-16a) increased by 14.3% between 1991–94 and 2005–06, from 21% 
to 24%, moving toward the 2010 target of 80%. The median red blood cell (RBC) folate 
level (objective 16-16b) among non-pregnant women aged 15–44 years increased by 58.2% 
between 1988–94 and 2005–06, from 158 to 250 ng/ml, exceeding the 2010 target of 220. 
Between 1996 and 2007, the rate of spina bifida and other neural tube defects (objective 
16-15) decreased by 20.0%, from 60 to 48 new cases per 100,000 live births, moving 
toward the 2010 target of 30 per 100,000. 
 The proportion of mothers who breastfed their infants (objectives 16-19a through e) 
increased for every category, moving toward the 2010 targets. The largest increase was 
observed for the proportion of mothers who breastfed their infants at one year after birth 
(objective 16-19c). Between 2000 and 2006, the proportion increased by 43.8%, from 16% 
to 23%, moving toward the 2010 target of 25%. 
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Summary of Progress 
 Figure 16-1 presents a quantitative assessment of progress in achieving the Healthy People 
2010 objectives for Maternal, Infant, and Child Health [1]. Data to measure progress toward 
target attainment were available for 42 objectives. Of these: 
 Three objectives (16-13, 16-14c, and 16-16b) exceeded their 2010 targets. 
 Twenty-five objectives moved toward their targets. A statistically significant 
difference between the baseline and the final data points was observed for 19 of 
these objectives (16-1a through e; 16-1g and h; 16-2a and b; 16-3a and b; 16-6a and 
b; 16-17c; and 16-19a through e). No significant differences were observed for three 
objectives (16-4, 16-5a, and 16-21); and data to test the significance of the 
difference were unavailable for three objectives (16-8, 16-15, and 16-16a). 
 Five objectives (16-1f; 16-11c; and 16-17a, b, and d) showed no change. 
 Nine objectives moved away from their targets. A statistically significant difference 
between the baseline and final data points was observed for seven of these 
objectives (16-3c; 16-9a and b; 16-10a and b; and 16-11a and b). No significant 
differences were observed for two objectives (16-14a and b). 
 Three objectives (16-12, and 16-20a and b) remained developmental [5]. Data were 
unavailable to measure progress for four objectives (16-7, 16-18, 16-22, and 16-23). Four 
objectives (16-5b and c, 16-14d, and 16-20c) were dropped during the decade [6]. 
 Figure 16-2 displays health disparities in Maternal, Infant, and Child Health from the best 
group rate for each characteristic at the most recent data point [2]. It also displays changes 
in disparities from baseline to the most recent data point [4]. 
 Thirty-three objectives had statistically significant racial and ethnic health 
disparities of 10% or more, and four additional objectives had racial and ethnic 
health disparities of 10% or more but lacked data to assess statistical significance. 
Of these 37 objectives, the Asian or Pacific Islander population had the only best 
rate for 13 objectives (16-1b through f; 16-2a; 16-3a through c; 16-10b; and 16-11a 
through c). The white non-Hispanic population had the only best rate for 11 
objectives (16-2b, 16-4, 16-5a, 16-6a and b, 16-7, 16-13, 16-14a, 16-14c, and 16-16a 
and b). The Asian population had the only best rate for four objectives (16-19b 
through e). The Hispanic or Latino population had the only best rate for three 
objectives (16-1h, 16-10a, and 16-19a). And the black non-Hispanic and American 
Indian or Alaska Native population each had the only best rate for one objective (16-
15 and 16-9a, respectively). The white non Hispanic and Hispanic or Latino 
populations both had the best rate for two objectives (16-1g and 16-18). The Asian 
or Pacific Islander and white non-Hispanic populations both had the best rate for 
one objective (16-1a). And the Asian or Pacific Islander and Hispanic or Latino 
populations both had the best rate for one objective (16-17c). 
 Twelve objectives had statistically significant health disparities of 10% or more by 
sex. Females had better rates for 11 of these 12 objectives (16-1b through 1e; 16-1h; 
16-2a and b; 16-3a through c; and 16-14a). Males had the better rate for the 
remaining objective (16-10a). 
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 Twenty-three objectives had statistically significant health disparities of 10% or 
more by education level (16-1a through h; 16-4; 16-6a and b; 16-10a and b; 16-11a 
through c; 16-16a and b; 16-17c; and 16-19a through d), and one additional 
objective (16-7) had a health disparity of 10% or more by education level but lacked 
data to assess statistical significance. Persons with at least some college education 
had the best rate for each of these 24 objectives. 
 Persons without disabilities had the better rate for the one objective (16-16a) with 
statistically significant health disparities of 10% or more by disability status. 
 Twenty objectives had racial and ethnic health disparities of 100% or more. Three 
objectives had health disparities of 100% or more by sex, and six objectives had 
health disparities of 100% or more by education level. Changes in disparity between 
the baseline and most recent points were observed for several objectives. Many of 
these disparities are discussed in the Highlights, above. 
 
Transition to Healthy People 2020 
For Healthy People 2020, the Maternal, Infant, and Child Health Topic Area continues to address a 
wide range of conditions, health behaviors, and health systems indicators that affect the health, 
wellness, and quality of life of women, infants, children, and families. See HealthyPeople.gov for a 
complete list of Healthy People 2020 topics and objectives. 
The Healthy People 2020 Maternal, Infant, and Child Health objectives can be grouped into seven 
sections: 
 Morbidity and mortality 
 Pregnancy health and behaviors 
 Preconception health behaviors 
 Postpartum health and behaviors 
 Infant care 
 Disability and other impairments 
 Health services. 
The transition from Healthy People 2010 to Healthy People 2020 objectives is summarized below: 
 The Healthy People 2020 Maternal, Infant, and Child Health Topic Area has 71 objectives, 10 
of which are developmental, whereas the Healthy People 2010 Focus Area had 53 
objectives, three of which were developmental [5]. 
 Thirty Healthy People 2010 objectives, including 13 mortality objectives (16-1a through h; 
16-2a and b; and 16-3a through c), five morbidity objectives (16-5a, 16-10a and b, and 16-
11a and c), five breastfeeding objectives (16-19a through e), three obstetrical/infant care 
objectives (16-9a and b, and 16-22), one folic acid intake objective (16-16a), two objectives 
on abstinence from illicit drugs and alcohol during pregnancy (objectives 16-17a and d), 
and one objective on VLBW infants born at level III facilities (objective 16-8) were retained 
“as is” [7]. 
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 One Healthy People 2010 objective (16-14a), children diagnosed with mental retardation, 
was archived [8]. 
 Four Healthy People 2010 objectives were dropped during the decade due to the lack of a 
national data source [6]. The dropped objectives include hospitalization for ectopic 
pregnancies (objective 16-5b), hospitalizations for postpartum complications including 
depression (objective 16-5c), children diagnosed with epilepsy (objective 16-14d), and 
enrollment of infants with disorders diagnosed through newborn bloodspot screening in 
appropriate service interventions (objective 16-20c). 
 Eighteen Healthy People 2010 objectives were modified to create 24 Healthy People 2020 
objectives [9]: 
 Maternal mortality statistics are based upon the information recorded on death 
certificates and collected by state and local vital records offices. Due to concerns 
about data quality in the ascertainment of maternal mortality, the 2003 revision of 
the standard death certificate introduced improved data quality but produced rates 
that are not comparable to rates produced using the 1989 version of the death 
certificate [10]. For Healthy People 2010, data obtained from the 1989 version of 
the standard death certificate were used from baseline through 2002 to track this 
objective (16-4). The Healthy People 2020 objective will be tracked with data from 
the 2003 standard death certificate. 
 Objectives on prenatal care (objective 16-6a and b) and maternal smoking during 
pregnancy (objective 16-17c) were derived from information recorded on birth 
certificates and also collected by states and local vital records offices. Due to the 
desire to produce more robust information, the 2003 revision of the standard birth 
certificate introduced improved data quality but produced rates that are not 
comparable to rates produced using the 1989 version of the birth certificate [11,12]. 
For Healthy People 2010, data obtained from the 1989 version of the standard birth 
certificate were used from baseline through 2002 to track these objectives. The 
Healthy People 2020 objectives will be tracked with data from the 2003 standard 
birth certificate. 
 The objective on maternal weight gain during pregnancy (objective 16-12) 
remained developmental throughout the tracking period for Healthy People 2010. 
New data from the 2003 revision of the standard birth certificate will be used to 
track this objective in Healthy People 2020. 
 In Healthy People 2010, only one national data point could be obtained to monitor 
the proportion of pregnant women who attended childbirth classes (objective 16-7). 
The data system used to track this objective is being changed for Healthy People 
2020 in the effort to provide trend data. 
 Preterm birth at 32–36 weeks gestation (objective 16-11b) was revised to include 
an additional objective to monitor the rate of late preterm birth (live births at 34–36 
weeks gestation) in addition to live births at 32–33 weeks gestation, live births at 
less than 32 weeks gestation, and total preterm births. This change was made in 
recognition of evidence showing that late preterm infants, those born between 34 
and 36 completed weeks of gestation, comprise over 70% of all preterm births and 
account for almost all of the increase in the U.S. preterm birth rate over the past two 
decades [13]. These new reporting categories are consistent with reports on birth 
outcomes [14]. 
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 Fetal alcohol syndrome (objective 16-18) is tracked with data from the Fetal Alcohol 
Syndrome Surveillance Network (FASSNet). For Healthy People 2010, the overall 
prevalence was determined using data from four of the five funded states for the 
birth years 1995 through 1997 [15]. When the FASSNet cooperative agreement 
ended, seven programs from eight states were funded under a different agreement 
to conduct prevention and surveillance of fetal alcohol syndrome. Colorado was the 
only state to be funded under both FASSNet and the new agreement. Since the 
remaining funded states did not include the FASSNet states, the data used to 
monitor the Healthy People 2020 objective are not comparable to the Healthy 
People 2010 data. 
 In 2002, the National Institute on Alcohol Abuse and Alcoholism revised the 
definition of binge drinking for women from drinking five or more alcoholic 
beverages at the same time or within a couple of hours of each other to four or more 
alcoholic beverages [16]. For Healthy People 2010, binge drinking during pregnancy 
(objective 16-17b) is tracked with the original definition. Healthy People 2020 will 
track binge drinking with the revised definition. 
 Data for newborn bloodspot screening and follow-up was never obtained to track 
the two Healthy People 2010 objectives (16-20a and b). In Healthy People 2020, the 
data source was changed, and the objectives were modified so that they could be 
tracked. An additional objective that tracks annual assessments of services was also 
added. 
 The Healthy People 2010 infant sleep position objective (16-13) was tracked using 
data from the National Infant Sleep Position Study. The Pregnancy Risk Assessment 
Monitoring System is used to measure infant sleep position for the Healthy People 
2020 objective. The new data source will monitor the percentage of infants who are 
placed to sleep on their backs. 
 The Healthy People 2010 objective monitoring the rate of cerebral palsy in children 
(objective 16-14b) was revised to track the proportion of children with cerebral 
palsy born at low birth weight (less than 2,500 grams). The scope was shifted 
because cerebral palsy is the most common motor disability in childhood affecting 
approximately 1.5 to 3.3 per 1,000 live births [17]. The inverse relationship 
between increased risk of cerebral palsy and being born at lower birth weights has 
been consistently well supported over time [18]. 
 The Healthy People 2010 objective that tracked the average age at which autism 
spectrum disorders were identified in children (objective 16-14c) was revised into 
three Healthy People 2020 objectives: the proportion of young children screened for 
autism spectrum disorders (ASD) by 24 months of age, the proportion of children 
with an ASD with a first evaluation by 36 months of age, and the proportion of 
children with an ASD enrolled in special services by 48 months of age. 
 The Healthy People 2010 objective that tracked the occurrence of spina bifida and 
other neural tube defects (objective 16-15) was revised into two Healthy People 
2020 objectives: the rate of anencephaly diagnosed in infants and the rate of spina 
bifida diagnosed in infants. 
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 The Healthy People 2010 objective that tracked the median red blood cell (RBC) 
folate concentration in non-pregnant women (objective 16-16b) was revised for 
Healthy People 2020 to track the proportion of non-pregnant women with low RBC 
folate levels. The Healthy People 2010 target for this objective was exceeded; the 
revision reflects a continued interest in monitoring women at greatest risk sub-
optimal RBC folate concentrations. 
 The Healthy People 2010 objective that tracked the rate of hospitalization for sickle 
cell disease in black or African American children (objective 16-21) was moved to 
the Blood Disorders and Blood Safety Topic Area for Healthy People 2020. 
 The Healthy People 2010 objective addressing the proportion of children with 
special health care needs under 18 years of age who receive their care in family-
centered, comprehensive, coordinated systems (objective 16-23) was divided into 
two objectives: children less than 11 years and children aged 12–17 years. 
 Seventeen new objectives, seven of which are developmental, were added to the Healthy 
People 2020 Topic Area: 
 Two new objectives that track infant deaths; one from sudden unexpected infant 
deaths (SUID) and the other is for infants diagnosed with Down syndrome. 
 Six new objectives relate to preconception care services and health behaviors prior 
to pregnancy: 
 Discussed preconception health with a health professional 
 Took multivitamins/folic acid 
 Did not smoke 
 Did not drink 
 Had a healthy weight 
 Used contraception to plan pregnancy. 
 Two new objectives (targeting men and women, individually) will track impaired 
fecundity. 
 Two new objectives will track postpartum health and behaviors: the relapse of 
smoking among women who quit smoking during pregnancy and the proportion of 
women giving birth who attend a postpartum care visit with a health care 
professional. 
 Three new objectives will target infant care: 
 Employers that have worksite lactation support programs 
 Breastfed newborns not given formula within the first 2 days of life 
 Births in facilities that provide recommended care for lactating mothers and 
their babies. 
 Two new objectives will track children with developmental delays. The first will 
track the child’s age at first evaluation and the second will track the child’s age when 
enrolled in special services. 
Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” 
summarizes the changes between the two decades of objectives, reflecting new knowledge and 
direction for this area. 
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Data Considerations 
Education and income are the primary measures of socioeconomic status (SES) in Healthy People 
2010. Most data systems used in Healthy People 2010 define income as a family’s income before 
taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size 
and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed 
by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. 
These categories may be overridden by considerations specific to the data system, in which case 
they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. 
In general, data on educational attainment are presented for persons aged 25 years and over, 
consistent with guidance given by the U.S. Bureau of the Census. However, because of the 
requirements of the different data systems, the age groups used to calculate educational attainment 
for any specific objective may differ from the age groups used to report the data for other Healthy 
People 2010 objectives, as well as from select populations within the same objective. Therefore, the 
reader is urged to exercise caution in interpreting the data by educational attainment shown in the 
Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. 
Beginning in 2003, education data from the National Vital Statistics System have been suppressed. 
The educational attainment item was changed in the new U.S. Standard Certificates for Births, 
Deaths, and Fetal Death in 2003 to be consistent with the U.S. Census Bureau data and to improve 
the ability to identify specific types of educational degrees. Many states, however, are still using the 
1989 version of the U.S. Standard Certificates, which focuses on highest school grade completed. As 
a result, educational attainment data collected using the 2003 version are not comparable with data 
collected using the 1989 version [19]. 
Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can 
be found in the Operational Definitions on the DATA2010 website, available from 
http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement 
can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, 
which is available in the Data Issues section of the NCHS Healthy People website under 
Healthy People 2010. 
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Comprehensive Summary of Objectives: Maternal, Infant, and Child Health 
Objective  Description Data Source or Objective Status 
16-1a Fetal deaths (20+ weeks gestation, per 1,000 live births plus fetal 
deaths) 
National Vital Statistics System—Fetal Death and Natality (NVSS-FD, 
NVSS-N), CDC, NCHS. 
16-1b Perinatal deaths (28 weeks gestation to <7 days after birth, per 1,000 
live births plus fetal deaths) 
National Vital Statistics System—Fetal Death, Mortality and Natality 
(NVSS-FD, NVSS-M, NVSS-N), CDC, NCHS. 
16-1c All Infant deaths (<1 year, per 1,000 live births) National Vital Statistics System—Mortality and Natality (NVSS-M, 
NVSS-N), CDC, NCHS. 
16-1d Neonatal deaths (<28 days, per 1,000 live births) National Vital Statistics System—Mortality and Natality (NVSS-M, 
NVSS-N), CDC, NCHS. 
16-1e Postneonatal deaths (28 days to <1 year, per 1,000 live births) National Vital Statistics System—Mortality and Natality (NVSS-M, 
NVSS-N), CDC, NCHS. 
16-1f Infant deaths due to birth defects (<1 year, per 1,000 live births) National Vital Statistics System—Mortality and Natality (NVSS-M, 
NVSS-N), CDC, NCHS. 
16-1g Infant deaths due to congenital heart defects (<1 year, per 1,000 live 
births) 
National Vital Statistics System—Mortality and Natality (NVSS-M, 
NVSS-N), CDC, NCHS. 
16-1h Infant deaths due to sudden infant death syndrome (SIDS) (<1 year, per 
1,000 live births) 
National Vital Statistics System—Mortality and Natality (NVSS-M, 
NVSS-N), CDC, NCHS. 
16-2a Child deaths—1–4 years (per 100,000 population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
16-2b Child deaths—5–9 years (per 100,000 population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
16-3a Adolescent and young adult deaths—10–14 years (per 100,000 
population) 
National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
16-3b Adolescent and young adult deaths—15–19 years (per 100,000 
population) 
National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
16-3c Adolescent and young adult deaths—20–24 years (per 100,000 
population) 
National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
16-4 Maternal deaths (per 100,000 live births) National Vital Statistics System—Mortality and Natality (NVSS-M, 
NVSS-N), CDC, NCHS. 
16-5a Maternal complications during hospitalized labor and delivery (per 100 
deliveries) 
National Hospital Discharge Survey (NHDS), CDC, NCHS. 
16-5b Maternal illness and complications due to pregnancy—Hospitalizations 
for ectopic pregnancies 
Dropped 
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Objective  Description Data Source or Objective Status 
16-5c Maternal illness and complications due to pregnancy—Hospitalizations 
for postpartum complications, including depression 
Dropped 
16-6a Prenatal care—Beginning in first trimester National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-6b Prenatal care—Early and adequate National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-7 Childbirth class attendance—Pregnant women who attend National Survey of Early Childhood Health (NSECH): HRSA, MCHB; CDC, 
NCHS. 
16-8 Very low birth weight infants born at level III hospitals Title V Reporting System, HRSA. 
16-9a Cesarean births—No prior cesarean birth National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-9b Cesarean births—Prior cesarean birth National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-10a Low birth weight (LBW), infants (<2,500 grams) National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-10b Very low birth weight (VLBW), infants (<1,500 grams) National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-11a Preterm live births—Total (<37 weeks gestation) National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-11b Preterm live births—32–36 weeks gestation National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-11c Preterm live births—<32 weeks gestation National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-12 Recommended weight gain during pregnancy Developmental 
16-13 Infants put to sleep on their backs (<8 months) National Infant Sleep Position Study (NISP), NIH, NICHD. 
16-14a Developmental disabilities—Mental retardation—IQ ≤70 (per 10,000 
population, Metropolitan Atlanta, 8 years) 
Metropolitan Atlanta Development Disabilities Surveillance Program 
(MADDSP), CDC, NCBDDD. 
16-14b Developmental disabilities—Cerebral palsy (per 10,000 population, 
Metropolitan Atlanta, 8 years) 
Metropolitan Atlanta Development Disabilities Surveillance Program 
(MADDSP), CDC, NCBDDD. 
16-14c Developmental disabilities—Age at first identification of autism 
spectrum disorder (in months, Metropolitan Atlanta, 8 years) 
Metropolitan Atlanta Development Disabilities Surveillance Program 
(MADDSP), CDC, NCBDDD. 
16-14d Epilepsy—Metropolitan Atlanta Dropped 
16-15 Spina bifida and other neural tube defects (new cases per 100,000 live 
births) 
National Birth Defects Prevention Network (NBDPN), CDC, NCBDDD. 
16-16a Folic acid consumption ≥400µg daily by nonpregnant women (15–44 
years) 
National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
16-16b Median red blood cell (RBC) folate level among nonpregnant women 
(ng/ml, 15–44 years) 
National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
16-17a Pregnant women abstaining from alcohol in past month (15–44 years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 
Maternal, Infant, and Child Health  Page 16-16 
Objective  Description Data Source or Objective Status 
16-17b Pregnant women abstaining from binge drinking in past month (15–44 
years) 
National Survey on Drug Use and Health (NSDUH), SAMHSA. 
16-17c Pregnant women abstaining from cigarette smoking during pregnancy National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-17d Pregnant women abstaining from illicit drugs in past month (15–44 
years) 
National Survey on Drug Use and Health (NSDUH), SAMHSA. 
16-18 Fetal alcohol syndrome (cases per 1,000 live births) Fetal Alcohol Syndrome Surveillance System (FASSNet), CDC, NCBDDD. 
16-19a Breastfeeding—Ever National Immunization Survey (NIS), CDC, NCIRD and NCHS. 
16-19b Breastfeeding—At 6 months National Immunization Survey (NIS), CDC, NCIRD and NCHS. 
16-19c Breastfeeding—At 1 year National Immunization Survey (NIS), CDC, NCIRD and NCHS. 
16-19d Exclusive breastfeeding—Through 3 months National Immunization Survey (NIS), CDC, NCIRD and NCHS. 
16-19e Exclusive breastfeeding—Through 6 months National Immunization Survey (NIS), CDC, NCIRD and NCHS. 
16-20a Newborn bloodspot screening—State-mandated conditions Developmental 
16-20b Newborn bloodspot screening—Timely follow-up diagnostic testing for 
screening positives 
Developmental 
16-20c Newborn bloodspot screening—Timely enrollment of infant with 
diagnosed disorders in appropriate service interventions 
Dropped 
16-21 Hospital discharges for sickle cell disease (per 100,000 black or African 
American children, ≤9 years) 
National Hospital Discharge Survey (NHDS), CDC, NCHS. 
16-22 Medical homes for children with special health care needs National Survey of Children with Special Health Care Needs (NS-
CSHCN), CDC, NCHS. 
16-23 Service systems for children with special health care needs National Survey of Children with Special Health Care Needs (NS-
CSHCN), CDC, NCHS. 
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Figure 16-1. Progress Toward Target Attainment for Focus Area 16: Maternal, Infant, and Child Health 
Percent of targeted change achieved5 (continued) 
 
16-1a. Fetal deaths (20+ weeks gestation, per 1,000 
live births plus fetal deaths) 
16-1b. Perinatal deaths (28 weeks  gestation to <7 
days after birth, per 1,000 live births plus 
fetal deaths)  
16-1c. All Infant deaths (<1 year, per 1,000 live 
births) 
16-1d. Neonatal deaths (<28 days, per 1,000 live 
births) 
16-1e. Postneonatal deaths (28 days to <1 year, per 
1,000 live births)  
  
16-1f. Infant deaths due to birth defects (<1 year, 
per 1,000 live births) 
16-1g. Infant deaths due to congenital heart defects 
(<1 year, per 1,000 live births) 
16-1h. Infant deaths due to sudden infant death 
syndrome (SIDS) (<1 year, per 1,000 live 
births) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
4.1 
6.8 
(1997) 
6.2 
(2005) 
-0.6 Yes -8.8% 
4.4 
7.3 
(1997) 
6.6 
(2005) 
-0.7 Yes -9.6% 
4.5 
7.2 
(1998) 
6.7 
(2006) 
-0.5 Yes -6.9% 
2.9 
4.8 
(1998) 
4.5 
(2006) 
-0.3 Yes -6.2% 
1.2 
2.4 
(1998) 
2.2 
(2006) 
-0.2 Yes -8.3% 
0.7 
1.4 
(1999) 
1.4 
(2006) 
0.0 No 0.0% 
0.23 
0.46 
(1999) 
0.38 
(2006) 
-0.08 Yes -17.4% 
0.23 
0.67 
(1999) 
0.55 
(2006) 
0.12 Yes -17.9 
22.2% 
24.1% 
18.5% 
15.8% 
16.7% 
0.0% 
34.8% 
27.3% 
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Figure 16-1. Progress Toward Target Attainment for Focus Area 16: Maternal, Infant, and Child Health (continued) 
Percent of targeted change achieved5 (continued) 
 
16-2. Child deaths (per 100,000 population) 
  a. 1–4 years  
  b. 5–9 years   
16-3. Adolescent and young adult deaths (per 
100,000 population) 
  a. 10–14 years 
  b. 15–19 years  
  c. 20–24 years  
16-4. Maternal deaths (per 100,000 live births)  
16-5a. Maternal complications during hospitalized 
labor and delivery (per 100 deliveries) 
16-6. Prenatal care 
  a. Beginning in first trimester 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
20.0 
34.1 
(1998) 
28.6 
(2007) 
-5.5 Yes -16.1% 
13.0 
17.2 
(1998) 
13.7 
(2007) 
-3.5 Yes -20.3% 
16.5 
21.5 
(1998) 
16.9 
(2007) 
-4.6 Yes -21.4% 
38.0 
69.5 
(1998) 
61.9 
(2007) 
-7.6 Yes -10.9% 
41.5 
92.7 
(1998) 
98.3 
(2007) 
5.6 Yes 6.0% 
4.3 
9.9 
(1999) 
8.9 
(2002) 
-1.0 No -10.1% 
24.0 
31.2 
(1998) 
31.1 
(2007) 
-0.1 No -0.3% 
90% 
83% 
(1998) 
84% 
(2002) 
1 Yes 1.2% 
39.0% 
83.3% 
92.0% 
24.1% 
17.9% 
1.4% 
14.3% 
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Percent of targeted change achieved5 (continued) 
 
16-6. Prenatal care 
  b. Early and adequate 
16-8. Very low birth weight infants born at level III 
hospitals   
16-9. Cesarean births 
  a. No prior cesarean birth 
  b. Prior cesarean birth 
16-10a. Low birth weight (LBW), infants (<2,500 
grams)   
16-10b. Very low birth weight (VLBW), infants 
(<1,500 grams)  
16-11. Preterm live births  
   a. Total (<37 weeks gestation)  
  b. 32–36 weeks gestation 
 
Figure 16-1. Progress Toward Target Attainment for Focus Area 16: Maternal, Infant, and Child Health (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
90% 
74% 
(1998) 
75% 
(2002) 
1 Yes 1.4% 
90% 
73% 
(1996–97) 
76% 
(2008) 
3 
Not 
tested 
4.1% 
15% 
18% 
(1998) 
26% 
(2007) 
8 Yes 44.4% 
63% 
72% 
(1998) 
91% 
(2007) 
19 Yes 26.4% 
5.0% 
7.6% 
(1998) 
8.2% 
(2007) 
0.6 Yes 7.9% 
0.9% 
1.4% 
(1998) 
1.5% 
(2007) 
0.1 Yes 7.1% 
7.6% 
11.6% 
(1998) 
12.7% 
(2007) 
1.1 Yes 9.5% 
6.4% 
9.6% 
(1998) 
10.6% 
(2007) 
1.0 Yes  10.4% 
6.3% 
17.6% 
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Percent of targeted change achieved5 (continued) 
 
16-11. Preterm live births 
  c. <32 weeks gestation  
16-13. Infants put to sleep on their backs (<8 
months)    
16-14. Developmental disabilities (Metropolitan 
Atlanta, 8 years) 
  a. Mental retardation—IQ ≤70 (per 
   10,000 population) 
  b. Cerebral palsy (per 10,000  
  population)  
  c. Age at first identification of autism 
   spectrum disorder (in months)   
16-15. Spina bifida and other neural tube defects 
(new cases per 100,000 live births)   
16-16a. Folic acid consumption ≥400µg daily by 
nonpregnant women (15–44 years)  
16-16b. Median red blood cell (RBC) folate level 
among nonpregnant women (ng/ml, 15–
44 years)  
 
Figure 16-1. Progress Toward Target Attainment for Focus Area 16: Maternal, Infant, and Child Health (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
1.1% 
2.0% 
(1998) 
2.0% 
(2007) 
0.0 No 0.0% 
70% 
36% 
(1996) 
74% 
(2009) 
38 
Not 
tested 
105.6% 
118.7 
124.9 
(1991–94) 
136.0 
(2008) 
11.1 No 8.9% 
30.2 
31.8 
(1991–94) 
36.4 
(2008) 
4.6 No 14.5% 
66 
69 
(1996) 
60 
(2008) 
-9 
Not 
tested 
-13.0% 
30 
60 
(1996) 
48 
(2007) 
-12 
Not 
tested 
-20.0% 
80% 
21% 
(1991–94) 
24% 
(2005–06) 
3 
Not 
tested 
14.3% 
220 
158 
(1988–94) 
250 
(2005–06) 
92 Yes 58.2% 
40.0% 
5.1% 
0.0% 
            111.8% 
            300.0% 
            148.4% 
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Percent of targeted change achieved5 (continued) 
 
16-17. Pregnant women abstaining from 
   a. Alcohol in past month (15–44 years)  
  b. Binge drinking in past month (15–44 
  years)  
  c. Cigarette smoking during pregnancy 
  
  d. Illicit drugs in past month (15–44 years)  
16-19 Breastfeeding 
  a. Ever  
  b. At 6 months  
  c. At 1 year  
 Exclusive breastfeeding 
  d. Through 3 months  
 
 
Figure 16-1. Progress Toward Target Attainment for Focus Area 16: Maternal, Infant, and Child Health (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
95% 
90% 
(2002–03) 
90% 
(2008–09) 
0 No 0.0% 
100% 
96% 
(2002–03) 
96% 
(2008–09) 
0 No  0.0% 
99% 
87% 
(1998) 
89% 
(2002) 
2 Yes 2.3% 
100% 
96% 
(2002–03) 
96% 
(2008–09) 
0 No 0.0% 
75% 
71% 
(2000) 
74% 
(2006) 
3 Yes 4.2% 
50% 
34% 
(2000) 
43% 
(2006) 
9 Yes 26.5% 
25% 
16% 
(2000) 
23% 
(2006) 
7 Yes 43.8% 
40% 
30% 
(2003) 
34% 
(2006) 
4 Yes 13.3% 
0.0% 
0.0% 
16.7% 
0.0% 
75.0% 
56.3% 
77.8% 
40.0% 
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Percent of targeted change achieved5 
(continued) 
 
16-19. Exclusive breastfeeding 
  e. Through 6 months    
16-21. Hospital discharges for sickle cell disease 
(per 100,000 black or African American 
children, ≤9 years)  
 
Figure 16-1. Progress Toward Target Attainment for Focus Area 16: Maternal, Infant, and Child Health (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
17% 
10% 
(2003) 
14% 
(2006) 
4 Yes 40.0% 
182.2 
227.8 
(1995–99) 
185.2 
(2003–07) 
-42.6 No -18.7% 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 16-7, 16-12, 16-18, 16-20a, 16-20b, 16-22, and 16-23.  Objectives 16-5b, 16-5c, 16-14d, and 16-20c were deleted at the Midcourse Review. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
 
 
57.1% 
93.4% 
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DATA SOURCES 
 
16-1a. National Vital Statistics System—Fetal Death and Natality (NVSS-FD, NVSS-N), CDC, NCHS.  
16-1b. National Vital Statistics System—Fetal Death, Mortality and Natality (NVSS-FD, NVSS-M, NVSS-N), CDC, NCHS.  
16-1c–h. National Vital Statistics System—Mortality and Natality (NVSS-M, NVSS-N), CDC, NCHS.  
16-2a–b. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
16-3a–c. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
16-4. National Vital Statistics System—Mortality and Natality (NVSS-M, NVSS-N), CDC, NCHS. 
16-5a. National Hospital Discharge Survey (NHDS), CDC, NCHS. 
16-6a–b. National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-8. Title V Reporting System, HRSA. 
16-9a–b. National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-10a–b. National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-11a–c. National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-13. National Infant Sleep Position Study (NISP), NIH, NICHD. 
16-14a–c. Metropolitan Atlanta Development Disabilities Surveillance Program (MADDSP), CDC, NCBDDD. 
16-15. National Birth Defects Prevention Network (NBDPN), CDC, NCBDDD. 
16-16a–b. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
16-17a–b. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
16-17c. National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
16-17d. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
16-19a–e. National Immunization Survey (NIS), CDC, NCIRD and NCHS. 
16-21. National Hospital Discharge Survey (NHDS), CDC, NCHS 
 
 
 
Figure 16-1. Progress Toward Target Attainment for Focus Area 16: Maternal, Infant, and Child Health (continued) 
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16-1a. Fetal deaths (20+ weeks gestation, per 1,000 live births 
plus fetal deaths) (1997, 2005)1,2,3* 2 NA
2d1
4 Bii 3 B 1 2 2 B 2 NA NA
16-1b. Perinatal deaths (28 weeks  gestation to <7 days after 
birth, per 1,000 live births plus fetal deaths) (1997, 
2005)1,2,3* 2d1
NA 2 4 1 2 B 2 2 2 B 2 NA NA
16-1c. All Infant deaths (<1 year, per 1,000 live births) (1998, 
2006)1,2,3* 3 NA
2u1 4u1 2u1 3u1
B 2 3 3 B 3 NA NA
16-1d. Neonatal deaths (<28 days, per 1,000 live births) (1998, 
2006)1,2,3* 2 NA 2
4u1
2d3 3d1
B 2 2 2 B 2 NA NA
16-1e. Postneonatal deaths (28 days to <1 year, per 1,000 live 
births) (1998, 2006)1,2,3* 4 NA 2
4u1 2u1
4 B 2 4
3u1
B
4u1
NA NA
16-1f. Infant deaths due to birth defects (<1 year, per 1,000 live 
births) (1999, 2006)1,2,3* 2 NA 2 3 2 2 B 1 2 2 B 2 NA NA
16-1g. Infant deaths due to congenital heart defects (<1 year, per 
1,000 live births) (1999, 2006)1,2,3* NA NA Bii
2d1
B NA B Bii
2d1
2 B 2 NA NA
16-1h. Infant deaths due to sudden infant death syndrome (SIDS) 
(<1 year, per 1,000 live births) (1999, 2006)1,2,3* 4 NA B 4
4u1
NA B
2d1
4 4 B 4 NA NA
16-2a. Child deaths—1–4 years (per 100,000 population) (1998, 
2007)* 4 NA 2
4d2 2d1
3 B 2 NA NA NA NA NA NA
16-2b. Child deaths—5–9 years (per 100,000 population) (1998, 
2007)* 1 NA 1
2d2
Bii NA B 2 NA NA NA NA NA NA
16-3a. Adolescent and young adults deaths—10–14 years (per 
100,000 population) (1998, 2007)* 3 NA 2 4 2 3 B
2d1
NA NA NA NA NA NA
16-3b. Adolescent and young adult deaths—15–19 years (per 
100,000 population) (1998, 2007)*
4u2
NA 3 4 3 4 B 4 NA NA NA NA NA NA
16-3c. Adolescent and young adult deaths—20–24 years (per 
100,000 population) (1998, 2007)*
4d2
NA
3d1 4d3 3d1 4d2
B 4 NA NA NA NA NA NA
16-4. Maternal deaths (per 100,000 live births) (1999, 2002)*
NA NA 1 4 B 4 NA NA 3 4 B 3 NA NA
16-5a. Maternal complications during hospitalized labor and 
delivery (per 100 deliveries) (1998, 2007)* NA NA NA NA NA 2iii Biii NA NA NA NA NA NA NA NA NA
16-6a. Prenatal care—Beginning in first trimester (1998, 2002)* 4u1
NA 4 4 B 4 NA NA
4u1 4u1
B
4u1
NA NA
16-6b. Prenatal care—Early and adequate (1998, 2002)*
3 NA 3 3 B 3 NA NA
3d1
2 B
3d1
NA NA
16-7. Childbirth class attendance among pregnant women 
(2000)† NA NA NA NA 4 4 B 4 NA NA 4 4 B 4 NA NA
16-9a. Cesarean births—No prior cesarean birth (1998, 
2007)1,2,3* B NA 1
2d1
1 2 NA NA B 1 1 1 NA NA
16-9b. Cesarean births—Prior cesarean birth (1998, 2007)1,2,3*
B NA 1 1 1 1 NA NA Bii 1 1 1 NA NA1
i
Figure 16-2. Health Disparities Table for Focus Area 16: Maternal, Infant, and Child 
Health
Disparities from the best group rate for each characteristic at the most recent data point and changes in 
disparity from the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Disability
NAi
(continued)
Population-based objectives
Bi
Bi
Bi
Bi
Bi
Bi
bi
bi
Bi
bi
Bi, ii
Bi
Bi
2i
2i
2i
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Characteristics and Groups
Race and Ethnicity Sex Education Disability
Figure 16-2. Health Disparities Table for Focus Area 16: Maternal, Infant, and Child 
Health (continued)
Population-based objectives
16-10a. Low birth weight (LBW), infants (<2,500 grams) (1998, 
2007)1,2,3* 1 NA B 4 1 2 2 B
2d1
2 B 2 NA NA
16-10b. Very low birth weight (VLBW), infants (<1,500 grams) 
(1998, 2007)1,2,3* 2 NA 1 4 1 3 Bii B 1 2 B 2 NA NA
16-11a. Preterm live births—Total (<37 weeks gestation) (1998, 
2007)1,2,3* 2 NA 2 3 1 2 B 1 2 2 B 2 NA NA
16-11b. Preterm live births—32–36 weeks gestation (1998, 
2007)1,2,3* 2 NA 2 3 1 2 B 1 2 2 B 2 NA NA
16-11c. Preterm live births—<32 weeks gestation (1998, 
2007)1,2,3* 2 NA 2
4d1
1 3 B 1 2 2 B 2 NA NA
16-13. Infants put to sleep on their backs (<8 months) (1996, 
2009)† NA NA NA NA NA
3u2iii
Biii NA NA NA NA NA NA NA NA NA
16-14a. Developmental disabilities—Mental retardation—IQ ≤70 
(per 10,000 population, Metropolitan Atlanta, 8 years) 
(1991–94, 2008)*
NA NA NA NA 3 4 B 4iv B
4u2
NA NA NA NA NA NA
16-14b. Developmental disabilities—Cerebral palsy (per 10,000 
population, Metropolitan Atlanta, 8 years) (1991–94, 
2008)*
NA NA NA NA NA NA NA NA NA NA NA
16-14c. Developmental disabilities—Age at first identification of 
autism spectrum disorder (in months, Metropolitan Atlanta, 
8 years) (1996, 2008)†
NA NA NA NA 1 2 B 2 Bii 1 NA NA NA NA NA NA
16-15. Spina bifida and other neural tube defects (new cases per 
100,000 live births) (1996, 2007)4* NA NA NA NA 3 Bii 2 3iv NA NA NA NA NA NA NA NA
16-16a. Folic acid consumption ≥400µg daily by nonpregnant 
women (15–44 years) (1991–94, 2005–06)5‡ NA NA NA NA 2v 2 B 2 NA NA
2u1 2u1
B
2u1
2 B
16-16b. Median red blood cell (RBC) folate level among 
nonpregnant women (ng/ml, 15–44 years) (1988–94, 
2005–06)6*
NA NA NA NA 1v 2 B 2 NA NA 1 2 B 2 B 1
16-17a. Pregnant women abstaining from alcohol in past month 
(15–44 years) (2002–03, 2008–09)* NA NA NA NA NA NA NA NA NA NA
16-17b. Pregnant women abstaining from binge drinking in past 
month (15–44 years) (2002–03, 2008–09)* NA NA NA NA NA NA NA NA NA NA NA NA NA
16-17c. Pregnant women abstaining from cigarette smoking during 
pregnancy (1998, 2002)* 4 NA Bii
4d1 4d1 4d2
NA NA 4
4u1
B
4u1
NA NA
16-17d. Pregnant women abstaining from illicit drugs in past month 
(15–44 years) (2002–03, 2008–09)* NA NA NA NA NA NA NA NA NA NA NA NA
16-18. Fetal alcohol syndrome (cases per 1,000 live births) 
(1995–97)† 4 NA NA NA Bvi 4iii B 4 NA NA NA NA NA NA NA NA
16-19a. Breastfeeding—Ever (2000, 2006)2,3*
3 b 1
2u1
Bii
4u2
2 NA NS NS 3 3 B 3 NA NA
16-19b. Breastfeeding—At 6 months (2000, 2006)2,3* 3u2
B 2
2u1
2
3u1 2u1
2iv NS NS 2 2 B 2 NA NA
16-19c. Breastfeeding—At 1 year (2000, 2006)2,3* 2u1
Bii 1 2 2
2u1 2u1
2iv NS NS 1 2 B 2 NA NA
16-19d. Exclusive breastfeeding—Through 3 months (2003, 
2006)2,3* 2 Bii 1 2 2
2u1
1 2iv NS NS 2 2 B 2 NA NA
16-19e. Exclusive breastfeeding—Through 6 months (2003, 
2006)2,3*
2u1
Bii 1
2u1
1
2u1
1 2iv NS NS 1 1 B 1 NA NA
2i
Bi
Bi, ii
Bi, ii
Bi
Bi
(continued)
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16-21.
NA NA NA NA NA NA NA NA NA NA NA NA NA NA
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
‡
1
2
3
4
5
6
i
ii
iii
iv
v
vi
16-1a. 
16-1b. 
16-1c–h.
16-2a–b.
16-3a–c.
16-4. 
16-5a. 
16-6a–b.
16-7. 
16-9a–b.
16-10a–b.
Disability
Population-based objectives
Education
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 16-8, 
16-12, 16-20a and b, 16-22, and 16-23. Objectives 16-5b and c, 16-14d, and 16-20c, were deleted at Midcourse Review.
Sex
Hospital discharges for sickle cell disease (per 
100,000 black or African American children, ≤9 
years) (1995–99, 2003–07)*
Race and Ethnicity
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
Baseline data by race and ethnicity are for 2001–02. Measures of variability were available by race and ethnicity for 2001–02, see footnote * above.
NOTES
Years in parentheses represent the baseline and most recent data years (if available).
Figure 16-2. Health Disparities Table for Focus Area 16: Maternal, Infant, and Child Health 
(continued)
Characteristics and Groups
Baseline data by race and ethnicity are for 1998.
Baseline data by disability status are for 1991–94.
DATA SOURCES
Data are for Asian or Pacific Islander.
Data include persons of Hispanic origin.
Change in the summary index cannot be assessed. See Technical Appendix.
Data are for Mexican American.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race 
and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at 
baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary 
index at the most recent data point. See Technical Appendix for more information.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more are 
displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows when the 
changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. Nonetheless, 
disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
Measures of variability for data by education level and disability status were available only for the most recent data. Thus, the variability of best group rates was 
assessed only for the most recent data, and statistical significance was tested only for the most recent data. Disparities of 10% or more are displayed when the 
differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are displayed according to their magnitude, since 
measures of variability were not available at baseline and therefore statistical significance of changes in disparity could not be tested. See Technical Appendix.
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
Increase in disparity (percentage points)
10–49 points 50–99 points 100 points or more
LEGEND
Data by education level are for the mother.
Data by race and ethnicity are for the mother.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Data exclude black of Hispanic origin.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Most recent data by education level are for 2002.
National Vital Statistics System—Natality (NVSS-N), CDC, NCHS.
National Vital Statistics System—Natality (NVSS-N), CDC, NCHS.
National Vital Statistics System—Fetal Death and Natality (NVSS-FD, NVSS-N), CDC, 
NCHS. 
National Vital Statistics System—Fetal Death, Mortality, and Natality (NVSS-FD, NVSS-
M, NVSS-N), CDC, NCHS. 
National Vital Statistics System—Mortality and Natality (NVSS-M, NVSS-N), CDC, 
NCHS.
National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
National Vital Statistics System—Mortality and Natality (NVSS-M, NVSS-N), CDC, 
NCHS.
National Hospital Discharge Survey (NHDS), CDC, NCHS.
National Vital Statistics System—Natality (NVSS-N), CDC, NCHS.
National Survey of Early Childhood Health (NSECH): HRSA, MCHB; CDC, NCHS.
National Survey on Drug Use and Health (NSDUH), SAMHSA.
16-21. National Hospital Discharge Survey (NHDS), CDC, NCHS.
National Immunization Survey (NIS), CDC, NCIRD and NCHS.
Fetal Alcohol Syndrome Surveillance System (FASSNet), CDC, NCBDDD.
16-17d. 
16-18. 
16-19a. 
16-11a–c.
16-13. 
16-14a–c.
16-15.
16-16a–b.
National Vital Statistics System—Natality (NVSS-N), CDC, NCHS.
National Infant Sleep Position Study (NISP), NIH, NICHD.
Metropolitan Atlanta Development Disabilities Surveillance Program (MADDSP), 
CDC, NCBDDD.
16-17a–b.
16-17c. National Vital Statistics System—Natality (NVSS-N), CDC, NCHS.
National Birth Defects Prevention Network (NBDPN), CDC, NCBDDD.
National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
National Survey on Drug Use and Health (NSDUH), SAMHSA.
NOTES: Data are for low (< 2,500 grams) birth weight births as a percent of all live births 
Rates are displayed by modified Jenks classification for U. S. health service area. 
SOURCE: National Vital Statistics System – Natality, CDC, NCHS. 
Figure 16-3. Low Birth Weight (LBW), Infants 2006-08 
Healthy People 2010 objective 16-10a 
Target = 5.0 
lowest category (green) shows health service areas that met the target 
rates are unreliable 
Percent 
Maternal, Infant, and Child Health Page 16-27 
3.8 - 5.0 
5.1 - 7.6 
7.7 - 9.1 
9.2 - 11.2 
11.3 - 16.4 
NOTES: Data are for preterm births (< 37 weeks gestations) as a percent of all live births 
Rates are displayed by modified Jenks classification for U. S. health service area. 
SOURCE: National Vital Statistics System – Natality, CDC, NCHS. 
Figure 16-4. Preterm Live Births  Total (<37 Weeks Gestation) 2006-08 
Healthy People 2010 objective 16-11a 
Target = 7.6 
lowest category (green) shows health service areas that met the target 
rates are unreliable 
Percent 
Maternal, Infant, and Child Health Page 16-28 
5.4 - 7.6 
7.7 - 12.6 
12.7 - 14.5 
14.6 - 17.2 
17.3 - 23.7 
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Goal: Ensure the safe and effective use of medical 
products 
The objectives in this chapter track the use of electronic medical records and prescription services, patient receipt of counseling about prescriptions, and availability of surveillance systems to monitor adverse drug reactions. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data1010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Some progress was achieved in objectives for this Focus Area during the past decade [1]. Five of the eight Medical Product Safety objectives with data to measure progress (objectives 17-2a through 17-2d, and 17-5a) moved toward or achieved their Healthy People 2010 targets (Figure 17-1). 
 The use of electronic medical records by health care providers in health care organizations (objective 17-2a) increased by 166.7% between 2000 and 2007, from 12% to 32%, exceeding the 2010 target of 18%. 
 The use of computerized prescriber order entry in general and children’s hospitals (objective 17-2c) increased by 533.3% between 2003 and 2010, from 3% to 19%, exceeding the 2010 target of 4%. Similarly, the use of computerized prescriber order entry in urban acute care facilities (objective 17-2d) increased by 76.9% between 2007 and 2009, from 13% to 23%, exceeding the 2010 target of 20%. 
 The monitoring of adverse events associated with medical practice (objective 17-1a) declined by 25.6% between 1999 and 2009, from 82% to 61%, moving away from the 2010 target of 90%. 
 Blood donations among adults aged 18 years and over (objective 17-6) remained stable. Six percent (age-adjusted) of the U.S. population donated blood in 2008, showing no change from 1998. This objective did not meet the 2010 target of 8%.  
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Summary of Progress 
 Figure 17-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Medical Product Safety [1]. Data to measure progress toward target attainment were available for eight objectives. Of these: 
• Three objectives (17-2a, c and d) met or exceeded their Healthy People 2010 targets. 
• Two objectives (17-2b and 17-5a) moved toward their targets, but data to test the significance of the difference between the baseline and final data points were unavailable. 
• One objective (17-6) showed no change. 
• Two objectives (17-1a and 17-5b) moved away from their targets, but data to test the significance of the difference between the baseline and final data points were unavailable. 
 One objective (17-4) had no data available to measure progress and two objectives (17-1b and 17-3) were dropped during the decade [2]. 
 Figure 17-2 displays health disparities in Medical Product Safety from the best group rate for each characteristic at the most recent data point [3]. It also displays changes in disparities from baseline to the most recent data point [4]. 
• Disparity data were available for only one objective (17-6, blood donations). This objective showed no health disparities of 10% or more by race and ethnicity, sex, education level, or disability status.  
Transition to Healthy People 2020 The range of topics covered in the Medical Product Safety chapter for Healthy People 2020 has been narrowed in comparison to the objectives presented in Healthy People 2010. The Healthy People 2010 Focus Area covered various topics such as electronic medical record use, blood donation, oral counseling on prescription medications and adverse medical events. In contrast, the Healthy People 2020 Topic Area focuses on overall improvement of patient treatment and appropriate use of medical products including drugs, biological products and medical devices. The Healthy People 2020 objectives reflect strong scientific support for safe use of medical products, which promotes better health among Americans. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. Objectives in the Healthy People 2020 Medical Product Safety Topic Area fall into two major categories: 
 Monitoring of adverse medical events 
 Safe and effective treatment of pain. 
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The differences between the Healthy People 2010 objectives and those included in Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Medical Product Safety Topic Area has a total of 11 objectives, five of which are developmental [5]. The Healthy People 2010 Medical Product Safety Focus Area also had 11 objectives. 
 Two Healthy People 2010 objectives were retained “as is” [6]. Monitoring and analyzing adverse medical events within healthcare organizations and blood donations (objective 17-1a) was retained. The blood donation objective (objective 17-6) was also retained, but was moved to the Blood Safety Topic Area. 
 Two Healthy People 2010 objectives were deleted at the Midcourse Review due to a lack of tracking data [2]. The objectives on adverse medical events associated with medical devices (objective 17-1b) and provider review of medications taken by patients and those with chronic conditions (objective 17-3) were dropped. 
 Seven Healthy People 2010 objectives were archived [7]. 
• Three objectives that dealt with receipt of oral counseling and useful information regarding prescription medications were archived due to a lack of national data in the future (objectives 17-4, 17-5a, and 17-5b). 
• Four objectives that refer to electronic medical record use (objectives 17-2a through 17-2d) in Healthy People 2010 were also archived as the Medical Product Safety Topic Area is no longer focusing on that issue. 
 While the Healthy People 2010 objectives on electronic medical record use have all been archived there is a new objective on monitoring the proportion of medical practices that use electronic health records in the Healthy People 2020 Health Communication and Health Information Technology Topic Area. 
 Nine new objectives were added to the Healthy People 2020 Medical Product Safety Topic Area: 
• Four objectives to track the safe and effective treatment of pain have been added. These objectives track patients suffering from untreated pain due to a lack of access to pain treatment, the number of non-FDA approved pain medication on the market, and serious injuries and death from pain medications. 
• Another new objective tracks the use of safe and effective medical products associated with predictive biomarkers. 
• Four objectives were added to measure the number of emergency department visits for common, preventable adverse events from medication. Appendix D, “A Crosswalk Between Objectives from Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
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Data Considerations In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
Notes 1. Displayed in the Progress Chart (Figure 17-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 17-1 footnotes, as well as the Technical Appendix, for more detail. 2. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 3. Information about disparities among select populations is shown in the Health Disparities Table (Figure 17-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health 
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insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 17-2 footnotes, as well as the Technical Appendix, for more detail. 4. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 17-2 footnotes, as well as the Technical Appendix, for more detail. 5. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 6. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 7. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020.  
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Comprehensive Summary of Objectives: Medical Product Safety 
Objective Description Data Source or Objective Status 17-1a Monitoring and analyzing adverse events associated with medical therapies National Survey of Pharmacy Practice in Acute Care Settings; American Society of Health Systems Pharmacists. 17-1b Monitoring of adverse medical events associated with medical devices  Dropped 17-2a Electronic medical record use by health care providers in health care organizations Annual Health Care Information and Management Systems Society Leadership Survey, Healthcare Information and Management Systems Society. 17-2b Electronic medical record use by pharmacists in managed care and integrated health systems National Survey of Ambulatory Care Responsibilities of Pharmacists in Managed Care and Integrated Health Systems, American Society of Health Systems Pharmacists. 17-2c Computerized prescriber order entry use by general and children's hospitals National Survey of Pharmacy Practice in Hospital Settings, American Society of Health Systems Pharmacists. 17-2d Computerized prescriber order entry use by urban acute care facilities The Leapfrog Group Hospital Patient Safety Survey. 17-3 Provider review of medications taken by older patients and those with chronic conditions Dropped 17-4 Receipt of useful information about prescriptions from pharmacies Evaluation of Written Prescription Information Provided In Community Pharmacies, Food and Drug Administration. 17-5a Oral counseling about medications from prescribers National Survey of Prescription Medicine Information Received by Consumers, FDA. 17-5b Oral counseling about medications from pharmacists National Survey of Prescription Medicine Information Received by Consumers, FDA. 17-6 Blood donations (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS.  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
90% 
82% 
(1998) 
61% 
(2009) 
-21 Not tested -25.6% 
18% 
12% 
(2000) 
32% 
(2007) 
20 Not tested 166.7% 
46% 
31% 
(1999) 
33% 
(2001) 
2 Not tested 6.5% 
4% 
3% 
(2003) 
19% 
(2010) 
16 Not tested 533.3% 
20% 
13% 
(2007) 
23% 
(2009) 
10 Not tested 76.9% 
95% 
24% 
(1998) 
26% 
(2004) 
2 Not tested 8.3% 
95% 
14% 
(1998) 
6% 
(2004) 
-8 Not tested -57.1% 
8% 
6% 
(1998) 
6% 
(2008) 
0 No 0.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 17-1. Progress Toward Target Attainment for Focus Area 17: Medical Product Safety  
13.3% 
Percent of targeted change achieved5 (continued) 
2.8% 
0.0% 
 
17-1a. Monitoring and analyzing adverse events 
associated with medical therapies 
17-2. Electronic medical record use by 
   a. Health care providers in health care 
    organizations   
  b. Pharmacists in managed care and 
   integrated health systems 
 Computerized prescriber order entry use by 
   c. General and children's hospitals 
  d. Urban acute care facilities  
17-5. Oral counseling about medications from  
  a. Prescribers 
  b. Pharmacists 
17-6. Blood donations (age adjusted, 18+ years) 
            333.3% 
           142.9% 
          1600.0% 
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DATA SOURCES 
 
17-1a. National Survey of Pharmacy Practice in Acute Care Settings; American Society of Health Systems Pharmacists.  
17-2a. Annual Health Care Information and Management Systems Society Leadership Survey, Healthcare Information and Management Systems Society. 
17-2b. National Survey of Ambulatory Care Responsibilities of Pharmacists in Managed Care and Integrated Health Systems, American Society of Health Systems Pharmacists. 
17-2c. National Survey of Pharmacy Practice in Hospital Settings, American Society of Health Systems Pharmacists. 
17-2d. The Leapfrog Group Hospital Patient Safety Survey. 
17-5a–b. National Survey of Prescription Medicine Information Received by Consumers, FDA. 
17-6. National Health Interview Survey (NHIS), CDC, NCHS. 
 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objective 17-4. Objectives 17-1b and 17-3 were deleted at the Midcourse Review.  
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
 
 
 
Figure 17-1. Progress Toward Target Attainment for Focus Area 17: Medical Product Safety (continued) 
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17-6. Blood donations (age adjusted, 18+ 
years) (1998, 2008)1 NA 1 NA Bi 1 1 B 1 1 B 1 1 B 1 Bi B
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
1
i
17-6. National Health Interview Survey (NHIS), CDC, NCHS.
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Baseline data by race and ethnicity are for 1999.
DATA SOURCES
Characteristics and Groups
Race and Ethnicity Sex Education Disability
Population-based objectives
Data not available. Characteristic not selected for this objective.
FOOTNOTES
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
10–49 points
Measures of variability were available for the objective in this table. Thus, the variability of best group rates was assessed, and statistical significance was tested. 
Disparities of 10% or more are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over 
time are indicated by arrows when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical 
Appendix.
LEGEND
Decrease in disparity (percentage points)
10–49 points 50–99 points
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99%
Increase in disparity (percentage points)
100 points or more
100% or more
100 points or more50–99 pointsChanges in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
NOTES
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
17-1a, 17-2a through d, 17-4, and 17-5a and b. Objectives 17-1b and 17-3 were deleted at Midcourse Review.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity 
from the baseline to the most recent data point.
Figure 17-2. Health Disparities Table for Focus Area 17: Medical Product Safety
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Goal: Improve mental health and ensure access to 
appropriate, quality, mental health services 
The objectives in this chapter monitor a broad range of mental health disorders, behaviors and problems as well as the availability of a variety of community-based and other treatment programs for persons in need of mental health services. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade [1]. All but one of the 11 Mental Health and Mental Disorders objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 18-1). However, health disparities persisted among racial and ethnic populations, as well as by sex and education level [2]. As discussed below, health disparities of 50% or more were observed for a number of objectives (Figure 18-2). 
 The suicide rate (objective 18-1) increased by 7.6% between 1999 and 2007, from 10.5 to 11.3 per 100,000 population (age adjusted), moving away from the 2010 target of 4.8 per 100,000. Disparities were observed for a number of population groups, for example: 
• Among racial and ethnic groups, the black non-Hispanic population had the lowest (best) suicide rate, 5.1 per 100,000 population (age adjusted) in 2007. The rates for the American Indian or Alaska Native and the white non-Hispanic populations were 11.5 and 13.5 per 100,000 (age adjusted), respectively. The rate for the American Indian or Alaska Native population was almost two and a half times the best group rate (that for the black non-Hispanic population), while the white non-Hispanic rate was more than two and a half times the best group rate [2]. 
 The white non-Hispanic population had suicide rates of 12.0 per 100,000 population (age adjusted) in 1999 and 13.5 in 2007, whereas the black non-Hispanic population had rates of 5.7 in 1999 and 5.1 in 2007. The disparity between the white non-Hispanic and black non-Hispanic populations increased by 54 percentage points between 1999 and 2007 [3]. 
• Females had a lower (better) suicide rate than males, 4.7 per 100,000 population (age adjusted) in 2007. The rate for males was 18.4 per 100,000 (age adjusted) in 2007, almost four times the rate for females [2]. 
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 Males had suicide rates of 17.8 per 100,000 population (age adjusted) in 1999 and 18.4 in 2007, whereas females had rates of 4.0 in 1999 and 4.7 in 2007. The disparity between males and females declined by 53 percentage points between 1999 and 2007 [3]. 
• Among education groups, persons with at least some college education had the lowest (best) suicide rate, 9.9 per 100,000 population (age adjusted) in 2002, whereas high school graduates had a rate of 18.4 per 100,000 (age adjusted) in 2002, almost twice the best group rate [2]. 
• Suicide rates varied by geographic region. In 2005–07, the suicide rate was generally higher in the western U.S. than in the rest of the country (Figure 18-3). 
 Suicide attempts by students in grades 9–12 that required medical attention (objective 18-2) decreased by 26.9% between 1999 and 2009, from 2.6% to 1.9%, moving toward the 2010 target of 1.0%. 
 Six objectives exceeded their 2010 targets: 
• The proportion of homeless adults aged 18 years and over with mental health problems who received mental health services (objective 18-3) increased by 85.2% between 2000 and 2009, from 27% to 50%, exceeding the target of 30%. 
• The proportion of adolescents (students in grades 9–12) who engaged in disordered eating to control their weight (objective 18-5) declined by 26.3% between 2001 and 2009, from 19% to 14%, exceeding the target of 16%. Disparities were observed for some population groups, for example: 
 Boys had a lower (better) rate of disordered eating than girls, 10% in 2009, whereas girls had a rate of 19% in 2009, almost twice the rate for boys. 
• The proportion of primary care facilities that provided mental health treatment (objective 18-6) increased by12.9% between 2000 and 2009, from 62% to 70%, exceeding the target of 68%. 
• The proportion of children aged 4–17 years with mental health problems who received treatment (objective 18-7) increased by 15.0% between 2000 and 2008, from 60% to 69%, exceeding the target of 67%. 
• The proportion of juvenile residential facilities that screened new admissions for mental health problems (objective 18-8) increased by 16.0% between 2000 and 2006, from 50% to 58%, exceeding the target of 55%. 
• The proportion of counties served by community-based jail diversion programs for adults with serious mental illness (objective 18-11) more than doubled between 2004 and 2010, from 6.9% to 14.1%, exceeding the target of 7.6%. 
 Racial and ethnic health disparities were observed in the treatment of adults for serious mental illness, depression, and schizophrenia (objectives 18-9a through c). 
• White non-Hispanic adults aged 18 years and over had the highest (best) rate of treatment for serious mental illness (objective 18-9a), 68% in 2002, whereas Hispanic or Latino and black non-Hispanic adults had rates of 45% and 51% in 2002, respectively. When expressed as persons not receiving treatment, the rate for Hispanic or Latino adults was more than one and a half times the best group rate (that for white non-Hispanic adults) [2]. The rate for black non-Hispanic adults was about one and a half times the best group rate. 
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• White non-Hispanic adults also had the highest (best) rate of treatment for depression (objective 18-9b), 63% in 2002, whereas Hispanic or Latino and black non-Hispanic adults had rates of 42% and 43% in 2002, respectively. When expressed as persons not receiving treatment, the rate for Hispanic or Latino adults was more than one and a half times the best group rate (that for white non-Hispanic adults), while the rate for black non-Hispanic adults was about one and a half times the best group rate [2]. 
• Similarly, white non-Hispanic adults had the highest (best) rate of treatment for schizophrenia (objective 18-9c), 63% in 2002, whereas Hispanic or Latino and black non-Hispanic adults had rates of 42% and 41% in 2002, respectively. When expressed as persons not receiving treatment, the rates for both groups (Hispanic or Latino and black non-Hispanic adults) were more than one and a half times the best group rate [2]. 
 Males had a higher (better) rate of employment than females for persons with serious mental illness (objective 18-4), 60% vs. 46% in 2002. When expressed as persons with serious mental illness who were unemployed, the rate for females was almost one and a half times that for males [2].  
Summary of Progress 
 Figure 18-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Mental Health and Mental Disorders [1]. Data to measure progress toward target attainment were available for 11 objectives. Of these: 
• Six objectives (18-3, 18-5 through 18-8, 18-11) exceeded their Healthy People 2010 targets. 
• Four objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for one of these objectives (18-2). Data to test the significance of the difference were unavailable for the other three objectives (18-12 through 18-14). 
• One objective moved away from the 2010 target. A statistically significant difference between the baseline and final data points was observed for this objective (18-1). 
 Six objectives had no data available to measure progress (objectives 18-4, 18-9a through d, and 18-10). 
 Figure 18-2 displays health disparities in Mental Health and Mental Disorders from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Five objectives had statistically significant racial and ethnic health disparities of 10% or more (objectives 18-1, 18-5, and 18-9a, b, and d), and one objective had racial and ethnic health disparities of 10% or more but lacked data to assess statistical significance (objective 18-9c). Of these six objectives, the white non-Hispanic population had the best rate for five objectives (18-5, and 18-9a through d), and the black non-Hispanic population had the best rate for one objective (18-1). 
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 Health disparities of 50% to 99% between the white non-Hispanic (best rate) population and the other racial and ethnic populations with data (the Hispanic or Latino and the black non-Hispanic populations) were observed for three treatment-related objectives: the proportion of adults with mental disorders who received treatment for serious mental illness (objective 18-9a), depression (objective 18-9b), and schizophrenia (objective 18-9c); see Highlights, above. 
• Females had better rates than males for three of the five objectives with statistically significant health disparities of 10% or more by sex (objectives 18-1, and 18-9a and b). Males had better rates for the remaining two objectives (18-4, 18-5). Females also had a better rate of treatment for schizophrenia (objective 18-9c), the one objective with health disparities of 10% or more by sex that lacked data to assess statistical significance. 
• Four objectives had statistically significant health disparities of 10% or more by education level (objectives 18-1, 18-4, and 18-9a and d), and one objective (18-9c) had health disparities of 10% or more by education level but lacked data to assess statistical significance. Persons with at least some college education had the best rates for three of these five objectives (18-1, 18-4, and 18-9d). High school graduates had the best rates for two objectives (18-9a and c). 
• The disparities for objective 18-1, suicide, are discussed in the Highlights, above.  
Transition to Healthy People 2020 The focus of the Mental Health and Mental Disorders Healthy People 2020 Topic Area continues to include the broad range of objectives presented in Healthy People 2010. Two objectives were added to the Topic Area, as noted below. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The differences between the Healthy People 2010 objectives and those included in Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Mental Health and Mental Disorders Topic Area has a total of 16 objectives, whereas the Healthy People 2010 Mental Health and Mental Disorders Focus Area had 17 objectives. 
 Eleven Healthy People 2010 objectives (18-1 through 18-3, 18-5 through 18-8, and 18-11 through 18-14) were retained “as is” [4]. 
 Three Healthy People 2010 objectives were modified [5]. Data sources had not been available for objectives addressing adults with mental health problems who received treatment (objectives 18-9a and b), adults with co-occurring substance abuse and mental health problems who received treatment (objective 18-10), and adults with serious mental illness who were employed (objective 18-4). These objectives have been modified and will be tracked through the National Survey on Drug Use and Health. 
 Two treatment objectives were archived due to lack of data: adults with generalized anxiety disorder who receive treatment (objective 18-9d), and adults with schizophrenia who received treatment (objective 18-9c) [6]. 
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 Two new objectives were added to the Healthy People 2020 Topic Area. These objectives address: 
• The proportion of persons who experience major depressive episode 
• Depression screening by primary care providers. Appendix D, “A Crosswalk Between Objectives from Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. Beginning in 2003, education data for mortality objective 18-1 (suicide) from the National Vital Statistics System have been suppressed. The educational attainment item was changed in the new U.S. Standard Certificate of Death in 2003 to be consistent with the U.S. Census Bureau data and to improve the ability to identify specific types of educational degrees. Many states, however, are still using the 1989 version of the U.S. Standard Certificate of Death, which focuses on highest school grade completed. As a result, educational attainment data collected using the 2003 version are not comparable with data collected using the 1989 version [7]. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
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 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
References and Notes 1. Displayed in the Progress Chart (Figure 18-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 18-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 18-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 18-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 18-2 footnotes, as well as the Technical Appendix, for more detail. 4. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 
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5. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 6. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 7. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf.  
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Comprehensive Summary of Objectives: Mental Health and Mental Disorders 
Objective Description Data Source 18-1 Suicide (age adjusted per 100,000 standard population)  National Vital Statistics System—Mortality (NVSS–M), CDC, NCHS. 18-2 Suicide attempts by students that required medical attention (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 18-3 Homeless adults with mental health problems who receive mental health services (18+ years) Projects for Assistance in Transition from Homelessness (PATH) Annual Application, SAMHSA. 18-4 Employment of persons with serious mental illness (SMI) (18+ years) National Comorbidity Survey—Replication (NCS-R), NIH, NIMH. 18-5 Students engaging in disordered eating (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 18-6 Primary care facilities that provide mental health treatment Uniform Data System (UDS), HRSA. 18-7 Treatment for children with mental health problems (4–17 years) National Health Interview Survey (NHIS), CDC, NCHS. 18-8 Juvenile residential facilities that screen admissions for mental health problems Juvenile Residential Facility Census (JRFC), National Center for Juvenile Justice. 18-9a Treatment for adults with serious mental illness (SMI) (18+ years) National Comorbidity Survey—Replication (NCS-R), NIH, NIMH. 18-9b Treatment for adults with depression (18+ years)  National Comorbidity Survey—Replication (NCS-R), NIH, NIMH. 18-9c Treatment for adults with schizophrenia (18+ years) Epidemiologic Catchment Area (ECA) Program, NIH, NIMH 18-9d Treatment for adults with generalized anxiety disorder (18+ years) National Comorbidity Survey—Replication (NCS-R), NIH, NIMH. 18-10 Treatment for co-occurring substance abuse and mental disorders (18+ years) National Comorbidity Survey—Replication (NCS-R), NIH, NIMH. 18-11 Community-based jail diversion programs for adults with serious mental illness (SMI) Mental Health Courts Survey (MHCS), SAMHSA. 18-12 State tracking of consumer satisfaction with mental health services (no. States and D.C.) Uniform Reporting System (URS), SAMHSA. 18-13 State mental health plans addressing cultural competence (no. States and D.C.) State Mental Health Agency Profiling System, National Association of State Mental Health Program Directors, National Research Institute; SAMHSA, CMHS. 18-14 State mental health plans addressing care of elderly persons (no. States and D.C.) State Mental Health Agency Profiling System, National Association of State Mental Health Program Directors, National Research Institute; SAMHSA, CMHS.  
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Figure 18-1. Progress Toward Target Attainment for Focus Area 18: Mental Health and Mental Disorders 
Percent of targeted change achieved5 (continued) 
 
18-1. Suicide (age adjusted, per 100,000 
  population)  
18-2. Suicide attempts by students that required 
medical attention (grades 9–12)    
18-3. Homeless adults with mental health 
problems who receive mental health services 
(18+ years)  
18-5. Students engaging in disordered eating 
(grades 9–12)  
18-6. Primary care facilities that provide mental 
health treatment  
18-7. Treatment for children with mental health 
problems (4–17 years)   
18-8. Juvenile residential facilities that screen 
admissions for mental health problems  
18-11. Community-based jail diversion programs for 
adults with serious mental illness (SMI)  
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Mental Health and Mental Disorders Page 18-10 
2010 
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Figure 18-1. Progress Toward Target Attainment for Focus Area 18: Mental Health and Mental Disorders (continued) 
Percent of targeted change achieved5 
 
18-12. State tracking of consumer satisfaction with 
mental health services (no. States and D.C.)  
18-13. State mental health plans addressing cultural 
competence  (no. States and D.C.) 
18-14. State mental health plans addressing care of 
elderly persons (no. States and D.C.)   
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 18-4, 18-9a through d, and 18-10. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                   × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =              × 100. 
     Healthy People 2010 target – Baseline value 
 
 
94.1% 
33.3% 
12.1% 
(continued) 
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Figure 18-1. Progress Toward Target Attainment for Focus Area 18: Mental Health and Mental Disorders (continued) 
DATA SOURCES 
 
18-1. National Vital Statistics System—Mortality (NVSS–M), CDC, NCHS. 
18-2. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
18-3. Projects for Assistance in Transition from Homelessness (PATH) Annual Application, SAMHSA. 
18-5. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
18-6. Uniform Data System (UDS), HRSA. 
18-7. National Health Interview Survey (NHIS), CDC, NCHS. 
18-8. Juvenile Residential Facility Census (JRFC), National Center for Juvenile Justice. 
18-11. Mental Health Courts Survey (MHCS), SAMHSA. 
18-12. Uniform Reporting System (URS), SAMHSA. 
18-13–18-14. State Mental Health Agency Profiling System, National Association of State Mental Health Program Directors, National Research Institute; SAMHSA, CMHS. 
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18-1. Suicide (age adjusted, per 100,000 population) 
(1999, 2007)1*
4u1
NA
2u1
B
4u2 3u1
B
4d2
3
4u1
B 3 NA NA NA NA
18-2. Suicide attempts by students that required medical 
attention (grades 9–12) (1999, 2009)* NA NA NA NA NA NA NA NA NA NA NA NA NA
18-4. Employment of adults with serious mental illness 
(SMI) (18+ years) (2002)* NA NA NA NA 1 1 B 1 2 B 3 1 B 2 NA NA NA NA
18-5. Students engaging in disordered eating (grades 
9–12) (2001, 2009)* NA NA NA NA 2 1 B 1ii 3 B NA NA NA NA NA NA NA NA
18-7. Treatment for children with mental health problems 
(4–17 years) (2001, 2008)* NA NA NA NA NA NA NA NA NA NA
18-9a. Treatment for adults with serious mental illness (SMI) 
(18+ years) (2002)* NA NA NA NA 3 3 B 3 B 3 2 B b NA NA NA NA NA
18-9b. Treatment for adults with depression (18+ years) 
(2002)* NA NA NA NA 3 3 B 3 B 2 1 1 B 1 NA NA NA NA
18-9c. Treatment for adults with schizophrenia (18+ years) 
(1984)† NA NA NA NA 3 3 B 3 B 2 3 B 2 2 NS NS NS NS
18-9d. Treatment for adults with generalized anxiety 
disorder (18+ years) (2002)* NA NA NA NA NA 2 B NA B 1 1 2 B 2 NA NA NA NA
18-10. Treatment for co-occurring substance abuse and 
mental disorders (18+ years) (2002)* NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
Population-based objectives
2u1i
Figure 18-2. Health Disparities Table for Focus Area 18: Mental Health and Mental 
Disorders
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income
(continued)
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
1
i
ii
18-1. National Vital Statistics System—Mortality (NVSS–M), CDC, NCHS.
18-2. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
18-4. National Comorbidity Survey—Replication (NCS–R), NIH, NIMH.
18-5. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
18-7. National Health Interview Survey (NHIS), CDC, NCHS.
18-9a–b. National Comorbidity Survey—Replication (NCS–R), NIH, NIMH.
18-9c. Epidemiologic Catchment Area (ECA) Program, NIH, NIMH.
18-9d. National Comorbidity Survey—Replication (NCS–R), NIH, NIMH.
18-10. National Comorbidity Survey—Replication (NCS–R), NIH, NIMH.
Characteristic not selected for this objective.
DATA SOURCES
Data are for Asian or Pacific Islander.
Change in the summary index cannot be assessed. See Technical Appendix.
Most recent data by education level are for 2002.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows 
when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. 
Nonetheless, disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
NOTES
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
18-3, 18-6, 18-8, and 18-11 through 18-14.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Figure 18-2. Health Disparities Table for Focus Area 18: Mental Health and Mental 
Disorders (continued)
50%–99%
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
100% or more
100 points or more
100 points or more
Increase in disparity (percentage points)
10–49 points 50–99 points
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49%
Data not available.
Figure 18-3.  Suicide  2005-07 
Healthy People 2010 objective 18-1 
Target = 4.8 
NOTES: Data are for ICD-10 codes X60-X84, Y87.0 reported as underlying cause.  Rates are per 100,000 U. S. Population age-adjusted to  
the 2000 standard population.  Rates are displayed by a Jenks classification for U.S. health service area. 
SOURCE: National Vital Statistics System – Mortality, CDC, NCHS. 
Rate per 100,000 
rates are unreliable 
0.0 - 4.8 
4.9 - 13.1 
13.2 - 17.8 
17.9 - 27.8 
27.9 - 48.3 
no health service areas with a reliable rate met the target 
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Goal: Promote health and reduce chronic disease 
associated with diet and weight 
The objectives in this chapter monitor trends in overweight and obesity, growth retardation, the consumption of various types of foods and nutrients, iron deficiency, diet and nutrition counseling, and food security (access to food). All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Almost no progress was made toward the Healthy People 2010 targets for objectives in this Focus Area [1]. Only one Nutrition and Overweight objective (19-11, calcium intake) showed significant positive movement (Figure 19-1). In addition, statistically significant health disparities were observed among racial and ethnic populations, as well as by sex, income, and disability status (Figure 19-2), some of which are discussed below [2]. 
 The proportion of adults aged 20 years and over who were at a healthy weight based on directly measured weight and height (objective 19-1) decreased by 26.2% between 1988–94 and 2005–08, from 42% to 31% (age adjusted), moving away from the Healthy People 2010 target of 60%. 
 Obesity in the U.S. population has increased, moving away from Healthy People 2010 targets. Based on directly measured weight and height, between 1988–94 and 2005–08 the proportion of adults aged 20 years and over who were obese (objective 19-2) rose by 47.8%, from 23% to 34% (age adjusted), moving away from the 2010 target of 15%. During the same period, obesity increased by 54.5% in children aged 6–11 years, from 11% to 17%, (objective 19-3a) and by 63.6% in adolescents aged 12–19 years, from 11% to 18% (objective 19-3b), moving away from the 2010 targets of 5%. 
• Obesity in adults varied by geographic area. Based on self-reported weight and height, in 2008, Colorado, Connecticut, the District of Columbia, Rhode Island, and Massachusetts had the lowest obesity rates, whereas Alabama, Mississippi, Oklahoma, South Carolina, and West Virginia had the highest rates (Figure 19-3). 
 The proportion of persons with healthful eating patterns, objectives 19-5 through 19-11, showed little change. These objectives remained well below their 2010 targets. One objective did show some positive progress: calcium intake among persons aged two years and over (objective 19-11) increased by 35.5% between 1988–94 and 2003-04, from 31% to 42% (age adjusted), moving toward the Healthy People 2010 target of 74%. 
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 Food security among U.S. households (objective 19-18) declined by 3.4% between 1995 and 2008, from 88% to 85%, moving away from the 2010 target of 94%. Disparities were observed for a number of population groups, for example: 
• Among racial and ethnic groups, white non-Hispanic households had the highest (best) rate of food security, 89% in 2008, whereas black non-Hispanic, Hispanic or Latino, and American Indian or Alaska Native households had rates of 74%, 73%, and 77% in 2008, respectively. When expressed as households with food insecurity, the rates for black non-Hispanic and Hispanic or Latino households were almost two and a half times the best rate (that for white non-Hispanic households), while the rate for American Indian or Alaska Native households was more than twice the best rate (Figure 19-2) [2].  
Summary of Progress 
 Figure 19-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Nutrition and Overweight. Data to measure progress toward target attainment were available for 20 objectives [1]. Of these: 
• Two objectives moved toward their 2010 targets. A statistically significant difference between the baseline and the final data points was observed for one of these objectives (19-11). No significant difference was observed for the other objective (19-5). 
• Three objectives (19-4, 19-6, and 19-12a) showed no change. 
• Fifteen objectives moved away from their targets. A statistically significant difference between the baseline and final data points was observed for nine objectives (19-1, 19-2, 19-3a through c, 19-7, 19-12c, 19-17, and 19-18). No significant differences were observed for five objectives (19-8 through 19-10, 19-12b, and 19-14); and data to test the significance of the difference were unavailable for one objective (19-13). 
 One objective (19-16) had no follow-up data available to measure progress and one objective (19-15) was dropped during the decade [3]. 
 Figure 19-2 displays health disparities in Nutrition and Overweight from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [4]. 
• Statistically significant health disparities of 10% or more by race and ethnicity were observed for 10 objectives. Health disparities of 10% or more by race and ethnicity were observed for two additional objectives, though data to test their statistical significance were unavailable. Of these 12 objectives, the white non-Hispanic population had the best rate for six objectives (19-1, 19-2, 19-11, 19-12c, 19-13, and 19-18). The black non-Hispanic and American Indian or Alaska Native populations had the best rate for one objective each (objectives 19-3a and 19-4, respectively). The Mexican American population had the best rate for four objectives (19-5 and 19-8 through 19-10). 
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• Females had better rates than males for two of the three objectives with statistically significant health disparities of 10% or more by sex (objectives 19-1 and 19-10). Males had a better rate for the third objective (19-11). Females also had a better rate for one objective with a disparity of 10% or more by sex for which statistical significance could not be assessed (objective 19-4).  
• Persons whose income was above 130% of the poverty threshold (Federal poverty level; see Data Considerations section below) had better rates than persons whose income was below 130% of the poverty threshold for six of the seven objectives with statistically significant health disparities of 10% or more by income (objectives 19-2, 19-3b and c, 19-11, 19-12c, and 19-18). Persons whose income was below 130% of the poverty threshold had a better rate for the seventh objective (19-9). 
• Persons without disabilities had a better rate than persons with disabilities for the one objective with statistically significant health disparities of 10% or more by disability status (objective 19-2).  
Transition to Healthy People 2020 For Healthy People 2020, the focus of the Nutrition and Weight Status objectives was expanded to include a broader range of policies and environmental factors that support eating a healthful diet and maintaining a healthy body weight in settings such as schools, worksites, health care organizations, and communities. In addition, the wording and definitions of the food and nutrient consumption objectives have been revised to be applicable to the 2010 Dietary Guidelines for Americans (DGA) and minimize the need to revise the objectives with subsequent updates [5]. The Healthy People 2010 Focus Area name was changed from “Nutrition and Overweight” to “Nutrition and Weight Status” to better describe the range of weight-related objectives. The Nutrition and Weight Status objectives primarily assess individual behaviors regarding the consumption of healthful diets and achievement and maintenance of healthy body weights, and the policies and environments that support these behaviors. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 Nutrition and Weight Status Topic Area can be grouped into six sections: 
 Healthier Food Access 
 Healthcare and Worksite Settings 
 Weight Status 
 Food Insecurity 
 Food and Nutrient Consumption 
 Iron Deficiency. The differences between the Healthy People 2010 objectives and those included in Healthy People 2020 are summarized below: 
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 The Healthy People 2020 Nutrition and Weight Status Topic Area has a total of 38 objectives, seven of which are developmental [6]. The Healthy People 2010 Nutrition and Overweight Focus Area had 22 objectives, one of which was dropped at Midcourse Review [3]. 
 Six Healthy People 2010 objectives were retained “as is” [7]. These objectives include: healthy weight in adults (objective 19-1), obesity in adults (objective 19-2), obesity in children (separately assessed for those aged 6–11 years and 12–19 years; objectives 19-3a and b, respectively), iron deficiency in pregnant females (objective 19-14), and the complement to food security (i.e., food insecurity) among U.S. households (objective 19-18). 
 Four Healthy People 2010 objectives were archived or dropped [3,8]. Growth retardation in low-income children (objective 19-4), anemia in low-income pregnant females (objective 19-13), and total fat intake (objective 19-9) were archived. The meals and snacks at school objective (19-15) was deleted at Midcourse Review due to the lack of a national data source. 
 Twelve Healthy People 2010 objectives were modified to create 13 Healthy People 2020 objectives [9]. 
• The age group tracked for obesity in children (objective 19-3c) was expanded from 6–19 years to 2–19 years. 
• Three Food Consumption objectives for fruits (objective 19-5), vegetables (objective 19-6), and grains (objective 19-7) were changed to create four objectives that are applicable to the 2010 DGA and assess mean intake. The objective for vegetables was divided into two objectives to separately monitor the quantity and variety of vegetables consumed. 
• Three Nutrient Consumption objectives, including the percentage of calories from saturated fat (objective 19-8), total sodium (objective 19-10), and total calcium (objective 19-11), were also changed to assess mean intake rather than the percent of the population meeting the DGA, to allow population groups’ progress to be assessed in meeting DGA recommendations over the decade without the need to modify the objectives with future releases of the DGA. 
• The model used to determine iron deficiency was changed from the ferritin model to the body iron stores model for three iron deficiency objectives (19-12a through c) assessed among young children (aged 1–2 years and 3–4 years) and non-pregnant females. 
• The objective (19-16) on worksite nutrition and weight management classes or counseling was moved back to developmental status until more current data become available. 
• The objective (19-17) tracking physician office visits that include nutrition counseling or education for patients with cardiovascular disease, diabetes, or hyperlipidemia was modified to include additional diagnostic information from the patient record. 
 Nineteen new objectives, six of which are developmental, were added to the Healthy People 2020 Nutrition and Weight Status Topic Area [6]: 
• Five new objectives tracking healthier food access include state nutrition standards for child care, schools not offering calorically sweetened beverages, school requirements for fruit and vegetable availability, state-level incentive policies for food retail, and a developmental objective on access to food retail outlets that sell a variety of foods that are encouraged by the DGA. 
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• Four new healthcare objectives include primary care physicians who assess child and adult patients’ body mass index (BMI), physician office visits with weight reduction, nutrition or physical activity counseling or education for obese patients, and nutrition counseling for all patients. 
• Six new weight status objectives include obesity among children aged 2–5 years, and five developmental objectives on inappropriate weight gain among youth and adults. 
• A new food security objective tracks very low food security among children. 
• Three new nutrient consumption objectives focus on the percentage of calories from solid fats, added sugars, and both. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations State level rates for obesity among adults (objective 19-2) in Figure 19-3 are based on self-reported weight and height data from Behavioral Risk Factory Surveillance System (BRFSS) telephone interviews and may not be comparable to national rates in Figures 19-1 and 19-2, which are based on directly measured weight and height from National Health and Nutrition Examination Survey (NHANES). BMI estimates derived from self-reported height and weight tend to be lower than those derived from measured height and weight due to underreporting of weight and over-reporting of height [10]. However, BRFSS data is still useful in assessing geographic differences and changes over time. The data label used for objectives 19-3a through c “overweight or obesity” in children and adolescents, was revised since the Healthy People 2010 Midcourse Review and progress reviews to “obesity” even though the definition (BMI at or above the sex-and age-specific 95th percentile from the 2000 CDC Growth Charts) and interpretation are still the same. This terminology change in NCHS and other CDC publications is consistent with revisions made by the American Academy of Pediatrics, the Institute of Medicine, and other organizations. Because the indexes used are based on body mass rather than fatness, the original terminology of “overweight” for children at or above the 95th percentile was intended to clarify that this cut-off point should not be used as diagnostic criteria. Rather, these children may or may not have excess body fat and should, therefore, be screened for obesity. However, because body fat is difficult to measure and the majority of children with BMI at or above the 95th percentile have high adiposity, on a population-wide basis, high weight-for-height can be considered as an indicator for obesity [11]. Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
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 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
References and Notes 1. Displayed in the Progress Chart (Figure 19-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 19-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 19-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 19-2 footnotes, as well as the Technical Appendix, for more detail. 
Nutrition and Overweight  Page 19-8 
3. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 4. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 19-2 footnotes, as well as the Technical Appendix, for more detail. 5. US Department of Health and Human Services and US Department of Agriculture (USDA). Dietary guidelines for Americans, 2010. 7th ed. Washington: US Government Printing Office, 2011 Jan. Available from http://www.health.gov/dietaryguidelines/. 6. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 7. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 8. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 9. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 10. Gorber SC, Tremblay M, Moher D, Gorber B. A comparison of direct vs.self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev 8(4):307-26. 2007 Jul. 11. Ogden CL, Flegal KM. Changes in terminology for childhood overweight and obesity. National health statistics reports; no 25. Hyattsville, MD: National Center for Health Statistics. 2010. Available from http://www.cdc.gov/nchs/data/nhsr/nhsr025.pdf. 
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Comprehensive Summary of Objectives: Nutrition and Overweight 
Objective Description Data Source or Objective Status 19-1 Healthy weight in adults (age adjusted, 20+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 19-2 Obesity in adults (age adjusted, 20+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 19-3a Obesity—Children 6–11 years National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 19-3b Obesity—Adolescents 12–19 years National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 19-3c Obesity—Children and adolescents 6–19 years National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 19-4 Growth retardation in low-income children (<5 years) Pediatric Nutrition Surveillance System (PedNss), CDC, NCCDPHP. 19-5 Fruit intake—At least two daily servings (age adjusted, 2+ years) Baseline: Continuing Survey of Food Intake by Individuals (CSFII), Department of Agriculture (USDA). Final: National Health and Nutrition Examination Survey (NHANES): CDC, NCHS; USDA, ARS. 19-6 Vegetable intake—At least three daily servings with at least 1/3 dark green or orange (age adjusted, 2+ years) Baseline: Continuing Survey of Food Intake by Individuals (CSFII), Department of Agriculture (USDA). Final: National Health and Nutrition Examination Survey (NHANES): CDC, NCHS; USDA, ARS. 19-7 Grain product intake—At least six daily servings with at least three being whole grains (age adjusted, 2+ years) Baseline: Continuing Survey of Food Intake by Individuals (CSFII), Department of Agriculture (USDA). Final: National Health and Nutrition Examination Survey (NHANES): CDC, NCHS; USDA, ARS. 19-8 Saturated fat intake—Less than 10% of caloric intake (age adjusted, 2+ years) Baseline: Continuing Survey of Food Intake by Individuals (CSFII), Department of Agriculture (USDA). Final: National Health and Nutrition Examination Survey (NHANES): CDC, NCHS; USDA, ARS. 
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Objective Description Data Source or Objective Status 19-9 Total fat intake—No more than 30% of caloric intake (age adjusted, 2+ years) Baseline: Continuing Survey of Food Intake by Individuals (CSFII), Department of Agriculture (USDA). Final: National Health and Nutrition Examination Survey (NHANES): CDC, NCHS; USDA, ARS. 19-10 Total sodium intake—No more than 2,400 mg daily (age adjusted, 2+ years) National Health and Nutrition Examination Survey (NHANES): CDC, NCHS; USDA, ARS. 19-11 Total calcium intake—At or above recommended level (age adjusted, 2+ years) National Health and Nutrition Examination Survey (NHANES): CDC, NCHS; USDA, ARS. 19-12a Iron deficiency—Children 1–2 years National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 19-12b Iron deficiency—Children 3–4 years National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 19-12c Iron deficiency—Nonpregnant females 12–49 years  National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 19-13 Anemia in low-income pregnant females in their third trimester Pregnancy Nutrition Surveillance System, CDC, NCCDPHP. 19-14 Iron deficiency in pregnant females National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 19-15 Meals and snacks at school—Children and Adolescents (6–19 years)  Dropped 19-16 Worksite nutrition and weight management classes or counseling National Worksite Health Promotion Survey (NWHPS), Partnership for Prevention and OPHS, ODPHP. 19-17 Physician office visits with nutrition counseling for patients with cardiovascular disease, diabetes, or hyperlipidemia (age adjusted, 20+ years) National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS. 19-18 Food security among U.S. households Current Population Survey (CPS): Department of Commerce, Census Bureau; Department of Labor, Bureau of Labor Statistics.  
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Figure 19-1. Progress Toward Target Attainment for Focus Area 19: Nutrition and Overweight 
Percent of targeted change achieved5 (continued) 
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Figure 19-1. Progress Toward Target Attainment for Focus Area 19: Nutrition and Overweight (continued) 
Percent of targeted change achieved5 (continued) 
 
19-7. Grain product intake—At least six daily 
servings with at least three being whole 
grains (age adjusted, 2+ years)  
19-8. Saturated fat intake—Less than 10% of 
caloric intake (age adjusted, 2+ years) 
19-9. Total fat intake—No more than 30% of 
caloric intake (age adjusted, 2+ years)  
 
19-10. Total sodium intake—No more than 2,400  
 mg daily (age adjusted, 2+ years)  
19-11. Total calcium intake—At or above 
recommended level (age adjusted, 2+ years) 
19-12. Iron deficiency 
   a. Children 1–2 years  
  b. Children 3–4 years  
  c. Nonpregnant females 12–49 years  
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NOTES  
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objective 19-16. Objective 19-15 was deleted at the Midcourse Review. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                     ×  100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =                ×  100. 
     Healthy People 2010 target – Baseline value 
 
 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
19-13. Anemia in low-income pregnant females 
 in their third trimester   
19-14. Iron deficiency in pregnant females      
19-17. Physician office visits with nutrition  
counseling for patients with  
 cardiovascular disease, diabetes, or 
hyperlipidemia (age adjusted, 20+ years)  
19-18. Food security among U.S. households     
 
Percent of targeted change achieved5 
(continued) 
 
Figure 19-1. Progress Toward Target Attainment for Focus Area 19: Nutrition and Overweight (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
20% 
29% 
(1996) 
34% 
(2009) 
5 
Not 
tested 
17.2% 
9% 
14% 
(1999–02) 
16% 
(2003–06) 
2 No 14.3% 
75% 
42% 
(1997) 
28% 
(2007) 
-14 Yes -33.3% 
94% 
88% 
(1995) 
85% 
(2008) 
-3 Yes -3.4% 
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DATA SOURCES  
 
19-1–19-2. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
19-3a–c. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
19-4. Pediatric Nutrition Surveillance System (PedNss), CDC, NCCDPHP. 
19-5–19-9. Baseline: Continuing Survey of Food Intake by Individuals (CSFII), Department of Agriculture (USDA). Final: National Health and Nutrition Examination Survey (NHANES), 
 CDC, NCHS. 
19-10–19-11. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
19-12a–c. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
19-13. Pregnancy Nutrition Surveillance System, CDC, NCCDPHP. 
19-14. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
19-17. National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS. 
19-18. Current Population Survey (CPS): Department of Commerce, Census Bureau; Department of Labor, Bureau of Labor Statistics. 
  
 
 
 
Figure 19-1. Progress Toward Target Attainment for Focus Area 19: Nutrition and Overweight (continued) 
Nutrition and Overweight Page 19-14
Nutrition and Overweight Page 19-15
A
m
er
ic
an
 In
di
an
 o
r 
A
la
sk
a 
N
at
iv
e
A
si
an
N
at
iv
e 
H
aw
ai
ia
n 
or
 
ot
he
r P
ac
ifi
c 
Is
la
nd
er
Tw
o 
or
 m
or
e 
ra
ce
s
H
is
pa
ni
c 
or
 L
at
in
o
B
la
ck
, n
ot
 H
is
pa
ni
c
W
hi
te
, n
ot
 H
is
pa
ni
c
Su
m
m
ar
y 
in
de
x
Fe
m
al
e
M
al
e
Lo
w
er
 ( ≤
13
0%
 o
f 
Fe
de
ra
l p
ov
er
ty
 le
ve
l)
H
ig
he
r 
(>
13
0%
 o
f 
Fe
de
ra
l p
ov
er
ty
 le
ve
l)
P
er
so
ns
 w
ith
 
di
sa
bi
lit
ie
s
P
er
so
ns
 w
ith
ou
t 
di
sa
bi
lit
ie
s
19-1. Healthy weight in adults (age adjusted, 20+ years) 
(1988–94, 2005–08)1* NA NA NA NA
2d1i
2 B 2 B 2 1 B 1 B
19-2. Obesity in adults (age adjusted, 20+ years) (1988–94, 
2005–08)1* NA NA NA NA
2d1i
2 B 2
1d1
B
2d1
B 2 B
19-3a. Obesity—Children 6–11 years (1988–94, 2005–08)*
NA NA NA NA 2i B b NA NA NA
19-3b. Obesity—Adolescents 12–19 years (1988–94, 2005–08)*
NA NA NA NA i NA B 1ii 2ii B NA NA
19-3c. Obesity—Children and adolescents 6–19 years (1988–94, 
2005–08)* NA NA NA NA 1i Biii b NA B 1 2 B NA NA
19-4. Growth retardation in low-income children (<5 years) 
(1997, 2009)† B NA 2 2 2 2 B
2u1
NA NA NA NA
19-5. Fruit intake—At least two daily servings (age adjusted, 2+ 
years) (1994–96, 2003–04)* NA NA NA NA Bi 1 2 2 Biii B 1 B NS NS
19-6. Vegetable intake—At least three daily servings with at 
least 1/3 dark green or orange (age adjusted, 2+ years) 
(1994–96, 2003–04)*
NA NA NA NA NAi 1 Biii NA B Biii 1 B NS NS
19-7. Grain product intake—At least six daily servings with at 
least three being whole grains (age adjusted, 2+ years) 
(1994–96, 2003–04)*
NA NA NA NA NAi NA NA 1 B 1 B NS NS
19-8. Saturated fat intake—Less than 10% of caloric intake (age 
adjusted, 2+ years) (1994–96, 2005–08)* NA NA NA NA Bi 2
2u1 2u1
B 1 Biii 1 NS NS
19-9. Total fat intake—No more than 30% of caloric intake (age 
adjusted, 2+ years) (1994–96, 2005–08)* NA NA NA NA Bi 2 2 2 B 1 Biii 2 NS NS
19-10. Total sodium intake—No more than 2,400 mg daily (age 
adjusted, 2+ years) (1988–94, 2003–04)1* NA NA NA NA Bi 1 2 1 B 2 B 1 B 1
19-11. Total calcium intake—At or above recommended level 
(age adjusted, 2+ years) (1988–94, 2003–04)1* NA NA NA NA 2i
3u1
B
2u1
2d1
B 2 B 1 Biii
19-12a. Iron deficiency—Children 1–2 years (1988–94, 1999–02)*
NA NA NA NA i NA NA NS NS NA NA
19-12b. Iron deficiency—Children 3–4 years (1988–94, 2003–06)2*
NA NA NA NA i NA NA NA NS NS NA NA NA
19-12c. Iron deficiency—Nonpregnant females 12–49 years 
(1988–94, 2003–06)1* NA NA NA NA 4i 3 B 3 NA NA 3 B 1ii B
19-13. Anemia in low-income pregnant females in their third 
trimester (1996, 2009)†
2d1
NA 2 3 B 2 NA NA NA NA NA NA
19-14. Iron deficiency in pregnant females (1999–02, 2003–06)*
NA NA NA NA i NA NA NA NA NA
19-17. Physician office visits with nutrition  counseling for patients 
with cardiovascular disease, diabetes, or hyperlipidemia 
(age adjusted, 20+ years) (1997, 2007)*
NA NA NA NA NA Bv 1v NA 1 B NA NA NA NA
19-18. Food security among U.S. households (1995, 2008)3,4*
4 NA
4d1 4d1
B NA NA NA
4d2
B NA NA
2iv
Disparities from the best group rate for each characteristic at the most recent data point and changes in 
disparity from the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Income Disability
biv
Figure 19-2. Health Disparities Table for Focus Area 19: Nutrition and Overweight
2d1iv
Population-based objectives
(continued)
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
1
2
3
4
i
ii
iii
iv
v
19-1–19-2. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
19-3a–c. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
19-4. Pediatric Nutrition Surveillance System (PedNss), CDC, NCCDPHP.
19-5–19-9. 
19-10–19-11. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
19-12a–c. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
19-13. Pregnancy Nutrition Surveillance System, CDC, NCCDPHP.
19-14. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
19-17. National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS.
19-18. Current Population Survey (CPS): Department of Commerce, Census Bureau; Department of Labor, Bureau of Labor Statistics.
FOOTNOTES
Baseline data by disability status are for 1991–94.
Most recent data by race and ethnicity are for 1988–94.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows 
when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. 
Nonetheless, disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
DATA SOURCES
Data are for Mexican American.
Data include persons of Hispanic origin.
Baseline data for American Indian or Alaska Native are based on years 1995–97.
Most recent data for American Indian or Alaska Native are based on years 2006–08.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical 
Appendix.
Data are for Asian or Pacific Islander.
100 points or more
Data not available. Characteristic not selected for this objective.
10–49 points 50–99 points 100 points or moreChanges in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
Decrease in disparity (percentage points)
10–49 points 50–99 points
Baseline: Continuing Survey of Food Intake by Individuals (CSFII), Department of Agriculture (USDA). 
Final: National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
NOTES
Years in parentheses represent the baseline and most recent data years (if available).
Increase in disparity (percentage points)
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Figure 19-2. Health Disparities Table for Focus Area 19: Nutrition and Overweight (continued)
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objective 
19-16. Objective 19-15 was deleted at Midcourse Review.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Most favorable group rate for 
specified characteristic, but reliability 
criterion not met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Figure 19-3. Obesity in Adults (20+ Years) 2008 
Healthy People 2010 objective 19-2 
Target = 15 
Notes: Data are age-adjusted to the 2000 standard population. Rates are displayed by a Jenks classification for U.S. states. National data 
for the objective are based on measured height and weight from the National Health and Nutrition Examination Survey (NHANES) and are the  
basis for setting the target. State data from the BRFSS are based on self-reported weight and height and may not be comparable to the national  
data from the NHANES. SOURCE: Behavioral Risk Factor Surveillance System (BRFSS), CDC. 
19.7 - 22.7 
22.8 - 26.2 
26.3 - 28.7 
28.8 - 30.9 
31.0 - 34.0 
Percent 
No states met  the target 
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US (2005-08 NHANES) – 34 percent 
US (2008 BRFSS) – 27 percent 
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Goal: Promote the health and safety of people at work 
through prevention and early intervention 
The objectives in the chapter track work-related deaths, injuries, and selected health conditions, for example, hearing loss, elevated blood lead levels, and worksite stress reduction. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, (DATA2010), available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved for objectives in this Focus Area during the past decade [1]. Almost two-thirds (64%) of the Occupational Safety and Health objectives achieved their Healthy People 2010 targets. Only three objectives (20-1d through e, and 20-9) did not make progress toward the 2010 targets (Figure 20-1). Health disparities among racial and ethnic groups and by sex were observed for one objective (Figure 20-2) [2]. 
 Work-related injury deaths among workers aged 16 years and over in all industries (objective 20-1a) declined by 26.7% between 1998 and 2009, from 4.5 to 3.3 deaths per 100,000 workers, moving toward the 2010 target of 3.2 deaths per 100,000 workers. Work-related injury deaths among workers aged 16 years and over in mining (objective 20-1b) declined by 46.2% between 1998 and 2009, from 23.6 to 12.7 per 100,000, exceeding the 2010 target of 16.5, Similarly, work-related injury deaths among workers aged 16 years and over in construction (objective 20-1c) declined by 33.1%, from 14.5 to 9.7 per 100,000, exceeding the target of 10.1. 
• Female workers had a lower (better) rate of work-related injury deaths in all industries than male workers, 0.6 deaths per 100,000 in 2009. The rate for male workers, 5.5 deaths per 100,000, was more than nine times the rate for female workers [2]. 
 Work-related injuries per 100 full-time workers (objective 20-2) declined for all industry groups (objectives 20-2a through g), exceeding the 2010 targets. Work-related injuries in all industries (objective 20-2a) declined by 45.2% between 1998 and 2009, from 6.2 to 3.4 injuries per 100 full-time workers, exceeding the 2010 target of 4.3. Similar results were observed for individual industry sectors (e.g., construction, health services). Statistically significant downward trends in injuries were observed between the baseline (1997 or 1998) and 2009 for all industry sectors [3]. 
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 Work-related homicides among workers aged 16 years and over (objective 20-5) declined by 20% between 1998 and 2006, from 0.5 to 0.4 per 100,000 workers, meeting the 2010 target of 0.4. Work-related assaults among workers aged 16 years and over (objective 20-6) declined by 66.4% between 1998 and 2009, from 1.10 to 0.37 per 100 workers, exceeding the 2010 target of 0.78.  
Summary of Progress 
 Figure 20-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Occupational Safety and Health [1]. Data to measure progress toward target attainment were available for 22 objectives. Of these: 
• Fourteen objectives (20-1b and c, 20-2a through g, 20-3, 20-5, 20-6, 20-8, and 20-11) met or exceeded their Healthy People 2010 targets. 
• Five objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for one of these objectives (20-7). Data to test the significance of the difference were unavailable for four objectives (20-1a, 20-2h, 20-4, and 20-10). 
• Three objectives (20-1d, 20-1e, and 20-9) moved away from their targets, but data to test the significance of the difference between the baseline and the final data points were unavailable for these objectives. 
 Figure 20-2 displays health disparities in Occupational Safety and Health from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [4]. Health disparities data were only available for objective 20-1a, work-related injury deaths for all industries: 
• The black non-Hispanic population had a lower rate of work-related injury deaths than the Hispanic or Latino or the white non-Hispanic populations. 
• Females had a lower rate than males of work-related injury deaths.  
Transition to Healthy People 2020 The Healthy People 2020 Occupational Safety and Health Topic Area consists of fewer objectives than those included in Healthy People 2010. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 objectives can be grouped into several sections: 
 Work related fatalities 
 Work related injuries 
 Objectives that target specific occupational hazards. The differences between the Healthy People 2010 and Healthy People 2020 objectives are summarized below: 
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 The Healthy People 2020 Occupational Safety and Health Topic Area has 16 objectives, whereas the Healthy People 2010 Focus Area had 22 objectives. 
 Eleven Healthy People 2010 objectives were retained “as is” [5]. 
• Reduce deaths from work-related injuries. The titles of two of these five objectives were modified: deaths from work-related injury—Transportation (objective 20-1d) was changed to Transportation and warehousing; and deaths from work-related injury—Agriculture, forestry, and fishing (objective 20-1e) was changed to Agriculture, forestry, fishing, and hunting. 
• Reduce the rate of injury and illness cases involving days away from work due to overexertion or repetitive motion (objective 20-3). 
• Reduce pneumoconiosis deaths (objective 20-4). 
• Reduce deaths from work-related homicides (objective 20-5). 
• Reduce the proportion of persons who have elevated blood lead concentrations from work exposures (objective 20-7). 
• Reduce occupational skin diseases or disorders among full-time workers (objective 20-8). 
• Reduce new cases of work-related, noise-induced hearing loss (objective 20-11). 
 Ten Healthy People 2010 objectives were modified [6]. 
• Objectives for non-fatal work-related injuries were reduced to a single objective tracking all industries (objectives 20-2a through 20-2g).  
• The targeted population for adolescent workers was expanded from 15–17 years to 15–19 years of age (objective 20-2h). 
• The objective to reduce work-related assaults will be tracked with a new data source (objective 20-6). 
• The objective to increase the proportion of employees who have access to workplace programs that prevent or reduce employee stress will be tracked with a new data source (objective 20-9). 
 Seven Healthy People 2010 objectives were archived [7]. Non-fatal work-related injury rates by specific industry sector were not substantially different than the overall rate. Existing data sources for needle stick injuries were not adequate to accurately track the objective because there is no single national sharps injury surveillance system. Another limitation is underreporting of injuries. It is estimated that approximately half of exposures are reported, with reporting rates varying by occupational group. 
• Reduce non-fatal work-related injuries: 
 Construction (objective 20-2b) 
 Health Services (objective 20-2c) 
 Agriculture, Forestry, and Fishing (objective 20-2d) 
 Transportation (objective 20-2e) 
 Mining (objective 20-2f) 
 Manufacturing (objective 20-2g). 
• Reduce occupational needle stick injuries among hospital-based health care workers (objective 20-10). 
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 One new objective was added to track work-related injuries treated in emergency departments. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations A number of objectives in this Focus Area are tracked through the data sources maintained by the Bureau of Labor Statistics. Work-related injury deaths (objective 20-1) are monitored through the Census of Fatal Occupational Injuries and non-fatal injuries and illnesses are tracked through the Survey of Occupational Injuries and Illnesses. Over the past decade, industry data from these two sources were classified according to several different classification systems. From 1998 to 2002, data were classified using the 1987 Standard Industrial Classification (SIC) Manual. Data from 2003 to 2008 were classified using the 2002 North American Industry Classification System (NAICS). Industry data after 2008 are classified using the 2007 NAICS. The substantial differences between the SIC and NAICS result in breaks in series. From 1998 to 2005 rates were employment-based, whereas from 2006 to 2009 rates were hours-based. Effective January 1, 2002, the Occupational Safety and Health Administration (OSHA) revised its requirements for recording occupational injuries and illnesses. Due to the changes in classification systems and the revised OSHA reporting requirements, users are urged to use caution when examining trend data for the past decade. Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, (DATA2010), available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
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 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
Notes 1. Displayed in the Progress Chart (Figure 20-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 20-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 20-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 20-2 footnotes, as well as the Technical Appendix, for more detail. 3. The presence of a monotonic increasing or decreasing trend in the underlying measure was tested with the nonparametric Mann-Kendall test, then the slope of a linear trend was estimated with the nonparametric Sen’s method. See Technical Appendix for more information. 4. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 20-2 footnotes, as well as the Technical Appendix, for more detail. 5. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 
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6. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 7. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020.  
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Comprehensive Summary of Objectives: Occupational Safety and Health 
Objective Description Data Source 20-1a Work-related injury deaths—All industries (per 100,000 workers, 16+ years) Census of Fatal Occupational Injuries (CFOI), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-1b Work-related injury deaths—Mining (per 100,000 workers, 16+ years) Census of Fatal Occupational Injuries (CFOI), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-1c Work-related injury deaths—Construction (per 100,000 workers, 16+ years) Census of Fatal Occupational Injuries (CFOI), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-1d Work-related injury deaths—Transportation (per 100,000 workers, 16+ years) Census of Fatal Occupational Injuries (CFOI), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-1e Work-related injury deaths—Agriculture, forestry, and fishing (per 100,000 workers, 16+ years) Census of Fatal Occupational Injuries (CFOI), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-2a Work-related injuries—All industries (per 100 full-time workers) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-2b Work-related injuries—Construction (per 100 full-time workers) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-2c Work-related injuries—Health services (per 100 full-time workers) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-2d Work-related injuries—Agricultural, forestry, and fishing (per 100 full-time workers) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-2e Work-related injuries—Transportation (per 100 full-time workers) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-2f Work-related injuries—Mining (per 100 full-time workers) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-2g Work-related injuries—Manufacturing (per 100 full-time workers) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-2h Work-related injuries among adolescent workers (per 100 full-time workers, 15–17 years) National Electronic Injury Surveillance System (NEISS): Consumer Product Safety Commission (CPSC); CDC, NIOSH. 20-3 Overexertion or repetitive motion injuries (per 100,000 full-time workers) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-4 Pneumoconiosis deaths (number, 15+ years) National Occupational Respiratory Mortality System (NORMS), CDC, NIOSH. 
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Objective Description Data Source 20-5 Work-related homicides (per 100,000 workers, 16+ years) Census of Fatal Occupational Injuries (CFOI), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-6 Work-related assaults (per 100 workers, 16+ years) National Crime Victimization Survey (NCVS), Department of Justice (DOJ), Bureau of Justice Statistics (BJS). 20-7 Elevated blood lead levels—≥25 µg/dL (per 100,000 employed, 16+ years) Adult Blood Lead Epidemiology and Surveillance Program (ABLES), CDC, NIOSH. 20-8 Occupational skin diseases or disorders (per 100,000 full-time workers) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 20-9 Worksite stress reduction programs—Worksites with 50+ employees National Survey of Worksite Health Promotion Activities (NSWHP), Association for Worksite Health Promotion (AWHP) and OPHS, ODPHP. 20-10 Needlestick injuries among hospital-based health care workers (thousands) National Surveillance System for Hospital Health Care Workers (NaSH), CDC, NCPDCID, and Exposure Prevention Information Network (EPINet), International Health Care Worker Safety Center, University of Virginia. 20-11 Noise-induced hearing loss, work-related (per 10,000 full-time workers) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS).  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
3.2 
4.5 
(1998) 
3.3 
(2009) 
-1.2 Not tested -26.7% 
16.5 
23.6 
(1998) 
12.7 
(2009) 
-10.9 Not tested -46.2% 
10.1 
14.5 
(1998) 
9.7 
(2009) 
-4.8 Not tested -33.1% 
8.3 
11.8 
(1998) 
12.1 
(2009) 
0.3 Not tested 2.5% 
16.3 
23.3 
(1998) 
26.0 
(2009) 
2.7 Not tested 11.6% 
4.3 
6.2 
(1998) 
3.4 
(2009) 
-2.8 Yes -45.2% 
6.1 
8.7 
(1998) 
4.2 
(2009) 
-4.5 Yes -51.7% 
5.5 
7.9 
(1997) 
5.0 
(2009) 
-2.9 Not tested -36.7% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 20-1. Progress Toward Target Attainment for Focus Area 20: Occupational Safety and Health 
Percent of targeted change achieved5 (continued) 
 
20-1. Work-related injury deaths (per 100,000 
workers, 16+ years) 
  a. All industries 
  b. Mining  
  c.  Construction  
  d. Transportation 
  e. Agriculture, forestry, and fishing 
20-2. Work-related injuries (per 100 full-time 
workers)  
  a. All industries 
  b. Construction  
  c.  Health services  
92.3% 
153.5% 
109.1% 
147.4% 
            120.8% 
            173.1% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
5.3 
7.6 
(1998) 
5.1 
(2009) 
-2.5 Yes -32.9% 
5.5 
7.9 
(1997) 
5.0 
(2009) 
-2.9 Not tested -36.7% 
3.3 
4.7 
(1998) 
2.3 
(2009) 
-2.4 Yes -51.1% 
6.0 
8.5 
(1998) 
3.9 
(2009) 
-4.6 Yes -54.1% 
3.5 
4.9 
(1998) 
3.8 
(2008) 
-1.1 Not tested -22.4% 
338 
675 
(1997) 
284 
(2009) 
-391 Not tested -57.9% 
1,900 
2,928 
(1997) 
2,194 
(2007) 
-734 Not tested -25.1% 
0.4 
0.5 
(1998) 
0.4 
(2006) 
-0.1 Not tested -20.0% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 20-1. Progress Toward Target Attainment for Focus Area 20: Occupational Safety and Health (continued) 
Percent of targeted change achieved5 (continued) 
 
20-2. Work-related injuries (per 100 full-time 
workers)  
  d. Agricultural, forestry, and fishing  
  e. Transportation   
  f. Mining  
  g. Manufacturing 
20-2h. Work-related injuries among adolescent 
workers (per 100 full-time workers, 15–17 
years)  
20-3. Overexertion or repetitive motion injuries 
(per 100,000 full-time workers)  
20-4. Pneumoconiosis deaths (number, 15+ years) 
20-5. Work-related homicides (per 100,000 
workers, 16+ years) 
100% 
108.7% 
120.8% 
171.4% 
184.0% 
78.6% 
116.0% 
71.4% 
100.0  
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
0.78 
1.10 
(1998) 
0.37 
(2009) 
-0.73 Not tested -66.4% 
0.0 
12.1 
(1998) 
6.3 
(2009) 
-5.8 Yes -47.9% 
47 
67 
(1997) 
38 
(2009) 
-29 Not tested -43.3% 
50% 
37% 
(1992) 
25% 
(2004) 
-12 Not tested -32.4% 
269 
384 
(1998) 
315 
(2000) 
-69 Not tested -18.0% 
2.2 
3.2 
(2004) 
2.2 
(2009) 
-1.0 Yes -31.3% 
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from target1          target                   target 
 
 
 
Figure 20-1. Progress Toward Target Attainment for Focus Area 20: Occupational Safety and Health (continued) 
Percent of targeted change achieved5 (continued) 
 
20-6. Work-related assaults (per 100 workers, 16+ 
years) 
20-7. Elevated blood lead levels—≥25 µg/dL (per 
100,000 employed, 16+ years)    
20-8. Occupational skin diseases or disorders (per 
100,000 full-time workers) 
20-9. Worksite stress reduction programs—
Worksites with 50+ employees 
20-10. Needlestick injuries among hospital-based 
health care workers (thousands)  
20-11. Noise-induced hearing loss, work-related 
(per 10,000 full-time workers)   
 
100% 
228.1% 
47.9% 
145.0% 
60.0% 
10 .  
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Figure 20-1. Progress Toward Target Attainment for Focus Area 20: Occupational Safety and Health (continued) 
DATA SOURCES 
 
20-1a–e. Census of Fatal Occupational Injuries (CFOI), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 
20-2a–g. Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 
20-2h. National Electronic Injury Surveillance System (NEISS): Consumer Product Safety Commission (CPSC); CDC, NIOSH. 
20-3. Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 
20-4. National Occupational Respiratory Mortality System (NORMS), CDC, NIOSH. 
20-5. Census of Fatal Occupational Injuries (CFOI), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 
20-6. National Crime Victimization Survey (NCVS), Department of Justice (DOJ), Bureau of Justice Statistics (BJS). 
20-7. Adult Blood Lead Epidemiology and Surveillance Program (ABLES), CDC, NIOSH. 
20-8. Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 
20-9. National Survey of Worksite Health Promotion Activities (NSWHP), Association for Worksite Health Promotion (AWHP) and OPHS, ODPHP. 
20-10. National Surveillance System for Hospital Health Care Workers (NaSH), CDC, NCPDCID, and Exposure Prevention Information Network (EPINet), International Health Care 
 Worker Safety Center, University of Virginia. 
20-11. Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 
  
  
  
 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
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20-1a. Work-related injury deaths—All 
industries (per 100,000 workers, 16+ 
years) (1998, 2009)1†
NA NA NA NA
2d1
B 2
2d1
B
4d1
NA NA NA NA NA NA
20-2h. Work-related injuries among 
adolescent workers (per 100 full-time 
workers, 15–17 years) (1998, 2008)‡
NA NA NA NA NA NA NA NA NA NA NA NA NA NA
20-6. Work-related assaults (per 100 
workers, 16+ years) (1998, 2009)1,2* NA NA NA NA NA NA NA NA NA NA NA NA
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
‡
1
2
20-1a. Census of Fatal Occupational Injuries (CFOI), Department of Labor (DOL), Bureau of Labor Statistics (BLS).
20-2h. National Electronic Injury Surveillance System (NEISS): Consumer Product Safety Commission (CPSC); CDC, NIOSH.
20-6. National Crime Victimization Survey (NCVS), Department of Justice (DOJ), Bureau of Justice Statistics (BJS).
NOTES
LEGEND
Population-based objectives
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
20-1b through e, 20-2a through g, 20-3 through 20-5, and 20-7 through 20-11.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity 
from the baseline to the most recent data point.
Figure 20-2. Health Disparities Table for Focus Area 20: Occupational Safety and Health
DATA SOURCES
Characteristics and Groups
Race and Ethnicity Sex Income Disability
Data not available. Characteristic not selected for this objective.
FOOTNOTES
Measures of variability were available only for the most recent data. Thus, the variability of best group rates was assessed only for the most recent data, and 
statistical significance was tested only for the most recent data. Disparities of 10% or more are displayed when the differences from the best group rate are 
statistically significant at the 0.05 level. Changes in disparities over time are displayed according to their magnitude, since measures of variability were not 
available at baseline and therefore statistical significance of changes in disparity could not be tested. See Technical Appendix.
Increase in disparity (percentage points)
10–49 points 50–99 points
Decrease in disparity (percentage points)
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
10%–49% 50%–99%
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Baseline data by race and ethnicity are for 2000.
Baseline data by sex are for 2000.
100% or more
100 points or more
100 points or more
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows 
when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. 
Nonetheless, disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
10–49 points 50–99 points
A reformatted, typeset version of this report will replace the current version 
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 Centers for Disease Control and Prevention 
 Health Resources and Services Administration 
 Indian Health Service 
 National Institutes of Health 
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Goal: Prevent and control oral and craniofacial diseases, 
conditions, and injuries and improve access to related 
services 
The objectives in this chapter track dental caries, tooth loss, periodontal disease, and untreated 
dental decay. Preventive measures such as annual dental visits, the use of dental sealants, 
fluoridation programs, and the availability of school and community-based dental services are also 
monitored. 
All Healthy People tracking data quoted in this chapter, along with technical information and 
operational definitions for each objective, can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
More information about this focus area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from 
http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from 
http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas. 
 
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade 
[1]. Seventy-one percent of the Oral Health objectives with data to measure progress moved 
toward or achieved their Healthy People 2010 targets (Figure 21-1). However, health 
disparities among racial and ethnic population groups, as well as by sex and by education 
level, were observed (Figure 21-2), some of which are highlighted below [2]. 
 Dental caries experience in the primary teeth of children aged 2–4 years (objective 21-1a) 
increased by 33.3% between 1988–94 and 1999–2004, from 18% to 24%, moving away 
from the Healthy People 2010 target of 11%. 
 Dental caries experience in permanent teeth of adolescents aged 15 years (objective 21-1c) 
decreased by 8.2% between 1988–94 and 1999–2004, from 61% to 56%, moving toward 
the 2010 target of 51%. 
 Untreated dental decay in permanent teeth of adolescents aged 15 years (objective 21-2c) 
decreased by 10.0% between 1988–94 and 1999–2004, from 20% to 18%, moving toward 
the 2010 target of 15%. 
 The proportion of adults aged 35–44 years with untreated dental decay (objective 21-2d) 
increased by 3.7% between 1988–94 and 1999–2004 from 27% to 28%, moving away from 
the 2010 target of 15%. However, the change was not statistically significant 
 Among education groups, persons with at least some college education had the 
lowest (best) rate of untreated dental decay, 18% in 1999–2004. Persons with less 
than a high school education had a rate of 50% in 1999–2004, almost three times 
the best group rate [2]. 
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 The proportion of adults aged 35–44 years with no permanent tooth loss due to caries or 
periodontal disease (objective 21-3) increased by 26.7% between 1988–94 and 1999–2004, 
from 30% to 38%, moving toward the 2010 target of 40%. During the same period, the 
proportion of adults aged 65–74 years who experienced complete tooth loss (objective 21-
4) declined by 17.2%, from 29% to 24%, moving toward the 2010 target of 22%. 
 The proportion of children aged 8 years and of adolescents aged 14 years (objectives 21-8a 
and b, respectively) who had a dental sealant on at least one molar increased by 39.1% and 
40.0%, from 23% to 32% and 15% to 21%, respectively, between 1988–94 and 1999–2004, 
moving toward their 2010 targets of 50%. 
 Several objectives met or exceeded their 2010 targets: 
 The proportion of school-based health centers providing dental sealants as part of 
an oral health program (objective 21-13a) doubled, increasing from 12% in 2001–
02 to 24% in 2007–08, and exceeding the 2010 target of 15%. 
 The proportion of community-based health centers with an oral health component 
(objective 21-14) increased by 44.2% between 1997 and 2007, from 52% to 75%, 
meeting the 2010 target of 75%. 
 The number of State and local dental programs directed by public health 
professionals (objective 21-17a) increased by 38.5% between 2003 and 2009, from 
39 to 54 programs, exceeding the 2010 target of 41 programs. 
 The number of Indian Health Service and Tribal dental programs directed by public 
health professionals (objective 21-17b) increased from 9 programs in 2003 to 10 in 
2006. The target for this objective (9 programs) was met at baseline and exceeded 
at the final data point. 
 
Summary of Progress 
 Figure 21-1 presents a quantitative assessment of progress in achieving the Healthy People 
2010 objectives for Oral Health [1]. Data to measure progress toward target attainment 
were available for 24 objectives. Of these: 
 Four objectives (21-13a, 21-14, and 21-17a and b) met or exceeded their 2010 
targets. 
 Thirteen objectives moved toward their targets. A statistically significant difference 
between the baseline and the final data points was observed for five of these 
objectives (21-3, 21-4, 21-5b, 21-7, and 21-12). No significant differences were 
observed for four objectives (21-1c, 21-2c, and 21-8a and b); and data to test the 
significance of the difference were unavailable for four objectives (21-9, 21-13b, 21-
15, and 21-16). 
 Seven objectives moved away from their targets. A statistically significant difference 
between the baseline and final data points was observed for one objective (21-1a). 
No significant differences were observed for five objectives (21-1b; 21-2a, b, and d; 
and 21-10); and data to test the significance of the difference were unavailable for 
one objective (21-6). 
 Data were unavailable to measure progress for two objectives (21-5a and 21-11). 
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 Figure 21-2 displays health disparities in Oral Health from the best group rate for each 
characteristic at the most recent data point [2]. It also displays changes in disparities from 
baseline to the most recent data point [3]. 
 Nine objectives had statistically significant racial and ethnic health disparities of 
10% or more (objectives 21-1a and b, 21-2d, 21-3, 21-5b, 21-7, 21-8a and b, and 21-
10). Two additional objectives (21-5a and 21-6) had racial and ethnic health 
disparities of 10% or more, but lacked data to assess statistical significance. The 
white non-Hispanic population had the only best group rate for 10 of these 
objectives; while the Hispanic or Latino and white non-Hispanic populations both 
had the best group rate for objective 21-6. 
 Four objectives had statistically significant health disparities of 10% or more by sex 
(objectives 21-1a, 21-2d, 21-3, and 21-10), and two objectives (21-5a and 21-6) had 
health disparities of 10% or more by sex but lacked data to assess statistical 
significance. Females had the better rate for five of these six objectives (21-1a, 21-
2d, 21-5a, 21-6, and 21-10). Males had a better rate for the sixth objective (21-3). 
 Nine objectives had statistically significant health disparities of 10% or more by 
education level (objectives 21-1b and c, 21-2d, 21-3, 21-5b, 21-7, 21-8a and b, and 
21-10), and one objective (21-5a) had health disparities of 10% or more by 
education level but lacked data to assess statistical significance. Persons with at 
least some college education had the best group rate for all 10 of these objectives. 
 Two objectives had health disparities of 100% or more by education level 
(objectives 21-2d and 21-5b), and one objective (21-5b) had a change in disparity 
by education level over time of 100 percentage points or more [3]. 
 
Transition to Healthy People 2020 
For Healthy People 2020, the focus of the Oral Health objectives has expanded to include a broader 
range of health behaviors, interventions to reduce tooth decay, improved methods of monitoring 
oral diseases and conditions, and programs that provide preventive oral health services at the 
community and national levels. See HealthyPeople.gov for a complete list of Healthy People 2020 
topics and objectives. 
The Healthy People 2020 objectives for Oral Health can be grouped into several sections: 
 Oral health of children and adolescents 
 Oral health of adults 
 Access to preventive services 
 Oral health interventions 
 Monitoring, surveillance systems 
 Public health infrastructure. 
The differences between the Healthy People 2010 and Healthy People 2020 objectives are 
summarized below: 
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 The Healthy People 2020 Oral Health Topic Area has 33 objectives, five of which are 
developmental, whereas the Healthy People 2010 Oral Health Focus Area had 26 objectives 
[4]. 
 Seven Healthy People 2010 objectives were retained “as is” [5]. These objectives include: 
untreated dental decay in adults (objective 21-2d), complete tooth loss in older adults 
(objective 21-4), community water fluoridation (objective 21-9), annual dental visits 
(objective 21-10), dental care and sealants provided in school-based health centers 
(objectives 21-13a and b), and community-based health centers with an oral health 
component (objective 21-14). 
 Two Healthy People 2010 objectives were archived [6]. 
 The methodology for assessing gingival bleeding used at baseline was modified over 
the course of the decade and a new definition has yet to be defined. Therefore, 
gingivitis in adults (objective 21-5a) will not be tracked in Healthy People 2020. 
 Use of the oral health care system by nursing home residents has not been collected 
in a national survey since baseline. Therefore, the objective for residents in long-
term facilities (objective 21-11) was archived due to lack of national data. 
 Seventeen Healthy People 2010 objectives were modified to create 18 Healthy People 2020 
objectives [7]. 
 The age groups tracked for the following objectives were modified and expanded: 
dental caries experience and untreated dental decay in children and adolescents 
(objectives 21-1a through c, and 21-2a through c), dental sealants in children and 
adolescents (objectives 21-8a and b), permanent tooth loss in adults (objective 21-
3), and destructive periodontal diseases in adults (objective 21-5b). 
 The data sources for early detection of oral and pharyngeal cancers (objective 21-6) 
and oral and pharyngeal cancer screening by a dental professional (objective 21-7) 
were modified. In addition, the age group tracked for oral and pharyngeal cancer 
screening was expanded. This objective is developmental in Healthy People 2020 
[4]. 
 The definition of an annual preventive dental services visit for low-income youth 
(objective 21-12) has been changed. The Healthy People 2010 objective defines a 
preventive visit as one in which the patient received 1) an examination, 2) a dental 
sealant, 3) a fluoride treatment, 4) a dental prophylaxis, or 5) an X-ray examination. 
The Healthy People 2020 objective defines a preventive visit as one in which the 
patient received 1) a dental sealant, 2) a fluoride treatment, or 3) a dental 
prophylaxis. In addition, the age group tracked was changed from 2–19 years to 2–
18 years. 
 The objective tracking the number of states that record and refer children and youth 
diagnosed with a cleft lip or palate (objective 21-15) has been expanded to two 
developmental objectives, tracking the registry and referral of such children 
separately. 
 The definitions of state oral and craniofacial surveillance systems (objective 21-16) 
and state and local dental health programs directed by public health professionals 
(objective 21-17a) were modified. 
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 The number of Indian Health Service and Tribal dental programs that serve 
jurisdictions of 30,000 or more persons and are directed by a public health 
professional (objective 21-17b) has increased to 33: one headquarter or national 
program, 20 field programs, and 12 regional or area offices. 
 Eight new objectives, two of which are developmental were added to the Healthy People 
2020 Topic Area [4]. 
 One new objective tracks the proportion of patients who receive oral health at 
federally qualified health centers. Two objectives track untreated dental decay: 
adults aged 65–74 years with coronal caries in at least one tooth, and adults aged 75 
years and over with root surface caries in at least one tooth. 
 Two developmental prevention objectives focus on counseling to reduce tobacco 
use and encourage smoking cessation and referral for glycemic control by dental 
professionals. 
 One new objective tracks sealant placement on primary molars for children aged 3–
5 years. 
 One new objective expands the scope of services tracked in school-based health 
centers to include fluoride treatments. 
 One new objective tracks the expansion of existing infrastructure by monitoring the 
increase of oral health prevention and care services provided by local health 
departments. 
Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” 
summarizes the changes between the two decades of objectives, reflecting new knowledge and 
direction for this area. 
 
Data Considerations 
Education and income are the primary measures of socioeconomic status (SES) in Healthy People 
2010. Most data systems used in Healthy People 2010 define income as a family’s income before 
taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size 
and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed 
by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. 
These categories may be overridden by considerations specific to the data system, in which case 
they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. 
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In general, data on educational attainment are presented for persons aged 25 years and over, 
consistent with guidance given by the U.S. Bureau of the Census. However, because of the 
requirements of the different data systems, the age groups used to calculate educational attainment 
for any specific objective may differ from the age groups used to report the data for other Healthy 
People 2010 objectives, as well as from select populations within the same objective. Therefore, the 
reader is urged to exercise caution in interpreting the data by educational attainment shown in the 
Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. 
Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can 
be found in the Operational Definitions on the DATA2010 website, available from 
http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement 
can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, 
which is available in the Data Issues section of the NCHS Healthy People website under 
Healthy People 2010. 
 
Notes 
1. Displayed in the Progress Chart (Figure 21-1), the percent of targeted change achieved expresses the 
difference between the baseline and the final value relative to the initial difference between the 
baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward 
attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When 
standard errors were available, the difference between the baseline and the final value was tested at 
the 0.05 level of significance. See the Figure 21-1 footnotes, as well as the Technical Appendix, for 
more detail. 
2. Information about disparities among select populations is shown in the Health Disparities Table 
(Figure 21-2). Disparity from the best group rate is defined as the percent difference between the 
best group rate and each of the other group rates for a characteristic. For example, racial and ethnic 
health disparities are measured as the percent difference between the best racial and ethnic group 
rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as 
the percent difference between the better group rate (e.g., female) and the rate for the other group 
(e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be 
increased, while others are expressed in terms of adverse events or conditions that are to be reduced. 
In order to facilitate comparison of health disparities across different objectives, disparity is 
measured only in terms of adverse events or conditions. For comparability across objectives, 
objectives that are expressed in terms of favorable events or conditions are re-expressed using the 
adverse event or condition for the purpose of computing disparity, but they are not otherwise 
restated or changed. For example, objective 1-1, to increase the proportion of persons with health 
insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had 
some form of health insurance in 2008), is expressed in terms of the percentage of persons without 
health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged 
under 65 years did not have any form of health insurance in 2008) when the disparity from the best 
group rate is calculated. See the Reader’s Guide for more information. When standard errors were 
available, the difference between the best group rate and each of the other group rates was tested at 
the 0.05 level of significance. See the Figure 21-2 footnotes, as well as the Technical Appendix, for 
more detail. 
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3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the 
most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s 
Guide for more information. When standard errors were available, the change in disparity was tested 
at the 0.05 level of significance. See the Figure 21-2 footnotes, as well as the Technical Appendix, for 
more detail. 
4. To be included in Healthy People 2010, an objective must have a national data source that provides a 
baseline and at least one additional data point for tracking progress. Some objectives lacked baseline 
data at the time of their development but had a potential data source and were considered of 
sufficient national importance to be included in Healthy People. These are called “developmental” 
objectives. When data become available, a developmental objective is moved to measurable status 
and a Healthy People target can be set. 
5. Retained “as is” objectives have no change in the numerator definition or in the denominator 
definition between the Healthy People 2010 and Healthy People 2020 objectives. These include 
objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 
2020 and for which no numerator or denominator information was available. 
6. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward 
into Healthy People 2020.  
7. Modified objectives have some change in the numerator definition or in the denominator definition 
between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that 
went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice 
versa. 
Oral Health  Page 21-9 
Comprehensive Summary of Objectives: Oral Health 
Objective Description Data Source 
21-1a Dental caries experience—Primary teeth—Young children (2–4 years) National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
21-1b Dental caries experience—Primary or permanent teeth—Children (6–8 
years) 
National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
21-1c Dental caries experience—Permanent teeth—Adolescents (15 years) National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
21-2a Untreated dental decay—Primary teeth—Young children (2–4 years) National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS 
21-2b Untreated dental decay—Primary or permanent teeth—Children (6–8 
years) 
National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS 
21-2c Untreated dental decay—Permanent teeth—Adolescents (15 years) National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS 
21-2d Untreated dental decay—Adults (35–44 years) National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS 
21-3 No permanent tooth loss due to caries or periodontal disease in adults 
(35–44 years) 
National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
21-4 Complete tooth loss in older adults (65–74 years) National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
21-5a Gingivitis in adults (35–44 years)  National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
21-5b Destructive periodontal disease in adults (35–44 years) National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS; Oral Health Survey of Native Americans, 1999-2000, IHS. 
21-6 Early detection of oral and pharyngeal cancers Surveillance, Epidemiology, and End Results (SEER) Program, NIH, NCI. 
21-7 Annual examinations for oral and pharyngeal cancers in adults (age 
adjusted, 40+ years) 
National Health Interview Survey (NHIS), CDC, NCHS. 
21-8a Dental sealants—Children (8 years) National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
21-8b Dental sealants—Adolescents (14 years) National Health and Nutrition Examination Survey (NHANES), CDC, 
NCHS. 
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Objective Description Data Source 
21-9 Population served by optimally fluoridated community water CDC Fluoridation Census, CDC, NCCDPHP. 
21-10 Annual dental visits (age adjusted, 2+ years) Medical Expenditure Panel Survey (MEPS), AHRQ. 
21-11 Use of oral health care system by residents in long-term care facilities National Nursing Home Survey (NNHS), CDC, NCHS. 
21-12 Annual preventive dental services for low-income children and 
adolescents (<19 years) 
Medical Expenditure Panel Survey (MEPS), AHRQ. 
21-13a School-based health centers with oral health component—Dental 
sealants 
School-Based Health Care Census, National Assembly of School Based 
Health Care. 
21-13b School-based health centers with oral health component—Dental care School-Based Health Care Census, National Assembly of School Based 
Health Care. 
21-14 Community-based health centers with oral health components HRSA, Bureau of Primary Health Care. 
21-15 Recording and referral of children and youth with cleft lip or palate (no. 
States and D.C.) 
Annual Synopses of State and Territorial Dental Public Health 
Programs, Association of State and Territorial Dental Directors 
(ASTDD). 
21-16 Oral and craniofacial State-based surveillance systems (no. States and 
D.C.) 
Annual Synopses of State and Territorial Dental Public Health 
Programs, Association of State and Territorial Dental Directors 
(ASTDD). 
21-17a State and local dental programs directed by public health professionals Association of State and Territorial Dental Directors (ASTDD). 
21-17b Indian Health Service and Tribal dental programs directed by public 
health professionals 
IHS, Division of Oral Health. 
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Figure 21-1. Progress Toward Target Attainment for Focus Area 21: Oral Health 
Percent of targeted change achieved5 (continued) 
 
21-1. Dental caries experience 
  a. Primary teeth—Young children  
   (2–4 years) 
  b. Primary or permanent teeth— 
   Children (6–8 years)   
  c. Permanent teeth—Adolescents (15 
   years) 
21-2. Untreated dental decay 
  a. Primary teeth—Young children 
   (2–4 years) 
  b. Primary or permanent teeth— 
   Children (6–8 years)  
  c. Permanent teeth—Adolescents (15 
   years)  
  d. Adults (35–44 years) 
21-3. No permanent tooth loss due to caries or 
periodontal disease in adults (35–44 years) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
11% 
18% 
(1988–94) 
24% 
(1999–2004) 
6 Yes 33.3% 
42% 
52% 
(1988–94) 
53% 
(1999–2004) 
1 No 1.9% 
51% 
61% 
(1988–94) 
56% 
(1999–2004) 
-5 No -8.2% 
9% 
16% 
(1988–94) 
19% 
(1999–2004) 
3 No 18.8% 
21% 
28% 
(1988–94) 
29% 
(1999–2004) 
1 No 3.6% 
15% 
20% 
(1988–94) 
18% 
(1999–2004) 
-2 No -10.0% 
15% 
27% 
(1988–94) 
28% 
(1999–2004) 
1 No 3.7% 
40% 
30% 
(1988–94) 
38% 
(1999–2004) 
8 Yes 26.7% 
50.0% 
40.0% 
80.0% 
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Figure 21-1. Progress Toward Target Attainment for Focus Area 21: Oral Health (continued) 
Percent of targeted change achieved5 (continued) 
 
21-4. Complete tooth loss in older adults (65–74 
years)  
21-5b. Destructive periodontal disease in adults 
(35–44 years)   
21-6. Early detection of oral and pharyngeal 
cancers  
21-7. Annual examinations for oral and pharyngeal 
cancers in adults (age adjusted, 40+ years)  
21-8. Dental sealants 
  a. Children (8 years) 
  b. Adolescents (14 years) 
21-9. Population served by optimally fluoridated 
community water 
21-10. Annual dental visits (age adjusted,  
 2+ years)  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
22% 
29% 
(1988–94) 
24% 
(1999–2004) 
-5 Yes -17.2% 
14% 
22% 
(1988–94) 
16% 
(1999–2004) 
-6 Yes -27.3% 
51% 
36% 
(1992–95) 
33% 
(2006) 
-3 
Not 
tested 
-8.3% 
20% 
13% 
(1998) 
18% 
(2008) 
5 Yes 38.5% 
50% 
23% 
(1988–94) 
32% 
(1999–2004) 
9 No 39.1% 
50% 
15% 
(1988–94) 
21% 
(1999–2004) 
6 No 40.0% 
75% 
62% 
(1992) 
72% 
(2008) 
10 
Not 
tested 
16.1% 
56% 
44% 
(1996) 
43% 
(2008) 
-1 No -2.3% 
71.4% 
75.0% 
71.4% 
33.3% 
17.1% 
76.9% 
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Percent of targeted change achieved5 
 
21-12. Annual preventive dental services for low-
income children and adolescents (<19 years)  
21-13. School-based health centers with oral health 
component 
  a. Dental sealants    
  b. Dental care  
21-14. Community-based health centers with oral 
health components  
21-15. Recording and referral of children and youth 
with cleft lip or palate (no. States and D.C.)   
21-16. Oral and craniofacial State-based 
surveillance systems (no. States and D.C.)   
21-17a. State and local dental programs directed by 
public health professionals  
21-17b. Indian Health Service and Tribal dental 
programs directed by public health 
professionals    
 
Figure 21-1. Progress Toward Target Attainment for Focus Area 21: Oral Health (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
66% 
25% 
(1996) 
31% 
(2008) 
6 Yes 24.0% 
15% 
12% 
(2001–02) 
24% 
(2007–08) 
12 
Not 
tested 
100.0% 
11% 
9% 
(2001–02) 
10% 
(2007–08) 
1 
Not 
tested 
11.1% 
75% 
52% 
(1997) 
75% 
(2007) 
23 
Not 
tested 
44.2% 
51 
16 
(2003) 
33 
(2009) 
17 
Not 
tested 
106.3% 
51 
0 
(1999) 
43 
(2010) 
43 
Not 
tested 
* 
41 
39 
(2003) 
54 
(2009) 
15 
Not 
tested 
38.5% 
9 
9 
(2003) 
10 
(2006) 
1 
Not 
tested 
11.1% 
14.6% 
50.0% 
48.6% 
84.3% 
            400.0% 
            750.0% 
   Target met at baseline and  
           exceeded at final 
100.0% 
(continued) 
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DATA SOURCES 
 
21-1a–c. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
21-2a–d. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS 
21-3–21-4. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
21-5b. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
21-6. Surveillance, Epidemiology, and End Results (SEER) Program, NIH, NCI. 
21-7. National Health Interview Survey (NHIS), CDC, NCHS. 
21-8a–b. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
21-9. CDC Fluoridation Census, CDC, NCCDPHP. 
21-10. Medical Expenditure Panel Survey (MEPS), AHRQ. 
21-12. Medical Expenditure Panel Survey (MEPS), AHRQ. 
21-13a–b. School-Based Health Care Census, National Assembly of School Based Health Care. 
21-14. HRSA, Bureau of Primary Health Care. 
21-15–21-16. Annual Synopses of State and Territorial Dental Public Health Programs, Association of State and Territorial Dental Directors (ASTDD). 
21-17a. Association of State and Territorial Dental Directors (ASTDD). 
21-17b. IHS, Division of Oral Health. 
 
 
 
 
Figure 21-1. Progress Toward Target Attainment for Focus Area 21: Oral Health (continued) 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 21-5a and 21-11. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
 
* Percent change cannot be calculated. See Technical Appendix for more information. 
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Figure 21-2. Health Disparities Table for Focus Area 21: Oral Health
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21-1a. Dental caries experience—Primary 
teeth—Young children (2–4 years) (1988–94, 
1999–2004)1*
NA NA NA NA 3i 2 Bii 3iii Bii 2 NA NA NA
21-1b. Dental caries experience—Primary or 
permanent teeth—Children (6–8 years) 
(1988–94, 1999–2004)1*
NA NA NA NA 2i 2 B 2 Bii 1 2 1 B 2 NA NA
21-1c. Dental caries experience—Permanent 
teeth—Adolescents (15 years) (1988–94, 
1999–2004)1*
NA NA NA NA 1i Bii 1 1iii 1iv B 1iv 2iv Bii 2iii NA NA
21-2a. Untreated dental decay—Primary teeth—Young 
children (2–4 years) (1988–94, 1999–2004)1* NA NA NA NA i NA B 1 NA NA NA
21-2b. Untreated dental decay—Primary or permanent 
teeth—Children (6–8 years) (1988–94, 
1999–2004)1*
NA NA NA NA 1i B b NA NA NA NA
21-2c. Untreated dental decay—Permanent 
teeth—Adolescents (15 years) (1988–94, 
1999–2004)1*
NA NA NA NA i NA NA NA NA
21-2d. Untreated dental decay—Adults (35–44 years) 
(1988–94, 1999–2004)* NA NA NA NA 3i 3 B 3 B 2 4 3 B 4 NS NS
21-3. No permanent tooth loss due to caries or 
periodontal disease in adults (35–44 years) 
(1988–94, 1999–2004)*
NA NA NA NA 1i 2 B 2 2 Bii 3 2 B 2 NS NS
21-4. Complete tooth loss in older adults (65–74 
years) (1988–94, 1999–2004)* NA NA NA NA bi 1 Bii NA 1 B NA NA
21-5a. Gingivitis in adults (35–44 years) (1988–94)†
NA NA NA NA 2i 2 B 2 B 2 2 2 B 2 NS NS
21-5b. Destructive periodontal disease in adults 
(35–44 years) (1988–94, 1999–2004)* NA NA NA NA 1i 3 B 2
4u3
3 Bii 4iii NS NS
21-6. Early detection of oral and pharyngeal cancers 
(1992–95, 2006)† 2 NA Bii
2d1
B
1d1
B
2u1
NA NA NA NA NA NA
21-7. Annual examinations for oral and pharyngeal 
cancers in adults (age adjusted, 40+ years) 
(1998, 2008)2*
NA 2 NA NA 2 2 B 2 B 1
2u1
2 B 2 NS NS
21-8a. Dental sealants—Children (8 years) (1988–94, 
1999–2004)1* NA NA NA NA 2i 2 B 2 B Bii 2iv 1iv B 2iii NA NA
21-8b. Dental sealants—Adolescents (14 years) 
(1988–94, 1999–2004)1* NA NA NA NA 1i, iv 2iv B 2iii 1iv B 2iv 1iv B 2iii NA NA
21-10. Annual dental visits (age adjusted, 2+ years) 
(1996, 2008)3* 2 2 2 2 2 2 B 2 B 2 3 2 B 3 2 B
21-11. Use of oral health care system by residents in 
long-term care facilities (1997)* NA NA NA NA 1 B 1 1 1 B NA NA NA NA NA NA
21-12. Annual preventive dental services for low-
income children and adolescents (<19 years) 
(1996, 2008)3*
b 1 NA Bii 1 1 1 NA B B NA NA NA NA NS NS
Population-based objectives
Disparities from the best group rate for each characteristic at the most recent data point and changes 
in disparity from the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Disability
1d1v
(continued)
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Figure 21-2. Health Disparities Table for Focus Area 21: Oral Health (continued)
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
1
2
3
i
ii
iii
iv
v
21-1a–c. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
21-2a–d. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
21-3–21-4. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
21-5a–b. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
21-6. Surveillance, Epidemiology, and End Results (SEER) Program, NIH, NCI.
21-7. National Health Interview Survey (NHIS), CDC, NCHS.
21-8a–b. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
21-10. Medical Expenditure Panel Survey (MEPS), AHRQ.
21-11. National Nursing Home Survey (NNHS), CDC, NCHS.
21-12. Medical Expenditure Panel Survey (MEPS), AHRQ.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Baseline data by race and ethnicity are for 2008.
Baseline data by race and ethnicity are for 2002.
Data are for Mexican American.
DATA SOURCES
Change in the summary index cannot be assessed. See Technical Appendix.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical 
Appendix.
Data are for Asian or Pacific Islander.
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
21-9, 21-13a and b, 21-14 through 21-16, and 21-17a and b.
Increase in disparity (percentage points)
10–49 points 50–99 points 100 points or more
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99%
Most favorable group rate for specified 
characteristic, but reliability criterion not 
met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
100% or more
Data by education level are for the head of household.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows 
when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. 
Nonetheless, disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
NOTES
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Years in parentheses represent the baseline and most recent data years (if available).
A reformatted, typeset version of this report will replace the current version 
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Goal: Improve health, fitness, and quality of life through 
daily physical activity 
This chapter includes objectives that track participation in physical activities, access to physical activity and fitness programs, and the availability of physical activity facilities at schools and worksites. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade. About 70% of the Physical Activity and Fitness objectives with data to measure progress moved toward their Healthy People 2010 targets (Figure 22-1) [1]. However, almost all of the objectives in this Focus Area exhibited statistically significant health disparities among select populations [2]. These disparities ranged from 10% to 49% in magnitude, with the exception of two objectives (discussed below) which displayed statistically significant disparities of 50% or more (Figure 22-2). 
 Television viewing by students in grades 9–12 (objective 22-11) declined. The percentage of students who watched television for two or fewer hours a day increased by 17.5% between 1999 and 2009, from 57% to 67%, moving toward the Healthy People 2010 target of 75%. Disparities were observed for a number of population groups, for example: 
• Among racial and ethnic groups, white non-Hispanic students had the highest (best) rate of television viewing for two or fewer hours a day, 75% in 2009, whereas Hispanic or Latino students and black non-Hispanic students had rates of 58% and 44% in 2009, respectively. When expressed as viewing television for more than two hours a day, the rate for Hispanic or Latino students was more than one and one-half times the best group rate (that for white non-Hispanic students). The rate for black non-Hispanic students was more than twice the best group rate. 
 The proportion of adults who did not participate in any form of leisure time physical activity (objective 22-1) decreased by 9% between 1997 and 2008, from 40% to 36%, moving toward the 2010 target of 20%. 
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• Among education groups, persons with at least some college education had the lowest (best) rate of no leisure time physical activity, 27% in 2008. Persons with less than a high school education had a rate of 59% in 2008, more than twice the best group rate. 
• Participation in leisure time physical activity varied by geographic region. Colorado, Minnesota, Oregon, Vermont, and Washington had the lowest rates of non-participation in 2008. These states achieved the Healthy People 2010 target. Kentucky, West Virginia, and a contiguous group of southern states (Alabama, Arkansas, Louisiana, Mississippi, Oklahoma, and Texas) had the highest rates (Figure 22-3).  
Summary of Progress 
 Figure 22-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Physical Activity and Fitness [1]. Data to measure progress toward target attainment were available for 17 objectives.  
• None of the objectives in this Focus Area achieved the Healthy People 2010 targets. 
• Twelve objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for five of these objectives (22-1, 22-4, 22-11, and 22-14a and b). No significant differences were observed for seven objectives (22-3, 22-5 through 22-7, 22-8a, 22-9, and 22-10). 
• One objective showed no change (objective 22-2). 
• Four objectives moved away from their targets. A statistically significant difference between the baseline and final data point was observed for two objectives (22-8b and 22-15a). No significant differences were observed for the other two objectives (22-12 and 22-15b). 
 Data were unavailable to measure progress for one objective (22-13); this objective had baseline data only. 
 Figure 22-2 displays health disparities in Physical Activity and Fitness from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Of the 10 objectives with statistically significant health disparities of 10% or more among racial and ethnic populations, the white non-Hispanic population had the best rate for seven objectives (22-1 through 22-4, 22-6, 22-7, and 22-11); the Hispanic or Latino population had the best rate for two objectives (22-9 and 22-10); and persons of two or more races had the best rate for one objective (22-5). 
♦ Health disparities of 100% or more were observed for one objective (22-11, student television viewing); see Highlights, above. 
• Males had better rates than females for the four objectives with statistically significant health disparities of 10% or more by sex (objectives 22-1, 22-4, 22-7, and 22-10). 
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• Persons with at least some college education had the best rates for five of the six objectives with statistically significant health disparities of 10% or more by education level (objectives 22-1 through 22-4, and 22-5). Persons with less than a high school education had the best rate for one objective (22-14a). 
• Residents of urban or metropolitan areas had better rates than residents of rural areas for the three objectives with statistically significant health disparities of 10% or more by geographic location (objectives 22-1, and 22-14a and b). 
• Persons without disabilities had better rates than persons with disabilities for the four objectives with statistically significant health disparities of 10% or more by disability status (objectives 22-1 through 22-4).  
Transition to Healthy People 2020 For Healthy People 2020, the focus of the Physical Activity objectives has been expanded to include a broader range of activities than those included in Healthy People 2010. The Healthy People 2010 Focus Area name was changed from “Physical Activity and Fitness” to “Physical Activity” to be consistent with 2008 Physical Activity Guidelines for Americans [4]. With the exception of muscle strengthening, the objectives primarily assess aerobic physical activity behaviors and the environments and policies that support being physically active. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 Physical Activity Topic Area can be grouped into several sections: 
 Aerobic physical activity and muscular strengthening activity in adults 
 Aerobic physical activity and muscular strengthening activity in children and adolescents 
 Physical education and school recess 
 Access to school physical activity facilities 
 Environmental policies enhancing physical activity opportunities 
 Physical activity policies in child care setting 
 Physical counseling related to physical activity. The differences between the Healthy People 2010 and Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Physical Activity Topic Area has a total of 36 objectives, 10 of which are developmental, whereas the Healthy People 2010 Physical Activity and Fitness Focus Area had 18 objectives [5]. 
 Five Healthy People 2010 objectives, including no leisure time physical activity (objective 22-1), physical education requirement (objectives 22-8a and b), participation in daily physical education in schools (objective 22-9), and access to physical activities in school facilities (objective 22-12), were retained “as is” [6]. 
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 Six Healthy People 2010 objectives were modified (objectives 22-2 through 22-4, 22-6, 22-7, and 22-11) [7]. These physical activity and muscle strengthening activity in adults and adolescents objectives were changed to reflect 2008 Federal Physical Activity Guidelines recommendations. 
 Five objectives addressing worksite physical activity programs (objective 22-13), walking and bicycling for transportation (objectives 22-14a and b, and 22-15a and b), were returned to developmental status due to a lack of baseline data [5]. 
 Two objectives were archived [8]. The flexibility objective (22-5) was archived due to a change in the physical activity guideline recommendations. The physical activity in physical education class measure (objective 22-10) was archived because it lacked a national data source. 
 The objective that tracks physician counseling about physical activity (objective 1-3a) was moved from Healthy People 2010 Focus Area “Access to Quality Health Services” into the Healthy People 2020 Physical Activity Topic Area and modified to include two objectives on physician counseling or education related to exercise. 
 Seventeen new objectives were added to the Healthy People 2020 Physical Activity Topic Area: 
• Seven new objectives address physical activity programs for children and adolescents objectives: time for recess, regularly scheduled school recess, daily physical education in elementary schools, and physical activity policies in child care settings. 
• The television viewing objective (22-11) was expanded to include seven new objectives of other types of screen time such as computer use, video and computer games among children and adolescents aged less than 17 years. 
• Three new Healthy People 2020 environment objectives include measures to track legislative policies that enhance access and availability of physical activity opportunities. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
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Data Considerations Figure 22-3 (no leisure time physical activity among adults) presents state-level data from the Behavioral Risk Factor Surveillance System (BRFSS). National data for this objective comes from the National Health Interview Survey (NHIS) and is the basis for setting the target. BRFSS data may not be comparable to the National data from the NHIS. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/ 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
References and Notes 1. Displayed in the Progress Chart (Figure 22-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 22-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 22-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the 
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adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 22-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 22-2 footnotes, as well as the Technical Appendix, for more detail. 4. 2008 Physical Activity Guidelines for Americans. Washington, DC: US Department of Health and Human Services (USDHHS); 2008. Available from: http://www.health.gov/PAGuidelines/ 5. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 6. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 7. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 8. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020.  
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Comprehensive Summary of Objectives: Physical Activity and Fitness 
Objective Description Data Source 22-1 No leisure-time physical activity (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 22-2 Regular physical activity—Moderate or vigorous (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 22-3 Regular physical activity—Vigorous (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 22-4 Regular muscle-strengthening activity (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 22-5 Flexibility training (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 22-6 Moderate physical activity in students (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 22-7 Vigorous physical activity in students (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 22-8a Physical education requirement in middle and junior high schools School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 22-8b Physical education requirement in senior high schools School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 22-9 Student participation in daily physical education in schools (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 22-10 Student physical activity in physical education class (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 22-11 Student television viewing—At most 2 hours per school day (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 22-12 Access to school physical activity facilities during non-school time School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 22-13 Worksite physical activity and fitness programs National Worksite Health Promotion Survey (NWHPS), Association for Worksite Health Promotion (AWHP and OPHS, ODPHP. 22-14a Walking for transportation—Adults—Trips ≤1 mile (age adjusted, 18+ years) National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT). 22-14b Walking for transportation—Children and adolescents—Trips to school ≤1 mile (5–15 years) National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT). 22-15a Bicycling for transportation—Adults—Trips ≤5 miles (age adjusted, 18+ years ) National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT). 22-15b Walking for transportation—Children and adolescents—Trips to school ≤2 miles (5–15 years) National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT).  
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Figure 22-1. Progress Toward Target Attainment for Focus Area 22: Physical Activity and Fitness 
Percent of targeted change achieved5 (continued) 
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adjusted, 18+ years) 
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Figure 22-1. Progress Toward Target Attainment for Focus Area 22: Physical Activity and Fitness (continued) 
Percent of targeted change achieved5 (continued) 
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Figure 22-1. Progress Toward Target Attainment for Focus Area 22: Physical Activity and Fitness (continued) 
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NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objective 22-13. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =                × 100. 
     Healthy People 2010 target – Baseline value 
 
 
DATA SOURCES 
 
22-1–22-5. National Health Interview Survey (NHIS), CDC, NCHS.  
22-6–22-7. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.   
22-8a–b. School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP.  
22-9–22-11. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.   
22-12. School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP.  
22-14a–b. National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT).  
22-15a–b. National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT).  
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22-1. No leisure-time physical activity 
(age adjusted, 18+ years) (1997, 2008)1 3 1 NA b
2d1
2 B NA 2 B 4
3u1
B 3 B
2u1 3u1
B
22-2. Regular physical activity—Moderate or vigorous 
(age adjusted, 18+ years) (1997, 2008)1 2 1 NA 2 2 2 Bi 2 1 B 2 2 B 2 B 1 2 B
22-3. Regular physical activity—Vigorous 
(age adjusted, 18+ years) (1997, 2008)1 2 1 NA 2 2 2 Bi 2 1 B 2 2 B 2 B 1 2 B
22-4. Regular muscle-strengthening activity 
(age adjusted, 18+ years) (1998, 2008)1 2 1 NA 1 2 1 Bi 1 2 B 2 2 B 2 B 1 2 B
22-5. Flexibility training (age adjusted, 18+ years) 
(1998, 2001)2 2 1 NA B 2 2 1 2 B 1 2 2 B 2 B 1 1 Bi
22-6. Moderate physical activity in students (grades 9–12) 
(1999, 2009) NA NA NA NA 1 2 B 2 1 B NA NA NA NA NS NS NS NS
22-7. Vigorous physical activity in students (grades 9–12) 
(1999, 2009) NA NA NA NA 2 2 B 2 3 B NA NA NA NA NS NS NS NS
22-9. Student participation in daily physical education in 
schools (grades 9–12) (1999, 2009) NA NA NA NA B 1 2 1 1 B NA NA NA NA NS NS NS NS
22-10. Student physical activity in physical education class 
(grades 9–12) (1999, 2009) NA NA NA NA B 2 1 2 2 B NA NA NA NA NS NS NS NS
22-11. Student television viewing—At most 2 hours per school 
day (grades 9–12) (1999, 2009) NA NA NA NA 3 4 B 3 B 1 NA NA NA NA NS NS NS NS
22-14a. Walking for transportation—Adults
—Trips ≤1 mile (age adjusted, 18+ years) (1995, 2001) NA NA NA NA NA NA NA NA B Bi B 2 2 2 B 2 NS NS
22-14b. Walking for transportation—Children and adolescents
—Trips to school ≤1 mile (5–15 years) (1995, 2001) NA NA NA NA NA NA NA NA Bi 1 NA NA NA NA B 2 NS NS
22-15a. Bicycling for transportation—Adults
—Trips ≤5 miles (age adjusted, 18+ years) (1995, 2001) NA NA NA NA NA NA NA NA 1 B B 1 1 1 B 1 NS NS
22-15b. Bicycling for transportation—Children and adolescents
—Trips to school ≤2 miles (5–15 years) (1995, 2001)3 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NS NS
Figure 22-2. Health Disparities Table for Focus Area 22: Physical Activity and Fitness
(continued)
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Location Disability
Population-based objectives
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
1
2
3
i
22-1–22-5. National Health Interview Survey (NHIS), CDC, NCHS.
22-6–22-7. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
22-9–22-11. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
22-14a–b. National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT).
22-15a–b. National Household Travel Survey (NHTS), formerly Nationwide Personal Transportation Survey (NPTS), Department of Transportation (DOT).
Measures of variability were available for all objectives in this table. Thus, the variability of best group rates was assessed, and statistical significance was tested. 
Disparities of 10% or more are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over 
time are indicated by arrows when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical 
Appendix.
Most favorable group rate for specified 
characteristic, but reliability criterion not 
met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
NOTES
Years in parentheses represent the baseline and most recent data years (if available).
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
22-8a and b, 22-12, and 22-13.
Figure 22-2. Health Disparities Table for Focus Area 22: Physical Activity and Fitness 
(continued)
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
10–49 points 50–99 points 100 points or more
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
Increase in disparity (percentage points)
DATA SOURCES
Baseline data by race and ethnicity are for 2001.
Most current data by location are for 1995.
Baseline data by race and ethnicity are for 1999.
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
17.9 - 20.0 
20.1 - 23.2 
23.3 - 25.6 
25.7 - 28.0 
28.1 - 32.4 
Percent 
Figure 22-3.  No Leisure Time Physical Activity Among Adults (18+ Years) 2008 
Healthy People 2010 objective 22-1 
Target = 20 
NOTES: Data are age-adjusted to the 2000 standard population. Rates are displayed by a modified Jenks classification for U.S. states. National data 
for the objective come from the National Health Interview Survey (NHIS) and is the basis for setting the target.  State data from the BRFSS 
may not be comparable to the national data from the NHIS. 
SOURCE: Behavioral Risk Factor Surveillance System (BRFSS), CDC.  
lowest category (green) shows states that met target 
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A reformatted, typeset version of this report will replace the current version 
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Goal: Ensure that Federal, Tribal, State, and local health 
agencies have the infrastructure to provide essential 
public health services effectively 
The Public Health Infrastructure Focus Area supports the goals and objectives of all other Focus Areas, particularly those that address preparedness and prevention, the management of chronic disease, and those that emphasize healthy behavioral choices. The Public Health Infrastructure objectives encompass Tribal, rural, and urban populations. They focus on four components: data and information systems, workforce, public health organizations, and prevention research. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Over two-thirds of the Public Health Infrastructure objectives were developmental when 
Healthy People 2010 was first published [1,2]. During the past decade, data sources were identified for many of these objectives, allowing them to be tracked and monitored. Since a number of objectives were revised and others added, the counts of objectives are not strictly comparable. As of this Final Review, 14% of the objectives remain developmental, and 7% were dropped during the decade [3]. 
 Substantial progress was achieved in objectives for this Focus Area during the past decade, although the tracking period for a number of objectives was five years or less [4]. Seventy percent of the Public Health Infrastructure objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (see Figure 23-1). 
 The timely release of Healthy People 2010 data increased over the decade. The proportion of objectives measured by major data systems from which data were released within one year of the end of data collection (objective 23-7) increased by 83.3 % between 2000 and 2009, from 36% to 66%, moving toward the Healthy People 2010 target of 100%. 
 The National Public Health Performance Standards Program assesses the public health system’s capacity to perform essential services (objectives 23-11a through d). 
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• The use of performance standards by State public health systems (objective 23-11a) increased by 177.8% between 2004 and 2009, from 9 to 25 states, moving toward the 2010 target of 35 states. The use of standards by local public health systems (objective 23-11b) more than doubled between 2004 and 2009, from 12% to 28%, moving toward the target of 50%. 
• During the same period, there was a small increase in the number of states meeting the optimal performance standards (objective 23-11c), from 0% to 4%, moving toward the target of 50%. The proportion of local public health systems meeting the standards (objective 23-11d) increased by 52.8 % between 2004 and 2009, from 36% to 55%, exceeding the 2010 target of 50%. 
 The percent of State epidemiologists with formal training in epidemiology (objective 23-14a) increased by 50% between 2001 and 2008, from 58% to 87%, exceeding the target of 80%.  
Summary of Progress 
 Figure 23-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Public Health Infrastructure [4]. Data to measure progress toward target attainment were available for 30 objectives. Of these: 
• Five objectives (23-2a, c and d; 23-11d; and 23-14a) met or exceeded their Healthy People 2010 targets. 
• Sixteen objectives (23-4; 23-6; 23-7; 23-11a through c; 23-13c, e, g, i, j, and k; 23-14c and d; and 23-15a and b) moved toward their targets. Data to test the significance of the difference between the baseline and the final data points were unavailable for all of these objectives. 
• One objective (23-3) showed no change. 
• Eight objectives moved away from their targets. A statistically significant difference between the baseline and final data points was observed for one objective (23-8b). Data to test the significance of the difference were unavailable for the other seven objectives (23-12c and d, and 23-13a, b, d, f, and h). 
 Six objectives (23-2b, 23-8a, 23-10a, 23-12a, 23-14b, and 23-17) remained developmental and four objectives (23-9, 23-10b and c, and 23-12b) had no data available to measure progress [1]. Three objectives (23-1, 23-5, and 23-16) were dropped during the decade [3].  
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Transition to Healthy People 2020 The objectives in the Healthy People 2020 Public Health Infrastructure Topic Area continue to be anchored in the provision of essential services. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. In addition, the Healthy People 2020 objectives focus more on education of the workforce and improvement of health departments than in Healthy People 2010. Public health law and public health systems research objectives proved to be difficult to measure for Healthy People 2010 and therefore have been dropped, at least until appropriate measures can be identified. The Healthy People 2020 objectives can be grouped into three sections: 
 Workforce 
 Data and information systems 
 Public health organizations. The differences between the Healthy People 2010 objectives and Healthy People 2020 are summarized below: 
 The Healthy People 2020 Public Health Infrastructure Topic Area has 44 objectives, 19 of which are developmental, whereas the Healthy People 2010 Focus Area had 43 objectives, including six that were still developmental at the end of the decade [1]. 
 Fifteen Healthy People 2010 objectives with data were retained “as is” [5]. These include: the use of core competencies in job descriptions at local health agencies and in public health curricula (objectives 23-8b and 23-9), the use of performance standards in local public health systems (objective 23-11b), provision or assurance of comprehensive laboratory services to support essential public health services (objectives 23-13a through k), and the formal training of State epidemiologists (objective 23-14a). An additional four objectives that address Tribal health agency activities (objectives 23-8a, 23-10a, 23-12a, and 23-14b) were also retained “as is” in developmental status [1]. 
 Ten Healthy People 2010 objectives were modified [6]. A new data source is being sought for monitoring the provision of continuing education to public health workers (objectives 23-10b and c); health improvement plans implemented at the state and local levels (objectives 23-12b through d) will be tracked and counted if conducted within the last five, rather than three, years; and the mechanisms for measuring several other objectives (23-4, 23-6, 23-7, and 23-14c and d) will be changed. 
 Eleven Healthy People 2010 objectives were archived [7]. Three of these (objectives 23-1, 23-5, and 23-16) had been dropped at the Midcourse Review [3]. Of the remaining eight, the availability of health indicator data was considered complete (objectives 23-2a, c, and d); geo-coding of major data systems (objective 23-3) could not expand further than it had during the previous decade; the meeting of national performance standards (objective 23-11c and d) will be subsumed into the accreditation objective; and public health law and public health systems research (objectives 23-15a and b) cannot be adequately measured at this time. 
Public Health Infrastructure  Page 23-5 
 Sixteen new objectives were added to the Healthy People 2020 Topic Area: 
• Five new objectives measure availability of public health programs at the community college and undergraduate levels, as well as the uniformity of undergraduate programs in public health that incorporate core competencies in their curriculum. 
• Objectives that track the levels of government expected to incorporate Core Competencies for Public Health Professions into job descriptions and performance evaluations have been expanded to include Federal and State public health agencies. Local boards of health were added to the objective targeting public health system assessment. 
• Three objectives monitoring the number of states using the most recent edition of the U.S. Standard Certificates to collect vital statistics data were added. 
• Objectives that track the quality and quantity of Healthy People 2020 data were expanded. 
• A public health laboratory systems performance objective was added. 
• Objectives addressing public health agency quality improvement and accreditation of State, Tribal and local health departments were also added. The Healthy People 2020 objectives reflect the ever-present importance of public health infrastructure to effectively provide essential public health services. For objectives that were deleted due to lack of data, the U.S. Department of Health and Human Services and the agencies that serve as the leads for the Healthy People 2020 initiative will consider ways to ensure that these public health issues retain prominence despite the lack of data to track them. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations Data collection and data analysis has been a challenge for measuring the Tribal objectives in the Public Health Infrastructure Focus Area due to the diversity of services, methods of service delivery, and data collection and measurement. The data source used to measure continuing education of public health workers (objectives 23-10b and c) was a national survey of registered nurses. These data were used to characterize all public health workers but only include one type of such employee. Furthermore, the survey was discontinued in 2000. The Epidemiology Capacity Assessment, conducted by the Council of State and Territorial Epidemiologists, was the data source for tracking State epidemiologic services (objectives 23-14a and c). States were asked if they had adequate epidemiologic capacity to provide the four essential public health services. The National Profile of Local Health Departments, conducted by the National Association of County and City Health Departments, was the data source for tracking epidemiology 
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services provided through local public health agencies (objective 23-14d). Respondents were asked to indicate which organization provided epidemiology and surveillance services in six categories. Agencies responding that services were provided by the local health department only, another local government agency only, a State agency only, or a non-government organization only, were categorized as providing adequate epidemiologic services. Because of the different definitions of adequate services used, the data for State and local health departments should not be compared. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
References and Notes 1. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 2. U.S. Department of Health and Human Services. Healthy People 2010. 2nd ed. With Understanding and 
Improving Health and Objectives for Improving Health. 2 vols. Washington, DC: U.S. Government Printing Office, November 2000. 3. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 4. Displayed in the Progress Chart (Figure 23-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 23-1 footnotes, as well as the Technical Appendix, for more detail. 5. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 6. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 7. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020.  
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Comprehensive Summary of Objectives: Public Health Infrastructure 
Objective Description Data Source or Objective Status 23-1 Public health employee access to the Internet Dropped 23-2a Health-related indicator data available—National Assessment of Objective Data Availability (AODA), CDC, NCHS. 23-2b Health-related indicator data available—Tribal  Developmental 23-2c Health-related indicator data available—State Assessment of Objective Data Availability (AODA), CDC, NCHS. 23-2d Health-related indicator data available—Local Assessment of Objective Data Availability (AODA), CDC, NCHS. 23-3 Use of geo-coding in major health data systems Assessment of Objective Data Availability (AODA), CDC, NCHS. 23-4 Data for all population groups in Healthy People 2010 objectives Assessment of Objective Data Availability (AODA), CDC, NCHS. 23-5 Data for Leading Health Indicators Dropped 23-6 Healthy People 2010 objectives tracked at least every three years Assessment of Objective Data Availability (AODA), CDC, NCHS. 23-7 Release of data on Healthy People 2010 objectives within one year of collection Assessment of Objective Data Availability (AODA), CDC, NCHS. 23-8a Tribal agencies with core competencies in job descriptions and performance evaluations Developmental 23-8b Local agencies with core competencies in job descriptions and performance evaluations National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 23-9 Core competencies in public health curricula Public Health Competencies Survey, Council on Linkages, American Schools of Public Health, Association of Teachers of Preventive Medicine, and the Quad Council 23-10a Continuing education—Tribal public health personnel Developmental 23-10b Continuing education—State public health personnel National Sample Survey of Registered Nurses, HRSA, Bureau of Health Professionals 23-10c Continuing education—Local public health personnel National Sample Survey of Registered Nurses, HRSA, Bureau of Health Professionals 23-11a Use of performance standards—State public health systems (no. States) National Public Health Performance Standards Program, CDC, OCPHP. 23-11b Use of performance standards—Local public health systems National Public Health Performance Standards Program, CDC, OCPHP. 23-11c Met performance standards—State public health systems  National Public Health Performance Standards Program, CDC, OCPHP. 23-11d Met performance standards—Local public health systems National Public Health Performance Standards Program, CDC, OCPHP. 23-12a Health improvement plans—Tribal health agencies Developmental 
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Objective Description Data Source or Objective Status 23-12b Health improvement plans—State health agencies Salary Survey of State and Territorial Health Officials, Association of State and Territorial Health Officials (ASTHO) 23-12c Health improvement plans—Local health agencies National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 23-12d Health improvement plans—Local plan linked to State plan National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 23-13a Public health laboratory services (States and D.C.)—Disease prevention control and surveillance Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-13b Public health laboratory services (States and D.C.)—Integrated data management Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-13c Public health laboratory services (States and D.C.)—Reference and specialized testing Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-13d Public health laboratory services (States and D.C.)—Environmental health and protection Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-13e Public health laboratory services (States and D.C.)—Food safety Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-13f Public health laboratory services (States and D.C.)—Laboratory improvement and regulation Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-13g Public health laboratory services (States and D.C.)—Policy development Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-13h Public health laboratory services (States and D.C.)—Emergency response Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-13i Public health laboratory services (States and D.C.)—Public health related research Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-13j Public health laboratory services (States and D.C.)—Training and education Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-13k Public health laboratory services (States and D.C.)—Partnerships and communication Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 23-14a Provide or assure comprehensive epidemiology services—State epidemiologists with formal training Epidemiology Capacity Assessment, Council of State and Territorial Epidemiologists (CSTE). 23-14b Provide or assure comprehensive epidemiology services—Tribal agencies Developmental 
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Objective Description Data Source or Objective Status 23-14c Provide or assure comprehensive epidemiology services—State agencies Epidemiology Capacity Assessment, Council of State and Territorial Epidemiologists (CSTE). 23-14d Provide or assure comprehensive epidemiology services—Local agencies National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 23-15a Evaluation of public health laws—Turning Point Model State Public Health Act (no. States and D.C.) Center for Public Health Law and the Public's Health, Georgetown University Law Center and Johns Hopkins Bloomberg School of Public Health. 23-15b Evaluation of public health laws—Model State Emergency Powers Act (no. States and D.C.) Center for Public Health Law and the Public's Health, Georgetown University Law Center and Johns Hopkins Bloomberg School of Public Health. 23-16 Data on public health expenditures Dropped 23-17 Population-based prevention research Developmental  
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Figure 23-1. Progress Toward Target Attainment for Focus Area 23: Public Health Infrastructure 
Percent of targeted change achieved7 (continued) 
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2010 
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Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
35 
9 
(2004) 
25 
(2009) 
16 Not tested 177.8% 
50% 
12% 
(2004) 
28% 
(2009) 
16 Not tested 133.3% 
50% 
0% 
(2004) 
4% 
(2009) 
4 Not tested N/A
6 
50% 
36% 
(2004) 
55% 
(2009) 
19 Not tested 52.8% 
80% 
53% 
(1999) 
49% 
(2008) 
-4 Not tested -7.5% 
41% 
37% 
(2005) 
33% 
(2008) 
-4 Not tested -10.8% 
100% 
98% 
(2006) 
88% 
(2008) 
-10 Not tested -10.2% 
73% 
59% 
(2006) 
55% 
(2008) 
-4 Not tested -6.8% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 23-1. Progress Toward Target Attainment for Focus Area 23: Public Health Infrastructure (continued) 
Percent of targeted change achieved7 (continued) 
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Figure 23-1. Progress Toward Target Attainment for Focus Area 23: Public Health Infrastructure (continued) 
Percent of targeted change achieved7 (continued) 
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Figure 23-1. Progress Toward Target Attainment for Focus Area 23: Public Health Infrastructure (continued) 
100.0% 
Percent of targeted change achieved7 (continued) 
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DATA SOURCES 
 
23-2a. Assessment of Objective Data Availability (AODA), CDC, NCHS.  
23-2c–d. Assessment of Objective Data Availability (AODA), CDC, NCHS.  
23-3–23-4. Assessment of Objective Data Availability (AODA), CDC, NCHS. 
23-6–23-7. Assessment of Objective Data Availability (AODA), CDC, NCHS. 
23-8b. National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO).  
23-11a–d. National Public Health Performance Standards Program, CDC, OCPHP. 
23-12c–d. National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO). 
23-13a–k. Comprehensive Laboratory Services Survey, Association of Public Health Laboratories (APHL). 
23-14a. Epidemiology Capacity Assessment, Council of State and Territorial Epidemiologists (CSTE). 
23-14c. Epidemiology Capacity Assessment, Council of State and Territorial Epidemiologists (CSTE). 
23-14d. National Profile of Local Health Departments, National Association of County and City Health Officials (NACCHO).  
23-15a–b. Center for Public Health Law and the Public's Health, Georgetown University Law Center and Johns Hopkins Bloomberg School of Public Health. 
  
 
 
  
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 23-2b, 23-8a, 23-9, 23-10a through c, 23-12a, 23-12b, 23-14b, and 23-17. Objectives 23-1, 23-5, and 23-16 were deleted at the Midcourse Review.  
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
5 Data beyond the baseline are not available; difference, statistical significance , and percent change cannot be calculated. See Technical Appendix for more information. 
6 Percent change cannot be calculated. See Technical Appendix for more information. 
 
                  Final value – Baseline value 
7 Percent of targeted change achieved =                × 100. 
     Healthy People 2010 target – Baseline value 
 
 
 
 
Figure 23-1. Progress Toward Target Attainment for Focus Area 23: Public Health Infrastructure (continued) 
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A reformatted, typeset version of this report will replace the current version 
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Goal: Promote respiratory health through better 
prevention, detection, treatment, and education efforts 
The objectives in this chapter track deaths, hospitalizations, and lost school or work days due to 
asthma; appropriate asthma care; and State-based asthma surveillance systems. Chronic 
obstructive pulmonary disease (COPD) deaths and activity limitations due to chronic lung and 
breathing problems are also monitored, as are issues related to persons with sleep apnea. 
All Healthy People tracking data quoted in this chapter, along with technical information and 
operational definitions for each objective, can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from 
http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from 
http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas. 
 
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade 
[1]. Seventy-one percent of the Respiratory Diseases objectives with data to monitor 
progress moved toward or achieved their Healthy People 2010 targets (Figure 24-1). 
However, statistically significant health disparities were observed for some objectives by 
race and ethnicity, as well as by sex, education level, and income [2]. Disparities of 50% or 
more remained for severe outcomes such as asthma and COPD deaths (Figure 24-2), as 
discussed below. 
 The asthma death rate declined among adolescents and adults, especially at older ages. 
Between 1999 and 2007, asthma deaths among persons aged 15–34 years (objective 24-1c) 
declined by 28.6%, from 5.6 to 4.0 deaths per million population, moving toward the 
Healthy People 2010 target of 1.9 deaths per million; asthma deaths among persons aged 
15–34 years (objective 24-1c) declined by 29.0%, from 15.5 to 11.0 deaths per million 
population, moving toward the 2010 target of 8.0 deaths per million; and asthma deaths 
among persons aged 65 years and over (objective 24-1e) declined by 37.7%, from 69.5 to 
43.3 deaths per million population, exceeding the 2010 target of 47.0 deaths per million. 
 Among adolescents and adults aged 15–34 years (objective 24-1c), the black non-
Hispanic population had an asthma death rate of 11.5 deaths per million in 2007, 
approximately four times the rate for the white non-Hispanic population (2.9 deaths 
per million in 2007) [2]. Among persons aged 35–64 years in 2007, the asthma 
death rate for the black non-Hispanic population (34.0 deaths per million) was more 
than four times that of the white non-Hispanic population (8.3 deaths per million). 
The asthma death rates among adults aged 65 years and over (objective 24-1e) for 
the Asian or Pacific Islander and the black non-Hispanic populations were 63.9 and 
63.8 deaths per million in 2007, respectively, more than one and a half times the 
rate for the white non-Hispanic population (40.9 deaths per million in 2007). 
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 Females aged 65 years and over (objective 24-1e) had asthma death rates of 84.2 
deaths per million in 1999 and 55.0 in 2007, whereas males had rates of 48.4 in 
1999 and 27.2 in 2007. In 2007, the asthma death rate for females was 
approximately twice the rate for males [2]. Between 1999 and 2007, the disparity 
between females and males increased by 28 percentage points [3]. 
 Adults aged 35–64 years (objective 24-1d) with at least some college education had 
the lowest (best) asthma death rate among education groups, 7.6 deaths per million 
in 2002, whereas high school graduates and persons with less than a high school 
education had rates of 20.5 and 25.7 deaths per million in 2002, respectively. The 
rate for high school graduates was more than two and a half times the best group 
rate, while the rate for persons with less than a high school education was almost 
three and a half times the best group rate [2]. 
 The asthma hospitalization rates for persons 65 years and over (objective 24-2c) increased 
by 42.9% between 1998 and 2007, from 17.7 to 25.3 hospitalizations per 10,000 population 
(age adjusted), moving away from the 2010 target of 11.0 hospitalizations per 10,000. 
 The proportion of persons with asthma who received assistance in reducing exposure to 
environmental risk factors (objective 24-7f) increased by 18.6% between 2002 and 2008, 
from 43% to 51% (age adjusted), exceeding the 2010 target of 50%. 
 The number of states (including D.C.) with state-based asthma surveillance systems 
(objective 24-8) increased from 19 states in 2003 to 36 states in 2009, exceeding the 2010 
target of 25 states. 
 The rates of activity limitations due to chronic lung and breathing problems (objective 24-
9) for poor and near-poor persons aged 45 years and over (5.1% in 2008, age adjusted) 
were more than three times the rate for middle/high income persons (1.6% in 2008, age 
adjusted) [2]. Between 1997 and 2008, the disparity between near-poor persons (3.8% in 
1997, age adjusted; 5.1% in 2008) and persons with middle/high incomes (1.8% in 1997, 
age adjusted; 1.6% in 2008) increased by 108 percentage points [3]. 
 Deaths from COPD among persons aged 45 years and over (objective 24-10) declined by 
9.3% between 1999 and 2007, from 123.9 to 112.4 deaths per 100,000 population (age 
adjusted), moving toward the 2010 target of 62.3 deaths per 100,000. 
 Among racial and ethnic groups, the Asian or Pacific Islander population had the 
lowest (best) death rate for COPD: 47.6 deaths per 100,000 (age adjusted) in 1999 
and 33.9 in 2007. The American Indian or Alaska Native population had COPD death 
rates of 91.8 per 100,000 (age adjusted) in 1999 and 83.8 in 2007; the black non-
Hispanic population had rates of 83.4 per 100,000 (age adjusted) in 1999 and 73.8 
in 2007; and the white non-Hispanic population had rates of 133.1 per 100,000 (age 
adjusted) in 1999 and 124.8 in 2007.  
 In 2007, the rate for the American Indian or Alaska Native population was 
about two and a half times the best group rate (that for the Asian or Pacific 
Islander population); the black non-Hispanic population’s rate was more 
than twice the best group rate; and the rate for the white non-Hispanic 
population was more than three and a half times the best group rate [2]. 
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 Between 1999 and 2007, the disparity in COPD death rates between the 
American Indian or Alaska Native population and the Asian or Pacific 
Islander population (group with the best rate) increased by 54 percentage 
points [3]. During the same period, the disparity between the white non-
Hispanic population and the Asian or Pacific Islander population increased 
by 89 percentage points. 
 Persons aged 45–64 years with at least some college education had the lowest (best) 
COPD mortality rate (6.9 deaths per 100,000 in 2002, age adjusted) among 
education groups. The rate for high school graduates, 28.4 deaths per 100,000 (age 
adjusted) in 2002, was more than four times the best group rate; while the rate for 
persons with less than a high school education, 49.7 deaths per 100,000 (age 
adjusted) in 2002, was more than seven times the best group rate [2]. 
 COPD death rates vary by geographic region. In 2005–07, the highest rates were 
observed in the Ohio River Valley, the Great Plains, and Northern California (Figure 
24-3). A few areas met the 2010 target. 
 
Summary of Progress 
 Figure 24-1 presents a quantitative assessment of progress in achieving the Healthy People 
2010 objectives for Respiratory Diseases [1]. Data to measure progress toward target 
attainment were available for 24 objectives. Of these: 
 Three objectives (24-1e, 24-7f, and 24-8) met or exceeded their Healthy People 
2010 targets. 
 Fourteen objectives moved toward their targets. A statistically significant difference 
between the baseline and the final data points was observed for four of these 
objectives (24-1c and d, 24-3b, and 24-10). No significant differences were observed 
for nine objectives (24-1b, 24-2a and b, 24-3a and c, 24-4, 24-5, 24-7d, and 24-9); 
and data to test the significance of the difference were unavailable for one objective 
(24-12). 
 Two objectives (24-7a and c) showed no change. 
 Five objectives moved away from their targets. A statistically significant difference 
between the baseline and final data point was observed for one objective (24-2c). 
No significant difference was observed for the remaining four objectives (24-1a, 24-
6, 24-7b, and 24-7e). 
 One objective (24-11b) remained developmental [4]. 
 Follow-up data were unavailable to measure progress for one objective (24-11a). 
Respiratory Diseases  Page 24-5 
 Figure 24-2 displays health disparities in Respiratory Diseases from the best group rate for 
each characteristic at the most recent data point [2]. It also displays changes in disparities 
from baseline to the most recent data point [3]. 
 Of the 11 objectives with statistically significant health disparities of 10% or more 
by race and ethnicity, the white non-Hispanic population had the best rate for six 
objectives (24-1c through e, 24-4, 24-7d, and 24-11a) and the white population 
(including persons of Hispanic origin) had the best rate for one objective (24-3b). 
The black non-Hispanic population had the best rate for three objectives (24-6, and 
24-7a and c), and the Asian or Pacific Islander population had the best rate for one 
objective (24-10). 
 Males had better rates than females for four of the eight objectives with statistically 
significant health disparities of 10% or more by sex (objectives 24-1d and e, 24-3b, 
and 24-9); females had better rates than males for the other four objectives (24-1c, 
24-7f, 24-10, and 24-11a). 
 Persons with at least some college education had the best rate for both of the 
objectives with statistically significant health disparities of 10% or more by 
education level (objectives 24-1d and 24-10). 
 Persons with middle/high incomes had the best rate for the three objectives with 
statistically significant health disparities of 10% or more by income (objectives 24-
7c and d, and 24-9). 
 Several objectives had health disparities of 100% or more. Many of these are 
discussed in the Highlights, above. 
 
Transition to Healthy People 2020 
The Healthy People 2010 Respiratory Diseases Focus Area was divided into two Healthy People 
2020 Topic Areas: Respiratory Diseases and Sleep Health. Sleep’s contribution to public health is 
best communicated as a separate topic area because sleep is a fundamental biological requirement 
for health that cross-cuts many topic areas and there are many non-respiratory causes of 
disordered sleep. For Healthy People 2020, the Respiratory Diseases objectives have been 
expanded to include additional National Asthma Education and Prevention Program (NAEPP) 
guidelines for asthma care and indicators of the burden of COPD. The Respiratory Diseases 
objectives primarily assess the burden of asthma and COPD and related measures on prevention, 
detection, treatment, and education efforts. Sleep Health has added objectives tracking sufficient 
sleep. The Sleep Health objectives are focused on adequate sleep and treatment of sleep disorders 
as well as the impact of fatigue on motor vehicle crashes. See HealthyPeople.gov for a complete list 
of Healthy People 2020 topics and objectives. 
The Healthy People 2020 Respiratory Diseases Topic Area can be grouped into two sections: 
 Asthma 
 Chronic Obstructive Pulmonary Disease. 
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The differences between the Healthy People 2010 objectives and those included in Healthy People 
2020 are summarized below: 
 The Healthy People 2020 Respiratory Diseases Topic Area has a total of 27 objectives, four 
of which are developmental [4]. The Sleep Topic Area has a total of four objectives. The 
Healthy People 2010 Respiratory Diseases Focus Area had 26 objectives, one of which was 
developmental. 
 Sixteen Healthy People 2010 objectives were retained “as is” [5]. These include: asthma 
deaths, separately assessed for persons aged 35–64 years (objective 24-1d), and persons 
aged 65 years and over (objective 24-1e); hospitalizations for asthma, separately assessed 
for persons under age 5 years (objective 24-2a), persons aged 5–64 years (objective 24-2b), 
and persons aged 65 years and over (objective 24-2c); emergency department visits for 
asthma, separately assessed for persons under age 5 years (objective 24-3a), persons aged 
5–64 years (objective 24-3b), and persons aged 65 years and over (objective 24-3c); activity 
limitations among persons with asthma (objective 24-4); patient education among persons 
with asthma (objective 24-6); five objectives tracking NAEPP guidelines for asthma care, 
namely receipt of written asthma plans from health care provider (objective 24-7a), proper 
use instructions with inhalers (objective 24-7b), education on early signs, symptoms and 
response to asthma episodes (objective 24-7c), appropriate medication regimens for 
asthma care (objective 24-7d), and assistance in reducing exposure to environmental risks 
for asthma (objective 24-7f); and COPD deaths (objective 24-10). 
 Two Healthy People 2010 Respiratory Diseases objectives were archived or dropped [6,7]. 
Long-term management care after hospitalization for asthma (objective 24-7e) was 
archived due to a lack of reliable data. The developmental objective (objective 24-11b) on 
long-term medical management for persons with symptoms of obstructive sleep apnea was 
dropped due to the lack of a national data source. 
 Six Healthy People 2010 Respiratory Diseases objectives were modified to create five 
Healthy People 2020 Respiratory Disease objectives [8]. 
 Three asthma deaths objectives among persons under age 5 years (objective 24-1a), 
5–14 years (objective 24-1b), and 15–34 years (objective 24-1c) were combined 
into one objective for persons 35 years and under. 
 The objective tracking the average number of school or work days lost due to 
asthma (objective 24-5) was divided into two separate objectives for children and 
adults and modified to assess the percentage of persons that miss school days or 
work days due to asthma, respectively. 
 The objective tracking states with asthma surveillance systems (objective 24-8) was 
expanded to also count territories and the definition was modified to include 
recipients of either of two funding sources that require asthma surveillance in 
addition to states and territories participating in a detailed asthma survey. 
 The objective tracking activity limitations due to chronic lung and breathing 
problems (objective 24-9) was modified to target adults with COPD instead of adults 
with activity limitations. 
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 Six new objectives were added to the Healthy People 2020 Respiratory Diseases Topic Area: 
 Three new developmental NAEPP asthma care objectives: routine annual follow-up 
visits for asthma, annual medical assessment of asthma control, and consultation on 
any work related causes of asthma. 
 Two new health care utilization objectives for COPD: hospitalizations and 
emergency department visits. 
 A new developmental objective tracking the diagnosis of underlying COPD. 
 Two objectives were moved to the new Sleep Health Topic Area including persons with 
symptoms of obstructive sleep apnea who seek medical evaluation (objective 24-11a) and 
motor vehicle crashes due to drowsy driving (objective 24-12). The motor vehicle crash 
objective was modified to include all crashes, not just those involving driver fatalities. 
 Two new objectives were added to the Healthy People 2020 Sleep Health Topic Area: 
 Sufficient sleep among students in grades 9–12 
 Sufficient sleep among adults. 
Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” 
summarizes the changes between the two decades of objectives, reflecting new knowledge and 
direction for this area. 
 
Data Considerations 
Education and income are the primary measures of socioeconomic status (SES) in Healthy People 
2010. Most data systems used in Healthy People 2010 define income as a family’s income before 
taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size 
and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed 
by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. 
These categories may be overridden by considerations specific to the data system, in which case 
they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. 
Beginning in 2003, education data for asthma and COPD deaths (objectives 24-1c and d and 24-10) 
from the National Vital Statistics System have been suppressed. The educational attainment item 
was changed in the new U.S. Standard Certificate of Death in 2003 to be consistent with the U.S. 
Census Bureau data and to improve the ability to identify specific types of educational degrees. 
Many states, however, are still using the 1989 version of the U.S. Standard Certificate of Death, 
which focuses on highest school grade completed. As a result, educational attainment data collected 
using the 2003 version are not comparable with data collected using the 1989 version [9]. 
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In general, data on educational attainment are presented for persons aged 25 years and over, 
consistent with guidance given by the U.S. Bureau of the Census. However, because of the 
requirements of the different data systems, the age groups used to calculate educational attainment 
for any specific objective may differ from the age groups used to report the data for other Healthy 
People 2010 objectives, as well as from select populations within the same objective. Therefore, the 
reader is urged to exercise caution in interpreting the data by educational attainment shown in the 
Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. 
Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, 
DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can 
be found in the Operational Definitions on the DATA2010 website, available from 
http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement 
can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, 
which is available in the Data Issues section of the NCHS Healthy People website under 
Healthy People 2010. 
 
References and Notes 
1. Displayed in the Progress Chart (Figure 24-1), the percent of targeted change achieved expresses the 
difference between the baseline and the final value relative to the initial difference between the 
baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward 
attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When 
standard errors were available, the difference between the baseline and the final value was tested at 
the 0.05 level of significance. See the Figure 24-1 footnotes, as well as the Technical Appendix, for 
more detail. 
2. Information about disparities among select populations is shown in the Health Disparities Table 
(Figure 24-2). Disparity from the best group rate is defined as the percent difference between the 
best group rate and each of the other group rates for a characteristic. For example, racial and ethnic 
health disparities are measured as the percent difference between the best racial and ethnic group 
rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as 
the percent difference between the better group rate (e.g., female) and the rate for the other group 
(e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be 
increased, while others are expressed in terms of adverse events or conditions that are to be reduced. 
In order to facilitate comparison of health disparities across different objectives, disparity is 
measured only in terms of adverse events or conditions. For comparability across objectives, 
objectives that are expressed in terms of favorable events or conditions are re-expressed using the 
adverse event or condition for the purpose of computing disparity, but they are not otherwise 
restated or changed. For example, objective 1-1, to increase the proportion of persons with health 
insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had 
some form of health insurance in 2008), is expressed in terms of the percentage of persons without 
health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged 
under 65 years did not have any form of health insurance in 2008) when the disparity from the best 
group rate is calculated. See the Reader’s Guide for more information. When standard errors were 
available, the difference between the best group rate and each of the other group rates was tested at 
the 0.05 level of significance. See the Figure 24-2 footnotes, as well as the Technical Appendix, for 
more detail. 
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3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the 
most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s 
Guide for more information. When standard errors were available, the change in disparity was tested 
at the 0.05 level of significance. See the Figure 24-2 footnotes, as well as the Technical Appendix, for 
more detail. 
4. To be included in Healthy People 2010, an objective must have a national data source that provides a 
baseline and at least one additional data point for tracking progress. Some objectives lacked baseline 
data at the time of their development but had a potential data source and were considered of 
sufficient national importance to be included in Healthy People. These are called “developmental” 
objectives. When data become available, a developmental objective is moved to measurable status 
and a Healthy People target can be set. 
5. Retained “as is” objectives have no change in the numerator definition or in the denominator 
definition between the Healthy People 2010 and Healthy People 2020objectives. These include 
objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 
2020 and for which no numerator or denominator information was available. 
6. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward 
into Healthy People 2020. 
7. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either 
developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy 
People 2010. 
8. Modified objectives have some change in the numerator definition or in the denominator definition 
between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that 
went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice 
versa. 
9. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics 
reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available from: 
http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf. 
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Comprehensive Summary of Objectives: Respiratory Diseases 
Objective  Description Data Source or Objective Status 
24-1a Deaths from asthma—Children <5 years (per million population) National Vital Statistics System—Mortality (NVSS-M), CDC, 
NCHS. 
24-1b Deaths from asthma—Children and adolescents 5–14 years (per 
million population) 
National Vital Statistics System—Mortality (NVSS-M), CDC, 
NCHS. 
24-1c Deaths from asthma—Adolescents and adults 15–34 years (per 
million population) 
National Vital Statistics System—Mortality (NVSS-M), CDC, 
NCHS. 
24-1d Deaths from asthma—Adults 35–64 years (per million 
population) 
National Vital Statistics System—Mortality (NVSS-M), CDC, 
NCHS. 
24-1e Deaths from asthma—Older adults 65+ years (per million 
population) 
National Vital Statistics System—Mortality (NVSS-M), CDC, 
NCHS. 
24-2a Hospitalizations for asthma—Children <5 years (per 10,000 
population) 
National Hospital Discharge Survey (NHDS), CDC, NCHS.  
24-2b Hospitalizations for asthma—Children and adults 5–64 years 
(age adjusted per 10,000 standard population)  
National Hospital Discharge Survey (NHDS), CDC, NCHS. 
24-2c Hospitalizations for asthma—Older adults 65+ years (age 
adjusted per 10,000 standard population) 
National Hospital Discharge Survey (NHDS), CDC, NCHS. 
24-3a Emergency department visits for asthma—Children <5 years 
(per 10,000 population) 
National Hospital Ambulatory Medical Care Survey (NHAMCS), 
CDC, NCHS. 
24-3b Emergency department visits for asthma—Children and adults 
5–64 years (per 10,000 population) 
National Hospital Ambulatory Medical Care Survey (NHAMCS), 
CDC, NCHS. 
24-3c Emergency department visits for asthma—Older adults 65+ 
years (per 10,000 population) 
National Hospital Ambulatory Medical Care Survey (NHAMCS), 
CDC, NCHS. 
24-4 Activity limitations among persons with asthma (age adjusted) National Health Interview Survey (NHIS), CDC, NCHS. 
24-5 School or work days missed by persons with asthma, due to 
asthma (5–64 years) 
National Health Interview Survey (NHIS), CDC, NCHS. 
24-6 Patient education among persons with asthma (age adjusted) National Health Interview Survey (NHIS), CDC, NCHS. 
24-7a Persons with asthma receiving written asthma plans from health 
care provider (age adjusted) 
National Health Interview Survey (NHIS), CDC, NCHS. 
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Objective  Description Data Source or Objective Status 
24-7b Persons with asthma receiving proper-use instructions with 
prescribed inhalers (age adjusted) 
National Health Interview Survey (NHIS), CDC, NCHS. 
24-7c Persons with asthma receiving education on early signs, 
symptoms and responses to asthma episodes (age adjusted) 
National Health Interview Survey (NHIS), CDC, NCHS. 
24-7d Persons with asthma receiving medication regimens that 
prevent need for >1 beta agonist inhalation canister per month 
(age adjusted) 
National Health Interview Survey (NHIS), CDC, NCHS. 
24-7e Persons with asthma receiving long-term management care after 
hospitalization due to asthma (age adjusted) 
National Health Interview Survey (NHIS), CDC, NCHS. 
24-7f Persons with asthma receiving assistance in reducing exposure 
to environmental risk factors (age adjusted) 
National Health Interview Survey (NHIS), CDC, NCHS. 
24-8 State-based asthma surveillance systems (no. States) Behavioral Risk Factor Surveillance System (BRFSS), CDC, 
NCCDPHP. 
24-9 Activity limitations due to chronic lung and breathing problems 
(age adjusted, 45+ years) 
National Health Interview Survey (NHIS), CDC, NCHS. 
24-10 Deaths from chronic obstructive pulmonary disease (COPD, 
excluding asthma) (age adjusted per 100,000 standard 
population, 45+ years) 
National Vital Statistics System—Mortality (NVSS-M), CDC, 
NCHS. 
24-11a Medical evaluation for persons with symptoms of obstructive 
sleep apnea (age adjusted, aged 20 years and over) 
National Health and Nutrition Examination Survey (NHANES), 
CDC, NCHS. 
24-11b Long-term medical management among persons with symptoms 
of obstructive sleep apnea 
Developmental 
24-12 Drivers involved in fatal motor vehicle crashes due to excessive 
sleepiness 
Fatality Analysis Reporting System (FARS), Department of 
Transportation (DOT). 
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Figure 24-1. Progress Toward Target Attainment for Focus Area 24: Respiratory Diseases 
Percent of targeted change achieved5 (continued) 
 
24-1. Deaths from asthma (per million 
 population) 
  a. Children <5 years 
  b. Children and adolescents 5–14 years  
  c. Adolescents and adults 15–34 years 
  d. Adults 35–64 years 
  e. Older adults 65+ years  
24-2.   Hospitalizations for asthma  
  a. Children <5 years (per 10,000 
   population)  
  b. Children and adults 5–64 years (age 
   adjusted, per 10,000 population) 
  c. Older adults 65+ years (age  
   adjusted, per 10,000 population) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
0.9 
1.7 
(1999) 
2.2 
(2007) 
0.5 No 29.4% 
0.9 
3.1 
(1999) 
2.7 
(2007) 
-0.4 No -12.9% 
1.9 
5.6 
(1999) 
4.0 
(2007) 
-1.6 Yes -28.6% 
8.0 
15.5 
(1999) 
11.0 
(2007) 
-4.5 Yes -29.0% 
47.0 
69.5 
(1999) 
43.3 
(2007) 
-26.2 Yes -37.7% 
25.0 
45.6 
(1998) 
41.4 
(2007) 
-4.2 No -9 .2% 
7.7 
12.5 
(1998) 
11.1 
(2007) 
-1.4 No -11.2% 
11.0 
17.7 
(1998) 
25.3 
(2007) 
7.6 Yes 42.9% 
18.2% 
43.2% 
60.0% 
20.4% 
29.2% 
           116.4% 
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Figure 24-1. Progress Toward Target Attainment for Focus Area 24: Respiratory Diseases (continued) 
Percent of targeted change achieved5 (continued) 
 
24-3. Emergency department visits for asthma 
   a. Children <5 years (per 10,000 
   population)  
  b. Children and adults 5–64 years (per 
   10,000 population)    
  c. Older adults 65+ years (per 10,000 
   population)  
24-4. Activity limitations among persons with 
asthma (age adjusted)  
24-5. School or work days missed by persons with 
asthma, due to asthma (5–64 years)   
24-6. Patient education among persons with  
 asthma (age adjusted)   
24-7. Persons with asthma receiving 
   a. Written asthma plans from health care 
    provider (age adjusted)  
  b. Proper-use instructions with  
   prescribed inhalers (age adjusted) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
80.0 
150.0 
(1995–97) 
132.8 
(2005–07) 
-17.2 No -11.5% 
50.0 
71.1 
(1995–97) 
57.0 
(2005–07) 
-14.1 Yes -19.8% 
15.0 
29.5 
(1995–97) 
21.9 
(2005–07) 
-7.6 No -25.8% 
7% 
14% 
(2001) 
13% 
(2008) 
-1 No -7.1% 
1.9 
5.8 
(2002) 
4.3 
(2008) 
-1.5 No -25.9% 
38% 
13% 
(2003) 
12% 
(2008) 
-1 No -7.7% 
40% 
33% 
(2002) 
33% 
(2008) 
0 No 0.0% 
98.8% 
96.0% 
(2003) 
95.9% 
(2008) 
-0.1 No -0.1% 
24.6% 
66.8% 
52.4% 
14.3% 
38.5% 
0.0% 
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Percent of targeted change achieved5 (continued) 
 
24-7. Persons with asthma receiving 
  c. Education on early signs, symptoms 
   and responses to asthma episodes (age 
    adjusted) 
  d. Medication regimens that prevent  
   need for >1 beta agonist inhalation 
   canister per month (age adjusted)   
  e. Long-term management care after  
   hospitalization due to asthma (age  
   adjusted) 
  f. Assistance in reducing exposure to 
   environmental risk factors (age 
   adjusted) 
24-8. State-based asthma surveillance systems 
(no. States)  
24-9. Activity limitations due to chronic lung and 
breathing problems (age adjusted, 45+ 
years)  
24-10. Deaths from chronic obstructive pulmonary 
disease (COPD, excluding asthma) (age 
adjusted, per 100,000 population, 45+ years) 
24-12. Drivers involved in fatal motor vehicle 
crashes due to excessive sleepiness 
 
Figure 24-1. Progress Toward Target Attainment for Focus Area 24: Respiratory Diseases (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
68% 
65% 
(2003) 
65% 
(2008) 
0 No 0.0% 
94% 
86% 
(2003) 
88% 
(2008) 
2 No 2.3% 
87% 
76% 
(2003) 
69% 
(2008) 
-7 No -9.2% 
50% 
43% 
(2002) 
51% 
(2008) 
8 Yes 18.6% 
25 
19 
(2003) 
36 
(2009) 
17 Not tested 89.5% 
1.9% 
2.5% 
(1997) 
2.4% 
(2008) 
-0.1 No -4.0% 
62.3 
123.9 
(1999) 
112.4 
(2007) 
-11.5 Yes -9.3% 
1.4% 
2.4% 
(2000) 
1.6% 
(2009) 
-0.8 Not tested -33.3% 
0.0% 
25.0% 
16.7% 
18.7% 
80.0% 
           114.3% 
           283.3% 
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 DATA SOURCES 
 
24-1a–e. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
24-2a–c. National Hospital Discharge Survey (NHDS), CDC, NCHS. 
24-3a–c. National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 
24-4–24-6. National Health Interview Survey (NHIS), CDC, NCHS. 
24-7a–f. National Health Interview Survey (NHIS), CDC, NCHS. 
24-8. Behavioral Risk Factor Surveillance System (BRFSS), CDC, NCCDPHP. 
24-9. National Health Interview Survey (NHIS), CDC, NCHS. 
24-10. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
24-12. Fatality Analysis Reporting System (FARS), Department of Transportation (DOT). 
  
  
 
 
 
Figure 24-1. Progress Toward Target Attainment for Focus Area 24: Respiratory Diseases (continued) 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 24-11a and 24-11b . 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =                × 100. 
     Healthy People 2010 target – Baseline value 
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24-1a. Deaths from asthma—Children <5 years [per million 
population (pop.)] (1999, 2007) NA NA NA NA NA NA NA NA NA NA NA NA NA
24-1b. Deaths from asthma—Children and adolescents 
5–14 years (per million pop.) (1999, 2007) NA NA NA NA NA NA NA NA NA NA NA NA
24-1c. Deaths from asthma—Adolescents and adults 
15–34 years (per million pop.) (1999, 2007)1 NA NA b 4 B NA B
3u1
NA NA NA NA NA
24-1d. Deaths from asthma—Adults 35–64 years (per 
million pop.) (1999, 2007)1 NA NA b 4 B NA
2d1
B 4 4 B 4 NA NA NA NA
24-1e. Deaths from asthma—Older adults 65+ years (per 
million pop.) (1999, 2007) NA NA b 3 B NA
4u1
B NA NA NA NA NA NA NA NA
24-2a. Hospitalizations for asthma—Children <5 years (per 
10,000 pop.) (1998, 2007) NA NA NA NA NA ii ii NA NA NA NA NA NA NA NA NA
24-2b. Hospitalizations for asthma—Children and adults 
5–64 years (age adjusted, per 10,000 pop.) (1998, 
2007)
NA NA NA NA NA ii ii NA NA NA NA NA NA NA NA NA
24-2c. Hospitalizations for asthma—Older adults 65+ years 
(age adjusted, per 10,000 pop.) (1998, 2007) NA NA NA NA NA ii ii NA NA NA NA NA NA NA NA NA
24-3a. Emergency department visits for asthma—Children 
<5 years (per 10,000 pop.) (1995–97, 2005–07) NA NA NA NA NA ii ii NA NA NA NA NA NA NA NA NA
24-3b. Emergency department visits for asthma—Children 
and adults 5–64 years (per 10,000 pop.) (1995–97, 
2005–07)
NA NA NA NA NA 4ii Bii NA 3 B NA NA NA NA NA NA NA NA
24-3c. Emergency department visits for asthma—Older 
adults 65+ years (per 10,000 pop.) (1995–97, 
2005–07)
NA NA NA NA NA NAii ii NA NA NA NA NA NA NA NA NA
24-4. Activity limitations among persons with asthma (age 
adjusted) (2001, 2008) NA NA NA
4u3
b 1 B NA NS NS NS NS NA
24-5. School or work days missed by persons with 
asthma, due to asthma (5–64 years) (2002, 2008)2 NA NA NA NA NA NS NS NS NS NA NA NA
24-6. Patient education among persons with asthma (age 
adjusted) (2003, 2008) NA 1 NA NA 1 Biii 2 2iv B 1 NS NS NS NS Biii 1 1 1
24-7a. Persons with asthma receiving written asthma plans 
from health care provider (age adjusted) (2002, 
2008)
NA 1 NA 1
2u1
B 2 2iv B 1 NS NS NS NS 1 1 B 1
24-7b. Persons with asthma receiving proper-use 
instructions with prescribed inhalers (age adjusted) 
(2003, 2008)
NA NA NA NA NA NA NS NS NS NS NA
24-7c. Persons with asthma receiving education on early 
signs, symptoms and responses to asthma 
episodes (age adjusted) (2003, 2008)
NA b NA 1 2 B 1 NA B 1 NS NS NS NS 2 2 B 2
24-7d. Persons with asthma receiving medication regimens 
that prevent need for >1 beta agonist inhalation 
canister per month (age adjusted) (2003, 2008)
NA NA NA 1 1 2 B 2iv NS NS NS NS 3 2 B 3
24-7e. Persons with asthma receiving long-term 
management care after hospitalization due to 
asthma (age adjusted) (2003, 2008)2
NA NA NA NA NA NA NA NA NA NS NS NS NS NA NA NA NA
24-7f. Persons with asthma receiving assistance in 
reducing exposure to environmental risk factors 
(age adjusted) (2002, 2008)
NA 1 NA b 1 Biii 1 NA B 2 NS NS NS NS 1 Biii 1 1
24-9. Activity limitations due to chronic lung and breathing 
problems (age adjusted, 45+ years) (1997, 2008)3 NA NA NA NA b 1 B NA 2 Biii NS NS NS NS 4
4u3
B 4
Figure 24-2. Health Disparities Table for Focus Area 24: Respiratory Diseases
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity 
from the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income
NAi
NAi
NAi
(continued)
Population-based objectives
3i
bi
Respiratory Diseases Page 24-17
A
m
er
ic
an
 In
di
an
 o
r 
A
la
sk
a 
N
at
iv
e
A
si
an
N
at
iv
e 
H
aw
ai
ia
n 
or
 
ot
he
r P
ac
ifi
c 
Is
la
nd
er
Tw
o 
or
 m
or
e 
ra
ce
s
H
is
pa
ni
c 
or
 L
at
in
o
B
la
ck
, n
ot
 H
is
pa
ni
c
W
hi
te
, n
ot
 H
is
pa
ni
c
Su
m
m
ar
y 
in
de
x
Fe
m
al
e
M
al
e
Le
ss
 th
an
 h
ig
h 
sc
ho
ol
H
ig
h 
sc
ho
ol
 
gr
ad
ua
te
A
t l
ea
st
 s
om
e 
co
lle
ge
Su
m
m
ar
y 
in
de
x
P
oo
r
N
ea
r p
oo
r
M
id
dl
e/
hi
gh
 in
co
m
e
Su
m
m
ar
y 
in
de
x
24-10. 4u2
NA 2
4u1 4u2 4u1
B
2d1
4
4u1
B 4 NA NA NA NA
24-11a.
NA NA NA NA 2v 1 B 2 B 2 1 1 B 1 B B 1 1
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
1
2
3
i
ii
iii
iv
v
24-1a–e. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
24-2a–c. National Hospital Discharge Survey (NHDS), CDC, NCHS.
24-3a–c. National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS.
24-4
–24-6. National Health Interview Survey (NHIS), CDC, NCHS.
24-7a–f. National Health Interview Survey (NHIS), CDC, NCHS.
24-9. National Health Interview Survey (NHIS), CDC, NCHS.
24-10. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
24-11a. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
DATA SOURCES
Sex Education Income
Population-based objectives
Baseline data by race and ethnicity are for 1999.
Data are for Asian or Pacific Islander.
Data include persons of Hispanic origin.
Change in the summary index cannot be assessed. See Technical Appendix.
Data are for Mexican American.
Data not available. Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage points 
and estimates of variability were not available. See Technical Appendix.
50–99 points
Decrease in disparity (percentage points)
10–49 points 50–99 points
100 points or more
100 points or more
NOTES
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 24-
8, 24-11b, and 24-12.
Increase in disparity (percentage points)
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99%
Figure 24-2. Health Disparities Table for Focus Area 24: Respiratory Diseases (continued)
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Bi
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Race and Ethnicity
Characteristics and Groups
Deaths from chronic obstructive pulmonary 
disease (COPD, excluding asthma) (age adjusted, 
per 100,000 pop., 45+ years) (1999, 2007)1
Medical evaluation for persons with symptoms of 
obstructive sleep apnea (age adjusted, 20+ years) 
(2005–08)
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race 
and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at 
baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary 
index at the most recent data point. See Technical Appendix for more information.
Measures of variability were available for all objectives in this table. Thus, the variability of best group rates was assessed, and statistical significance was tested. 
Disparities of 10% or more are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time 
are indicated by arrows when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
100% or more
FOOTNOTES
Most recent data by education level is for 2002.
Most recent data by sex is for 2003.
10–49 points
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Figure 24-3. Deaths from Chronic Obstructive Pulmonary Disease  
(Excluding Asthma, 45+ Years) 2005-07 
Healthy People 2010 objective 24-10 
Target = 62.3 
NOTES: Data are for ICD-10 codes J40-J44 reported as underlying cause, for ages 45 and older.  Rates are per 100,000 U. S. Population age-adjusted to  
the 2000 standard population.  Rates are displayed by a modified Jenks classification for U.S. health service area. 
SOURCE: National Vital Statistics System – Mortality, CDC, NCHS. 
lowest category (green) shows health service areas that met target 
Rate per 100,000 
rates are unreliable 
43.2 - 62.3 
62.4 - 120.2 
120.3 - 145.9 
146.0 - 181.1 
181.2 - 260.3 
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Goal: Promote responsible sexual behaviors, strengthen 
community capacity, and increase accessibility to quality 
services to prevent sexually transmitted diseases (STDs) 
and their complications 
Sexually transmitted diseases (STDs) refer to the more than 25 infectious organisms that are transmitted primarily through sexual activity. This chapter includes objectives that monitor cases of STD, responsible sexual behavior among adolescents, and the availability of screening programs for genital Chlamydia. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade [1]. Almost two thirds (63%) of the STD objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 10-1). However, health disparities of 50% or more among racial and ethnic populations, as well as by sex, were observed (Figure 10-2), as highlighted below [2]. 
 Chlamydia infections (objectives 25-1a through d) increased, moving away from the Healthy People 2010 targets [3]. Infections among females aged 15–24 years attending family planning clinics (objective 25-1a) increased by 62% between 1997 and 2009, from 5.0% to 8.1%. Similarly, for persons attending STD clinics, infections among females (objective 25-1b) increased by 34.4% between 1997 and 2009, from 12.2% to 16.4%, whereas infections among males (objective 25-1c) increased by 52.9% between 1997 and 2009, from 15.7% to 24.0%. Each of these three objectives had a 2010 target of 3.0%. Chlamydia infections among females aged 24 years and under who were enrolled in National Job Training Programs (objective 25-1d) increased by 15.8% between 2002 and 2009, from 10.1% to 11.7%, moving away from the 2010 target of 6.8%. Health disparities among racial and ethnic groups were observed for all four of these objectives. For example: 
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• In 2009, white non-Hispanic women attending family planning clinics, STD clinics, or enrolled in National Job Training Programs had the lowest (best) rates of Chlamydia infection among racial and ethnic groups: 5.4%, 12.1%, and 5.9%, respectively. The rate for black non-Hispanic women attending family planning clinics, 14.8% in 2009, was more than two and a half times the best rate (that for white non-Hispanic women), while the rate for black non-Hispanic women enrolled in National Job Training Programs, 14.8% in 2009, was twice the best rate [2]. 
• Asian men attending STD clinics had the lowest (best) rate of Chlamydia infection among racial and ethnic populations, 14.4% in 2009, whereas black non-Hispanic men had a rate of 29.4% in 2009, about twice the best rate [2]. 
 Chlamydia infection varied by geographic area. In 2009, the states of Idaho, Maine, New Hampshire, Utah, Vermont, and West Virginia had the lowest rates. Rates were highest in Alaska and Mississippi (Figure 25-3). 
 The incidence of gonorrhea (objective 25-2a) declined by 18.9% between 1997 and 2009, from 122 to 99 new cases per 100,000 population, moving toward the 2010 target of 19 new cases per 100,000 population. New cases of gonorrhea among females aged 15–44 years (objective 25-2b) declined by 8.6% between 2002 and 2009, from 279 to 255 per 100,000 population, moving toward the target of 42 new cases per 100,000 population. 
• Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) rates of new cases of gonorrhea (objective 25-2a), 19 new cases per 100,000 population in 1997 and 18 new cases per 100,000 in 2009. The Hispanic or Latino population had rates of 65 per 100,000 in 1997 and 59 in 2009; the American Indian or Alaska Native population had rates of 97 per 100,000 in 1997 and 113 in 2009; and the black non-Hispanic population had rates of 809 per 100,000 in 1997 and 556 in 2009.  
 In 2009, the rate for the Hispanic or Latino population was almost three and a half times the best group rate (that for the Asian or Pacific Islander population); the rate for the American Indian or Alaska Native was almost six and a half times the best rate; and the rate for the black non-Hispanic population was almost 31 times the best rate [2].  
 Between 1997 and 2009, the disparity between the American Indian or Alaska Native population and the Asian or Pacific Islander population (group with the best rate) increased by 117 percentage points, while the disparity between the black non-Hispanic population and the Asian or Pacific Islander population decreased by 1,169 percentage points [4]. 
• Racial and ethnic disparities in the incidence of gonorrhea among females aged 15–44 years (objective 25-2b) were similar to those observed in the total population.  
 The Asian or Pacific Islander population had the lowest (best) rate, 37 per 100,000 population in 2009. The rates for the white non-Hispanic, Hispanic or Latino, American Indian or Alaska Native, and black non-Hispanic populations were 83, 128, 311, and 1,198 per 100,000 in 2009, respectively.  
 The rate for the white non-Hispanic population was more than twice the best group rate (that for the Asian or Pacific Islander population); the rate for the Hispanic or Latino population was about three and a half times the best rate; the rate for the American Indian or Alaska Native population was almost eight and a half times the best rate; and the rate for the black non-Hispanic population was over 32 times the best rate [2]. 
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• The incidence of gonorrhea among females aged 15–44 years (objective 25-2b) for the Asian or Pacific Islander population was 43 new cases per 100,000 population in 1997 and 37 per 100,000 in 2009, whereas the rates for the American Indian or Alaska Native populations were 304 per 100,000 in 1997 and 311 in 2009.  
 Between 1997 and 2009, the disparity between the American Indian or Alaska Native population and the Asian or Pacific Islander population (group with the best rate) increased by 134 percentage points [4]. 
 Gonorrhea incidence varied by geographic region. In 2009, incidence was lower in the West, Midwest, and Northeast. Seven states, including Idaho, Montana, and Utah in the West, and Maine, New Hampshire, and Vermont in New England, achieved the Healthy People 2010 target. The District of Columbia had the highest incidence of gonorrhea (Figure 25-4). 
 Domestic transmission of primary and secondary syphilis (objective 25-3) increased by 43.7% between 1997 and 2009, from 3.2 new cases per 100,000 population to 4.6 new cases per 100,000, moving away from the Healthy People 2010 target of 0.2 new cases per 100,000 population. 
• Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) rates of new cases of syphilis: 0.3 new cases per 100,000 population in 1997 and 1.6 in 2009. Rates for the American Indian or Alaska Native population were 2.0 per 100,000 in 1997 and 2.4 in 2009; rates for the Hispanic or Latino population were 1.6 per 100,000 in 1997 and 4.5 in 2009; and rates for the black non-Hispanic population were 22.0 per 100,000 in 1997 and 19.2 in 2009.  
 In 2009, the rate for the Hispanic or Latino population was almost three times the best group rate (that for the Asian or Pacific Islander population), while the rate for the black non-Hispanic population was 12 times the best rate [2].  
 Between 1997 and 2009, the disparity between the American Indian or Alaska Native population and the Asian or Pacific Islander population (group with the best rate) declined by 517 percentage points; while the disparity between the Hispanic or Latino population and the Asian or Pacific Islander population declined by 252 percentage points; and the disparity between the black non-Hispanic population and the Asian or Pacific Islander population declined by 6,133 percentage points [4]. 
• Females had lower (better) rates of new cases of syphilis than males: 2.9 new cases per 100,000 population in 1997, and 1.4 in 2009. The rates for males were 3.6 new cases per 100,000 in 1997 and 7.8 in 2009. The 2009 rate for males was more than five and a half times the rate for females [2]. Between 1997 and 2009, the disparity between males and females increased by 433 percentage points [4]. 
 Domestic transmission of primary and secondary syphilis varied by geographic area. Four states achieved the Healthy People 2010 target: Alaska, Idaho, South Dakota, and Vermont. In 2009, Louisiana had the highest incidence of domestic transmission of primary and secondary syphilis (Figure 25-5). 
 The incidence of congenital syphilis (objective 25-9) declined by 64.3% between 1997 and 2009, from 28 new cases per 100,000 live births to 10 new cases per 100,000 live births, moving toward the 2010 target of 1 new case per 100,000 population. 
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• Among racial and ethnic groups, the white non-Hispanic population had the lowest (best) rates of new cases of congenital syphilis: 4 new cases per 100,000 live births in 1997 and 3 in 2009. The American Indian or Alaska Native population had rates of 11 new cases per 100,000 live births in 1997 and 12 in 2009; the Hispanic or Latino population had rates of 34 new cases per 100,000 live births in 1997 and 12 in 2009; and the black non-Hispanic population had rates of 123 new cases per 100,000 live births in 1997 and 35 in 2009.  
 In 2009, the rates for the American Indian or Alaska native and the Hispanic or Latino populations were four times the best rate (that for the white non-Hispanic population), while the rate for the black non-Hispanic population was almost 12 times the best rate [2].  
 Between 1997 and 2009, the disparity between the American Indian or Alaska Native population and the white non-Hispanic population (group with the best rate) increased by 125 percentage points; while the disparity between the Hispanic or Latino and the white non-Hispanic population declined by 450 percentage points; and the disparity between the black non-Hispanic population and the white non-Hispanic population declined by 1,908 percentage points [4]. 
 The proportion of persons aged 20–29 years with genital herpes infections (objective 25-4) declined by 35.3% between 1988–94 and 2005–08, from 17% to 11%, exceeding the 2010 target of 14%. 
 The proportion of women aged 15–44 years who had ever required treatment for pelvic inflammatory disease (PID) (objective 25-6) declined by 50% between 1995 and 2006–08, from 8% to 4%, exceeding the 2010 target of 5%.  
Summary of Progress 
 Figure 25-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for STDs [1]. Data to measure progress toward target attainment were available for 16 objectives. Of these: 
• Two objectives exceeded their 2010 targets (objectives 25-4 and 25-6). 
• Eight objectives moved toward their targets. No statistically significant difference between the baseline and final data points was observed for one of these objectives (25-7). Data to test the significance of the difference were unavailable for seven objectives (25-2a and b; 25-9; 25-11a and c; and 25-16-a and b). 
• Six objectives moved away from their targets (objectives 25-1a through d; 25-3; and 25-11b). Data to test the significance of the difference between the baseline and final data points were unavailable for all of these objectives. 
 One objective remained developmental (objective 25-5) and one objective had no data available to measure progress (objective 25-13) [5]. One objective (25-8) was moved to the HIV Focus Area and seven were dropped during the decade (objectives 25-10, 25-12, 25-14, 25-15, 25-17, 25-18, and 25-19) [6]. 
Sexually Transmitted Diseases  Page 25-6 
 Figure 25-2 displays health disparities from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [4]. 
• Two objectives had statistically significant health disparities of 10% or more by race and ethnicity (objectives 25-4 and 25-7) and eight additional objectives with racial and ethnic disparities of 10% or more lacked data to assess statistical significance (objectives 25-1a through d; 25-2a and b; 25-3; and 25-9). 
• Of these 10 objectives, the white non-Hispanic population had the best rate for six objectives (25-1a, b, and d; 25-2a; 25-9; 25-11a; and 25-11c). The Asian or Pacific Islander population had the best rate for three objectives (25-2a and b, and 25-3) and the Asian population had the best rate for one objective (25-1c). 
• One objective had statistically significant disparities of 10% or more by sex (objective 25-11c) and two additional objectives with disparities of 10% or more by sex lacked data to assess statistical significance (objectives 25-2a and 25-3). Of these three objectives, males had better rates for two objectives (25-2a and 25-11c) and females had a better rate for one objective (25-3). 
• Health disparities of 100% or more were observed among racial and ethnic populations, as well as by sex. Changes in disparity of 100 percentage points or more also were observed. These are discussed in the Highlights, above.  
Transition to Healthy People 2020 For Healthy People 2020, the Sexually Transmitted Disease Topic Area has a smaller set of objectives than were included in Healthy People 2010. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 objectives can be grouped into several sections: 
 Bacterial STD illness and disability 
 Viral STD illness and disability 
 STD complications affecting females 
 STD complications affecting fetuses and newborns 
 Personal health services. The differences between the Healthy People 2010 and Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Sexually Transmitted Diseases Topic Area has 18 objectives, whereas the Healthy People 2010 Focus Area had 26 objectives. 
 Six Healthy People 2010 objectives, were retained “as is” [7]. These objectives include: 
• Chlamydia infections among females aged 15–24 years attending family planning clinics (objective 25-1a) 
• Chlamydia infections among females aged 24 years and under enrolled in a National Job Training Program (objective 25-1d) 
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• Gonorrhea infections among females aged 15–44 years (objective 25-2b) 
• Young adults with genital herpes infection due to herpes simplex, type 2 (objective 25-4) 
• Females aged 15–44 years who have ever required treatment for pelvic inflammatory disease (PID) (objective 25-6) 
• Congenital syphilis (objective 25-9). 
 Four Healthy People 2010 objectives (25-3, 25-5, and 25-16a and b) were modified to create nine Healthy People 2020 objectives [8]. 
• Sustained domestic transmission of primary and secondary syphilis (objective 25-3) was divided into two objectives: domestic transmission of primary and secondary syphilis among males, and domestic transmission of primary and secondary syphilis among females. 
• Sexually active females aged 24 years and under enrolled in commercial health insurance plans who are screened for genital Chlamydia infections during the measurement year (objective 25-16a) was split into two objectives: 1) sexually active females aged 16–20 years enrolled in commercial health insurance plans who are screened for genital Chlamydia infections during the measurement year; and 2) sexually active females aged 21–24 years enrolled in commercial health insurance plans who are screened for genital Chlamydia infections during the measurement year. 
• Sexually active females aged 24 years and under enrolled in Medicaid plans who are screened for genital Chlamydia infections during the measurement year (objective 25-16b) was divided into two objectives: 1) sexually active females aged 16–20 years enrolled in Medicaid plans who are screened for genital Chlamydia infections during the measurement year; and 2) sexually active females aged 21–24 years enrolled in Medicaid plans who are screened for genital Chlamydia infections during the measurement year. 
• Human papillomavirus (HPV) infections among females aged 14–49 years (objective 25-5) was split into three objectives depicting the different HPV types: HPV types 6 and 11; HPV types 16 and 18; and all other HPV types. 
 One developmental Healthy People 2010 objective was moved to the HIV Focus Area: heterosexually transmitted HIV infections in women aged 13–24 years (objective 25-8) [5]. 
 Seven Healthy People 2010 objectives were dropped during the decade due to lack of nationally representative data sources: neonatal STDs (objective 25-10); responsible sexual behavior messages on television (objective 25-12); screening for STDs in jails (objective 25-14); contracts with managed care providers to treat partners of STD patients (objective 25-15); STD screening of pregnant women during prenatal visits (objective 25-17); primary care provider compliance with STD treatment standards (objective 25-18); and provider referral services for partners of STD patients (objective 25-19). 
 Eight objectives were archived [9]. 
• Two objectives, Chlamydia infections among females and males aged 15–24 years attending STD clinics (objectives 25-1b and c), were archived because they were not deemed accurate measures of the community burden associated with Chlamydia since they focused on persons who had sought care for a suspected STD. 
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• One objective, new cases of gonorrhea (objective 25-2a), was archived because it was redundant with the Healthy People 2020 gonorrhea objectives.  
• One objective, fertility problems among childless females with an STD or PID (objective 25-7), was archived because it did not differentiate between STDs and PID and hence could not be used to assess STD-associated infertility. 
• Three objectives, measuring responsible sexual behavior among students in grades 9–12 (objectives 25-11a through c), were archived because they overlapped with the Family Planning objectives. 
• One objective, Hepatitis B vaccines offered in tribal, state, and local STD clinics (objective 25-13), was archived because it lacked a viable data source. 
 Three new objectives were added to the Healthy People 2020 Sexually Transmitted Diseases Topic Area: 
• Gonorrhea infections among males aged 15–44 years 
• Chlamydia infections among females aged 15–44 years 
• Chlamydia infections among males aged 24 years and under who enrolled in a National Job Training Program. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations Figures 25-3 (Chlamydia), 25-4 (Gonorrhea) and 25-5 (Primary and Secondary Syphilis) present state-level data from state and local health department STD control programs. National data for these objectives come from the STD Surveillance System (STDSS) and are the basis for setting the targets. The state level data may not be comparable to the National data from the STDSS. Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the 
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requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010..  
Notes 1. Displayed in the Progress Chart (Figure 25-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 25-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 25-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 25-2 footnotes, as well as the Technical Appendix, for more detail. 3. Most of the observed increases in Chlamydia infections (objectives 25-1a through d) were due to increases in test sensitivity, which resulted in previously undiagnosed infections being detected. In 
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addition, the Chlamydia infection rates tracked in objectives 25-1a through d have not been adjusted for increases in screening rates and efforts to target screening to persons most at risk of infection. Therefore, the reader is urged to exercise caution in interpreting the observed increases in Chlamydia infections. 4. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 25-2 footnotes, as well as the Technical Appendix, for more detail. 5. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 6. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 7. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 8. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 9. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020.  
Sexually Transmitted Diseases  Page 25-11 
Comprehensive Summary of Objectives: Sexually Transmitted Diseases 
Objective Description Data Source or Objective Status 25-1a Chlamydia infections—Females 15–24 years attending family planning clinics  STD Surveillance System (STDSS), CDC, NCHHSTP. 25-1b Chlamydia infections—Females 15–24 years attending STD clinics STD Surveillance System (STDSS), CDC, NCHHSTP. 25-1c Chlamydia infections—Males 15–24 years attending STD clinics STD Surveillance System (STDSS), CDC, NCHHSTP. 25-1d Chlamydia infections—Females ≤24 years enrolled in National Job Training Program STD Surveillance System (STDSS), CDC, NCHHSTP; National Job Training Program. 25-2a Gonorrhea—New cases per 100,000 population STD Surveillance System (STDSS), CDC, NCHHSTP. 25-2b Gonorrhea—New cases per 100,000 population among females 15–44 years STD Surveillance System (STDSS), CDC, NCHHSTP. 25-3 Domestic transmission of primary and secondary syphilis (new cases per 100,000 population) STD Surveillance System (STDSS), CDC, NCHHSTP. 25-4 Genital herpes infection among adults 20–29 years National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 25-5 Human papillomavirus (HPV) infection—females 14–49 years Developmental 25-6 Treatment for pelvic inflammatory disease (PID) among females (15–44 years) National Survey of Family Growth (NSFG), CDC, NCHS. 25-7 Fertility problems among childless females with an STD or PID (15–44 years) National Survey of Family Growth (NSFG), CDC, NCHS. 25-9 Congenital syphilis (new cases per 100,000 live births) STD Surveillance System (STDSS), CDC, NCHHSTP; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 25-10 Neonatal STDs Dropped 25-11a Students who never had sexual intercourse (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 25-11b Students who had sexual intercourse, but not in the past 3 months (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 25-11c Students who used condoms at last intercourse (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 25-12 Responsible sexual behavior messages on television Dropped 25-13 Hepatitis B vaccines offered in STD clinics—Tribal, State and local Survey of STD Programs, National Coalition of STD Directors (NCSD); HIS. 
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Objective Description Data Source or Objective Status 25-14 Screening for sexually transmitted diseases in detention facilities and jails Dropped 25-15 Contracts with managed care providers to treat non-plan partners of STD patients Dropped 25-16a Annual screening for genital Chlamydia among females ≤25 years—Enrolled in commercial managed care organizations (MCOs) Healthcare Effectiveness Data and Information Set (HEDIS), National Committee for Quality Assurance (NCQA). 25-16b Annual screening for genital Chlamydia among females ≤25 years—Enrolled in Medicaid managed care organizations (MCOs) Healthcare Effectiveness Data and Information Set (HEDIS), National Committee for Quality Assurance (NCQA). 25-17 STD screening of pregnant women during prenatal healthcare visits Dropped 25-18 Primary care provider compliance with recognized STD treatment standards Dropped 25-19 Provider referral services for partners of STD patients Dropped  
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Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 25-1. Progress Toward Target Attainment for Focus Area 25: Sexually Transmitted Diseases 
Percent of targeted change achieved5 (continued) 
 
25-1. Chlamydia infections 
  a. Females 15–24 years attending  
  family planning clinics 
  b. Females 15–24 years attending  
   STD clinics 
  c. Males 15–24 years attending STD  
  clinics 
  d. Females ≤24 years enrolled in  
  National Job Training Program 
25-2. Gonorrhea 
  a. New cases per 100,000 population  
  b. New cases per 100,000 population  
   among females 15–44 years  
25-3. Domestic transmission of primary and 
secondary syphilis (new cases per  
 100,000 population) 
25-4. Genital herpes infection among adults 20–
29 years 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
3.0% 
5.0% 
(1997) 
8.1% 
(2009) 
3.1 
Not 
tested 
62.0% 
3.0% 
12.2% 
(1997) 
16.4% 
(2009) 
4.2 
Not 
tested 
34.4% 
3.0% 
15.7% 
(1997) 
24.0% 
(2009) 
8.3 
Not 
tested 
52.9% 
6.8% 
10.1% 
(2002) 
11.7% 
(2009) 
1.6 
Not 
tested 
15.8% 
19 
122 
(1997) 
99 
(2009) 
-23 
Not 
tested 
-18.9% 
42 
279 
(2002) 
255 
(2009) 
-24 
Not 
tested 
-8.6% 
0.2 
3.2 
(1997) 
4.6 
(2009) 
1.4 
Not 
tested 
43.7% 
14% 
17% 
(1988–94) 
11% 
(2005–08) 
-6 Yes -35.3% 
22.3% 
10.1% 
            200.0% 
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Figure 25-1. Progress Toward Target Attainment for Focus Area 25: Sexually Transmitted Diseases (continued) 
Percent of targeted change achieved5 
 
25-6. Treatment for pelvic inflammatory disease 
(PID) among females (15–44 years)  
25-7. Fertility problems among childless females 
with an STD or PID (15–44 years)    
25-9. Congenital syphilis (new cases per 100,000 
live births)  
25-11a. Students who never had sexual intercourse 
(grades 9–12)  
25-11b. Students who had sexual intercourse, but  
 not in the past 3 months (grades 9–12) 
   
25-11c. Students who used condoms at last 
intercourse (grades 9–12)   
25-16. Annual screening for genital chlamydia 
among females ≤25 years 
  a. Enrolled in commercial managed  
   care organizations (MCOs) 
  b. Enrolled in Medicaid managed 
   care organizations (MCOs) 
  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
5% 
8% 
(1995) 
4% 
(2006–08) 
-4 
Not 
tested 
-50.0% 
15% 
27% 
(1995) 
21% 
(2006–08) 
-6 No -22.2% 
1 
28 
(1997) 
10 
(2009) 
-18 
Not 
tested 
-64.3% 
56% 
50% 
(1999) 
54% 
(2009) 
4 
Not 
tested 
8.0% 
30% 
27% 
(1999) 
26% 
(2009) 
-1 
Not 
tested 
-3.7% 
65% 
58% 
(1999) 
61% 
(2009) 
3 
Not 
tested 
5.2% 
62% 
25% 
(2002) 
43% 
(2009) 
18 
Not 
tested 
72.0% 
62% 
41% 
(2002) 
58% 
(2009) 
17 
Not 
tested 
41.5% 
50.0% 
66.7% 
66.7% 
42.9% 
48.6% 
81.0% 
            133.3% 
(continued) 
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Figure 25-1. Progress Toward Target Attainment for Focus Area 25: Sexually Transmitted Diseases (continued) 
DATA SOURCES 
 
25-1a–c. STD Surveillance System (STDSS), CDC, NCHHSTP. 
25-1d. STD Surveillance System (STDSS), CDC, NCHHSTP; National Job Training Program. 
25-2a–b. STD Surveillance System (STDSS), CDC, NCHHSTP. 
25-3. STD Surveillance System (STDSS), CDC, NCHHSTP. 
25-4. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
25-6–25-7. National Survey of Family Growth (NSFG), CDC, NCHS. 
25-9 STD Surveillance System (STDSS), CDC, NCHHSTP; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS. 
25-11a–c. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
25-16a–b. Healthcare Effectiveness Data and Information Set (HEDIS), National Committee for Quality Assurance (NCQA). 
  
 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 25-5 and 25-13. Objective 25-8 has been moved to Focus Area 13; see objective 13-18. Objectives 25-10, 25-12, 25-14, 25-15, 25-17, 25-18, and 25-19 were deleted 
at the Midcourse Review. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
 
 
Sexually Transmitted Diseases Page 25-15 
Sexually Transmitted Diseases Page 25-16
A
m
er
ic
an
 In
di
an
 o
r 
A
la
sk
a 
N
at
iv
e
A
si
an
N
at
iv
e 
H
aw
ai
ia
n 
or
 
ot
he
r P
ac
ifi
c 
Is
la
nd
er
Tw
o 
or
 m
or
e 
ra
ce
s
H
is
pa
ni
c 
or
 L
at
in
o
B
la
ck
, n
ot
 H
is
pa
ni
c
W
hi
te
, n
ot
 H
is
pa
ni
c
Su
m
m
ar
y 
in
de
x
Fe
m
al
e
M
al
e
Le
ss
 th
an
 h
ig
h 
sc
ho
ol
H
ig
h 
sc
ho
ol
 
gr
ad
ua
te
A
t l
ea
st
 s
om
e 
co
lle
ge
Su
m
m
ar
y 
in
de
x
P
oo
r
N
ea
r p
oo
r
M
id
dl
e/
hi
gh
 in
co
m
e
Su
m
m
ar
y 
in
de
x
25-1a. Chlamydia infections—Females 15–24 years 
attending family planning clinics (1997, 2009)†
3d1
2 3 NA
2d1 4d2
B 3i NA NA NS NS NS NS NA NA NA NA
25-1b. Chlamydia infections—Females 15–24 years 
attending STD clinics (1997, 2009)†
3u1
2 NA NA
2d1
3 B 2i NA NA NS NS NS NS NA NA NA NA
25-1c. Chlamydia infections—Males 15–24 years attending 
STD clinics (1997, 2009)† NA B NA NA
2d2
4u1
2 3i NA NA NS NS NS NS NA NA NA NA
25-1d. Chlamydia infections—Females ≤24 years enrolled 
in National Job Training Program (2002, 2009)† 3 NA NA NA
3u1 4u2
B
3u1
NA NA NS NS NS NS NA NA NA NA
25-2a. Gonorrhea—New cases per 100,000 population 
(1997, 2009)†
4u3
NA
4d1 4d3
3u1
4d3
2 Biii NS NS NS NS NA NA NA NA
25-2b. Gonorrhea—New cases per 100,000 population 
among females 15–44 years (2002, 2009)†
4u3
NA
4u1
4
4u1 4u1
NA NA NS NS NS NS NA NA NA NA
25-3. Domestic transmission of primary and secondary 
syphilis (new cases per 100,000 population) (1997, 
2009)† 3d3
NA
4d3 4d3 2d1 4d3
B
4u3
NS NS NS NS NA NA NA NA
25-4. Genital herpes infection among adults 20–29 years 
(1988–94, 2005–08)* NA NA NA NA iv NA NS NS NS NS NA
25-6. Treatment for pelvic inflammatory disease (PID) 
among females (15–44 years) (1995, 2006–08)‡ NA NA NA NA NA NA NA NA NA
25-7. Fertility problems among childless females with an 
STD or PID (15–44 years) (1995, 2006–08)* NA NA NA NA NA NA NA NA NA NA NA NS NS NS NS
25-9. Congenital syphilis (new cases per 100,000 live 
births) (1997, 2009)†
4u3
NA
4d3 4d3
B
4d3
NA NA NS NS NS NS NS NS NS NS
25-11a. Students who never had sexual intercourse (grades 
9–12) (1999, 2009)‡ NA NA NA NA 2 3 B 2 B Biii NS NS NS NS NS NS NS NS
25-11b. Students who had sexual intercourse, but not in the 
past 3 months (grades 9–12) (1999, 2009)‡ NA NA NA NA B 1 1 1 1 B NS NS NS NS NS NS NS NS
25-11c. Students who used condoms at last intercourse 
(grades 9–12) (1999, 2009)‡ NA NA NA NA
2d1
1 Biii
2d1
2 B NS NS NS NS NS NS NS NS
Population-based objectives
Bii
Bii
Bii
3d1ii
(continued)
Figure 25-2. Health Disparities Table for Focus Area 25: Sexually Transmitted Diseases
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity 
from the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income
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B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
‡
i
ii
iii
iv
25-1a–c. STD Surveillance System (STDSS), CDC, NCHHSTP.
25-1d. STD Surveillance System (STDSS), CDC, NCHHSTP; National Job Training Program.
25-2a–b. STD Surveillance System (STDSS), CDC, NCHHSTP.
25-3. STD Surveillance System (STDSS), CDC, NCHHSTP.
25-4. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
25-6–25-7. National Survey of Family Growth (NSFG), CDC, NCHS.
25-9. STD Surveillance System (STDSS), CDC, NCHHSTP; National Vital Statistics System—Natality (NVSS-N), CDC, NCHS.
25-11a–c. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
LEGEND
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows 
when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
FOOTNOTES
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
10–49 points 50–99 points 100 points or more
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Increase in disparity (percentage points)
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. 
Nonetheless, disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
Measures of variability were available only for the most recent data. Thus, the variability of best group rates was assessed only for the most recent data, and 
statistical significance was tested only for the most recent data. Disparities of 10% or more are displayed when the differences from the best group rate are 
statistically significant at the 0.05 level. Changes in disparities over time are displayed according to their magnitude, since measures of variability were not 
available at baseline and therefore statistical significance of changes in disparity could not be tested. See Technical Appendix.
DATA SOURCES
Data are for Asian or Pacific Islander.
Data are for Mexican American.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Change in the summary index cannot be assessed. See Technical Appendix.
NOTES
Figure 25-2. Health Disparities Table for Focus Area 25: Sexually Transmitted Diseases 
(continued)
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
25-5, 25-8, 25-13, and 25-16a and b. Objectives 25-10, 25-12, 25-14, 25-15, and 25-17 through 25-19, were deleted at Midcourse Review.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Figure 25-3. Chlamydia Infections - (New Cases Per 100,000 Population) 2009 
Notes: Data are crude rates, not age-adjusted to the 2000 standard population. Rates are displayed by a modified Jenks classification for U.S. states.  
National data for the objective come from the STD Surveillance System (STDSS) and is the basis for setting the target.  State data from State and local  
Health Department STD Control Programs may not be comparable to the national data from the STDSS. Both US rates are shown for comparison purposes.  
SOURCE: STD Surveillance System (STDSS), CDC, NCHHSTP. 
Rate per 100,000 
159.7 - 252.1 
252.2 - 346.4 
346.5 - 457.0 
457.1 - 626.4 
626.5 - 1106.6 
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Figure 25-4. Gonorrhea - (New Cases Per 100,000 Population) 2009 
Healthy People 2010 objective 25-2a 
Target = 19 
Notes: Data are crude rates, not age-adjusted to the 2000 standard population. Rates are displayed by a modified Jenks classification  for U.S. states.  
National data for the objective come from the STD Surveillance System (STDSS) and is the basis for setting the target.  State data from State and local  
Health Department STD Control Programs may not be comparable to the national data from the STDSS. Both US rates are shown for comparison purposes.  
SOURCE: STD Surveillance System (STDSS), CDC, NCHHSTP. 
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Figure 25-5. Domestic Transmission of Primary and Secondary Syphilis 
(New Cases Per 100,000 Population) 2009 
Healthy People 2010 objective 25-3 
Target = 0.2 
Notes: Data are crude rates, not age-adjusted to the 2000 standard population. Rates are displayed by a modified Jenks classification for U.S. states.  
National data for the objective come from the STD Surveillance System (STDSS) and is the basis for  setting the target.  State data from State and local  
Health Department STD Control Programs may not be comparable to the national data from the STDSS. Both US rates are shown for comparison purposes.  
SOURCE: STD Surveillance System (STDSS), CDC, NCHHSTP. 
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Goal: Reduce substance abuse to protect the health, 
safety, and quality of life for all, especially children 
This chapter includes objectives that track alcohol and drug-related deaths, the use of alcohol and illicit drugs by adolescents and young adults, adolescent attitudes toward alcohol and/or drug use, and state laws addressing driving under the influence of alcohol (DUI). All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this focus area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade [1]. Almost two thirds (63%) of the Substance Abuse objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 26-1). However, health disparities of 10% or more were observed among racial and ethnic populations, as well as by sex, education level, and income (Figure 26-2), some of which are highlighted below [2]. 
 The rate of alcohol-related motor vehicle crash deaths (objective 26-1a) declined by 24.5% between 1998 and 2009, from 5.3 to 4.0 deaths per 100,000 population, exceeding the Healthy People 2010 target of 4.8. 
• Among racial and ethnic populations, the Asian population had the lowest (best) rate of alcohol-related motor vehicle crash deaths, 0.6 per 100,000 population in 2008. The Hispanic or Latino, white non-Hispanic, black non-Hispanic, Native Hawaiian or Other Pacific Islander, and American Indian or Alaska Native populations had rates of 3.3, 3.6, 3.9, 3.9 and 10.9 per 100,000 population in 2008, respectively.  
 The rates for the Hispanic or Latino, white non-Hispanic, black non-Hispanic, and Native Hawaiian or Other Pacific Islander populations were five and a half to six and a half times the best rate (that for the Asian population). The rate for the American Indian or Alaska Native population was more than 18 times the best rate [2].  
 Between 2000 and 2008, the disparities between these populations and the Asian population increased by at least 100 percentage points [3]. 
• Females had a lower (better) rate of motor vehicle crash deaths than males, 1.7 per 100,000 population in 2009. The rate for males, 6.3 in 2009, was more than three and a half times the rate for females [2]. 
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 The cirrhosis death rate (objective 26-2) declined by 5.2% between 1999 and 2007, from 9.6 to 9.1 deaths per 100,000 population (age adjusted), moving toward the target of 3.2. 
• Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) cirrhosis death rate, 3.3 deaths per 100,000 population (age adjusted) in 2007. The white non-Hispanic, black non-Hispanic, Hispanic or Latino, and American Indian or Alaska Native populations had rates of 7.5, 8.7, 13.8, and 24.8 deaths per 100,000 (age adjusted) in 2007, respectively.  
 The rate for the white non-Hispanic population was almost two and a half times the best rate (that for the Asian or Pacific Islander population); the rate for the black non-Hispanic population was more than two and a half times the best rate; the rate for the Hispanic or Latino population was more than four times the best rate; and the rate for the American Indian or Alaska Native population was about seven and a half times the best rate [2]. 
• Females had a better cirrhosis death rate than males, 5.9 vs. 12.7 deaths per 100,000 population (age adjusted) in 2007. The rate for males was more than twice the rate for females. 
• Among education groups, persons aged 25–64 years with at least some college education had the lowest (best) cirrhosis death rate, 5.6 deaths per 100,000 population (age adjusted), in 2002. High school graduates had a rate of 15.2, and persons with less than a high school education had a rate of 20.9. The rate for high school graduates was more than two and a half times the best group rate, while the rate for persons with less than a high school education was more than three and a half times the best group rate [2]. 
 Cirrhosis death rates varied by geographical area. In 2005–07, the rates were highest in areas of the Southwest and West (Figure 26-3). 
 The rate of drug-induced deaths (objective 26-3) increased by 85.3% between 1999 and 2007, from 6.8 deaths per 100,000 population (age adjusted) to 12.6, moving away from the 2010 target of 1.2. 
• Among racial and ethnic groups, the Asian or Pacific Islander population had the lowest (best) rates of drug-induced deaths: 1.4 per 100,000 population (age adjusted) in 1999 and 2.0 in 2007. The Hispanic or Latino population had rates of 6.5 per 100,000 (age adjusted) in 1999 and 6.5 in 2007; the black non-Hispanic population had rates of 9.4 per 100,000 (age adjusted) in 1999 and 11.4 in 2007; the American Indian or Alaska Native population had rates of 6.1 per 100,000 (age adjusted) in 1999 and 12.1 in 2007; and the white non-Hispanic population had rates of 6.8 per 100,000 (age adjusted) in 1999 and 15.1 in 2007.  
 In 2007, the rate for the Hispanic or Latino population was almost three and a half times the best rate (that for the Asian or Pacific Islander population); the rates for the black non-Hispanic and American Indian or Alaska Native population were about six times the best rate; the rate for the white non-Hispanic population was more than seven and a half times the best rate [2]. 
 Between 1999 and 2007, the disparity between the American Indian or Alaska Native population and the Asian or Pacific Islander population (the group with the best rate) increased by 169.3 percentage points, while the disparity between the white non-Hispanic and the Asian or Pacific Islander populations increased by 269.3 percentage points.  
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 During the same period, the disparity between the Hispanic or Latino population and the Asian or Pacific Islander population decreased by 132 percentage points [3]. 
• Among education groups, persons aged 25–64 years with at least some college education had the lowest (best) rate of drug induced deaths, 7.4 per 100,000 population (age adjusted), in 2002. High school graduates had a rate of 22.4, about three times the best group rate. Persons with less than a high school education had a rate of 27.3, more than three and a half times the best group rate [2]. 
 Drug-related hospital emergency department visits (objective 26-4) increased by 27.9% between 2004 and 2009, from 1,619.05 (thousands) to 2,070.44, moving away from the 2010 target of 1,044.46 (thousands). 
 The proportion of students in grades 9–12 who reported riding with a driver who had been drinking alcohol within the past 30 days (objective 26-6) decreased by 15.2% between 1999 and 2009, from 33% to 28%, exceeding the 2010 target of 30%. 
 The proportion of high school seniors who never consumed alcohol (objective 26-9c) increased by 47.4% between 1998 and 2009, from 19% to 28%, moving toward the 2010 target of 29%. During the same period, the proportion of high school seniors who never used illicit drugs (objective 26-9d) increased by 15.2%, from 46% to 53%, moving toward the 2010 target of 56%. 
 Between 1998 and 2009, steroid use among students in eighth, tenth, and twelfth grades (objectives 26-14a through c) increased by 8.3%, 8.3% and 29.4% respectively, from 1.2% to 1.3%, 1.2% to 1.3%, and 1.7% to 2.2% respectively, moving away from the 2010 targets of 0.4% each. 
 The number of states and the District of Columbia with laws restricting the legal operation of motor vehicles for drivers who had been drinking alcohol to a maximum blood alcohol concentration of 0.08 (objective 26-25) increased from 15 in 1998 to 51 in 2006, meeting the 2010 target of 51.  
Summary of Progress 
 Figure 26-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Substance Abuse [1]. Data to measure progress toward target attainment were available for 38 objectives. Of these: 
• Four objectives (26-1a, 26-6, 26-16d, and 26-25) met or exceeded their 2010 targets. 
• Twenty objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for 14 of these objectives (26-2, 26-9a through d, 26-10a and b, 26-11a and d, 26-15, 26-16b and e, and 26-17a and b). No significant differences were observed for three objectives (26-16a, c, and f); and data to test the significance of the difference were unavailable for three objectives (26-13a and b, and 26-20). 
• Three objectives (26-10c, 26-18b, and 26-24) showed no change. 
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• Eleven objectives moved away from their targets. A statistically significant difference between the baseline and final data points was observed for two of these objectives (26-3 and 26-4). No significant differences were observed for seven objectives (26-11c, 26-14a through c, 26-17c, 26-18a, and 26-21); and data to test the significance of the difference were unavailable for two objectives (26-11b and 26-12). 
 Five objectives (26-5, 26-7, 26-19, 26-22, and 26-23) remained developmental and two objectives (26-8a and b) had no data available to measure progress [4]. Three objectives (26-1b through d) were dropped during the decade [5]. 
 Figure 26-2 displays health disparities in Substance Abuse from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Twenty-three objectives had statistically significant racial and ethnic health disparities of 10% or more (objectives 26-2 through 26-4; 26-6; 26-9a through d; 26-10a through c; 26-11a, c, and d; 26-14a; 26-16a c, d, and f; 26-17a through c; and 26-21). Three additional objectives had racial and ethnic health disparities of 10% or more but lacked data to assess statistical significance (objectives 26-1a, and 26-13a and b). Of these 26 objectives, the black non-Hispanic population had the best rate for nine objectives (26-4, 26-9c and d, 26-10a and b, 26-11a and c, 26-17c, and 26-21). The Asian population had the best rate for six objectives (26-1a, 26-9a, 26-13a and b, and 26-17a and b). The white non-Hispanic population had the best rate for five objectives (26-6, 26-9b, 26-14a, and 26-16a and d); the Hispanic or Latino population had the best rate for four objectives (26-10c, 26-11d, and 26-16c and f); and the Asian or Pacific Islander population had the best rate for two objectives (26-2 and 26-3). 
• Sixteen objectives had statistically significant health disparities of 10% or more by sex (objectives 26-2 through 26-4, 26-9d, 26-10b and c, 26-11a through c, 26-16a through f, and 26-17a). One additional objective had health disparities of 10% or more by sex but no data to assess statistical significance (objective 26-1a). Females had the better group rate for all 17 of these objectives. 
• Three objectives had statistically significant health disparities of 10% or more by education level (objectives 26-2, 26-3, and 26-10c) and one objective had health disparities of 10% or more by education level but no data to assess statistical significance (objectives 26-13b). Persons with at least some college education had the best group rate for all four of these objectives. 
• Persons in the poor population had the best group rate for four of the six objectives with statistically significant health disparities of 10% or more by income (objectives 26-10a, 26-11d, and 26-18a and b). Persons in the middle/high income population had the best group rate for the remaining two objectives (26-9b and 26-15). 
• Racial and ethnic health disparities of 100% or more were observed for several objectives, as were health disparities of 100% or more by sex and education level. Changes in disparity between the baseline and most recent data points also were observed. Many of these disparities are discussed in the Highlights, above.  
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Transition to Healthy People 2020 For Healthy People 2020, the focus of the Substance Abuse topic area continues to address a wide range of health behaviors and interventions. Specific objectives are targeted to protect the health, safety, and quality of life for all, especially children. The Healthy People 2020 Substance Abuse topic area can be grouped into three sections: 
 Policy and prevention 
 Screening and treatment 
 Epidemiology and surveillance. The differences between the Healthy People 2010 and Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Topic Area has 44 objectives whereas the Healthy People 2010 Substance Abuse Focus Area had 48 objectives. 
 Twenty-seven Healthy People 2010 objectives were retained “as is” [6]. These include: nine objectives that target perceptions about and disapproval of substance use and abuse (objectives 26-16a through f and 26-17a through c), eight drug use/abstinence objectives (26-9d, 26-10b and c, 26-12, 26-14a through c, and 26-15), four treatment objectives (26-18a and b, 26-20 and 26-21), three alcohol use/abstinence objectives (26-9c, and 26-11a and b), two mortality objectives (26-2 and 26-3) and an objective that targets riding with a driver who has been drinking alcohol (objective 26-6). 
 Five Healthy People 2010 objectives were archived [7]. 
• Statistics to track lost productivity due to alcohol and drug abuse have not been calculated at the national level since baseline year data were obtained. As a result, these two objectives (26-8a and b) could not be retained in Healthy People 2020. 
• During the course of the tracking period for Healthy People 2010, all states and the District of Columbia had enacted laws restricting the legal operation of motor vehicles for drivers, aged 21 years and over, who had been drinking alcohol to a maximum blood alcohol concentration of 0.08. Due to the success experienced in the past decade, this objective (26-25) was archived in Healthy People 2020. 
• Drug-related emergency department visits were tracked with data obtained from the Drug Abuse Warning Network (DAWN). Because all data collection activity will end once 2010 data have been collected, this objective (26-3) will be archived in Healthy People 2020. 
• The Healthy People 2010 objective (26-24) that tracked administrative license revocation laws for persons under the influence of intoxicants also was archived in Healthy People 2020. 
 Eight Healthy People 2010 objectives were dropped [5]. Five of these had remained developmental, and three were dropped during the decade [4]. 
• The dropped objectives include: 
 Drug-related motor vehicle crash deaths (objective 26-1c) 
 Drug-related motor vehicle crash injuries (objective 26-1d) 
 Alcohol-related motor vehicle crash injuries (objective 26-1b). 
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• The data systems proposed to measure five of the Substance Abuse objectives were unable to produce reliable estimates; therefore, the following objectives were not included in Healthy People 2020: 
 Alcohol-related emergency department visits (objective 26-5) 
 Intentional injuries from alcohol and drug-related violence (objective 26-7) 
 Treatment in correctional institutions (objective 26-19) 
 Emergency department referrals for alcohol or drug problems and suicide attempts (objective 26-22) 
 Community partnerships and coalitions to prevent substance abuse (objective 26-23). 
 Eight Healthy People 2010 objectives were modified to create seven Healthy People 2020 objectives [8]. 
• Alcohol-related motor vehicle crash deaths (objective 26-1a) were tracked in Healthy People 2010 as a rate per 100,000 population. In Healthy People 2020, the rate of death will be tracked per vehicle miles traveled (VMT). 
• The Healthy People 2010 objectives that tracked the average age at first use of adolescents who used alcohol (objective 26-9a) and marijuana (objective 26-9b) for the first time in the previous year were modified. The two revised objectives will track the proportion of at risk adolescents who used alcohol and marijuana for the first time in the previous year. 
• The proportion of adolescents who did not use alcohol or illicit drugs in the past 30 days (objective 26-10a) was tracked in Healthy People 2010. In Healthy People 2020, the complement of this objective will be monitored (i.e., the proportion of adolescents who did use alcohol or illicit drugs in the past 30 days). 
• In 2002, the National Institute on Alcohol Abuse and Alcoholism revised the definition of binge drinking for women from drinking five or more alcoholic beverages at the same time or within a couple of hours of each other to four or more alcoholic beverages [9]. For the Healthy People 2010, binge drinking for adolescents and adults (objectives 26-11c and d) was tracked with the original definition. Healthy People 2020 will track binge drinking with the revised definition. 
• Male and female adults who exceeded guidelines for low-risk drinking (objectives 26-13a and b) were tracked separately in Healthy People 2010. In Healthy People 2020, the focus was modified slightly to track excessive drinking and the two objectives were combined into one. 
 Ten new objectives, two of which are developmental, were added to the Healthy People 2020 Topic Area: 
• Five objectives track past-year use of prescription drugs: 
 Pain relievers 
 Tranquilizers 
 Stimulants 
 Sedatives 
 Any psychotherapeutic drug (including any noted above). 
• Two new infrastructure-related objectives were added: one will track drug, driving while intoxicated (DWI) and other specialty courts, and the other will track states with mandatory ignition interlock laws for DWI offenders. 
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• Two new treatment-related objectives were added: one will track referrals and follow-up of emergency department patients treated for alcohol and/or drug problems, and the other will track medical facilities that implement alcohol Screening and Brief Intervention (SBI). 
• One new objective will track the number of deaths attributable to alcohol use. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. Beginning in 2003, education data for cirrhosis and drug-induced deaths (objectives 26-2 and 26-3) from the National Vital Statistics System were suppressed. The educational attainment item was changed in the new U.S. Standard Certificate of Death in 2003 to be consistent with the U.S. Census Bureau data and to improve the ability to identify specific types of educational degrees. Many states, however, are still using the 1989 version of the U.S. Standard Certificate of Death, which focuses on highest school grade completed. As a result, educational attainment data collected using the 2003 version are not comparable with data collected using the 1989 version [10]. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. 
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Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
References and Notes 1. Displayed in the Progress Chart (Figure 26-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 26-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 26-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 26-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 26-2 footnotes, as well as the Technical Appendix, for more detail. 
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4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 5. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 6. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 7. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 8. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 9. NIAAA Newsletter, NIH Publication No. 04–5346. Available from: http://pubs.niaaa.nih.gov/publications/Newsletter/winter2004/Newsletter_Number3.pdf 10. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf.. 
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Comprehensive Summary of Objectives: Substance Abuse 
Objective Description Data Sources or Objective Status 26-1a Alcohol-related motor vehicle crash deaths (per 100,000 population) Fatality Analysis Reporting System (FARS), Department of Transportation (DOT). 26-1b Alcohol-related motor vehicle crash injuries (per 100,000 population) Dropped 26-1c Drug-related motor vehicle crash deaths (per 100,000 population) Dropped 26-1d Drug-related motor vehicle crash injuries (per 100,000 population) Dropped 26-2 Cirrhosis deaths (age adjusted, per 100,000 population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 26-3 Drug-induced deaths (age adjusted, per 100,000 population) National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 26-4 Drug-related hospital emergency department visits (thousands) Drug Abuse Warning Network (DAWN), SAMHSA. 26-5 Alcohol-related hospital emergency department visits Developmental 26-6 Students who rode with a driver who had been drinking alcohol (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 26-7 Intentional injuries from alcohol and drug-related violence Developmental 26-8a Lost productivity due to alcohol abuse (Loss in dollars per capita) NIH, NIAAA. 26-8b Lost productivity due to drug abuse (Loss in dollars per capita) Office of National Drug Control Policy (ONPCP). 26-9a Average age at first use among adolescents who used alcohol for the first time in past year (12–17 years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-9b Average age at first use among adolescents who used marijuana for the first time in past year (12–17 years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-9c High school seniors never consuming alcoholic beverages Monitoring the Future Study (MTF), NIH, NIDA. 26-9d High school seniors never using illicit drugs Monitoring the Future Study (MTF), NIH, NIDA. 26-10a Adolescents not using alcohol or illicit drugs in past 30 days (12–17 years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-10b Adolescents using marijuana in past 30 days (12–17 years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-10c Adults using illicit drugs in past 30 days (18+ years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-11a Binge drinking in the past 2 weeks—High school seniors Monitoring the Future Study (MTF), NIH, NIDA. 26-11b Binge drinking in the past 2 weeks—College students Monitoring the Future Study (MTF), NIH, NIDA. 26-11c Binge drinking in the past month—Adults (18+ years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 
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Objective Description Data Sources or Objective Status 26-11d Binge drinking in the past month—Adolescents (12–17 years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-12 Average annual alcohol consumption (gallons per person, 14+ years) Alcohol Epidemiologic Data System (AEDS), NIH, NIAAA. 26-13a Adults who exceed guidelines for low-risk drinking—Females (21+ years) National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), NIH, NIAAA. 26-13b Adults who exceed guidelines for low-risk drinking—Males (21+ years) National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), NIH, NIAAA. 26-14a Steroid use among students—8th graders Monitoring the Future Study (MTF), NIH, NIDA. 26-14b Steroid use among students—10th graders Monitoring the Future Study (MTF), NIH, NIDA. 26-14c Steroid use among students—12th graders Monitoring the Future Study (MTF), NIH, NIDA. 26-15 Inhalant use among adolescents (12–17 years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-16a Disapproval of people who take 1–2 drinks a day of alcohol—8th graders Monitoring the Future Study (MTF), NIH, NIDA. 26-16b Disapproval of people who take 1–2 drinks a day of alcohol—10th graders Monitoring the Future Study (MTF), NIH, NIDA. 26-16c Disapproval of people who take 1–2 drinks a day of alcohol—12th graders Monitoring the Future Study (MTF), NIH, NIDA. 26-16d Disapproval of people who try marijuana or hashish once or twice—8th graders Monitoring the Future Study (MTF), NIH, NIDA. 26-16e Disapproval of people who try marijuana or hashish once or twice—10th graders Monitoring the Future Study (MTF), NIH, NIDA. 26-16f Disapproval of people who try marijuana or hashish once or twice—12th graders  Monitoring the Future Study (MTF), NIH, NIDA. 26-17a Adolescents’ perception of risk (12–17 years)—5+ alcoholic drinks, once or twice per week National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-17b Adolescents’ perception of risk (12–17 years)—Smoking marijuana once a month National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-17c Adolescents’ perception of risk (12–17 years)—Cocaine use once a month National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-18a Treatment for illicit drugs (12+ years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-18b Treatment for alcohol and/or drugs (12+ years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-19 Substance abuse treatment in correctional institutions Developmental 
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Objective Description Data Sources or Objective Status 26-20 Admissions for treatment for injection drug use (thousands) Treatment Episodes Data System (TEDS), SAMHSA. 26-21 Treatment for alcohol abuse or dependence (12+ years) National Survey on Drug Use and Health (NSDUH), SAMHSA. 26-22 Hospital emergency department referrals for alcohol or drug problems and suicide attempts Developmental 26-23 Community partnerships and coalitions to prevent substance abuse Developmental 26-24 Administrative license revocation laws for DUI (no. states and D.C.) Department of Transportation (DOT), National Highway Traffic Safety Administration (NHTSA). 26-25 Maximum blood alcohol concentration of 0.08 for motor vehicle drivers (21+ years, no. states and D.C.) Department of Transportation (DOT), National Highway Traffic Safety Administration (NHTSA). 
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Figure 26-1. Progress Toward Target Attainment for Focus Area 26: Substance Abuse 
Percent of targeted change achieved5 (continued) 
 
26-1a. Alcohol-related motor vehicle crash deaths 
(per 100,000 population) 
26-2. Cirrhosis deaths (age adjusted, per 100,000 
population)   
26-3. Drug-induced deaths (age adjusted, per 
100,000 population) 
26-4. Drug-related hospital emergency 
 department visits (thousands) 
26-6. Students who rode  with a driver who had 
been drinking alcohol (grades 9–12)  
26-9a. Average age at first use among adolescents 
who used alcohol for the first time in past 
year (12–17 years) 
26-9b. Average age at first use among adolescents 
who used marijuana for the first time in past 
year (12–17 years) 
26-9c. High school seniors never consuming 
alcoholic beverages 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
4.8 
5.3 
(1998) 
4.0 
(2009) 
-1.3 
Not 
tested 
-24.5% 
3.2 
9.6 
(1999) 
9.1 
(2007) 
-0.5 Yes -5.2% 
1.2 
6.8 
(1999) 
12.6 
(2007) 
5.8 Yes 85.3% 
1,044.46 
1,619.05 
(2004) 
2,070.44 
(2009) 
451.39 Yes 27.9% 
30% 
33% 
(1999) 
28% 
(2009) 
-5 Yes -15.2% 
17.0 
14.7 
(2002) 
14.9 
(2008) 
0.2 Yes 1.4% 
17.0 
15.0 
(2002) 
15.2 
(2008) 
0.2 Yes 1.3% 
29% 
19% 
(1998) 
28% 
(2009) 
9 Yes 47.4% 
7.8% 
8.7% 
10.0% 
90.0% 
            260.0% 
            166.7% 
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Figure 26-1. Progress Toward Target Attainment for Focus Area 26: Substance Abuse (continued) 
Percent of targeted change achieved5 (continued) 
 
26-9d. High school seniors never using illicit drugs  
26-10a. Adolescents not using alcohol or illicit drugs 
in past 30 days (12–17 years)    
26-10b. Adolescents using marijuana in past 30 days 
(12–17 years)  
26-10c. Adults using illicit drugs in past 30 days (18+ 
years)  
26-11. Binge drinking in the past 2 weeks 
   a. High school seniors   
  b. College students   
 Binge drinking in the past month 
   c. Adults (18+ years)  
  d. Adolescents (12–17 years)  
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
56% 
46% 
(1998) 
53% 
(2009) 
7 Yes 15.2% 
91% 
78% 
(2002) 
82% 
(2008) 
4 Yes 5.1% 
0.7% 
8.2% 
(2002) 
6.7% 
(2008) 
-1.5 Yes -18.3% 
3.2% 
7.9% 
(2002) 
7.9% 
(2008) 
0 No 0.0% 
11% 
32% 
(1998) 
25% 
(2009) 
-7 Yes -21.9% 
20% 
39% 
(1998) 
40% 
(2009) 
1 
Not 
tested 
2.6% 
13.4% 
24.3% 
(2002) 
24.9% 
(2008) 
0.6 No 2.5% 
3.1% 
10.7% 
(2002) 
8.8% 
(2008) 
-1.9 Yes -17.8% 
70.0% 
30.8% 
20.0% 
0.0% 
33.3% 
25.0% 
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Percent of targeted change achieved5 (continued) 
 
26-12. Average annual alcohol consumption 
(gallons per person, 14+ years)  
26-13. Adults who exceed guidelines for low-risk 
drinking (21+ years)  
  a. Females     
  b. Males   
26-14. Steroid use among students 
  a. 8th graders  
  b. 10th graders   
  c. 12th graders  
26-15. Inhalant use among adolescents (12–17 
years)  
26-16. Disapproval of  people who take 1–2 drinks a 
day of alcohol 
  a. 8th graders  
 
Figure 26-1. Progress Toward Target Attainment for Focus Area 26: Substance Abuse (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
1.96 
2.14 
(1997) 
2.31 
(2007) 
0.2 
Not 
tested 
7.9% 
50% 
72% 
(1992) 
55% 
(2001–02) 
-17 
Not 
tested 
-23.6% 
50% 
74% 
(1992) 
61% 
(2001–02) 
-13 
Not 
tested 
-17.6% 
0.4% 
1.2% 
(1998) 
1.3% 
(2009) 
0.1 No 8.3% 
0.4% 
1.2% 
(1998) 
1.3% 
(2009) 
0.1 No 8.3% 
0.4% 
1.7% 
(1998) 
2.2% 
(2009) 
0.5 No 29.4% 
2.2% 
4.4% 
(2002) 
3.9% 
(2008) 
-0.5 Yes -11.4% 
83% 
77% 
(1998) 
78% 
(2009) 
1 No 1.3% 
77.3% 
54.2% 
22.7% 
16.7% 
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Percent of targeted change achieved5 (continued) 
 
26-16. Disapproval of people who take 1-2 drinks a 
day of alcohol 
   b. 10th graders 
  c. 12th graders   
 Disapproval of people who try marijuana or 
hashish once or twice 
   d. 8th graders  
  e. 10th graders  
  f. 12th graders   
26-17 Adolescents’ perception of risk (12–17 years) 
   a. 5+ alcoholic drinks, once or twice per 
  week   
  b. Smoking marijuana once a month 
  c. Cocaine use once a month  
 
Figure 26-1. Progress Toward Target Attainment for Focus Area 26: Substance Abuse (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
83% 
75% 
(1998) 
78% 
(2009) 
3 Yes 4.0% 
83% 
69% 
(1998) 
70% 
(2009) 
1 No 1.4% 
72% 
69% 
(1998) 
75% 
(2009) 
6 Yes 8.7% 
72% 
56% 
(1998) 
60% 
(2009) 
4 Yes 7.1% 
72% 
52% 
(1998) 
55% 
(2009) 
3 No 5.8% 
50% 
38% 
(2002) 
41% 
(2008) 
3 Yes 7.9% 
36% 
32% 
(2002) 
34% 
(2008) 
2 Yes 6.3% 
57% 
51% 
(2002) 
50% 
(2008) 
-1 No -2.0% 
37.5% 
7.1% 
25.0% 
15.0% 
25.0% 
50.0% 
            200.0% 
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Percent of targeted change achieved5 (continued) 
 
26-18a. Treatment for illicit drugs (12+ years)  
26-18b. Treatment for alcohol and/or drugs (12+ 
years)   
26-20. Admissions for treatment for injection drug 
use (thousands)  
26-21. Treatment for alcohol abuse or  
 dependence (12+ years)  
26-24. Administrative license revocation laws for 
DUI (no. States and D.C.)   
26-25. Maximum blood alcohol concentration of 
0.08 for motor vehicle drivers (21+ years, no. 
States and D.C.)  
 
Figure 26-1. Progress Toward Target Attainment for Focus Area 26: Substance Abuse (continued) 
2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
24% 
18% 
(2002) 
16% 
(2008) 
-2 No -11.1% 
16% 
10% 
(2002) 
10% 
(2008) 
0 No 0.0% 
256.680 
215.560 
(1997) 
254.278 
(2008) 
38.718 
Not 
tested 
18.0% 
11.9% 
8.3% 
(2002) 
8.2% 
(2008) 
-0.1 No -1.2% 
51 
42 
(1998) 
42 
(2007) 
0 
Not 
tested 
0.0% 
51 
15 
(1998) 
51 
(2006) 
36 
Not 
tested 
240.0% 
0.0% 
94.2% 
0.0% 
100.0% 
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DATA SOURCES  
 
26-1a. Fatality Analysis Reporting System (FARS), Department of Transportation (DOT). 
26-2–26-3. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS. 
26-4. Drug Abuse Warning Network (DAWN), SAMHSA. 
26-6. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
26-9a–b. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-9c–d. Monitoring the Future Study (MTF), NIH, NIDA. 
26-10a–c. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-11a–b. Monitoring the Future Study (MTF), NIH, NIDA. 
26-11c–d. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-12. Alcohol Epidemiologic Data System (AEDS), NIH, NIAAA. 
26-13a–b. National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), NIH, NIAAA. 
26-14a–c. Monitoring the Future Study (MTF), NIH, NIDA. 
26-15. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-16a–f. Monitoring the Future Study (MTF), NIH, NIDA. 
26-17a–c. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-18a–b. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-20. Treatment Episodes Data System (TEDS), SAMHSA. 
26-21. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
26-24–26-25. Department of Transportation (DOT), National Highway Traffic Safety Administration (NHTSA). 
 
 
 
Figure 26-1. Progress Toward Target Attainment for Focus Area 26: Substance Abuse (continued) 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 26-5, 26-7, 26-8a, 26-8b, 26-19, 26-22, and 26-23. Objectives 26-1b through d were deleted at the Midcourse Review. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =               × 100. 
     Healthy People 2010 target – Baseline value 
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Figure 26-2. Health Disparities Table for Focus Area 26: Substance Abuse
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26-1a. Alcohol-related motor vehicle crash deaths (per 
100,000 population) (1998, 2009)1,2†
4u3
B
4u3
NA
4u3 4u3 4u3 4u3
B
4u1
NA NA NA NA NA NA NA NA
26-2. Cirrhosis deaths (age adjusted, per 100,000 
population) (1999, 2007)3* 4 NA 4
4d1
4 4 B 4 4
4u1
B 4 NA NA NA NA
26-3. Drug-induced deaths (age adjusted, per 
100,000 population) (1999, 2007)3*
4u3
NA
4d3
4
4u3
4 B
3d1 4d1
4 B 4 NA NA NA NA
26-4. Drug-related hospital emergency department 
visits (thousands) (2004, 2009)* NA NA NA NA NA Biii
4u3iii
NA B
2d1
NA NA NA NA NA NA NA NA
26-6. Students who rode with a driver who had been 
drinking alcohol (grades 9–12) (1999, 2009)* NA NA NA NA 2 2 B 2 1 Biv NA NA NA NA NA NA NA NA
26-9a. Average age at first use among adolescents 
who used alcohol for the first time in past year 
(12–17 years) (2002, 2008)4*
3 B 1 2 2 2 2 2i 1 Biv NA NA NA NA 1 1 B 1
26-9b. Average age at first use among adolescents 
who used marijuana for the first time in past 
year (12–17 years) (2002, 2008)4*
2 b NA 1 2 2 B NA 1 B NA NA NA NA 2 2 B
2u1
26-9c. High school seniors never consuming alcoholic 
beverages (1998, 2009)5,6,7‡ NA NA NA NA 2 B 2 2 B Biv NA NA NA NA NA NA NA NA
26-9d. High school seniors never using illicit drugs 
(1998, 2009)5,6,7‡ NA NA NA NA
1d1
B
2d1 1d1
B 2 NA NA NA NA NA NA NA NA
26-10a. Adolescents not using alcohol or illicit drugs in 
past 30 days (12–17 years) (2002, 2008)4* 3 b NA 1 2 B 2 NA 1 B NA NA NA NA Biv 1 2 2
26-10b. Adolescents using marijuana in past 30 days 
(12–17 years) (2002, 2008)4* 3 b NA 3 1 Biv 2 NA B 2 NA NA NA NA 1 B 1 1
26-10c. Adults using illicit drugs in past 30 days (18+ 
years) (2002, 2008)* 2 b 1 4 B 3 2 NA B 3 2 2 B 2 NS NS NS NS
26-11a. Binge drinking in the past 2 weeks—High 
school seniors (1998, 2009)5,6,7‡ NA NA NA NA
3d1
B
4d2 4d1
B 3 NA NA NA NA NA NA NA NA
26-11b. Binge drinking in the past 2 weeks—College 
students (1998, 2009)8* NA NA NA NA NA NA NA NA B
2d1
NA NA NA NA NA NA NA NA
26-11c. Binge drinking in the past month—Adults (18+ 
years) (2002, 2008)4* 2 b NA 1 2 B 2 NA B 4 NS NS NS NS 1 B 1 1
26-11d. Binge drinking in the past month—Adolescents 
(12–17 years) (2002, 2008)4*
1d3
b NA b Biv b
2d3
NA B 1 NA NA NA NA Biv 2 2 2
26-13a. Adults who exceed guidelines for low-risk 
drinking—Females (21+ years) (1992, 
2001–02)†
3u1
Biv 2 NA
2u1
2
2u1
2i NA NA 1 Biv 1 1 NA NA NA NA
26-13b. Adults who exceed guidelines for low-risk 
drinking—Males (21+ years) (1992, 2001–02)†
3u1
Biv 3 NA
3u2
3 3 3i NA NA 2 1 B 2 NA NA NA NA
26-14a. Steroid use among students—8th graders 
(1998, 2009)5,6,7‡ NA NA NA NA 2 1 Biv 1 NA NA NA NA NA NA NA NA
26-14b. Steroid use among students—10th graders 
(1998, 2009)5,6,7‡ NA NA NA NA
1d1
b Biv NA NA NA NA NA NA NA NA NA
26-14c. Steroid use among students—12th graders 
(1998, 2009)5,6,7‡ NA NA NA NA b 1 Biv NA NA NA NA NA NA NA NA NA
Population-based objectives
Bii
Bii
(continued)
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity 
from the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income
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Figure 26-2. Health Disparities Table for Focus Area 26: Substance Abuse (continued)
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Population-based objectives
Characteristics and Groups
Race and Ethnicity Sex Education Income
26-15. Inhalant use among adolescents (12–17 years) 
(2002, 2008)4* 1 b NA b 1 b B NA 1 Biv NA NA NA NA 1 2 B 2i
26-16a. Disapproval of people who take 1–2 drinks a 
day of alcohol—8th graders (1998, 2009)5,6,7‡ NA NA NA NA
2u1
2 B 2 B 2 NA NA NA NA NA NA NA NA
26-16b. Disapproval of people who take 1–2 drinks a 
day of alcohol—10th graders (1998, 2009)5,6,7‡ NA NA NA NA 1 B
1d1 1d1
B 3 NA NA NA NA NA NA NA NA
26-16c. Disapproval of people who take 1–2 drinks a 
day of alcohol—12th graders (1998, 2009)5,6,7‡ NA NA NA NA Biv 1
3d1 2d1
B 3 NA NA NA NA NA NA NA NA
26-16d. Disapproval of people who try marijuana or 
hashish once or twice—8th graders (1998, 
2009)5,6,7‡
NA NA NA NA 2
2d1
B
2d1
B 2 NA NA NA NA NA NA NA NA
26-16e. Disapproval of people who try marijuana or 
hashish once or twice—10th graders (1998, 
2009)5,6,7‡
NA NA NA NA 1 Biv 1 1 B
2u1
NA NA NA NA NA NA NA NA
26-16f. Disapproval of people who try marijuana or 
hashish once or twice—12th graders (1998, 
2009)5,6,7‡
NA NA NA NA B 1 2 2 B 2 NA NA NA NA NA NA NA NA
26-17a. Adolescents' perception of risk (12–17 
years)—5+ alcoholic drinks, once or twice per 
week (2002, 2008)4*
2 Biv b 2 2 1 2 NA B 2 NA NA NA NA B 1 1 1
26-17b. Adolescents' perception of risk (12–17 
years)—Smoking marijuana once a month 
(2002, 2008)4*
2u1
Biv 1
2u1
2 2 2 2i B 1 NA NA NA NA Biv 1 1 1
26-17c. Adolescents' perception of risk (12–17 
years)—Cocaine use once a month (2002, 
2008)4*
2 2 NA 2 2 B 2 2 Biv 1 NA NA NA NA B 1 1 1
26-18a. Treatment for illicit drugs (12+ years) (2002, 
2008)4* NA NA NA NA 1 1 Biv 1 B Biv NA NA NA NA B 1 2 1
26-18b. Treatment for alcohol and/or drugs (12+ years) 
(2002, 2008)4* 1 NA NA Biv 1 B 1 1i 1 Biv NA NA NA NA B 1 2 1
26-21. Treatment for alcohol abuse or dependence 
(12+ years) (2002, 2008)4* 1 NA NA 1 2 Biv 1 1 1 B NA NA NA NA B 1 1 1
(continued)
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Figure 26-2. Health Disparities Table for Focus Area 26: Substance Abuse (continued)
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
‡
1
2
3
4
5
6
7
8
i
ii
iii
iv
26-1a. Fatality Analysis Reporting System (FARS), Department of Transportation (DOT).
26-2–26-3. National Vital Statistics System—Mortality (NVSS-M), CDC, NCHS.
26-4. Drug Abuse Warning Network (DAWN), SAMHSA.
26-6. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
26-9a–b. National Survey on Drug Use and Health (NSDUH), SAMHSA.
26-9c–d. Monitoring the Future Study (MTF), NIH, NIDA.
26-10a–c. National Survey on Drug Use and Health (NSDUH), SAMHSA.
26-11a–b. Monitoring the Future Study (MTF), NIH, NIDA.
26-11c–d. National Survey on Drug Use and Health (NSDUH), SAMHSA.
26-13a–b. National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), NIH, NIAAA.
26-14a–c. Monitoring the Future Study (MTF), NIH, NIDA.
26-15. National Survey on Drug Use and Health (NSDUH), SAMHSA.
26-16a–f. Monitoring the Future Study (MTF), NIH, NIDA.
26-17a–c. National Survey on Drug Use and Health (NSDUH), SAMHSA.
26-18a–b. National Survey on Drug Use and Health (NSDUH), SAMHSA.
26-18b. National Survey on Drug Use and Health (NSDUH), SAMHSA.
26-21. National Survey on Drug Use and Health (NSDUH), SAMHSA.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage 
points and estimates of variability were not available. See Technical Appendix.
Baseline data by race and ethnicity are for 2000.
Most recent data by race and ethnicity are for 2008.
Data by education level are for persons aged 25–64 years. Most recent data by education level are for 2002. 
Baseline data by race and ethnicity are for 2004–05.
FOOTNOTES
Baseline data by income are for 2005.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., 
race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the 
disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline 
from the summary index at the most recent data point. See Technical Appendix for more information.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows 
when the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. 
Nonetheless, disparities and changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
Measures of variability for data by race and ethnicity were available only for the most recent data. Thus, the variability of best group rates was assessed only for 
the most recent data, and statistical significance was tested only for the most recent data. Disparities of 10% or more are displayed when the differences from the 
best group rate are statistically significant at the 0.05 level. Changes in disparities over time are displayed according to their magnitude, since measures of 
variability were not available at baseline and therefore statistical significance of changes in disparity could not be tested. See Technical Appendix.
Decrease in disparity (percentage points)
10–49 points 50–99 points 100 points or more
Data not available. Characteristic not selected for this objective.
Increase in disparity (percentage points)
10–49 points 50–99 points 100 points or more
LEGEND
DATA SOURCES
Data are for Asian or Pacific Islander.
Data include persons of Hispanic origin.
Most recent data by race and ethnicity are for 2008–09.
Measures of variability were available for data by sex. See footnote * above.
Most recent data by sex are for 2007.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Change in the summary index cannot be assessed. See Technical Appendix.
The "best" group rate at the most recent 
data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Disparity from the best group rate at the 
most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99% 100% or more
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
NOTES
Years in parentheses represent the baseline and most recent data years (if available).
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 
26-5, 26-7, 26-8a and b, 26-12, 26-19, 26-20, and 26-22 through 26-25. Objectives 26-1b through d were deleted at Midcourse Review.
Figure 26-3.  Cirrhosis Deaths  2005-07 
Healthy People 2010 objective 26-2 
Target = 3.2 
NOTES: Data are for ICD-10 codes K70, K73-K74 reported as underlying cause.  Rates are per 100,000 U. S. Population age-adjusted to  
the 2000 standard population.  Rates are displayed by a manual classification for U.S. health service area. 
SOURCE: National Vital Statistics System – Mortality, CDC, NCHS. 
no health service areas with a reliable rate met the target 
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Goal: Reduce illness, disability, and death related to 
tobacco use and exposure to secondhand smoke 
The objectives in this chapter monitor tobacco use, smoking cessation and the availability of treatment programs, environmental exposure to tobacco smoke, adolescent attitudes toward smoking, and tobacco control laws. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was achieved in objectives for this Focus Area during the past decade [1]. Eighty-five percent of the Tobacco Use objectives with data to measure progress moved toward or achieved their Healthy People 2010 targets (Figure 27-1). However, statistically significant health disparities were observed among racial and ethnic populations, as well as by sex, education level, income, and disability status (Figure 27-2), as discussed below [2]. 
 The percentage of adults aged 18 years and over who were current cigarette smokers (objective 27-1a) decreased by 12.5% between 1998 and 2008, from 24% to 21% (age adjusted), moving toward the Healthy People 2010 target of 12%. However, from 2004 to 2008, the proportion of U.S. adults who were current cigarette smokers did not noticeably change. Disparities were observed for a number of populations, for example: 
• Among educational groups, adults aged 25 years and over with at least some college education had the lowest (best) current cigarette smoking rate, 15% (age adjusted) in 2008. Adults aged 25 years and over with less than a high school education had a rate of 30% (age adjusted) in 2008, twice the best group rate [2].  
• Current cigarette smoking varied by geographic area. Utah was the only state to exceed the 2010 target, with an adult smoking rate of 9.2% in 2008. Indiana, Kentucky, Missouri, Oklahoma, and West Virginia had the highest smoking rates (Figure 27-3). 
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 The percentage of students in grades 9–12 who used tobacco products in the last month declined between 1999 and 2009. Student use of all tobacco products (which includes use of cigarettes, chewing tobacco, snuff, or cigars) (objective 27-2a) decreased by 35.0%, from 40% in 1999 to 26% in 2009, moving toward the 2010 target of 21%. Student cigarette smoking (objective 27-2b) decreased by 45.7%, from 35% in 1999 to 19% in 2009, moving toward the 2010 target of 16%; whereas cigar use (objective 27-2d) declined by 22.2%, from 18% to 14%, moving toward the 2010 target of 8%. Student bidi use (objective 27-2e) declined by 41.5% between 2000 and 2009, from 4.1% to 2.4%, meeting the target of 2.4%. 
• Female students had a lower (better) rate of cigar use in the past month than male students, 19% vs. 9% in 2009. The rate for male students was more than twice that of female students [2]. 
• The percentage of children aged six years and under exposed to tobacco smoke at home (objective 27-9) decreased by 70.4% between 1994 and 2005, from 27% to 8%, exceeding the Healthy People 2010 target of 10%. Disparities were observed among a number of population groups, for example: among income groups, children aged six years and under living in middle/high income households had the lowest (best) rates of exposure to tobacco smoke at home, 5% in 2005, whereas children living in poor or near-poor households had rates of 15% and 12% in 2005, respectively. The rate for children living in poor households was three times the best group rate, while the rate for children living in near-poor households was almost two and a half times the best group rate [2]. 
• Children living in poor households had rates of exposure to tobacco smoke of 38% in 1994 and 15% in 2005; those living in near-poor households had rates of 33% in 1994 and 12% in 2005; whereas those living in middle/high income households had rates of 19% in 1994 and 5% in 2005. The disparity between children living in poor households and those living in middle/high income households increased by 100 percentage points between 1994 and 2005. During the same period, the disparity between children living in near-poor households and those living in middle/high income households increased by 66 percentage points [3]. 
 The percentage of nonsmokers aged four years and over exposed to environmental tobacco smoke (objective 27-10) declined by 51.2% between 1988–94 and 2005–08, from 84% to 41% (age adjusted), exceeding the 2010 target of 56%. 
 The number of states with smoke-free indoor air laws (objectives 27-13a through f, and i) increased between 1998 and 2009, moving toward the 2010 targets of 51 (all 50 states plus the District of Columbia). The number of states that had laws prohibiting smoking in private workplaces increased from zero states in 1998 to 30 (29 states plus the District of Columbia) in 2009 (objective 27-13a). The number of states that prohibited smoking in restaurants increased from one in 1998 to 28 (27 states plus the District of Columbia) in 2009 (objective 27-13c). And the number of states that prohibited smoking in bars increased from zero states in 1998 to 22 (21 states plus the District of Columbia) in 2009 (objective 27-13i). 
• Twenty-one states had laws prohibiting smoking in private workplaces, restaurants, and bars in 2009. Nineteen states, including large-population states like California and Texas, had no such laws (Figure 27-4). 
 Exposure to tobacco advertising on the Internet among students in grades 6–12 (objective 27-16a) increased by 32.1% between 2000 and 2009, from 28% to 37%, moving away from the 2010 target of 25%. 
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 The average combined Federal and State excise taxes on a standard pack of cigarettes (objective 27-21a) increased nearly four-fold, from $0.63 in 1998 to $2.35 in 2009, exceeding the 2010 target of $2.00. (The 2009 figure includes an increase in the Federal cigarette tax to $1.01.) 
• Twenty-nine states had cigarette taxes of at least $2.00 per pack in 2009, achieving the target. South Carolina had the lowest combined tax rate: $1.08 per pack (Figure 27-5).  
Summary of Progress 
 Figure 27-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Tobacco Use [1]. Data to measure progress toward target attainment were available for 40 objectives. Of these: 
• Six objectives (27-2e, 27-9, 27-10, 27-16b, 27-20a, and 27-21a) met or exceeded their Healthy People 2010 targets. 
• Twenty-eight objectives moved toward their 2010 targets. A statistically significant difference between the baseline and the final data points was observed for 11 of these objectives (27-1a, 27-2a and b, 27-2d, 27-4a, 27-5, 27-11, 27-12, and 27-17a through c). No significant differences were observed for three objectives (27-1b and c, and 27-3a); and data to test the significance of the difference were unavailable for 14 objectives (27-13a through f, 27-13i, 27-14a and b, 27-15, 27-19, 27-20a through c, and 27-21a and b). 
• Six objectives moved away from their 2010 targets. A statistically significant difference between the baseline and final data points was observed for two objectives (27-3b and 27-16a); no significant differences were observed for four objectives (27-2c, 27-4b, 27-6, and 27-7). 
 Four objectives remained developmental (objectives 27-13g and h, and 27-18b and d), and three had no data available to measure progress (objectives 27-8a and b, and 27-18a) [4]. Two objectives were dropped during the decade (objectives 27-1d and 27-8c) [5]. 
 Figure 27-2 displays health disparities in Tobacco Use from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Of the ten objectives with statistically significant health disparities of 10% or more by race and ethnicity, the Asian population had the best rate for three objectives (27-12, and 27-16a and b); the black non-Hispanic population had the best rate for two objectives (27-2a and b); the Hispanic or Latino population had the best rate for two objectives (27-1a and 27-10); the white non-Hispanic population had the best rate for two objectives (27-9 and 27-17a); and the white non-Hispanic and black non-Hispanic populations were tied for the best rate for one objective (27-4a). 
• Females had better rates than males for 10 of the 12 objectives with statistically significant health disparities of 10% or more by sex (objectives 27-1a, 27-2a and d, 27-3b, 24-5, 27-7, 27-10, 27-12, and 27-17a and b). Males had better rates than females for two objectives (27-3a and 27-4a). 
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• Persons with at least some college education had the best rates for all five of the objectives with statistically significant health disparities of 10% or more by education level (27-1a and b, 27-5, 27-10, and 27-12). 
• Persons with middle/high incomes had the best rates for the four objectives with statistically significant health disparities of 10% or more by income (objectives 27-1, 27-4a, 27-9, and 27-12). 
• Persons without disabilities had the better rates for both objectives with statistically significant health disparities of 10% or more by disability status (objectives 27-1a and c).  
Transition to Healthy People 2020 The focus of the Healthy People 2020 Tobacco Use objectives remains similar to that of Healthy People 2010. There have been some changes in organization and some objectives have been expanded. See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. The Healthy People 2020 objectives can be grouped into several sections: 
 The Tobacco Use Prevalence section focuses on reducing tobacco use and initiation among youth and adults. 
 The Health System Changes section addresses policies and strategies to increase access, affordability, and use of smoking cessation services and treatments. 
 The Social and Environmental Changes section monitors policies to reduce exposure to secondhand smoke, increase the cost of tobacco, restrict tobacco advertising, and reduce illegal sales to minors. The differences between the Healthy People 2010 and Healthy People 2020 objectives are summarized below: 
 The Healthy People 2020 Tobacco Use Topic Area has a total of 70 objectives, 19 of which are developmental, whereas the Healthy People 2010 Tobacco Use Focus Area had 49 objectives, two of which were deleted at Midcourse Review [4,5]. 
 Twenty-two Healthy People 2010 objectives were retained “as is” [6]. These include: adult and adolescent tobacco use (objectives 27-1a through c, and 27-2a through d); initiation of cigarette use (objectives 27-3a and b); smoking cessation attempts for adults (objective 27-5), adolescents (objective 27-7), and during pregnancy (objective 27-6); indoor worksite policies (objective 27-12); smoke-free indoor air laws in private and public workplaces (objectives 27-13a and b), restaurants (objective 27-13c), public transportation (objective 27-13d), and bars (objective 27-13i); enforcement of illegal tobacco sales to minors (objectives 27-14a and b); and adolescent exposure to tobacco advertising and promotion on the Internet or in magazines and newspapers (objectives 27-16a and b). 
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 Seven Healthy People 2010 objectives were modified and expanded into 14 objectives [7]. 
• Medicaid program coverage for treatment of nicotine dependency (objective 27-8b) will be measurable in Healthy People 2020 using a different data source. 
• Exposure to environmental tobacco smoke (objective 27-10) was split into three age-group objectives including 3–11 years, 12–17 years, and 18 years and over. 
• The smoke-free and tobacco-free schools objective (27-11) was modified to tobacco-free schools and has been split into three objectives including junior high, middle school, and high school. 
• The objective on smoke-free indoor air laws in day care centers (objective 27-13e) was divided into two objectives for commercial and home based centers. 
• The preemptive tobacco control laws objective (27-19) was expanded to include objectives for preemption in smoke-free indoor air, advertising, and youth access. 
• Two objectives that monitor increases in Federal and State tax on cigarettes (objective 27-21a) and smokeless tobacco products (objective 27-21b) will be measured differently in Healthy People 2020. 
 Three Healthy People 2010 objectives, evidence based tobacco control programs for states, territories, and for tribes, were retained as developmental due to lack of baseline data (objectives 27-18a through c) [4]. 
 Thirteen Healthy People 2010 objectives were archived [8]. These include: adolescent use of bidis (objective 27-2e); average age at first use of tobacco (objectives 27-4a and b); managed care organization coverage for treatment of nicotine dependency (objective 27-8a); exposure to tobacco smoke at home (objective 27-9); smoke-free indoor air laws for retail stores (objective 27-13f); retail license suspension for sales to minors (objective 27-15); adolescent disapproval of smoking for eighth (objective 27-17a), tenth (objective 27-17b) and twelfth (objective 27-17c) graders; sales-weighted average tobacco specific nitrosamines (objective 27-20a); and polyaromatic hydrocarbon compounds (objective 27-20b) and volatile organic compounds (objective 27-20c) in cigarette smoke. 
• While objective 27-9, to reduce the proportion of children who are regularly exposed to tobacco smoke at home, was archived, modified Healthy People 2020 objective TU-11.1 measures the exposure to second hand smoke among children aged 3–11 years using measured serum cotinine levels and is thought to measure children’s exposure more accurately than self-report data.  
 Two objectives were dropped at the Midcourse Review due to lack of data: adult use of other tobacco (objective 27-1d); and insurance coverage for treatment of nicotine dependency (objective 27-8c) [5]. Two additional objectives were dropped during the transition to Healthy People 2020 due to lack of data: smoke free indoor air laws for tribes (objective 27-13g) and territories (objective 27-13h). 
 Thirty one new objectives were added to the Healthy People 2020 Tobacco Use Topic Area: 
• Six new objectives address age at first use for all tobacco products, smokeless tobacco, and cigars for both the 12–17 years and the 18–25 years age groups. 
• Three new objectives monitor smoking cessation success and smoking cessation using evidence based strategies. 
• Eight objectives address screening and counseling in office based ambulatory care settings, hospital ambulatory care settings, dental care settings, and substance abuse care settings. 
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• Ten new smoke-free indoor air objectives track indoor air in gaming halls, hotels and motels, multi-unit housing, vehicles with children, prisons and correctional facilities, substance abuse treatment facilities, mental health treatment facilities, entrances and exits of all public places, hospital campuses, and college and university campuses. 
• An objective was added to include Head Start on the list of smoke-free and tobacco-free schools.  
• One new objective will monitor increases in Federal and state tax on “other” smoked tobacco products.  
• Two new objectives address adolescent exposure to tobacco advertising at the movies and at point of purchase. Appendix D, “A Crosswalk Between Objectives from Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations Figure 27-3 (Tobacco Use by Adults—Cigarettes) presents state-level data from the Behavioral Risk Factor Surveillance System (BRFSS). National data for these objectives come from the National Health Interview Survey (NHIS) and are the basis for setting the targets. BRFSS data may not be comparable to the National data from the NHIS. Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. 
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Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
Notes 1. Displayed in the Progress Chart (Figure 27-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 27-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 27-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 27-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 27-2 footnotes, as well as the Technical Appendix, for more detail. 
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4. To be included in Healthy People 2010, an objective must have a national data source that provides a baseline and at least one additional data point for tracking progress. Some objectives lacked baseline data at the time of their development but had a potential data source and were considered of sufficient national importance to be included in Healthy People. These are called “developmental” objectives. When data become available, a developmental objective is moved to measurable status and a Healthy People target can be set. 5. Dropped objectives were not carried forward into Healthy People 2020. These objectives were either developmental or deleted at the Healthy People 2010 Midcourse Review or at another time in Healthy People 2010. 6. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 7. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa. 8. Archived objectives had at least one data point in Healthy People 2010 but were not carried forward into Healthy People 2020. 
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Comprehensive Summary of Objectives: Tobacco Use 
Objective Description Data Source or Objective Status 27-1a Tobacco use by adults—Cigarettes (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 27-1b Tobacco use by adults—Spit tobacco (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 27-1c Tobacco use by adults—Cigars (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 27-1d Tobacco use by adults—Other (age adjusted, 18+ years) Dropped 27-2a Tobacco use in past month by students—Tobacco products (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 27-2b Tobacco use in past month by students—Cigarettes (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 27-2c Tobacco use in past month by students—Spit tobacco (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 27-2d Tobacco use in past month by students—Cigars (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 27-2e Tobacco use in past month by students—Bidis (grades 9–12) National Youth Tobacco Survey: American Legacy Foundation; CDC, NCCDPHP. 27-3a Initiation of cigarette use—Adolescents 12–17 years (percent at risk) National Survey on Drug Use and Health (NSDUH), SAMHSA. 27-3b Initiation of cigarette use—Young adults 18–25 years (percent at risk) National Survey on Drug Use and Health (NSDUH), SAMHSA. 27-4a Average age at first tobacco use—Adolescents 12–17 years National Survey on Drug Use and Health (NSDUH), SAMHSA. 27-4b Average age at first tobacco use—Young adults 18–25 years National Survey on Drug Use and Health (NSDUH), SAMHSA. 27-5 Smoking cessation attempts by adults (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 27-6 Smoking cessation in first trimester and for remainder of pregnancy (females, 18–49 years) National Health Interview Survey (NHIS), CDC, NCHS. 27-7 Smoking cessation attempts by students (grades 9–12) Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 27-8a Managed care organization coverage for treatment of nicotine dependency Addressing Tobacco in Managed Care Survey, Robert Wood Johnson Foundation. 27-8b Medicaid program coverage for treatment of nicotine dependency (no. States and D.C.) Health Policy Tracking Service, National Conference of State Legislators. 27-8c Insurance coverage for treatment of nicotine dependency Dropped 27-9 Exposure to tobacco smoke at home among children (≤6 years)  National Health Interview Survey (NHIS), CDC, NCHS. 
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Objective Description Data Source or Objective Status 27-10 Exposure to environmental tobacco smoke among nonsmokers (age adjusted, 4+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 27-11 Smoke-free and tobacco-free schools School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 27-12 Indoor worksite policies that prohibit smoking Current Population Survey (CPS): Department of Commerce, Census Bureau; Department of Labor, Bureau of Labor Statistics. 27-13a Smoke-free indoor air laws—Private workplaces (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 27-13b Smoke-free indoor air laws—Public workplaces (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 27-13c Smoke-free indoor air laws—Restaurants (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 27-13d Smoke-free indoor air laws—Public transportation (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 27-13e Smoke-free indoor air laws—Day care centers (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 27-13f Smoke-free indoor air laws—Retail stores (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 27-13g Smoke-free indoor air laws—Tribes (number) Developmental 27-13h Smoke-free indoor air laws—Territories (number) Developmental 27-13i Smoke-free indoor air laws—Bars (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 27-14a Jurisdictions with ≤5% illegal tobacco buy rate among minors—States and D.C. State Synar Enforcement Reporting, SAMHSA. 27-14b Jurisdictions with ≤5% illegal tobacco buy rate among minors—Territories State Synar Enforcement Reporting, SAMHSA. 27-15 Retail license suspension for sales to minors (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 27-16a Exposure to tobacco advertising and promotions among students—Internet (grades 6–12) National Youth Tobacco Survey: American Legacy Foundation; CDC, NCCDPHP. 27-16b Exposure to tobacco advertising and promotions among students—Magazines and newspapers (grades 6–12) National Youth Tobacco Survey: American Legacy Foundation; CDC, NCCDPHP. 
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Objective Description Data Source or Objective Status 27-17a Student disapproval of smoking 1+ pack of cigarettes per day—8th graders Monitoring the Future Study (MTF), NIH, NIDA. 27-17b Student disapproval of smoking 1+ pack of cigarettes per day—10th graders Monitoring the Future Study (MTF), NIH, NIDA. 27-17c Student disapproval of smoking 1+ pack of cigarettes per day—12th graders Monitoring the Future Study (MTF), NIH, NIDA. 27-18a Evidence-bases tobacco control programs (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP, OSH. 27-18b Evidence-based tobacco control programs (no. Territories) Developmental 27-18c Evidence-based tobacco control programs (no. Tribes) Developmental 27-19 Preemptive tobacco control laws (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 27-20a Sales-weighted average tobacco-specific nitrosamines in cigarette smoke (ng per cigarette) Office on Smoking and Health, CDC, NCCDPHP; Division of Laboratory Sciences, CDC, NCEH. 27-20b Sales-weighted average polyaromatic hydrocarbon compounds in cigarette smoke (ng per cigarette) Office on Smoking and Health, CDC, NCCDPHP; Division of Laboratory Sciences, CDC, NCEH. 27-20c Sales-weighted average volatile organic compounds in cigarette smoke (µg per cigarette) Office on Smoking and Health, CDC, NCCDPHP; Division of Laboratory Sciences, CDC, NCEH. 27-21a Average combined Federal and State excise taxes on retail price of a standard pack of cigarettes in all 50 States and D.C. State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 27-21b Increased taxes on smokeless tobacco (no. States and D.C.) State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP.  
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Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 27-1. Progress Toward Target Attainment for Focus Area 27: Tobacco Use 
Percent of targeted change achieved5 (continued) 
27-1. Tobacco use by adults (age adjusted, 18+ 
years) 
  a. Cigarettes 
  b. Spit tobacco 
  c.  Cigars 
27-2. Tobacco use in past month by students 
(grades 9–12)  
  a. Tobacco products 
  b. Cigarettes  
  c. Spit tobacco 
  d. Cigars 
  e. Bidis 100% 
 25.0% 
9.5% 
16.7% 
73.7% 
84.2% 
40.0% 
100. % 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
4.1% 
6.7% 
(2002) 
6.2% 
(2008) 
-0.5 No -7.5% 
4.4% 
6.7% 
(2002) 
8.3% 
(2008) 
1.6 Yes 23.9% 
17.6 
14.7 
(2002) 
15.1 
(2008) 
0.4 Yes 2.7% 
20.9 
19.0 
(2002) 
18.9 
(2008) 
-0.1 No -0.5% 
80% 
45% 
(1998) 
48% 
(2008) 
3 Yes 6.7% 
30% 
14% 
(1998) 
11% 
(2005) 
-3 No -21.4% 
64% 
61% 
(2001) 
59% 
(2009) 
-2 No -3.3% 
10% 
27% 
(1994) 
8% 
(2005) 
-19 Yes -70.4% 
         0           25          50          75         100   
Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 27-1. Progress Toward Target Attainment for Focus Area 27: Tobacco Use (continued) 
Percent of targeted change achieved5 (continued) 
 
27-3. Initiation of cigarette use (percent at risk) 
  a. Adolescents 12–17 years 
  b. Young adults 18–25 years 
27-4. Average age at first tobacco use 
   a. Adolescents 12–17 years 
  b. Young adults 18–25 years 
27-5. Smoking cessation attempts by adults (age 
adjusted, 18+ years)  
27-6. Smoking cessation in first trimester 
 and for remainder of pregnancy 
 (females, 18–49 years) 
27-7. Smoking cessation attempts by  
 students (grades 9–12)  
27-9. Exposure to tobacco smoke at home among 
children (≤6 years)  
19.2% 
13.8% 
8.6% 
            111.8% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
56% 
84% 
(1988–94) 
41% 
(2005–08) 
-43 Yes -51.2% 
100% 
38% 
(1994) 
64% 
(2006) 
26 Yes 68.4% 
100% 
69% 
(1998–99) 
75% 
(2006–07) 
6 Yes 8.7% 
51 
0 
(1998) 
30 
(2009) 
30 Not tested * 
51 
10 
(1998) 
34 
(2009) 
24 Not tested 240.0% 
51 
1 
(1998) 
28 
(2009) 
27 Not tested 2,700.0% 
51 
16 
(1998) 
38 
(2009) 
22 Not tested 137.5% 
51 
21 
(1998) 
40 
(2009) 
19 Not tested 90.5% 
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Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 27-1. Progress Toward Target Attainment for Focus Area 27: Tobacco Use (continued) 
Percent of targeted change achieved5 (continued) 
 
27-10. Exposure to environmental tobacco smoke 
among nonsmokers (age adjusted, 4+ years)  
27-11. Smoke-free and tobacco-free schools    
27-12. Indoor worksite policies that prohibit smoking  
27-13. Smoke-free indoor air laws (no. States and 
D.C.) 
   a. Private workplaces 
  b. Public workplaces   
  c. Restaurants    
  d. Public transportation  
  e. Day care centers  
            153.6% 
41.9% 
19.4% 
58.8% 
58.5% 
54.0% 
62.9% 
63.3% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
51 
1 
(1998) 
27 
(2009) 
26 Not tested 2,600.0% 
51 
0 
(1998) 
22 
(2009) 
22 Not tested * 
51 
0 
(1998) 
5 
(2009) 
5 Not tested * 
8 
0 
(1998) 
1 
(2009) 
1 Not tested * 
51 
23 
(1998) 
25 
(2009) 
2 Not tested 8.7% 
25% 
28% 
(2000) 
37% 
(2009) 
9 Yes 32.1% 
67% 
74% 
(2000) 
49% 
(2009) 
-25 Yes -33.8% 
95% 
80% 
(1998) 
87% 
(2009) 
7 Yes 8.8% 
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Moved away           Moved toward                   Met or exceeded      
from target1          target                   target 
 
 
 
Figure 27-1. Progress Toward Target Attainment for Focus Area 27: Tobacco Use (continued) 
Percent of targeted change achieved5 (continued) 
 
27-13. Smoke-free indoor air laws (no. States and 
D.C.) 
   f. Retail stores  
  i. Bars    
27-14. Jurisdictions with ≤5% illegal tobacco buy 
rate among minors 
  a. States and D.C. 
  b. Territories  
27-15. Retail license suspension for sales to minors 
(no. States and D.C.)   
27-16. Exposure to tobacco advertising and 
promotions among students (grades 6–12) 
    a. Internet   
  b. Magazines and newspapers  
27-17. Student disapproval of smoking 1+ pack of 
cigarettes per day 
  a. 8th graders  
52.0% 
43.1% 
9.8% 
12.5% 
7.1% 
46.7% 
            357.1% 
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2010 
Target 
Baseline 
(Year) 
Final 
(Year) 
Baseline vs. Final 
Difference2 
Statistically 
Significant3 
Percent  
Change4 
95% 
75% 
(1998) 
85% 
(2009) 
10 Yes 13.3% 
95% 
69% 
(1998) 
82% 
(2009) 
13 Yes 18.8% 
0 
28 
(1998) 
27 
(2009) 
-1 Not tested -3.6% 
109.4 
121.5 
(2003–04) 
108.1 
(2007) 
-13.4 Not tested -11.0% 
894.3 
993.7 
(2003–04) 
929.5 
(2007) 
-64.2 Not tested -6.5% 
636.3 
707.0 
(2002) 
637.4 
(2007) 
-69.6 Not tested -9.8% 
$2.00 
$0.63 
(1998) 
$2.35 
(2009) 
$1.72 Not tested 273.0% 
51 
3 
(2000) 
38 
(2009) 
35 Not tested 1,166.7% 
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from target1          target                   target 
 
 
 
Figure 27-1. Progress Toward Target Attainment for Focus Area 27: Tobacco Use (continued) 
Percent of targeted change achieved5 (continued) 
 
27-17. Student disapproval of smoking 1+ pack of 
cigarettes per day 
  b. 10th graders  
  c. 12th graders   
27-19. Preemptive tobacco control laws (no. States 
and D.C.) 
27-20a. Sales-weighted average tobacco-specific 
nitrosamines in cigarette smoke (ng per 
cigarette)  
27-20b. Sales-weighted average polyaromatic 
hydrocarbon compounds in cigarette smoke 
(ng per cigarette)   
27-20c. Sales-weighted average volatile organic 
compounds in cigarette smoke (µg per 
cigarette)  
27-21a. Average combined Federal and state excise 
taxes on retail price of a standard pack of 
cigarettes in all 50 States and D.C.  
27-21b. Increased taxes on smokeless tobacco (no. 
States and D.C.)  
50.0% 
50.0% 
3.6% 
64.6% 
98.4% 
72.9% 
            110.7% 
            125.5% 
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Figure 27-1. Progress Toward Target Attainment for Focus Area 27: Tobacco Use (continued) 
 
NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data  are not 
available for objectives 27-8a, 27-8b, 27-13g, 27-13h, and 27-18a through c. Objectives 27-1d and 27-8c were deleted at the Midcourse Review. 
 
FOOTNOTES 
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
 
  Final value – Baseline value 
4 Percent change =                    × 100. 
              Baseline value 
 
                  Final value – Baseline value 
5 Percent of targeted change achieved =                × 100. 
     Healthy People 2010 target – Baseline value 
 
* Percent change cannot be calculated. See Technical Appendix for more information. 
 
 
DATA SOURCES 
 
27-1a–c. National Health Interview Survey (NHIS), CDC, NCHS. 
27-2a–d. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
27-2e. National Youth Tobacco Survey: American Legacy Foundation; CDC, NCCDPHP.  
27-3a–b. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
27-4a–b. National Survey on Drug Use and Health (NSDUH), SAMHSA. 
27-5–27-6. National Health Interview Survey (NHIS), CDC, NCHS. 
27-7. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP. 
27-9. National Health Interview Survey (NHIS), CDC, NCHS. 
27-10. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
27-11. School Health Policies and Programs Study (SHPPS), CDC, NCCDPHP. 
27-12. Current Population Survey (CPS): Department of Commerce, Census Bureau; Department of Labor, Bureau of Labor Statistics. 
27-13a–f. State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 
27-13i. State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 
27-14a–b. State Synar Enforcement Reporting, SAMHSA. 
27-15. State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 
27-16a–b. National Youth Tobacco Survey: American Legacy Foundation; CDC, NCCDPHP. 
27-17a–c. Monitoring the Future Study (MTF), NIH, NIDA. 
27-19. State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 
27-20a–c. Office on Smoking and Health, CDC, NCCDPHP; Division of Laboratory Sciences, CDC, NCEH. 
27-21a–b. State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP. 
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Figure 27-2. Health Disparities Table for Focus Area 27: Tobacco Use
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27-1a. Tobacco use by adults—Cigarettes (age 
adjusted, 18+ years) (1998, 2008)1* 3 b NA 2 B 2 3 NA B 2 4
3u1
B 3
3u1
3 B
3u1 3u1
B
27-1b. Tobacco use by adults—Spit tobacco (age 
adjusted, 18+ years) (1998, 2005)2* NA NA NA NA NA NA
3d2
3 B 3 b 1 B NA 1 B
27-1c. Tobacco use by adults—Cigars (age adjusted, 
18+ years) (1998, 2005)2* NA NA NA NA NA b 1 B NA NA 3 B
27-2a. Tobacco use in past month by 
students—Tobacco products (grades 9–12) 
(1999, 2009)*
NA NA NA NA 2 B 3 3 B 2 NA NA NA NA NA NA NA NA NA NA
27-2b. Tobacco use in past month by 
students—Cigarettes (grades 9–12) (1999, 
2009)*
NA NA NA NA 3 Bi
4u3
4ii B 1 NA NA NA NA NA NA NA NA NA NA
27-2c. Tobacco use in past month by students—Spit 
tobacco (grades 9–12) (1999, 2009)* NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
27-2d. Tobacco use in past month by students—Cigars 
(grades 9–12) (1999, 2009)* NA NA NA NA Bi B 1 1 B 4iii NA NA NA NA NA NA NA NA NA NA
27-2e. Tobacco use in past month by students—Bidis 
(grades 9–12) (2000, 2009)* NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
27-3a. Initiation of cigarette use—Adolescents 12–17 
years (percent at risk) (2002, 2008)3* 1 b NA b b b B NA 2 B NA NA NA NA b Bi 1 NA NA NA
27-3b. Initiation of cigarette use—Young adults 18–25 
years (percent at risk) (2002, 2008)3* NA NA NA B 2 NA NA NA NA NA NA NA
27-4a. Average age at first tobacco use—Adolescents 
12–17 years (2002, 2008)3* 2 b NA 2 1 Bi B NA 2 B NA NA NA NA 1 2 B 2 NA NA
27-4b. Average age at first tobacco use—Young adults 
18–25 years (2002, 2008)3* 1 b NA Bi 1 1 1 NA B 1 NA NA NA NA 1 Bi 1 1 NA NA
27-5. Smoking cessation attempts by adults (age 
adjusted, 18+ years) (1998, 2008)1* 1 b NA b 1 B 1 NA B 2 1 2 B 1 Bi 1 1 1 B 1
27-6. Smoking cessation in first trimester and for 
remainder of pregnancy (females, 18–49 years) 
(1998, 2005)4*
NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
27-7. Smoking cessation attempts by students (grades 
9–12) (2001, 2009)* NA NA NA NA Bi 1 B 1 B 2 NA NA NA NA NA NA NA NA NA NA
27-9. Exposure to tobacco smoke at home among 
children (≤6 years) (1994, 2005)4* NA NA NA 1 b 2 B NA 1 B NA NA NA NA
4u3 4u2
B
4u2
NS NS
27-10. Exposure to environmental tobacco smoke 
among nonsmokers (age adjusted, 4+ years) 
(1988–94, 2005–08)*
NA NA NA NA Biv
3u2
2
3u1
B 2
3u1 2u1
B
2u1
NS NS NS NS NS NS
27-12. Indoor worksite policies that prohibit smoking 
(1998–99, 2006–07)5* 2 B 1 2
2u1
1 1 2ii B
2d1 3d1 2d1
B
3d1
2 2 B 2 NA NA
27-16a. Exposure to tobacco advertising and promotions 
among students—Internet (grades 6–12) (2000, 
2009)*
1 Bi 3 NA 2 2 1 2 1 B NA NA NA NA NA NA NA NA NA NA
27-16b. Exposure to tobacco advertising and promotions 
among students—Magazines and newspapers 
(grades 6–12) (2000, 2009)*
2 Bi 1 NA
2u1
2 2 2 1 B NA NA NA NA NA NA NA NA NA NA
Population-based objectives
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from the 
baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Disability
(continued)
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Figure 27-2. Health Disparities Table for Focus Area 27: Tobacco Use (continued)
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27-17a. Student disapproval of smoking 1+ pack of 
cigarettes per day—8th graders (1998, 2009)6‡ NA NA NA NA 2 3 B 3 B 3 NA NA NA NA NA NA NA NA NA NA
27-17b. Student disapproval of smoking 1+ pack of 
cigarettes per day—10th graders (1998, 2009)6‡ NA NA NA NA 1 B Bi 1 B 2 NA NA NA NA NA NA NA NA NA NA
27-17c. Student disapproval of smoking 1+ pack of 
cigarettes per day—12th graders (1998, 2009)6‡ NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
‡
1
2
3
4
5
6
i
ii
iii
iv
27-1a–c. National Health Interview Survey (NHIS), CDC, NCHS.
27-2a–d. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
27-2e. National Youth Tobacco Survey, American Legacy Foundation and CDC.
27-3a–b. National Survey on Drug Use and Health (NSDUH), SAMHSA.
27-4a–b. National Survey on Drug Use and Health (NSDUH), SAMHSA.
27-5–27-6. National Health Interview Survey (NHIS), CDC, NCHS.
27-7. Youth Risk Behavior Surveillance System (YRBSS), CDC, NCCDPHP.
27-9. National Health Interview Survey (NHIS), CDC, NCHS.
27-10. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
27-12. Current Population Survey (CPS): Department of Commerce, Census Bureau; Department of Labor, Bureau of Labor Statistics.
27-16a–b. National Youth Tobacco Survey, American Legacy Foundation and CDC, NCCDPHP.
27-17a–c. Monitoring the Future Study (MTF), NIH, NIDA.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See 
Technical Appendix.
Change in the summary index cannot be assessed. See Technical Appendix.
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 27-
8a and b, 27-11, 27-13a through i, 27-14a and b, 27-15, 27-18a through c, 27-19, 27-20a through c, and 27-21a and b. Objectives 27-1d and 27-8c were deleted at 
Midcourse Review.
Years in parentheses represent the baseline and most recent data years (if available).
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race 
and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at 
baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the 
summary index at the most recent data point. See Technical Appendix for more information.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more are 
displayed when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows when 
the changes are greater than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were available only for the most recent data. Thus, the variability of best group rates was assessed only for the most recent data, and 
statistical significance was tested only for the most recent data. Disparities of 10% or more are displayed when the differences from the best group rate are 
statistically significant at the 0.05 level. Changes in disparities over time are displayed according to their magnitude, since measures of variability were not available 
at baseline and therefore statistical significance of changes in disparity could not be tested. See Technical Appendix.
10–49 points 50–99 points
Decrease in disparity (percentage points)
10–49 points 50–99 points
100 points 
or more
100 points 
or more
Baseline data by income group are for 2005.
Most favorable group rate for specified 
characteristic, but reliability criterion not 
met.
Data are for Mexican American.
DATA SOURCES
Race and Ethnicity Sex Education Income Disability
Population-based objectives
Baseline data by race and ethnicity are for 2005.
Baseline data by race and ethnicity are for 2003.
Baseline data by race and ethnicity are for 2004–05, while most recent data by race and ethnicity are for 2008–09.
Data not available.
FOOTNOTES
Baseline data by race and ethnicity are for 1999.
Baseline data by race and ethnicity are for 2000.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical Appendix.
Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically significant, 
or when the change is greater than or equal to 10 percentage points and estimates of 
variability were not available. See Technical Appendix.
NOTES
Increase in disparity (percentage points)
LEGEND
The "best" group rate at the most recent data point.
The group with the best rate for 
specified characteristic.
Percent difference from the best group rate
Reliability criterion for best 
group rate not met, or data 
available for only one group.
Disparity from the best group rate at the most recent 
data point.
Less than 10%, or not statistically 
significant (when estimates of 
variability are available).
10%–49% 50%–99% 100% or more
Figure 27-3. Tobacco Use by Adults – Cigarettes (18+ Years) 2008 
Healthy People 2010 objective 27-1a 
Target = 12 
NOTES: Data are age-adjusted to the 2000 standard population.  Data are for persons who have at least 100 cigarettes in their lifetime and currently  
report smoking everyday or some days. Rates are displayed by a modified Jenks classification for U.S. states. National data for the  objective come from  
the National Health Interview Survey (NHIS) and is the basis for setting the target.  State data from the BRFSS may not be comparable to the national  
data from the NHIS.  Both US rates are shown for comparison purposes.  BRFSS data displayed here may not BRFSS data elsewhere that is not age-adjusted. 
SOURCE: Behavioral Risk Factor Surveillance System (BRFSS), CDC.  
lowest category (green) shows 
states that met target 
9.2 
9.3 - 16.7 
16.8 - 19.4 
19.5 - 22.8 
22.9 - 27.8 
Percent 
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US (2008 NHIS) – 20.6 
US (2008 BRFSS) – 18.5 
Figure 27-4.  Comprehensive Smoke-free Laws (2009) 
Healthy People 2010 objectives 27-13a, 27-13c, and 27-13i 
0 
1 
2 
3 
Number of State Laws 
Restricting Smoking in  
Public Places 
NOTES: Number of state laws restricting  smoking  in public places includes  comprehensive state laws enacted banning smoking in: private  
worksites (27-13a), restaurants (27-13c), and bars (27-13i).  Each measure has target of 51 states and the District of Columbia.   
SOURCE: State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP, OSH, CDC.  
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Figure 27-5. Average Combined Federal and State Excise Taxes on Retail Price  
of a Standard Pack of Cigarettes in All 50 States and D.C.  2009 
Healthy People 2010 objective 27-21a 
Target = 2.00 
NOTES: Data are combined state and federal ($1.01) cigarette excise taxes. Rates are displayed by a manual classification for U.S. states.  
SOURCE: State Tobacco Activities Tracking and Evaluation System (STATE), CDC, NCCDPHP, OSH, CDC.  
highest category (green) shows 
states that met target 
1.08 
1.09 - 1.50 
1.51 - 1.75 
1.76 - 1.99 
2.00 - 4.47 
Cigarette Taxes 
(dollars) 
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A reformatted, typeset version of this report will replace the current version 
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Vision and Hearing  Page 28-2 
Goal: Improve the visual and hearing health of the 
Nation through prevention, early detection, treatment, 
and rehabilitation 
This chapter includes objectives that monitor progress in two major Healthy People areas: 
 Vision. The objectives in this area track visual impairments, occupational eye injuries, eye examinations, visual rehabilitation services, and the use of protective equipment. 
 Hearing. This area includes objectives that monitor hearing loss, newborn screening for hearing problems, the use of hearing aids, and hearing examinations. All Healthy People tracking data quoted in this chapter, along with technical information and operational definitions for each objective, can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. More information about this Focus Area can be found in the following publications: 
 Healthy People 2010: Understanding and Improving Health, available from http://www.healthypeople.gov/2010/Document/tableofcontents.htm#under. 
 Healthy People 2010 Midcourse Review, available from http://www.healthypeople.gov/2010/data/midcourse/html/default.htm#FocusAreas.  
Highlights 
 Substantial progress was made in the Vision and Hearing Focus Area objectives during the past decade (Figure 28-1) [1]. Two thirds of the Vision objectives and over half of the Hearing objectives with data available to measure progress moved toward or achieved their Healthy People 2010 targets. Health disparities were observed for some objectives among select population groups (Figure 28-2), as highlighted below [2]. 
 Several Vision objectives exceeded their Healthy People 2010 targets: 
• Visual impairment due to diabetic retinopathy among adults aged 18 years and over with diabetes (objective 28-5) declined, decreasing by 40.0% between 2002 and 2008, from 45.8 to 27.5 per 1,000 population (age adjusted), exceeding the 2010 target of 40.9. 
• Occupational eye injuries declined. A decrease of 39.6% was observed for injuries resulting in lost work days (objective 28-2a) between 2002 and 2008, from 4.8 to 2.9 per 10,000 full time workers in private industry, exceeding the 2010 target of 3.4. The rate of eye injuries treated in emergency departments (objective 28-2b) also decreased by 38.6% between 1999 and 2008, from 21.0 to 12.9 per 10,000 full-time workers, exceeding the target of 14.7. 
 Females had a lower (better) rate of occupational eye injuries resulting in lost work days, 1.3 per 10,000 full time workers in private industry in 2008. The rate for males, 4.0 per 10,000 full-time workers in private industry in 2008, was more than three times the rate for females [2]. 
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• Adult use of protective eyewear at home (objective 28-9b) increased by 21.2% between 2002 and 2008, from 33% to 40% (age adjusted), exceeding the Healthy People 2010 target of 37%. 
• The use of vision rehabilitation services by visually impaired persons (objective 28-10a) more than doubled during the same period, increasing from 14.0 to 30.1 per 1,000 visually impaired adults aged 18 years and over (age adjusted), exceeding the 2010 target of 15.5. 
 A statistically significant disparity was observed in blindness and visual impairment among children and adolescents (objective 28-4). Persons without disabilities had lower (better) rates of blindness and visual impairment in both 1997 and 2008, 19 and 24 per 1,000 population aged 17 years and under, respectively. The rates for persons with disabilities, were 92 per 1,000 population in 1997 and 68 in 2008. In 2008, the rate for children and adolescents with disabilities was almost three times the rate for those without disabilities. The disparity between children and adolescents without disabilities and those with disabilities declined by more than 100 percentage points between 1997 and 2008 [2,3]. 
 Several Hearing objectives, including the following, exceeded the 2010 targets: 
• Otitis media in children and adolescents (objective 28-12) declined by almost 30% between 1997 and 2007, from 344.7 to 246.6 per 1,000 population aged under 18 years, exceeding the target of 294. 
• The use of cochlear implants by deaf or very hard of hearing persons (objective 28-13b) increased between 2001 and 2006, from 57 to 92 per 10,000 population, exceeding the target of 63. 
• The use of hearing aids by adults with hearing loss (objectives 28-13c) also increased between 2001 and 2007, from 255.2 to 289.1 per 1,000 population aged 70 years and over, exceeding the target of 280.7.  
Summary of Progress 
 Figure 28-1 presents a quantitative assessment of progress in achieving the Healthy People 2010 objectives for Vision and Hearing. Data to measure progress toward target attainment were available for 25 objectives [1]. Of these: 
• Nine objectives (28-5, 28-8a and b, 28-9b, 28-10a, 28-12, 28-13b and c, and 28-14b) met or exceeded their Healthy People 2010 targets. 
• Six objectives moved toward their targets. A statistically significant difference between the baseline and the final data points was observed for one of these objectives (28-2). No significant differences were observed for three objectives (28-7, 28-9b, and 28-17); and data to test the significance of the difference were unavailable for two objectives (28-11a and b). 
• One objective (28-1) showed no change. 
• Nine objectives moved away from their targets. A statistically significant difference between the baseline and the final data points was observed for two of these objectives (28-3 and 28-10b). No significant differences were observed for six objectives (28-4, 28-6, 28-13a, 28-14a, 28-16a, and 28-18); and data to test the significance of the difference were unavailable for one objective (28-11c). 
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 Four objectives (28-13d, 28-14c, 28-15, and 28-16b) had no data available to measure progress. 
 Figure 28-2 displays health disparities in Vision and Hearing from the best group rate for each characteristic at the most recent data point [2]. It also displays changes in disparities from baseline to the most recent data point [3]. 
• Of the 10 objectives with statistically significant racial and ethnic health disparities of 10% or more, the white non-Hispanic population had the best rate for five objectives (28-3, 28-9b, 28-13c, 28-15, and 28-16b); the black non-Hispanic population had the best rate for two objectives (28-14a and b), as did the population of persons of two or more races (28-1 and 28-2); and the Hispanic or Latino population had the best rate for one objective (28-16a). 
• For seven objectives, statistically significant health disparities of 10% or more were observed between females and males (objectives 28-1, 28-7, 28-9b, 28-13c, 28-14a, and 28-16a and b). In addition, one objective exhibited a health disparity of 100% or more (see Highlights, above), but lacked data to assess statistical significance (objective 28-8a). Males had better rates than females for six of these eight objectives (28-7, 28-9b, 28-13c, 28-14a, and 28-16a and b). Females had better rates for two objectives (28-1 and 28-8a). 
• Persons with at least some college education had the best group rate for three of the four objectives with statistically significant health disparities of 10% or more by education level (28-1, and 28-13a and c). High school graduates had the best group rate for one objective (28-7) 
• Persons with middle/high incomes had the best group rate for three of the four objectives with statistically significant health disparities of 10% or more by income (objectives 28-3, 28-13-d, and 28-16a). Near-poor persons had the best group rate for the fourth objective (28-9a). 
• Persons with disabilities had better rates than persons without disabilities for two of the three objectives with statistically significant health disparities of 10% or more by disability status (objectives 28-14b and 28-15). Persons without disabilities had the better rate for one objective (28-4). 
• Health disparities of 100% or more were observed for two objectives: blindness and visual impairment in children and adolescents (objective 28-4), and occupational eye injuries resulting in lost work days (objective 28-8a). A statistically significant decline in disparity also was observed for blindness and visual impairment in children and adolescents; see Highlights, above.  
Transition to Healthy People 2020 To emphasize the individual importance of Vision and Hearing, the Healthy People 2010 Vision and Hearing Focus Area was divided into two separate Topic Areas for Healthy People 2020: 1) Vision, and 2) Hearing and Other Sensory or Communication Disorders. Other sensory or communication disorders include disorders of the ear, nose, throat, and conditions associated with voice, speech, and language (ENT-VSL). See HealthyPeople.gov for a complete list of Healthy People 2020 topics and objectives. 
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The Healthy People 2020 Vision Topic Area covers: 
 Eye examinations among adults and vision screening among children 
 Visual impairment due to selected eye diseases 
 Occupational eye injuries 
 Use of protective eyewear at home and during recreational activities 
 Use of vision rehabilitation services and visual adaptive devices 
 Comprehensive vision health service provided in Federally Qualified Health Centers. The Healthy People 2020 Hearing and Other Sensory or Communication Disorders Topic Area includes new objectives in addition to Healthy People 2010 hearing objectives. The Topic Area can be grouped into several sections: 
 Newborn hearing screening 
 Ear infections (otitis media) 
 Hearing 
 Tinnitus 
 Balance and dizziness 
 Smell and taste (chemosenses) 
 Voice, speech, and language 
 Internet health care resources for ENT-VSL. The differences between the objectives for Healthy People 2010 and Healthy People 2020 are summarized below: 
 The Healthy People 2010 Vision and Hearing Focus Area had a total of 29 objectives, including 13 vision and 16 hearing objectives. For Healthy People 2020, the Vision Topic Area has 15 objectives and the Hearing and Other Sensory or Communication Disorders Topic Area has 36 objectives. 
Vision 
 Ten Healthy People 2010 Vision objectives (28-1 through 28-4, 28-8a and b, 28-9a and b, and 28-10a and b) were retained “as is” [4]. 
 Three Vision objectives (28-5, 28-6, and 28-7) on reduction of visual impairment caused by age-related eye diseases were modified because of changes in survey methodology [5]. 
 Two new Vision objectives were added to the Healthy People 2020 Topic Area: 
• The first addresses visual impairment due to age-related macular degeneration. 
• The second measures the proportion of Federally Qualified Health Centers (FQHCs) that provide comprehensive vision health services. 
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Hearing and Other Sensory or Communication Disorders 
 All sixteen Healthy People 2010 Hearing objectives (28-11a through 28-18) were retained “as is” [4]. 
 Twenty new objectives were added to this Healthy People 2020 Topic Area: 
• Three tinnitus objectives focus on adults bothered by tinnitus who have seen a health provider, audiologist or otolaryngologist and tried appropriate treatment. 
• Twelve new objectives on balance, dizziness and smell or taste disorders will track use of health care services, referrals to health care specialist, treatment, negative or adverse outcomes, falls and injuries caused by balance and dizziness conditions, and impact of these conditions on general health status and quality of life. 
• Four voice, speech, and language objectives were introduced to Healthy People 2020 to highlight the importance of timely evaluation, treatment, and use of rehabilitation services in improving the quality of life of patients with VSL conditions. 
• One new objective on the use of Internet health care resources for ENT-VSL disorders was added to measure the number of people who used Internet for health care information, guidance, or advice. Appendix D, “A Crosswalk Between Objectives From Healthy People 2010 to Healthy People 2020,” summarizes the changes between the two decades of objectives, reflecting new knowledge and direction for this area.  
Data Considerations Education and income are the primary measures of socioeconomic status (SES) in Healthy People 2010. Most data systems used in Healthy People 2010 define income as a family’s income before taxes. In order to facilitate comparisons among groups and over time, while adjusting for family size and for inflation, Healthy People 2010 categorizes income using the poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. These categories may be overridden by considerations specific to the data system, in which case they are modified as appropriate. See Healthy People 2010: General Data Issues, referenced below. In general, data on educational attainment are presented for persons aged 25 years and over, consistent with guidance given by the U.S. Bureau of the Census. However, because of the requirements of the different data systems, the age groups used to calculate educational attainment for any specific objective may differ from the age groups used to report the data for other Healthy People 2010 objectives, as well as from select populations within the same objective. Therefore, the reader is urged to exercise caution in interpreting the data by educational attainment shown in the Health Disparities Table. See Healthy People 2010: General Data Issues, referenced below. 
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Additional information on data issues is available from the following sources: 
 All Healthy People 2010 tracking data can be found in the Healthy People 2010 database, DATA2010, available from http://wonder.cdc.gov/data2010/. 
 Detailed information about the data and data sources used to support these objectives can be found in the Operational Definitions on the DATA2010 website, available from http://wonder.cdc.gov/data2010/focusod.htm. 
 More information on statistical issues related to Healthy People tracking and measurement can be found in the Technical Appendix and in Healthy People 2010: General Data Issues, which is available in the Data Issues section of the NCHS Healthy People website under Healthy People 2010.  
Notes 1. Displayed in the Progress Chart (Figure 28-1), the percent of targeted change achieved expresses the difference between the baseline and the final value relative to the initial difference between the baseline and the Healthy People 2010 target. As such, it is a relative measure of progress toward attaining the Healthy People 2010 target. See the Reader’s Guide for more information. When standard errors were available, the difference between the baseline and the final value was tested at the 0.05 level of significance. See the Figure 28-1 footnotes, as well as the Technical Appendix, for more detail. 2. Information about disparities among select populations is shown in the Health Disparities Table (Figure 28-2). Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic. For example, racial and ethnic health disparities are measured as the percent difference between the best racial and ethnic group rate and each of the other racial and ethnic group rates. Similarly, disparities by sex are measured as the percent difference between the better group rate (e.g., female) and the rate for the other group (e.g., male). Some objectives are expressed in terms of favorable events or conditions that are to be increased, while others are expressed in terms of adverse events or conditions that are to be reduced. In order to facilitate comparison of health disparities across different objectives, disparity is measured only in terms of adverse events or conditions. For comparability across objectives, objectives that are expressed in terms of favorable events or conditions are re-expressed using the adverse event or condition for the purpose of computing disparity, but they are not otherwise restated or changed. For example, objective 1-1, to increase the proportion of persons with health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 65 years had some form of health insurance in 2008), is expressed in terms of the percentage of persons without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native population aged under 65 years did not have any form of health insurance in 2008) when the disparity from the best group rate is calculated. See the Reader’s Guide for more information. When standard errors were available, the difference between the best group rate and each of the other group rates was tested at the 0.05 level of significance. See the Figure 28-2 footnotes, as well as the Technical Appendix, for more detail. 3. The change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point and, therefore, is expressed as a change in percentage points. See the Reader’s Guide for more information. When standard errors were available, the change in disparity was tested at the 0.05 level of significance. See the Figure 28-2 footnotes, as well as the Technical Appendix, for more detail. 
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4. Retained “as is” objectives have no change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that were developmental in Healthy People 2010 and are developmental in Healthy People 2020 and for which no numerator or denominator information was available. 5. Modified objectives have some change in the numerator definition or in the denominator definition between the Healthy People 2010 and Healthy People 2020 objectives. These include objectives that went from developmental in Healthy People 2010 to measurable in Healthy People 2020 or vice versa.  
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Comprehensive Summary of Objectives: Vision and Hearing 
Objective Description Data Source 28-1 Dilated eye examination within the past 2 years (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 28-2 Vision screening for children (<6 years)  National Health Interview Survey (NHIS), CDC, NCHS. 28-3 Uncorrected visual impairment due to refractive errors (age adjusted per 1,000 standard population, 12+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 28-4 Blindness and visual impairment in children and adolescents (per 1,000 population, ≤17 years) National Health Interview Survey (NHIS), CDC, NCHS.  28-5 Visual impairment due to diabetic retinopathy (age adjusted per 1,000 standard population, 18+ years with diabetes) National Health Interview Survey (NHIS), CDC, NCHS. 28-6 Visual impairment due to glaucoma (age adjusted per 1,000 standard population, 45+ years)  National Health Interview Survey (NHIS), CDC, NCHS. 28-7 Visual impairment due to cataract (age adjusted per 1,000 standard population, 65+ years) National Health Interview Survey (NHIS), CDC, NCHS. 28-8a Occupational eye injuries resulting in lost work days (per 10,000 full-time workers in private industry) Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 28-8b Occupational eye injuries treated in emergency departments (per 10,000 full-time workers) National Electronic Injury Surveillance System (NEISS), Consumer Product Safety Commission (CPSC) and CDC, NIOSH. 28-9a Use of protective eyewear at home—Children and adolescents 6–17 years National Health Interview Survey (NHIS), CDC, NCHS. 28-9b Use of protective eyewear at home—Adults 18+ years (age adjusted) National Health Interview Survey (NHIS), CDC, NCHS. 28-10a Use of vision rehabilitation services by visually impaired persons (age adjusted per 1,000 standard population, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 28-10b Use of visual adaptive devices by visually impaired persons (age adjusted, 18+ years) National Health Interview Survey (NHIS), CDC, NCHS. 28-11a Newborns receiving hearing screening before age 1 month Baseline: Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Final: Early Hearing Detection and Intervention (EHDI) Program, CDC, NCBDD; and/or specific State data. 
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Objective Description Data Source 28-11b Infants with possible hearing loss receiving hearing evaluation before age 3 months Baseline: Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Final: Early Hearing Detection and Intervention (EHDI) Program, CDC, NCBDD; and/or specific State data. 28-11c Infants with hearing loss receiving intervention services before age 6 months Baseline: Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Final: Early Hearing Detection and Intervention (EHDI) Program, CDC, NCBDD; and/or specific State data. 28-12 Otitis media in children and adolescents (per 1,000 population, <18 years)  National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 28-13a Use of hearing aids by adults with hearing loss (per 1,000 population, 20–69 years) National Health Interview Survey (NHIS), CDC, NCHS; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 28-13b New cochlear implants by deaf or very hard of hearing persons (per 10,000 population) Healthcare Cost and Utilization Project (HCUP), AHRQ; National Health Interview Survey (NHIS), CDC, NCHS. 28-13c Use of hearing aids by older adults with hearing loss (per 1,000 population, 70+ years) National Health Interview Survey (NHIS), CDC, NCHS; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 28-13d Use of assistive listening devices by older adults with hearing loss (per 1,000 population, 70+ years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 28-14a Hearing examination in past 5 years—Adults 20–69 years (age adjusted) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 28-14b Hearing examination in past 5 years—Older adults 70+ years National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 28-14c Hearing examination in past 5 years—Adolescents 12–19 years National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 28-15 Primary care provider referrals for hearing evaluation and treatment National Health Interview Survey (NHIS), CDC, NCHS. 28-16a Use of ear protection devices when exposed to loud noises (age adjusted per 1,000 standard population, 20–69 years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 28-16b Use of ear protection devices among adolescents when exposed to loud noises (per 1,000 population, 12–19 years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 28-17 Audiometric notches (both ears) signifying noise-induced hearing loss among adolescents (per 1,000 population, 12–19 years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 28-18 Audiometric notches (both ears) signifying noise-induced hearing loss (age adjusted per 1,000 standard population, 20–69 years) National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.  
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Figure 28-1. Progress Toward Target Attainment for Focus Area 28: Vision and Hearing 
Percent of targeted change achieved5 (continued) 
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Figure 28-1. Progress Toward Target Attainment for Focus Area 28: Vision and Hearing (continued) 
Percent of targeted change achieved5 (continued) 
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Figure 28-1. Progress Toward Target Attainment for Focus Area 28: Vision and Hearing (continued) 
Percent of targeted change achieved5 (continued) 
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NOTES 
 
See the Reader’s Guide for more information on how to read this figure. See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Tracking data are not 
available for objectives 28-13d, 28-14c, 28-15, and 28-16b. 
 
FOOTNOTES  
 
1 Movement away from target is not quantified using the percent of targeted change achieved. See Technical Appendix for more information. 
2 Difference = Final value – Baseline value.  Differences between percents (%) are measured in percentage points. 
3 When estimates of variability are available, the statistical significance of the difference between the final value and the baseline value is assessed at the 0.05 level. See Technical Appendix 
for more information. 
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Figure 28-1. Progress Toward Target Attainment for Focus Area 28: Vision and Hearing (continued) 
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Figure 28-1. Progress Toward Target Attainment for Focus Area 28: Vision and Hearing (continued) 
 
 
DATA SOURCES 
 
28-1–28-2. National Health Interview Survey (NHIS), CDC, NCHS. 
28-3. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
28-4–28-7. National Health Interview Survey, (NHIS), CDC, NCHS. 
28-8a. Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS). 
28-8b. National Electronic Injury Surveillance System (NEISS), Consumer Product Safety Commission (CPSC) and CDC, NIOSH. 
28-9a–b. National Health Interview Survey (NHIS), CDC, NCHS. 
28-10a–b. National Health Interview Survey (NHIS), CDC, NCHS. 
28-11a–c. Baseline: Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Final: Early Hearing Detection and Intervention (EHDI) Program, CDC, NCBDD; 
 and/or specific State data. 
28-12. National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS. 
28-13a. National Health Interview Survey (NHIS), CDC, NCHS; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
28-13b. Healthcare Cost and Utilization Project (HCUP), AHRQ; National Health Interview Survey (NHIS), CDC, NCHS. 
28-13c. National Health Interview Survey (NHIS), CDC, NCHS; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
28-14a–b. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
28-16a. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
28-17–28-18. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS. 
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Figure 28-2. Health Disparities Table for Focus Area 28: Vision and Hearing
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28-1. Dilated eye examination within the past 2 years 
(age adjusted, 18+ years) (2002, 2008)* 1 1 NA Bi 2 1
1d1
1 B 2 3 2 B 2 NS NS NS NS NS NS
28-2. Vision screening for children (<6 years) (2002, 
2008)* NA 2 NA B 1 1 1 1 Bi B NS NS NS NS 1 1 Bi 1
28-3. Uncorrected visual impairment due to refractive 
errors (age adjusted, per 1,000 population, 12+ 
years) (1999–02, 2005–08)*
NA NA NA NA 3ii 2 B 2 1 B NS NS NS NS
2d1
2 B 2 NS NS
28-4. Blindness and visual impairment in children 
and adolescents (per 1,000 population, ≤17 
years) (1997, 2008)1*
NA NA NA NA NS NS NS NS NA
4d3
B
28-5. Visual impairment due to diabetic retinopathy 
(age adjusted, per 1,000 population, 18+ years 
with diabetes) (2002, 2008)*
NA NA NA NA NA NA NA NA NA NA NS NS NS NS NS NS
28-6. Visual impairment due to glaucoma (age 
adjusted, per 1,000 population, 45+ years) 
(2002, 2008)*
NA NA NA NA NA NA NS NS NS NS NS NS
28-7. Visual impairment due to cataract (age 
adjusted, per 1,000 population, 65+ years) 
(2002, 2008)*
NA 1 NA NA b b B NA 2 B 2 B 1 1 NS NS NS NS NS NS
28-8a. Occupational eye injuries resulting in lost work 
days (per 10,000 full-time workers in private 
industry) (2002, 2008)2†
NA NA NA NA NA NA NA NA B
4u1
NA NA NA NA NS NS NS NS NS NS
28-8b. Occupational eye injuries treated in emergency 
departments (per 10,000 full-time workers) 
(1999, 2008)*
NA NA NA NA NA NA NA NA NA NA NA NA NS NS NS NS NS NS
28-9a. Use of protective eyewear at home—
Children and adolescents 6–17 years (2002, 
2008)*
NA 1 NA 1 1 Bi 1 1iii 1 B NS NS NS NS 2 Bi 1 1 NS NS
28-9b. Use of protective eyewear at home—
Adults 18+ years (age adjusted) (2002, 2008)* NA 1 NA 1 1 2 Bi 2 2 B 1 1 B 1 NS NS NS NS NS NS
28-10a. Use of vision rehabilitation services by visually 
impaired persons (age adjusted, per 1,000 
population, 18+ years) (2002, 2008)*
NA NA NA NA NA NA B NA 1iv B NA 1 Bi NA NS NS NS NS NS NS
28-10b. Use of visual adaptive devices by visually 
impaired persons (age adjusted, 18+ years) 
(2002, 2008)*
NA NA NA NA 1 B Bi 1iii Bi 1 1 B 1 1 NS NS NS NS NS NS
28-12. Otitis media in children and adolescents (per 
1,000 population, <18 years) (1997, 2007)* NA NA NA NA NA NA NA NA i NS NS NS NS NA NA NA NA NA NA
28-13a. Use of hearing aids by adults with hearing loss 
(per 1,000 population, 20–69 years) (2001, 
2006)*
NA NA NA NA NA i NA 2 1 Bi 1 NS NS NS NS 1iv Biv
28-13b. New cochlear implants by deaf or very hard of 
hearing persons (per 10,000 population) (2001, 
2006)*
NA NA NA NA NA NA NA NA B 1 NA NA NA NA NS NS NS NS NS NS
28-13c. Use of hearing aids by older adults with hearing 
loss (per 1,000 population, 70+ years) (2001, 
2007)*
NA NA NA NA NA 2 B NA 2 B 2 1 Bi 1 NS NS NS NS Biv 1iv
28-13d. Use of assistive listening devices by older 
adults with hearing loss (per 1,000 population, 
70+ years) (2005–06)*
NA NA NA NA 1ii NA B NA 1 B 1 1 B 1 2 1 B 2 NA NA
28-14a. Hearing examination in past 5 years—
Adults 20–69 years (age adjusted) (1999–02, 
2003–04)*
NA NA NA NA 2ii B 2 2 2 B NS NS NS NS 1 1 B 1 B 1
28-14b. Hearing examination in past 5 years—
Older adults 70+ years (1999–02, 2003–06)* NA NA NA NA 2ii Bi 1 2
1d1
B NS NS NS NS
1d1 1d1
B
1d1
B 2
28-14c. Hearing examination in past 5 years—
Adolescents 12–19 years (2005–06)* NA NA NA NA ii NA NS NS NS NS NA NA NA
Population-based objectives
(continued)
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from 
the baseline to the most recent data point.
Characteristics and Groups
Race and Ethnicity Sex Education Income Disability
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28-15. Primary care provider referrals for hearing 
evaluation and treatment (2007)* 2 2 NA 1 2 2 B 2 1 B 1 1 B 1 1 1 B 1 B 2
28-16a. Use of ear protection devices when exposed to 
loud noises [age adjusted, per 1,000 population 
(pop.), 20–69 years] (1999–02, 2003–04)*
NA NA NA NA Bi, ii 2 1 1 3 B NS NS NS NS
1d1
2 B 2 NS NS
28-16b. Use of ear protection devices among 
adolescents when exposed to loud noises (per 
1,000 pop., 12–19 years) (2005–06)*
NA NA NA NA 2ii 2 B 2 2 B NS NS NS NS 1 B 1 1 NS NS
28-17. Audiometric notches (both ears) signifying noise-
induced hearing loss among adolescents (per 
1,000 pop., 12–19 years) (1988–94, 2005–06)*
NA NA NA NA ii NA NS NS NS NS NA NA NA NS NS
28-18. Audiometric notches (both ears) signifying noise-
induced hearing loss (age adjusted, per 1,000 
pop., 20–69 years) (1999–02, 2003–04)*
NA NA NA NA ii NA NS NS NS NS NA NS NS
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
*
†
1
2 Baseline data by sex are for 2006.
i
ii
iii
iv
v
28-1–28-2. National Health Interview Survey (NHIS), CDC, NCHS.
28-3. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
28-4–28-7. National Health Interview Survey (NHIS), CDC, NCHS.
28-8a. Survey of Occupational Injuries and Illnesses (SOII), Department of Labor (DOL), Bureau of Labor Statistics (BLS).
28-8b. National Electronic Injury Surveillance System (NEISS), Consumer Product Safety Commission (CPSC) and CDC, NIOSH.
28-9a–b. National Health Interview Survey (NHIS), CDC, NCHS.
28-10a–b. National Health Interview Survey (NHIS), CDC, NCHS.
28-12. National Ambulatory Medical Care Survey (NAMCS), CDC, NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC, NCHS.
28-13a. National Health Interview Survey (NHIS), CDC, NCHS; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
28-13b. Healthcare Cost and Utilization Project (HCUP), AHRQ; National Health Interview Survey (NHIS), CDC, NCHS.
28-13c. National Health Interview Survey (NHIS), CDC, NCHS; National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
28-13d. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
28-14a–c. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
28-15. National Health Interview Survey (NHIS), CDC, NCHS.
28-16a–b. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
28-17–28-18. National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
Percent difference from the best group rate
Reliability criterion for best 
group rate not met, or data 
available for only one group.
The group with the best rate for 
specified characteristic.
NOTES
LEGEND
Population-based objectives
The "best" group rate at the most recent data 
point.
Figure 28-2. Health Disparities Table for Focus Area 28: Vision and Hearing (continued)
Race and Ethnicity Sex Education Income
DATA SOURCES
Disability
Characteristic not selected for this objective.Data not available.
FOOTNOTES
Increase in disparity (percentage points)
10–49 points 50–99 points
Decrease in disparity (percentage points)
10–49 points 50–99 points
See DATA2010 at http://wonder.cdc.gov/data2010 for all Healthy People 2010 tracking data. Disparity data are either unavailable or not applicable for objectives 28-11a through 
c.
Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (e.g., race and 
ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at baseline from the 
disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary index at the most recent data 
point. See Technical Appendix for more information.
Years in parentheses represent the baseline and most recent data years (if available).
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
Most favorable group rate for 
specified characteristic, but reliability 
criterion not met.
Baseline data by race and ethnicity are for 1999.
Data are for Mexican American.
For this objective, only activity limitations are considered as disabilities.
10%–49% 50%–99%
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage points and 
estimates of variability were not available. See Technical Appendix.
Measures of variability were available. Thus, the variability of best group rates was assessed, and statistical significance was tested. Disparities of 10% or more are displayed 
when the differences from the best group rate are statistically significant at the 0.05 level. Changes in disparities over time are indicated by arrows when the changes are greater 
than or equal to 10 percentage points and are statistically significant at the 0.05 level. See Technical Appendix.
Measures of variability were not available. Thus, the variability of best group rates was not assessed, and statistical significance could not be tested. Nonetheless, disparities and 
changes in disparities over time are displayed according to their magnitude. See Technical Appendix.
The group with the best rate at the most recent data point is different from the group with the best rate at baseline. Both rates met the reliability criterion. See Technical 
Appendix.
100% or 
more
100 points 
or more
100 points 
or more
Change in the summary index cannot be assessed. See Technical Appendix.
Disparity from the best group rate at the most 
recent data point.
Reliability criterion for best group rate not met, or data available for only one group, at baseline. Change in disparity cannot be assessed. See Technical Appendix.
A reformatted, typeset version of this report will replace the current version 
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Appendix A: Technical Appendix 
This appendix provides additional information on a number of issues related to monitoring 
progress in Healthy People 2010. 
 Measuring progress toward target attainment—procedures used to measure 
progress toward the targets for Healthy People 2010 objectives. 
 Measuring quality and years of healthy life—procedures used to measure quality 
and years of healthy life in connection with the first goal of Healthy People 2010. 
 Measuring health disparities—procedures used to measure and track health 
disparities among select population groups in connection with the second goal of 
Healthy People 2010. 
 Mapping—procedures used for mapping select Healthy People 2010 objectives. 
 DATA2010—the online database for Healthy People 2010 objectives. 
 General Data Issues—the guide to measurement issues in Healthy People 2010. 
 Tracking Period—a note on how an objective’s tracking period is defined in the 
Healthy People 2010 Final Review. 
 
Measuring Progress toward Target Attainment  
Progress toward the Healthy People 2010 targets at Final Review is shown in a Progress 
Chart (labeled Figure 1 in each Focus Area chapter). This chart displays the percent of 
targeted change that has been achieved for each objective. 
 
Percent of Targeted Change Achieved 
Targeted change is the difference between the baseline and the Healthy People 2010 
(HP2010) target. The formula for the percent of targeted change achieved is as follows: 
 ercent o  targeted change achieved  
 ina  va  e    ase ine va  e
       target    ase ine va  e
      
The percent of targeted change achieved expresses the difference between the baseline and 
the final value as a percent of the initial difference between the baseline and the Healthy 
People 2010 target. As such, it is a relative measure of progress toward attaining the 
Healthy People 2010 target. In addition, the comparability of the percent of targeted change 
achieved does not depend on whether the underlying objective is expressed in terms of 
adverse or favorable events or conditions; see Measuring Health Disparities section, below. 
The percent of targeted change achieved was also used to monitor progress in Healthy 
People 2000 and was previously referred to as the progress quotient [1,2]. 
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Baseline data values were published at the beginning of the decade for Healthy People 2010 
objectives for which data were available [3]. Baseline data for additional objectives have 
become available since the publication of Healthy People 2010 [4]. Data beyond the baseline 
are available for about 76 percent of the objectives in Healthy People 2010. 
 
Example A-1 
School-based objective 7-2c in Healthy People 2010 called for an increase in the proportion 
of middle/junior and senior high schools that provide education to prevent violence, from a 
baseline of 58 percent in 1994 to a target of 80 percent by 2010. In 2006, 77 percent of 
schools provided education to prevent violence, see Figure 7-1 in the Focus Area 7 chapter. 
Using the formula above, 86.4 percent of the targeted change from the 1994 baseline to the 
Healthy People 2010 target was achieved in 2006. Indeed, 
 ercent o  targeted change achieved  
       
       
      
  
  
                    
 
For population-based objectives, the percent of targeted change achieved also can be used 
to measure progress toward the Healthy People 2010 target for each population group with 
data beyond the baseline. 
Example A-2 
The Healthy People 2010 target for objective 16-1c was to reduce the infant death rate to 
4.5 deaths per 1,000 live births by 2010. For the total population, the 1998 baseline rate 
was 7.2 infant deaths per 1,000 live births, while that for the year 2006 was 6.7 infant 
deaths per 1,000 live births, see Figure 16-1 in the Focus Area 16 chapter. When the 
formula above is applied, 18.5 percent of the targeted change from the 1998 baseline to the 
Healthy People 2010 target was achieved in 2006: 
 ercent o  targeted change achieved  
         
         
      
    
    
                    
In contrast, among infants of Asian or Pacific Islander mothers, the infant death rate 
declined from 5.5 deaths per 1,000 live births at baseline to 4.5 deaths per 1,000 live births 
in 2006. Using the formula above, 100 percent of the targeted change from the 1998 
baseline to the Healthy People 2010 target was achieved in 2006: 
 ercent o  targeted change achieved  
         
         
      
    
    
                   
Thus, the Healthy People 2010 target was met for the Asian or Pacific Islander group in 
2006, while, overall, the population only achieved 18.5 percent of the targeted change. 
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Limitations 
In addition to assessing differentials in progress toward target attainment within the 
population, the percent of targeted change achieved may be used to compare how much of 
the targeted change was achieved for an objective relative to other objectives, though care 
must be exercised in its interpretation. Generally speaking, the reader is advised to keep the 
following points in mind: 
 The percent of targeted change achieved is calculated using only the Healthy People 
2010 target, baseline, and final data points. Fluctuations that may occur during the 
intervening years are not considered, even though they may be substantial. 
 The number of years between the baseline and final data points for Healthy People 
2010 might vary both between objectives and within objectives. 
 Between objectives, differences in the number of years available to meet 
targets are a function of the data sources and any choices that were made 
regarding the most appropriate baseline year for each objective. 
 To assist the reader in the interpretation of these comparisons, the 
baseline and final data years used for each objective are shown in 
parentheses following the short descriptions in the left-most panel of 
the Progress Chart for each Focus Area. 
 Within objectives, differences in the number of years available to meet 
Healthy People 2010 targets for specific groups within the population can be 
affected by changes in the data templates used to classify the population 
(e.g., by race and ethnicity) during the tracking period. 
 The period used to compute the percent of targeted change achieved 
will generally be consistent with that used to estimate disparities, 
see the Measuring Health Disparities section below for more details. 
 The (absolute) value of the Healthy People 2010 targeted change from baseline 
might vary among select populations or across objectives with identical values for 
the percent of targeted change achieved. Therefore, two objectives may be identical 
in their percent of targeted change achieved, even though they differ in the 
magnitude of the change. See Example A-3 below. 
 
Example A-3. Objective 7-4b in Healthy People 2010 called for 50 percent of senior high 
schools to attain a nurse-to-student ratio of at least 1:750 by year 2010, while objective 7-
4d called for 48 percent of elementary school to achieve that same nurse-to-student ratio by 
year 2010. The 1994 baseline data point for senior high schools was 26 percent, thus the 
absolute value of the targeted change for objective 7-4b was 24 percentage points. On the 
other hand, the 2000 baseline data point for elementary schools was 42 percent, resulting 
in a targeted change of only 6 percentage points. In 2006, 38 percent of senior high schools 
and 45 percent of elementary schools had attained the desired nurse-to-student ratio. As a 
result, both objectives achieved 50 percent of their targeted change—12 of the targeted 24 
percentage points for objective 7-4b, and 3 of the targeted 6 percentage points for objective 
7-4d—even though they differed in the magnitude of the change. See Figure 7-1 in the Focus 
Area 7 chapter. 
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In addition to the above limitations, there are a number of cases in which the percent of 
targeted change achieved cannot be calculated or does not adequately reflect change in an 
objective. Five hypothetical scenarios are presented below  or the reader’s consideration, 
further illustrating the care that must be exercised in the interpretation of the percent of 
targeted change achieved in Healthy People 2010. 
 
Scenario 1: Target met at baseline, movement in a positive direction 
Target = 5; Baseline value = 5; Final value = 4. 
 ercent o  targeted change achieved  
     
     
      
  
 
                  
Cannot divide by 0. 
 
Scenario 2: Target met at baseline, movement in a negative direction: 
Target = 0; Baseline value = 0; Final value = 2. 
 ercent o  targeted change achieved  
     
     
      
 
 
                 
Cannot divide by 0. 
 
Scenario 3: Target exceeded at baseline—further progress beyond target: 
Target = 30; Baseline value = 35; Final value = 40. 
 ercent o  targeted change achieved  
       
       
      
 
  
                    
Here, progress has been made, but the percent of targeted change achieved appears to 
indicate movement away from the target. 
 
Scenario 4: Target exceeded at baseline—movement in a negative direction 
Target = 30; Baseline value = 35; Final value = 25. 
 ercent o  targeted change achieved  
       
       
      
   
  
                   
Here, progress has not been made, but the percent of targeted change achieved appears to 
indicate the target has been exceeded. 
In the Progress Chart (Figure 1 for each Focus Area chapter), objectives as in scenarios 1 
and 3 above are shown with arrows in the positive direction, with “   +%” indicating that 
the target has been exceeded. Those as in scenarios 2 and 4 are shown with arrows in the 
negative direction. In all cases, footnotes indicate the precise amount cannot be calculated. 
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Finally, when the targeted amount of change is small relative to the actual amount of 
observed change, the percent of targeted change achieved can have relatively large values 
that are difficult to interpret. Furthermore, the reader should be aware that target setting 
has a sizeable impact on the measure of progress toward target attainment used in Healthy 
People 2010. This phenomenon is illustrated in the following hypothetical scenario. 
 
Scenario 5: Target set closer to baseline—movement in a negative direction 
Consider: Target = 30; Baseline value = 50; Final value = 70. 
 ercent o  targeted change achieved  
       
       
      
  
   
                    
Compare to: Target = 40; Baseline value = 50; Final value = 70. 
 ercent o  targeted change achieved  
       
       
      
  
   
                    
In both cases, progress has not been made, the final value having exceeded the baseline 
value by 20 points. Yet, a target of 30 having been set closer to the baseline value than a 
target of 40, the percent of targeted change achieved appears to indicate a worse scenario in 
the second case than in the first, even though the difference between the baseline and final 
values remains unchanged. 
In order to circumvent the difficulty in interpretation that arises for objectives like in 
scenario 5 above, movement away from the Healthy People 2010 target is not quantified 
using the percent of targeted change achieved in the Progress Chart (see footnote 1 for 
Figure 1 in each of the Focus Area chapters) for the Final Review. Instead, for such 
objectives, the reader is urged to examine the difference between the baseline and final 
values to assess progress. 
 
Testing for Trends 
As stated in the limitations section above, the percent of targeted change achieved is 
calculated using only the Healthy People 2010 target, baseline, and final data points. 
Fluctuations that may occur during the intervening years are not considered, even though 
they may be substantial. In addition, the number of years between the baseline and final 
data points for Healthy People 2010 might vary both between objectives and within 
objectives. 
Nonetheless, the presence of a monotonic increasing or decreasing trend in the underlying 
measure can be tested with the nonparametric Mann-Kendall test, and the slope of a linear 
trend estimated with the nonparametric Sen’s method [5]. 
The Mann-Kendall test is suitable for cases where the trend may be assumed to be 
monotonic, and thus where no seasonal or other cycle is present in the data. 
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The Sen’s method  ses a  inear mode  to estimate the s ope o  the trend when the variance 
of the residuals may be assumed constant in time. Missing values are allowed and the data 
need not con orm to any partic  ar distrib tion  A so, the Sen’s method is not greatly 
affected by single data errors or outliers. 
When the n mber o  data points is  ess than   , Sen’s S statistic can be used. When the 
number of data points is 10 or more, a normal approximation holds, and a Z statistic can be 
used instead. 
Results of the trend tests described above are used in the Highlights section of select Focus 
Area chapters—namely, chapters 6, 10, 13, 15, and 20—in order to supplement findings on 
progress toward achieving Healthy People 2010 targets during the decade. 
 
Measuring Quality and Years of Healthy Life 
Goal 1 of Healthy People 2010 is to increase the quality and length of healthy life-years. This 
goal is tracked with three summary measures of health that belong to the family of 
meas res ca  ed “hea thy  i e expectancy ” The three summary measures are: 
1) Expected years of life in good or better health, 
2) Expected years of life free of activity limitation, and 
3) Expected years of life free of selected chronic diseases. 
These healthy life expectancy measures are given in life-years, which indicate the average 
number of healthy years a person can expect to live if age-specific death rates and age-
specific illness rates remain the same throughout his or her lifetime. Thus, healthy life 
expectancy is a “snapshot” o  c rrent death and i  ness patterns and can i   strate the  ong-
range implications of the prevailing age-specific death and illness rates. The methods used 
to create the healthy life expectancy measures are described next. 
 
Methods 
The healthy life expectancies used in the Final Review publication are calculated using a 
double-decrement life table technique, based on the Sullivan method [6,7]. A traditional life 
table presents what would happen to a hypothetical cohort if it experienced exactly the 
same age-specific death rates during a given period of time [8]. A double-decrement life 
table analyzes what would happen to a hypothetical cohort if it experienced exactly the 
same age-specific death and age-specific illness rates during a given period of time. 
Although it is possible to create life tables based on single years of age, this analysis uses an 
abridged life table, with age intervals of five years. 
To produce healthy life expectancies, age-specific death rates are combined with age-
specific health prevalence rates to produce an estimate of overall healthy life expectancy 
[9]. 
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The life table includes the following quantities: 
 qx—probability of dying—This column shows the probability of dying during the age 
interval. It is derived from death rates for a given year. 
 lx—number surviving—This column shows the number of persons from birth 
surviving to the beginning of the next age interval. The life table typically begins 
with a population at birth of 100,000, called the radix. 
 dx—number dying—This column shows the number of deaths in each age interval 
out of the original 100,000 births. It is calculated by multiplying the qx for the age 
interval by the lx for the same age interval. 
 Lx—person-years lived—This column shows the total time lived (in years) within the 
age interval by all of those who have survived to the beginning of the age interval. 
 Tx—total number of person-years lived—This column shows the total number of 
person-years lived that would be lived after the beginning of the age interval. 
 Ex—expectation of life—This column shows the average number of years remaining 
to be lived by those surviving to the age interval. It is derived by dividing the total 
number of person-years lived at the age interval and above by the number surviving 
to the beginning of the age interval (Tx/lx). 
Life tables used to calculate healthy life expectancy include all of the quantities described 
above in addition to the following quantities regarding illness: 
 Px—age-specific illness rate—This column shows the percentage of persons in the 
age interval in a given poor health state. 
 Px × Lx—Healthy person-years lived—This column shows the number of healthy 
person-years lived during the age interval. This number is derived by multiplying 
the age-specific illness rate by the corresponding number of person-years lived 
during the age interval (Lx). 
 THx—Total number of healthy person-years lived—This column shows the total 
number of healthy person-years that would be lived after the age interval. 
 HLEx—Expectation of healthy life—The expectation of healthy life is the average 
number of years in good health remaining for those surviving to a given age with a 
given set of age-specific death rates and age-specific illness rates. It is derived by 
dividing the total healthy person-years that would be lived at age x by the total 
number of persons who survived to that age interval (THx/lx). 
The use of healthy life expectancies enables comparisons across populations, as well as over 
long periods of time. The use of the Sullivan method for estimating healthy life expectancies 
is most appropriate for the cross-sectional data used to track Healthy People 2010 [10]. 
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Data Systems 
Analyses are based on 2000 01 (2002 03 for chronic conditions) and 2006 07 death data 
from the National Vital Statistics System (NVSS) and 2000 01 (2002 03 for chronic 
conditions) and 2006 07 health data from the National Health Interview Survey (NHIS).  
NHIS is a nationally representative continuing cross-sectional survey, which provides a 
“snapshot” o  the health of the U.S. population. Approximately 35,000 households are 
interviewed each year. NVSS is a complete registration of all vital events and includes 
detailed data on all of the deaths that occur within the U.S. 
These data systems are used for the study of healthy life expectancy because they contain 
detailed information on health and death. However, the institutionalized population is 
excluded from the NHIS sample. Because the institutionalized population is more likely to 
report poor health, the Healthy People 2010 healthy life expectancy measures might 
underestimate the effect of poor health on healthy life expectancies. 
 
Survey Questions 
Self-rated health status is measured by the single question from NHIS that asked 
respondents to rate their hea th as “exce  ent,” “very good,” “good,” “ air,” or “poor ”  or the 
purpose of determining Healthy People 2010 healthy life expectancy, a respondent was 
considered to be in poor health if he or she answered “ air” or “poor ” This self-assessed 
health rating was shown to be a  se    indicator o  one’s hea th  or a variety of populations 
and allows for broad comparisons across different conditions and populations [11]. The 
measure also is included in the Behavioral Risk Factor Surveillance Survey, the National 
Health and Nutrition Examination Survey, and other health surveys. 
Activity limitation is measured using questions about personal care needs, limitations of 
activities, and use of special equipment. Adults were asked whether they needed assistance 
with personal care needs, such as eating, bathing, dressing, or getting around inside the 
home; whether they needed assistance with routine care needs, such as household chores; 
and whether they had a mental or physical problem that kept them from working at a job or 
limits their activity in any way. They also were asked whether they had health problems 
that required the use of special equipment, such as a cane, wheelchair, or special telephone. 
If a respondent answered “yes” to any of these questions, he or she was classified as having 
activity limitations. Children were considered limited in activity if the proxy adult 
respondent responded “yes” to any o  the  imitation, specia  services, or specia  eq ipment 
questions that were specific to children. 
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Selected chronic disease prevalence is measured by several questions that asked 
respondents whether a doctor had ever diagnosed them with a given disease. The list of 
selected chronic diseases represented those chronic diseases that were included in Healthy 
People 2010 and NHIS: heart disease, stroke, cancer, diabetes, hypertension, kidney disease, 
arthritis, and asthma. If a respondent answered “yes” to any o  the se ected diagnoses, he or 
she was classified as having a chronic disease. Ideally such a healthy life expectancy would 
adjust for severity of disease. However, NHIS does not collect data on the severity of the 
disease. The primary limitation of this measure is that it is restricted to diseases noted 
above. Thus, it underestimates the contribution of chronic disease to healthy life expectancy 
because other chronic conditions, especially chronic mental health conditions, are not 
included. 
 
Healthy People 2000 
The 2010 healthy life expectancy measures differ from the measure used for Goal 1 of 
Healthy People 2000. The Healthy People 2000 measure combined information about death, 
self-rated health, and activity limitations into a single measure known as years of healthy 
life [12]. For Healthy People 2010, these illness components have been separated into 
distinct measures. This strategy allows for greater ease in interpreting change and 
determining the mechanisms of change. The same double-decrement life table technique 
used in Healthy People 2000 is used to create the healthy life expectancy measures for 
Healthy People 2010. 
 
Limitations 
Healthy life expectancy is computed using the Sullivan method, the standard method for 
computing healthy life expectancy on a routine basis. Although the Sullivan method 
accurately depicts the c rrent stat s o  the pop  ation’s hea th, it does not re  ect the 
underlying transitions into and out of poor health states. In other words, the Sullivan 
method assumes that if a respondent reports an activity limitation at a given point in time, 
that respondent is limited in activities for the rest of his or her life. However, as the 
underlying disease processes have episodic fluctuations of deterioration and improvement 
over time, poor health states will also fluctuate. For example, a person diagnosed with 
functional limitations due to severe arthritis may take medication and experience better 
health states in the future, however, the Sullivan method does not account for future years 
of good health for such a person. 
In addition, the Sullivan method can be biased when evaluating trends over a short period 
of time. Biases in trends of healthy life expectancy can occur if there are fluctuations in 
health over a short time period. The Sullivan method is less likely to give misleading 
estimates of trends in healthy life expectancy when changes in death rates and health status 
rates are smooth and relatively even. 
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Future Plans 
Goal 1 of Healthy People 2010 challenged the Nation increase quality and years of healthy 
life. Identifying the best approaches for measuring quality and years of healthy life is an 
evolving field. Future research will build upon these initial measures of healthy life 
expectancy. It would be desirable to include measures that account for the contribution of 
mental health status to quality of life and other health variables. In addition, the Healthy 
People 2010 healthy life expectancy measures are expected to be expanded to include 
expected years of life with good health behaviors in Healthy People 2020. 
 
Measuring Health Disparities 
The second overarching goal of Healthy People 2010 calls for eliminating health disparities 
among segments of the population, including differences that occur by race or ethnicity, sex, 
education or income, geographic location, disability, or sexual orientation [3]. These 
characteristics are applicable to objectives that measure aspects of the health of the 
population and do not apply to objectives that are based on schools, worksites, states, or 
other units of measures that are not population-based. The Health Disparities Table (Figure 
2 in each of the Focus Area chapters) summarizes information about disparities from the 
best group rate for each of a selected set of population characteristics at the most recent 
data point, and changes in disparities from the baseline to the most recent data point. 
The methods used to create the Health Disparities Table are described below. The rationale 
for methods employed in measuring disparity in Healthy People 2010 was provided in a 
previous report [13]. The “Goa   : E iminate ea th Disparities” section in the Healthy 
People 2010 Final Review Executive Summary presents key findings concerning disparities. 
 
Measuring Objectives and Defining Groups 
Technical information (i.e., Operational Definitions) concerning the measurement of each 
objective and the classification of the population characteristics employed in monitoring the 
objectives is provided in Tracking Healthy People 2010 [14]. The original classification of 
racial and ethnic groups shown in Healthy People 2010 was altered based on revisions to the 
standards for the classification of Federal data on race and ethnicity that were published by 
the Office of Management and Budget in 1997 [3,15]. These standards permit each person 
to identify either with only one race or with more than one race. The race and ethnicity 
categories used to monitor the Healthy People 2010 population-based objectives were 
modified accordingly, resulting in the following categories: 
 American Indian or Alaska Native 
 Asian 
 Native Hawaiian or other Pacific Islander 
 Black or African American 
Appendix A  Page A-11 
 White 
 Two or more races 
 American Indian or Alaska Native; White 
 Black or African American; White 
 Hispanic or Latino 
 Not Hispanic or Latino 
 Black or African American 
 White 
Federal data systems have been revising their collection and tabulation procedures to 
comply with the new standards on racial and ethnic identification. Some data systems 
began reporting data for calendar year 1999 using the new standards, and most of the 
remaining systems have adopted the new standards since then. However, some data 
systems are still in the process of adopting the revised standards, so the availability of 
comparable data for racial and ethnic groups varies by data source and across objectives. 
In the Healthy People 2010 Final Review, seven racial and ethnic groups are shown in the 
Health Disparities Table (Figure 2 in each of the Focus Area chapters): American Indian or 
Alaska Native; Asian; Native Hawaiian or other Pacific Islander; two or more races; 
Hispanic; white, not Hispanic; and black, not Hispanic. The first four groups might also 
include small numbers of persons of Hispanic origin. The data systems used to track the 
population-based objectives in Healthy People 2010 might not provide data for all of these 
groups. Departures from the above categories are footnoted in the Health Disparities Table. 
To maintain comparability of data by race and ethnicity over time for some objectives, a 
more recent data year might be used as the baseline because of the revised standards [15]. 
NHIS, for example, began reporting data according to the new racial and ethnic categories in 
1999. Although the baseline year for objectives tracked with NHIS might be 1997 or 1998, 
data for 1999 are employed as the baseline for measuring disparities for race and ethnicity 
data only. These departures are indicated by footnotes in the Health Disparities Table. 
Education and income are the primary measures of socioeconomic status (SES) in Healthy 
People 2010. Most data systems sed in ea thy  eop e      de ine income as a  ami y’s 
income before taxes. In order to facilitate comparisons among groups and over time, while 
adjusting for family size and for inflation, Healthy People 2010 categorizes income using the 
poverty thresholds developed by the U.S. Census Bureau. Thus, the three categories of 
family income that are primarily used are: 
 Poor—below the Federal poverty level 
 Near poor—100% to 199% of the Federal poverty level 
 Middle/high income—200% or more of the Federal poverty level. 
These categories may be overridden by considerations specific to the data system, in which 
case they are modified as appropriate. See Healthy People 2010: General Data Issues [16]. 
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Availability of Data 
The data used to monitor the Healthy People 2010 objectives come from a wide variety of 
data systems. Data for a particular population group might not be available because they are 
not collected by the data system, because they have been collected but not analyzed, or 
because they have been suppressed. Data are suppressed when the number of events is too 
small to produce statistically reliable estimates, when disclosure might violate 
confidentiality requirements, when the sample design does not produce representative 
estimates for a particular group, or when there is high item nonresponse or a large number 
o  “ nknown” entries  Criteria for data suppression for the data systems included in Healthy 
People 2010 are published in a previous report [17]. 
 
Content of the Health Disparities Table 
The Health Disparities Table (Figure 2 in each of the Focus Area chapters) provides 
information about disparities between groups for the population-based objectives in each 
Focus Area. Short descriptions of the population-based objectives are listed along the left-
most column of the table. The baseline data year(s) is (are) shown in parentheses and, when 
more recent data are available, the most recent data year(s) is (are) also shown. The 
description of an objective generally also includes in parentheses any applicable 
information regarding the underlying measure (e.g., measurement unit) and/or the age of 
the targeted population. 
Characteristics of the population (race and ethnicity, sex, education, income, geographic 
location, and disability status) are listed across the top of the Health Disparities Table. In 
general, characteristics applicable to each objective were designated in the original Healthy 
People 2010 document [3]. Race and ethnicity, sex, and education or income are available 
and included for most objectives; geographic location and disability status are included only 
if applicable and/or available. 
Characteristics that were not designated for a particular objective are shaded in dark gray. 
When a characteristic is not applicable for any of the objectives in a Focus Area, it is omitted 
from the Health Disparities Table for that Focus Area. When data are not available for a 
particular population or for a particular characteristic, the corresponding boxes are shaded 
in light gray (see the fourth section of the legend reproduced in Figure A-1 below). If there 
are no characteristic-specific data available for an objective, or if it is not population-based, 
the objective is excluded from the table and annotated in the notes. In some cases, the data 
source for an objective provides data for groups that are defined in nonstandard ways. For 
example, some data sources provide data for the black and white populations that include 
persons of Hispanic origin. These departures from the standardized template used to 
monitor the Healthy People 2010 population-based objectives are indicated by footnotes in 
the Health Disparities Table. 
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Measuring Disparity from the Best Group Rate 
Definition. Disparity from the best group rate is defined as the percent difference between 
the best group rate and each of the other group rates for a characteristic. 
For example, health disparities by race and ethnicity are measured as the percent difference 
between the best racial and ethnic group rate and each of the other racial and ethnic group 
rates. Similarly, disparities by sex are measured as the percent difference between the 
better group rate (e.g., female) and the rate for the other group (e.g., male). 
Formula. The formula for disparity from the best group rate for a group G is as follows: 
Disparity  or gro p G  
       
  
      
where RB is the best group rate and RG is the rate for group G for a particular characteristic. 
Note. In computing disparities, the Healthy People 2010 Final Review uses the display 
values for rates, proportions, and other estimates in DATA2010. Those are typically 
rounded to the nearest whole number or to at most one decimal place, see section on 
DATA2010 below. As a result, the best group rate RB may in some rare instances be 
displayed as zero and subsequently treated as a zero in the above formula, resulting in an 
undefined division by zero. In order to avoid such an artificial situation, a small continuity 
correction is applied so as to always enable a meaningful calculation of disparities relative 
to the best group rate. 
Some Healthy People 2010 objectives are expressed in terms of favorable events or 
conditions that are to be increased, while others are expressed in terms of adverse events 
or conditions that are to be reduced. In order to facilitate comparison of disparities across 
different objectives, disparity is measured only in terms of adverse events or conditions in 
Healthy People 2010 [1]. Those dichotomous objectives that are expressed in terms of 
favorable events or conditions are re-expressed using the adverse event or condition for the 
purpose of computing disparity [12,18,19], but they are not otherwise restated or changed. 
Example. Healthy People 2010 objective 1-1, to increase the proportion of persons with 
health insurance (e.g., 72% of the American Indian or Alaska Native population aged under 
65 years had health insurance in 2008), is expressed in terms of the percentage of persons 
without health insurance (e.g., 100%-72%=28% of the American Indian or Alaska Native 
population aged under 65 years did not have health insurance in 2008) when the disparity 
from the best group rate is calculated. 
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Special cases. Healthy People 2010 objectives 26-9a, 26-9b, and 27-4a, aim to increase 
the (average) age at first use of alcohol, marijuana, and tobacco, respectively, among 
adolescents aged 12 17 years. In order to facilitate comparison of disparities across 
different objectives, those three objectives are re-expressed using an adverse condition, as 
follows: decrease the (average) number of years between the (average) age at first use and 
age 18 years. Similarly, objective 27-4b aims to increase the (average) age at first use of 
tobacco among young adults aged 18 25 years. This objective is re-expressed as follows: 
decrease the (average) number of years between the (average) age at first use and age 26 
years. Finally, objective 16-16b aims to increase the median red blood cell (RBC) folate level 
among nonpregnant women aged 15 44 years. The underlying measure for this objective is 
a continuous measure which does not have a known upper limit. Nonetheless, an 
approximate upper limit is given by the 97.5th percentile of RBC folate concentration among 
women aged 20 59 years, estimated at 596 ng/mL [20]. Thus, objective 16-16b can be re-
expressed using an adverse measure by subtracting the aggregate median RBC folate level 
for each population group from the value 596 ng/mL.  or the reader’s re erence, among the 
population groups considered in the Health Disparities Table, the population group with the 
highest median RBC folate level was the group with at least some college education, with an 
aggregate median RBC folate level of 267 ng/mL in 2005 06. 
As a result of measuring disparity only in terms of adverse events or conditions, the group 
identified as having the best rate for a given characteristic in the Health Disparities Table is 
always the group with the least adverse event or condition. Thus, disparities defined by the 
above formula remain nonnegative quantities, equal zero only when the group G for which 
disparity is being assessed has rate equal to the best group rate. 
In the few instances when two groups for a characteristic have identical best rates, both 
gro ps are identi ied by a “B.” To ensure that disparity is measured from a reasonably 
stable data point, the most favorable group rate must have a relative standard error of less 
than 10 percent. When the relative standard error for the most favorable group rate is 
greater than or eq a  to    percent, a sma    etter “b” is inc  ded in the ce   and the next 
most favorable group rate with a relative standard error of less than 10 percent is identified 
as the reference group for that characteristic. Disparities are not calculated for cells 
identi ied by a sma    etter “b.” When there is only one group with a relative standard error 
of less than 10 percent, a best group is not identified for purposes of measuring disparity, 
and the cells for all groups with data are blank, indicating that disparities could not be 
assessed. The first section of the legend for the Health Disparities Table (reproduced, here, 
in Figure A-1) addresses the identification of the best group rate for each characteristic. 
When standard errors are not available, the best group is determined by the most favorable 
rate, see section on Estimates of Variability below. 
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Figure A-1. Legend for the Health Disparities Table (Figure 2) in each of the Focus Area chapters 
 
 
 
B b
1 2 3 4
u1 u2 u3
d1 d2 d3
Availability of Data NA NS
100% or more
Most favorable group rate for specified 
characteristic, but reliability criterion not met.
Reliability criterion for best 
group rate not met, or data 
available for only one group.
100 points or 
more
Decrease in disparity (percentage points)
10–49 points 50–99 points
Data not available. Characteristic not selected for this objective.
Changes in disparity over time are shown when: 
(a) disparities data are available at both baseline and most recent time points; 
(b) data are not for the group(s) indicated by "B" or "b" at either time point; and 
(c) the change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage points 
and estimates of variability were not available. See Technical Appendix.
Increase in disparity (percentage points)
10–49 points 50–99 points
LEGEND
The "best" group rate at the most 
recent data point.
The group with the best rate for 
specified characteristic.
100 points or 
more
Percent difference from the best group rate
Disparity from the best group rate at 
the most recent data point.
Less than 10%, or difference not 
statistically significant (when 
estimates of variability are available).
10%–49% 50%–99%
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Representing the Size of Health Disparities by a Color Gradient 
In the Health Disparities Table, a color gradient is used to represent the size of the 
disparities (i.e., the percent differences between each group rate and the best group rate) at 
the most recent data point. In some cases, baseline data might be the only data available. 
The color gradient is shown in the second section of the legend, see Figure A-1. 
When measures of variability (i.e., standard errors) are available, the variability of best 
group rates is assessed, and statistical significance is tested. For a group G within a given 
characteristic, a disparity of 10% or more is displayed when the (simple) difference from 
the best group rate (i.e., RG – RB) is statistically significant at the 0.05 level (see Figure A-1): 
 The lightest color in the color gradient indicates a group with a disparity < 10% 
from the best group rate. When measures of variability are available, the lightest 
color in the color gradient also indicates disparities for which the difference RG – RB 
is not statistically significant at the 0.05 level. 
 The darkest color in the color gradient indicates a group with a disparity ≥    % 
and, when measures of variability are available, a difference RG – RB from the best 
group rate that is statistically significant. 
 The two intermediate colors in the color gradient indicate groups with a disparity of 
10%−49% and groups with a disparity of 50%−99%. 
The statistical significance of the (simple) difference RG – RB between groups can be 
assessed using the following Z-statistic: 
   
       
√   
      
 
   
where RG is the rate for a group G of interest, RB is the rate for the best group, SEG is the 
standard error of the rate for group G, and SEB is the standard error of the best group rate. 
This formula assumes that the two groups are independent. Because, as mentioned earlier, 
the difference RG – RB remains nonnegative, a one-tailed test is employed to assess statistical 
significance. When Z ≥1.645, the difference RG – RB between the two group rates is 
statistically significant at the 0.05 level. When the (simple) difference RG – RB between the 
two group rates is significant, the disparity for group G relative to the best group rate is 
considered significant. 
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Changes in Health Disparities over Time 
When data beyond the baseline are available, change in disparity over time is estimated by 
subtracting the disparity at baseline from the disparity at the most recent data point. The 
change is expressed in percentage points: positive differences represent an increase in 
disparity, and negative differences represent a decrease in disparity. See the third section of 
the legend reproduced in Figure A-1. 
Changes in disparity over time are shown when: 
a) Disparities data are available at both baseline and most recent time points; 
b) Data are neither for the group(s) with the best rate for the specified characteristic, 
nor for the group(s) with the most favorable rate but for which the reliability 
criterion was not met, at either time point; and  
c) The change is greater than or equal to 10 percentage points and statistically 
significant, or when the change is greater than or equal to 10 percentage points and 
estimates of variability are not available. 
When standard errors are available for a data system, only statistically significant changes 
in disparities of 10 percentage points or more between the baseline and the most recent 
data points are indicated with arrows, see Figure A-1. Several steps are required to evaluate 
the statistical significance of a change in disparities over time. 
Step 1. The disparity or percent difference (PD) from the best group rate at each time point 
is based on the ratio of the simple difference SD = RG – RB between the rate for the group of 
interest and the best group rate to the best group rate RB: 
Disparity  or gro p G  
  
  
      
Step 2. The relative standard error (RSE) of the above ratio is computed based on the RSE 
of the numerator and the denominator. The RSE for the numerator SD is calculated as: 
      
√   
      
 
       
   
where SEG is the standard error of the rate for a group G of interest, SEB is the standard 
error for the best rate, RG is the rate for group G, and RB is the best group rate. 
Step 3. The RSE of the best group rate in the denominator of the above ratio is given by 
     
   
  
   
Step 4. An approximate relative standard error RSEPD for the disparity or percent 
difference (PD) is computed via the so-ca  ed “De ta Method”—a first-order Taylor series 
linearization of the variance of the ratio of two random variables [21]—using the 
numerator RSE (from step 2) and the denominator RSE (from step 3): 
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      √     
       
    
This first-order linearization assumes the simple difference SD = RG – RB between the rate RG 
for the group G of interest and the best group rate RB is independent of the best group rate. 
Step 5. An approximate standard error SEPD for the percent difference (PD) is given by: 
                 
Step 6. The statistical significance of a change in disparity or percent difference from the 
best group rate over time at the 0.05 level is assessed using the following Z-statistic: 
   
         
√      
         
 
   
where PD1 is the percent difference at the most recent time point, PD0 is the percent 
difference at baseline, SEPD,1 is the standard error of the percent difference at the most 
recent time, and SEPD,0 is the standard error of the percent difference at baseline. 
Note. Because of the various assumptions involved in deriving an approximate standard 
error SEPD for the percent difference in step 5 above, and because an alternative, more 
direct method for testing statistical significance is available for the simple difference RG – RB 
between the two group rates, the standard error SEPD is not used for assessing the 
significance of disparities at each data point. As explained earlier, when the simple 
difference RG – RB between the two group rates is statistically significant, the disparity for 
group G relative to the best group rate (i.e., the percent difference) is considered significant. 
When measures of variability are not available, the variability of best group rates is not 
assessed, and statistical significance cannot be tested. Nonetheless, disparities and changes 
in disparities over time are displayed according to their magnitude. This is usually indicated 
in the footnotes of the Health Disparities Tab e by a †  ootnote  See also the Estimates of 
Variability section below for more information. 
When measures of variability are available only for the most recent data, the variability of 
best group rates is assessed only for the most recent data, and statistical significance is 
tested only for the most recent data. Changes in disparities of 10 percentage points or more 
over time are displayed according to their magnitude, since measures of variability are not 
available at baseline and therefore statistical significance of changes in disparity could not 
be tested. This is usually indicated in the footnotes of the Health Disparities Tab e by a ‡ 
footnote. See also the Estimates of Variability section below for more information. 
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Summary Measures 
Disparities are measured as percent differences between the best group rate and other 
group rates for a given population characteristic. When more than two groups are 
associated with that characteristic, such as race and ethnicity, income, and education, a 
summary index provides a way to determine whether, on average, disparities from the best 
group rate are increasing or decreasing. The formula for the summary index, also known as 
the index of disparity [22], is: 
               
∑    
   
   
   
   
where PDG is the nonnegative—possibly zero—disparity (i.e., percent difference) from the 
best group rate for each of the groups of interest (G = 1,2,… n), and n is the number of 
groups. Because the disparities are calculated with the best group rate as the reference 
point, the number of comparisons is equal to the number of groups minus one. These 
comparisons are made only when data are available for the same groups defined in the 
same way at the baseline and most recent data points. 
Note. As explained previously, when the relative standard error for the most favorable 
group rate is greater than or equal to 10 percent, that group is flagged using a small letter 
“b” in the Health Disparities Table, and the next most favorable group rate with a relative 
standard error of less than 10 percent is identified as the reference group for that 
characteristic and   agged  sing a capita   etter “  ” As a res  t, the observed disparity or 
percent difference from the best group rate for a group that is   agged with a sma    etter “b” 
becomes negative, since its observed rate is better than the best rate identified. Thus, all 
s ch gro ps with a “b” m st be exc  ded  rom the calculation of the summary index, since 
the latter must remain nonnegative. However, in doing so, the summary index no longer 
accurately reflects the observed disparities in the population, since, by excluding the better 
rates, it necessarily underestimates the average disparity. For this reason, summary indices 
are not calculated for objectives where at least one group is identi ied with a sma    etter “b” 
for a given characteristic. The corresponding cell in the Health Disparities Table is shaded in 
light gray to indicate that data are not available to accurately compute the summary index. 
The statistical significance of a change in the summary index over time is assessed when 
standard errors for the rates on which the summary index is based are available. The 
magnitude and direction of changes are indicated by arrow symbols as described above. 
When standard errors are not available for the rates on which the summary index is based, 
changes are classified by size and direction without regard to statistical significance. 
To obtain a standard error for the summary index, a type o  resamp ing or “bootstrap” 
procedure is employed [23]. This procedure uses the rate and standard error for each group 
to reestimate each group rate 25,000 times assuming a random normal distribution. Based 
on these group rates, 25,000 estimates of the summary index of disparity are generated, and 
the distribution of these estimates is used to estimate the standard error of the summary 
index. 
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The bootstrap procedure is used to estimate standard errors for the summary index at the 
most recent time and at baseline, in order to determine whether a change in the summary 
index over time is statistically significant. A Z test for the change in the summary index can 
be computed as follows: 
   
         
√      
         
 
   
where ID1 is the summary index at the most recent time point, ID0 is the summary index at 
baseline, SEID,1 is the standard error of the summary index at the most recent time point, 
and SEPD,0 is the standard error of the summary index at baseline. 
Because the value of the index could either increase or decrease, a two-tailed test is 
employed to assess statistical significance: a value of |Z| ≥      indicates that the change in 
the summary index is statistically significant at the 0.05 level. 
 
Estimates of Variability 
Estimates of variability (standard errors) are available for most of the population-based 
objectives in Healthy People 2010. When standard errors are available, they can be 
employed to assess the reliability of the best group rate as described above. This 
assessment is performed to ensure that the group chosen as the reference point is 
reasonably stable. Standard errors also are used to perform the tests of statistical 
significance described above. Generally speaking, these tests guard against the possibility 
that observed disparities or changes in disparities occur because of sampling error or other 
random sources of error. 
When measures of variability are not available, the stability of best group rates is not 
assessed, and statistical significance of disparities and changes in disparities could not be 
tested. For such objectives, there is no quantifiable assurance that observed disparities and 
changes in disparities are not due to sampling error or other random sources of error. For 
such objectives, the reader is urged to exercise caution in interpreting disparities findings. 
In the Health Disparities Table, objectives based on data for which estimates of variability 
are available and those for which estimates of variability are not available are designated by 
footnotes following the short description of each objective. These footnotes are as follows: 
*  Measures of variability were available. Thus, the variability of best group rates 
was assessed, and statistical significance was tested. Disparities of 10% or more 
are displayed when the differences from the best group rate are statistically 
significant at the 0.05 level. Changes in disparities over time are indicated by 
arrows when the changes are greater than or equal to 10 percentage points and 
are statistically significant at the 0.05 level. See Technical Appendix. 
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†  Measures of variability were not available. Thus, the variability of best group rates 
was not assessed, and statistical significance could not be tested. Nonetheless, 
disparities and changes in disparities over time are displayed according to their 
magnitude. See Technical Appendix. 
 
‡  Measures of variability were available only for the most recent data. Thus, the 
variability of best group rates was assessed only for the most recent data, and 
statistical significance was tested only for the most recent data. Disparities of 10% 
or more are displayed when the differences from the best group rate are 
statistically significant at the 0.05 level. Changes in disparities over time are 
displayed according to their magnitude, since measures of variability were not 
available at baseline and therefore statistical significance of changes in disparity 
could not be tested. See Technical Appendix. 
If a footnote applies to all objectives in a particular Health Disparities Table, then it is added 
to the notes and no footnote is inserted. 
 
Mapping 
When data are available at the sub-national level, selected objectives are mapped to display 
spatial variation in percents, rates, or counts. Sub-national data is presented either at the 
state or Health Service Area (HSA) level. HSAs are de ined as “…one or more counties that 
are relatively self-contained with respect to the provision of routine hospital care” [24]. 
HSAs are contiguous but may span state boundaries. They frequently contain more than one 
county with an average of four and maximum of 20 counties. The current HSA classification 
system is based on the presence of at least one hospital in the HSA and patterns of travel 
between counties. 
Maps are presented as simple chloropleths and use either a Jenks or modified Jenks 
classification [25]. A Jenks classification is a way to group ordered data in such a way that 
within group variance is minimized and between group variance is maximized. When 
geographic units (states or HSAs) have values that met the Healthy People 2010 target, the 
classification is modified by manually setting the best (lowest for objectives that seek to 
reduce events and highest for objectives that seek to increase events) cut-point to the 
Healthy People 2010 target. In some instances where the number of geographic units 
meeting the target is large a cut-point in the middle of the distribution is set to the target. 
The Jenks classification is an iterative process whereby an arbitrary number of classes are 
created from an ordered set of data. For most maps presented here the default number of 
classes is five. The process proceeds by calculating the sum of the squared deviations 
between classes (SDBC), calculating the sum of squared deviations from the array mean 
(SDAM), subtract the SDBC from SDAM giving the squared deviation from class means 
(SDCM). Observations are iteratively moved from classes with larger SDBC to those with 
smaller SBDC until all SBDC are minimized. 
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Mapping was done using ArcGIS ArcMap [26]. Maps are presented using a North American 
conic equidistant projection based on the 1983 North America geographic coordinate 
system. The states of Alaska and Hawaii retain these attributes but are not shown to scale or 
correct location, and were placed independently for greater ease of interpretation. 
 
DATA2010 
DATA2010 is an online, searchable database that contains baseline data, tracking data, and 
targets for all measurable objectives in Healthy People 2010 [4]. The database has been 
updated throughout the decade, generally quarterly, to provide the most accurate and up-
to-date data for tracking Healthy People 2010 objectives. 
DATA2010 allows users to search the database for estimates by Focus Area, objective, data 
source, and keyword. In addition, users can access Healthy People 2010 Final Review data 
by downloading designated standard or statistical data spreadsheets in Excel format by 
Focus Area, accessible from http://wonder.cdc.gov/data2010/ftpselec.htm. Standard 
spreadsheets contain rounded estimates, whereas statistical spreadsheets contain rounded 
data as well as unrounded data and standard errors (both rounded to one decimal place), 
when available. 
All of the data used to produce the Final Review Progress Charts and Disparity Tables are 
reflected in these static Final Review tables. Calculations on the Progress Charts and 
Disparities Tables are based on standard estimates and their associated unrounded 
standard errors, when available. 
In addition, DATA2010 contains other technical information related to the Healthy People 
2010 objectives, including Operational Definitions for each objective. 
 
General Data Issues 
Tracking Healthy People 2010 is a comprehensive guidebook on the statistics used for 
Healthy People 2010 [14]. It provides detailed information on how the data are derived and 
the major issues affecting the interpretation of the statistics. During the Healthy People 
2010 Final Review, the General Data Issues section, Part A of Tracking Healthy People 2010, 
was updated as a standalone document titled Healthy People 2010: General Data Issues [16]. 
Healthy People 2010: General Data Issues discusses data-related topics that affect multiple 
objectives. Subjects covered include measuring years of healthy life; measuring health 
disparities; population estimates; the Healthy People 2010 population templates, including 
issues related to the revised Federal standards for classifying race and Hispanic origin; 
issues related to target setting and target adjustment; age adjustment, including 
implications of changes in the standard population for age adjustment; the ICD used for 
illness and death classification; state, local, and national data issues; and DATA2010. 
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Tracking Period 
In general, the tracking period for Healthy People 2010 was designed to cover a 10-year 
period. For most data systems, the final data year for Healthy People 2010 was selected to 
coincide with the baseline year used in Healthy People 2020 for those systems, even if more 
recent data were available when the Healthy People 2010 Final Review was being prepared. 
For example, the Healthy People 2010 final data point for most objectives based on data 
from the National Health Interview Survey (NHIS) was 2008, matching the baseline year for 
Healthy People 2020, although 2009 data were available. For objectives that were tracked 
from data sources that are not used in Healthy People 2020, the most recent data available 
were used as the baseline. 
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Appendix B: Published Issues of Healthy People 
Statistical Notes 
This appendix provides a listing of published Healthy People statistical notes.  
Number Title Date 1 Health Status Indicators for the Year 2000 Fall 1991 2 Infant Mortality Winter 1991 3 Health Status Indicators: Definitions and National Data Spring 1992 4 Issues Related to Monitoring the Year 2000 Objectives Summer 1993 5 Revisions to Healthy People 2000 Baselines July 1993 6 Direct Standardization (Age-Adjusted Death Rates) March 1995 7 Years of Healthy Life April 1995 8 Evaluating Public Health Data Systems: A Practical Approach  June 1995 9 Monitoring Air Quality in Healthy People 2000 September 1995 10 Health Status Indicators: Differentials by Race and Hispanic Origin September 1995 11 Operational Definitions for Year 2000 Objectives: Priority Area 20, Immunization and Infectious Diseases February 1997 12 Operational Definitions for Year 2000 Objectives: Priority Area 13, Oral Health May 1997 13 Healthy People 2000 Midcourse Revisions: A Compendium August 1997 14 Operational Definitions for Year 2000 Objectives: Priority Area 14, Maternal and Infant Health December 1997 15 Priority Data Needs: Sources of National, State, and Local-level Data and Data Collection Systems December 1997 16 Operational Definitions for Year 2000 Objectives: Priority Area 6, Mental Health and Mental Disorders February 1998 17 Operational Definitions for Year 2000 Objectives: Priority Area 21, Clinical Preventive Services December 1998 18 Operational Definitions for Year 2000 Objectives: Priority Area 1, Physical Activity and Fitness December 1998 19 Healthy People 2000: An Assessment Based on the Health Status Indicators for the United States and Each State November 2000 20 Age Adjustment Using the 2000 Projected U.S. Population January 2001 21 Summary Measures of Population Health: Methods for Calculating Healthy Life Expectancy August 2001 22 Summary Measures of Population Health: Addressing the First Goal of Healthy People 2010, Improving Health Expectancy September 2001 23 Trends in Racial and Ethnic-Specific Rates for the Health Status Indicators: United States, 1990-98 January 2002 24 Healthy People 2010 Criteria for Data Suppression July 2002 25 Measuring Progress in Healthy People 2010 September 2004 26 Comparing Racial and Ethnic Populations Based on Healthy People 2010 Objectives August 2008  
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Appendix C: Healthy People 2010 Workgroup 
Coordinators and Contributing Members 
1. Access to Quality Health Services 
Workgroup Coordinators 
Anne Dievler, PhD 
Senior Public Health Analyst 
Office of Research and Evaluation 
Health Resources and Services Administration 
Email: adievler@hrsa.gov 
 
Claire A. Weschler, MSEd, CHES. 
Agency for Healthcare Research and Quality 
Center for Primary Care, Prevention, and 
Clinical Partnerships 
Email: claire.kendrick@ahrq.hhs.gov 
 
Contributing Members 
Samara Lorenz, MPA 
(formerly Special Assistant 
Office of Planning, Analysis and Evaluation 
Health Resources and Services 
Administration) 
 
Lenee Simon, MPH 
 (formely Public Health Advisor 
Office of Disease Prevention and Health 
Promotion  
Office of the Assistant Secretary for Health  
U.S. Department of Health and Human 
Services) 
 
2. Arthritis, Osteoporosis, and 
Chronic Back Conditions 
Workgroup Coordinators 
Charles G. Helmick, MD 
Medical Epidemiologist 
Division of Adult and Community Health 
National Center for Chronic Disease 
Prevention and Health Promotion  
Centers for Disease Control and Prevention 
Email: cgh1@cdc.gov 
 
Phil Tonkins 
LCDR, USPHS 
Health Scientist Administrator 
Division of Skin and Rheumatic Diseases 
National Institute of Arthritis and 
Musculoskeletal and Skin Diseases (NIAMS) 
National Institutes of Health (NIH) 
Email: tonkinsw2@mail.nih.gov 
 
Contributing Members 
Joan A. McGowan, PhD 
Director, Division of Musculoskeletal Diseases 
NIAMS, NIH 
One Democracy Plaza, MSC 4872 
Email: joan_mcgowan@nih.gov 
 
James S. Panagis, MD MPH 
CAPT, USPHS 
Director, Orthopaedics Program 
Division of Musculoskeletal Diseases 
National Institute of Arthritis and 
Musculoskeletal and Skin Diseases, NIH, DHHS 
Email: panagisj@mail.nih.gov 
 
Paul A. Scherr, PhD, DSc 
Former workgroup coordinator 
Supervisory Epidemiologist, retired 
Division of Adult and Community Health 
National Center for Chronic Disease 
Prevention and Health Promotion  
Centers for Disease Control and Prevention 
 
Susana A. Serrate-Sztein, MD 
Former workgroup coordinator 
Director, Division of Skin and Rheumatic 
Diseases 
National Institute of Arthritis and 
Musculoskeletal and Skin Diseases (NIAMS) 
National Institutes of Health (NIH) 
Email: szteins@mail.nih.gov 
 
3. Cancer 
Workgroup Coordinators 
Kathy Cronin, PhD 
Mathematical Statistician 
Statistical Research and Applications Branch 
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Division of Cancer Control and Population 
Sciences 
National Cancer Institute 
National Institutes of Health 
Email: cronink@mail.nih.gov 
 
Lisa C. Richardson, MD, MPH 
Associate Director for Science 
Division of Cancer Prevention and Control 
National Center for Chronic Disease 
Prevention and Health Promotion  
Centers for Disease Control and Prevention 
Email: LRichardson@cdc.gov 
 
Martina V. Taylor, MT (ASCP) 
Senior Advisor for Implementation Science 
Office of the Director 
Division of Cancer Control and Population 
Sciences 
National Cancer Institute 
National Institutes of Health 
E-mail: martina.taylor@nih.gov 
 
Contributing Members 
Ralph J. Coates, PhD  
Acting Associate Director for Science 
Public Health Surveillance Program Office, 
OSELS 
Centers for Disease Control & Prevention 
Email: rcoates@cdc.gov  
 
Laurie Cynkin, MHS 
Program Analyst 
Office of the Director 
Division of Cancer Control and Population 
Sciences 
National Cancer Institute 
National Institutes of Health 
E-mail: cynkinl@mail.nih.gov  
 
Jon Kerner, PhD 
(formerly Deputy Director for Research 
Dissemination and Diffusion 
Division of Cancer Control and Population 
Sciences 
National Cancer Institute 
National Institutes of Health) 
 
Cheryl C. Thomas, MPH 
Deputy Associate Director for Science 
Division of Cancer Prevention and Control 
National Center for Chronic Disease 
Prevention and Health Promotion  
Centers for Disease Control and Prevention 
Email: ccthomas@cdc.gov 
 
4. Chronic Kidney Disease 
Workgroup Coordinators 
Lawrence Agodoa, MD, FACP 
Director 
Chronic Kidney Disease and End Stage Renal 
Disease Programs 
Office of Minority Health Research 
Coordination 
National Institute of Diabetes, Digestive and 
Kidney Diseases 
National Institutes of Health 
Email: agodaoL@mail.nih.gov 
 
Paul W. Eggers, PhD 
Program Director for 
Kidney and Urology Epidemiology 
National Institute of Diabetes and 
Digestive and Kidney Diseases  
National Institutes of Health 
Email: eggersp@extra.niddk.nih.gov 
 
Desmond Williams, MD PhD 
Assoc. Branch Chief 
Team Lead for the CDC CKD Initiative 
Epidemiology and Statistic Branch (ESB) 
Division of Diabetes Translation 
NCCDPHP 
Centers for Disease Control & Prevention 
Email: dewilliams@cdc.gov 
 
Contributing Member 
Beth Forrest 
USRDS Coordinating Center 
Email: bforrest@usrds.org 
 
5. Diabetes 
Workgroup Coordinators 
Lawrence Barker, PhD 
Associate Director of Science  
Division of Diabetes Translation 
Centers for Disease Control and Prevention 
Email: LBarker1@cdc.gov 
 
Sanford Garfield, PhD 
Senior Advisor 
Biometry and Behavioral Research Program 
Division of Diabetes, Endocrinology and 
Metabolic Diseases 
National Institute of Diabetes and 
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Digestive and Kidney Diseases  
National Institutes of Health 
Email: garfields@ep.niddk.nih.gov 
 
Edward Gregg, PhD 
Chief, Epidemiology and Statistics Branch  
Division of Diabetes Translation 
Centers for Disease Control and Prevention 
Email: EGregg@cdc.gov 
 
6. Disability and Secondary 
Conditions 
Workgroup Coordinators 
Donald Betts, MPA 
Deputy Director 
Division of Human Development and 
Disability 
National Center on Birth Defects and 
Developmental Disabilities 
Centers for Disease Control and Prevention 
Email: dbetts@cdc.gov 
 
David Keer, MA 
Program Manager 
National Institute on Disability and 
Rehabilitation Research 
U.S. Department of Education 
Email: david.keer@ed.gov 
 
Monica M. Manns  
Public Health Analyst  
Office of Policy, Planning and Evaluation  
National Center on Birth Defects and  
Developmental Disabilities  
Centers for Disease Control and Prevention  
E-mail: mmanns@cdc.gov  
 
Louis Quatrano, PhD 
Program Director, BSRE, NCMRR 
Eunice Kennedy Shriver National Institute of 
Child Health and Human Development 
National Institutes of Health 
Email: quatranol@mail.nih.gov 
 
7. Educational and Community-Based 
Programs 
Workgroup Coordinators 
Chandak Ghosh, MD, MPH 
Medical Consultant for Federal Policy 
Office of Regional Operations 
Health Resources and Services Administration 
E-mail: cghosh@hrsa.gov 
 
Audrey Williams 
Public Health Advisor 
Division of Adult and Community Health 
Centers for Disease Control and Prevention 
Email: akwilliams@cdc.gov 
 
8. Environmental Health 
Workgroup Coordinators 
Whitney Neal, MSPH 
Health Scientist 
NCEH/ATSDR Office of Science 
Centers for Disease Control and Prevention / 
Agency for Toxic Substances and Disease 
Registry 
Email: WNeal@cdc.gov 
 
Radha Pennotti, MPH  
Public Health Analyst 
NCEH/ATSDR Office of Policy Planning and 
Evaluation 
Centers for Disease Control and Prevention / 
Agency for Toxic Substances and Disease 
Registry 
Email: RPennotti@cdc.gov 
 
9. Family Planning 
Workgroup Coordinators 
Vanessa A. White, MPH 
Public Health Advisor 
Office of Family Planning 
Office of Population Affairs 
U.S. Department of Health and Human 
Services 
Email: vanessa.white@hhs.gov 
 
Contributing Members 
Evelyn Kappeler (former coordinator) 
Acting Director 
Office of Adolescent Health 
Office of the Assistant Secretary for Health 
(ASH) 
U.S. Department of Health and Human 
Services 
evelyn.kappeler@hhs.gov 
 
Amy Margolis, MPH, CHES (former 
coordinator) 
Public Health Analyst 
Office of Adolescent Health 
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Office of the Assistant Secretary for Health 
(ASH) U.S. Department of Health and Human 
Services 
amy.margolis@hhs.gov 
 
Susan Moskosky, MS, RNC 
Director 
Office of Family Planning 
Office of Population Affairs 
Office of the Assistant Secretary for Health 
U.S. Department of Health and Human 
Services 
susan.moskosky@hhs.gov 
 
Gladys Martinez 
Statistician 
National Center for Health Statistics 
Centers for Disease Control and Prevention 
gmm7@CDC.GOV 
 
William Mosher 
Statistician 
National Center for Health Statistics 
Centers for Disease Control and Prevention 
wdm1@CDC.GOV 
 
Stephanie Ventura 
Chief, Reproductive Statistics Branch 
National Center for Health Statistics 
Centers for Disease Control and Prevention 
sjv1@CDC.GOV 
 
10. Food Safety 
Workgroup Coordinators 
Elisa L. Elliot, PhD 
Microbiologist 
FDA, Center for Food Safety and Applied 
Nutrition 
OFDCER, Emergency Coordination and 
Response Team HFS-15 
Email: elisa.elliot@fda.hhs.gov 
 
Delila Parham, DVM 
Chief, Zoonoses and Food Hazards 
Surveillance Branch 
Applied Epidemiology Division 
Office of Public Health Science 
Food Safety and Inspection Service 
U.S. Department of Agriculture 
Aerospace Center 
Email: delila.parham@fsis.usda.gov 
 
11. Health Communication 
Workgroup Coordinators 
Cynthia Baur, PhD 
Senior Advisor, Health Literacy 
Office of the Associate Director for 
Communication 
Centers for Disease Control and Prevention 
Email: cbaur@cdc.gov 
 
Linda Harris, PhD 
Public Health Advisor 
Team Lead Health Communication and 
eHealth  
Office of Disease Prevention and Health 
Promotion 
Email: Linda.Harris@hhs.gov 
 
12. Heart Disease and Stroke 
Workgroup Coordinators 
Yuling Hong, MD, PhD 
Associate Director for Science 
Division for Heart Disease and Stroke 
Prevention 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: yhong@cdc.gov 
 
Fleetwood Loustalot, PhD 
Commission Corps Officer 
Division for Heart Disease and Stroke 
Prevention 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: hgn1@cdc.gov 
 
Joylene John-Sowah, MD, MPH 
Medical Officer 
Division for the Application of Research 
Discoveries 
National Heart and Lung and Blood Institute 
National Institutes of Health 
E-mail: johnsowahj@mail.nih.gov 
 
Contributing Members 
James I. Cleeman, MD 
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Senior Medical Officer 
Center for Quality Improvement and Patient 
Safety 
Agency for Healthcare Research and Quality 
E-mail: james.cleeman@ahrq.gov 
 
Kurt Greenlund, PhD  
Senior Epidemiologist  
Division for Heart Disease and  
Stroke Prevention  
National Center for Chronic Disease  
and Health Promotion  
Centers for Disease Control and Prevention  
E-mail: keg9@cdc.gov  
 
Robinson Fulwood, PhD, MSPH. 
Former workgroup coordinator, 
Acting Deputy Director, retired  
Division for the Application of Research 
Discoveries 
National Heart and Lung and Blood Institute 
National Institutes of Health 
 
Nora Keenan, PhD 
Former workgroup coordinator  
Epidemiologist, retired 
Division for Heart Disease and Stroke 
Prevention 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
 
Darwin Labarthe, MD, MPH, PhD 
Former workgroup coordinator 
Director, retired 
Division for Heart Disease and Stroke 
Prevention 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
 
Paul A. Scott, PhD 
Director 
Office of Science Policy and Planning 
National Institute of Neurological Disorders 
and Stroke 
National Institutes of Health 
Email: scottp@ninds.nih.gov 
 
13. HIV 
Workgroup Coordinators 
J. Stan Lehman, MPH 
Epidemiologist 
Office of Policy and Planning 
Division of HIV/AIDS Prevention 
Centers for Disease Control and Prevention 
Email: slehman@cdc.gov 
 
Pamela Wilson, MSW, LCSW-C 
Division of Science and Policy 
Policy Development Branch 
HIV/AIDS Bureau 
Health Resources and Services Administration 
Email: pwilson@hrsa.gov 
 
14. Immunization and Infectious 
Diseases 
Workgroup Coordinators 
Rebecca Gold, JD 
Policy Analyst 
National Center for Immunization and 
Respiratory Diseases 
Centers for Disease Control and Prevention 
CORP Bldg 12 Room 5401 
MS E05 
E-mail: rgold@cdc.gov 
 
C. Erik Williams 
Office of Program Planning and Policy 
Coordination 
National Center for HIV/AIDS, Viral Hepatitis, 
STD, and TB Prevention 
Coordinating Center for Infectious Diseases 
Centers for Disease Control and Prevention 
Email: gqu2@cdc.gov  
 
Contributing Members 
Bethany Anderson, MPH 
Health Policy Analyst 
Financial Management Office 
Centers for Disease Control and Prevention 
Email: bja3@cdc.gov 
 
Lawrence Barker 
Science Officer 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: lsb8@cdc.gov 
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Achal Bhatt, PhD 
Health Communications Specialist 
National Center for Immunization and 
Respiratory Diseases 
Centers for Disease Control and Prevention 
Email: zvg8@cdc.gov 
 
Shelly Bratton 
Public Health Analyst 
Center for Global Health 
Centers for Disease Control and Prevention 
Email: bwp8@cdc.gov 
 
Jennifer Brooks 
Public Health Analyst 
Office of Public Health Preparedness and 
Response 
Centers for Disease Control and Prevention 
Email: jlc9@cdc.gov 
 
Sandra Cook 
Management and Program Analyst 
Office of Public Health Preparedness and 
Response 
Centers for Disease Control and Prevention 
Email: sbc7@cdc.gov 
 
Jonathan Edwards 
Mathematician Statistician 
National Center for Emerging Zoonotic and 
Infectious Diseases 
Centers for Disease Control and Prevention 
Email: jde3@cdc.gov 
 
Paulette Ford-Knights 
Public Health Analyst 
National Center for Emerging Zoonotic and 
Infectious Diseases 
Centers for Disease Control and Prevention 
Email: pbf7@cdc.gov 
 
Teresa Horan 
Epidemiologist 
National Center for Emerging Zoonotic and 
Infectious Diseases 
Centers for Disease Control and Prevention 
Email: tch1@cdc.gov 
 
Laurie Johnson 
Deputy Director 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: laj1@cdc.gov 
 
Peng-Jun Lu 
Senior Service Fellow 
National Center for Immunization and 
Respiratory Diseases 
Centers for Disease Control and Prevention 
 Email: lhp8@cdc.gov 
 
Karen Mason, MPA 
Public Health Analyst 
National Center for Immunization and 
Respiratory Diseases 
Centers for Disease Control and Prevention 
Email: bbx3@cdc.gov 
 
Nancy Meissonier 
Medical Officer 
National Center for Immunization and 
Respiratory Diseases 
Centers for Disease Control and Prevention 
Email: nar5@cdc.gov 
 
Thomas Navin 
Chief, Surveillance and Epidemiology Branch 
National Center for Emerging Zoonotic and 
Infectious Diseases 
Centers for Disease Control and Prevention 
Email: trn1@cdc.gov 
 
Amy Pulver 
Public Health Analyst 
Office of the Director 
Centers for Disease Control and Prevention 
CDC/Washington 
Email: cex3@cdc.gov 
 
Daniel Riedford 
Associate Director for Policy Planning and 
Exter 
National Center for Hepatitis, HIV and STD 
Prevention 
Centers for Disease Control and Prevention 
Email: dgr0@cdc.gov 
 
Valerie Robison 
Dental Officer 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: vcr6@cdc.gov 
 
Sandra Roush, MT, MPH 
Epidemiologist 
National Center for Immunization and 
Respiratory Diseases 
Centers for Disease Control and Prevention 
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Email: swr1@cdc.gov 
 
James Singleton 
Branch Chief and Epidemiologist 
National Center for Immunization and 
Respiratory Diseases 
Centers for Disease Control and Prevention 
xzs8@cdc.gov 
 
Nicole Smith 
Associate Director for Policy 
Center for Global Health 
Centers for Disease Control and Prevention 
nba8@cdc.gov 
 
Jeremy Sobel 
Medical Officer 
Center for Global Health 
Centers for Disease Control and Prevention 
Email: qzs3@cdc.gov 
 
Carole Stanwyck 
Epidemiologist 
National Center for Immunization and 
Respiratory Diseases 
Centers for Disease Control and Prevention 
Email: cea9@cdc.gov 
 
Shannon Stokley 
Lead Epidemiologist 
National Center for Immunization and 
Respiratory Diseases 
Centers for Disease Control and Prevention 
Email: zma2@cdc.gov 
 
Susan Van Aacken, MSPP 
Public Health Analyst 
National Center for Chronic Disease and 
Public Health Promotion 
Centers for Disease Control and Prevention 
zqi7@cdc.gov 
 
Annemarie Wasley 
Epidemiology 
Center for Global Health 
Centers for Disease Control and Prevention 
Email: acw5@cdc.gov 
 
Cindy Weinbaum 
Medical Officer 
National Center for Emerging Zoonotic and 
Infectious Diseases 
Centers for Disease Control and Prevention 
Email: chw4@cdc.gov 
 
Elizabeth Zell 
Mathematical Statistician 
National Center for Immunization and 
Respiratory Diseases 
Centers for Disease Control and Prevention 
Email: ezr1@cdc.gov 
15. Injury and Violence Prevention 
Workgroup Coordinator 
Arlene Greenspan, DrPH, MPH 
Associate Director for Science 
National Center for Injury Prevention and 
Control 
Centers for Disease Control and Prevention 
Email: aig0@cdc.gov 
 
Contributing Members 
J. Lee Annest, PhD 
Director 
Office of Statistics and Programming  
National Center for Injury Prevention and 
Control 
Centers for Disease Control and Prevention  
Email: lannest@cdc.gov 
 
Mick Ballesteros, PhD 
Deputy Associate Director for Science 
Division of Unintentional Injury Prevention 
National Center for Injury Prevention and 
Control 
Centers for Disease Control and Prevention 
Email: mballesteros@cdc.gov 
 
Tad Haileyesus, MS 
Mathematical Statistician 
Office of Statistics and Programming 
National Center for Injury Prevention and 
Control 
Centers for Disease Control and Prevention 
Email: boq2@cdc.gov 
 
Robin M. Ikeda, MD, MPH (Former workgroup 
coordinator) 
Director  
Office of Noncommunicable Diseases, Injury 
and Environmental Health 
National Center for Injury Prevention and 
Control 
Centers for Disease Control and Prevention 
Email: Rmi0@cdc.gov 
 
Renee L. Johnson, RPT, MSPH 
Epidemiologist 
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Division of Injury Response 
Centers for Disease Control and Prevention  
National Center for Injury Prevention and 
Control  
Email: rjohnson1@cdc.gov 
 
Caryll Rinehart  
Public Health Analyst 
Office of Policy, Planning, and Evaluation 
National Center for Injury Prevention and 
Control 
Centers for Disease Control and Prevention 
Email: cdr6@cdc.gov 
 
George W. Ryan, PhD 
Mathematical Statistician 
Office of Statistics and Programming 
National Center for Injury Prevention and 
Control 
Centers for Disease Control and Prevention 
Email: gyr0@cdc.gov 
 
Thomas R. Simon, PhD  
Deputy Associate Director for Science  
Division of Violence Prevention  
National Center for Injury Prevention and 
Control  
Centers for Disease Control and Prevention  
Email: tsimon@cdc.gov 
 
David A. Sleet, PhD 
Associate Director for Science 
Division of Unintentional Injury Prevention 
National Center for Injury Prevention and 
Control 
Centers for Disease Control and Prevention 
Email: dds6@cdc.gov 
 
Margarette Warner, PhD 
Health Statistician 
Office of Analysis and Epidemiology 
National Center for Health Statistics 
Centers for Disease Control and Prevention 
Email: MWarner@cdc.gov 
 
Li-Hiu Chen, MS, PhD 
Senior Service Fellow 
Office of Analysis and Epidemiology 
National Center for Health Statistics 
Centers for Disease Control and Prevention 
Email: LChen3@cdc.gov 
 
16. Maternal, Infant, and Child Health 
Workgroup Coordinators 
Reem M. Ghandour, DrPH, MPA 
Public Health Analyst, Office of Epidemiology, 
Policy and Evaluation Maternal and Child 
Health Bureau  
Health Resources and Services Administration  
Email rghandour@hrsa.gov 
 
Monica M. Manns  
Public Health Analyst  
Office of Policy, Planning and Evaluation  
National Center on Birth Defects and  
Developmental Disabilities  
Centers for Disease Control and Prevention  
E-mail: mmanns@cdc.gov  
 
Mirna Perez, MA 
Office of the Director, Division of 
Reproductive Health 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: mperezrodriquez@cdc.gov 
 
Contributing Members 
William Byram Clayton 
Public Health Analyst 
Centers for Disease Control and Prevention 
National Center for Chronic Disease 
Prevention and Health Promotion 
Office of the Director, Division of 
Reproductive Health 
Email: Bjc5@cdc.gov 
 
Heather C. Hamner, PhD, MS, MPH 
Health Scientist 
Centers for Disease Control and Prevention 
National Center on Birth Defects and 
Developmental Disabilities 
Division of Birth Defects and Developmental 
Disabilities  
Email: hfc2@cdc.gov 
 
Harriet Jett, JD; MPA  
Division of Reproductive Health; 
Associate Director for Partnership, Program 
Development, Policy, and Evaluation  
National Center for Chronic Disease 
Prevention and Health Promotion  
Centers for Disease Control and Prevention  
Email: hjett@cdc.gov 
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James Kucik, MPH  
Health Scientist 
Centers for Disease Control and Prevention  
National Center on Birth Defects and 
Developmental Disabilities  
Division of Birth Defects and Developmental 
Disabilities 
Email: jkucik@cdc.gov 
 
Cara Mai, MPH  
Public Health Analyst 
Centers for Disease Control and Prevention  
National Center on Birth Defects and 
Developmental Disabilities  
Division of Birth Defects and Developmental 
Disabilities 
Email: cmai@cdc.gov 
 
Kim Van Naarden Braun, Ph.D 
Epidemiologist 
Centers for Disease Control and Prevention  
National Center on Birth Defects and 
Developmental Disabilities  
Division of Birth Defects and Developmental 
Disabilities 
Email: Kvannaardenbraun@cdc.gov 
 
Joe Mulinare, MD, MSPH 
Medical Epidemiologist 
Centers for Disease Control and Prevention 
National Center on Birth Defects and 
Developmental Disabilities 
Division of Birth Defects and Developmental 
Disabilities  
Email: jmulinare@cdc.gov 
 
Sarah Tinker, PhD, MPH  
Epidemiologist 
Centers for Disease Control and Prevention  
National Center on Birth Defects and 
Developmental Disabilities  
Division of Birth Defects and Developmental 
Disabilities 
Email: stinker1@cdc.gov 
 
17. Medical Product Safety 
Workgroup Coordinators 
Mary Ghods, RPh 
Pharmacist 
Office of the Center Director - Safe Use 
Initiative 
Center for Drug Evaluation and Research, 
Food and Drug Administration 
Email: Mary.ghods@fda.hhs.gov 
 
Dale Slavin, PhD 
Associate Director of 
Programs/Program/Policy Analyst 
Office of the Center Director - Safe Use 
Initiative 
Center for Drug Evaluation and Research, 
Food and Drug Administration 
Email: dale.slavin@fda.hhs.gov 
 
18. Mental Health and Mental 
Disorders 
Workgroup Coordinators 
Kevin J. Malone 
Public Health Analyst 
Office of Policy Planning and Innovation 
Substance Abuse and Mental Health Services 
Administration 
Department of Health and Human Services 
Email: kevin.malone@samhsa.hhs.gov 
 
19. Nutrition and Overweight 
Workgroup Coordinators 
Nancy T. Crane, MS, MPH, RD 
Expert Regulatory Review Scientist 
Nutrition Programs and Labeling Staff (HFS-
830) 
Office of Nutrition, Labeling and Dietary 
Supplements 
Food and Drug Administration 
Email: nancy.crane@fda.hhs.gov 
 
Deborah A. Galuska, MPH, PhD 
Associate Director for Science 
Division of Nutrition, Physical Activity, and 
Obesity 
Centers for Disease Control 
Email: dgaluska@cdc.gov 
 
Van S. Hubbard, MD, PhD 
Rear Admiral, U.S. Public Health Service (ret.) 
Director  
NIH Division of Nutrition Research 
Coordination 
National Institutes of Health 
Email: hubbardv@mail.nih.gov 
 
Pamela E. Starke-Reed, PhD 
Deputy Director 
Division of Nutrition Research Coordination 
National Institutes of Health 
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Email: starkep@mail.nih.gov 
 
Contributing Members 
Mary E. Cogswell RN, DrPH 
Epidemiologist 
Division of Heart Disease and Stroke 
Prevention 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: MCogswell@cdc.gov 
 
Karen Dalenius, RD, MPH 
Team Lead 
Division of Nutrition, Physical Activity, and 
Obesity 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: KDalenius@cdc.gov 
 
Vincent DeJesus, MS 
Nutritionist 
Nutrition Programs and Labeling Staff  
Office of Nutrition, Labeling and Dietary 
Supplements 
Food and Drug Administration 
Email: vincent.dejesus@fda.hhs.gov  
 
Kevin W. Dodd PhD 
Mathematical Statistician 
Division of Cancer Prevention 
National Cancer Institute 
National Institutes of Health 
E-mail doddk@mail.nih.gov  
 
Joseph D. Goldman MA 
Mathematical Statistician 
Food Surveys Research Group 
Agricultural Research Service 
U.S. Department of Agriculture 
E-mail joe.goldman@ars.usda.gov  
 
Laurence Grummer-Strawn, PhD 
Branch Chief 
Division of Nutrition, Physical Activity, and 
Obesity 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: LGrummer-Strawn@cdc.gov 
 
Anne C. Looker PhD 
Distinguished Consultant 
Office of Surveillance, Epidemiology and 
Laboratory Services 
National Center for Health Statistics 
Centers for Disease Control and Prevention 
Email: ALooker@cdc.gov 
 
Zuguo Mei, MD, MPH 
Epidemiologist 
Division of Nutrition, Physical Activity, and 
Obesity 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: ZMei@cdc.gov 
 
 
Crystal McDade-Ngutter, PhD 
Health Program Specialist 
Division of Nutrition Research Coordination 
National Institutes of Health 
e-mail: mcdadengutterc@mail.nih.gov 
 
Mark Nord, PhD 
Sociologist 
Food Assistance Branch, Food Economics 
Division 
Economic Research Service 
U.S. Department of Agriculture 
E-mail marknord@ers.usda.gov 
 
Christine Pfeiffer, PhD 
Supervisory Research Chemist 
Division of Laboratory Sciences 
National Center for Environmental Health 
Centers for Disease Control and Prevention 
Email: CPfeiffer@cdc.gov 
 
Barbara O. Schneeman, PhD 
Director 
Office of Nutrition, Labeling and Dietary 
Supplements 
Food and Drug Administration 
Email: barbara.schneeman@fda.hhs.gov  
 
Bettylou Sherry, PhD 
Team Lead 
Division of Nutrition, Physical Activity, and 
Obesity 
National Center for Chronic Disease 
Prevention and Health Promotion 
Centers for Disease Control and Prevention 
Email: BSherry@cdc.gov 
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20. Occupational Safety and Health 
Workgroup Coordinators 
Jessica Bilics, MPH 
Public Health Analyst 
Office of the Director 
National Institute for Occupational Safety and 
Health 
Centers for Disease Control and Prevention 
Email: JBilics@cdc.gov 
 
Lore Jackson Lee, MPH 
Public Health Analyst 
Office of the Director 
National Institute for Occupational Safety and 
Health 
Centers for Disease Control and Prevention 
Email: LJAcksonLee@cdc.gov 
 
21. Oral Health 
Workgroup Coordinators 
Patrick Blahut, DDS, MPH, Diplomate ABDPH 
Deputy Director, Division of Oral Health, 
Indian Health Service 
801 Thompson Ave., Rockville MD 20852 
301-443-4323 (office) 
301-256-7448 (cell) 
patrick.blahut@ihs.gov 
 
Amit Chattopadhyay 
Office of Science Policy Analysis 
NIH, National Institute of Dental and 
Craniofacial Research 
Email: chattopadhyaya@nidcr.nih.gov  
 
Janet E. Leigh BDS, DMD, 
Senior Dental Advisor 
Office of Strategic Priorities, Office of Special 
Health Affairs, HRSA 
E-mail: jleigh@hrsa.gov 
  
Hyewon Lee, DMD  
Dental Consultant 
Office of Strategic Priorities, Office of Special 
Health Affairs, HRSA 
Email: hlee@hrsa.gov 
 
Gina Thornton-Evans, DDS, MPH 
Dental Officer 
Surveillance, Investigations and Research 
Team 
Centers for Disease Control and Prevention, 
National Center for Chronic Disease 
Prevention and Health Promotion,  
Division of Oral Health 
Email: gdt4@cdc.gov 
 
Contributing Member 
Bruce A. Dye, DDS, MPH 
USPHS Dental Epidemiology Officer 
Centers for Disease Control and Prevention 
National Center for Health Statistics 
Division of Health and Nutrition Examination 
Statistics 
Email bfd1@cdc.gov 
 
22. Physical Activity and Fitness 
Workgroup Coordinators 
Janet Fulton 
Epidemiologist 
NCCDPHP/DNPAO/PAHB 
Centers for Disease Control and Prevention 
Email: janet.fulton@cdc.hhs.gov 
 
Jane Wargo 
Program Analyst 
President’s Council on Sports, Fitness and 
Nutrition 
Email: jane.wargo@hhs.gov 
 
Contributing Members 
Sandra Ham (Former workgroup lead)  
Health Statistician 
Physical Activity and Health Branch 
Division of Nutrition, Physical Activity, and 
Obesity 
Centers for Disease Control and Prevention 
 
Christine G. Spain 
(Former workgroup lead – retired  
Director) 
Research, Planning, and Special Projects 
President's Council on Physical Fitness and 
Sports 
 
23. Public Health Infrastructure 
Workgroup Coordinators 
Liza Corso 
Acting Branch Chief 
Agency and Systems Improvement Branch 
Division of Public Health Performance 
Improvement 
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Office of State, Tribal, Local, and Territorial 
Support 
Centers for Disease Control and Prevention 
Email: Lcorso@cdc.gov 
 
Emily DeCoster, MPH 
Healthy People Workgroup Coordinator  
Health Resources and Services Administration 
Office of Research and Evaluation 
Office of Planning, Analysis and Evaluation 
Email: edecoster@hrsa.gov 
 
Contributing Members 
Stephanie Bailey, MD (retired) 
Centers for Disease Control and Prevention 
 
Beverly Helene Smith, MHS, R.R.T. 
Grants Management Specialist/ Public Health 
Analyst 
Health Resources and Services Administration 
Office of Federal Assistance Management  
Division of Grants Management Operations 
Health Services Branch 
Email: bsmith@hrsa.gov 
 
24. Respiratory Diseases 
Workgroup Coordinators 
Joylene John-Sowah, MD, MPH 
Medical Officer 
Division for the Application of Research 
Discoveries National Heart Lung and Blood 
Institute  
National Institutes of Health  
Email: johnsowahj@mail.nih.gov 
 
Jeanne Moorman, MS 
Survey Statistician 
Air Pollution and Respiratory Health Branch 
National Center for Environmental Health 
Centers for Disease Control and Prevention 
Email: zva9@cdc.gov 
 
Contributing Members 
Lara Akinbami, MD 
CDR, USPHS 
Medical Officer III 
Office of Analysis and Epidemiology 
National Center for Health Statistics 
Centers for Disease Control and Prevention 
Email: LAkinbami@cdc.gov 
 
M. Beth Benedict, DrPH, JD (retired) 
Social Science Research Analyst  
Division of State Program Research  
Research and Evaluation Group  
Office of Research, Development and 
Information  
Centers for Medicare & Medicaid Services  
Email: beth.benedict@cms.hhs.gov  
 
Charles F. Dillon, MD, PhD, MPH 
Medical Research Officer 
Division of Health and Nutrition Examination 
Statistics  
National Center for Health Statistics 
Centers for Disease Control and Prevention 
Email: cid2@cdc.gov 
 
Robinson Fulwood, PhD, MSPH. (former 
colead, retired) 
Acting Deputy Director  
Division for the Application of Research 
Discoveries 
National Heart and Lung and Blood Institute 
National Institutes of Health 
 
Peter J. Gergen, MD, MPH 
Division of Allergy, Immunology and 
Transplantation 
Asthma, Allergy, and Inflammation Branch 
National Institute of Allergy and Infectious 
Diseases 
National Institutes of Health 
Email: pgergen@niaid.nih.gov 
 
Jeanette Guyton-Krishnan, PhD (former 
colead) 
Acting Lead, Community Strategies Team 
Office of Disease Prevention and Health 
Promotion/OASH/OS 
Email: Jeanette.Guyton-Krishnan@hhs.gov 
 
William Jirles, MPH 
Program Analyst 
Office of Policy, Planning, and Evaluation 
National Institute of Environmental Health 
Sciences 
National Institutes of Health 
Email: jirles@niehs.nih.gov 
 
Elizabeth Lancet 
Assistant Vice President, Research 
American Lung Association 
Email: elancet@lungusa.org 
 
Daniel S. Lewin, PhD, D.ABSM 
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Program Director 
Sleep Disorders Medicine Program 
National Center on Sleep Disorders Research  
Division of Lung Diseases  
National Heart Lung and Blood Institute  
National Institutes of Health  
Email: LewinDS@nhlbi.nih.gov 
 
Antonello Punturieri, MD, PhD  
Program Director  
Division of Lung Diseases  
National Heart, Lung, and Blood Institute  
Email: punturieria@nhlbi.nih.gov  
 
Stephen Reed, MD (former colead) 
RADM, USPHS  
Director 
Influenza Coordination Unit 
Office of Infectious Diseases 
Centers for Disease Control and Prevention 
Email: SRedd@cdc.gov  
Diana Schmidt, MPH 
Coordinator, (retired) 
National Asthma Education and Prevention 
Program 
Division for the Application of Research 
Discoveries 
National Heart, Lung, and Blood Institute 
National Institutes of Health 
 
Michael Twery, PhD 
Director 
National Center on Sleep Disorders Research  
Division of Lung Diseases, NHLBI, NIH 
Email: Twery@nih.gov 
 
25. Sexually Transmitted Diseases 
Workgroup Coordinator 
Rachel S. Wynn, MPH  
Office of Policy, Planning, and External 
Relations  
Division of STD Prevention  
National Center for HIV/AIDS, Viral Hepatitis, 
STD and TB Prevention  
Email: rwynn@cdc.gov 
 
Contributing Members 
Hillard Weinstock, MD, MPH 
Medical Epidemiologist  
National Center for HIV/AIDS, Viral Hepatitis, 
STD, and TB Prevention (NCHHSTP) 
Division of STD Prevention 
Centers for Disease Control and Prevention 
HWeinstock@cdc.gov  
 
John Douglas, MD 
Chief Medical Officer 
National Center for HIV/AIDS, Viral Hepatitis, 
STD, and TB Prevention (NCHHSTP)  
Centers for Disease Control and Prevention 
JDouglas@cdc.gov 
 
Stuart Berman, MD, ScM 
Senior Advisor to the Director  
National Center for HIV/AIDS, Viral Hepatitis, 
STD, and TB Prevention (NCHHSTP) 
Division of STD Prevention 
Centers for Disease Control and Prevention 
SBerman@cdc.gov 
 
Amy Pulver, MA, MBA, MA 
Policy Analyst 
Office of the Associate Director For Policy 
Centers for Disease Contol and Prevention 
Washington Office 
Amy.Pulver@cdc.hhs.gov  
 
Jill Wasserman, MPH 
Health Education Specialist 
Department of Health and Human Services 
Office of the Assistant Secretary for Health 
Office on Women's Health  
Jill.Wasserman1@hhs.gov  
 
26. Substance Abuse 
Workgroup Coordinators 
Ralph W. Hingson, ScD, MPH  
Director  
Division of Epidemiology and  
Prevention Research  
National Institute on Alcohol Abuse  
and Alcoholism  
National Institutes of Health  
E-mail: rhingson@mail.nih.gov  
 
Geoffrey Laredo  
Senior Advisor to the Director  
Office of Science Policy and Communications  
National Institute on Drug Abuse  
National Institutes of Health  
E-mail: glaredo@nida.nih.gov  
 
Kevin J. Malone 
Public Health Analyst 
Department of Health and Human Services 
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Substance Abuse and Mental Health Services 
Administration 
Office of Policy, Planning, and Innovation 
Email: kevin.malone@samhsa.hhs.gov 
 
Contributing Members  
Nancy P. Brady 
Special Assistant & 
Public Health Analyst 
Substance Abuse & Mental Health Services 
Administration 
Center for Behavioral Health Statistics & 
Quality 
Nancy.brady@samhsa.hhs.gov 
 
Bennett W. Fletcher, PhD 
CAPT, USPHS 
Senior Research Psychologist 
Services Research Branch 
Division of Epidemiology, Services and 
Prevention Research 
National Instititute on Drug Abuse 
National Institutes of Health 
 
Andrea K. Kamargo, MSW  
Senior Public Health Analyst  
Office of Program Analysis and Coordination  
Substance Abuse and Mental Health  
Services Administration  
E-mail: andrea.kamargo@samhsa.hhs.gov  
 
Nancy J. Kennedy, DrPH 
Senior Public Health Advisor 
Division of Systems Development 
E-mail: nancy.kennedy@samhsa.hhs.gov 
 
Kari Kinnard 
Highway Safety Specialist 
Impaired Driving Division 
NHTSA 
 
Dorothy B. Lewis 
Project Officer HIV/AIDS Team 
Substance Abuse Mental Health Services 
Administration  
Center for Substance Abuse Treatment  
Health Services Branch/Division of Services 
Improvement 
Dorothy.Lewis@samhsa.hhs.gov 
 
Carter A. Roeber, PhD 
Senior Research Associate 
LTG Associates, Inc. 
 
27. Tobacco Use 
Workgroup Coordinators 
Allison MacNeil, MPH 
Health Scientist 
Centers for Disease Control and Prevention 
(CDC) 
National Center for Chronic Disease 
Prevention and Health Promotion 
Office on Smoking and Health 
Email: amacneil@cdc.gov 
 
Gabbi Promoff, MA 
Issues Management Team Lead 
Centers for Disease Control and Prevention 
(CDC) 
National Center for Chronic Disease 
Prevention and Health Promotion 
Office on Smoking and Health 
GPromoff@cdc.gov  
 
Contributing Members 
Ralph Caraballo, PhD 
Epidemiology Branch Chief 
Centers for Disease Control and Prevention 
(CDC) 
National Center for Chronic Disease 
Prevention and Health Promotion 
Office on Smoking and Health 
RCaraballo@cdc.gov  
 
Terry Pechacek, PhD 
Associate Director for Science   
Centers for Disease Control and Prevention 
(CDC) 
National Center for Chronic Disease 
Prevention and Health Promotion 
Office on Smoking and Health 
TPechacek@cdc.gov 
 
Dana Shelton, MPH 
Associate Director for Policy 
Centers for Disease Control and Prevention 
(CDC) 
National Center for Chronic Disease 
Prevention and Health Promotion 
Office on Smoking and Health 
DShelton@cdc.gov 
 
28. Vision and Hearing 
Workgroup Coordinators 
Rosemary Janiszewski, MS, CHES 
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Associate Director for Communication, Health 
Education, and Public Liaison 
National Eye Institute 
National Institutes of Health 
Email: rjaniszewski@nei.nih.gov 
 
Howard J. Hoffman 
Program Director for Epidemiology and 
Statistics 
Division of Scientific Programs 
National Institute on Deafness and Other 
Communication Disorders 
National Institutes of Health 
Email: hoffmanh@nidcd.nih.gov 
 
Lonnie L. Lisle 
Office of Health Communication and Public 
Liaison 
National Institute on Deafness and Other 
Communication Disorders  
National Institutes of Health 
Email: lislel@nidcd.nih.gov 
 
Adolescent Health 
Trina Anglin, MD, PhD 
Chief, Office of Adolescent Health 
Maternal and Child Health Bureau 
Health Resources and Services Administration 
Email: tanglin@hrsa.gov 
 
Cherie Gray, MA 
Public Health Analyst 
Office of the Director 
Division of Adolescent and School Health 
Centers for Disease Control and Prevention 
E-mail: cng2@cdc.gov 
 
Health of Racial/Ethnic Minority 
Populations 
Myrtha Beadle 
Acting Deputy Director 
Office of Public Health Science 
Office of Minority Health 
Email: mbeadle@osophs.dhhs.gov 
 
Women’s Health 
Suzanne Haynes, PhD 
Senior Science Advisor 
PHS Office of Women's Health 
U.S. Department of Health and Human 
Services 
shaynes@osophs.dhhs.gov 
 
Health of People With Disabilities 
Eileen Elias  
Deputy Director  
Office on Disability and Health  
U.S. Department of Health and Human 
Services 
E-mail: eileen.elias@hhs.gov 
 
Appendix D: A Crosswalk Between Objectives From 
Healthy People 2010 to Healthy People 2020
Definition of terms:
▪ Retained “as is” objectives have no change in the numerator definition or in the denominator 
definition between the Healthy People (HP) 2010 and HP2020 objectives. These include objectives 
that were developmental in HP2010 and are developmental in HP2020 and for which no numerator 
information is available.
▪ Modified objectives have some change in the numerator definition or in the denominator 
definition between the HP2010 and HP2020 objectives. These include objectives that went from 
developmental in HP2010 to measurable in HP2020 or vice versa.
▪ Archived objectives had at least one data point in HP2010 but were not carried forward into HP2020.
▪ Dropped objectives were not carried forward into HP2020. These objectives were either 
developmental or deleted at the HP2010 Midcourse Review or at another time in HP2010.
Legend:  
One objective in HP2010 was divided into two or more objectives in HP2020.
Two or more objectives in HP2010 were combined into one objective in HP2020.
HP2020 ObjectivesHP2010
Objectives Retained Modified Archived Dropped
Focus Area 1: Access to Quality Health Services 
1–1 AHS-1.1
1–2 Dropped
1–3a Archived
1–3b Archived
1–3c Archived
1–3d Archived
1–3e Dropped
1–3f Archived
1–3g Dropped
1–3h Archived
1–4a AHS-5.1
1–4b AHS-5.2
AHS-5.31–4c AHS-5.4
1–5 AHS-3
AHS-6.1
AHS-6.21–6 
AHS-6.3
AHS-6.4
1–7a Archived
1–7b Archived
1–7c Archived
1–7d Archived
1–7e Archived
1–7f Archived
1–7g Archived
1–7h Archived
1–8a Archived
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HP2010
Objectives
HP2020 Objectives
Retained Modified Archived Dropped
1–8b Archived
1–8c Archived
1–8d Archived
1–8e Archived
1–8f Archived
1–8g Archived
1–8h Archived
1–8i Archived
1–8j Archived
1–8k Archived
1–8l Archived
1–8m Archived
1–8n Archived
1–8o Archived
1–8p Archived
1–8q Archived
1–8r Archived
1–8s Archived
1–8t Archived
1–9a Archived
1–9b Archived
1–9c Archived
1–10 Archived
1–11a AHS-8.1
1–11b AHS-8.2
1–11c Archived
1–11d Archived
1–11e Archived
1–11f Archived
1–11g Archived
1–12 Archived
1–13a Archived
1–13b Archived
1–13c Archived
1–13d Archived
1–13e Archived
1–13f Archived
1–13g Archived
1–13h Archived
1–13i Archived
1–14a Archived
1–14b Archived
1–15a Archived
1–15b Archived
1–15c Archived
1–15d Archived
1–16 Archived
Focus Area 2: Arthritis, Osteoporosis and Chronic Back Conditions 
2–1 AOCBC-1
2–2 AOCBC-2
2–3 AOCBC-4
2–4a AOCBC-7.1
2–4b AOCBC-7.2
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HP2010
Objectives
HP2020 Objectives
Retained Modified Archived Dropped
2–5a AOCBC-6.1
2–5b AOCBC-6.2
2–6 Archived
2–7 AOCBC-9
2–8 AOCBC-8
2–9 AOCBC-10
2–10 Archived
2–11 AOCBC-12
Focus Area 3: Cancer
3–1 C-1
3–2 C-2
3–3 C-3
3–4 C-4
3–5 C-5
3–6 C-6
3–7 C-7
3–8 C-8
3–9a C-20.5
3–9b C-20.6
3–10a Archived
3–10b Archived
3–10c Archived
3–10d C-18.33–10e 
3–10f C-18.1
3–10g C-18.2
3–10h Archived
3–11a Archived
3–11b C-15
3–12a C-163–12b 
3–13 C-17
3–14 C-12
3–15 C-13
Focus Area 4: Substance Abuse: Chronic Kidney Disease 
4–1 CKD-8
4–2 CKD-14.3CKD-14.5
4–3 CKD-10
4–4 
CKD-11.1
CKD-11.2
CKD-11.3
4–5 CKD-12
4–6 CKD-13.1CKD-13.2
4–7 CKD-9.1CKD-9.2
4–8a CKD-4.1CKD-4.2
4–8b CKD-5
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HP2010
Objectives
HP2020 Objectives
Retained Modified Archived Dropped
Focus Area 5: Diabetes
5–1 D-14
5–2 D-1
5–3 Archived
5–4 D-15
5–5 D-3
5–6 Archived
5–7 Archived
5–8 Dropped
5–9 Dropped
5–10 D-4
5–11 D-12
5–12 D-11
5–13 D-10
5–14 D-9
5–15 D-8
5–16 Archived
5–17 D-13
Focus Area 6: Disability and Secondary Conditions 
6–1 DH-1
6–2 Archived
6–3 DH-18
6–4 DH-13
6–5 DH-17
6–6 Archived
6–7a DH-12.1
6–7b DH-12.2
6–8 DH-16
6–9 DH-14
6–10 DH-8
6–11 DH-10
6–12a 
DH-96–12b 6–12c 
6–12d 
6–13a Archived
6–13b DH-2.4
6–13c DH-2.1
6–13d DH-2.5
6–13e DH-2.2
6–13f DH-2.6
6–13g DH-2.3
6–13h DH-2.7
Focus Area 7: Educational and Community-Based Programs
7–1 ECBP-6
7–2a ECBP-2.1
7–2b ECBP-2.2
7–2c ECBP-2.3
7–2d ECBP-2.4
7–2e ECBP-2.5
7–2f ECBP-2.6
7–2g ECBP-2.7
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7–2h ECBP-2.8
7–2i ECBP-2.9
7–2j Archived
7–3 ECBP-7.1
7–4a ECBP-5.1
7–4b ECBP-5.2
7–4c ECBP-5.3
7–4d ECBP-5.4
7–5a ECBP-8.1
7–5b ECBP-8.2
7–5c ECBP-8.3
7–5d ECBP-5.4
7–5e ECBP-8.5
7–5f ECBP-8.6
7–6 ECBP-9
7–7 Dropped
7–8 Dropped
7–9 Dropped
7–10 
ECBP-10.1
ECBP-10.2
ECBP-10.3
ECBP-10.4
ECBP-10.5
ECBP-10.6
ECBP-10.7
ECBP-10.8
ECBP-10.9
7–11a Dropped
7–11b Dropped
7–11c Archived
7–11d Dropped
7–11e Dropped
7–11f Dropped
7–11g ECBP-11
7–11h Archived
7–11i Archived
7–11j Dropped
7–11k Dropped
7–11l Dropped
7–11m Archived
7–11n Archived
7–11o Archived
7–11p Dropped
7–11q Archived
7–11r Archived
7–11s Archived
7–11t Archived
7–11u Archived
7–11v Archived
7–11w Dropped
7–11x Dropped
7–11y Archived
7–11z Archived
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7–11A Archived
7–11B Dropped
7–12 Archived
Focus Area 8: Environmental Health
8–1a 
EH-1
8–1b 
8–1c 
8–1d 
8–1e 
8–1f 
8–1g 
8–2a EH-2.1
8–2b EH-2.2
8–2c EH-2.3
8–2d EH-2.4
8–3 Archived
8–4 
EH-3.1
EH-3.2
EH-3.3
8–5 EH-4
8–6 EH-5
8–7 EH-6
8–8a Archived
8–8b Archived
8–9 EH-7
8–10a Archived
8–10b Archived
8–11 EH-8.1
8–12a EH-9
8–12b Archived
8–12c Archived
8–12d Archived
8–13 EH-10
8–14a Dropped
8–14b EH-11
8–15 EH-12
8–16a Archived
8–16b Archived
8–16c EH-13.1
8–17 Dropped
8–18 Archived
8–19 EH-14EH-15
8–20 
EH-16.1
EH-16.2
EH-16.3
EH-16.4
EH-16.5
EH-16.6
EH-16.7
EH-16.8
EH-16.9
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8–21 Archived
8–22 
EH-17.1
EH-17.2
EH-17.3
8–23 EH-19
8–24a Dropped
8–24b EH-20.9
8–24c EH-20.10
8–24d Archived
8–25a EH-20.1
8–25b EH-20.2
8–25c EH-20.3
8–25d Dropped
8–25e EH-20.4
8–25f Archived
8–25g Archived
8–25h EH-20.11
8–25i Archived
8–25j EH-20.12EH-20.13
8–25k EH-20.14
8–25l Dropped
8–25m EH-20.6
8–25n Archived
8–25o EH-20.7
8–25p EH-20.8
8–25q EH-20.5
8–25r Archived
8–25s Archived
8–26 EH-21
8–27a EH-22.1
8–27b EH-22.2
8–27c EH-22.3
8–27d EH-22.4
8–27e EH-22.5
8–27f Archived
8–27g EH-22.6
8–27h EH-22.7
8–27i Archived
8–27j Archived
8–27k Archived
8–27l Dropped
8–27m Dropped
8–27n Dropped
8–27o Archived
8–28 Dropped
8–29 EH-24
8–30a Archived
8–30b Archived
8–30c Archived
8–30d Archived
8–30e Archived
8–30f Archived
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8–30g Archived
8–30h Archived
8–30i Archived
8–30j Archived
8–30k Archived
8–30l Archived
Focus Area 9: Family Planning 
9–1 FP-1
9–2 FP-5
9–3 FP-6
9–4 FP-2
9–5 FP-3.2
9–6a Archived
9–6b Archived
9–6c Archived
9–7 FP-8.1 FP-8.2
9–8a FP-9.3
9–8b FP-9.4
9–9a FP-9.1
9–9b FP-9.2
9–10a FP-10.1
9–10b FP-10.2
9–10c FP-11.1
9–10d FP-11.2
9–10e FP-10.3
9–10f FP-10.4
9–10g FP-11.3
9–10h FP-11.4
9–11a FP-12.1
9–11b FP-12.2
9–11c FP-12.3
9–11d FP-12.4
9–11e FP-12.5
9–11f FP-12.6
9–11g FP-12.7
9–11h FP-12.8
9–11i FP-13.1
9–11j FP-13.2
9–11k FP-13.3
9–11l FP-13.4
9–11m FP-13.5
9–11n FP-13.6
9–11o FP-13.7
9–11p FP-13.8
9–12 MICH-17.1MICH-17.2
9–13 FP-4
Focus Area 10: Food Safety 
10–1a FS-1.1
10–1b FS-1.2
10–1c FS-1.3
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10–1d FS-1.4
10–1e Dropped
10–1f FS-1.5
10–1g Dropped
10–2a Archived
10–2b Archived
10–3a FS-3.1
10–3b FS-3.2
10–3c FS-3.3
10–3d FS-3.4
10–3e Dropped
10–3f Dropped
10–3g Dropped
10–3h Dropped
10–3i Dropped
10–3j Dropped
10–3k Dropped
10–3l Dropped
10–3m Dropped
10–3n Dropped
10–3o Dropped
10–3p Dropped
10–4a Dropped
10–4b FS-4
10–5 
FS-5.1
FS-5.2
FS-5.3
FS-5.4
10–6a 
FS-6
10–6b 
10–6c 
10–6d 
10–6e 
10–6f 
10–6g 
10–6h 
10–6i 
10–7 Dropped
Focus Area 11: Health Communication 
11–1 HCHIT-6.1
11–2a Archived
11–2b Archived
11–3a Archived
11–3b Archived
11–3c Archived
11–4a HCHIT-8.1
11–4b HCHIT-8.2
11–4c Archived
11–4d Archived
11–4e Archived
11–4f Archived
11–4g Archived
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11–5 Archived
11–6a HCHIT-2.1
11–6b HCHIT-2.2
11–6c HCHIT-2.3
11–6d HCHIT-2.4
Focus Area 12: Heart Disease and Stroke 
12–1 HDS-2
12–2 
HDS-16.1
HDS-16.2
HDS-16.3
12–3a HDS-19.1
12–3b HDS-19.2
12–4 HDS-1812–5 
12–6a HDS-24.1
12–6b HDS-24.2
12–6c HDS-24.3
12–7 HDS-3
12–8 HDS-17.2
12–9 HDS-5.1
12–10 HDS-12
12–11
HDS-10.1
HDS-10.2
HDS-10.3
HDS-10.4
HDS-10.5
HDS-11
12–12 HDS-4
12–13 HDS-8
12–14 HDS-7
12–15 HDS-6
12–16 HDS-20.1
Focus Area 13: HIV
13–1 HIV-4
13–2 HIV-6
13–3 HIV-7
13–4 Archived
13–5 HIV-1
13–6a HIV-17.1
13–6b HIV-17.2
13–7 HIV-13
13–8 HIV-16
13–9 Dropped
13–10 Dropped
13–11 HIV-15
13–12 Dropped
13–13a 
HIV-10
13–13b 
13–13c 
13–13d 
13–13e 
13–13f 
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13–14 HIV-12
13–15 HIV-9
13–16 HIV-11
13–17a HIV-8.1
13–17b HIV-8.2
13–18 Dropped
Focus Area 14: Immunizations and Infectious Diseases 
14–1a IID-1.1
14–1b Archived
14–1c IID-1.2
14–1d IID-1.3
14–1e IID-1.4
14–1f IID-1.5
14–1g IID-1.6
14–1h IID-1.8
14–1i IID-1.9
14–1j Archived
14–1k IID-1.10
14–2 IID-24
14–3a 
IID-25.114–3b 
14–3c 
14–3d IID-25.2
14–3e Archived
14–3f IID-25.3
14–3g Archived
14–4 Archived
14–5a IID-4.1
14–5b IID-4.2
14–5c IID-4.3
14–5d IID-4.4
14–6 IID-23
14–7 IID-3
14–8 Archived
14–9 IID-26
14–10 Archived
14–11 IID-29
14–12 IID-30
14–13 IID-31
14–14 IID-32
14–15 Dropped
14–16 IID-2
14–17 Archived
14–18 IID-5
14–19 IID-6
14–20a Archived
14–20b HAI-1
14–20c Archived
14–20d Archived
14–20e Archived
14–21 Archived
14–22a IID-7.1
14–22b IID-7.2
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14–22c IID-7.3
14–22d IID-7.4
14–22e IID-7.5
14–22f IID-7.6
14–22g IID-7.7
14–22h IID-12.1
14–23a Archived
14–23b Archived
14–23c Archived
14–23d Archived
14–23e Archived
14–23f IID-10.1
14–23g IID-10.2
14–23h IID-10.3
14–23i IID-10.4
14–23j IID-10.5
14–23k Archived
14–23l Archived
14–24a IID-8
14–24b Dropped
14–25a IID-17.1
14–25b IID-17.2
14–26 IID-18
14–27a Archived
14–27b Archived
14–27c IID-11.1
14–27d IID-11.2
14–28a IID-15.1
14–28b IID-15.2
14–28c IID-15.3
14–29a IID-12.7
14–29b IID-13.1
14–29c IID-12.6
14–29d IID-13.2
14–29e IID-12.8
14–29f IID-13.3
14–29g IID-12.9
14–30a Archived
14–30b Archived
14–31a IID-16
14–31b Archived
Focus Area 15: Injury and Violence Prevention
15–1 IVP-2.2
15–2 IVP-3.2
15–3 IVP-30
15–4 Archived
15–5 IVP-31
15–6 IVP-4
15–7 IVP-10
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15–8 
IVP-9.1
IVP-9.2
IVP-9.3
IVP-9.4
15–9 
IVP-24.1
IVP-24.2
IVP-24.3
15–10 IVP-6
15–11 IVP-7
15–12 IVP-1.3
15–13 IVP-11
15–14 IVP-12
15–15a IVP-13.1
15–15b IVP-13.2
15–16 IVP-18
15–17 IVP-14
15–18 IVP-19
15–19 IVP-15
15–20 
IVP-16.1
IVP-16.2
IVP-16.3
IVP-16.4
15–21 IVP-22
15–22 IVP-17
15–23a Archived
15–23b Archived
15–24 IVP-21
15–25 IVP-28
15–26a Archived
15–26b Archived
15–27 IVP-23.1 IVP-23.2
15–28a AOCBC-11.1
15–28b AOCBC-11.2
15–29 IVP-25
15–30 Archived
15–31a IVP-27.1
15–31b Archived
15–31c IVP-27.2
15–32 IVP-29
15–33a IVP-38
15–33b IVP-37
15–34 IVP-39.1
15–35 IVP-40.1
15–36 IVP-40.2IVP-40.3
15–37 IVP-33
15–38 IVP-34
15–39 IVP-36
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Focus Area 16: Maternal, Infant, and Child Health
16–1a MICH-1.1
16–1b MICH-1.2
16–1c MICH-1.3
16–1d MICH-1.4
16–1e MICH-1.5
16–1f MICH-1.6
16–1g MICH-1.7
16–1h MICH-1.8
16–2a MICH-3.1
16–2b MICH-3.2
16–3a MICH-4.1
16–3b MICH-4.2
16–3c MICH-4.3
16–4 MICH-5
16–5a MICH-6
16–5b Dropped
16–5c Dropped
16–6a MICH-10.1
16–6b MICH-10.2
16–7 MICH-12
16–8 MICH-33
16–9a MICH-7.1
16–9b MICH-7.2
16–10a MICH-8.1
16–10b MICH-8.2
16–11a MICH-9.1
16–11b MICH-9.2MICH-9.3
16–11c MICH-9.4
16–12 MICH-13
16–13 MICH-20
16–14a Archived
16–14b MICH-27
16–14c 
MICH-29.1
MICH-29.2
MICH-29.3
16–14d Dropped
16–15 MICH-28.1MICH-28.2
16–16a MICH-14**
16–16b MICH-15**
16–17a MICH-11.1
16–17b MICH-11.2
16–17c MICH-11.3
16–17d MICH-11.4
16–18 MICH-25
16–19a MICH-21.1
16–19b MICH-21.2
16–19c MICH-21.3
16–19d MICH-21.4
16–19e MICH-21.5
16–20a MICH-32.1
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16–20b MICH-32.2MICH-32.3
16–20c Dropped
16–21 BDBS-7
16–22 MICH-30.2
16–23 MICH-31.1MICH-31.2
Focus Area 17: Medical Product Safety 
17–1a MPS-1
17–1b Dropped
17–2a Archived
17–2b Archived
17–2c Archived
17–2d Archived
17–3 Dropped
17–4 Archived
17–5a Archived
17–5b Archived
17–6 BDBS-17
Focus Area 18: Mental Health and Mental Disorders
18–1 MHMD-1
18–2 MHMD-2
18–3 MHMD-12
18–4 MHMD-8
18–5 MHMD-3
18–6 MHMD-5
18–7 MHMD-6
18–8 MHMD-7
18–9a MHMD-9.1
18–9b MHMD-9.2
18–9c Archived
18–9d Archived
18–10 MHMD-10
18–11 Archived
18–12 Archived
18–13 Archived
18–14 Archived
Focus Area 19: Nutrition and Weight Status
19–1 NWS-8
19–2 NWS-9
19–3a NWS-10.2
19–3b NWS-10.3
19–3c NWS-10.4
19–4 Archived
19–5 NWS-14
19–6 NWS-15.1NWS-15.2
19–7 NWS-16
19–8 NWS-18
19–9 Archived
19–10 NWS-19
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19–11 NWS-20
19–12a NWS-21.1
19–12b NWS-21.2
19–12c NWS-21.3
19–13 Archived
19–14 NWS-22
19–15 Dropped
19–16 NWS-7
19–17 NWS-6.1
19–18 NWS-13*
Focus Area 20: Occupational Safety and Health
20–1a OSH-1.1
20–1b OSH-1.2
20–1c OSH-1.3
20–1d OSH-1.4
20–1e OSH-1.5
20–2a OSH-2.1
20–2b Archived
20–2c Archived
20–2d Archived
20–2e Archived
20–2f Archived
20–2g Archived
20–2h OSH-2.3
20–3 OSH-3
20–4 OSH-4
20–5 OSH-5
20–6 OSH-6
20–7 OSH-7
20–8 OSH-8
20–9 OSH-9
20–10 Archived
20–11 OSH-10
Focus Area 21: Oral Health
21–1a OH-1.1
21–1b OH-1.2
21–1c OH-1.3
21–2a OH-2.1
21–2b OH-2.2
21–2c OH-2.3
21–2d OH-3.1
21–3 OH-4.1
21–4 OH-4.2
21–5a Archived
21–5b OH-5
21–6 OH-6
21–7 OH-14.2
21–8a OH-12.2
21–8b OH-12.3
21–9 OH-13
21–10 OH-7
21–11 Archived
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21–12 OH-8
21–13a OH-9.1
21–13b OH-9.2
21–14 OH-10.1
21–15 OH-15.1OH-15.2
21–16 OH-16
21–17a OH-17.1
21–17b OH-17.2
Focus Area 22: Physical Activity and Fitness
22–1 PA-1
22–2 PA-2.1
22–3 PA-2.2
22–4 PA-2.3
22–5 Archived
22–6 PA-3.1
22–7 PA-3.2
22–8a PA-4.2
22–8b PA-4.3
22–9 PA-5
22–10 Archived
22–11 
PA-8.1
PA-8.2
PA-8.3
22–12 PA-10
22–13 PA-12
22–14a PA-1322–14b 
22–15a PA-1422–15b 
Focus Area 23: Public Health Infrastructure
23–1 Dropped
23–2a Archived
23–2b Dropped
23–2c Archived
23–2d Archived
23–3 Archived
23–4 PHI-7
23–5 Dropped
23–6 PHI-8.3
23–7 PHI-9
23–8a PHI-1.1
23–8b PHI-1.2
23–9 PHI-3
23–10a PHI-2
23–10b PHI-223–10c 
23–11a PHI-14.1
23–11b PHI-14.2
23–11c Archived
23–11d Archived
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23–12a PHI-15.1
23–12b PHI-15.2
23–12c PHI-15.3
23–12d PHI-15.4
23–13a PHI-11.1
23–13b PHI-11.2
23–13c PHI-11.3
23–13d PHI-11.4
23–13e PHI-11.5
23–13f PHI-11.6
23–13g PHI-11.7
23–13h PHI-11.8
23–13i PHI-11.9
23–13j PHI-11.10
23–13k PHI-11.11
23–14a PHI-13.1
23–14b PHI-13.2
23–14c PHI-13.3
23–14d PHI-13.4
23–15a Archived
23–15b Archived
23–16 Dropped
23–17 Dropped
Focus Area 24: Respiratory Diseases
24–1a
RD-1.124–1b 
24–1c 
24–1d RD-1.2
24–1e RD-1.3
24–2a RD-2.1
24–2b RD-2.2
24–2c RD-2.3
24–3a RD-3.1
24–3b RD-3.2
24–3c RD-3.3
24–4 RD-4
24–5 RD-5.1RD-5.2
24–6 RD-6
24–7a RD-7.1
24–7b RD-7.2
24–7c RD-7.3
24–7d RD-7.4
24–7e Archived
24–7f RD-7.5
24–8 RD-8
24–9 RD-9
24–10 RD-10
24–11a SH-1
24–11b Dropped
24–12 SH-2
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Focus Area 25: Sexually Transmitted Diseases
25–1a STD-1.1
25–1b Archived
25–1c Archived
25–1d STD-1.2
25–2a Archived
25–2b STD-6.1
25–3 STD-7
25–4 STD-10
25–5 STD-9
25–6 STD-5
25–7 Archived
25–8 Dropped
25–9 STD-8
25–10 Dropped
25–11a Archived
25–11b Archived
25–11c Archived
25–12 Dropped
25–13 Archived
25–14 Dropped
25–15 Dropped
25–16a STD-4.1STD-4.2
25–16b STD-3.1STD-3.2
25–17 Dropped
25–18 Dropped
25–19 Dropped
Focus Area 26: Substance Abuse
26–1a SA-17
26–1b Dropped
26–1c Dropped
26–1d Dropped
26–2 SA-11
26–3 SA-12
26–4 Archived
26–5 Dropped
26–6 SA-1
26–7 Dropped
26–8a Archived
26–8b Archived
26–9a SA-2.1
26–9b SA-2.2
26–9c SA-2.3
26–9d SA-2.4
26–10a SA-13.1
26–10b SA-13.2
26–10c SA-13.3
26–11a SA-14.1
26–11b SA-14.2
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26–11c SA-14.3
26–11d SA-14.4
26–12 SA-16
26–13a SA-1526–13b 
26–14a SA-18.1
26–14b SA-18.2
26–14c SA-18.3
26–15 SA-21
26–16a SA-3.1
26–16b SA-3.2
26–16c SA-3.3
26–16d SA-3.4
26–16e SA-3.5
26–16f SA-3.6
26–17a SA-4.1
26–17b SA-4.2
26–17c SA-4.3
26–18a SA-8.1
26–18b SA-18.2
26–19 Dropped
26–20 SA-7
26–21 SA-8.3
26–22 Dropped
26–23 Dropped
26–24 Archived
26–25 Archived
Focus Area 27: Tobacco Use
27–1a TU-1.1
27–1b TU-1.2
27–1c TU-1.3
27–1d Dropped
27–2a TU-2.1
27–2b TU-2.2
27–2c TU-2.3
27–2d TU-2.4
27–2e Archived
27–3a TU-3.2
27–3b TU-3.6
27–4a Archived
27–4b Archived
27–5 TU-4.1
27–6 TU-6
27–7 TU-7
27–8a Archived
27–8b TU-8
27–8c Dropped
27–9 Archived
27–10 
TU-11.1
TU-11.2
TU-11.3
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27–11 
TU-15.1
TU-15.2
TU-15.3
TU-15.4
27–12 TU-12
27–13a TU-13.1
27–13b TU-13.2
27–13c TU-13.3
27–13d TU-13.8
27–13e TU-13.6TU-13.7
27–13f Archived
27–13g Dropped
27–13h Dropped
27–13i TU-13.4
27–14a TU-19.1
27–14b TU-19.2
27–15 Archived
27–16a TU-18.1
27–16b TU-18.2
27–17a Archived
27–17b Archived
27–17c Archived
27–18a TU-20.1
27–18b TU-20.2
27–18c TU-20.3
27–19 
TU-16.1
TU-16.2
TU-16.3
27–20a Archived
27–20b Archived
27–20c Archived
27–21a TU-17.1
27–21b TU-17.2
Focus Area 28: Vision and Hearing
28–1 V-4
28–2 V-1
28–3 V-5.1
28–4 V-2
28–5 V-5.2
28–6 V-5.3
28–7 V-5.4
28–8a V-3.1
28–8b V-3.2
28–9a V-6.1
28–9b V-6.2
28–10a V-7.1
28–10b V-7.2
28–11a ENT-VSL-1.1
28–11b ENT-VSL-1.2
28–11c ENT-VSL-1.3
28–12 ENT-VSL-2
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HP2010
Objectives
HP2020 Objectives
Retained Modified Archived Dropped
28–13a ENT-VSL-3.1
28–13b ENT-VSL-3.2
28–13c ENT-VSL-3.3
28–13d ENT-VSL-3.4
28–14a ENT-VSL-4.1
28–14b ENT-VSL-4.2
28–14c ENT-VSL-4.3
28–15 ENT-VSL-5
28–16a ENT-VSL-6.1
28–16b ENT-VSL-6.2
28–17 ENT-VSL-7
28–18 ENT-VSL-8
* Has been changed to the complement (i.e., 100%–’19–18’=’NWS–13’).
** Data for HP2010 are 2-year averages; HP2020 data are 4-year averages.
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Appendix E: Evolution of Healthy People 
Target Year 1990 
 
2000 
 
2010 
 
 
2020 
 
Overarching Goals 
 
 
 
 Decrease mortality: 
infants-adults 
 
 Increase 
independence 
among older adults 
 
 
 Increase span of 
healthy life 
 
 Reduce health 
disparities 
 
 Achieve access to 
preventive services 
for all 
 
 
 
 Increase quality 
and years of 
healthy life 
 
 Eliminate health 
disparities 
 
 
 Attain high-quality, 
longer lives free of 
preventable 
disease, disability, 
injury, and 
premature death 
 Achieve health 
equity; eliminate 
disparities 
 Create social and 
physical 
environments that 
promote good 
health 
 Promote quality of 
life, healthy 
development, 
healthy behaviors 
across life stages 
Number of 
Topic Areas 
 
 
15 
 
 
22 
 
 
28 
 
 
42 
Number of 
Objectives 
 
 
226 
 
 
319 
 
 
969 
 
 
1,200 
 
